cell_line_id,drug_id,response
P31/FUJ,46174525,2.51911302821391
SK-UT-1,445091,4.399813328633606
HOP-92,54765302,4.391270447130891
SW1116,5470400,-2.8803761043427656
NCI-H647,11214940,4.257869480151831
YH-13,44632017,0.8741642499289622
SNU-175,5746,-1.7673707844984643
SCC-25,676352,2.310654015469205
RCH-ACV,6918736,-2.57604272919248
KMH-2,151289,-0.4757556797265575
TCCSUP,16038120,0.8222497592988807
RKO,3025986,-0.6013959236761957
RPMI-8402,51039095,1.754224423001102
NCI-H647,11234052,4.722929365926151
BT 239,54678924,1.3629500523303135
RKO,11625818,4.5581118700811105
HOP-92,3543504,5.174232399616583
BT 245,135875424,2.904149434910518
PC-14,54613361,-0.3915773914647401
Capan-1,11707110,-0.4635141015041703
SIG-M5,11178236,-3.6971916261482143
AML-193,71466578,4.065358334027492
BT 232,135398516,3.3504908057129916
WM793,44632017,4.453745957700664
HGC-27,2708,3.3376859351468258
SK-UT-1,5291,3.873544658482056
KALS-1,135659046,3.8631943181286
HDLM-2,9911463,3.4490026877809674
KU-19-19,selumetinib-vorinostat (8-1 mol-mol),1.3262473417693337
HDLM-2,675434,4.5266182689505365
HGC-27,54596490,4.386231335265865
SIG-M5,5284329,2.633922458082562
PC-14,136227924,3.162840410264972
HOP-92,46224516,2.300932731183138
SUP-T1,3038522,3.081019379233118
YH-13,24772860,-1.8932225377928673
NCI-H1092,24772860,3.2138830329080563
VMRC-LCD,16038120,0.1201993599008201
HDLM-2,4261,0.6816208489275483
KALS-1,5978,-6.370452327707962
RPMI-8402,67156097,-2.2404906947993566
KMS-26,3634881,2.5079456986700066
SUP-T1,5287620,-1.8540778952355033
SK-N-SH,753704,3.7144950614194583
HuH-28,637858,2.0135028750477275
NCI-H647,421610,3.535034080438844
EoL-1,135875424,2.3813180528282416
NCI-H1092,selumetinib-vorinostat (8-1 mol-mol),2.4548144613596885
KYSE-180,3038522,3.921557797457244
BT 239,9825149,-0.3018869297121182
VMRC-LCD,3854666,0.6115412380814026
KYSE-450,44137675,3.8479858767038944
NCI-H647,JQ-1-navitoclax (2-1 mol-mol),0.892372753090758
TCCSUP,5470400,0.0875702939988733
SK-N-SH,285033,-3.510340285209218
BT 232,3689413,-0.4723000491663335
EoL-1,71680916,3.427059907424463
P31/FUJ,11625818,3.2136174191857174
NCI-N87,alisertib-navitoclax (2-1 mol-mol),-1.7331970522410185
IGR-37,52947716,3.107645865330631
NCI-H716,25126798,2.144631423865378
SCC-25,49836020,1.4878182873068626
IGR-37,9927531,5.0345741970674975
AML-193,151289,0.234280169646735
NCI-H2081,44566777,0.9156481361850354
NCI-H647,135659046,3.6743271693589854
L3.3,24785538,3.6784067404983394
KALS-1,73707386,3.625166654480883
SIG-M5,409805,3.8770489658245344
L3.3,3815108,3.6939531026178
AU565,selumetinib-UNC0638 (4-1 mol-mol),4.121266553774429
Capan-1,46843906,1.9939596008652567
BT 232,6436223,-5.3439468690177305
NCI-N87,54613361,-1.4178620324204825
RCM-1 [Human rectal adenocarcinoma],11455910,0.3019920512168372
TCCSUP,23725625,5.945522035236543
MG-63,613753,2.567390275989232
RCC10RGB,navitoclax-MST-312 (1-1 mol-mol),1.0881941253840328
VMRC-LCD,23725625,5.0133103136869295
NCI-H716,JQ-1-navitoclax (2-1 mol-mol),-0.4829888068293631
TCCSUP,107970,2.506866971737107
NCI-H716,46907787,-0.166954561973427
HARA [Human squamous cell lung carcinoma],selumetinib-MK-2206 (8-1 mol-mol),2.6906074312139676
KMS-26,11234052,2.383296789319324
JeKo-1,25102847,1.9902855194665063
SK-UT-1,71751553,5.981983562576585
SK-N-SH,54678924,1.8262940012319235
SK-N-SH,51039095,1.635144290616786
MFE-319,2945648,2.648304151043395
RCC10RGB,11404337,1.763382313076518
RCM-1 [Human rectal adenocarcinoma],11626560,1.948909455015208
SK-MEL-3,3634881,3.8280106842062303
RCC10RGB,11626560,2.6825909392900376
VMRC-LCD,36314,3.0749722596532374
AML-193,40482356,5.132384685555445
P31/FUJ,vorinostat-navitoclax (4-1 mol-mol),-0.3847698718995038
RCC10RGB,9936388,2.3235560801623465
PC-14,445643,4.0648720096321656
MSTO-211H,44819697,0.327886174428457
KU-19-19,2945648,2.475372674219151
MG-63,16741245,5.610815912084649
HT-1197,66577038,3.159361623628899
A3/Kawakami,46943432,-0.8824204154734967
NCI-H1092,vorinostat-navitoclax (4-1 mol-mol),0.5832215278438359
MSTO-211H,44489675,3.600660518296678
HARA [Human squamous cell lung carcinoma],11178236,-2.833191042701781
RPMI-8402,54619238,4.737525032857017
SNU-175,568763,0.2153176031489672
HCC2108,119607,5.317172466903883
AU565,72193861,-0.1764123403705666
BT 232,10184653,2.158436415989401
AML-193,selumetinib-BRD-A02303741 (4-1 mol-mol),0.6927849137400492
MFE-319,tanespimycin-bortezomib (250-1 mol-mol),0.5813484013187771
AU565,3825829,3.6732705699214105
NCI-H1092,24901704,2.360617916449716
RCH-ACV,11647372,-2.009659989634799
SK-UT-1,135398516,5.33568205462979
SCC-25,3062316,-3.181685296937967
HOP-92,54596490,4.357567293340528
A3/Kawakami,1716436,3.761082437930757
BT 232,tanespimycin-gemcitabine (1-1 mol-mol),-1.226190679245739
KU-19-19,73707398,1.7453733414385195
MSTO-211H,25062766,2.0532887481804605
TCCSUP,135411,0.4235399042489139
EHEB,4261,0.2305529532215675
PC-14,159324,4.972641562462416
HDLM-2,73707438,4.365152408260493
NCI-H716,3634881,3.5450288523564684
PC-14,23635314,-2.371895382371369
BT 232,11178236,-5.381107451140038
SW1116,6184667,2.8854186783997755
PC-14,25105715,3.150741396456321
P31/FUJ,2729026,1.895106624580685
HGC-27,50905018,4.400331910364342
HARA [Human squamous cell lung carcinoma],445643,3.755641736641804
HARA [Human squamous cell lung carcinoma],sirolimus-bortezomib (250-1 mol-mol),1.6380791342220933
RCH-ACV,60750,-0.8120802423167262
KMS-26,15953870,2.1274684282642387
VMRC-LCD,1716436,2.860905064789495
EoL-1,54596490,3.971496787644092
SK-MEL-3,5566,2.774402748610496
RCH-ACV,55508,0.7110417134359552
HOP-92,24951314,0.5267439222303741
A3/Kawakami,71680916,4.1548001277649
AML-193,26596,-1.9434141476174296
L3.3,navitoclax-MST-312 (1-1 mol-mol),2.4950782279808656
BEN,selumetinib-MK-2206 (8-1 mol-mol),4.820256549397779
KYSE-450,262093,3.266752988649651
BT 239,navitoclax-sorafenib (1-1 mol-mol),-2.559138174030536
KMH-2,11404337,-1.9075326301634037
HGC-27,5746,1.2385475547692044
P31/FUJ,135928012,4.893710575363991
SUP-T1,5328940,0.7452967988757115
HuH-28,tretinoin-navitoclax (4-1 mol-mol),0.3909303773124833
PC-14,11396600,4.745127634228124
RKO,568763,0.6942409100068829
HGC-27,5287620,-1.80011717241934
RCM-1 [Human rectal adenocarcinoma],135398516,4.64558268257279
SUP-T1,10427712,1.413041066010715
SCC-25,16065773,2.956287784096274
SW1116,5282054,3.6747840983488143
PC-14,26596,-1.584314299248499
KMH-2,322968,1.9273620383949697
SW1116,159324,1.6231393918689625
RPMI-8402,doxorubicin-navitoclax (2-1 mol-mol),-4.077764285874262
NCI-H647,crizotinib-PLX-4032 (2-1 mol-mol),1.2860591026296406
MFE-319,67156097,-0.0203202049461481
KMS-26,1750826,-6.062956606675466
WM793,selumetinib-GDC-0941 (4-1 mol-mol),1.528214563174997
SK-N-SH,322968,2.2846494168874663
HGC-27,2742550,2.8025291770000846
IGR-37,9911463,4.34930148495989
MFE-319,11977753,-2.52646717553838
KYSE-450,446155,3.327914204468242
HDLM-2,6918736,-3.083021740839069
KHM-1B,25195348,3.649934480073114
NCI-H647,11455910,1.3155768042278373
RCC10RGB,16741245,4.755009504271123
BT 428,selumetinib-decitabine (4-1 mol-mol),1.6180700398906596
MSTO-211H,16720766,-0.9979081980160748
RCM-1 [Human rectal adenocarcinoma],24797083,2.1636765251680625
BT 239,24753719,3.429710725233414
HOP-92,15983966,1.752552736614132
KHM-1B,46191454,-0.9954887816979984
HARA [Human squamous cell lung carcinoma],100016,5.315547253627084
EoL-1,11955716,-5.7642968090545885
MFE-319,15983966,-4.193578706114954
SNU-719,5470400,-1.2028104322245674
JeKo-1,44819697,-3.303902560608629
AU565,5328940,1.3384832652905083
KMH-2,124202324,0.6842828421146526
MFE-319,135875424,4.6574477212915015
A3/Kawakami,448949,1.8106255972602463
NCI-H716,107970,2.192898211455521
HuH-28,9903786,2.984330186348554
BT 428,44589607,1.8173716428837667
EoL-1,9823820,-6.592231898014473
VMRC-LCD,23582824,1.797441213587389
SK-UT-1,54678924,1.6137433728432382
NCI-N87,969516,2.8189934287936733
NCI-H2009,46943432,2.8478796444115835
HCC2108,24772860,-2.301082023311665
P31/FUJ,702558,3.294053878414949
SK-N-SH,44202524,2.1384757574415905
Capan-1,46901937,3.7752545515470737
BT 428,11257553,0.3310775523045738
KU-19-19,selumetinib-GDC-0941 (4-1 mol-mol),1.3867335606828617
EoL-1,5280436,0.072344270827452
EoL-1,49766530,-3.8413897802106014
MG-63,selumetinib-piperlongumine (8-1 mol-mol),4.693689347593229
KHM-1B,409805,3.6418621708763945
KYSE-180,56963564,-0.5572024388331268
L3.3,5311281,4.47128753759965
MFE-319,11494412,1.4507368814002106
RCM-1 [Human rectal adenocarcinoma],11640390,3.7299689357319257
RCC10RGB,5287620,-0.3857243809023412
MSTO-211H,9936388,-4.464575449065994
PK-59,11234052,4.666164585144223
MG-63,637858,1.1304564766926708
BT 428,docetaxel-tanespimycin (2-1 mol-mol),-3.547853493396119
KMS-26,448949,1.4550952195558724
SNU-175,31703,-1.448540730863029
RCM-1 [Human rectal adenocarcinoma],23725625,5.154585398323981
EoL-1,2871966,-2.1473410919649014
NCI-H2081,57330099,4.306968967458579
BT 228,31703,-1.1690547377182787
NCI-H1092,4259181,1.0265302606919988
KHM-1B,JQ-1-navitoclax (2-1 mol-mol),-1.1171420900170967
HGC-27,11213558,0.9337899625970632
AML-193,2708,3.1870505459991803
AML-193,3062316,1.9470014263876316
MFE-319,2874250,4.354237263222453
PK-59,9903786,2.9850600541065764
BT 232,285033,0.7702222449833974
RCM-1 [Human rectal adenocarcinoma],4917,3.7649934219972727
SNU-719,439501,-0.6056911297010781
NCI-H716,216345,4.062891636583204
RCC10RGB,UNC0638-navitoclax (1-1 mol-mol),1.9805139183388023
HDLM-2,11152667,-0.0982473466118714
MFE-319,24901704,4.319506451406296
SCC-25,446155,3.4658914017275384
SK-MEL-3,219104,3.978378501273132
WM793,9936388,1.3359302595984517
KMH-2,4259181,-1.7257445215614664
BT 239,11214940,2.8562314629915604
HCC2108,11152667,0.6161783395316693
BT 428,3025986,-0.7916627895218987
SIG-M5,5746,-0.5648104190692045
BT 245,644241,2.053411949495115
SK-BR-3,54618305,4.3856791246446365
SNU-175,637858,-0.1007556152188427
EoL-1,3634881,1.1100701914723798
NCI-H2081,doxorubicin-navitoclax (2-1 mol-mol),-3.331282092417488
HGC-27,11167602,1.8077063625690304
HGC-27,54618164,3.7690202033971416
IGR-37,65064,5.41903349737344
EoL-1,9444,2.9086692641518663
YH-13,16038120,1.3752099545726146
SCC-25,44543605,3.628695028197318
VMRC-LCD,11175137,2.2311240170558104
HDLM-2,JQ-1-navitoclax (2-1 mol-mol),-0.6242082251200336
HGC-27,10113978,2.0227934891809274
L3.3,3081361,5.558675862138055
SK-BR-3,285033,-1.253838708144824
JeKo-1,5287969,-2.4318747624242807
BT 428,54619267,4.122118553601479
HOP-92,6917907,2.930670925019417
RCH-ACV,6918878,-0.3632511703905712
AML-193,9887053,2.7928557450616327
MFE-319,3038522,3.1043688395552818
NCI-N87,73707386,2.4106113659233723
SK-N-SH,702558,5.202803756811596
KU-19-19,4477,-0.0533500132034658
HT-1197,6438330,1.7148370605053564
BT 232,3552672,2.1649562651193444
MFE-319,11364421,-5.534279347846748
IGR-37,60750,-3.537926279301999
RCC10RGB,227681,3.758665689171896
A3/Kawakami,46199207,1.755041565676336
Capan-1,53232,4.830860605240607
KMH-2,piperlongumine-MST-312 (1-1 mol-mol),1.4395715644832294
SUP-T1,31703,-3.702510628199306
BT 232,4917,2.24121274749965
NCI-H647,2749,1.6400034102926475
PC-14,71466380,5.576948071004914
JeKo-1,9887053,3.7322509372114014
TCCSUP,4917,2.9384011746955467
SIG-M5,12003241,-2.3044245068014826
BT 232,51037431,5.349427182034413
IGR-37,selumetinib-navitoclax (8-1 mol-mol),-0.4823759014816776
MSTO-211H,49766530,-4.866552298919663
RCH-ACV,3815108,2.1259817413634976
NCI-H2081,9823820,3.6115894739916414
P31/FUJ,73707398,-0.9687174770786582
SUP-T1,9915743,0.2147589739019727
P31/FUJ,11427553,0.2126015278922564
HT-1197,444795,4.721186439495217
HCC2108,72376,-2.554295384171075
MG-63,9956119,4.726316591943148
KYSE-180,54613361,-0.6142200008025552
RKO,448949,2.722052887717566
AML-193,1566236,0.9779280105236772
BT 228,SNX-2112-bortezomib (250-1 mol-mol),-1.2515355215252697
EHEB,ISOX-bortezomib (250-1 mol-mol),0.0742448904105083
JeKo-1,54639665,4.459417646835938
JeKo-1,navitoclax-pluripotin (1-1 mol-mol),-1.8472662016336163
BT 228,24771867,4.536409167426945
SK-MEL-3,1566236,2.444556915654436
L3.3,54619267,4.657132666629917
PC-14,3025986,-0.7418591282491218
BT 228,54649381,3.7325588856509753
SK-BR-3,9956119,4.0680346704900145
KYSE-450,11364421,0.1587398851119797
SK-MEL-3,54678924,1.5975213191557645
BT 245,135440466,2.1626976795757544
SNU-175,6252,0.7023423829566947
HuH-28,11238147,3.888621805970629
BT 239,44566777,-1.7826828544578817
BT 428,16722836,1.7142885941810502
NCI-H2009,44202524,1.444691297679544
RPMI-8402,55508,1.9385713728996312
RCH-ACV,24797083,1.3648617432845789
BT 239,24964624,2.065857329568735
JeKo-1,56649450,3.577524855747576
SIG-M5,5287969,-2.5539887618915724
SK-UT-1,49867930,6.152644057002921
HARA [Human squamous cell lung carcinoma],11238147,2.905443405294126
KMS-26,carboplatin-UNC0638 (2-1 mol-mol),2.643615695830579
NCI-H2009,168313047,3.1000323585702083
NCI-H2081,5281321,-4.529040765604765
MG-63,3854666,1.0280422807059248
EHEB,6918878,1.3489098367208612
VMRC-LCD,6610355,5.058084641409844
NCI-N87,11455910,1.6652699053284308
BT 232,10231331,3.6027232306656933
KHM-1B,46224516,1.9552041904833992
KYSE-180,selumetinib-UNC0638 (4-1 mol-mol),4.875323970784825
TCCSUP,10385095,1.359914637472657
KYSE-450,54618771,1.2705031609145587
HT-1197,11485656,1.6876827017729057
NCI-H716,216239,0.7487680440057565
KYSE-180,409805,5.709174911109602
NCI-H716,104842,-0.1504012012194223
A3/Kawakami,5287969,-2.5830309830420006
KMS-26,65064,3.1089230956452303
RCH-ACV,25150857,1.971363827125423
KYSE-180,10385095,1.0867111286980162
HCC2108,9911830,2.581322243172156
SNU-719,9926054,1.5286214740335768
BT 232,serdemetan-SCH-529074 (1-1 mol-mol),1.6263041788353885
NCI-H716,5287620,-2.982203263499563
NCI-H647,carboplatin-etoposide (40-17 mol-mol),3.882335936620864
BT 228,24772860,-2.116396582484206
PC-14,piperlongumine-MST-312 (1-1 mol-mol),2.990616335790466
RCH-ACV,9903786,1.555646026251057
JeKo-1,16736978,0.8044347339487026
A3/Kawakami,5566,3.1660065431537614
KMH-2,135984461,4.570908568849745
EoL-1,vorinostat-carboplatin (1-1 mol-mol),1.218009940831794
P31/FUJ,2708,3.1798246734444535
SK-MEL-3,11977753,3.120341239181036
NCI-H1092,6918638,-0.0011423595466388
HT-1197,54626689,4.141422873724605
AML-193,426756,4.374075684035772
L3.3,51037431,2.2305263064792396
AU565,439501,-2.8703859168743384
KYSE-450,72193861,3.11569572197334
HT-1197,135423438,4.472256481601468
SK-BR-3,JQ-1-navitoclax (2-1 mol-mol),2.435531837838617
NCI-H1092,984333,-1.1758296018465422
JeKo-1,445643,3.9418367158423577
SIG-M5,753704,4.127265712911682
HARA [Human squamous cell lung carcinoma],9823820,4.297752192216693
HOP-92,16065773,2.5275698462391185
SNU-175,24901704,0.2546154218045286
BT 245,JQ-1-vorinostat (2-1 mol-mol),1.251473973168844
SNU-719,selumetinib-vorinostat (8-1 mol-mol),0.3154855809643748
HGC-27,71576739,4.3583892657938845
HOP-92,BRD-K55473186,4.134538098469765
SCC-25,6917907,-7.985612103262112
HDLM-2,11404337,-0.3778039113995139
VMRC-LCD,9915743,2.4183813584018616
RPMI-8402,tretinoin-navitoclax (4-1 mol-mol),0.8550833585368602
HuH-28,4917,2.9302529952595138
A3/Kawakami,49793307,-4.567795121400408
SIG-M5,11609586,-0.1594654407384478
SK-BR-3,44607530,0.8406220329719474
SK-UT-1,2729026,3.1641569062038997
KYSE-450,ISOX-bortezomib (250-1 mol-mol),0.3236912354061821
HOP-92,serdemetan-SCH-529074 (1-1 mol-mol),2.297794039930623
SK-MEL-3,60700,1.022706659657428
KMH-2,73707398,0.2398101632779203
SNU-719,637858,2.2997289437945487
RCH-ACV,2708,1.343547840781128
SK-MEL-3,44491742,3.867059457044452
SUP-T1,44607530,1.6746519133262894
HARA [Human squamous cell lung carcinoma],57330099,4.527264318285619
PC-14,11167602,2.3645338141956924
HARA [Human squamous cell lung carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.088944743887487
NCI-N87,11683005,3.6426598339920297
BT 232,208908,1.730438881979907
IGR-37,3136844,4.235582061446334
BT 428,erlotinib-PLX-4032 (2-1 mol-mol),3.2976456828741796
MG-63,9825149,1.5034123864961606
MSTO-211H,4705,2.457156821386339
IGR-37,ISOX-bortezomib (250-1 mol-mol),0.8435356243322174
KHM-1B,selumetinib-JQ-1 (4-1 mol-mol),-1.6661106827496956
HCC2108,46224516,5.492132817641468
HDLM-2,9936388,-6.699544688001925
MFE-319,6917907,-5.250873315750457
SIG-M5,613000,2.549655732249996
RKO,46191454,0.9841477576830012
WM793,5281672,4.440104889072824
AML-193,56649450,3.0160210677610704
NCI-H1092,9967941,1.8935629998367884
MFE-319,135398516,3.4649854096656343
PC-14,46174525,4.355295994323497
SK-MEL-3,navitoclax-birinapant (1-1 mol-mol),3.1980078217532664
BT 239,selumetinib-piperlongumine (8-1 mol-mol),2.485223423406384
PK-59,11683005,3.780619841517865
RCM-1 [Human rectal adenocarcinoma],10410894,5.33973414369723
WM793,24821094,4.44664829967469
SK-UT-1,613753,3.318153471243221
PC-14,tanespimycin-bortezomib (250-1 mol-mol),-0.4303356181915626
Capan-1,16065773,2.4900091452999673
BEN,5311,1.638187816251549
EHEB,11178236,-3.253133430351509
TCCSUP,12001922,1.8065976043630063
HCC2108,100016,5.291323338255078
SK-UT-1,151289,2.928498055248494
WM793,25262965,-0.5623706777584844
AU565,11228183,3.2105327090314133
RCH-ACV,676352,2.3486182752429103
MSTO-211H,107970,1.929708493397844
BT 232,5329102,2.2598247819590314
HuH-28,23725625,4.996899233581609
KMH-2,24771867,-0.8834131311064513
PK-59,3025944,4.881913785381984
RCC10RGB,219104,3.453227771477981
KALS-1,5113032,5.2391459068909745
RCH-ACV,613753,2.594810859173983
BT 232,54649381,4.617404703214
SUP-T1,208908,2.184176309332511
PC-14,400769,-2.2191284270813516
BT 228,tretinoin-carboplatin (2-1 mol-mol),4.781731370267981
SIG-M5,6505803,-0.1487060693646739
HGC-27,54626689,3.6847810571078936
MG-63,676352,1.7263394119133868
SUP-T1,46843906,1.3070180763554708
BT 245,45279963,3.911554370960284
NCI-H2009,452548,-0.9979896146805513
EHEB,107985,-3.431566617096362
EHEB,6914657,-4.098891510643266
NCI-H2081,5282054,2.482146692013313
NCI-H716,44819697,-2.0835694077757605
BT 245,24180125,3.7251003604929167
P31/FUJ,9908783,6.361014450142155
BT 232,60750,5.718674080093584
KYSE-180,25154868,3.555107240815876
YH-13,carboplatin-UNC0638 (2-1 mol-mol),3.6332761748484255
RCC10RGB,46843906,4.246883034106686
RCH-ACV,753704,6.389654405522462
SK-N-SH,44185566,1.7312265634503268
HCC2108,selumetinib-GDC-0941 (4-1 mol-mol),1.612699878393228
RCH-ACV,19582717,2.6016474120833237
NCI-H647,4378219,6.350983381036
KHM-1B,262093,0.9728016968076376
RKO,216239,1.9979551619375524
P31/FUJ,6918878,-0.2487475841908946
A3/Kawakami,5351362,1.0710266929623862
KU-19-19,44493528,4.383684457454455
RKO,387447,-4.452540898932811
EHEB,9907093,3.575019057407179
SK-N-SH,119607,5.930500864805693
PK-59,selumetinib-GDC-0941 (4-1 mol-mol),1.3854215252632525
HT-1197,241158,3.8644992212078617
BT 228,3025986,-0.4318747131820534
P31/FUJ,11485656,1.9746673234827223
HGC-27,54649381,3.670670285859323
HARA [Human squamous cell lung carcinoma],9911830,2.811378702432749
P31/FUJ,selumetinib-JQ-1 (4-1 mol-mol),-1.737174960648273
KYSE-180,16741245,1.8564307397104032
MFE-319,56946209,-0.2111319899638173
AML-193,15983966,1.5600685940554742
SUP-T1,135999136,2.1938595349455885
KYSE-180,25150857,2.8174172252005127
NCI-H716,piperlongumine-MST-312 (1-1 mol-mol),1.241418900994914
WM793,46843906,2.7108569638472666
NCI-H647,6917907,-5.699423210718665
SK-UT-1,vorinostat-carboplatin (1-1 mol-mol),4.302325577715062
EoL-1,6610355,3.310861858756741
EoL-1,123631,-0.0451715381441892
RKO,44491742,4.905526099010324
A3/Kawakami,44486219,3.722344552887859
Capan-1,123631,3.6370491427841807
SNU-719,11609586,3.001704377195206
PC-14,285033,-0.2516082958086743
MSTO-211H,25126798,3.885175037199499
RPMI-8402,9444,3.6707366819511713
HCC2108,44589607,3.0217801905225365
PK-59,11175137,3.384395759818981
KMH-2,JQ-1-UNC0638 (2-1 mol-mol),1.1907602496556098
PC-14,5281321,2.005542943561995
KMH-2,445643,6.18756328874756
HOP-92,54618771,0.6588876018328178
L3.3,11507802,1.6932869737181035
HT-1197,2729026,3.074740900920968
KALS-1,selumetinib-piperlongumine (8-1 mol-mol),3.833556040427386
P31/FUJ,54649500,4.423311343715707
RKO,60700,-0.2024014556335324
BT 228,JQ-1-vorinostat (2-1 mol-mol),1.5914879293048303
HOP-92,44202524,6.082447103554384
BT 239,11609586,0.0821911793800378
RCH-ACV,71304818,3.918287334394859
BT 232,24748573,2.4622180177949136
HDLM-2,6505803,-0.3959336559510797
NCI-H647,5470400,1.806821260258092
WM793,3634881,3.628870809117573
HuH-28,9935249,3.1558005109772376
AML-193,navitoclax-MST-312 (1-1 mol-mol),-0.309250560513518
BT 228,6918638,2.21176132394779
PC-14,168313047,3.256575471584884
PK-59,25062766,2.177609157002552
RCH-ACV,JQ-1-carboplatin (1-1 mol-mol),-0.5668300449210979
L3.3,44486219,4.220339607908531
NCI-H1092,54618164,3.7504442983527104
HARA [Human squamous cell lung carcinoma],erlotinib-PLX-4032 (2-1 mol-mol),3.6972893846800545
HCC2108,4477,-0.2147784559751654
TCCSUP,4096211,2.136030263591951
MSTO-211H,6252,0.7966303392140095
HDLM-2,11238147,2.6008303895462506
IGR-37,23635314,-2.477874441400284
BT 428,82146,3.6863025741457136
MSTO-211H,2708,3.2234156242084073
BT 232,alisertib-navitoclax (2-1 mol-mol),5.507972592464938
SUP-T1,57330099,4.175969235729193
RCH-ACV,23635314,-2.294116925469135
SK-N-SH,alisertib-navitoclax (2-1 mol-mol),-3.2436351951446136
Capan-1,6917907,-5.5096877384277345
KHM-1B,11626560,-0.6143155119678699
KYSE-450,753704,5.119991159407921
BT 428,148198,-5.072102147760655
SIG-M5,241158,3.2994951506114827
AML-193,54678924,1.5597535482502265
RCM-1 [Human rectal adenocarcinoma],675434,4.441344472745021
A3/Kawakami,24978538,3.026022437500325
SUP-T1,9825149,1.534124662764536
SUP-T1,2841722,3.328164782657644
PK-59,53392493,2.658462092997055
RPMI-8402,44185566,1.0018599873294745
KMH-2,9929138,5.036636108742583
PC-14,72193861,0.0281288419645521
SK-MEL-3,46843906,2.837795546766125
RCC10RGB,374536,3.743226525407361
NCI-H716,24771867,-0.0340246669047214
MSTO-211H,54619267,2.133098694540018
NCI-N87,5281672,5.2421020595736145
JeKo-1,4578,4.347079490106182
AU565,4261,1.5351844706992892
RCC10RGB,441298,3.7731685554529384
RCC10RGB,5280436,4.525748645562069
VMRC-LCD,107985,-2.7871276455414273
HuH-28,44491742,4.601953674704061
AU565,44137675,3.533476650788096
HARA [Human squamous cell lung carcinoma],36462,1.692464431977034
IGR-37,445643,3.8809547796511654
KALS-1,5746,2.735470561571794
BT 239,65628,2.367518289741246
NCI-H2009,31703,-0.97323545782719
NCI-H716,25262965,-0.8127039656087446
BT 245,44566777,1.3945602166606237
SK-N-SH,25262965,-0.8648376760859202
SIG-M5,24180125,3.729213633628688
IGR-37,53495165,1.58008376849822
KMH-2,17759555,3.503053967041157
VMRC-LCD,72193861,0.7189495512720293
MFE-319,24180719,4.375964654470909
EoL-1,selumetinib-UNC0638 (4-1 mol-mol),0.0152027038109705
SK-UT-1,54626689,4.825189757508342
VMRC-LCD,241158,4.61265608430858
HuH-28,6852167,2.4785220942658137
SK-BR-3,104842,-5.289337081672255
SCC-25,11234052,4.316651782987715
BT 228,JQ-1-UNC0638 (2-1 mol-mol),3.833257728613677
NCI-H647,4917,3.428415968026914
SCC-25,439501,-2.292727593069412
NCI-H2081,25105715,3.7171475325174703
NCI-H647,selumetinib-vorinostat (8-1 mol-mol),3.465801087956738
KMS-26,46398810,1.8187556511943173
KYSE-180,135411,0.6343145122787996
KYSE-180,24964624,3.1608590023354712
RKO,46843906,3.289277038806309
PC-14,9927531,4.079128694018213
SIG-M5,BRD-A02303741-navitoclax (2-1 mol-mol),2.50174654754019
L3.3,2858523,3.1166554672991604
A3/Kawakami,156414,1.7639181798832415
EoL-1,25161177,-6.177123563272923
NCI-H716,selumetinib-BRD-A02303741 (4-1 mol-mol),2.0513049093415066
SUP-T1,10184653,0.7579222350732797
SNU-175,5351362,0.8262769816122771
SK-BR-3,89183176,4.895426320493529
NCI-N87,42642645,0.5523493290598761
NCI-H716,135423438,0.7002351169719838
MG-63,11214940,1.7497964413119815
A3/Kawakami,navitoclax-PLX-4032 (1-1 mol-mol),3.1478618270233536
AML-193,10113978,2.9410064998360967
RCH-ACV,10302451,2.577047280767927
HCC2108,5311,1.3772121830259485
NCI-H1092,54596558,4.902565947797631
MFE-319,216239,1.621822070370419
KHM-1B,navitoclax-pluripotin (1-1 mol-mol),-0.8283845367813834
WM793,3689413,0.565505634508756
NCI-H2009,3854666,0.912328636385412
SK-N-SH,56946209,-5.044157679345508
BT 228,6438330,0.8842537803258417
RKO,44137675,4.282234128328841
KMS-26,452548,-2.306647372021263
NCI-H716,11455910,0.5118733249267832
NCI-H647,selumetinib-UNC0638 (4-1 mol-mol),4.146167198644584
NCI-H2009,4259181,1.0344432117954978
WM793,36462,4.293096910683363
BT 245,262093,2.3897148405812536
SCC-25,selumetinib-tretinoin (2-1 mol-mol),0.517156611966055
MG-63,16659841,3.062001664054086
A3/Kawakami,5951923,3.834827915789955
NCI-H1092,19582717,5.304024438034291
KALS-1,53495165,0.7468343308117502
P31/FUJ,24785538,-0.2737810661065927
KU-19-19,5280436,3.7375704611092657
NCI-H1092,11234052,4.115847054230737
NCI-N87,3025986,-2.1031012904407818
HOP-92,3503,2.1832457980130093
KYSE-450,6914657,-3.3347468513388994
Capan-1,5281321,0.2489908520100857
PK-59,2708,5.444161268698026
KMS-26,10427712,3.2605131819414477
KYSE-180,439501,-1.6605779697575254
RCM-1 [Human rectal adenocarcinoma],65628,4.3030211924112125
SK-N-SH,9903786,1.912941590488841
MFE-319,9884685,0.756895604366277
BT 228,71466578,4.404461763620343
RCC10RGB,11640390,5.2605770793622275
TCCSUP,5282054,3.8186779909070094
SK-MEL-3,568763,0.9149031186002008
Capan-1,216239,3.2812667812729623
KYSE-180,123631,1.841294475412796
BEN,4261,1.7542037452727506
IGR-37,67156097,-1.55116824504637
SNU-719,6610216,4.511373507313099
NCI-H2081,vorinostat-carboplatin (1-1 mol-mol),1.7925408533831422
YH-13,53495165,2.0012799986886822
NCI-H1092,4261,0.9195387417672236
KMS-26,selumetinib-decitabine (4-1 mol-mol),-1.7896525184747982
BT 428,168312962,2.6972045295653304
MSTO-211H,9956119,3.2798548332341246
P31/FUJ,5311,0.3390662723443479
HARA [Human squamous cell lung carcinoma],selumetinib-UNC0638 (4-1 mol-mol),6.072288250407716
JeKo-1,44607530,1.1368608299874223
HGC-27,carboplatin-etoposide (40-17 mol-mol),1.6252023790934296
KALS-1,6917907,-7.033077427214407
NCI-H716,53325874,4.568442526764025
EoL-1,6917907,-6.411170386866504
RCC10RGB,serdemetan-SCH-529074 (1-1 mol-mol),2.3426493996230424
WM793,135440466,3.4729537866645828
EoL-1,11647372,-0.3781805970083859
SK-MEL-3,5351362,3.249712293835619
HGC-27,10231331,6.356350936699628
AML-193,285033,-4.219165006876047
KYSE-450,24856436,0.9513610633306496
SUP-T1,3081361,2.2670625399453224
KHM-1B,654092,-1.7753167598635085
PC-14,9826308,0.392936157903732
SIG-M5,53495165,-3.008677254413069
EoL-1,53392493,0.540922563323483
SNU-719,decitabine-carboplatin (1-1 mol-mol),6.432606624598396
MFE-319,6918638,0.7924367103155517
BEN,46907787,0.3993513147154109
HGC-27,71466380,4.756891957226841
KALS-1,6610355,4.87178206095567
EoL-1,9840324,5.169153133951751
KMH-2,51037431,3.7952030815775166
BT 232,439501,-1.8419260323239657
P31/FUJ,23635314,-1.6494447832357666
KYSE-180,104842,-0.8703497694822725
SCC-25,136227924,2.958495944269512
BT 239,9907093,3.603271584286786
RPMI-8402,sirolimus-bortezomib (250-1 mol-mol),0.331212001560029
HOP-92,5278396,3.687445030830259
HGC-27,2842253,5.280754099219135
SNU-719,51039095,3.00014222910277
HDLM-2,9967941,4.629655620571264
L3.3,3385,2.739789505554014
RPMI-8402,4096211,0.2807129862919859
SNU-175,24771867,-1.8998752396068417
HT-1197,16741245,2.768505667381288
RCC10RGB,4261,3.441062261939301
KMS-26,3025986,-1.0140680977888408
BT 428,5280436,3.3234949053398912
HT-1197,3854666,2.5073606400565143
L3.3,24964624,2.8332468869362115
YH-13,446155,1.265827677839166
SW1116,107970,1.8262752967373983
SW1116,selumetinib-navitoclax (8-1 mol-mol),2.0727315273172016
NCI-H647,53495165,-0.2019889589752092
HGC-27,navitoclax-PLX-4032 (1-1 mol-mol),1.6601682460916405
EoL-1,54619267,1.8627389475637304
NCI-H647,969516,2.747315327895399
MFE-319,31703,0.4513887291591194
SK-BR-3,5311,0.7568828831902215
SK-N-SH,1242560,3.4327115635231356
SNU-719,216345,1.79974346682559
SNU-719,SNX-2112-bortezomib (250-1 mol-mol),-3.3376258097405382
HOP-92,7326481,2.8278751061318013
BT 428,219104,3.143766971234363
L3.3,9907093,5.18450339753338
KMS-26,656346,-0.2825100782753012
PK-59,6918837,-2.1043378222911464
MSTO-211H,9840324,5.369584805162093
VMRC-LCD,5291,3.960606900439106
WM793,3503,2.6868893579078006
BT 228,9952709,2.424036610534759
BT 428,5978,1.459738910059954
VMRC-LCD,446155,4.703432343183924
BT 428,439501,-3.4900182991978936
KHM-1B,vorinostat-navitoclax (4-1 mol-mol),0.9297533405267338
RCC10RGB,12001922,2.277970650057297
HuH-28,5351362,0.906216113711752
HOP-92,70680404,5.05219645134538
HuH-28,6918328,-0.501538681731036
RCC10RGB,60700,3.171193268028763
NCI-N87,5281321,-1.2852273423113845
KMH-2,4788,3.979356944296041
HCC2108,17755052,3.0973240129693833
RCC10RGB,10184653,2.2305820416370965
NCI-H716,374536,2.3104255721837
MG-63,24785538,1.4917474688307009
TCCSUP,46907787,2.977323633088547
BT 228,44185566,2.26929995489079
HOP-92,6852167,3.546901057497169
KALS-1,2708,4.964455322707892
HT-1197,5284616,2.9161742702527516
BT 245,3676137,5.948892437693733
KALS-1,5328940,2.2946886179774393
KYSE-450,637858,3.2826178661178003
NCI-H2081,25227462,-3.2054871570484114
SK-N-SH,crizotinib-PLX-4032 (2-1 mol-mol),0.6702029646362611
HOP-92,11167602,2.8847454841740108
SIG-M5,462382,1.1999188232329467
BT 239,327653,2.683807943934812
BT 239,16736978,2.0451409590847076
SK-MEL-3,36314,4.014677642072391
SK-N-SH,54618164,3.749880315376081
PK-59,42642645,0.6067807783414038
TCCSUP,219104,4.0410651584060435
VMRC-LCD,6610216,4.359775252992096
RKO,446155,4.170579555483674
HuH-28,46943432,1.6312961638133356
NCI-H716,10231331,0.9999723434962392
HDLM-2,9956119,3.994160385068238
P31/FUJ,151289,0.3376751835645198
HDLM-2,navitoclax-MST-312 (1-1 mol-mol),-0.7361564493970328
PK-59,6852167,1.7961367286330785
MG-63,3552672,3.6308684464698704
RPMI-8402,piperlongumine-MST-312 (1-1 mol-mol),1.574418583034306
SNU-175,11214940,1.2656435961906818
KU-19-19,400769,-0.482585358097733
RCH-ACV,17759555,4.040527244822353
YH-13,6914657,-1.321976768912636
HGC-27,64971,2.4011097142716142
NCI-H647,11707110,4.331001472976579
VMRC-LCD,5328940,1.3270303094388507
KALS-1,44507138,2.574184155002155
RCH-ACV,6918328,-2.893428152942504
HARA [Human squamous cell lung carcinoma],46199207,3.289640650109998
HDLM-2,11228183,-1.5065606659581765
BT 245,19582717,3.826422257929177
RPMI-8402,4259181,-1.5890412699882153
AML-193,44566777,1.0024700964173072
SK-BR-3,60750,-3.681310900863558
WM793,54619267,5.3024181995472635
HOP-92,12003241,-2.2936384439521156
BT 245,3384730,0.4138471294371557
EHEB,5281321,-1.964184492535214
SW1116,3081361,1.1972149531991412
NCI-N87,76446078,4.157863043796239
SIG-M5,9952709,1.3400851864026362
SK-MEL-3,ISOX-bortezomib (250-1 mol-mol),0.3633459233666246
EHEB,5281672,5.758571308107243
SUP-T1,navitoclax-pluripotin (1-1 mol-mol),-2.0797004543419693
KYSE-180,613753,3.360667218558787
IGR-37,5566,3.0225192311529887
RCH-ACV,11719255,2.095514420783027
NCI-N87,5351362,0.9196567139345124
AML-193,445091,3.8551855215033064
WM793,SNX-2112-bortezomib (250-1 mol-mol),-1.3644142128989931
NCI-H1092,10302451,4.171918094429464
HGC-27,53393127,3.376542026788385
TCCSUP,erlotinib-PLX-4032 (2-1 mol-mol),3.460916777406278
RKO,57330099,4.8516025997257275
HDLM-2,5280436,3.575287426199748
BT 239,3543504,3.3608595375555925
KYSE-180,3503,2.347380717343577
KYSE-180,2708,6.074726642360877
WM793,16725315,3.226655824606768
NCI-H716,5281321,-3.244487423337963
HGC-27,4259181,-1.3994815184637035
SK-BR-3,44819697,3.662805287360184
BEN,selumetinib-GDC-0941 (4-1 mol-mol),4.689872875355836
HOP-92,5978,5.276701659850081
HARA [Human squamous cell lung carcinoma],5280436,4.238746998760762
YH-13,5978,-2.977787383275712
YH-13,9911463,4.412003433189975
RCM-1 [Human rectal adenocarcinoma],5280436,3.538296903160907
HARA [Human squamous cell lung carcinoma],3062316,1.9438846554207736
RCH-ACV,285033,-3.897415256578704
JeKo-1,decitabine-navitoclax (2-1 mol-mol),-0.8924587370529753
HuH-28,409805,5.781601088371211
BT 245,5978,-1.7749534353098049
RKO,19582717,4.345992572306107
SUP-T1,10026128,4.303456831196379
RPMI-8402,5566,2.210095325631507
RKO,44607530,2.6096687798301677
NCI-H2009,11178236,-2.605718631753464
RCC10RGB,168312962,4.335962117924443
L3.3,10296883,4.354494828099719
L3.3,36462,1.8942720792997911
KU-19-19,439501,-2.2192304341921205
EHEB,67156097,-1.752576547113972
A3/Kawakami,11485656,1.2537678238706411
RCC10RGB,selumetinib-JQ-1 (4-1 mol-mol),3.398592660488386
SCC-25,9911830,2.7876324164703736
KMS-26,52912189,-2.85243070983681
AML-193,9927531,3.384669993922374
NCI-H2009,6917907,-5.363195379340594
NCI-H647,24753719,4.184864317200406
HGC-27,53325874,4.473624518706666
EHEB,322968,2.810351153697849
RPMI-8402,11214940,0.5720418614822255
HOP-92,11494412,3.5967755894760645
HuH-28,11234052,4.459609875751625
RCM-1 [Human rectal adenocarcinoma],25126798,4.131561769072402
HGC-27,24772860,-2.344763599796839
SK-MEL-3,11485656,2.032350870448147
SCC-25,navitoclax-PLX-4032 (1-1 mol-mol),3.076730064934409
RCH-ACV,15547703,3.0542305736127404
RPMI-8402,9911463,3.009293370203492
AML-193,54626689,3.941845874506918
KHM-1B,6918289,1.9648890084430677
EoL-1,227681,1.6687869803933162
BEN,3025944,4.3802138685452
EHEB,44259,0.6162293307337288
RPMI-8402,71466578,1.8491766960577096
KHM-1B,135999136,4.388497598108013
HOP-92,3038522,2.7867900504057577
SIG-M5,selumetinib-JQ-1 (4-1 mol-mol),-2.937192443891954
NCI-H2081,135440466,3.0899746157429173
KYSE-450,51039095,3.763234499146495
KHM-1B,44491742,4.066156285625521
RKO,445091,4.342692134156949
BEN,25150857,2.5507552812982044
KYSE-450,216345,4.4435224891329
SW1116,JQ-1-MK-0752 (1-1 mol-mol),-0.6001255913717273
KYSE-450,135999136,4.777760732357945
RCM-1 [Human rectal adenocarcinoma],selumetinib-vorinostat (8-1 mol-mol),2.2938712073349152
PK-59,12003241,-0.8874443449539482
SIG-M5,6918878,0.8815480847980426
NCI-H1092,5746,1.1584970745481975
P31/FUJ,JQ-1-vorinostat (2-1 mol-mol),-0.2741289026450685
KU-19-19,12003241,-0.0608702413973226
JeKo-1,135398738,2.011087364730918
EoL-1,11964036,-2.6262251864964976
RCC10RGB,9911830,4.5526597563763795
HARA [Human squamous cell lung carcinoma],4477,-0.0807211341972061
NCI-H2081,135398516,2.933732637162879
PK-59,54649381,3.782815852131327
RCC10RGB,25161177,5.612412997721579
MG-63,crizotinib-PLX-4032 (2-1 mol-mol),1.3463353379809684
TCCSUP,selumetinib-BRD-A02303741 (4-1 mol-mol),5.6777204255641305
NCI-H2009,409805,3.859994247591149
NCI-H716,11707110,-2.9021961297394903
RPMI-8402,637858,1.581832583062169
RCC10RGB,10296883,4.350673741830848
SNU-719,89928392,1.4324927398478458
AML-193,9825149,0.3677124559483302
HDLM-2,3634881,3.6967672592774776
Capan-1,10296883,4.201537501236006
SUP-T1,24772860,-3.5014548125708473
HuH-28,5566,2.9714916691120536
P31/FUJ,168313047,1.7496121138347704
MSTO-211H,2113511,3.4014041807223228
MFE-319,46224516,3.4262240525167336
SK-MEL-3,17755052,3.0587743308059947
EoL-1,44607531,0.8577266269579584
HDLM-2,25154868,4.6602403648554676
BT 228,10184653,1.7267976808067695
WM793,5278396,3.634614455861616
JeKo-1,11626560,1.6079975543202032
SIG-M5,16065773,2.5599027857235996
SIG-M5,11234052,2.1455365718752675
HOP-92,11485656,3.011235199919159
SUP-T1,46215462,0.922103993835428
KYSE-180,1641662,2.753321741973846
NCI-H716,42642645,-2.759309700895452
BEN,16038120,2.300784375710347
KHM-1B,135398738,4.5070735955788255
NCI-H2009,navitoclax-gemcitabine (1-1 mol-mol),0.4354090663504973
BT 239,11238147,3.0762484712678706
HGC-27,445091,4.063670763768332
HOP-92,44507138,1.4251688501267783
AML-193,409805,3.6159664447279583
RCM-1 [Human rectal adenocarcinoma],9866186,0.0174318535432376
NCI-H647,56946209,-5.371764451605231
MG-63,375860,-0.4723696527252595
BEN,5566,2.8029658227308913
EHEB,serdemetan-SCH-529074 (1-1 mol-mol),1.3155569018374509
EoL-1,11364421,-6.889763455330288
KU-19-19,10090485,5.355458016675434
L3.3,12001922,2.4292832661010557
KYSE-450,1716436,4.321900870881558
SIG-M5,tanespimycin-bortezomib (250-1 mol-mol),-0.3458205812117419
TCCSUP,135875424,4.238752084680578
WM793,136227924,4.7819042035619255
P31/FUJ,49766530,-2.577046245506879
HT-1197,16013152,3.860675395835584
TCCSUP,49867926,4.195310139581862
JeKo-1,65064,6.65652451201734
AML-193,5329102,0.9327260014804644
HGC-27,2729026,1.9408315260564617
MG-63,navitoclax-birinapant (1-1 mol-mol),3.4112074346329155
KMS-26,2126,3.690468789794576
WM793,452548,1.1404647506174352
TCCSUP,6917907,-5.896507975955653
HDLM-2,6914657,-4.517606303799425
TCCSUP,24785538,1.2023292009410418
SK-N-SH,72193861,-0.8630087499800246
SNU-719,49793307,-3.637443754173901
EHEB,9903786,1.657877258917439
BT 239,navitoclax-gemcitabine (1-1 mol-mol),-4.49344601383989
BT 245,119182,-0.4253634129387354
NCI-H647,3025944,4.03511237340253
NCI-H716,73707398,1.3705255443510411
P31/FUJ,11656518,-0.8295634521320199
MG-63,6918328,1.4553304789362504
SUP-T1,71466578,2.7252792802134422
EoL-1,2858523,1.309804378818278
NCI-H2009,9926054,2.181635437582939
BT 232,54618305,4.404663674911541
HARA [Human squamous cell lung carcinoma],carboplatin-etoposide (40-17 mol-mol),3.125998778003278
HARA [Human squamous cell lung carcinoma],11228183,1.9492387662676105
YH-13,44607531,1.7046203795980872
HOP-92,9936388,1.480575569609934
NCI-N87,676352,1.7095816234371617
SUP-T1,decitabine-navitoclax (2-1 mol-mol),0.4484420152575381
P31/FUJ,5746,-1.0128835373821496
KYSE-450,5282054,4.505957787336516
HARA [Human squamous cell lung carcinoma],6918289,2.581505632245523
KYSE-180,26596,-0.879665743021705
PC-14,387447,-3.812338595624124
TCCSUP,4259181,1.0116551093848198
WM793,568763,-0.2625590328104358
HARA [Human squamous cell lung carcinoma],6184667,2.5882672266365128
AML-193,44185566,1.315362270523774
BT 228,9926054,2.418157139092261
BEN,4259181,0.1509293562542142
HOP-92,25161177,3.94059289170501
Capan-1,613753,3.1795827776611336
HT-1197,42611257,3.3661227918025394
SK-BR-3,erlotinib-PLX-4032 (2-1 mol-mol),2.319978449332628
PC-14,alisertib-navitoclax (2-1 mol-mol),-1.0906231063902465
HT-1197,53325874,4.522599599812321
RPMI-8402,135999136,1.132884235732898
EoL-1,72199292,-2.5781323146037516
NCI-H2081,65064,5.195192489742978
PC-14,2746,2.459398202696394
VMRC-LCD,9866186,0.9507859628817308
HuH-28,44185566,2.5705999488289635
NCI-H716,46191454,3.896511703775965
RCH-ACV,2729026,1.7385305215865103
HCC2108,11222830,1.6798861627317594
P31/FUJ,60750,-3.4241008025920396
EoL-1,decitabine-navitoclax (2-1 mol-mol),-6.011043984688028
SNU-719,72376,-2.6011364191506416
RPMI-8402,54618164,3.265888368810329
HOP-92,4788,5.491001748173414
KMH-2,2828334,5.602104318797055
MSTO-211H,selumetinib-navitoclax (8-1 mol-mol),0.5648552965523568
AU565,136227924,2.2371309282915184
KYSE-450,11507802,4.680867496065348
NCI-N87,sirolimus-bortezomib (250-1 mol-mol),-1.2024587113239409
BT 228,11485656,1.932859050078464
PC-14,446155,-0.7424552052477895
KMH-2,400769,-1.5896546527981914
KYSE-450,selumetinib-piperlongumine (8-1 mol-mol),5.043149849236574
VMRC-LCD,135421197,1.103585656826272
PK-59,46843906,3.798000448481125
HARA [Human squamous cell lung carcinoma],44491742,4.175098575791361
MFE-319,25102847,4.2478205932350654
KMS-26,20959075,-3.911891244617068
KMS-26,445455,4.452377974140755
RCH-ACV,10385095,1.3487937317088552
EHEB,2945648,4.948774095176571
PC-14,17755052,2.3851104377198995
BT 228,15983966,1.842720356216376
PK-59,10184653,1.3879688044305338
HGC-27,BRD-A02303741-navitoclax (2-1 mol-mol),2.05590292778867
WM793,doxorubicin-navitoclax (2-1 mol-mol),-0.741764803207122
MG-63,3081361,3.237364440834169
MG-63,24180719,4.195294954911166
SCC-25,65064,4.665504308821312
MFE-319,2729026,3.0699087026199696
SK-UT-1,104842,-1.774878693515325
JeKo-1,3689413,-2.4394197066593835
HARA [Human squamous cell lung carcinoma],3136844,4.042885024123848
RPMI-8402,JQ-1-vorinostat (2-1 mol-mol),-0.3921267111733187
KYSE-450,6918328,1.5468903828461986
HGC-27,24951314,-0.7472572230728453
NCI-H647,2871966,1.3466459958216583
SCC-25,168313016,4.190269075253486
SUP-T1,doxorubicin-navitoclax (2-1 mol-mol),-1.5877666412594742
RCM-1 [Human rectal adenocarcinoma],6917907,-5.490132832786946
HuH-28,568763,0.1208002605302807
EoL-1,6918328,-5.010441841325409
SIG-M5,navitoclax-sorafenib (1-1 mol-mol),1.2012654473036255
AML-193,12003241,-1.5379973109398848
TCCSUP,selumetinib-MK-2206 (8-1 mol-mol),3.0080662514608845
BT 428,5351362,1.220598971741878
KALS-1,selumetinib-decitabine (4-1 mol-mol),3.8976668615414303
KMH-2,11960529,4.291330287455724
MG-63,piperlongumine-MST-312 (1-1 mol-mol),2.5303306475786145
EoL-1,446155,0.015043047614251
KYSE-180,400769,-0.4834890789520504
KHM-1B,135421197,0.982032972009238
HGC-27,53495165,-3.744733348646452
NCI-H1092,24889392,4.210253207752649
WM793,11396600,4.503186389543736
IGR-37,11152667,-1.3185458372175074
VMRC-LCD,11222830,1.6250830201500015
P31/FUJ,9903786,1.0734919883099745
SIG-M5,decitabine-carboplatin (1-1 mol-mol),2.2941312414415957
RPMI-8402,119182,-4.184696087325495
SK-N-SH,11404337,-0.9981993214283256
EoL-1,23582824,-0.3527214398689994
HDLM-2,216239,2.4907571408712252
SUP-T1,2708,3.159296683549462
NCI-H1092,568763,-0.3741146279376747
PK-59,11964036,2.115726774413945
P31/FUJ,156414,0.8249508749632878
Capan-1,4578,6.408643590799246
MFE-319,11214940,4.5456769197242535
PC-14,11317348,1.2633354719410963
NCI-H2081,3385,5.204021808998722
L3.3,1750826,0.7937145951404149
EHEB,JQ-1-UNC0638 (2-1 mol-mol),1.0981019184979366
MFE-319,11238147,3.81451666212916
AU565,44489675,4.101715930322606
L3.3,vorinostat-navitoclax (4-1 mol-mol),2.138826011171234
HDLM-2,36462,1.1917482107311113
SNU-719,53232,1.5997953700215817
BT 428,216345,2.5172942638537172
EHEB,71680916,4.542174615812289
BT 428,10184653,-0.1229780329138256
SIG-M5,11626560,0.8029190784328468
WM793,51039095,3.547305313608344
KHM-1B,ISOX-bortezomib (250-1 mol-mol),-0.0879001565107233
NCI-H716,241158,3.477027636615277
PC-14,4705,-3.029150478382576
NCI-H647,6610216,4.146662237643
SNU-719,104842,-1.2036159553563328
HOP-92,49766530,-2.5153256499879517
SCC-25,11396600,2.765145835118827
MSTO-211H,10296883,3.6762481855456985
EoL-1,73707438,3.8080668715796153
SCC-25,3689413,-0.8116745291609476
PK-59,16720766,0.6877547107928741
HT-1197,46843906,3.810669740936621
HuH-28,2841722,4.642710621780122
KMS-26,9956119,1.652768760935721
RCM-1 [Human rectal adenocarcinoma],5282054,4.302238331478781
HARA [Human squamous cell lung carcinoma],72193861,-0.0489023079435419
MFE-319,44137675,3.760778415788738
SK-N-SH,25062766,1.64740954182391
NCI-H2009,11485656,2.228831542035607
SCC-25,2945648,3.0792329502595246
MFE-319,11396600,2.9869741461400956
NCI-H2009,10127622,-1.471627480680591
SK-MEL-3,12001922,1.3656226676364642
PC-14,52912189,3.471072781641098
BT 232,6852167,4.665057754555266
MG-63,12003241,-0.4675070550973023
EoL-1,6918638,-2.889280053807362
JeKo-1,11152667,-3.245778632504348
HuH-28,carboplatin-UNC0638 (2-1 mol-mol),3.239648974604076
BT 232,53392493,3.3085468850045263
SIG-M5,navitoclax-MST-312 (1-1 mol-mol),0.8287864768658232
KYSE-180,151289,0.6004966681509784
NCI-H716,11222830,1.7586306365809377
KMS-26,11609586,2.397522238122495
MSTO-211H,71466380,4.302501611697816
SK-UT-1,doxorubicin-navitoclax (2-1 mol-mol),-1.417611513602161
RCH-ACV,24856436,-0.8315479058129305
KYSE-450,16741245,5.34317896453295
WM793,11960529,4.980101224880268
RKO,BRD-A02303741-carboplatin (1-1 mol-mol),3.1646455891745084
EoL-1,3025986,-4.375739724817739
SK-N-SH,53392493,1.819092218500275
HGC-27,5291,4.668464419261121
RCH-ACV,51037431,3.7555499191540824
KYSE-450,387447,-4.1038253742642725
HGC-27,4477,-0.3650194805327509
MSTO-211H,19582717,3.17062921236116
BT 232,24775005,3.5127472599729868
AML-193,navitoclax-piperlongumine (1-1 mol-mol),0.0246336591134803
MFE-319,11427553,3.7830270591399526
HARA [Human squamous cell lung carcinoma],44589607,3.368220225067554
KALS-1,24180125,2.594623206570859
BEN,409805,5.771182466366909
NCI-N87,piperlongumine-MST-312 (1-1 mol-mol),3.209921452990857
KU-19-19,vorinostat-carboplatin (1-1 mol-mol),2.5196906513135913
RCH-ACV,24772860,-4.5180020483726455
AML-193,46843906,1.6256788521912846
A3/Kawakami,3543504,3.3758419834185887
NCI-N87,56963564,-0.4773091963101655
KMH-2,44589607,2.1056689776685404
HCC2108,selumetinib-JQ-1 (4-1 mol-mol),3.0515246299931205
HGC-27,168313016,4.744843210420601
MG-63,702558,5.053456919647359
EoL-1,25183872,-4.273618073570144
A3/Kawakami,navitoclax-birinapant (1-1 mol-mol),3.0433168717110406
EoL-1,3025944,1.8481652790086776
EHEB,11238147,2.9573925088138537
NCI-H1092,navitoclax-MST-312 (1-1 mol-mol),0.5756040063373493
IGR-37,11507802,1.217877179623814
NCI-H1092,BRD-K55473186,3.7509315405702224
RCM-1 [Human rectal adenocarcinoma],24785538,2.5999055228125254
KMH-2,11609586,2.0637953316848896
RCH-ACV,24180125,3.0709250936055037
RKO,vorinostat-carboplatin (1-1 mol-mol),4.42147496708757
NCI-H647,46199207,3.439508794003328
KALS-1,135398516,2.4545697577372927
SUP-T1,2749,0.4619790624765804
KALS-1,24978538,3.550533039227631
SUP-T1,44589607,1.0174785191243576
NCI-H2081,JQ-1-UNC0638 (2-1 mol-mol),0.2107025154126548
MSTO-211H,9911463,2.6842905920893108
VMRC-LCD,12001922,1.4293091709925143
RPMI-8402,6252,-3.4513049469794876
BT 239,54596558,3.8152435227763584
NCI-H647,25154868,3.081553493893309
BT 428,53232,4.277150367073074
P31/FUJ,119607,5.165578068786105
BT 228,2858523,2.968443451554069
BT 428,15547703,2.074270824736883
KYSE-180,5738263,3.136309383400005
NCI-H2009,44259,0.1981246725332563
WM793,322968,3.984805339497546
MG-63,52947716,-6.003184787639283
NCI-H716,sirolimus-bortezomib (250-1 mol-mol),0.1986169667929478
SK-MEL-3,6918328,0.6246937987317053
NCI-H1092,24748573,1.407040997377024
HCC2108,6623618,2.894339950820384
RCH-ACV,6852167,1.1883730851322674
SK-BR-3,54613361,-1.791238150978595
SK-MEL-3,5287969,-1.1750352716039536
NCI-H2081,carboplatin-UNC0638 (2-1 mol-mol),2.641355380173533
BT 245,carboplatin-etoposide (40-17 mol-mol),3.681284032155918
BT 239,11404337,-1.7707193107124473
KYSE-450,56963564,2.961228752582631
BT 228,54618771,0.9979024036150752
RCH-ACV,11625818,1.991064566922076
BT 245,44137675,3.3906511834655517
BEN,11364421,0.6158541686842042
SK-BR-3,5460769,4.927732708716518
SK-UT-1,107970,2.916039273405532
VMRC-LCD,156414,1.548496680895589
SK-N-SH,16736978,2.1277536221803586
NCI-H647,25262965,-2.900803648566125
KMH-2,11175137,2.314084253176101
SCC-25,227681,2.9405159495907056
KMH-2,107970,2.222246268833958
SK-N-SH,3136844,3.72622002886312
BT 232,168313200,1.7449359098138864
BT 428,6918328,-1.0441125619868274
EoL-1,carboplatin-etoposide (40-17 mol-mol),-2.1649507442152753
RCC10RGB,piperlongumine-MST-312 (1-1 mol-mol),2.4761046612469944
P31/FUJ,10427712,4.089067276268696
RPMI-8402,crizotinib-PLX-4032 (2-1 mol-mol),1.0242594913505063
RCC10RGB,9903786,5.708919982977709
P31/FUJ,439501,-2.3575947617146475
AU565,54649381,3.996593912741648
BT 239,2749,-1.596664989428474
PK-59,JQ-1-vorinostat (2-1 mol-mol),1.6525916334631885
EoL-1,16659841,1.428595640850963
HARA [Human squamous cell lung carcinoma],135999136,4.433628677785179
NCI-H1092,6852167,4.811360661328789
SK-MEL-3,alisertib-navitoclax (2-1 mol-mol),4.302393478203626
EHEB,9926054,1.8810570858595552
Capan-1,252682,8.555044277951948
KYSE-180,9911830,2.764203258021631
Capan-1,462382,0.7143740324345121
JeKo-1,selumetinib-MK-2206 (8-1 mol-mol),3.977247961724044
BT 232,6610216,3.928895495899257
HuH-28,156414,2.1488017743760586
YH-13,439501,-2.216859157731525
EHEB,54649381,3.7669466213883425
SK-MEL-3,16038120,1.5575931525362368
A3/Kawakami,6610216,4.023576597985235
AU565,54626689,4.66017141288812
HARA [Human squamous cell lung carcinoma],24951314,2.561199492034659
YH-13,89928392,1.3765832739802537
JeKo-1,25154868,2.829910715009084
BT 232,71729975,2.114830626945071
JeKo-1,2749,0.8802739669354378
BT 428,44486219,4.295230339940746
EoL-1,135659046,2.6902533100653785
RCH-ACV,4521392,4.233187288430106
TCCSUP,tretinoin-carboplatin (2-1 mol-mol),6.838469471858124
PC-14,15953870,2.774112835405703
HARA [Human squamous cell lung carcinoma],54618771,1.4449475826214635
HGC-27,5311281,0.4154959123763051
SK-UT-1,carboplatin-UNC0638 (2-1 mol-mol),5.634306420745063
SIG-M5,6252,0.0400546645507724
KALS-1,135875424,3.665008490823154
MFE-319,54613361,0.2791688631534721
AML-193,44607530,0.941538126056788
SW1116,176870,0.3324645613200126
AML-193,selumetinib-navitoclax (8-1 mol-mol),-1.2033550826156838
RCH-ACV,sirolimus-bortezomib (250-1 mol-mol),0.6092850769346084
BT 232,44486219,4.440912820012912
KMS-26,3025944,3.327670074406969
EoL-1,16736978,-1.3843944453677044
KYSE-450,54626689,5.089860588921688
BEN,3062316,3.644313995710189
SIG-M5,10231331,-4.142163395953805
HDLM-2,11640390,2.5453321535790976
RCH-ACV,46174525,2.5354047062525704
HCC2108,107985,-3.038738614535184
AML-193,5335621,4.2776005576995635
PC-14,24821094,-1.655897912694663
MSTO-211H,10074640,2.8901374693183848
NCI-H1092,17755052,3.7440295863343342
PC-14,9911463,4.053685719227892
HDLM-2,11683005,3.908966398140302
SK-N-SH,selumetinib-BRD-A02303741 (4-1 mol-mol),4.579985171887308
TCCSUP,11222830,1.4125339406552515
SCC-25,36462,4.497362805225712
KHM-1B,5284616,-7.181826614115283
HOP-92,UNC0638-navitoclax (1-1 mol-mol),0.3347977995164087
SK-MEL-3,2874250,-4.784212936384415
RPMI-8402,49793307,-4.021412311506961
MSTO-211H,452548,-2.0931551112296742
IGR-37,5746,-0.9474757054185196
YH-13,JQ-1-vorinostat (2-1 mol-mol),1.6666990115178115
NCI-H2009,16725315,3.943728055015544
BT 228,10127622,3.096780589403279
RCH-ACV,16038120,0.465041873407557
BT 228,46926350,-3.6951487252010367
HT-1197,9967941,3.1531506582197304
P31/FUJ,3543504,4.167476980253382
NCI-N87,654092,-0.6954721735465327
KYSE-180,6184667,4.098294905261503
HDLM-2,656346,-0.0232583765908086
PC-14,322968,4.675722029453696
HT-1197,36314,3.986285962895903
HOP-92,tretinoin-navitoclax (4-1 mol-mol),1.2383929872157775
AU565,71751553,3.982904849419344
MSTO-211H,637858,1.3984482263345202
HCC2108,2828334,6.718139410602479
BT 428,104842,-4.933536114536035
JeKo-1,53495165,-1.8140558138679073
BT 232,10074640,2.9458790075107255
KYSE-450,168312962,-1.1635814375740514
SIG-M5,11977753,-0.5929439368280401
SK-UT-1,JQ-1-vorinostat (2-1 mol-mol),2.752157861333336
JeKo-1,445455,4.824049151445519
HDLM-2,135398516,2.7797913737427455
BT 232,54618771,0.7442415190466014
VMRC-LCD,2828334,6.045936905508995
HARA [Human squamous cell lung carcinoma],2126,5.112984415511083
HGC-27,10410894,2.559001929737323
AML-193,2742550,2.301530395833896
EHEB,5746,-0.445016034851696
MFE-319,66577038,3.440341912352182
RCM-1 [Human rectal adenocarcinoma],31703,0.9691163018023546
SK-N-SH,17755052,1.8955271395821771
RCH-ACV,SNX-2112-bortezomib (250-1 mol-mol),-2.3794698889289267
MG-63,448949,2.6523923094293145
KALS-1,16725315,3.2717631451003473
PC-14,2126,3.655976740297496
TCCSUP,25150857,2.738156002354857
BT 428,24180125,3.179416514721958
KHM-1B,24964624,-1.4057417627664983
IGR-37,5287969,-1.5852058977776935
PK-59,selumetinib-piperlongumine (8-1 mol-mol),2.2656122259892872
NCI-H647,72199292,2.5731211654879536
NCI-H716,11955716,-2.760697844175057
SCC-25,JQ-1-MK-0752 (1-1 mol-mol),0.085506460550442
KYSE-180,selumetinib-tretinoin (2-1 mol-mol),6.206720364804737
RKO,4261,2.924548439505643
EoL-1,55508,0.9955783703371504
SK-MEL-3,9840324,5.81740878703454
JeKo-1,SNX-2112-bortezomib (250-1 mol-mol),-1.8919557294968976
KMH-2,11178236,-2.554107614991997
HDLM-2,702558,5.411725476923554
P31/FUJ,44589607,2.3901798108348533
RKO,11214940,1.6564081526645635
SK-MEL-3,89183176,3.169018370296839
SCC-25,16722836,0.6501514762566919
PC-14,6918328,-0.4686854814308683
NCI-H2081,9952709,2.2305361453905284
YH-13,49793307,-1.1961754726416267
RKO,637858,2.400395947377078
HGC-27,2749,0.9475527419322864
SCC-25,11717001,4.346826813556944
HOP-92,9444,4.509099831513164
PK-59,71466445,3.6462946515492423
YH-13,3081361,3.4000588476390963
KALS-1,446155,3.582693843635558
KMH-2,135999136,4.261603598420712
SK-BR-3,25062766,2.169053002173838
KALS-1,49766530,-2.069599194374988
SCC-25,selumetinib-JQ-1 (4-1 mol-mol),-1.3511560119840642
BT 245,9826308,1.4872493836837797
RCH-ACV,UNC0638-navitoclax (1-1 mol-mol),-0.6973432503183749
BT 428,568763,0.9998879380091756
NCI-H647,10296883,4.213615092820639
BT 232,46174525,4.360408925598184
Capan-1,9907093,5.118190411109127
RPMI-8402,9907093,3.2898625102911048
MG-63,11455910,1.9804853910986304
VMRC-LCD,7251185,2.288609027580992
AU565,107970,1.9067452119355752
SK-UT-1,54143018,1.4978372615780644
KU-19-19,5460769,4.3332822587900255
NCI-N87,25102847,3.5806366762623645
SK-BR-3,16065773,1.5840545431554016
SUP-T1,216345,4.2622603237282055
HDLM-2,3384730,1.4581799510448863
HDLM-2,123631,1.89309642624308
KALS-1,24856436,0.1680727093544427
HCC2108,3062316,3.16488906574129
HARA [Human squamous cell lung carcinoma],55508,3.1590088041564752
NCI-H2081,984333,-0.4217004435784025
SK-MEL-3,6610355,5.589862233976148
TCCSUP,5281321,-1.6830882813028205
EHEB,9911830,3.0366000052999893
SIG-M5,25126798,3.8770365920397287
SIG-M5,9915743,0.6121664403334032
BT 228,selumetinib-piperlongumine (8-1 mol-mol),2.53368461009318
MSTO-211H,24951314,-1.1401244239295247
SK-BR-3,3825829,3.842512996646099
WM793,2708,5.5820491292106516
MG-63,5311281,3.377230572636521
VMRC-LCD,135411,0.8215868838845786
BT 232,676352,2.036529784529802
NCI-H1092,25161177,3.963642294094328
KMS-26,9907093,3.309442841930037
EHEB,11656518,-0.4921898134750562
RCH-ACV,selumetinib-UNC0638 (4-1 mol-mol),3.322381478469301
NCI-H2009,3825829,4.333180881174198
NCI-H2009,446155,3.3217785993510884
A3/Kawakami,9915743,1.8122427094959257
VMRC-LCD,selumetinib-JQ-1 (4-1 mol-mol),1.7266079975134632
KU-19-19,11222830,1.7129831318158657
NCI-H647,216468,3.54199169001124
HT-1197,54639126,4.482438699772688
AML-193,2871966,-1.0416610893099931
KU-19-19,navitoclax-MST-312 (1-1 mol-mol),0.8014531944430209
SCC-25,9826308,-2.5734966820900964
BT 228,11455910,0.8628346849534536
HOP-92,24785538,0.9001345149320218
HCC2108,6505803,-0.7557590797286265
KU-19-19,10074640,3.725362653690234
MSTO-211H,24785538,0.8010437121318222
MFE-319,selumetinib-MK-2206 (8-1 mol-mol),3.7149112421215937
RCH-ACV,1242560,3.024009274740604
SK-N-SH,BRD-A02303741-carboplatin (1-1 mol-mol),4.367398029981182
NCI-H647,vorinostat-carboplatin (1-1 mol-mol),3.872923089267758
KMS-26,BRD-K58730230,3.7625491780241433
P31/FUJ,76446078,4.256026108364254
WM793,107970,2.3599025930331368
EHEB,11683005,4.401325437142657
HCC2108,navitoclax-piperlongumine (1-1 mol-mol),3.2345753523038536
KALS-1,selumetinib-PLX-4032 (8-1 mol-mol),3.673610308282981
BT 428,322968,2.919860566395529
SK-UT-1,2858523,3.0356672469783
A3/Kawakami,51039095,1.693839009894316
RKO,46907787,4.104881837237831
RKO,piperlongumine-MST-312 (1-1 mol-mol),2.2495159802497864
BT 232,3634881,2.8371902379415666
EHEB,11626560,1.520000059512031
SK-BR-3,5281321,-2.478837666724364
SK-BR-3,52912189,2.382690632065125
HGC-27,selumetinib-piperlongumine (8-1 mol-mol),3.402082673668815
A3/Kawakami,11178236,-3.052774357803953
AML-193,docetaxel-tanespimycin (2-1 mol-mol),-2.6859238229154236
BT 428,25150857,2.4600208880197867
BT 232,5291,5.505199613426907
EoL-1,16038120,-2.8487553133964933
NCI-H1092,7251185,1.5138496531623726
BT 239,54613361,0.0493680286200869
KYSE-450,5287969,-1.404660564702432
Capan-1,navitoclax-gemcitabine (1-1 mol-mol),-2.1522005630317036
NCI-H1092,navitoclax-gemcitabine (1-1 mol-mol),-1.9058386314503173
BT 428,3676137,4.612104849545454
NCI-H2009,676352,1.803439035619831
RCM-1 [Human rectal adenocarcinoma],JQ-1-vorinostat (2-1 mol-mol),0.912398125341492
BEN,168312962,2.670989711092791
YH-13,216239,3.5317850372057875
RCC10RGB,navitoclax-gemcitabine (1-1 mol-mol),-0.0681716439191075
IGR-37,5470400,1.102883365724539
HARA [Human squamous cell lung carcinoma],17759555,3.7036804092868847
YH-13,6852167,1.959387815211575
NCI-H647,984333,1.5908208288295107
KALS-1,675434,4.401196198515506
JeKo-1,11228183,2.0020662588848572
KYSE-450,56946209,-4.220503618005704
BT 232,11427553,3.9046501795540225
NCI-H716,613753,3.179200638017833
PK-59,9911463,3.8863333115764416
RCH-ACV,24785538,0.9881299967635894
KU-19-19,16720766,1.6427063989874335
JeKo-1,5335621,4.109132902278792
KMS-26,navitoclax-gemcitabine (1-1 mol-mol),-3.965720396151891
BT 232,969516,2.897047931824826
SUP-T1,50905018,3.8202881961127058
NCI-H716,navitoclax-MST-312 (1-1 mol-mol),2.5304907564321883
PC-14,5951923,4.134666638146039
A3/Kawakami,11609586,1.144932091139606
SK-MEL-3,navitoclax-gemcitabine (1-1 mol-mol),2.557846018726741
MSTO-211H,11238147,2.1702387480753393
EHEB,6505803,-0.4928001321157277
KU-19-19,135411,0.3258457054887789
BT 239,24978538,-4.996600310096332
KALS-1,11175137,2.6672158931223597
BT 245,4705,2.436380122563236
Capan-1,12001922,2.315520056823488
Capan-1,46199207,3.653544230247388
KU-19-19,3025986,-0.2897675094370045
HT-1197,24775005,3.711276609631876
RCC10RGB,3101542,4.48788654191394
BT 245,2858523,2.81995217169792
HGC-27,984333,-1.146518949838332
YH-13,5328940,2.7108571472659073
EHEB,doxorubicin-navitoclax (2-1 mol-mol),-3.104964273062398
SNU-175,654092,0.1799535462159149
EHEB,selumetinib-navitoclax (8-1 mol-mol),1.9472378662197067
SK-UT-1,17755052,4.751735459117679
SIG-M5,53232,2.217687878740235
SUP-T1,9866186,-1.0881389773114043
HuH-28,136227924,3.512267666844948
BT 239,6918736,-2.8227101405092623
AML-193,136227924,2.0129973822753735
SUP-T1,6918736,-3.925021532267634
SK-BR-3,4705,1.1013734177792738
AML-193,5328940,1.1249177369340957
EoL-1,8515,1.249672185146308
KYSE-180,65064,4.87684368224317
BT 232,17755052,2.567620325730424
SIG-M5,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.947705202344947
IGR-37,11656518,2.0705088515261014
SCC-25,135411,1.9524899256814177
RKO,5282054,3.8735499096789856
BT 428,11175137,2.170481617676556
BT 232,9956119,4.364021186350167
SIG-M5,57519531,1.7629777432640874
L3.3,44507138,2.7873723049829544
SK-BR-3,9866186,-0.8133678327743514
HOP-92,selumetinib-piperlongumine (8-1 mol-mol),3.045437286685265
SIG-M5,25102847,2.1443391754309347
SIG-M5,navitoclax-gemcitabine (1-1 mol-mol),-4.831387077352121
SUP-T1,374536,1.6573185247098483
HCC2108,53232,1.9986728385566
HOP-92,5738263,3.739287752290629
HT-1197,73707398,1.1241151390025674
KMS-26,vorinostat-carboplatin (1-1 mol-mol),0.2693990643130005
RPMI-8402,73707386,2.4280869468438446
RCM-1 [Human rectal adenocarcinoma],44589607,3.248085405337134
RCC10RGB,44589607,3.0966280095343777
HT-1197,9911463,2.9411019344315217
MG-63,135999136,4.46138735599139
AML-193,selumetinib-tretinoin (2-1 mol-mol),5.019172663925958
HGC-27,9866186,-1.0751428446355198
L3.3,123631,2.1308858538649456
NCI-H2009,piperlongumine-MST-312 (1-1 mol-mol),1.2420237661253426
MSTO-211H,49793307,-4.316049670445352
NCI-H716,5978,-0.2734129222000759
BT 232,9868037,4.279293873867471
BT 245,24978538,0.3641664207117464
AML-193,9915743,-1.3116324914766342
BT 239,11396600,1.7772646645104542
BT 232,54618795,3.8321823335958993
KHM-1B,11167602,5.170482443949449
KMS-26,568763,-0.4328367150719261
NCI-H2081,serdemetan-SCH-529074 (1-1 mol-mol),0.921465468134936
RPMI-8402,11626560,0.2935207391972008
HT-1197,vorinostat-carboplatin (1-1 mol-mol),3.939367867956863
RPMI-8402,4917,2.530293234571438
SUP-T1,9868037,1.5835878510828882
PK-59,11485656,2.1797490126169823
NCI-H1092,5287969,-2.1818617821183457
KHM-1B,6918736,-1.6456969223035287
RCH-ACV,vorinostat-navitoclax (4-1 mol-mol),-0.359368182382017
NCI-H647,54454,2.7644981171263834
EoL-1,5282054,2.656693701847497
BT 239,3854666,0.6020621099838442
HGC-27,10074640,2.211572556787078
HARA [Human squamous cell lung carcinoma],5479543,3.520150804916199
HuH-28,71304818,2.6378118579781713
KYSE-450,448949,2.8281207411790374
IGR-37,10127622,1.9573486274748764
BT 428,5951923,5.385929406679104
BT 228,753704,4.364635443239377
MSTO-211H,44185566,1.3875680654995235
SNU-719,71304818,2.3584624013042013
PC-14,6505803,-1.6585666949761726
WM793,10385095,0.6081370186912695
WM793,carboplatin-UNC0638 (2-1 mol-mol),2.595896359447151
SNU-719,219104,3.896926149884957
SIG-M5,25154868,5.104337340213121
MG-63,3634881,3.437068494436706
NCI-H716,9915743,1.329215193121519
TCCSUP,650361,4.871702860557827
KMH-2,3038522,4.4632233034848845
Capan-1,148124,-0.5288233157580327
MG-63,9826308,1.4077143539681392
A3/Kawakami,16741245,2.834833796187368
RKO,66577038,3.1469091340303637
L3.3,71304818,3.108733273598676
AML-193,2842253,5.828340022759951
SK-BR-3,5470400,-4.043246788440684
BT 239,UNC0638-navitoclax (1-1 mol-mol),-3.437137028059637
NCI-N87,selumetinib-piperlongumine (8-1 mol-mol),3.3316492796689112
HuH-28,6918736,1.7706169715662914
BT 239,3136844,3.711091726367837
BT 428,10385095,1.1753953127951546
RCH-ACV,11626560,0.7366200370562143
KYSE-450,25227462,-0.8054559419348748
HGC-27,selumetinib-JQ-1 (4-1 mol-mol),2.474282481636993
HOP-92,68056272,5.758845872926524
HGC-27,66577038,2.65207731084844
VMRC-LCD,49766530,-0.8677922390975771
A3/Kawakami,24771867,3.580892472047786
JeKo-1,11175137,1.7215792952470157
EoL-1,navitoclax-birinapant (1-1 mol-mol),-4.674013438052355
KMS-26,10385095,0.2941309941627629
PC-14,168312962,0.2499622730963001
TCCSUP,54619267,4.2789999138556425
AU565,9887053,5.902090445564702
A3/Kawakami,56973724,1.7450360261352538
NCI-H716,24964624,1.3295288969366623
MSTO-211H,4917,2.9904400598930088
SW1116,24901704,3.5037025312133556
MFE-319,3136844,4.413081954029845
KYSE-450,2871966,1.4934903304989255
NCI-N87,2708,3.9537199090854673
SNU-175,56946209,-3.5418111220693893
KALS-1,107970,3.013495125773725
IGR-37,66577038,3.0053141543984205
RKO,119182,-2.4803685643523
KALS-1,11612883,4.336027970981442
SUP-T1,46943432,0.6688423816159417
KU-19-19,72376,-1.7461965003174784
SNU-175,11485656,1.332587487801819
HGC-27,400769,-0.928763069627888
AU565,2126,4.335330080531479
HGC-27,1716436,1.9925217715249943
Capan-1,10113978,4.8128338754609254
EHEB,439501,-2.4217048608799097
BT 245,1566236,1.7422793804281065
A3/Kawakami,3136844,4.207371856570791
MFE-319,375860,0.1651753747878266
HGC-27,375860,-1.0398325430166302
P31/FUJ,3025944,3.8644283212627895
HDLM-2,3689413,0.2567400255605154
A3/Kawakami,11427553,1.3853782089929667
HDLM-2,17759555,3.0253969697584435
HARA [Human squamous cell lung carcinoma],10074640,3.2082861236873814
NCI-N87,71304818,2.1951958800989133
NCI-H2009,44589607,3.679148722712513
NCI-H2009,151289,0.8401149520435854
VMRC-LCD,984333,1.221930693945283
SK-MEL-3,navitoclax-sorafenib (1-1 mol-mol),2.7790064611905048
KU-19-19,selumetinib-UNC0638 (4-1 mol-mol),2.3716952230277313
P31/FUJ,44507138,1.0120664141515707
KALS-1,25183872,-0.9082560747058204
Capan-1,5291,3.928198719783068
KMS-26,25150857,1.541946671679526
KHM-1B,9911830,2.660270688725906
MSTO-211H,446155,-0.2868964860821164
KMH-2,11485656,1.7580590050514375
NCI-H716,2828334,5.991591389358914
AML-193,erlotinib-PLX-4032 (2-1 mol-mol),2.8293014177430633
BT 245,227681,3.853642709543238
KMH-2,ISOX-bortezomib (250-1 mol-mol),-0.2001122906253291
NCI-H2009,72376,-1.9106633783650309
MFE-319,54765302,3.684205793723215
BT 428,2733526,2.631519198254746
JeKo-1,10074640,2.9459723871082075
PC-14,10127622,1.2028917526414225
KALS-1,selumetinib-UNC0638 (4-1 mol-mol),3.370212312774644
SK-MEL-3,327653,3.685418998479267
KMH-2,135421197,1.1476668863331456
HT-1197,17755052,2.7179422418699093
HGC-27,9887053,1.0468629495159063
SK-N-SH,462382,0.4984156160031604
AML-193,24753719,3.879406334074648
KYSE-180,9911463,4.116935332494812
SIG-M5,5460769,1.4726407580947376
JeKo-1,15983966,4.103747415253072
RPMI-8402,2828334,5.497833747321985
KMS-26,6917907,-5.559469795429441
BT 428,444795,3.9327551144919584
WM793,44486219,4.341209426760334
RPMI-8402,322968,1.3295481860111713
HT-1197,9927531,4.678863685283018
MG-63,46843906,2.7966929796584132
IGR-37,3503,3.0578944152750585
SK-N-SH,2749,1.4924581034680435
MFE-319,54678924,1.6063850966224358
TCCSUP,54618771,0.6448534643306117
RCH-ACV,11222830,0.8240598857505061
KYSE-450,SNX-2112-bortezomib (250-1 mol-mol),-1.628342695469425
HDLM-2,16722836,0.1354121280054115
BT 239,6917907,-6.730851397187987
SCC-25,11404337,-1.9627814938837227
Capan-1,54765302,4.332864132366626
HT-1197,216468,5.201930157391017
KU-19-19,9444,4.28834999434395
HARA [Human squamous cell lung carcinoma],16736978,1.7495486591528322
RCH-ACV,4261,-0.3042720322192142
KMS-26,5284616,-6.261875829560449
HT-1197,BRD-A02303741-navitoclax (2-1 mol-mol),3.4244052456275313
BT 228,44589607,2.3880422149333844
MSTO-211H,176870,1.3974668510804569
HuH-28,46199207,3.1897649160853025
JeKo-1,24964624,2.6290693939510636
NCI-N87,JQ-1-vorinostat (2-1 mol-mol),-1.1800761907808068
NCI-H2081,136227924,2.7498424735477913
BT 428,446155,4.139353973623935
NCI-H716,JQ-1-UNC0638 (2-1 mol-mol),0.1161677167722541
SIG-M5,44819697,0.114219758597126
SK-MEL-3,400769,0.3592194005093727
BT 228,25183872,-2.881347196340315
NCI-H2081,46199207,1.540391568515102
KALS-1,11317348,4.251712884552942
RPMI-8402,73707440,5.61171543505587
HOP-92,6918638,0.7630598951940987
AU565,5335621,4.583819394214033
BT 428,5738263,2.4213503087370003
KYSE-180,11625818,4.6401032525686
HDLM-2,9444,3.738276943273276
NCI-H647,9887053,4.301851174224865
RPMI-8402,5335621,4.282011310763953
NCI-H647,25195348,3.1397576749217353
KYSE-180,51037431,2.26453575909295
KYSE-180,54618771,0.8276624799970426
L3.3,49793307,-1.834464681937742
HGC-27,16038120,-0.7873484138174422
NCI-N87,24856436,-1.0645338149753525
SK-MEL-3,71751553,5.266797753387062
JeKo-1,46191454,1.5956094987572065
HT-1197,65064,6.128062662640732
AU565,89928392,2.1536851128845904
HuH-28,6438330,1.144404255564079
BT 228,24856436,2.9657883043937208
SUP-T1,5281321,-0.761404121598218
BT 228,6450551,3.116687781420001
KALS-1,60700,2.7414516719050948
BT 228,3062316,2.169739618197856
NCI-H716,56946209,-4.771685913904824
HCC2108,5460769,1.78766929460534
BT 428,6184667,4.121619595077629
KU-19-19,51039095,3.4730458815699743
TCCSUP,613753,3.3276324574262595
RPMI-8402,navitoclax-birinapant (1-1 mol-mol),0.6449033090606603
AML-193,374536,1.4242090888169197
HDLM-2,387447,-5.200166229864254
NCI-H2009,216345,4.438201480917741
JeKo-1,4477,0.1183199777091549
WM793,4788,5.954303225972929
NCI-H647,11213558,0.6549671609820341
BT 239,439501,-3.505235897057165
HOP-92,tanespimycin-bortezomib (250-1 mol-mol),0.1347275198729775
IGR-37,25062766,2.562517849253913
SK-UT-1,1750826,-1.6569845659636762
KMH-2,3815108,2.5903945820626006
RPMI-8402,BRD-A02303741-carboplatin (1-1 mol-mol),4.340682480333383
SIG-M5,vorinostat-navitoclax (4-1 mol-mol),0.8567397427275594
VMRC-LCD,54618164,3.9757148680155887
MG-63,44632017,1.0633179641876729
AML-193,11964036,1.1347367445859498
L3.3,selumetinib-UNC0638 (4-1 mol-mol),5.288673066884017
P31/FUJ,216345,2.9363986514954203
SIG-M5,piperlongumine-MST-312 (1-1 mol-mol),0.9953419305587962
SNU-175,selumetinib-navitoclax (8-1 mol-mol),-2.1765753754655153
Capan-1,216345,4.482172748198213
L3.3,54618771,1.1558037208399272
HOP-92,11717001,3.7765093234413656
SK-N-SH,ISOX-bortezomib (250-1 mol-mol),0.0358183886215451
BT 428,36314,-5.043833616010499
HGC-27,3634881,2.96668396678616
NCI-H1092,23635314,1.8043090109267528
SUP-T1,6610216,3.659307734000498
KALS-1,44607530,2.647029360233068
YH-13,36314,4.085888552358508
YH-13,6610216,4.911134346587397
BT 232,448949,3.085962419312288
RKO,439501,-1.8401322759847645
MG-63,25262965,-2.719246300983224
HGC-27,11214940,0.1213082583138162
MG-63,52912189,2.5195435345243253
KYSE-180,446155,1.8141725427218347
HuH-28,10385095,2.5639170726190867
HT-1197,55508,6.260209058849209
SCC-25,156414,-1.9517374046491416
NCI-N87,984333,0.3233765721021273
SUP-T1,9549297,2.119739649099135
PK-59,5328940,1.5878650798878486
SK-MEL-3,89928392,2.3474448791424023
RCM-1 [Human rectal adenocarcinoma],54454,4.0573540170920355
SNU-719,168313047,2.8209706419757357
P31/FUJ,9444,3.558733501871851
HDLM-2,44495899,4.354191044557594
Capan-1,11364421,1.3375918376182856
HOP-92,11427553,3.124149477915469
MSTO-211H,6610355,3.5448971464264507
KYSE-180,12003241,-0.805265861116592
HuH-28,9926054,2.302050382507772
NCI-H716,11364421,-3.5296035549742495
L3.3,5278396,3.196787051990793
SK-N-SH,6918837,-3.3933857247432897
KMS-26,54618771,-0.1721472849955331
EoL-1,10113978,-7.111785703174249
KMS-26,6610216,3.996132091239896
HuH-28,72376,-1.5102136453645405
SK-BR-3,11396600,4.1222338228644695
MFE-319,4096211,4.049341385018693
MG-63,JQ-1-vorinostat (2-1 mol-mol),0.5130827465258353
BT 239,5281672,4.287121565809501
KHM-1B,216345,3.77132854777876
MFE-319,241158,3.887445302538144
SK-UT-1,5278396,3.7471831605219665
AML-193,24180125,3.91654561081322
BT 239,1566236,1.2451641316505642
MG-63,doxorubicin-navitoclax (2-1 mol-mol),-1.2640418084484148
HCC2108,9926054,2.5765466804926445
SIG-M5,selumetinib-PLX-4032 (8-1 mol-mol),-3.545554120841611
NCI-H2009,11222830,1.732127254120576
JeKo-1,9915743,1.243422351043917
SK-N-SH,262093,1.5021437515873324
NCI-H716,5113032,4.647974216921404
RKO,24951314,1.467797052763695
BT 245,54678924,1.80603004006958
HGC-27,1239801,3.898003107755225
L3.3,docetaxel-tanespimycin (2-1 mol-mol),-3.9282194992049546
SUP-T1,11625818,4.118654757765602
HDLM-2,73707386,3.1146753521402712
WM793,49793307,-1.6505636238066363
NCI-H716,11977753,-0.0163957497357375
BT 239,11955716,-3.448386100971216
HT-1197,JQ-1-carboplatin (1-1 mol-mol),3.4670046988259675
SIG-M5,66577038,3.1256574693704473
BT 428,selumetinib-vorinostat (8-1 mol-mol),0.9101675495588571
KU-19-19,49793307,-2.3409308252506777
HDLM-2,44819697,-0.8531185318338873
JeKo-1,erlotinib-PLX-4032 (2-1 mol-mol),3.4014864653863937
PC-14,135398516,2.1549851018652393
AML-193,10427712,3.764747881268203
HARA [Human squamous cell lung carcinoma],135440466,2.4398826683273165
EoL-1,23939,4.4029330148444705
RPMI-8402,72734382,3.354986340268357
P31/FUJ,54143018,-1.089453758548118
SUP-T1,71466380,3.6210111497637225
PC-14,11977753,1.0998869929301478
SK-UT-1,1641662,3.5811505263635235
SCC-25,25126798,2.174408706335666
BT 228,44197249,3.53843395082337
TCCSUP,carboplatin-UNC0638 (2-1 mol-mol),3.7591677104919334
EoL-1,vorinostat-navitoclax (4-1 mol-mol),-3.164550861831628
RCC10RGB,11427553,3.4421917630858387
RCH-ACV,135984461,1.5871533406295049
NCI-H2081,44819697,-2.617512109063003
MSTO-211H,carboplatin-etoposide (40-17 mol-mol),1.373265530821681
RPMI-8402,46199207,2.246215646580309
SNU-719,135421197,0.9792842920964928
KALS-1,5335621,5.7898913270609045
PC-14,10385095,2.2928310628241455
YH-13,6505803,-0.6394660445903715
NCI-N87,54618164,3.997308077582706
NCI-N87,20959075,-3.4539866912118784
SIG-M5,9444,4.147538475095515
AU565,11317348,4.006750700524709
Capan-1,tanespimycin-bortezomib (250-1 mol-mol),1.8501996853499856
RCM-1 [Human rectal adenocarcinoma],100016,6.48277389223573
BT 245,25227462,1.3932006167455824
RCH-ACV,BRD-A02303741-navitoclax (2-1 mol-mol),0.9943753859087084
SW1116,alisertib-navitoclax (2-1 mol-mol),2.2992453746229047
SK-MEL-3,11612883,3.743784921717229
KALS-1,10184653,2.5281615949407494
L3.3,72193861,1.4096427828350668
MSTO-211H,12003241,-2.79016034960529
SK-N-SH,219104,2.2260343077900964
RCM-1 [Human rectal adenocarcinoma],4261,0.3806474761357037
A3/Kawakami,216468,1.9074797756666555
BT 228,52947716,0.8087953032339558
P31/FUJ,5282054,2.945149434876345
NCI-H716,16659841,-0.9974211277104696
PK-59,135421197,1.5554330287724354
KHM-1B,44493528,1.720576936641076
RCC10RGB,24753719,5.18895385781671
SIG-M5,7251185,1.6602205416703264
SCC-25,10302451,1.3739474591398615
SCC-25,124202324,1.8365175038978816
AU565,219104,2.449004695507307
RPMI-8402,72193861,-0.2078291585043472
KMH-2,16720766,0.9709420836572418
KYSE-180,crizotinib-PLX-4032 (2-1 mol-mol),2.1918539304937332
BT 245,107985,-3.2343864047016706
NCI-H2081,9825149,1.369929435911088
JeKo-1,serdemetan-SCH-529074 (1-1 mol-mol),1.9560364765262832
WM793,4261,1.9169510803510963
SUP-T1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.210011307070792
SK-UT-1,31703,-1.1985979493610477
HOP-92,4261,1.1405356414312626
NCI-H716,53495165,1.3603355181425605
SK-UT-1,46215462,2.208029425657124
SIG-M5,7326481,2.925773307894833
L3.3,1566236,3.261153981033622
BT 428,71466380,3.9196018251640097
PK-59,selumetinib-MK-2206 (8-1 mol-mol),1.1938726567560958
HARA [Human squamous cell lung carcinoma],452548,-0.3270885928487969
AML-193,9967941,4.22395937114927
JeKo-1,2828334,5.85432118365213
NCI-N87,49793307,-2.95740399691262
MSTO-211H,2733487,6.00734552009151
HGC-27,322968,3.2003140355169593
HGC-27,11955716,-1.9997001597056945
SK-N-SH,11427553,1.49208561139858
NCI-H2081,44462760,3.7666296085166375
NCI-H2081,49766530,1.2305991234309177
AML-193,54618164,3.973133793220512
JeKo-1,11317348,1.364605447238317
TCCSUP,JQ-1-vorinostat (2-1 mol-mol),1.622320227916817
HuH-28,44202524,3.897804001105924
A3/Kawakami,54596558,5.989522868613511
SIG-M5,44607531,1.5821035214714416
KALS-1,11719255,3.130607568351308
RCH-ACV,5328940,0.5104028657984032
HGC-27,11178236,-5.523696024922664
MFE-319,17755052,1.915267965468357
SIG-M5,135984461,4.131261553814095
RCH-ACV,44493952,2.971216444393721
SUP-T1,445455,3.819699781822124
HGC-27,54613361,-2.1899841529799615
HCC2108,4261,0.8119370263303683
BT 232,374536,3.676465900501084
HCC2108,452548,0.5467419816970324
SIG-M5,44462760,-8.214027942264352
SK-MEL-3,387447,-4.20138117116068
L3.3,16741245,2.275908063521695
MFE-319,decitabine-navitoclax (2-1 mol-mol),4.917730500597083
AU565,16722836,1.9939850778221897
NCI-H2081,5743,3.6602518190396616
NCI-H1092,10385095,0.6716651912361483
NCI-H1092,UNC0638-navitoclax (1-1 mol-mol),0.7964927017699627
EoL-1,decitabine-carboplatin (1-1 mol-mol),-3.8923019250416417
NCI-H2081,25161177,4.359001869176978
IGR-37,SNX-2112-bortezomib (250-1 mol-mol),0.4963896280875772
Capan-1,1566236,1.8786990481071677
NCI-H1092,24964624,2.2870226351654637
SW1116,11167602,2.496759203352098
A3/Kawakami,89928392,0.9766383855372393
BT 245,11494412,1.2412391063444357
KMS-26,10113978,0.5635415487749132
L3.3,54618164,4.298111449535211
A3/Kawakami,56649450,4.396349733546116
KALS-1,49867926,4.665084410003279
HCC2108,10231331,3.026437227257123
RCC10RGB,3552672,3.073432883089278
JeKo-1,piperlongumine-MST-312 (1-1 mol-mol),1.0333640021601038
SK-UT-1,51039095,3.5731759350620345
KHM-1B,11625818,2.7772036353291725
HuH-28,52912189,0.7282643702778396
SK-MEL-3,5291,3.740814880068654
KALS-1,136227331,4.320673828023345
HOP-92,24901704,2.363293850254704
NCI-H2081,5311281,1.3336176865333822
MG-63,44185566,2.973132427068735
P31/FUJ,10302451,4.186780329312711
RCM-1 [Human rectal adenocarcinoma],5281321,1.2119883175444373
EHEB,16722836,1.130353250152493
BT 228,9907093,5.763735571498202
SNU-719,JQ-1-vorinostat (2-1 mol-mol),0.1253953818144268
EHEB,23725625,4.849566011145166
BT 232,54618164,4.582446279989421
BEN,4917,2.9174699148140233
KYSE-450,3825829,4.738351974491715
HuH-28,15983966,1.8760919258148545
NCI-N87,selumetinib-tretinoin (2-1 mol-mol),6.374104250530425
KYSE-450,9444,4.430571093374375
NCI-H1092,11214940,3.734775459591196
NCI-H2081,11427553,0.4745229676826807
SK-MEL-3,3038522,2.144416931171414
EHEB,9868037,2.9297052804513934
PC-14,3384730,1.2394493376738462
HT-1197,5287620,-2.4585744756618912
AML-193,5460769,4.1891717596196205
BT 245,16065773,1.9991493943013103
SK-N-SH,3062316,2.125646623868334
SK-BR-3,9967941,3.58885560735393
PC-14,448949,0.9447027216168168
HT-1197,44491742,3.769562948559888
RKO,9956119,3.3077949428120195
RCH-ACV,54613361,-0.3353832335911876
SUP-T1,24901704,2.08106234795548
SIG-M5,9935249,-2.10947388119983
KALS-1,9444,3.926492119357736
HCC2108,11964036,2.450976446990399
RCC10RGB,navitoclax-PLX-4032 (1-1 mol-mol),2.769034348653669
SK-BR-3,5282054,2.5502647928198794
KHM-1B,9915743,0.5787442773030028
EHEB,67291369,2.0490464679075813
HARA [Human squamous cell lung carcinoma],969516,2.3775549977258836
EHEB,sirolimus-bortezomib (250-1 mol-mol),-0.8631286071127797
YH-13,53392493,1.9898975762013085
WM793,24748573,4.504607526938656
HARA [Human squamous cell lung carcinoma],6852167,2.790696024551457
NCI-H1092,44607531,1.5993128596295003
A3/Kawakami,6918878,-0.8008619766591237
HT-1197,11626560,2.6798594359528245
BT 239,9933475,1.5072755929728374
EoL-1,11612883,0.2355934249627359
Capan-1,2871966,0.3301367293841001
RPMI-8402,11238147,1.2578990921678592
L3.3,676352,2.5109454639647373
MFE-319,selumetinib-GDC-0941 (4-1 mol-mol),2.3179582755717356
EoL-1,6914657,-8.795216172135632
KYSE-180,navitoclax-MST-312 (1-1 mol-mol),1.0295834159957882
HOP-92,322968,3.590670219223897
BT 228,241158,4.2850908556877405
SCC-25,67291369,-1.3345987750976764
KMH-2,676352,1.6128431160442525
BT 245,6438330,1.320789290711093
MSTO-211H,15953870,2.3250629767102273
HuH-28,2858523,2.765221330859637
SNU-719,9444,3.248052058980071
SIG-M5,451668,3.142087218666312
P31/FUJ,42642645,-1.1469220315427042
NCI-H647,67156097,-0.2818439659518464
SW1116,53495165,-0.8053635066500726
RPMI-8402,241158,3.030815815171316
KHM-1B,6914657,-6.231607767095075
BT 232,BRD-K55473186,1.941212849623224
NCI-H1092,10113978,3.439379415042978
TCCSUP,25183872,-1.340391088642973
HOP-92,135398516,4.387014357249157
BT 232,selumetinib-MK-2206 (8-1 mol-mol),3.2995804168099294
RKO,6505803,-0.9276151073099124
RCH-ACV,52912189,0.5930487628924465
HCC2108,vorinostat-navitoclax (4-1 mol-mol),1.8283883364659943
SK-N-SH,3854666,-0.6483541731368345
BT 232,262093,2.843383638859083
L3.3,31703,-1.9667249709147607
HGC-27,selumetinib-GDC-0941 (4-1 mol-mol),-0.8359606589249554
AU565,vorinostat-navitoclax (4-1 mol-mol),1.0795272840825962
RPMI-8402,9887053,2.689325905031518
HARA [Human squamous cell lung carcinoma],54619238,4.4726064543510144
AML-193,9803433,3.267280979455868
JeKo-1,89928392,0.9698015741193092
HARA [Human squamous cell lung carcinoma],5287620,-1.762699468398793
KU-19-19,15983966,3.017543110767297
KMS-26,8515,1.9708227229968656
NCI-H716,135398516,2.749120058115229
HOP-92,135999136,4.381843912128879
BT 245,16725315,3.3086628671976026
BT 232,salermide-PLX-4032 (12-1 mol-mol),4.50138930646163
BT 232,3011155,4.45708113429603
TCCSUP,1716436,3.07523463483741
KMS-26,11238147,1.9604491037772993
NCI-H647,462382,0.8437454276963885
Capan-1,24785538,1.275873991053342
NCI-H2081,11317348,1.2192738417019382
SCC-25,3815108,3.850950395107492
SK-BR-3,5351362,0.946113550847828
MSTO-211H,selumetinib-BRD-A02303741 (4-1 mol-mol),2.4025987585573363
NCI-N87,135999136,4.294797881105147
SNU-175,5978,-2.8140999184751183
IGR-37,46926350,-3.713079769128535
NCI-H2009,44241473,6.22803294537171
SIG-M5,10385095,0.6926293967264278
PC-14,23725625,5.247138358431667
TCCSUP,676352,1.7918855242955138
EoL-1,24748573,0.6250348003206414
KALS-1,2945648,3.285014099761431
SK-N-SH,25102847,1.5856664535073286
PK-59,5311,1.6385970042075888
KMH-2,25150857,1.6846739388825889
HGC-27,9825149,2.2069915346345925
BT 228,60700,1.7240850338857503
MFE-319,23635314,-1.8322782285941384
BT 245,5738263,3.5833049599191904
BT 245,2708,6.067628010390521
KMH-2,19582717,3.4526761436377296
KMS-26,9887053,1.48109473328979
SUP-T1,vorinostat-carboplatin (1-1 mol-mol),2.232858997749175
TCCSUP,25262965,-1.8774141116985676
SUP-T1,54626689,6.947205003270078
NCI-H647,9911463,4.264902637756033
HARA [Human squamous cell lung carcinoma],carboplatin-UNC0638 (2-1 mol-mol),4.127490867447662
HARA [Human squamous cell lung carcinoma],2841722,4.596341456340547
SIG-M5,23635314,-4.307588552867441
L3.3,53495165,2.194695518305113
RKO,285033,-2.0365968290915393
BT 245,9956119,4.332681087090165
KHM-1B,5566,2.2801989314066637
P31/FUJ,11497983,-3.9754433923569295
EoL-1,46926350,-6.477823582380018
SUP-T1,52912189,-0.239139712530702
KMS-26,navitoclax-piperlongumine (1-1 mol-mol),-2.508797640980488
KHM-1B,20959075,-3.335325508403103
AU565,445455,4.9301368045011955
MFE-319,23582824,0.815697244933448
RPMI-8402,11455910,1.2135317922717286
MFE-319,613753,3.402758988900764
KALS-1,10296883,4.367875954814542
SK-UT-1,65628,4.642853879953485
SK-N-SH,568763,0.5140013751919663
YH-13,44185566,3.169017423167434
WM793,676352,2.515815978900982
SK-MEL-3,5311,1.8449807355150376
HGC-27,JQ-1-vorinostat (2-1 mol-mol),-0.0861984165999272
PC-14,5351362,1.7010534547277063
PC-14,51037431,1.133811841560157
BT 239,9967941,2.176546228821834
HCC2108,11640390,5.072951155223495
NCI-H1092,navitoclax-PLX-4032 (1-1 mol-mol),1.5069536319364394
AU565,156422,4.303267692822867
RCH-ACV,1750826,-3.3023205148062575
NCI-H2081,3384730,2.313537319887304
Capan-1,9927531,5.621022347820903
P31/FUJ,20959075,-3.3972839651855207
NCI-H1092,6918328,-0.0864293010170715
PC-14,5291,4.296849144403432
P31/FUJ,638278,2.9129004591727057
HCC2108,54618771,2.799542688239582
NCI-H2081,71466380,3.723063290723911
BT 228,piperlongumine-MST-312 (1-1 mol-mol),1.6604264536456286
EHEB,676352,2.3007932773454844
MFE-319,9933475,2.3015233045828194
MSTO-211H,56963564,1.234327129960966
SCC-25,9915743,-2.46733650734929
SK-UT-1,piperlongumine-MST-312 (1-1 mol-mol),2.2334203788003277
NCI-N87,72193870,2.948099148236623
RPMI-8402,46943432,1.849232999724565
SK-N-SH,11626560,0.7051537594020375
HGC-27,5280436,3.055306669536514
RCC10RGB,navitoclax-sorafenib (1-1 mol-mol),2.209619948834929
HDLM-2,5329102,1.410669019241895
HuH-28,31703,-0.8699697846828439
IGR-37,89928392,1.774333826002225
RKO,176870,5.862868084879783
BT 428,5566,2.5065261777793535
TCCSUP,644241,2.2463977673648823
KU-19-19,selumetinib-PLX-4032 (8-1 mol-mol),2.356754737959246
NCI-H2081,navitoclax-piperlongumine (1-1 mol-mol),0.7242013058592781
NCI-H2081,9884685,-0.1678318744759171
SK-BR-3,9444,3.160428224314401
L3.3,89928392,2.03013195184945
AU565,568763,-0.2996152351915113
SNU-719,4788,5.897561152382849
L3.3,5282054,4.901570069575592
HOP-92,448949,2.2953260929546113
SK-N-SH,11640390,1.8547145037939092
AU565,68056272,3.4490660549666425
NCI-H2081,11152667,0.3314648978290519
TCCSUP,44493528,4.420877523389051
P31/FUJ,2945648,2.3869646223252365
HARA [Human squamous cell lung carcinoma],156414,2.353598180094054
JeKo-1,462382,0.2184409725386158
AU565,168312962,1.8906319972872971
KYSE-450,24951314,3.0584617604997058
RKO,9908783,5.5436232623995805
NCI-H647,644241,2.820722009461978
VMRC-LCD,5978,-4.278832386182247
A3/Kawakami,135659046,2.928957386337573
HDLM-2,5311281,4.853597171537821
NCI-N87,409805,4.5069551273823585
MG-63,11977753,0.8219078888148021
SNU-719,4378219,6.704358439762523
KMS-26,9825149,-0.2351881005404589
HDLM-2,24951314,0.6313600680669538
NCI-H1092,168313200,1.6747772833697747
NCI-H1092,3689413,-0.2231155414175143
KHM-1B,11364421,-5.203168306963344
Capan-1,sirolimus-bortezomib (250-1 mol-mol),0.7071415431289269
SIG-M5,637858,1.0348469848357038
AU565,selumetinib-decitabine (4-1 mol-mol),5.684619389149027
HGC-27,25126798,2.56840928313056
SIG-M5,11507802,1.1191407076672832
HARA [Human squamous cell lung carcinoma],11964036,1.505983259630614
HOP-92,11640390,4.36799004931697
MFE-319,16736978,1.815892402740218
NCI-H1092,387447,-4.501071900555183
HGC-27,104842,-4.992458456730661
KMH-2,126941,-3.9779310000787382
KYSE-450,11167602,4.298081277499996
EoL-1,5311,-0.7178583787221055
BT 428,11404337,-0.9400136442546092
BT 228,44607531,1.2881785377107222
SK-N-SH,6252,-0.5652608862603458
SNU-175,44505237,4.300100197754533
BT 239,2828334,5.859400062214035
SK-N-SH,5328940,1.6961569476777063
WM793,12001922,1.7029195893812905
KHM-1B,crizotinib-PLX-4032 (2-1 mol-mol),0.397018981574428
HCC2108,6918878,2.040858445754197
KMH-2,11234052,3.795563896371719
HGC-27,54618771,0.7122849148463839
KU-19-19,5329102,2.6076401407195355
BT 239,156414,-0.3891739105228405
KALS-1,4477,1.3488519792411793
HOP-92,selumetinib-vorinostat (8-1 mol-mol),2.322415007077192
KMS-26,6918328,-5.158760772547194
HARA [Human squamous cell lung carcinoma],122327,4.478573115200279
SK-UT-1,16065773,2.499708535833016
P31/FUJ,216239,3.114152508734425
RCH-ACV,9868037,2.145537179112383
KYSE-450,navitoclax-pluripotin (1-1 mol-mol),0.3166156605789935
NCI-H1092,327653,2.585630282314354
BT 232,9926054,2.340014679513304
MSTO-211H,9868037,1.9157833543052896
MSTO-211H,46191454,1.2859626841233986
NCI-H1092,5281321,0.8486024687815589
MSTO-211H,navitoclax-gemcitabine (1-1 mol-mol),0.5051490037024954
HOP-92,262093,2.340026978235907
SIG-M5,doxorubicin-navitoclax (2-1 mol-mol),-3.7730166381481487
MSTO-211H,salermide-PLX-4032 (12-1 mol-mol),5.150950565200891
AU565,6610355,3.967539400054512
VMRC-LCD,5426,4.497910250324488
AML-193,navitoclax-pluripotin (1-1 mol-mol),-1.723740691522727
SUP-T1,5311,-0.3548493308179672
KHM-1B,navitoclax-sorafenib (1-1 mol-mol),2.457676578610422
HCC2108,5287620,-1.7107453647651585
SW1116,6438330,2.8803790171028996
PC-14,25183872,-0.3875173462259941
NCI-H2009,49793307,-2.1832388254663746
KYSE-180,135398738,4.479498150489159
VMRC-LCD,1750826,-0.8015714944723361
EHEB,65064,3.0143976665527368
BT 239,42642645,0.8810059710632603
RCH-ACV,20959075,-3.4363673565348014
NCI-H2081,107985,-4.4331361775732905
KMS-26,1242560,2.4573138002125128
HCC2108,12001922,1.7040984021547378
RCH-ACV,5335621,3.750530634133651
BT 245,tretinoin-navitoclax (4-1 mol-mol),0.1970229993280732
RKO,72376,-2.4980018930037673
RCH-ACV,46398810,2.1413343124486492
BT 245,67156097,-0.7783677327419868
MFE-319,71680916,5.674580078436401
SK-N-SH,navitoclax-piperlongumine (1-1 mol-mol),0.456166453816739
BT 245,sirolimus-bortezomib (250-1 mol-mol),0.5347503794304393
HT-1197,11152667,1.4681222423137998
RCC10RGB,2949965,2.9970768068045577
RCH-ACV,9823820,3.1572759201573204
SNU-719,44484440,3.623849068455505
NCI-H1092,969516,2.7305751680424573
YH-13,8515,4.054803825976401
SK-UT-1,24856436,-0.0772181005247894
NCI-H647,selumetinib-navitoclax (8-1 mol-mol),4.162350182031619
EHEB,44202524,1.2346784446145649
KMH-2,44492757,4.466240512188941
SK-N-SH,24797083,1.3591779587745332
HARA [Human squamous cell lung carcinoma],36314,-5.79294260923826
EoL-1,10074640,-6.631742345237831
MSTO-211H,3025944,3.596075182431598
NCI-H2081,navitoclax-MST-312 (1-1 mol-mol),0.8717360318084046
MG-63,46907787,1.9915589638341744
A3/Kawakami,409805,5.980791867932477
MFE-319,11626560,3.093226912668552
HOP-92,vorinostat-navitoclax (4-1 mol-mol),-0.3769877587719484
SK-N-SH,tanespimycin-gemcitabine (1-1 mol-mol),-1.1492509383511265
SK-BR-3,135875424,2.976147465835477
BT 228,16722836,1.920389692039809
RPMI-8402,135875424,3.838035457399833
TCCSUP,135999136,4.392620213932673
EoL-1,5287969,-2.768987362181538
RCC10RGB,65064,5.251967206688168
SK-BR-3,24821094,-4.39287000585535
NCI-N87,72734382,4.464771871646434
HuH-28,107985,-3.906817449798121
RCH-ACV,JQ-1-MK-0752 (1-1 mol-mol),-0.5667913159154929
BT 239,3038522,2.231588438926038
MFE-319,15953870,3.800473172062692
SIG-M5,54454,3.386880044212236
JeKo-1,3384730,2.0536255021044867
RKO,3543504,4.836700902585943
MSTO-211H,JQ-1-navitoclax (2-1 mol-mol),-0.1744059770900167
NCI-N87,vorinostat-navitoclax (4-1 mol-mol),0.7685195358482984
KMS-26,216468,1.554717177606884
HGC-27,6450551,0.2313594097283057
AML-193,2733526,2.490136049688855
MSTO-211H,11507802,-2.113337212450165
JeKo-1,148198,-5.137467449260085
EHEB,3384730,2.786060611815292
HOP-92,navitoclax-MST-312 (1-1 mol-mol),0.4430665042285512
SK-N-SH,46398810,1.5995333184877492
KYSE-180,44137675,3.5547718056396
HGC-27,3689413,-1.6532214726359813
KYSE-450,9926054,1.8553044985655331
VMRC-LCD,6918638,-0.8957275762534151
NCI-N87,5311281,2.449994968111211
HARA [Human squamous cell lung carcinoma],5281321,-1.682952924947167
YH-13,168313016,4.37029301578321
SW1116,navitoclax-piperlongumine (1-1 mol-mol),2.239630432937819
SK-UT-1,23635314,-1.1981704896676824
BT 232,322968,4.168077275493542
MFE-319,25062766,3.0479781134159425
NCI-N87,124202324,1.1856737577999816
NCI-N87,44620216,3.650574309449747
KU-19-19,3503,3.0769201112014803
SK-N-SH,1566236,1.1494040104220686
KMH-2,12001922,1.6434388157498154
NCI-H1092,5311,1.4107579527755432
HT-1197,5351362,1.1279123765590766
RKO,9825149,2.459088339864112
BT 228,24821094,2.4289884008965488
EoL-1,2949965,1.508052452587198
BT 228,10410894,2.072146929250839
TCCSUP,25062766,2.2291298825702666
A3/Kawakami,11507802,0.9681931846927482
SK-N-SH,73707398,0.8722989575210444
RKO,25126798,4.002843113400742
PK-59,2858523,3.1716449824221846
HGC-27,446155,3.5394129372244727
EoL-1,2842253,2.641486143080328
BT 239,285033,-1.0893795216554982
MG-63,salermide-PLX-4032 (12-1 mol-mol),5.9014457878492825
HCC2108,44819697,4.4512579007259605
SNU-719,11178236,-2.611448724817202
NCI-H2009,5351362,1.2372754831617516
JeKo-1,selumetinib-vorinostat (8-1 mol-mol),2.4453871376323955
SNU-719,decitabine-navitoclax (2-1 mol-mol),0.3169353541301504
NCI-N87,54143018,-0.5822633828546482
VMRC-LCD,168312962,-0.5229784292350136
SK-N-SH,11964036,1.0763718164787377
PK-59,3552672,2.0271262154915006
RCC10RGB,6610355,5.214940260192328
BT 228,5282054,3.2077859800939783
L3.3,51039095,3.7013514518444617
L3.3,654092,0.3260809528195456
RCH-ACV,11427553,1.4110700772108475
A3/Kawakami,9823820,4.016214501105414
NCI-H2081,12001922,1.0080325544819035
BT 428,52912189,1.3093593708240536
SCC-25,104842,-3.2278499759655306
NCI-H2081,10074640,2.3874549358623756
WM793,11238147,2.989890948344662
HGC-27,54765302,2.495215281939259
MG-63,2945648,3.095324669872749
HGC-27,60700,-2.2817071734005925
SCC-25,44607530,0.534856097750805
KYSE-450,11609586,3.5646213291444324
HCC2108,11497983,4.98436619743709
HCC2108,9907093,5.193371437314048
BEN,252682,6.378406892801343
TCCSUP,9825149,2.319100468711196
JeKo-1,53245473,3.5595370342095145
RCC10RGB,9952709,4.37754893062567
JeKo-1,135421197,1.3904667144592064
NCI-H716,45279963,3.78845268266162
RKO,navitoclax-MST-312 (1-1 mol-mol),1.4157691797100402
RCH-ACV,10427712,3.657506694965921
RCH-ACV,448949,0.0011991415602908
RKO,322968,3.8471310775605216
RCH-ACV,tanespimycin-bortezomib (250-1 mol-mol),0.4817586938326316
SCC-25,6918736,-2.444548176232172
AU565,9884685,0.3686008824574254
NCI-H2081,selumetinib-MK-2206 (8-1 mol-mol),3.504748246371747
VMRC-LCD,2871966,-1.8851832697414848
RCM-1 [Human rectal adenocarcinoma],136227924,3.314624698864007
BT 245,60750,-2.2202971803272624
SIG-M5,24901704,3.4276161487621555
HGC-27,25195348,3.1861934182155394
HARA [Human squamous cell lung carcinoma],49766530,5.57937649881164
BT 428,135659046,3.573763038343519
SUP-T1,51037431,1.7552359845454657
KYSE-180,6918837,-1.892651842131766
P31/FUJ,selumetinib-vorinostat (8-1 mol-mol),0.1511350548351421
P31/FUJ,168313016,4.690131242833582
BT 239,25150857,2.3352630248989388
EHEB,656346,0.7724879117712764
RCH-ACV,JQ-1-navitoclax (2-1 mol-mol),-1.405506337079897
SK-N-SH,44632017,0.5337438948225497
HOP-92,72193861,2.5905420332061015
A3/Kawakami,1750826,-2.5397560376574853
SCC-25,11507802,1.2406123718317306
MG-63,409805,5.820012776028697
AU565,46398810,1.9802808058059196
TCCSUP,51039095,2.6276542591354723
HOP-92,57519531,1.8398194530271303
NCI-H2081,UNC0638-navitoclax (1-1 mol-mol),0.8615686531760992
NCI-H647,25126798,3.1474138777332312
PK-59,9887053,5.458657189600831
HuH-28,216345,3.85667789105881
SW1116,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.3819919735240309
HCC2108,136227924,3.562843531024723
NCI-H716,3062316,1.3926581942111549
KYSE-180,6623618,2.424847215991005
YH-13,71751553,4.865573337264169
RPMI-8402,11364421,-5.278604578763047
HGC-27,5284373,1.8288062389783992
SK-N-SH,65628,2.1902058343213655
P31/FUJ,67156097,-2.27730723064269
SK-N-SH,11234052,4.191766271618224
EHEB,9908783,5.71177990312006
SK-BR-3,2949965,2.2365190803803867
SIG-M5,119607,5.713437420241561
AML-193,selumetinib-vorinostat (8-1 mol-mol),0.1935247845364687
SK-UT-1,9967941,4.506671205621334
KMH-2,44507138,1.688756154948792
RCC10RGB,3689413,-2.0864832427963336
BT 245,100016,6.42627295768896
HT-1197,6918837,-2.6536516147331346
EoL-1,9911463,2.487921562669019
HCC2108,10113978,2.890872158375319
JeKo-1,374536,1.812128388098807
TCCSUP,100016,6.5110410318476575
EoL-1,71466380,2.0794149402737983
BT 239,1750826,-0.5185577460325593
IGR-37,11175137,2.441539330708903
AML-193,119182,-3.9494879714270095
KALS-1,10302451,4.196627603085186
HOP-92,5287620,-2.033581236767259
SUP-T1,sirolimus-bortezomib (250-1 mol-mol),-0.9944486722205774
NCI-H2081,375860,-0.0986689884250349
AU565,11656518,2.4577765871660353
BT 239,10427712,3.403606013887073
SIG-M5,136227924,2.112174988724855
BT 428,135411,-0.3033533624025099
SUP-T1,16065773,1.930857870073883
BT 228,BRD-A02303741-navitoclax (2-1 mol-mol),2.002941742411454
L3.3,168313047,3.843757543685879
AML-193,54618795,3.398899129626543
NCI-H2081,72734382,3.7264145222957
BT 232,1716436,3.24358958747125
RPMI-8402,168313047,1.98118306136213
SK-UT-1,9840324,5.285920653944741
SK-UT-1,5287969,-1.264654811647733
NCI-H2081,navitoclax-birinapant (1-1 mol-mol),2.3090613202793473
RCC10RGB,selumetinib-UNC0638 (4-1 mol-mol),4.208062457345683
MFE-319,2113511,5.3883877243357965
IGR-37,46907787,3.599816729005436
HOP-92,6436223,-5.327429906494982
NCI-H647,387447,-3.8631001490746217
NCI-H2009,3025944,4.548991530576528
JeKo-1,984333,-1.332076622801918
NCI-H2081,6505803,1.279924414831301
SUP-T1,969516,1.2872846029900624
TCCSUP,SNX-2112-bortezomib (250-1 mol-mol),-2.4004107919331967
VMRC-LCD,7326481,2.363264843264514
MSTO-211H,119182,-3.3068023354733156
BT 239,89928392,-0.7022778551681762
HGC-27,100016,3.78981980973908
MFE-319,51039095,3.81892446116169
HCC2108,3689413,-1.830632797435868
KYSE-180,6852167,3.0076808179282213
RCH-ACV,11717001,5.609771509374233
BEN,carboplatin-UNC0638 (2-1 mol-mol),3.690873696873906
RCH-ACV,72193861,0.4063262549026097
NCI-H647,JQ-1-UNC0638 (2-1 mol-mol),1.437386580925085
PK-59,selumetinib-BRD-A02303741 (4-1 mol-mol),2.988609115043863
MSTO-211H,9926054,1.9546831701161536
BT 232,71304818,2.0065065461393266
SK-UT-1,53232,1.9955922885483088
BT 228,53495165,1.601402322426685
NCI-N87,selumetinib-navitoclax (8-1 mol-mol),1.647881556522465
NCI-H2081,24180719,4.062007967057392
TCCSUP,46191454,2.343192904170071
NCI-H2081,2746,1.7876165118995768
WM793,5329102,2.675345821939075
WM793,54454,5.104198308699605
NCI-N87,44607531,-2.3963447234482196
KYSE-180,656346,0.5035259214869502
RCM-1 [Human rectal adenocarcinoma],7251185,3.190616991183446
AML-193,42642645,-0.7623602768387703
VMRC-LCD,135875424,4.154555639991533
MSTO-211H,9825149,1.7087798179810727
TCCSUP,2729026,2.469162640243315
TCCSUP,24753719,4.825833368668945
TCCSUP,selumetinib-piperlongumine (8-1 mol-mol),4.721141400278082
HT-1197,2130404,2.673066632509084
KU-19-19,136227924,3.1447471190609217
SK-UT-1,5738263,2.328132593934741
RKO,2828334,5.934464187728916
WM793,448949,1.628822965430235
NCI-H2009,11175137,2.49599907102206
NCI-H716,3825829,4.114621834253342
IGR-37,2949965,2.7382121751724533
SK-N-SH,44589607,0.90563943044854
P31/FUJ,5335621,3.2282922271331613
SIG-M5,119182,-3.490270307115339
KALS-1,2949965,3.478734791213389
NCI-H647,241158,5.626860272324237
IGR-37,148124,-4.42288391393864
PC-14,73707440,4.422438937843538
Capan-1,24771867,4.358241115555216
P31/FUJ,6852167,1.016015239887951
KMS-26,71466380,3.547868145762021
SCC-25,6450551,2.660576747441137
IGR-37,4705,3.0869599188409658
NCI-H1092,53495165,1.5582645503568386
KHM-1B,24856436,-0.1873560944062299
PK-59,5280436,3.786862266766158
HT-1197,9956119,3.9992512134627063
MG-63,25150857,2.778559046553677
HOP-92,71729975,2.675559908784421
KMH-2,25154868,3.095260346153153
YH-13,11364421,-5.428256768560988
SK-BR-3,selumetinib-GDC-0941 (4-1 mol-mol),-0.2707280025522744
RPMI-8402,9926054,1.3971414667672897
HARA [Human squamous cell lung carcinoma],49867926,4.231294833351195
A3/Kawakami,11238147,1.7324650350463162
VMRC-LCD,46926350,-4.334636914427668
BT 232,613753,3.5034097375656237
SK-UT-1,11152667,-1.0251821128308043
NCI-H2081,11455910,0.9023670010212674
PK-59,51039095,2.883736730230709
RPMI-8402,JQ-1-navitoclax (2-1 mol-mol),-0.6897703019254647
WM793,67156097,1.6522934388361206
PK-59,11625818,4.318844179291863
RCH-ACV,445455,4.495041737765077
SK-MEL-3,3136844,4.68445729807332
BT 239,11507802,1.2045594845042635
HCC2108,1242560,3.356321570563672
MFE-319,2742550,4.226299136306918
A3/Kawakami,44607531,1.289822947830097
KYSE-180,9936388,-5.3897473887689
RCH-ACV,erlotinib-PLX-4032 (2-1 mol-mol),2.6930481808987525
KHM-1B,5328940,1.2346884816807109
SUP-T1,6505803,-0.1872119927245122
NCI-H1092,4477,0.1803011714935916
KYSE-450,3854666,3.622949827534998
TCCSUP,11497983,6.1177518304262195
SK-MEL-3,126941,-0.5420851447301378
NCI-H1092,12001922,1.6370209009668415
EoL-1,50905018,2.259945782522485
IGR-37,2733526,2.9276237247324732
SK-N-SH,9967941,3.841733878256667
JeKo-1,46199207,2.343552745237861
SK-N-SH,tanespimycin-bortezomib (250-1 mol-mol),0.2020120787076161
KMS-26,24753719,3.990171932388741
JeKo-1,3854666,0.6806935772544002
NCI-H2009,23725625,3.8804106674125713
RCM-1 [Human rectal adenocarcinoma],11364421,0.8746857299268361
NCI-N87,16720766,-1.168414694473064
AU565,3854666,0.9438607721687704
AU565,24797083,1.2091873523376886
PC-14,4378219,5.64918445258186
KYSE-180,219104,4.692697004252791
KYSE-180,9967941,4.960769213293647
AU565,6918736,-3.127988177088939
SK-N-SH,BRD-A02303741-navitoclax (2-1 mol-mol),2.567627921909525
KYSE-450,9903786,5.350068255808832
NCI-H2009,selumetinib-vorinostat (8-1 mol-mol),-1.4945582225586194
EoL-1,5284373,1.2830235427155103
BT 232,16038120,1.5799507168729374
SCC-25,24964624,0.0455462646617359
PK-59,53232,3.176863249466792
KALS-1,navitoclax-sorafenib (1-1 mol-mol),3.170427002469034
EoL-1,10127622,0.154807328495531
HT-1197,135984461,4.813315019512045
NCI-H1092,5287620,-3.3437578986524517
SNU-719,navitoclax-birinapant (1-1 mol-mol),-1.1353149805829168
P31/FUJ,5280436,3.1830796623136832
SK-UT-1,44462760,4.294065343841732
PC-14,124202324,1.9145516901942
KMH-2,44607531,1.2258651488337708
HT-1197,44543605,4.525009382874617
SK-MEL-3,2126,3.781178662898126
HGC-27,409805,5.82933383605485
SNU-719,2113511,6.535270456416352
JeKo-1,10322450,3.378353270661745
BT 428,25262965,-1.4038141839062968
IGR-37,5328940,1.6579064397220966
EHEB,4788,5.846509507330705
JeKo-1,24180719,3.9921486226338536
NCI-N87,49850262,3.22497182450996
IGR-37,9826308,0.7769358325608193
SNU-175,navitoclax-pluripotin (1-1 mol-mol),-2.1862318970488808
PK-59,10427712,6.44047406664822
YH-13,46199207,3.8574280996782337
HuH-28,49766530,-2.3300741099072937
KHM-1B,navitoclax-gemcitabine (1-1 mol-mol),-2.36446973278894
BT 228,6914657,-5.245128335481778
AML-193,11396600,2.463856517722703
MFE-319,erlotinib-PLX-4032 (2-1 mol-mol),4.499383590609944
KYSE-180,1242560,4.399331542534589
RCH-ACV,426756,3.898936124695487
NCI-H647,3503,2.174928240083436
KHM-1B,10077130,2.7522927679914764
YH-13,241158,3.687700430080618
PK-59,5282054,3.7039273712270417
NCI-H2081,11494412,-0.0076516448343769
SK-UT-1,46174525,5.191035054740717
SNU-175,55508,1.5132330524696662
HDLM-2,54143018,-0.956261446782216
IGR-37,71680916,5.164327333901399
EoL-1,71304818,-0.4798491954658831
EHEB,5329102,1.796828248778677
EoL-1,2742550,1.6225337364075894
NCI-H2081,446155,1.804477819432441
BT 232,vorinostat-carboplatin (1-1 mol-mol),4.4030456889491765
WM793,73707398,0.9042820542427616
SK-MEL-3,selumetinib-piperlongumine (8-1 mol-mol),4.610459348633768
RPMI-8402,6918328,-2.3895696347679616
NCI-N87,374536,0.3041613365805376
PK-59,54454,2.804023256585933
SIG-M5,44566777,0.0944361252910181
BT 232,44197249,3.8584447662296
VMRC-LCD,327653,2.851210955556481
SUP-T1,9907093,3.757688687647805
RCH-ACV,15953870,2.2250377095938294
JeKo-1,54143018,0.711888426071495
BT 232,5287620,-2.27764583088623
KYSE-450,selumetinib-PLX-4032 (8-1 mol-mol),5.261174592535557
AU565,selumetinib-PLX-4032 (8-1 mol-mol),5.080870453516365
VMRC-LCD,1242560,3.594189155894479
RKO,10074640,2.8357111382750646
SK-N-SH,16659841,2.396486758405747
AU565,9803433,4.3672163986823085
RPMI-8402,10385095,1.0671050599141887
TCCSUP,156414,2.0603521073886952
BEN,15983966,2.9266168369722214
KMS-26,327653,1.2405471954530771
WM793,44607531,2.1972673735163326
NCI-H716,5746,1.502560151690514
RPMI-8402,24772860,-2.3486934861709847
RCM-1 [Human rectal adenocarcinoma],54618164,4.275813843135039
NCI-H1092,tanespimycin-gemcitabine (1-1 mol-mol),0.9307316859155624
BT 428,selumetinib-GDC-0941 (4-1 mol-mol),0.5287087065167606
L3.3,126941,-2.2408794553514735
BT 428,25126798,3.982301536443088
KMH-2,JQ-1-carboplatin (1-1 mol-mol),1.5982474569998335
NCI-H2009,15953870,4.632669867834425
IGR-37,3689413,2.8374772536506407
YH-13,11404337,1.1602704800571209
RPMI-8402,3038522,2.654271984858451
HuH-28,navitoclax-piperlongumine (1-1 mol-mol),-1.6223565301134455
SCC-25,135928012,3.793388901602888
NCI-H716,46943432,2.344580529763938
SIG-M5,2871966,0.154383966783645
SK-UT-1,9936388,-5.820733292214098
SNU-175,44819697,2.0112279543836653
KYSE-180,11238147,3.6851797317879935
RCM-1 [Human rectal adenocarcinoma],24951314,1.1143156240073944
SK-BR-3,5566,3.084964267867065
BT 239,3025986,-1.8384003555666784
NCI-N87,selumetinib-vorinostat (8-1 mol-mol),2.348461304209469
HARA [Human squamous cell lung carcinoma],12003241,-0.2443339656532688
NCI-H716,4259181,-1.4668256372956798
SK-N-SH,54613361,-0.4852242290658693
MSTO-211H,46943432,4.749068259324704
BT 228,10231331,4.437777613633079
NCI-H716,44607530,0.8789538014274904
HDLM-2,52947716,-0.9454610901266096
VMRC-LCD,3025986,-1.3370681700457725
JeKo-1,15953870,2.808726897141004
JeKo-1,71680916,3.922917634979006
HCC2108,71466445,4.412506412183148
PC-14,selumetinib-UNC0638 (4-1 mol-mol),2.495606970321077
BT 245,219104,3.873499987829312
KALS-1,46215462,2.787502410142586
PC-14,9956119,3.2961236861869363
NCI-H2009,637858,2.463099291034241
NCI-H2009,tanespimycin-bortezomib (250-1 mol-mol),-0.207724504276561
JeKo-1,439501,-6.227788271417287
KHM-1B,60750,-3.330865145118168
BEN,selumetinib-UNC0638 (4-1 mol-mol),4.827276587557196
BT 228,vorinostat-navitoclax (4-1 mol-mol),2.692815415676739
BT 239,16720766,1.1010073299621792
KYSE-180,5329102,2.581374775055639
KMS-26,5284329,2.32954724944217
BT 228,16065773,1.6708856841745474
NCI-H647,16741245,3.8506591779946224
SIG-M5,71304818,2.1831671112672493
BT 428,119182,-0.1725624897830351
RCH-ACV,219104,1.0146710218775603
SK-MEL-3,4521392,6.178556411803294
A3/Kawakami,3038522,1.0658474576209709
RPMI-8402,2756,7.578757666272814
Capan-1,10127622,3.9465278330520985
SK-UT-1,54613361,0.5908991855322304
A3/Kawakami,6450551,2.468844987550313
A3/Kawakami,piperlongumine-MST-312 (1-1 mol-mol),1.0370835054961256
SNU-175,36314,-5.293411738044468
BT 232,10113978,4.381394722416578
KYSE-180,10074640,3.100626219289962
Capan-1,73707438,4.250824594228522
P31/FUJ,9907093,4.323796399268767
AU565,carboplatin-UNC0638 (2-1 mol-mol),2.4152389485219503
P31/FUJ,56963564,-0.6738396792941169
KHM-1B,44819697,-2.627948052735268
HARA [Human squamous cell lung carcinoma],2749,1.5155233624959286
SNU-719,11612883,2.302014777271453
AML-193,16065773,1.5807262211315378
AML-193,36314,-1.9048202459892132
SW1116,72734382,3.6555152633490335
YH-13,navitoclax-gemcitabine (1-1 mol-mol),-1.557893185204028
KYSE-180,navitoclax-pluripotin (1-1 mol-mol),-0.399119188986255
EHEB,25062766,1.0202887553204696
NCI-H1092,25102847,3.2602491068155572
SK-BR-3,16725315,3.1528413930889303
A3/Kawakami,252682,5.972607064315242
EoL-1,71466445,0.1992433528179963
NCI-H2081,5351362,0.7138229961516296
HARA [Human squamous cell lung carcinoma],54613361,-1.6613115011598742
TCCSUP,44137675,4.277803621948158
BT 245,6450551,3.220292002142508
KYSE-180,10113978,4.975324753626726
KHM-1B,selumetinib-UNC0638 (4-1 mol-mol),2.050672890925013
KHM-1B,11222830,0.8303711779930824
BT 245,15953870,3.843140095574177
BEN,selumetinib-vorinostat (8-1 mol-mol),4.272191912190305
AU565,11609586,0.8886557909894768
MG-63,4788,5.871872123805738
WM793,10127622,2.6063340682647325
RKO,676352,2.3070338313311547
RCH-ACV,24180719,3.4330934492594523
WM793,5311,2.1433101075982406
RPMI-8402,49850262,2.3471451975735618
MSTO-211H,alisertib-navitoclax (2-1 mol-mol),-1.8568151112874771
BT 239,6852167,2.2833850419098116
JeKo-1,10296883,3.632586939598192
MFE-319,10127622,5.317685949286485
NCI-H716,5291,3.775524780565102
RKO,36314,-4.63858923378885
KMH-2,24753719,2.762394243468006
P31/FUJ,5281321,-2.503740446113486
KMS-26,11612883,0.4070239451186664
WM793,2729026,2.380057317950378
SNU-175,44632017,1.0055162184475448
KALS-1,9826308,1.8067972384728272
SW1116,4096211,3.3002363530872216
BT 428,selumetinib-tretinoin (2-1 mol-mol),3.9972651302997098
SK-N-SH,216345,1.9669334599410335
PC-14,135411,0.053480983141028
YH-13,148198,-2.7695139562786526
BT 245,445091,5.914097889907909
SK-MEL-3,10385095,0.9651343435449692
RCM-1 [Human rectal adenocarcinoma],24753719,5.1478478816318685
HT-1197,SNX-2112-bortezomib (250-1 mol-mol),-0.0013433122398305
BT 245,24856436,1.3341337214479536
RKO,5287620,-1.9975210326345276
RPMI-8402,4477,-0.664368126340047
MG-63,54678924,3.066804462729575
MG-63,51037431,1.913822569778096
AU565,57330099,4.7929461834362606
HGC-27,24775005,2.9064497420340913
KMS-26,23939,3.93369862290964
BT 245,637858,1.8554051464132844
AU565,52912189,3.2475583793468994
KALS-1,2742550,5.776257078576174
RPMI-8402,9903786,1.556072952295762
BT 245,3634881,2.5111674809966917
EoL-1,10385095,0.4720665951427926
HDLM-2,5284373,-1.0646183688563662
NCI-H716,SNX-2112-bortezomib (250-1 mol-mol),-4.043984860445436
BT 245,24821094,3.241284674882521
RPMI-8402,24180719,3.632264594083036
SK-N-SH,135875424,2.927968967811746
NCI-N87,148198,-3.7864178683693774
L3.3,2746,3.431089753490113
EHEB,6610216,4.931191689693455
BT 228,44462760,4.035148057219351
BT 228,11626560,1.9713633934499728
NCI-H647,25183872,-0.1446639158872469
KALS-1,navitoclax-pluripotin (1-1 mol-mol),-0.2702821738299096
NCI-H716,168313200,3.967262456883907
TCCSUP,135398516,1.0514197344839231
A3/Kawakami,54618771,0.7801439877237109
EoL-1,54618164,2.9471076229602717
BT 428,55508,2.883090615031002
SK-N-SH,selumetinib-tretinoin (2-1 mol-mol),3.993846499363134
SK-UT-1,carboplatin-etoposide (40-17 mol-mol),2.668759687344188
KHM-1B,702558,3.340125476799818
NCI-H1092,3825829,4.014845832677727
SK-MEL-3,1716436,2.062931798331765
EHEB,73707386,3.258970186799186
BEN,serdemetan-SCH-529074 (1-1 mol-mol),2.5365842669906637
HARA [Human squamous cell lung carcinoma],9907093,5.03391680027973
P31/FUJ,11964036,1.0580497047985076
WM793,387447,-3.0647343941704603
PK-59,selumetinib-JQ-1 (4-1 mol-mol),1.6048028888022474
KMH-2,16038120,-0.0384022722184617
EHEB,24964624,0.9586889430420278
NCI-H2009,tanespimycin-gemcitabine (1-1 mol-mol),0.2582692893190324
MSTO-211H,11364421,-5.484172518994792
RCH-ACV,452548,-5.162110327862569
KYSE-450,11494412,3.783526385415406
PC-14,176870,-4.905616033041748
AML-193,11497983,-4.7551773127577786
KYSE-180,2828334,7.128860440334806
TCCSUP,6610216,4.746461050840166
RCH-ACV,25105715,3.2189608633005107
Capan-1,11175137,3.236365974895181
KMS-26,89928392,-0.6165479451757117
SK-MEL-3,322968,3.845858650008727
IGR-37,11609586,2.792713191004598
SIG-M5,11612883,1.505240829042385
NCI-H1092,10427712,4.783956203495579
HOP-92,100016,6.879559613863246
AU565,5291,4.2478378741719105
SIG-M5,9933475,1.819587507920044
MSTO-211H,3062316,0.3213577633457804
KYSE-450,6918837,-1.1193045710295215
SUP-T1,227681,2.6060407294241825
KYSE-180,5281321,1.5873257175067956
P31/FUJ,9936388,-7.166815071220185
SCC-25,doxorubicin-navitoclax (2-1 mol-mol),-1.3810843654442668
IGR-37,26596,-1.7212662992488197
SK-UT-1,135421197,2.4956722116312813
AML-193,24951314,-0.6545954307866556
PC-14,16725315,3.2048847799835665
Capan-1,4261,1.4846511256418882
IGR-37,400769,-0.4332927552869453
SK-UT-1,46926350,-4.372914941162361
NCI-H2009,5287620,-2.745575302534365
EoL-1,168312962,-6.441563034366049
KYSE-450,5113032,4.607851328424312
NCI-N87,135398516,0.1780104282584799
WM793,11640390,4.32157052643877
MFE-319,135411,0.9500150248105194
AU565,119182,0.402305157716339
BT 239,9887053,2.078731857230059
BT 239,carboplatin-UNC0638 (2-1 mol-mol),3.455211961627176
SK-UT-1,6252,5.554705519214965
KMH-2,navitoclax-MST-312 (1-1 mol-mol),1.0941690336919907
HuH-28,11626560,1.9917489118805345
AU565,crizotinib-PLX-4032 (2-1 mol-mol),2.690947224555452
AML-193,salermide-PLX-4032 (12-1 mol-mol),2.800611654761287
HARA [Human squamous cell lung carcinoma],49793307,-3.043253960744797
BT 239,11656518,0.2947729119505752
HuH-28,60700,1.3095831784397838
NCI-H1092,JQ-1-vorinostat (2-1 mol-mol),1.0867450445892073
SK-BR-3,71466445,3.826803162885657
MSTO-211H,3038522,3.865174160499475
WM793,753704,5.060805642150714
SK-UT-1,11612883,4.583054819879112
TCCSUP,16219061,3.6706292867258945
SK-N-SH,10184653,1.5852942026589345
EHEB,crizotinib-PLX-4032 (2-1 mol-mol),1.830977421252466
PK-59,9935249,3.732455742727782
VMRC-LCD,BRD-A02303741-navitoclax (2-1 mol-mol),1.856912782967946
AU565,44185566,1.721131526136141
HDLM-2,carboplatin-etoposide (40-17 mol-mol),1.7052147259857935
KMH-2,23725625,3.2494896570291383
BT 428,44543605,1.5827502950644723
KMH-2,9936388,-5.258192279265897
AU565,JQ-1-UNC0638 (2-1 mol-mol),2.17780253884304
MFE-319,4917,3.7173234015272607
BT 228,11214940,3.710046775292057
BT 232,2858523,2.799178831384965
SK-N-SH,71304818,2.3337998348887323
EHEB,6852167,1.7579387732994172
SK-BR-3,6610355,3.6639205330871576
NCI-H2081,25126798,4.162268106632209
BEN,6918328,1.2749085371739255
SUP-T1,24771867,-1.7526538791604511
RKO,241158,4.5302703569847305
HGC-27,54619267,2.965551733804946
BT 245,11455910,0.6053339220870597
NCI-H2081,11214940,0.770060608501173
NCI-H2081,4096211,1.423515993754231
SNU-175,124202324,1.5499054633640368
RKO,89928392,1.6264666324972337
P31/FUJ,6917907,-6.201167718101803
EoL-1,25195348,1.0717776214723558
HDLM-2,64971,4.379107750579555
YH-13,selumetinib-piperlongumine (8-1 mol-mol),4.547014115194958
KMH-2,JQ-1-navitoclax (2-1 mol-mol),0.3677156255237743
SK-MEL-3,4917,1.7495564307766611
NCI-H716,4917,4.242280035392134
BT 239,9915743,1.0912084303287637
RCC10RGB,4788,6.17872638158586
SIG-M5,docetaxel-tanespimycin (2-1 mol-mol),-5.411082165537119
KMS-26,11213558,0.3919015650396287
HGC-27,11228183,1.6094489249793251
KYSE-450,6610216,4.803414401111398
RCH-ACV,52947716,-6.125428154591031
HuH-28,24785538,0.867547886149609
IGR-37,44185566,2.8198193010981867
YH-13,2828334,6.017888903931418
YH-13,selumetinib-GDC-0941 (4-1 mol-mol),2.117878884448022
RCC10RGB,66577038,3.312011612499516
SK-BR-3,5281672,6.068673759640097
SCC-25,navitoclax-sorafenib (1-1 mol-mol),2.0868001774276523
KMH-2,6450551,0.9471042683627704
P31/FUJ,54613361,-1.6350280742113157
MSTO-211H,selumetinib-PLX-4032 (8-1 mol-mol),2.4533429181840307
AU565,5282054,3.2331302005717153
HT-1197,5566,3.077874058196746
TCCSUP,1242560,4.927972037074151
KMH-2,9825149,2.2749474319771648
SNU-719,JQ-1-carboplatin (1-1 mol-mol),0.748518031379031
NCI-H647,3634881,3.650249872205885
TCCSUP,9823820,4.428474658115308
KYSE-450,24964624,3.228483882418733
HOP-92,BRD9876-MK-1775 (4-1 mol-mol),1.7787626869577928
PC-14,72376,-2.4231616771308047
HGC-27,56963564,-0.5147313078950073
VMRC-LCD,36462,3.4209043337731475
SIG-M5,11427553,0.9118743990862194
MG-63,89928392,1.6217001023991622
BT 245,SNX-2112-bortezomib (250-1 mol-mol),-1.4733817260772628
EHEB,10302451,2.5081035375606295
KALS-1,11977753,-1.3713893625366136
BT 428,24889392,1.9932163515881467
RCH-ACV,44632017,0.3262715489883796
VMRC-LCD,702558,5.553833902086421
AML-193,9907093,4.347270323151619
P31/FUJ,24772860,-2.926152167827307
SK-N-SH,2828334,6.153562920121799
SCC-25,11178236,-2.723845060736429
SNU-175,selumetinib-vorinostat (8-1 mol-mol),1.1144482658649129
HT-1197,2945648,2.413591937704346
KYSE-450,49793307,-1.8889821153375816
MFE-319,25154868,3.187215643047067
SNU-175,56963564,0.4543933184686524
RCH-ACV,9911830,2.531185888082776
L3.3,66577038,3.645952100238679
YH-13,3825829,4.007616735103447
HT-1197,1566236,1.7604501004419797
SK-N-SH,decitabine-navitoclax (2-1 mol-mol),1.614640262292662
AU565,4378219,1.7809295710052302
BT 228,135875424,2.3307111472907263
SUP-T1,9840324,5.557913929015957
BT 232,148198,-4.3155726249188
NCI-H647,53392493,3.772422518009949
Capan-1,5287969,-2.0319560456354555
PK-59,9840324,5.820620843354779
HDLM-2,148198,-3.3078190571311925
KALS-1,119607,5.401600809688061
KMH-2,44486219,3.638973589174113
SCC-25,6610216,3.3967716099500604
VMRC-LCD,44566777,1.8332235733428115
MG-63,5280436,3.2227926016426274
HARA [Human squamous cell lung carcinoma],216239,2.4828561148565256
BT 245,71729975,1.93645259628117
JeKo-1,24771867,-4.008363796837406
TCCSUP,9866186,0.3225667435686323
TCCSUP,57330099,4.986462210926318
BT 232,53325874,4.410904287136781
A3/Kawakami,126941,-4.4185635440660205
SCC-25,216239,2.631839911115274
SW1116,9825149,1.137929652528347
HDLM-2,25183872,-1.8787872698623256
L3.3,56649450,3.0657913461458564
TCCSUP,10427712,4.456401436086168
KU-19-19,10127622,1.068304480617998
BT 232,6450551,3.5199211045957695
MFE-319,serdemetan-SCH-529074 (1-1 mol-mol),2.933016518340843
SK-N-SH,44607530,0.9513012204910344
EoL-1,4705,0.6699610598370959
NCI-N87,5978,-2.9043455823279185
HCC2108,327653,2.5162191828052713
MSTO-211H,25183872,0.3972499543283658
SIG-M5,11955716,-2.778165684642915
SCC-25,selumetinib-vorinostat (8-1 mol-mol),1.0923234996305136
NCI-H2081,9967941,3.827989580994779
NCI-H1092,148124,4.484868615111272
AML-193,2130404,3.279860888279668
SK-N-SH,6450551,0.9413664563785176
A3/Kawakami,JQ-1-vorinostat (2-1 mol-mol),-1.7158671198145423
RPMI-8402,navitoclax-gemcitabine (1-1 mol-mol),-2.3966985543506536
TCCSUP,3634881,3.232096710476599
HARA [Human squamous cell lung carcinoma],11317348,1.2268055094863417
A3/Kawakami,2126,3.4655511603832445
NCI-N87,selumetinib-decitabine (4-1 mol-mol),3.433626364692319
AU565,702558,5.325524002647016
HCC2108,44607531,1.6757338761058749
NCI-H2009,3062316,-2.678423554108453
BT 228,54626689,4.388884846293327
TCCSUP,57519531,2.9959744097146803
KALS-1,5280436,3.074463800608427
BT 228,25154868,4.792770726405113
BEN,6918878,3.6226335161338623
KYSE-450,49766530,0.7642756518369849
SUP-T1,135928012,2.4845707468799687
MSTO-211H,984333,0.926178476056404
RPMI-8402,2945648,2.8169144460713498
HOP-92,119607,5.365554942303737
KYSE-450,23582824,2.052408979108203
IGR-37,selumetinib-UNC0638 (4-1 mol-mol),1.4187526465973006
Capan-1,135659046,4.622208259682843
RPMI-8402,123631,1.7285307590566
SCC-25,4521392,3.9835433979038104
KHM-1B,1317464,5.275687871305658
NCI-H2081,11222830,0.8960915766388172
L3.3,168312962,-1.2002539688883909
AU565,44462760,4.31661778136252
BT 228,12001922,1.1334431152108806
PK-59,6914657,-3.026539722055946
SNU-719,452548,2.886420100245746
SK-UT-1,448949,1.7923015437003926
BT 428,5113032,1.9536793565337365
BT 232,119182,-0.1765652929582462
SK-UT-1,119607,5.172021096327679
NCI-H1092,16065773,1.6948884921799936
BT 245,9549297,1.7416110131046505
Capan-1,71466445,6.280411506729028
SK-N-SH,448949,1.52009683517405
AML-193,16659841,2.7658290977505553
HGC-27,44607530,0.9680341236071648
BT 239,135999136,1.6386300110242584
BT 232,24821094,3.9107523454307223
PK-59,36462,2.3986313317590384
A3/Kawakami,285033,-3.952367237514931
BT 232,46398810,1.8083583268556371
HDLM-2,6918837,-4.377363650483544
HGC-27,9926054,1.079439551544522
BT 428,44137675,3.735819095896295
SK-MEL-3,navitoclax-PLX-4032 (1-1 mol-mol),1.288790686118111
HARA [Human squamous cell lung carcinoma],67156097,-1.978765302962937
Capan-1,421610,1.8181364549582544
HDLM-2,219104,3.528872493311525
RCH-ACV,4259181,-1.0090631503985652
AU565,24785538,3.4507965915778387
BT 245,46843906,3.7085671186163847
RKO,6450551,2.9764230599456782
NCI-H2081,445091,4.108892916064877
HGC-27,tanespimycin-gemcitabine (1-1 mol-mol),-1.0506437530710049
RPMI-8402,selumetinib-UNC0638 (4-1 mol-mol),2.886633123208553
AU565,44819697,-0.774785052988496
EHEB,49766530,-1.6427312921557593
PK-59,2749,1.9059239983781768
HOP-92,5951923,5.399089006717534
KMS-26,10322450,3.1640442596906104
PC-14,navitoclax-gemcitabine (1-1 mol-mol),0.487794635289785
HGC-27,216239,1.7079407247070624
SIG-M5,6450551,1.6469806326118368
KYSE-450,alisertib-navitoclax (2-1 mol-mol),2.776253910680575
YH-13,selumetinib-BRD-A02303741 (4-1 mol-mol),4.816369737179264
KHM-1B,3025986,-1.4274880637865957
NCI-H647,374536,-1.0414949031211966
RCC10RGB,4378219,3.5112219508307017
KMH-2,36314,1.7071309844277265
HGC-27,9444,3.729338285529504
RCC10RGB,9915743,0.9759946846108524
PC-14,9926054,2.1919524814380846
KALS-1,10113978,4.928688234957125
P31/FUJ,6918837,-4.676526715032863
EHEB,5113032,4.507896458249702
IGR-37,5282054,4.318191351234756
KHM-1B,676352,1.5366481423958254
L3.3,24771867,2.302026780280536
HT-1197,119607,5.039941356847173
PC-14,24771867,-2.59629099527772
PC-14,2708,4.06004152790413
NCI-N87,selumetinib-BRD-A02303741 (4-1 mol-mol),3.924319992587928
KALS-1,227681,3.5785954992229905
SIG-M5,9866186,-0.469337765591878
BT 228,3503,0.9999363691273242
NCI-H2081,10385095,0.3312851708861742
KHM-1B,46199207,2.2678395325481415
SIG-M5,89183176,3.842326798283278
MFE-319,5738263,3.98283089484664
SCC-25,11364421,0.013611462917165
JeKo-1,5351362,0.9721509778156238
NCI-H2081,11167602,4.408206719858069
HDLM-2,119182,-1.5812655424486173
IGR-37,selumetinib-PLX-4032 (8-1 mol-mol),0.6893076914338833
KU-19-19,135999136,4.912207411852192
HDLM-2,8515,3.3185322051747836
BT 239,tanespimycin-gemcitabine (1-1 mol-mol),-2.950102783485222
MFE-319,2828334,6.199345914852255
SIG-M5,445091,4.328953840835418
KMS-26,24180719,3.7226536353071857
KHM-1B,73707398,-0.6689954941559422
AU565,23635314,-4.115690790244737
P31/FUJ,10127622,1.4388313131004449
VMRC-LCD,1641662,3.5479525195437676
KU-19-19,3854666,3.1161318305167995
KHM-1B,2130404,2.712460002003977
SNU-175,54649381,2.364761615724883
VMRC-LCD,44489675,3.5983377569365556
HDLM-2,24180719,3.0339345159321818
NCI-H1092,104842,-3.256755572593022
EHEB,54618164,4.264105290178519
BT 245,navitoclax-MST-312 (1-1 mol-mol),0.1557480826210676
EoL-1,4477,0.0660996533823934
HuH-28,11485656,3.308019517544549
RKO,11719255,3.406006587740275
SW1116,erlotinib-PLX-4032 (2-1 mol-mol),1.6239744026736935
YH-13,107985,-2.561016282380613
RCC10RGB,19582717,5.580606305911862
AML-193,9866186,-1.5364658845539516
HuH-28,25102847,2.7807790687271186
AU565,123631,0.0519428975879534
VMRC-LCD,3136844,5.056632986858395
MFE-319,5460769,5.093824644165235
SIG-M5,46215462,1.7611755194746446
NCI-N87,selumetinib-GDC-0941 (4-1 mol-mol),-0.1269197084307303
SK-MEL-3,24964624,3.0744003291406377
SUP-T1,168313047,1.6705294802822943
NCI-H2081,44632017,0.6530598645266015
L3.3,11427553,3.3742390950754984
EoL-1,crizotinib-PLX-4032 (2-1 mol-mol),0.3193591195038406
RCC10RGB,53392493,3.4706572822964072
BT 245,2828334,6.142751716210638
A3/Kawakami,135423438,3.073341155380334
SK-UT-1,53495165,1.179970512792514
BT 428,3825829,4.221207301902304
KMH-2,1641662,2.102070811011261
JeKo-1,vorinostat-carboplatin (1-1 mol-mol),1.6861887856922086
KHM-1B,65628,3.60559222842334
SCC-25,66577038,2.262441498043391
KU-19-19,5282054,4.451216911386669
KYSE-180,49793307,-3.1171537464519186
KU-19-19,2729026,3.069520174525383
RCH-ACV,5287620,-1.999855184083047
BT 232,227681,3.884127803096242
EoL-1,selumetinib-decitabine (4-1 mol-mol),-5.202726468202839
SCC-25,9907093,3.783259491623032
SCC-25,26596,-1.8912501387828335
HCC2108,10385095,1.3545455997149978
TCCSUP,2949965,6.201374753875732
SK-MEL-3,15953870,4.253247791185363
KU-19-19,2828334,6.071698785304069
VMRC-LCD,4096211,1.285277879618483
PK-59,10296883,3.535365595306604
SNU-719,3825829,4.72361363258027
P31/FUJ,4378219,1.2412027933720209
HuH-28,51039095,1.277138122024251
BT 428,5284373,2.202230893689752
RCC10RGB,216239,3.3222265979679375
KYSE-450,119607,5.938330428290203
BEN,11404337,0.9203658173456966
RCM-1 [Human rectal adenocarcinoma],49766530,0.9963320873999868
KMS-26,168313047,0.5540157140932079
L3.3,119607,5.267929584666067
HT-1197,462382,0.1412806005557634
SIG-M5,1239801,5.396829518614267
WM793,89928392,1.2506486576555742
JeKo-1,11494412,0.2725686605120115
HARA [Human squamous cell lung carcinoma],446155,2.5576922800664006
NCI-H2009,20959075,-3.4439076637996076
KMS-26,50905018,4.383613788238156
RCM-1 [Human rectal adenocarcinoma],439501,-1.003670618583837
MFE-319,3503,2.0418157338120353
NCI-H2009,124202324,1.390796248932456
AML-193,11626560,-0.2628385681665267
BT 428,25154868,3.538465934069667
HGC-27,54143018,-0.0860216731057537
EoL-1,156422,-3.1220560528338295
KU-19-19,31703,-0.69897788572983
HGC-27,44543605,4.098474383739348
BT 232,119607,5.65813496505513
PC-14,10113978,1.875995802268999
HuH-28,54619267,3.6753111823181666
RCM-1 [Human rectal adenocarcinoma],46199207,3.748216496798377
BT 228,46907787,3.432433507540363
NCI-N87,2749,1.4538564926114168
SK-BR-3,11656518,2.4414358271473424
BT 428,9911463,3.0361887786890693
HGC-27,3854666,0.4310237545100587
L3.3,46398810,3.0103098250539846
P31/FUJ,208908,3.0114989034455415
HT-1197,3081361,3.4894793934677586
BT 239,doxorubicin-navitoclax (2-1 mol-mol),-4.637144746332767
JeKo-1,637858,1.1914802653668115
BT 428,tanespimycin-gemcitabine (1-1 mol-mol),-4.211638249912254
P31/FUJ,10113978,2.718593007254544
KMH-2,241158,3.3374557271517
L3.3,54454,4.824648171697031
HCC2108,selumetinib-navitoclax (8-1 mol-mol),2.406642843246067
MSTO-211H,navitoclax-pluripotin (1-1 mol-mol),-2.948162650279317
HT-1197,168313200,2.2416260588252546
SNU-719,11964036,0.7949756003635832
RKO,25062766,2.7314931301361476
YH-13,19582717,5.382815759701368
SW1116,44607531,0.8272222761232554
PK-59,11152667,-0.441675469971464
KMH-2,9911463,2.975818602931934
NCI-H2081,55508,1.4698718095491496
BT 428,11964036,0.9395896328127812
AML-193,decitabine-navitoclax (2-1 mol-mol),0.1855968406093358
AML-193,navitoclax-sorafenib (1-1 mol-mol),0.3182760979090197
PC-14,selumetinib-navitoclax (8-1 mol-mol),0.9559974576764104
SCC-25,23725625,4.533632168001557
BT 232,40482356,5.459130936961733
HGC-27,10077130,1.9285990200430336
TCCSUP,3552672,2.292298404994988
EoL-1,44197249,1.1153126681709968
SK-UT-1,11640390,4.3621330098002815
VMRC-LCD,56946209,-6.524510578425562
RCM-1 [Human rectal adenocarcinoma],969516,2.888727843593038
RCC10RGB,16065773,4.176477311044804
RCC10RGB,24964624,2.93015987785669
BT 232,6918837,0.7720623301478966
SIG-M5,49766530,0.6577937335718277
SCC-25,5311,0.8315818161020944
RKO,9911463,3.963116579454927
SK-MEL-3,3689413,0.509275079548213
KU-19-19,54454,2.6957608866389866
KMS-26,5281321,-3.3638256948259593
RCM-1 [Human rectal adenocarcinoma],44819697,-0.1720631569254475
HuH-28,46398810,1.993626292784495
HOP-92,156414,1.5048646511910324
PC-14,71304818,2.390926518141532
EoL-1,10322450,2.2148801830684097
SK-UT-1,25183872,-1.299930208238578
KMS-26,11497983,-3.910605957229091
BEN,vorinostat-navitoclax (4-1 mol-mol),1.4283608810672992
BT 245,375860,-0.1637313030055035
NCI-N87,216345,3.97830172236079
BT 428,6610216,3.3816789870982547
KMS-26,16722836,-0.5250016445807598
SNU-719,9935249,4.380712428445992
RPMI-8402,docetaxel-tanespimycin (2-1 mol-mol),-5.635127851976312
NCI-N87,44202524,1.5092428544055756
SK-N-SH,serdemetan-SCH-529074 (1-1 mol-mol),1.078796767299459
HCC2108,10427712,4.666619490685044
MSTO-211H,25150857,2.632878402859221
SK-N-SH,104842,-6.263654222598093
BT 228,navitoclax-pluripotin (1-1 mol-mol),-1.5760462838556912
AML-193,7251185,1.5089606079337985
WM793,11964036,2.6064351819040885
SNU-175,46199207,2.8858196469082937
VMRC-LCD,4915,4.473021938888378
HDLM-2,11222830,1.6108042941217549
RCM-1 [Human rectal adenocarcinoma],19582717,3.1254677854052333
P31/FUJ,44185566,1.65624467652309
SIG-M5,2828334,5.799822491071952
P31/FUJ,1750826,-3.787471607079622
KMS-26,11964036,-0.7655869149357494
BT 228,54618164,3.930760792437564
PK-59,24753719,4.213783257625297
HT-1197,11364421,1.641937808385012
SW1116,25154868,4.68855505439891
RCH-ACV,53232,2.368299599767186
Capan-1,JQ-1-carboplatin (1-1 mol-mol),2.2044130423038477
A3/Kawakami,67156097,-1.8359458789137733
SNU-719,24964624,2.0110200986217857
SNU-175,5287620,-2.8682160610877827
RPMI-8402,26596,-2.3009998991377274
BT 245,54649381,3.7292740708947094
Capan-1,25105715,3.7624474612622247
SK-MEL-3,9933475,1.7061738525409735
SK-N-SH,salermide-PLX-4032 (12-1 mol-mol),5.024085484240503
IGR-37,19582717,3.944405371105941
RCH-ACV,444795,3.203280801108019
PC-14,89928392,2.519472731436531
AML-193,65064,4.623557590982378
NCI-H2081,11977753,-1.86082433815017
SNU-719,BRD-A02303741-navitoclax (2-1 mol-mol),-0.0760895514465109
PC-14,5278396,3.0631112652211296
BT 228,9866186,3.048331504408752
KMH-2,119182,-1.5017162048939945
NCI-H647,123631,3.077921503553636
EoL-1,89183176,1.5758667727220967
KMS-26,6252,-2.813635062887943
IGR-37,25105715,3.1930511112689506
AU565,11612883,2.0019521527087982
BT 239,11228183,-2.3557936870248657
HCC2108,126941,-1.9407933202051555
EoL-1,439501,-3.7702491221703145
NCI-H2009,6918328,-0.9509353973047906
KALS-1,1716436,3.6309348474737946
BT 245,54596558,4.562249989788446
HGC-27,ISOX-bortezomib (250-1 mol-mol),-0.1688227668765001
NCI-H647,BRD-A02303741-navitoclax (2-1 mol-mol),3.6260312402775665
SK-BR-3,15983966,-4.737641308190855
MG-63,23725625,5.465330148404254
MG-63,5282054,3.218025704030332
IGR-37,5460769,4.3562687129012625
HARA [Human squamous cell lung carcinoma],5278396,3.775794457804869
YH-13,16722836,2.280757149111382
KALS-1,20959075,-3.091354050892867
KMS-26,54619238,4.413075677535254
SNU-175,6918736,-1.7727815119126342
RCC10RGB,24821094,3.8097926200280225
AML-193,168313016,4.844735989269703
JeKo-1,72376,-2.8067690206076747
HuH-28,2729026,2.3275341188762764
IGR-37,9929138,7.412799255181445
HDLM-2,11178236,-2.492168621728649
RCH-ACV,71466578,2.2635028398543375
EoL-1,4096211,-0.1890756604124229
SCC-25,1750826,-2.650172637736591
HDLM-2,24785538,2.022879820292751
SNU-719,2945648,3.301014514847339
PK-59,carboplatin-etoposide (40-17 mol-mol),3.6001862575499963
KU-19-19,doxorubicin-navitoclax (2-1 mol-mol),-0.7241135755509572
HGC-27,2949965,2.233951818718664
KMH-2,6918878,1.3262621039986062
NCI-H647,2130404,3.252555231348748
HDLM-2,104842,-3.470702621312237
YH-13,44241473,5.475816552188209
SK-UT-1,72193861,1.4667643802381731
WM793,11507802,2.1513003303084592
HARA [Human squamous cell lung carcinoma],400769,-0.3643318812201842
KYSE-180,doxorubicin-navitoclax (2-1 mol-mol),0.1491747369052168
RPMI-8402,24951314,-0.3127200108094201
SCC-25,135984461,2.1535341859506776
HARA [Human squamous cell lung carcinoma],46191454,0.0255281814012309
NCI-H2081,3689413,-0.989992552174664
HGC-27,24856436,-0.6004298082102123
NCI-H1092,5291,3.938438464985971
KU-19-19,selumetinib-piperlongumine (8-1 mol-mol),2.2054937321135775
RCH-ACV,42642645,-0.768591236038087
BT 232,46224516,2.361248581225864
Capan-1,52947716,3.304297222777977
EHEB,3552672,2.013023360686031
EoL-1,24821094,-1.1254872805808611
BT 239,46843906,2.767533902526109
SUP-T1,selumetinib-vorinostat (8-1 mol-mol),2.3626230933029375
SCC-25,44487872,4.502394555510824
SNU-719,selumetinib-decitabine (4-1 mol-mol),-0.4388121930822217
BEN,6610216,5.086594972781992
MFE-319,445643,4.1892910778824
YH-13,31703,-0.371701474811386
NCI-H1092,462382,0.0075448360840851
AML-193,135411,-1.734836163391053
KALS-1,159324,3.9170291523443126
TCCSUP,168312962,2.9048095339563615
Capan-1,9926054,1.8783300658857656
EHEB,5280436,3.866090373293539
HGC-27,serdemetan-SCH-529074 (1-1 mol-mol),0.8892906783849385
BT 245,46926350,-3.489677690297977
HT-1197,44486219,4.25957230118065
SCC-25,25062766,2.1382066415948127
BT 239,444795,5.138852816460672
NCI-N87,46224516,3.4075734240800624
Capan-1,52912189,2.5666493161561816
MG-63,25126798,4.308100968194972
RPMI-8402,216468,-0.1655050849346186
BT 228,JQ-1-MK-0752 (1-1 mol-mol),4.454521139111631
HCC2108,54454,1.8049440069965668
NCI-H647,71466578,5.720751142332154
IGR-37,46843906,3.979408346870625
NCI-H2081,2858523,3.0254216671755114
NCI-H647,19582717,4.357971218178705
MG-63,5113032,4.89417585089853
NCI-H1092,71466445,6.1929235006275585
A3/Kawakami,327653,2.708987247942638
KYSE-180,68056272,3.810471876524393
P31/FUJ,124202324,0.9428129005296164
AML-193,11228183,0.0961308708955563
SK-N-SH,10410894,4.174700797268932
BT 228,24964624,2.995189092679441
EoL-1,25262965,-6.189790154739607
A3/Kawakami,613753,3.267752960174506
SIG-M5,navitoclax-pluripotin (1-1 mol-mol),-1.642489164003717
Capan-1,11656518,2.929937159966666
BT 245,439501,-4.061461225365729
NCI-H2081,11396600,3.4950774921622174
TCCSUP,decitabine-navitoclax (2-1 mol-mol),3.3142403079225073
EoL-1,5287620,-3.124327304073798
BT 428,2746,2.3155764073240177
SK-BR-3,4788,5.855936934267582
KYSE-450,serdemetan-SCH-529074 (1-1 mol-mol),2.594112814660752
MFE-319,3062316,3.7160649791058695
L3.3,71466380,3.127104498422419
KMH-2,carboplatin-UNC0638 (2-1 mol-mol),2.6282435613329405
HDLM-2,11626560,1.7756513842600683
P31/FUJ,24753719,3.279397605233023
MSTO-211H,9911830,2.3480580098381747
MSTO-211H,72376,-3.945669301292739
HARA [Human squamous cell lung carcinoma],23635314,-1.642514653884031
NCI-H1092,5328940,2.2239525200024812
AU565,tanespimycin-gemcitabine (1-1 mol-mol),-2.222908317148695
PK-59,568763,0.0204915362777041
Capan-1,vorinostat-navitoclax (4-1 mol-mol),1.1095937999699013
BT 428,66577038,3.041559321565452
AU565,25062766,2.0331930756167234
BT 239,322968,2.0264645639827847
RKO,53495165,0.8925500623489324
KMH-2,3854666,0.5486625704198924
A3/Kawakami,salermide-PLX-4032 (12-1 mol-mol),5.037957120829014
A3/Kawakami,9927531,2.786138883968946
SUP-T1,53495165,-2.6438462419362936
HDLM-2,11497983,4.369196080761882
L3.3,5328940,2.2327140114261597
AML-193,selumetinib-piperlongumine (8-1 mol-mol),1.087151646204532
SNU-175,72376,-2.940540387408821
RKO,168313200,3.1169425006108455
BT 232,23725625,6.127225552330633
RCC10RGB,71304818,3.488257335656729
MG-63,sirolimus-bortezomib (250-1 mol-mol),0.1277203686177557
BT 228,5351362,1.2005760032925734
HDLM-2,36314,1.7507937705683203
RCM-1 [Human rectal adenocarcinoma],6505803,-0.0377469333531859
MG-63,11404337,1.2234517903826516
NCI-H647,6918638,1.1619683266292729
SK-BR-3,45279963,4.0258353504782916
PC-14,24785538,0.8050188267583898
SK-BR-3,568763,-0.2171620544001349
SK-MEL-3,9911463,3.4367416892485556
YH-13,9935249,4.648604322917456
EHEB,11404337,0.0364567319098325
SCC-25,3503,2.797775000713882
EoL-1,alisertib-navitoclax (2-1 mol-mol),-4.496965368588885
KHM-1B,selumetinib-GDC-0941 (4-1 mol-mol),-0.3982194737494156
HDLM-2,126941,-1.8522795942282584
P31/FUJ,4788,5.1911977113578285
IGR-37,44819697,-0.2216354220733684
RCC10RGB,89928392,1.8749323034057075
BT 239,1716436,1.9087781155973864
AML-193,5470400,-1.8779825280775693
HGC-27,23635314,-3.8894976815867617
BT 228,11494412,2.9985974737490557
NCI-N87,10302451,0.4744399528749561
SNU-719,17755052,2.6362470054963505
RCM-1 [Human rectal adenocarcinoma],448949,2.472966773294446
MG-63,15953870,4.424502832603743
NCI-H2009,9935249,4.414461781647313
MFE-319,11152667,-0.9823368330260248
A3/Kawakami,135398516,1.4171407783076164
HDLM-2,23635314,-3.038184530924264
KMS-26,46174525,3.2410688667025913
SK-N-SH,44566777,-0.8987888691824246
NCI-H716,5278396,3.7187145555692904
BT 428,54649381,3.993232750237313
HuH-28,selumetinib-decitabine (4-1 mol-mol),4.8764935343159745
VMRC-LCD,44486219,4.223319783707999
HGC-27,2828334,5.730959013912689
NCI-N87,erlotinib-PLX-4032 (2-1 mol-mol),3.0192784761472
SCC-25,52912189,1.0303117125650771
BT 239,44197249,1.3567645545283795
BT 428,60700,-3.595237401616721
HCC2108,135875424,3.411556630339189
RPMI-8402,65628,2.821796268032044
AU565,72199292,-0.5217195589045935
BT 245,54619267,4.214911597646626
SK-BR-3,12003241,-1.7425302549890949
NCI-N87,10231331,4.183605147658756
RKO,selumetinib-decitabine (4-1 mol-mol),2.541552473841643
PK-59,1242560,3.3598439787312167
SK-MEL-3,72376,-0.9980687468762208
BEN,9936388,2.3760143279303096
A3/Kawakami,46926350,-5.375609263703226
RCH-ACV,54618771,-1.6129004186602771
MSTO-211H,25262965,-3.426128826799908
L3.3,3854666,3.761529361474975
HGC-27,selumetinib-PLX-4032 (8-1 mol-mol),4.849307138149301
HDLM-2,4917,2.819548964085276
SK-MEL-3,45279963,4.040507006188985
NCI-N87,11178236,-2.6087498623354977
BT 428,9884685,1.1692312726776757
KU-19-19,docetaxel-tanespimycin (2-1 mol-mol),1.4200175787881737
MG-63,445091,4.734162422347684
MSTO-211H,73707438,4.334782721865043
SK-BR-3,11257553,0.3314610538969854
HOP-92,2945648,2.934894880499461
Capan-1,piperlongumine-MST-312 (1-1 mol-mol),2.757417819143593
PC-14,71466578,4.3442351704394895
P31/FUJ,15983966,-4.570279214878008
SK-BR-3,selumetinib-piperlongumine (8-1 mol-mol),3.094008889152291
RCH-ACV,3136844,3.5130213724261647
IGR-37,selumetinib-vorinostat (8-1 mol-mol),0.5095178470220681
RCM-1 [Human rectal adenocarcinoma],135999136,4.538916733621322
MFE-319,409805,5.809457892580604
RCH-ACV,1641662,3.2051241704916387
KU-19-19,9936388,2.972521935644637
SK-MEL-3,15983966,1.6690197521001142
SK-UT-1,375860,0.2310503192742169
SNU-175,52947716,-5.051988653650285
KMH-2,46398810,2.11078357421812
BT 232,9952709,3.028747574067214
SUP-T1,navitoclax-piperlongumine (1-1 mol-mol),0.9320248243639676
BT 228,65628,4.442361591085553
SUP-T1,1242560,2.9817282050314864
KYSE-450,11455910,0.6287655004796859
TCCSUP,135423438,2.289740320598626
P31/FUJ,17755052,1.7010190253681206
HARA [Human squamous cell lung carcinoma],9911463,4.1556235611039405
NCI-H2009,3025986,-0.6988289053859157
MG-63,11497983,5.593172346619843
HCC2108,11404337,0.8287580393905775
PK-59,53495165,-1.117412066108967
KHM-1B,54649381,3.5405814758079117
SW1116,51039095,3.4783138882171794
MFE-319,carboplatin-etoposide (40-17 mol-mol),3.8111227483886614
KYSE-180,24753719,4.5603328664886815
HDLM-2,sirolimus-bortezomib (250-1 mol-mol),0.137697197491076
KHM-1B,24901704,2.862700156831434
SK-UT-1,46907787,3.5849510733980265
BT 228,53392493,1.829000017763953
RCM-1 [Human rectal adenocarcinoma],71466445,2.906568419759945
RCC10RGB,445643,3.986839371383198
HOP-92,25105715,3.16656341129952
BT 228,9868037,3.723299534994555
EoL-1,89928392,-1.2820639015336872
KYSE-180,31703,-0.5178877164646636
VMRC-LCD,9926054,1.8620502952585032
RCH-ACV,11977753,-2.8755723784306504
BT 232,11152667,1.540463264489362
AU565,5738263,3.0246848768630334
MSTO-211H,11640390,2.078497045728262
EoL-1,72734382,1.486975574252743
SNU-175,9826308,-2.398899340446053
MSTO-211H,51039095,-0.728954813106199
IGR-37,46199207,3.8129080291897894
KYSE-450,9911463,4.540289012412596
KMH-2,72734382,3.9996380799295497
YH-13,11977753,-2.376684100731715
L3.3,44202524,1.4046743198353957
EoL-1,156414,-3.3085458408804556
HCC2108,322968,3.4619795366418105
RKO,46398810,2.934390735401444
SCC-25,tanespimycin-gemcitabine (1-1 mol-mol),-0.6819650494842036
RCH-ACV,9956119,1.3602545384898377
YH-13,11214940,1.756237854396178
RPMI-8402,409805,3.6932223426421023
BT 228,selumetinib-navitoclax (8-1 mol-mol),2.0295466512917133
PK-59,9967941,4.046263495690824
KALS-1,53392493,2.849632328388207
EoL-1,46907787,-4.038494248120017
HT-1197,71466578,6.370396557453472
EoL-1,navitoclax-piperlongumine (1-1 mol-mol),-3.6869001282601808
HuH-28,216468,5.638711839256277
EHEB,89928392,-0.0785047887437129
Capan-1,969516,2.424795988745451
MSTO-211H,168313047,1.6297190097298295
VMRC-LCD,67156097,-1.546230739077336
BT 239,11152667,1.551234478397614
BT 232,selumetinib-UNC0638 (4-1 mol-mol),3.93204877640246
HGC-27,67156097,-2.742007821604922
RCM-1 [Human rectal adenocarcinoma],9887053,4.376213721678965
NCI-H1092,25154868,3.3407457586417566
SNU-719,24785538,-0.3769292247195751
HARA [Human squamous cell lung carcinoma],6438330,2.871193568039211
JeKo-1,6184667,1.8325682164292776
RKO,36462,3.4370564574699185
HARA [Human squamous cell lung carcinoma],11625818,4.840804819194981
HGC-27,crizotinib-PLX-4032 (2-1 mol-mol),1.1666271296419868
NCI-H2081,25150857,0.8996353500859205
HOP-92,3634881,2.754347251205212
KYSE-180,46907787,3.816228061036196
HGC-27,1242560,1.5600620461660333
HT-1197,44607530,2.314485300362582
NCI-H647,7251185,3.5380831009692995
RCC10RGB,selumetinib-vorinostat (8-1 mol-mol),3.237241333738756
AU565,25195348,3.492226581515367
BT 232,crizotinib-PLX-4032 (2-1 mol-mol),2.4628414245830483
MFE-319,5282054,4.489089240197072
BT 245,44507138,1.830901740816437
HOP-92,16722836,0.8101876956835254
PK-59,135440466,1.9897186815972312
VMRC-LCD,5394,4.085738770057183
SIG-M5,26596,-1.691579811002482
HCC2108,11626560,1.2483680324780997
EoL-1,44607530,0.6265198274361242
NCI-H2009,46907787,0.5680124512944033
BT 245,5460769,4.174087021944073
VMRC-LCD,5287620,0.3254355424911494
BT 239,51039095,2.389121571805182
KYSE-180,serdemetan-SCH-529074 (1-1 mol-mol),2.3762708337041993
RKO,5329102,2.192208184281935
MSTO-211H,44137675,1.9879298255329003
NCI-H716,10113978,-1.279300446936732
AU565,49766530,1.448288738772077
SK-BR-3,135398738,5.01530629716802
JeKo-1,9903786,1.7626830163965443
BT 239,49766530,0.6116447613594903
SIG-M5,navitoclax-birinapant (1-1 mol-mol),1.5504952637972276
EoL-1,46191454,-3.1896476089688046
SK-N-SH,135398738,4.9446672402637155
EoL-1,11626560,-1.0620802780440857
SK-N-SH,10296883,3.689781558622769
TCCSUP,sirolimus-bortezomib (250-1 mol-mol),0.3356822516851041
PK-59,16065773,3.0551899426712534
EoL-1,54613361,-2.445415255229565
KMH-2,46199207,1.948919632524886
BT 245,148198,-4.884445563516914
VMRC-LCD,46191454,1.8403120145643812
KMH-2,11152667,-1.1792266264119935
AU565,66577038,2.656766135213886
AML-193,11455910,0.2037712262055268
Capan-1,5280436,1.796996108196341
EoL-1,73707371,4.554484660299208
KYSE-450,44589607,3.132602917923117
NCI-H647,6918837,-2.8615556859762648
SK-BR-3,11977753,-2.859297640579403
SK-BR-3,322968,1.5727594688948032
Capan-1,JQ-1-navitoclax (2-1 mol-mol),0.9289890223415188
NCI-N87,17759555,3.435080423112301
SNU-719,9915743,1.2257458937302947
VMRC-LCD,10385095,1.1989116175151169
JeKo-1,2746,1.6598198436915612
BT 239,9884685,-0.9552991343653138
A3/Kawakami,10427712,4.087629069299278
RKO,44185566,2.4837284923488063
PK-59,54619267,5.6272889715375385
AU565,26596,-1.0644098452654434
HT-1197,JQ-1-UNC0638 (2-1 mol-mol),1.8142501830752336
NCI-H647,56973724,4.752864487226301
MSTO-211H,46907787,2.574686905184434
NCI-N87,10410894,1.83413876253328
BT 228,navitoclax-MST-312 (1-1 mol-mol),1.1066452548060508
KALS-1,1566236,2.244162575984816
HGC-27,6505803,-2.0578617298265787
RPMI-8402,11497983,-4.12444587448457
EHEB,66577038,2.720898706959581
BT 239,54618164,3.809265619154791
MSTO-211H,10231331,1.7809441814393978
MG-63,24856436,1.0444303109683877
Capan-1,6918638,0.6786915212188055
AML-193,52912189,0.6252060718354657
P31/FUJ,3825829,3.1586120375796516
HuH-28,5978,3.9323167273249537
KU-19-19,11626560,2.7733848967135017
SUP-T1,67291369,-0.1250326241307744
BT 232,selumetinib-BRD-A02303741 (4-1 mol-mol),5.055929245658767
KMS-26,5738263,2.636959700538162
IGR-37,4477,1.1348684317515705
SCC-25,selumetinib-piperlongumine (8-1 mol-mol),1.3441956580234826
BT 428,262093,2.2051737857299547
SK-MEL-3,148124,3.772454869250104
SK-BR-3,65064,5.220058644086049
AU565,135659046,3.967998335471068
HuH-28,3025986,-0.1333916501240696
MG-63,25102847,3.039304572516805
L3.3,6918736,-1.7247535795274376
NCI-H1092,9823820,4.957338648627321
KMH-2,6252,-0.7158420980115995
Capan-1,107985,-4.358554315773558
A3/Kawakami,135398738,1.9703291041453992
NCI-N87,15547703,1.070685995489879
NCI-H1092,SNX-2112-bortezomib (250-1 mol-mol),0.0447588085081416
KALS-1,285033,-2.086584000346929
RKO,doxorubicin-navitoclax (2-1 mol-mol),-1.0579033502847706
KMS-26,11647372,-2.027591770951244
AU565,25154868,3.4836730381065424
JeKo-1,45279963,3.0077702813978475
BT 239,25126798,4.183502066711839
RCM-1 [Human rectal adenocarcinoma],JQ-1-MK-0752 (1-1 mol-mol),2.1464995044057606
HARA [Human squamous cell lung carcinoma],decitabine-navitoclax (2-1 mol-mol),1.7884131125603568
PK-59,285033,-1.600549303351576
KMS-26,9936388,-7.293063549205381
KMH-2,216345,2.413590189878599
KU-19-19,168312962,-2.211081322704064
BT 228,navitoclax-gemcitabine (1-1 mol-mol),-0.3585266787111215
NCI-H716,vorinostat-carboplatin (1-1 mol-mol),3.685885210960624
SIG-M5,168312962,1.9531023160398255
KYSE-450,44819697,-0.2732564479087796
HGC-27,selumetinib-MK-2206 (8-1 mol-mol),-0.1421061524237457
MG-63,3038522,1.724028911225607
KHM-1B,11609586,2.3896686488847343
SNU-719,216468,3.941900421073096
TCCSUP,54454,2.1286318992115523
BT 232,409805,5.8765116213530195
RPMI-8402,107985,-3.808655830164077
HDLM-2,3825829,2.899481570882313
SK-UT-1,26596,0.4182972999713699
NCI-H647,9952709,2.637132127285373
RKO,5280436,4.655813696583822
VMRC-LCD,6914657,-3.9132184109485206
MFE-319,doxorubicin-navitoclax (2-1 mol-mol),-0.0136816460873924
VMRC-LCD,5282054,2.4488479192749937
RKO,67156097,-1.3338800856316015
NCI-H2009,9911463,4.220122302208283
BT 245,71466380,4.447315165962252
HDLM-2,16720766,0.9193427117059256
AU565,44632017,0.8977842888684593
MFE-319,navitoclax-birinapant (1-1 mol-mol),2.8521402779666727
NCI-H716,44607531,1.3141496664410284
NCI-N87,23725625,5.7035859672182125
HARA [Human squamous cell lung carcinoma],11612883,2.0711773248440783
MSTO-211H,3854666,2.1662920246080963
Capan-1,6918328,-0.3262868688636278
NCI-H647,44607531,1.555885964587704
EoL-1,445643,2.8251488274282197
RKO,5566,3.2270609816668308
A3/Kawakami,9887053,0.9849240365434958
L3.3,753704,5.0689754221003875
MG-63,71304818,1.1069839769884118
BT 239,SNX-2112-bortezomib (250-1 mol-mol),-4.499356026231561
KALS-1,11485656,3.631175776194637
HT-1197,navitoclax-sorafenib (1-1 mol-mol),1.5477016042234546
SK-MEL-3,serdemetan-SCH-529074 (1-1 mol-mol),0.974007621603094
NCI-N87,navitoclax-sorafenib (1-1 mol-mol),-0.0367825564296656
KMS-26,426756,5.5395571196206
RKO,46215462,1.869666408515056
EoL-1,9903786,-0.1437472034571408
YH-13,969516,2.628286868310954
SCC-25,73707398,0.6106904052422437
Capan-1,126941,-0.8787155865127281
P31/FUJ,72734382,3.508076038929844
KALS-1,25150857,2.546590145850423
P31/FUJ,16736978,2.2012912480094444
HCC2108,6852167,3.7271551469098583
HDLM-2,46191454,1.6344464979925033
SK-N-SH,vorinostat-carboplatin (1-1 mol-mol),2.6407198709944257
HOP-92,5329102,1.9582212596635515
IGR-37,16722836,1.580388366163465
P31/FUJ,3025986,-2.3655111331800067
EHEB,10113978,2.77276539003515
HGC-27,568763,-0.4986188962007457
PC-14,156414,-5.707063313851652
TCCSUP,15983966,0.2515630787348941
SK-UT-1,11485656,2.414217391257394
SK-UT-1,135875424,3.143376991018657
SIG-M5,25161177,2.9225997907660664
SW1116,135984461,2.388083333366143
SIG-M5,JQ-1-MK-0752 (1-1 mol-mol),-0.5958394937944917
HARA [Human squamous cell lung carcinoma],107985,-4.031127583701494
SNU-719,JQ-1-MK-0752 (1-1 mol-mol),0.3292119229546599
HT-1197,25105715,3.6162195429059816
NCI-H2081,54618771,1.045855982244366
P31/FUJ,5978,-3.805650321394954
RCM-1 [Human rectal adenocarcinoma],5113032,4.670023295767466
MSTO-211H,6505803,-0.0669493563910609
NCI-H1092,46843906,3.6069684847393666
HGC-27,72199292,-1.2278690358150604
RPMI-8402,1750826,-1.444625631410008
BT 239,2733526,2.0740339667337384
SNU-175,54613361,-1.3965990497686565
YH-13,44589607,3.382953504149869
PC-14,2749,1.485867030410151
KHM-1B,24951314,0.1876551064877586
KMH-2,SNX-2112-bortezomib (250-1 mol-mol),-2.245664195883502
WM793,10074640,3.0714713533769573
YH-13,71466578,4.92268847622802
VMRC-LCD,49793307,-5.170822190060226
KHM-1B,11396600,1.492899305921399
KMH-2,4917,2.732041462419925
BT 245,60700,-3.5416994906871917
HCC2108,46199207,2.9189708638806313
EoL-1,1566236,0.4316252370968399
NCI-H2081,54618164,3.631207373775394
PK-59,9911830,2.647954789959704
NCI-H716,60700,1.665827896276489
SIG-M5,72734382,3.9207348415188066
KYSE-180,10302451,1.5519577455009292
SUP-T1,24753719,2.6929520515821515
HARA [Human squamous cell lung carcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),2.096379077317258
RCM-1 [Human rectal adenocarcinoma],16722836,2.4867038992166783
MFE-319,6610216,4.57557190347099
RKO,3385,4.410917651107157
PC-14,6610216,4.542252614030989
JeKo-1,216239,1.61271536903043
KYSE-180,11427553,3.160880704621236
SK-BR-3,123631,0.8857593905475037
BT 232,216345,3.488955849502496
SNU-175,135440466,3.4947998798769686
MFE-319,10385095,0.9790688990862756
SK-UT-1,439501,-2.663904937582399
SIG-M5,46843906,1.3118635715915554
HGC-27,5702613,1.9033113486385655
AU565,1641662,2.8108586385203234
RCH-ACV,49793307,-4.408069888434549
KHM-1B,10074640,2.3153156166587783
JeKo-1,9956119,1.6267047228021096
NCI-H2009,11497983,-2.437134563400756
NCI-H647,42642645,0.6408660705553061
HOP-92,25022340,4.378300907267188
EoL-1,56949517,3.219336558022646
AML-193,24772860,-2.6394717232741254
RPMI-8402,135398738,1.2648797751440064
SK-MEL-3,11396600,4.278325283702902
MG-63,148198,-4.931736282287541
SIG-M5,ISOX-bortezomib (250-1 mol-mol),0.3537367143510763
SCC-25,SNX-2112-bortezomib (250-1 mol-mol),-2.6600002703122088
KALS-1,24951314,2.1789973537870564
HDLM-2,5278396,2.7792406999850945
JeKo-1,49867930,5.347568479020189
SK-BR-3,57519531,1.7224667867716767
MFE-319,42642645,1.7414638697140636
HuH-28,49836020,4.5831032591173635
VMRC-LCD,5746,1.4690604442227733
Capan-1,selumetinib-tretinoin (2-1 mol-mol),2.9790733875902884
HT-1197,selumetinib-navitoclax (8-1 mol-mol),1.5717713116425882
KYSE-180,selumetinib-navitoclax (8-1 mol-mol),5.444648861161274
NCI-N87,26596,-0.8687464208841552
NCI-H716,3081361,0.764315350347919
BT 228,107985,-1.863382776783745
NCI-H647,409805,3.845998553182997
KMH-2,100016,3.8705403745512017
Capan-1,9823820,6.097393911992554
YH-13,5311,2.0479305445727083
HT-1197,3689413,0.4105522735593818
BT 239,2708,3.1410255202002166
BT 232,219104,4.097873021244234
EHEB,72193861,-0.1168553281087315
AML-193,89928392,0.0827463898705476
YH-13,6450551,2.0238267614967644
AML-193,tretinoin-navitoclax (4-1 mol-mol),3.6314470727726262
WM793,24964624,2.7889757819511996
BT 228,11234052,4.091579723597007
JeKo-1,6918837,-5.238946245506037
L3.3,9866186,0.5756442482063215
SUP-T1,6852167,1.0606596994017583
SK-BR-3,BRD-K55473186,4.036164402365462
RKO,11455910,0.1271196393609195
SCC-25,44632017,0.7685727735433796
HGC-27,702558,2.9191642337389045
KYSE-180,carboplatin-etoposide (40-17 mol-mol),4.3219850025217434
BT 228,6610355,4.266473280430162
SNU-175,5328940,-0.4980205733637439
SNU-719,3689413,0.5380163789509392
RCH-ACV,5738263,2.8072247441111275
HDLM-2,JQ-1-carboplatin (1-1 mol-mol),4.397812362748352
IGR-37,51039095,3.0289329119308115
KYSE-180,6918736,-2.1145791698894056
JeKo-1,123631,2.6506512070094796
MSTO-211H,54649381,3.373909346349482
KALS-1,44819697,-0.0353672983069422
NCI-H647,44491742,3.8006488884614527
KMS-26,54626689,3.66942330100015
BT 239,23582824,-0.6583413172534509
IGR-37,3825829,4.196749191205033
YH-13,11175137,1.3907833057777284
AML-193,10296883,0.366102504312359
YH-13,409805,5.8043407056117395
HCC2108,49793307,-2.77688699099991
P31/FUJ,107970,2.0437014771117425
BT 239,25183872,-0.4344604999713712
SCC-25,3676137,4.957830242957624
RCH-ACV,23582824,0.0907163593087421
SCC-25,252682,6.442638935533368
SK-N-SH,JQ-1-vorinostat (2-1 mol-mol),0.8224153161812864
SIG-M5,11396600,3.2448183238044255
YH-13,44202524,1.4196385072137423
AU565,1566236,1.7493429265082687
AML-193,8515,4.304311331712035
SK-MEL-3,16659841,5.063292982884935
KALS-1,12001922,2.543795195369394
YH-13,11222830,1.7805573322131083
BT 428,76446078,5.6455430214390985
AU565,4521392,3.744925242939049
KMS-26,219104,1.7087945129103568
EHEB,24772860,-2.594982066939884
AU565,9444,3.6632568473184888
MFE-319,4788,5.850755160744142
NCI-N87,11625818,1.9405356473547937
HGC-27,24797083,0.4129072317113947
KMS-26,3384730,-0.4858783534397178
HCC2108,tanespimycin-bortezomib (250-1 mol-mol),-0.3667697976747508
PC-14,7326481,3.0182937737030944
BEN,637858,3.568953434975905
PC-14,3025944,4.10204120238025
EoL-1,135440466,-0.5351871815549306
IGR-37,6914657,-2.526935835205008
BEN,10184653,3.1299157513504574
P31/FUJ,126941,-4.476387704672624
NCI-H716,10385095,0.9651730847529224
A3/Kawakami,24951314,0.5426477140511695
KALS-1,24797083,2.7086194853360412
SK-BR-3,23725625,5.168592279171437
KYSE-180,54143018,-0.6121199451945726
Capan-1,6184667,4.087578686615426
NCI-N87,44137675,2.149558923433186
IGR-37,5978,-4.017908855040001
SCC-25,10385095,1.5155908276599988
MG-63,2746,4.323476175039674
BT 245,3136844,4.20302568044611
BT 428,969516,2.361614928218663
NCI-N87,6184667,4.346047693042568
RKO,107970,2.3673735748138265
JeKo-1,100016,6.219930850058466
HGC-27,5311037,3.764785074039358
NCI-H647,selumetinib-piperlongumine (8-1 mol-mol),5.578616541659659
SIG-M5,216239,2.1370508585777825
EHEB,11152667,-1.348021466254982
BT 239,4578,4.949732034896781
SK-N-SH,16038120,-1.125050585910246
YH-13,44566777,0.4820262026960841
TCCSUP,tanespimycin-bortezomib (250-1 mol-mol),-2.003630452657136
MSTO-211H,36462,1.134601353001676
RPMI-8402,54618305,4.0465755097564555
VMRC-LCD,54619267,3.8005532131256134
RCM-1 [Human rectal adenocarcinoma],6918638,-0.5937755297048425
SNU-719,400769,-0.4239069427794032
IGR-37,135875424,3.259806736853938
PK-59,15983966,2.1220283483139215
WM793,2749,2.5461703794044452
PC-14,969516,2.650113623960972
RCC10RGB,448949,3.406339167429426
SIG-M5,46199207,3.77824739681319
TCCSUP,25126798,3.72552014127361
L3.3,56946209,-3.919110396505915
HARA [Human squamous cell lung carcinoma],25183872,-0.077265330214196
MFE-319,44819697,-1.332719768254917
TCCSUP,3854666,3.617075113283279
AML-193,126941,-5.435326760942341
PC-14,9444,3.6058045572239146
VMRC-LCD,54143018,1.1055926663163584
AU565,54618164,4.092787142183454
MFE-319,11404337,1.7191748497396555
HDLM-2,65064,3.0664349920456164
PK-59,tanespimycin-gemcitabine (1-1 mol-mol),0.2161926210498007
KMS-26,67156097,-2.281769549012124
WM793,24797083,1.5845720068425453
HOP-92,9911463,3.5299931958283093
WM793,135999136,5.309745002054086
KU-19-19,67291369,2.2261044123877656
NCI-H647,11178236,-3.045494047774129
RKO,51039095,3.7257826703811014
KYSE-450,60700,2.353056656519086
SNU-175,60700,-1.7848423018180035
BT 228,11257553,1.1115385254117716
AML-193,6436223,-5.165033729936035
RPMI-8402,44819697,-3.223610574373075
BT 245,241158,3.5873529093746828
RCH-ACV,6610355,3.5548924646731295
BT 245,54618795,3.402542991199258
KMH-2,5280436,3.092917027837839
KHM-1B,9907093,3.851614847193926
PC-14,67156097,-2.5306538286794003
EoL-1,11234052,0.7463095093676793
TCCSUP,25102847,1.617856098484916
SK-UT-1,216468,3.1165109524206676
NCI-H716,54618771,0.9147566577185032
SIG-M5,3385,-0.262707811749381
HGC-27,4705,3.374202647698771
SK-MEL-3,25183872,-1.3667215137899045
SK-BR-3,11647372,-0.6602812282873978
IGR-37,44607531,1.980611515736158
BT 428,53495165,-0.8877317090546629
HOP-92,10410894,2.6004835002934983
NCI-H647,5566,3.0172768771567977
SK-MEL-3,36462,3.2398359693189622
HOP-92,1566236,3.231225690393918
SUP-T1,6450551,1.6020206531099637
RPMI-8402,15983966,-5.747293738403893
KYSE-180,vorinostat-carboplatin (1-1 mol-mol),3.9189821803734577
HARA [Human squamous cell lung carcinoma],53232,3.05929528970331
SK-MEL-3,52947716,2.200688832439177
PK-59,219104,3.4307179305896893
KU-19-19,serdemetan-SCH-529074 (1-1 mol-mol),2.9806718783116337
RCH-ACV,136227924,2.5365542828193957
NCI-N87,60750,-4.457686499395666
SK-N-SH,168312962,2.7235229145327855
KMS-26,6450551,0.444543699535665
JeKo-1,JQ-1-carboplatin (1-1 mol-mol),1.2993795236120171
BEN,54618164,4.350338596649304
KYSE-180,654092,0.3510982053718326
P31/FUJ,9935249,2.700947453739227
SK-UT-1,10127622,5.957744497618317
KYSE-180,11485656,1.9289585779871232
SK-MEL-3,49793307,-0.6789406555293712
SK-BR-3,selumetinib-PLX-4032 (8-1 mol-mol),5.484898435429615
WM793,53392493,3.001064949916278
SNU-175,375860,-0.9196869368343216
HGC-27,44202524,1.146453862333366
EoL-1,400769,-4.647626216851371
SUP-T1,23939,5.052024259848981
SCC-25,54619267,3.701359221707272
PC-14,135423438,1.1691167584744715
SK-UT-1,216345,4.640105934271291
KYSE-180,36462,3.219917830306027
SCC-25,56649450,-3.060720088726529
RKO,6914657,-2.9196237708628505
SCC-25,5287620,-2.3916098179785252
EoL-1,5311037,2.98054018593742
KYSE-450,5351362,2.5381052639488715
BT 228,5329102,1.816802868659091
RCC10RGB,72376,3.207429090732714
L3.3,15983966,-2.6250326320128066
KU-19-19,65064,5.4276979548790285
A3/Kawakami,11214940,3.898222633210524
RKO,24771867,6.323343540042099
BT 428,selumetinib-PLX-4032 (8-1 mol-mol),1.4792510835928452
VMRC-LCD,3384730,2.5751868439821006
KYSE-180,3025986,-1.575125214964891
PC-14,375860,-0.4543940661648492
TCCSUP,82146,3.724750281671297
BEN,24951314,2.113091892124973
IGR-37,vorinostat-navitoclax (4-1 mol-mol),1.4737492215362276
RKO,136227924,3.256787131627037
NCI-N87,25262965,-2.609521679715104
NCI-H716,24901704,1.0104816455891923
SUP-T1,3815108,1.917592883396542
L3.3,navitoclax-sorafenib (1-1 mol-mol),2.85899880302019
BT 245,2949965,2.7740961114738396
JeKo-1,252682,6.248333667397386
HDLM-2,11175137,2.771710337939778
RCH-ACV,9967941,3.459537646730281
NCI-H647,doxorubicin-navitoclax (2-1 mol-mol),0.5142141289439561
HARA [Human squamous cell lung carcinoma],navitoclax-pluripotin (1-1 mol-mol),-0.7875744304636512
NCI-H1092,11178236,-2.084013708263219
MFE-319,52947716,-5.792766425028857
HARA [Human squamous cell lung carcinoma],JQ-1-vorinostat (2-1 mol-mol),2.5839829159057848
HDLM-2,568763,0.4540596128760972
BT 245,4788,5.2477512116504785
KALS-1,11625818,5.0677445146134925
BT 228,135440466,1.3651653115997018
NCI-H2081,24856436,-0.1244268039061882
MG-63,73707398,1.4753017703355924
NCI-H2081,73707398,0.6809572071185331
BT 232,53481919,4.06170802897289
Capan-1,72734382,5.532990618944485
KHM-1B,375860,-0.460638651136882
HuH-28,439501,-2.3734651091068693
NCI-H2009,72193861,0.2482611586799762
NCI-H647,24785538,1.6054591997030152
YH-13,44137675,2.4918035822396973
WM793,44137675,3.8583923269749465
HGC-27,9868037,2.329533656521022
KHM-1B,24753719,3.787412928700261
SK-N-SH,5978,-2.2461330927490497
KYSE-450,selumetinib-JQ-1 (4-1 mol-mol),2.8795541061049104
L3.3,4096211,2.2417011569185763
EoL-1,44202524,0.325267399272861
SK-N-SH,387447,-5.520573584965203
P31/FUJ,1242560,3.8275456086274127
NCI-H647,44185566,2.9531207837717974
VMRC-LCD,15953870,4.086184190839628
IGR-37,42642645,1.428808433640827
SUP-T1,49850262,2.0657723983439444
HARA [Human squamous cell lung carcinoma],44632017,0.7187380309890276
SUP-T1,1716436,2.1561518100375627
RKO,11640390,5.295981617059328
AU565,216345,2.670108206329082
HOP-92,1750826,-3.449139065952659
KYSE-450,148124,3.78473118264584
P31/FUJ,docetaxel-tanespimycin (2-1 mol-mol),-5.9377835284500895
KMS-26,54618305,4.443948888927761
NCI-H1092,439501,-3.60207444945155
KALS-1,24964624,2.8237591524377277
VMRC-LCD,10302451,3.928958385850413
A3/Kawakami,11955716,-2.4185041720397553
NCI-H2081,ISOX-bortezomib (250-1 mol-mol),0.1773494358411905
YH-13,57519531,2.0380151734661185
HT-1197,11647372,2.548089020887478
PK-59,984333,0.7032656465439704
BT 228,219104,3.636472529702345
KHM-1B,6852167,0.7581222087853566
SK-N-SH,3384730,3.2666456597617293
SK-MEL-3,6450551,3.5683510843643296
P31/FUJ,selumetinib-MK-2206 (8-1 mol-mol),-0.6510792771612892
KHM-1B,4261,0.5935590694863259
P31/FUJ,19582717,2.23583270668625
BT 232,51039095,3.263057097205922
NCI-H2081,decitabine-navitoclax (2-1 mol-mol),1.4988648347854454
RCM-1 [Human rectal adenocarcinoma],46926350,-4.0983765968922485
RPMI-8402,36462,-2.7936372470857473
HCC2108,17759555,3.761463468003181
MFE-319,148198,-4.2483014049358685
SK-UT-1,5287620,-0.1399962541405603
RKO,126941,-5.081226966265268
SCC-25,100016,6.900174579464034
SUP-T1,25183872,-1.448915400178697
NCI-H716,119607,5.535403138368833
WM793,crizotinib-PLX-4032 (2-1 mol-mol),1.8719851046729632
AU565,JQ-1-carboplatin (1-1 mol-mol),2.695919157809604
VMRC-LCD,219104,3.9765641516050008
KU-19-19,10231331,0.2937024112037242
YH-13,JQ-1-navitoclax (2-1 mol-mol),1.7926263588909668
NCI-H647,73707398,1.965831350411136
PC-14,16722836,1.4200790699310284
SW1116,25150857,2.1563204213652076
RCM-1 [Human rectal adenocarcinoma],44566777,1.6377443255416146
NCI-H716,3689413,0.3516381459827891
A3/Kawakami,SNX-2112-bortezomib (250-1 mol-mol),-3.0137719749507657
KYSE-180,5566,3.0696761250239204
MSTO-211H,4521392,4.029667841571139
NCI-N87,57519531,1.4365599080949227
BT 245,176870,4.326082130585301
SK-UT-1,9903786,5.78516391020833
KU-19-19,10385095,1.1563887024661463
SNU-719,5278396,3.750450189223628
A3/Kawakami,3465537,1.3050221927736254
EoL-1,9926054,1.828019217783983
Capan-1,104842,-3.83546207968867
MSTO-211H,31703,-2.679199045886266
NCI-N87,637858,1.7879892218708664
WM793,24772860,-1.904667330479004
SCC-25,54454,1.4851556559902837
EHEB,148198,-2.104475544842142
RKO,24753719,3.882573791668401
YH-13,10184653,1.670229317933307
HuH-28,11222830,1.3281580031879587
MFE-319,25150857,2.514104945734586
RCC10RGB,49766530,-1.6086406954404375
MSTO-211H,67156097,-3.635314822435898
KMS-26,11656518,1.9070118652106465
MG-63,66577038,2.9978490185393514
HDLM-2,2708,4.535521013132918
BT 239,ISOX-bortezomib (250-1 mol-mol),0.5258067028276304
KMH-2,148198,-4.1260923744300015
RKO,sirolimus-bortezomib (250-1 mol-mol),1.0887451358800992
HuH-28,9911463,4.067632897122288
AML-193,24779724,5.0401581340070205
MG-63,25154868,2.5022989951012606
BT 239,navitoclax-PLX-4032 (1-1 mol-mol),-2.868217726198799
RCH-ACV,44507138,0.3962385262703788
HARA [Human squamous cell lung carcinoma],5978,-4.046402058806829
RPMI-8402,10302451,2.410020049442099
JeKo-1,568763,0.6001197299343016
RCM-1 [Human rectal adenocarcinoma],148198,-3.91492317301152
EHEB,5282054,3.0969047421141584
IGR-37,136227331,4.32939216676153
HGC-27,6918736,-1.8135892397803568
NCI-H716,selumetinib-PLX-4032 (8-1 mol-mol),2.9673509752410445
BT 239,374536,2.369267766826018
KALS-1,6610216,5.229804141244247
P31/FUJ,675434,4.075878142833804
WM793,446155,3.930863255707362
AML-193,16725315,3.155166838170859
HOP-92,107970,1.9922027058608
SNU-719,3025944,4.358234760248536
KYSE-180,3825829,3.0319007091325267
HT-1197,2749,1.6687513088045225
TCCSUP,11178236,-5.158668289111837
P31/FUJ,16741245,4.043144814115882
EHEB,24951314,0.722947577043057
AU565,11960529,4.91307375329511
SUP-T1,3384730,0.9398565863554073
P31/FUJ,753704,3.2802738483106766
KMH-2,2841722,5.090397309151612
BT 232,11257553,3.770324097055415
IGR-37,9952709,3.8772523508837695
AU565,navitoclax-sorafenib (1-1 mol-mol),2.1956268758246225
JeKo-1,24901704,2.1690783552166883
HGC-27,7251185,1.5878824650832335
HuH-28,UNC0638-navitoclax (1-1 mol-mol),-0.7244825162600496
YH-13,5287969,-1.6680517760665383
TCCSUP,navitoclax-piperlongumine (1-1 mol-mol),2.2323075762929863
Capan-1,9840324,7.027964948345808
NCI-N87,5470400,-1.6354434063399317
YH-13,11485656,3.672447929172867
A3/Kawakami,9933475,1.7986146545065222
P31/FUJ,387447,-5.269499156732966
NCI-H716,10184653,1.820810311914432
HARA [Human squamous cell lung carcinoma],crizotinib-PLX-4032 (2-1 mol-mol),1.0458249521104828
RKO,54649381,4.449908747747005
SUP-T1,6918837,-4.612213588117004
VMRC-LCD,crizotinib-PLX-4032 (2-1 mol-mol),1.017579495271234
NCI-H716,25227462,0.1802098106085927
HGC-27,JQ-1-carboplatin (1-1 mol-mol),1.0978980363153934
NCI-H2081,445643,4.277637250227414
MSTO-211H,2828334,5.714930690846282
EoL-1,9935249,-2.654152668854086
PK-59,ISOX-bortezomib (250-1 mol-mol),0.9805258280125868
JeKo-1,5978,-4.094561444484302
HCC2108,selumetinib-UNC0638 (4-1 mol-mol),4.394993613237598
SK-UT-1,SNX-2112-bortezomib (250-1 mol-mol),-2.387755678466967
SNU-719,11222830,1.7596118097913571
TCCSUP,5328940,1.4303575035748048
MSTO-211H,6918289,3.158366552983379
HT-1197,6914657,-2.865471562550679
AU565,5284616,2.6982931675931914
NCI-H647,25105715,3.343933068561814
IGR-37,46174525,5.7668423182750725
RCH-ACV,56649450,2.041681298355555
BT 232,10302451,4.010899903190945
RCM-1 [Human rectal adenocarcinoma],66577038,3.167694948675542
HGC-27,76446078,4.616529709663479
L3.3,17755052,1.4516432874311858
PC-14,53495165,1.0663117810977292
RCC10RGB,11228183,3.0224846047699288
MSTO-211H,676352,2.2606828184976955
HARA [Human squamous cell lung carcinoma],9840324,5.741888919857564
KU-19-19,89928392,2.8864230284497747
SCC-25,168313047,1.8065352647671076
VMRC-LCD,9840324,6.917758524428471
MSTO-211H,89928392,0.2675284607275224
BT 245,72376,-3.012363503164747
SNU-175,3038522,3.643308857974019
KHM-1B,73707438,4.044668520699287
KMH-2,navitoclax-gemcitabine (1-1 mol-mol),-2.789315361251211
HOP-92,49836020,5.403656238129832
RPMI-8402,carboplatin-etoposide (40-17 mol-mol),-1.825826072437498
KMS-26,168312962,-2.2820955597271237
HARA [Human squamous cell lung carcinoma],409805,4.942295126142001
SK-N-SH,6610216,4.236086050326451
HGC-27,12003241,-2.439316929165163
RPMI-8402,16725315,3.2867711234707753
NCI-H2081,969516,2.499381781732552
BEN,9911463,4.573978563534662
NCI-H2081,3062316,3.530909356574639
A3/Kawakami,11213558,1.242702017135905
NCI-N87,12001922,1.750767235665954
MG-63,9903786,3.648237948966595
NCI-N87,54454,3.669804409798402
RCC10RGB,JQ-1-vorinostat (2-1 mol-mol),1.4034358595851535
KMS-26,262093,1.018601177342637
BT 245,11717001,4.30673965068864
BT 428,5328940,1.4635647958516325
KHM-1B,SNX-2112-bortezomib (250-1 mol-mol),-3.421333600529768
YH-13,9866186,1.6052834410324497
BT 239,675434,2.880676233878023
IGR-37,6610216,4.326761658529103
BT 239,262093,1.5843139145133054
HARA [Human squamous cell lung carcinoma],56963564,-0.1933628562955875
HCC2108,439501,-2.3356100476768145
BT 239,12001922,0.6251306016836425
EoL-1,11626927,-3.9217248861811016
NCI-H2081,53392493,1.9098873697280916
SK-N-SH,11485656,1.632835295559006
A3/Kawakami,107970,2.2225148018694254
JeKo-1,JQ-1-MK-0752 (1-1 mol-mol),2.566083108332094
BT 245,71751553,4.246004451264995
AML-193,4705,3.164558666224438
RPMI-8402,439501,-3.664200727311063
HARA [Human squamous cell lung carcinoma],10184653,0.92256613856931
NCI-H2009,5281672,4.642324044569225
AML-193,24775005,3.602560196052679
SCC-25,44202524,1.346964188565438
BT 245,448949,2.080098144104233
RKO,9911830,2.9376280530386123
HOP-92,216239,2.3334657656622624
EoL-1,17755052,0.3808525125840174
JeKo-1,36462,0.9579475504198862
L3.3,24901704,4.5240834828138095
NCI-N87,159324,0.0331676951949142
SCC-25,5738263,2.914845718756115
EHEB,52912189,0.500352140326513
L3.3,25183872,0.3957917888669793
RPMI-8402,66577038,1.7029446781352855
KHM-1B,serdemetan-SCH-529074 (1-1 mol-mol),1.1284922177320384
SNU-175,11497983,-3.438900188422791
BT 428,6438330,1.457733766033089
NCI-H2081,44197249,1.2499480792075393
SNU-175,15983966,-4.597489073878393
NCI-H2081,56649450,3.184734939652862
SNU-175,52912189,1.5530512675805803
A3/Kawakami,135440466,0.7934902396937208
NCI-H647,60700,-0.0852741450726564
P31/FUJ,11612883,1.4537759753270971
MFE-319,24753719,4.037071783419627
BT 239,sirolimus-bortezomib (250-1 mol-mol),0.5713357079761969
NCI-H716,16736978,2.6494671322758645
RCM-1 [Human rectal adenocarcinoma],24771867,4.508296832673209
A3/Kawakami,5284616,2.8338281218759156
Capan-1,25126798,3.8771730982114287
WM793,23582824,1.6229283221646535
WM793,17755052,2.1349114715081345
HT-1197,10074640,3.654345482184804
NCI-H1092,46926350,-4.274443636172462
SNU-175,11647372,-3.7520090402847854
RCH-ACV,168313016,3.0928889111886337
SUP-T1,25195348,2.5476005309939036
Capan-1,11238147,4.50464663552057
P31/FUJ,JQ-1-navitoclax (2-1 mol-mol),-0.8945725612384452
HCC2108,5746,1.977916681532928
SK-N-SH,navitoclax-PLX-4032 (1-1 mol-mol),1.56291471109424
NCI-H2081,9903786,1.5566694513779922
KALS-1,5291,3.812943113186488
BT 232,1750826,0.2657050490424818
HGC-27,11626560,0.9017985495324256
MG-63,11609586,4.5664893123225845
EoL-1,387447,-5.86187072163508
BT 245,57519531,1.5304257987507106
MG-63,4917,3.2047684671437486
SK-UT-1,3634881,3.231814398730286
BT 245,selumetinib-UNC0638 (4-1 mol-mol),3.762551103580104
PC-14,11485656,2.0369141609233656
SUP-T1,11152667,-3.1666536530692477
NCI-H1092,46191454,1.930270640932621
SCC-25,JQ-1-vorinostat (2-1 mol-mol),0.5831475180184557
KMS-26,decitabine-navitoclax (2-1 mol-mol),-2.173455894008096
HCC2108,135984461,3.878993075429708
YH-13,11152667,0.725065654418547
Capan-1,11152667,-0.5862513866914233
VMRC-LCD,11640390,3.421038896709302
HARA [Human squamous cell lung carcinoma],1242560,4.08747373250943
P31/FUJ,3136844,4.357504973194935
AML-193,327653,3.166198380644303
BEN,BRD-K27188169,4.479794204289674
RPMI-8402,67291369,-1.0870898901213473
HOP-92,24964624,3.2342943199953313
NCI-H647,11955716,-2.1834919411483504
BT 232,6184667,4.015274236813867
HOP-92,2733526,2.7502154559797702
EoL-1,24797083,-0.6257576080585342
JeKo-1,9935249,0.8594033037358069
KMH-2,44185566,0.96665135195286
BT 245,44185566,2.5006343525335173
HT-1197,25062766,2.770555469752201
HOP-92,327653,3.5254813835673633
RCC10RGB,11175137,3.603105896683611
KU-19-19,6918328,0.0154884073180988
SNU-175,25150857,1.6464150032928937
JeKo-1,9825149,2.366643076060223
KHM-1B,5311281,2.058534783362704
SK-N-SH,5426,6.330323563512839
EoL-1,568763,-1.1494101834173986
KMS-26,400769,-1.4034190528978006
BT 239,11257553,0.2312808475598431
MFE-319,16013152,4.475491223269678
SK-BR-3,1242560,3.644538907414143
RKO,25195348,3.4491832635970585
VMRC-LCD,selumetinib-UNC0638 (4-1 mol-mol),4.957627426138031
SCC-25,46901937,3.6558386675701833
HOP-92,23582824,-0.1713998960220991
SK-N-SH,24856436,0.3721734025769492
KHM-1B,57519531,1.9307254851504612
HOP-92,36462,2.3533766692120737
L3.3,16736978,2.121770338408602
RCM-1 [Human rectal adenocarcinoma],selumetinib-PLX-4032 (8-1 mol-mol),2.814367803640325
BT 228,3689413,-1.5659127438457598
PC-14,24951314,0.973112962639724
SUP-T1,72199292,0.5004737553555892
BT 245,selumetinib-navitoclax (8-1 mol-mol),0.6574227652928758
WM793,piperlongumine-MST-312 (1-1 mol-mol),1.4459627223482716
AML-193,72376,-3.4771527992626523
L3.3,10385095,1.3503663642800654
BT 428,sirolimus-bortezomib (250-1 mol-mol),-0.137470191353476
KHM-1B,tanespimycin-bortezomib (250-1 mol-mol),-0.3010055650508828
IGR-37,71576739,-4.196145178897
RCC10RGB,57519531,5.003664553369681
KYSE-450,16038120,1.4472769553293552
SCC-25,24785538,0.696337603254719
AU565,3136844,3.8072298284959385
YH-13,JQ-1-carboplatin (1-1 mol-mol),2.725669158848688
MG-63,327653,2.9545446221362797
RCM-1 [Human rectal adenocarcinoma],JQ-1-navitoclax (2-1 mol-mol),1.3966963569100277
SCC-25,2749,1.9978442961930147
KU-19-19,445455,4.442962740031222
MG-63,6184667,2.3833914959698848
MG-63,135398516,2.6756883313640736
MSTO-211H,11222830,1.162959487763126
KHM-1B,selumetinib-PLX-4032 (8-1 mol-mol),4.453771782553302
MSTO-211H,SNX-2112-bortezomib (250-1 mol-mol),-1.2312117350271496
BT 232,11364421,1.2282578370962507
RKO,46224516,2.430810450928805
RCH-ACV,1566236,1.4143282835015505
WM793,3854666,3.254480086465336
SUP-T1,135875424,3.316622158258836
RKO,ISOX-bortezomib (250-1 mol-mol),0.9877489052510549
KYSE-450,15547703,4.417668058274178
SK-UT-1,24821094,3.742351584541763
EoL-1,11427553,-4.26804216674263
RPMI-8402,navitoclax-pluripotin (1-1 mol-mol),-0.9302110960305932
HuH-28,docetaxel-tanespimycin (2-1 mol-mol),3.811454837472056
L3.3,5460769,1.7814582708772182
KHM-1B,44495899,-1.7944693078792426
SK-MEL-3,135984461,4.369065349705821
BT 232,44489675,4.8357062460635545
RCM-1 [Human rectal adenocarcinoma],227681,1.7640901700531322
KALS-1,969516,3.104722850007976
HDLM-2,44607531,1.354937487410375
MG-63,54639126,4.467908548574037
KALS-1,46907787,2.274678241554836
SCC-25,71304818,2.2867090233906744
BT 228,67156097,2.587261772144617
Capan-1,26596,-0.6895285509385911
KMS-26,675434,3.798142400798781
KHM-1B,124202324,1.1821842907851436
HGC-27,2874250,4.634229805881186
NCI-H1092,2945648,2.0700638140292256
SIG-M5,176870,3.1843914465228287
SIG-M5,24856436,-1.1140237019410009
RCM-1 [Human rectal adenocarcinoma],selumetinib-UNC0638 (4-1 mol-mol),2.1355082647556127
RPMI-8402,10127622,5.103706318124389
SCC-25,1242560,2.8378810773258505
RCH-ACV,151289,0.3520860299882317
MG-63,753704,4.929441711190138
KMH-2,452548,-2.285409678805446
SIG-M5,46191454,-0.6926780789058757
SK-BR-3,4477,0.5971355994550803
EoL-1,44137675,0.8534374900316186
PC-14,navitoclax-pluripotin (1-1 mol-mol),-2.898024229695615
SK-N-SH,54143018,0.0487551738433134
BT 245,11626560,1.7100370824048363
KALS-1,11626560,2.461619332929273
RKO,5978,-3.7617282032773582
EoL-1,10302451,-0.9784650240234488
NCI-H647,24748573,2.807333312135794
RPMI-8402,12001922,1.505990013379826
SK-MEL-3,navitoclax-MST-312 (1-1 mol-mol),0.6870329816608218
SCC-25,5282054,3.4256549762735355
NCI-H716,66577038,3.189165185704297
Capan-1,navitoclax-piperlongumine (1-1 mol-mol),1.342751477958707
AU565,24821094,-3.121521346886189
MFE-319,135984461,4.655775210040696
SK-N-SH,327653,2.3985684531965887
HOP-92,227681,3.784287250764641
A3/Kawakami,53232,4.1035757519812
SK-UT-1,60750,-4.1322168678971956
HGC-27,11497983,-3.792200467560488
KALS-1,168313047,3.9529372000265366
SIG-M5,3552672,4.122052924509715
KALS-1,168312962,4.640672846799879
SK-BR-3,7251185,0.9560701414746414
MFE-319,navitoclax-pluripotin (1-1 mol-mol),0.1680410675647637
IGR-37,2828334,6.321912721309699
RPMI-8402,10113978,1.7647560509243465
SNU-719,969516,3.1563968571649132
SK-N-SH,piperlongumine-MST-312 (1-1 mol-mol),0.9493938034679744
EoL-1,57519531,0.80091980015932
NCI-H1092,374536,2.5568939719400707
Capan-1,16038120,0.4831769659049863
HOP-92,4521392,4.272707080702711
NCI-N87,5278396,3.196450874168962
TCCSUP,3825829,3.3137008216702686
IGR-37,219104,3.794109173732464
HCC2108,6610216,4.333266627123119
BT 245,15547703,2.990597174142391
SCC-25,9911463,3.418657228936731
HT-1197,3634881,3.1552951067583175
BT 232,5494449,3.952787030709392
MG-63,17755052,2.4264854422950526
A3/Kawakami,11364421,-5.454349144034342
HGC-27,4096211,0.4833504437276287
YH-13,10302451,3.810654470358069
NCI-H1092,135411,1.4198261476430412
BT 232,65064,5.457803746349754
HT-1197,60700,2.6650590155859377
SUP-T1,JQ-1-carboplatin (1-1 mol-mol),-0.4695857122816443
HDLM-2,124202324,1.2856563220279589
RCH-ACV,446155,1.682106404275009
BT 232,44607531,1.529620122771786
HGC-27,26596,-3.243081069551806
SK-UT-1,246676,5.689307282465742
SK-UT-1,6918328,1.9440877838795103
KU-19-19,crizotinib-PLX-4032 (2-1 mol-mol),2.7637212964945745
NCI-N87,tanespimycin-gemcitabine (1-1 mol-mol),-4.9778446176040845
AU565,54678924,2.5293429329053763
HT-1197,23635314,4.247894755350328
HDLM-2,navitoclax-gemcitabine (1-1 mol-mol),-2.26099632279545
NCI-H2081,15953870,2.893627667573686
SK-N-SH,11222830,1.5142239713041166
SK-N-SH,5281672,4.452535164451704
HARA [Human squamous cell lung carcinoma],selumetinib-piperlongumine (8-1 mol-mol),4.925037100159097
NCI-H2009,11609586,4.059888202416809
AML-193,9926054,0.8292500331421907
NCI-H716,44137675,3.004543555964594
MSTO-211H,10127622,2.776094640706434
KYSE-450,1641662,3.736286251526556
EHEB,6918289,-4.286720857258569
HOP-92,5280436,3.4435413406613917
KMS-26,54619267,3.163552019307735
HARA [Human squamous cell lung carcinoma],16720766,-0.0810608938508249
MG-63,ISOX-bortezomib (250-1 mol-mol),0.206528889102162
HARA [Human squamous cell lung carcinoma],5282054,3.837128949835148
HOP-92,46174525,4.837020405426086
SIG-M5,10113978,3.639405300708912
KHM-1B,44507138,1.4720976685290608
RPMI-8402,25105715,2.362184177035859
EHEB,3689413,-1.930959129148268
NCI-H716,selumetinib-vorinostat (8-1 mol-mol),1.3365473974528714
SW1116,644241,1.8306415261059923
IGR-37,15983966,-4.219704496709363
SNU-719,44259,2.7135893531874733
NCI-N87,151289,0.0450530603050232
HARA [Human squamous cell lung carcinoma],3385,4.962584280578164
SIG-M5,salermide-PLX-4032 (12-1 mol-mol),-0.1248750508165838
RCH-ACV,5278396,3.091979507719926
BT 232,docetaxel-tanespimycin (2-1 mol-mol),-3.0669859235075796
KHM-1B,11234052,4.09724714531712
PC-14,12003241,-2.6584563263219203
YH-13,6918638,0.7209706519949683
BT 239,24951314,1.2186142327930696
NCI-H2009,46199207,3.041674504763304
KYSE-180,5978,-1.6510640748820715
NCI-H2009,24951314,0.5822698862930126
KYSE-450,4259181,0.2433830255631184
A3/Kawakami,11228183,3.2437251109057232
RKO,124202324,3.4391315101947386
PC-14,4915,-5.791452728765355
KMH-2,11612883,2.5035978942287653
HGC-27,alisertib-navitoclax (2-1 mol-mol),-2.6539504297686034
KMH-2,439501,-2.384989575251817
AML-193,JQ-1-MK-0752 (1-1 mol-mol),0.3022225490801792
BT 239,3825829,4.303945684647588
HGC-27,1641662,2.835656283894692
BT 239,navitoclax-pluripotin (1-1 mol-mol),-3.6200227533568623
Capan-1,selumetinib-JQ-1 (4-1 mol-mol),1.4038636121829502
SK-N-SH,24901704,2.2488705339841015
AU565,tretinoin-navitoclax (4-1 mol-mol),4.550367433205839
AML-193,56963564,-1.1779441384902114
YH-13,60700,1.6423447574414731
HOP-92,5494449,3.4578639586422577
SK-N-SH,135440466,1.3720134641531985
MFE-319,753704,5.840457019000585
MSTO-211H,tretinoin-navitoclax (4-1 mol-mol),1.3222230725566817
HARA [Human squamous cell lung carcinoma],17755052,1.9898088824831797
MSTO-211H,4477,1.290064962685197
BT 245,10184653,1.720017419291484
SUP-T1,119182,-8.412770423630656
IGR-37,3062316,3.175132217649958
TCCSUP,2742550,3.882646249663198
AU565,24951314,-0.2220635763258615
IGR-37,216468,3.6862158948390102
HCC2108,44489367,5.96526198558648
SK-UT-1,5311,2.5232548896464824
NCI-H716,702558,3.3793802986498065
RCM-1 [Human rectal adenocarcinoma],613753,3.402609507762531
HCC2108,168312962,1.890328048752136
KYSE-450,11404337,-0.7664225185438103
BT 245,navitoclax-birinapant (1-1 mol-mol),0.4983707655364911
SUP-T1,451668,4.556026538218793
NCI-H716,81146,4.404249414618776
HGC-27,10127622,5.2177975004466886
MG-63,6450551,3.1665435182095387
HCC2108,24180719,3.7452058347449033
KALS-1,23582824,1.7973902078000787
NCI-H2009,219104,3.953506929532588
WM793,637858,1.8553013176450457
RCM-1 [Human rectal adenocarcinoma],9926054,2.0094388483046757
SCC-25,176870,0.5714863317316811
Capan-1,vorinostat-carboplatin (1-1 mol-mol),3.733480198684298
SIG-M5,2733526,4.895472503859331
BT 245,navitoclax-gemcitabine (1-1 mol-mol),-2.663697742680769
RCM-1 [Human rectal adenocarcinoma],168313016,4.590367789402496
L3.3,9840324,5.709572906398099
JeKo-1,72734382,3.662404473563815
PC-14,49793307,-2.2897588093070005
KYSE-450,selumetinib-vorinostat (8-1 mol-mol),4.7047853515595515
SUP-T1,168313016,4.416252700819181
KHM-1B,44589607,0.0686191939800993
SK-UT-1,11964036,2.7372114325499055
NCI-H716,400769,-0.885197829518651
KMS-26,135398738,3.439628300398984
PC-14,navitoclax-PLX-4032 (1-1 mol-mol),2.008859248665764
JeKo-1,9967941,3.870739767516892
NCI-H716,168312962,3.5506669617381346
RPMI-8402,89928392,0.3373120596520398
Capan-1,51039095,3.6072200326377186
TCCSUP,148198,-2.229154528716237
BT 245,6610355,5.432985905088436
HCC2108,89183176,4.824317563947827
TCCSUP,selumetinib-UNC0638 (4-1 mol-mol),4.619962365310146
KHM-1B,JQ-1-UNC0638 (2-1 mol-mol),-0.1764853483992549
SNU-175,6918878,0.7323937469600013
NCI-N87,tanespimycin-bortezomib (250-1 mol-mol),-5.300963645653278
MFE-319,6918837,-2.867714313059944
SW1116,66577038,3.382294797712358
EHEB,16720766,0.2436071662953463
HCC2108,123631,2.550362488689637
A3/Kawakami,tanespimycin-bortezomib (250-1 mol-mol),-0.2399210374743367
RKO,25102847,3.0524897378806033
NCI-N87,11485656,1.873926788766734
HGC-27,216468,0.4038812321949087
KALS-1,JQ-1-carboplatin (1-1 mol-mol),0.9205030835960966
L3.3,151289,1.4499844825237675
IGR-37,54143018,-1.1312090944098667
SK-MEL-3,53325874,5.8161260259059295
AML-193,2949965,1.9719035779101812
HOP-92,8515,3.613790274585256
SIG-M5,selumetinib-tretinoin (2-1 mol-mol),-4.006192944098582
BT 228,11178236,-4.124476549759828
SNU-175,selumetinib-UNC0638 (4-1 mol-mol),3.0447701343901987
RPMI-8402,vorinostat-carboplatin (1-1 mol-mol),1.5052817866509465
HDLM-2,72376,-2.195858117121505
BT 228,44486219,4.8846292745166835
PC-14,25150857,3.220593885644357
PC-14,10074640,3.427227628615904
HOP-92,12001922,1.8638170251241897
P31/FUJ,71304818,2.235751993715144
BT 239,2729026,1.0074649695027698
AML-193,64971,1.9507397269494229
MSTO-211H,51037431,1.7350128995421004
BT 228,9967941,3.5495568796409014
BT 239,selumetinib-JQ-1 (4-1 mol-mol),1.637299005229072
RKO,53392493,2.7606647137416616
JeKo-1,219104,2.0307164477496533
EoL-1,56649450,0.8438019542767966
A3/Kawakami,4378219,4.275687766465954
NCI-N87,16115403,-3.919428944380448
SIG-M5,11964036,0.5677579164406132
MSTO-211H,11175137,1.4320314455831638
KMS-26,72734382,1.3862074578417278
VMRC-LCD,15547703,3.2450033514517327
TCCSUP,1750826,0.4362415979696089
KHM-1B,24785538,-3.445065947322119
HCC2108,42611257,3.7693662038027
MG-63,5278396,3.6939254157538666
EoL-1,selumetinib-navitoclax (8-1 mol-mol),-2.7913769554426096
JeKo-1,JQ-1-navitoclax (2-1 mol-mol),0.1834915112231461
PC-14,2113511,4.109768785138769
SK-N-SH,148198,-4.813749517608016
SK-MEL-3,3062316,3.1441102172602102
BT 239,9866186,1.8467440035946192
KMH-2,3384730,0.3270351946480155
EoL-1,46224516,0.8098800276481413
IGR-37,675434,4.4344481586126365
HOP-92,4259181,1.0738738060955595
NCI-H2081,10127622,5.641065202822249
KMH-2,54649381,3.605505301942369
P31/FUJ,crizotinib-PLX-4032 (2-1 mol-mol),0.7828925550397006
KYSE-450,9936388,-0.9236320595886032
HCC2108,54613361,-0.9116007524668512
NCI-N87,9444,3.5890718830627923
RPMI-8402,10077130,2.6047588913590345
Capan-1,156414,1.6052662486376672
Capan-1,5738263,3.7448337072276665
RCH-ACV,24753719,3.8377277120048863
KALS-1,9935249,3.898562329613611
SK-BR-3,54678924,1.354575258484801
TCCSUP,136227924,3.28330337763218
SK-N-SH,5113032,4.445090486333167
JeKo-1,tanespimycin-bortezomib (250-1 mol-mol),0.4974732421347879
BT 239,piperlongumine-MST-312 (1-1 mol-mol),1.1000969378429624
WM793,5280436,4.679936736167119
RKO,23635314,-2.140231911981244
NCI-H647,11977753,-2.977279921495351
AU565,10322450,3.206832643999438
BT 428,10113978,3.275570081153744
Capan-1,6610216,4.674579245931144
AML-193,4259181,-0.4145932893303466
NCI-N87,11507802,1.464328650743575
WM793,15547703,2.941015852165493
SCC-25,5291,3.136416033699086
EoL-1,24856436,-1.9474317666565
PK-59,227681,3.151090202013685
HCC2108,3543504,4.151618491560986
Capan-1,2949965,2.5504901675982694
YH-13,54454,3.0632699075103926
HOP-92,16725315,3.3481374576383476
YH-13,11964036,1.205712988485349
IGR-37,135659046,4.488769216179786
HT-1197,5470400,-4.68855728712875
NCI-H2009,67156097,-1.7347724318553324
MFE-319,54618164,4.567083420097771
SK-MEL-3,107985,-3.869718224497346
KALS-1,637858,2.4646285747552747
KALS-1,3543504,5.254605796785472
KYSE-180,46199207,3.0515921936822092
HGC-27,3062316,-2.6306091849385704
BT 428,2871966,-0.987943438034776
AML-193,2858523,2.3903407212916994
HARA [Human squamous cell lung carcinoma],5284616,3.060508834181737
BEN,24964624,2.9642030235128556
EoL-1,selumetinib-JQ-1 (4-1 mol-mol),-1.4243084091722091
PC-14,135875424,3.4913396696572523
NCI-N87,448949,2.160730221150561
SNU-719,5311281,3.2010600826506774
SK-MEL-3,25062766,3.2609509025387795
BT 428,5282054,2.391287109666509
NCI-H2009,52912189,1.2519346625881922
KMH-2,2749,1.5222101236039662
EHEB,6917907,-5.860529942502672
EHEB,5278396,3.4775281227216936
SNU-719,46199207,2.844834500923274
RKO,44632017,0.9673312213076444
BT 428,11707110,-3.885075850112563
EoL-1,3552672,1.6334492105395295
SUP-T1,136227924,2.470227214750311
KHM-1B,12003241,-0.9345261470540068
HuH-28,1716436,3.2483302673256618
NCI-H647,46926350,-4.287716947966526
HOP-92,3081361,2.599727660071061
YH-13,3503,1.9021555788410789
SK-N-SH,navitoclax-MST-312 (1-1 mol-mol),0.2417910218718683
MFE-319,selumetinib-navitoclax (8-1 mol-mol),2.84319695974109
NCI-H716,selumetinib-UNC0638 (4-1 mol-mol),1.8614450538775895
EHEB,46191454,0.8192064691223043
WM793,44185566,2.5245605998161404
P31/FUJ,46907787,-0.8407426122417735
SIG-M5,6914657,-3.4039538598492496
MG-63,navitoclax-piperlongumine (1-1 mol-mol),1.5979872947134952
A3/Kawakami,erlotinib-PLX-4032 (2-1 mol-mol),2.8793564671377503
SCC-25,11214940,0.3445184541227316
HARA [Human squamous cell lung carcinoma],445455,6.075035505832661
SK-BR-3,24901704,2.9520769194408354
BT 245,11152667,0.6307471035808881
AU565,3689413,0.8257687517728082
KHM-1B,selumetinib-vorinostat (8-1 mol-mol),0.6358742405488887
BT 245,4261,1.712743889137908
NCI-H2009,36314,-5.253596358515139
EoL-1,25062766,-2.3292498623011584
SIG-M5,3062316,1.6654527005685154
EHEB,24856436,0.0947774634089656
NCI-N87,8515,4.286102801865053
P31/FUJ,72376,-3.3088434861533704
EoL-1,135421197,0.8401357676850814
MG-63,9908783,5.756640657527915
SK-BR-3,6852167,1.9054876714905489
PC-14,11497983,1.5451127638875048
SCC-25,tanespimycin-bortezomib (250-1 mol-mol),-2.0789545653070856
HDLM-2,49766530,-0.915068926729708
MG-63,216239,1.7008470171299808
NCI-H2081,60750,-4.420786299204752
YH-13,4261,1.8145650392112695
RPMI-8402,6914657,-7.131626249786096
SIG-M5,11717001,-0.892081748332024
KMH-2,135398516,1.5003320435026537
HOP-92,16013152,4.828289855403531
SK-N-SH,selumetinib-MK-2206 (8-1 mol-mol),2.55403626037511
WM793,9935249,4.106686148008307
MG-63,54626689,4.58773041441284
NCI-H2009,5281321,-2.3281539094269843
SNU-719,selumetinib-tretinoin (2-1 mol-mol),0.9341788224470796
KHM-1B,54619238,4.434806888853119
HARA [Human squamous cell lung carcinoma],selumetinib-JQ-1 (4-1 mol-mol),3.6659251122276015
JeKo-1,11222830,1.522036475666548
P31/FUJ,9887053,2.876589254443052
HGC-27,44491742,3.7914350891371114
PK-59,SNX-2112-bortezomib (250-1 mol-mol),-0.9848957324018716
NCI-H2009,navitoclax-MST-312 (1-1 mol-mol),0.6133760469311309
SUP-T1,24785538,0.992921552628288
SIG-M5,24821094,3.714974087301675
Capan-1,11955716,3.490268632121224
RPMI-8402,9935249,1.248313969132739
RPMI-8402,24180125,2.381809209442335
SK-MEL-3,5113032,4.0236662241585375
AU565,sirolimus-bortezomib (250-1 mol-mol),0.9370118878253954
EHEB,12001922,1.634649199110844
VMRC-LCD,53392493,1.9155247965138475
NCI-H716,9444,4.197235624009964
HDLM-2,10385095,1.1751737013594648
HCC2108,44241473,4.848973928948178
HGC-27,9933475,1.5767189414311074
PC-14,4477,-0.0975301875063986
KYSE-180,441298,2.642638918815539
SK-N-SH,11612883,2.399970394316785
NCI-H2081,135659046,2.9715500062667455
MFE-319,51037431,1.9089045572292656
HT-1197,445091,4.551622926079266
AML-193,44607531,0.73943280841126
MFE-319,9926054,1.8492827713698956
KALS-1,445091,5.156984597089338
MG-63,4378219,4.0528629596402705
HuH-28,24180719,3.69351158523283
EoL-1,49793307,-5.3772278162464335
SNU-719,44185566,2.3802879128356365
PC-14,216345,3.76636528013032
NCI-H647,3676137,3.999098563527988
PK-59,6610355,4.622942795631218
RCC10RGB,135659046,5.776465120313546
JeKo-1,16038120,-0.1835716800902385
RCH-ACV,6610216,4.070722186568696
SIG-M5,44137675,2.1511971527738796
RCH-ACV,6450551,1.4655211052911383
NCI-N87,119607,4.916125105909822
SUP-T1,selumetinib-navitoclax (8-1 mol-mol),4.034961670640176
MG-63,54618771,1.3665941956425405
HT-1197,serdemetan-SCH-529074 (1-1 mol-mol),1.1952519887788544
SCC-25,60750,-1.9384890824500984
BT 428,68056272,3.459545144261663
AU565,53232,3.892352285865555
HDLM-2,44632017,0.8936517454858782
YH-13,285033,-0.9199224136230332
Capan-1,44607530,3.887568912425482
NCI-H647,60750,3.4466140356648043
A3/Kawakami,UNC0638-navitoclax (1-1 mol-mol),3.0447804722614764
HGC-27,46215462,1.5283018396655064
SK-MEL-3,JQ-1-vorinostat (2-1 mol-mol),1.3336079691779
NCI-H716,387447,-5.314010938930765
BT 228,5566,2.4871013614663497
NCI-H2081,24748573,1.609194979965708
AU565,11625818,3.8205404098717457
HOP-92,selumetinib-GDC-0941 (4-1 mol-mol),0.6606964721280018
RKO,11626560,1.596896929931414
AML-193,11213558,2.656002918725855
NCI-H2009,11427553,1.9586555200212517
SK-MEL-3,122327,5.764567127685468
HT-1197,5281321,-2.6668310893493468
KALS-1,56963564,1.643612023760572
HARA [Human squamous cell lung carcinoma],2828334,6.6956020196427115
A3/Kawakami,5978,-4.472266827493876
SCC-25,1566236,1.5434275794698058
SK-BR-3,54618771,0.9510207607432342
KYSE-450,89928392,1.680457877716282
AU565,15953870,2.093538779145719
KYSE-180,25126798,3.589811911556444
KALS-1,3465537,2.6305189862843155
AML-193,54454,4.279967118510601
BT 228,51039095,2.942720847683078
PK-59,168313047,2.046331898255323
SIG-M5,10127622,-2.3742837319352574
MG-63,3825829,4.401803636096853
YH-13,selumetinib-PLX-4032 (8-1 mol-mol),4.578081619399974
KYSE-180,5282054,4.445709887408605
SNU-719,16722836,1.6739797915455783
KYSE-180,3025944,4.407646494118587
HOP-92,53232,-1.4886468541703477
VMRC-LCD,1566236,2.051225388786631
HARA [Human squamous cell lung carcinoma],613000,1.7145271439199108
IGR-37,4259181,-0.1199354810210708
A3/Kawakami,969516,2.0340744914156232
RPMI-8402,20959075,-3.3557997184159665
PK-59,selumetinib-tretinoin (2-1 mol-mol),4.429549180241363
KYSE-450,sirolimus-bortezomib (250-1 mol-mol),1.472196995185456
TCCSUP,123631,2.272054627361115
EHEB,6252,0.1933342673652495
KHM-1B,54618305,4.409714485426553
NCI-H2009,JQ-1-UNC0638 (2-1 mol-mol),1.1366258852040196
KYSE-450,1242560,3.7226437458360895
KYSE-180,25262965,0.0419540229516487
MG-63,24748573,1.7656760162135454
EoL-1,5479543,1.3987166318696314
KALS-1,44202524,1.376964085828414
MSTO-211H,5284616,-7.533473618112548
SIG-M5,5311,1.2727146525867343
BT 228,selumetinib-MK-2206 (8-1 mol-mol),2.129851800466683
NCI-H2009,49850262,3.4451640543988233
VMRC-LCD,11364421,-5.909222892081491
RCM-1 [Human rectal adenocarcinoma],65064,5.283352652805609
HT-1197,11396600,2.8973650572318213
BT 228,11497983,4.585609372767396
KU-19-19,5287620,-2.913600334543538
NCI-H2081,6450551,1.1680905848909615
HDLM-2,400769,-0.9910944547474942
KYSE-180,241158,4.333679160826191
MFE-319,3689413,0.3953423105508483
SK-N-SH,45279963,3.414285081152317
SIG-M5,5335621,3.941958668207105
PK-59,11609586,3.2750440078364305
SK-UT-1,219104,4.058043606422707
A3/Kawakami,44185566,2.8149787449020285
A3/Kawakami,5460769,1.7157310456182762
RPMI-8402,11656518,0.2787868980875497
BT 228,4259181,1.0401534550854912
SIG-M5,126941,-4.430963317682505
HOP-92,1641662,3.594577732555283
AML-193,65628,3.6139480198766822
NCI-H2009,25102847,2.121570289721804
NCI-H716,16065773,2.368812430200039
HT-1197,9935249,1.8352479707891152
NCI-H647,3062316,-4.0030440007638175
L3.3,5287620,-1.4617046509205764
AU565,54143018,-0.7127893506095456
JeKo-1,11612883,2.583893801799372
KALS-1,25126798,4.054453464226966
Capan-1,25227462,0.5348383191162759
AU565,9915743,-3.6885201415408098
MSTO-211H,JQ-1-UNC0638 (2-1 mol-mol),2.4218751645526573
BT 232,400769,0.7757070387535939
HARA [Human squamous cell lung carcinoma],6505803,-0.6058988133854029
KHM-1B,52947716,-7.453605591404808
PK-59,10231331,3.699323619498394
RPMI-8402,10427712,3.3611164657232364
PK-59,3815108,2.9593126918265553
VMRC-LCD,25227462,-0.8347951704113054
HDLM-2,vorinostat-navitoclax (4-1 mol-mol),-0.7662743145573527
MG-63,9927531,4.972527766781062
KYSE-450,7251185,3.3097037107461897
SK-UT-1,5281321,0.6651666607918505
P31/FUJ,72193861,-0.3659416399435479
PK-59,5566,3.045555792882338
BT 245,9926054,2.9422912383021393
SUP-T1,9967941,3.75474971777781
RCH-ACV,241158,1.6371386561823098
HDLM-2,66577038,2.745357344121332
BT 428,9952709,2.8094691608095257
HuH-28,135398516,3.481141870655675
YH-13,5738263,3.9080181125060496
NCI-H1092,selumetinib-navitoclax (8-1 mol-mol),4.937762967371625
HT-1197,448949,1.6149985474152375
SK-BR-3,11175137,0.8681426560629948
KALS-1,3503,3.069144143550792
AML-193,16722836,-0.1886359755635885
EHEB,65628,3.796785261187004
AU565,11964036,0.1505437081667179
SK-UT-1,selumetinib-GDC-0941 (4-1 mol-mol),2.9282697370514716
RCC10RGB,568763,0.4218853975706897
KMH-2,20959075,-4.058687349563306
NCI-H1092,16659841,4.30883248177806
SNU-719,5280436,4.376263814994886
SCC-25,2113511,5.682707141609532
MSTO-211H,123631,1.7071024302486195
KALS-1,selumetinib-MK-2206 (8-1 mol-mol),2.3664319474296818
RKO,11396600,3.504834935214814
P31/FUJ,10231331,0.360402840185862
WM793,16722836,1.9523853795205277
IGR-37,11719255,3.409635857158606
NCI-H1092,ISOX-bortezomib (250-1 mol-mol),0.1294529339414141
MSTO-211H,2749,1.2029234831790616
YH-13,5351362,2.4271787200041066
NCI-H2009,10231331,-1.9302715463885551
TCCSUP,11167602,2.834914441950803
JeKo-1,51037431,2.3721294187229165
SNU-175,5329102,1.705476325913873
SK-BR-3,5494449,3.733041440837719
KMS-26,16720766,-1.3057091598029198
NCI-H716,71680916,5.23140018018437
HOP-92,135440466,1.0257442191518549
KU-19-19,6914657,-4.990300196809823
MG-63,136227924,3.2795436313273685
KMH-2,637858,0.9367437449814346
HARA [Human squamous cell lung carcinoma],445091,4.978549366904043
EoL-1,5278396,1.712603042411842
MG-63,984333,-1.756478420917334
SK-BR-3,72376,-2.7614505406378345
P31/FUJ,613753,2.9305719806169432
KYSE-450,148198,-3.4919685284150876
KMS-26,44202524,0.5450243320007615
MG-63,navitoclax-sorafenib (1-1 mol-mol),2.8199620969609915
BT 239,25227462,0.8808544816193705
SUP-T1,54678924,1.3269981195464298
PC-14,73707398,2.0324483303809666
HGC-27,5278396,3.0140552180830325
JeKo-1,11404337,-1.0082771831534074
RPMI-8402,9927531,3.4344708783390856
VMRC-LCD,46224516,1.905669749105501
PC-14,JQ-1-navitoclax (2-1 mol-mol),0.2990026517861892
PK-59,tanespimycin-bortezomib (250-1 mol-mol),-0.1370541411444133
JeKo-1,44137675,2.372546178562621
KYSE-450,6918638,1.5500469019976144
TCCSUP,452548,0.1947021614919304
JeKo-1,451668,1.0292629026979645
HuH-28,selumetinib-JQ-1 (4-1 mol-mol),0.7023038761063913
MFE-319,5470400,1.0650658126441672
KYSE-180,3385,2.5391949123618036
RKO,5746,2.147448518007633
RCH-ACV,656346,0.7599670983619925
BT 228,tanespimycin-bortezomib (250-1 mol-mol),0.2023623064786018
PK-59,17755052,1.7138958301982952
HuH-28,72193861,2.607167383325233
MFE-319,151289,2.6257885280081945
VMRC-LCD,6918878,0.611810657347729
NCI-H2009,6623618,3.0922058987418315
IGR-37,44491742,4.84582247034579
Capan-1,23582824,1.3900708879508537
BT 239,25262965,-0.7801427323441544
BT 239,9926054,3.266360841464617
AU565,2842253,5.995707097044385
SUP-T1,3503,2.2047177310328276
KU-19-19,2858523,2.990442019675252
SIG-M5,9823820,4.010256829750292
KMS-26,44487872,4.333552536617936
AML-193,44491742,3.5122021187729184
NCI-H647,16659841,4.054351586135218
MG-63,navitoclax-PLX-4032 (1-1 mol-mol),2.92257043921908
NCI-H2081,67156097,-1.7291479863882548
RCC10RGB,9933475,1.608288384582936
SNU-175,100016,4.815284438481943
HARA [Human squamous cell lung carcinoma],9952709,3.695976506837269
RCC10RGB,15547703,6.556615668020641
BT 428,46224516,2.3722957038774095
SK-N-SH,107970,2.0186521104376904
HT-1197,11404337,0.4511848825128766
SUP-T1,71680916,4.148498237024039
RCC10RGB,11964036,2.4986740771219673
BT 245,44819697,-3.0488114017320056
Capan-1,54619267,4.402821141490893
P31/FUJ,6914657,-6.361388893160888
SK-N-SH,675434,4.186522087522556
NCI-H716,17755052,2.1263023291915593
MSTO-211H,656346,1.1626228980727835
SK-MEL-3,9927531,5.047514354060135
BT 239,135411,2.0122298788080255
RCH-ACV,crizotinib-PLX-4032 (2-1 mol-mol),1.1574095862565972
KALS-1,4261,2.743612286019707
SIG-M5,44632017,0.8927668670662008
HuH-28,5278396,3.086382941436871
BT 232,9911830,3.5363082238879504
KMS-26,3543504,3.7337600278634007
RKO,5311,2.326095881991792
RPMI-8402,44589607,0.7045885040365155
NCI-H647,65064,5.385570555071068
SCC-25,49850262,2.985319735286033
KHM-1B,446155,3.672634684818232
A3/Kawakami,carboplatin-etoposide (40-17 mol-mol),-0.1440415549142182
SUP-T1,53392493,1.4392548702585328
BT 228,25227462,1.537057914949187
NCI-H1092,11719255,3.2848713677183334
BT 228,1716436,2.8343338794517305
VMRC-LCD,71304818,1.8438129922501136
RCM-1 [Human rectal adenocarcinoma],5351362,2.343495237192863
JeKo-1,4521392,4.431337036849927
SK-N-SH,2874250,5.087697463292844
BT 245,54143018,-1.1109884999595483
SCC-25,25183872,-0.6781619990186089
BT 232,3384730,1.469194712946262
AML-193,1239801,4.177800730733592
BT 245,104842,-5.23594033549698
NCI-H2081,462382,-0.5652785498949985
KMS-26,decitabine-carboplatin (1-1 mol-mol),-3.1666046321953316
HT-1197,24951314,2.356152221761597
EoL-1,135398738,0.6320589107250222
HuH-28,148198,-2.021570879292896
BT 428,44607531,1.0296265544892458
HuH-28,11396600,3.662277898501366
RKO,11497983,5.954072388877685
YH-13,49766530,-0.8723369372860722
SNU-719,374536,0.7664524014772056
A3/Kawakami,5738263,2.35336701473153
EHEB,216468,1.5463895294433374
SIG-M5,25062766,1.465664798395614
AML-193,1750826,-1.0461411201873885
BEN,19582717,3.049789940706938
NCI-H1092,11955716,0.959637304928072
VMRC-LCD,docetaxel-tanespimycin (2-1 mol-mol),-7.612867430424945
SK-BR-3,3025944,4.363841199110729
BT 239,44819697,5.736402832756664
HOP-92,sirolimus-bortezomib (250-1 mol-mol),1.0049376292822905
EoL-1,7251185,0.7616229292007444
KMS-26,6184667,2.305966954188864
KYSE-180,119607,5.519962897909222
RCH-ACV,11175137,1.4620031867538488
WM793,44241473,6.43700199521037
HDLM-2,11396600,2.3384367351946604
SK-N-SH,135928012,5.794138033449565
EHEB,selumetinib-MK-2206 (8-1 mol-mol),0.5537503173054988
L3.3,10113978,3.760524207236511
HGC-27,56649450,-0.7877021867651114
RPMI-8402,9915743,0.1468401173271679
SK-UT-1,446155,0.911002973182342
SIG-M5,serdemetan-SCH-529074 (1-1 mol-mol),1.0289426256269394
SCC-25,445091,4.471780085411336
Capan-1,3038522,1.743067994955094
HuH-28,5329102,2.0778458240224316
MSTO-211H,2126,4.496176254172968
AML-193,73707398,0.1090219362628487
SW1116,selumetinib-GDC-0941 (4-1 mol-mol),0.1535490592284351
KALS-1,156414,2.413374739256189
RPMI-8402,65064,3.156004734336055
IGR-37,3025986,-0.8918621804817695
AU565,151289,0.4389765151464501
RCM-1 [Human rectal adenocarcinoma],6852167,4.10667945313068
KMS-26,107985,-4.9565801235489095
NCI-H1092,135421197,1.379439810077043
RPMI-8402,6852167,1.2289989467414018
P31/FUJ,135398738,-0.0291234665218711
YH-13,24785538,1.1754482929087915
VMRC-LCD,71751553,5.332417713766258
NCI-H647,alisertib-navitoclax (2-1 mol-mol),1.2121266203836196
KMS-26,3825829,2.5270100411904264
KMS-26,2828334,5.8087412573645505
SIG-M5,4259181,0.1435014224884159
AML-193,9884685,0.1171363640105301
AML-193,3385,6.128943540688345
NCI-H647,66577038,2.996996468979862
NCI-H1092,2113511,4.75362905375034
SUP-T1,16722836,0.7002069083217329
SCC-25,168313200,2.150051154835275
EoL-1,45279963,1.6418690840002708
HT-1197,alisertib-navitoclax (2-1 mol-mol),1.3900103588194144
MG-63,9933475,1.6010048203420135
IGR-37,4788,4.909080907380889
NCI-N87,5479543,3.770784511292927
P31/FUJ,3062316,2.2346133515561415
NCI-H2009,doxorubicin-navitoclax (2-1 mol-mol),-0.756296183538871
SK-MEL-3,5328940,1.8856233432074376
NCI-H2081,16725315,3.0839899254921095
AU565,4578,4.456552707084199
EoL-1,7326481,1.8006470036762536
SK-UT-1,123631,3.6786616828036
NCI-H2009,11625818,4.7000574258268255
P31/FUJ,4917,2.744589019426067
HT-1197,44241473,5.299907151085159
NCI-H647,4477,0.512291822011087
RCH-ACV,168313200,2.215457911819633
KMS-26,135999136,2.070918369097562
AU565,46174525,5.4998307146624255
HARA [Human squamous cell lung carcinoma],168312962,2.6720428895447412
HGC-27,71680916,4.423762981795568
MFE-319,11485656,1.6496792677763226
BT 232,11167602,3.700775508233816
KHM-1B,49850262,2.854623177297442
HDLM-2,UNC0638-navitoclax (1-1 mol-mol),-2.911208376881327
BT 428,5460769,2.5146871392563845
NCI-H647,3465537,2.923785800971271
EHEB,46199207,2.926466130058298
KMH-2,6623618,1.9063060401204115
Capan-1,285033,-1.7435020494089697
SK-BR-3,36462,-0.4893529517615315
HGC-27,11427553,0.8060604852701359
JeKo-1,135999136,1.7054412351562194
KU-19-19,159324,4.255883770522122
EHEB,10090485,5.892161708902715
HARA [Human squamous cell lung carcinoma],135423438,3.0787654328489986
HARA [Human squamous cell lung carcinoma],322968,4.828098936758316
RKO,613753,3.427719504210608
SUP-T1,10302451,2.7674350059847344
BT 428,1641662,3.5622392770893216
A3/Kawakami,11167602,1.5696684185546212
BT 232,sirolimus-bortezomib (250-1 mol-mol),1.5892274515835794
JeKo-1,3825829,3.5162020408315384
KU-19-19,navitoclax-pluripotin (1-1 mol-mol),-0.1990402991745543
NCI-H647,5284329,2.2649205746315766
KMS-26,613753,0.4724841465774915
AML-193,BRD-A02303741-carboplatin (1-1 mol-mol),6.251893413947503
SK-BR-3,54649381,3.8002658347162344
KHM-1B,16722836,0.0780331724282444
BT 228,6505803,-0.8466206341020581
BT 245,54613361,-1.1650114497450532
RKO,151289,1.190219151105647
BEN,46224516,2.247182808888496
SK-N-SH,9887053,3.900914446127006
HARA [Human squamous cell lung carcinoma],2708,4.268843127757034
VMRC-LCD,100016,6.5149453048399515
RCM-1 [Human rectal adenocarcinoma],16038120,1.1652003457864657
L3.3,285033,-1.389904047242399
AML-193,135398738,0.6336791872218647
SIG-M5,5738263,4.131881381835954
BT 228,448949,1.7954738243114898
PC-14,6252,2.490064475055688
SNU-175,5311,0.794395185206806
BT 428,9935249,1.746513548919668
RCC10RGB,262093,2.8343922904091134
SCC-25,56963564,0.3046818996127222
EoL-1,54618771,-1.3490437314976569
VMRC-LCD,56963564,0.632403756354812
JeKo-1,salermide-PLX-4032 (12-1 mol-mol),5.094614380660797
SK-BR-3,44566777,0.3192724240823377
JeKo-1,12001922,1.5537981384141524
HGC-27,11609586,-0.0835645082121754
BT 428,441298,1.4974571661607616
EoL-1,46174525,1.3800181571544643
KMS-26,984333,-2.3187431540180334
RCC10RGB,44185566,3.1564704709707856
BT 245,322968,3.5210488546658905
HuH-28,452548,2.119363714763093
NCI-H716,crizotinib-PLX-4032 (2-1 mol-mol),1.2286540597095394
SCC-25,16725315,3.186691652801314
BT 228,3634881,2.394898115527703
P31/FUJ,sirolimus-bortezomib (250-1 mol-mol),0.0617669843942014
KYSE-450,42642645,1.660330797131617
MFE-319,5281321,2.1976144191081413
SK-MEL-3,SNX-2112-bortezomib (250-1 mol-mol),2.8423941563131816
HuH-28,JQ-1-UNC0638 (2-1 mol-mol),-0.759092767813931
HGC-27,25105715,2.9168095437391472
YH-13,9967941,5.158466300514708
KMH-2,11964036,1.4191519849589271
BT 232,navitoclax-sorafenib (1-1 mol-mol),1.679249154243997
NCI-H647,erlotinib-PLX-4032 (2-1 mol-mol),2.9716985894557335
RCH-ACV,11214940,1.0031887666373993
HDLM-2,262093,2.5590696667733908
EoL-1,JQ-1-UNC0638 (2-1 mol-mol),-3.3299111912655563
NCI-H647,11238147,1.987384375025864
HT-1197,5280436,1.9157122819743224
PK-59,6438330,1.1119626905782527
BT 228,54619267,4.206636465451463
PK-59,11404337,0.8851709837592256
JeKo-1,decitabine-carboplatin (1-1 mol-mol),0.9349295368304223
KHM-1B,151289,0.8227956110380268
NCI-H716,9926054,1.9023068554939984
SK-BR-3,11507802,0.7205562465395257
A3/Kawakami,9884685,0.5438529954210741
HT-1197,71751553,5.426785505505591
KU-19-19,4259181,2.3072251676522835
SK-UT-1,45279963,3.814266670258307
TCCSUP,24889392,3.438580211915109
RKO,26596,-1.341584325458414
MG-63,44819697,-2.327146454435507
HGC-27,44484893,-1.3429486188322708
HCC2108,11364421,-0.8828017389399302
NCI-H716,11640390,1.608512617554127
A3/Kawakami,49766530,-0.4479480669957117
EHEB,327653,2.436506136039934
HGC-27,613753,2.99585247043353
EoL-1,10410894,1.6289117975907677
HuH-28,216239,2.8205458898350853
KU-19-19,25062766,2.9321374053838807
KALS-1,JQ-1-UNC0638 (2-1 mol-mol),1.6679481171420965
HCC2108,selumetinib-vorinostat (8-1 mol-mol),2.476774013379894
SK-UT-1,49793307,-1.387353739951522
BT 239,119607,6.472934757915228
P31/FUJ,44632017,0.6534437162154956
MSTO-211H,654092,-1.1984807631004837
MSTO-211H,5329102,1.1990183253858175
HDLM-2,15547703,3.1207570599390886
WM793,5282054,4.473294081689067
HOP-92,23725625,6.246483443122267
KMH-2,252682,7.011847260914495
AML-193,107970,1.008310161545622
VMRC-LCD,135440466,2.936312638524136
RPMI-8402,11507802,-0.4202648425037566
HARA [Human squamous cell lung carcinoma],SNX-2112-bortezomib (250-1 mol-mol),-1.7614271905544292
EHEB,25126798,3.800307973895597
HCC2108,24785538,0.6113377434133814
EoL-1,45100481,2.534836863733708
PK-59,10113978,3.7065604821837934
PC-14,2742550,4.050636111371891
SK-N-SH,4261,1.5985963504730103
HCC2108,9936388,-4.897775231329417
TCCSUP,104842,-1.1313342296159858
JeKo-1,25195348,1.4980482366971992
RCC10RGB,5311281,4.058856975975892
YH-13,56649450,3.222212852506819
EoL-1,doxorubicin-navitoclax (2-1 mol-mol),-5.595827582680457
JeKo-1,5566,3.02905379439855
BT 245,24785538,-0.3244918741267977
HT-1197,24753719,4.164524114468767
NCI-H2081,JQ-1-MK-0752 (1-1 mol-mol),1.5845874170404597
HuH-28,25126798,2.1142283112855575
BT 428,3062316,2.1273862607852423
HARA [Human squamous cell lung carcinoma],44259,0.8184068416156438
YH-13,44819697,0.6102500342217575
RKO,2708,5.0364138660049935
SK-UT-1,selumetinib-vorinostat (8-1 mol-mol),3.855507066103229
HDLM-2,6610355,4.560624324874948
PK-59,11238147,2.718340913580302
SK-UT-1,selumetinib-MK-2206 (8-1 mol-mol),3.6848335310272495
RCM-1 [Human rectal adenocarcinoma],219104,4.304261518356908
NCI-H2009,19582717,2.816304614086765
NCI-H716,23582824,1.007934659188214
SK-MEL-3,4259181,0.967538636263607
KALS-1,6852167,3.6016350818751097
SK-BR-3,11625818,4.0064243110723154
NCI-H2081,2113511,5.887523874573183
RPMI-8402,decitabine-navitoclax (2-1 mol-mol),-1.743151095414308
EHEB,262093,2.39806678929768
SK-UT-1,126941,-4.3077723126369944
BT 239,BRD-A02303741-navitoclax (2-1 mol-mol),-2.6707145375439367
Capan-1,25062766,1.954290829969376
HARA [Human squamous cell lung carcinoma],54454,2.560964814308564
AML-193,568763,0.5459618986684255
KALS-1,1750826,-2.854045515353042
KU-19-19,72193861,2.401782330602402
RCM-1 [Human rectal adenocarcinoma],3503,2.644951314615224
BT 239,44607530,0.8163188827498387
Capan-1,119607,5.701006367426189
TCCSUP,6623618,2.4538006710515186
KALS-1,selumetinib-GDC-0941 (4-1 mol-mol),1.963503577041432
SK-UT-1,6184667,3.933294050011487
A3/Kawakami,71466445,1.2297175943082674
RKO,56963564,0.5825206420774123
MSTO-211H,8515,1.6806311840995682
BT 232,2729026,1.7676166146417314
HuH-28,1750826,-2.613261730463971
SK-N-SH,2871966,-1.804534559666768
JeKo-1,136227924,2.4041415853814687
VMRC-LCD,16725315,5.242257337056552
P31/FUJ,BRD-K27188169-navitoclax (2-1 mol-mol),0.0086353275600694
L3.3,400769,-0.1977482396353321
HT-1197,10322450,2.509794666751626
BT 232,135999136,1.8601306956722656
L3.3,24856436,2.4877361998822924
PK-59,9936388,2.2614163852650377
BEN,11152667,1.5571390714565738
EHEB,44632017,1.189004229648695
P31/FUJ,6450551,0.3392586382091512
HDLM-2,44486219,3.7302740382369
SUP-T1,44137675,3.1902941192136165
BT 239,5494449,-0.1873889854988592
KALS-1,crizotinib-PLX-4032 (2-1 mol-mol),2.6473128858020023
WM793,3815108,3.0627718438622487
HARA [Human squamous cell lung carcinoma],navitoclax-PLX-4032 (1-1 mol-mol),1.441529788664552
AU565,9956119,3.3766215860348368
JeKo-1,24748573,1.5059513428290945
SK-BR-3,5280436,4.562478602687472
MG-63,6610216,5.0810751878936165
KHM-1B,3825829,3.6551708099406
SK-N-SH,3503,1.4185020323499384
IGR-37,7251185,3.713937798035306
NCI-H716,54613361,0.8613433023854142
PC-14,66577038,3.5004555474754824
BEN,46943432,2.875871955716667
BT 228,11152667,1.5826836079285618
BT 428,6914657,-5.3524044733018545
NCI-H647,9915743,2.3861555081982035
KHM-1B,4788,4.7580664761718054
HGC-27,9823820,3.2657655487251382
SK-MEL-3,4578,4.582935901143828
MG-63,46398810,2.653886782040105
NCI-N87,11396600,3.282772907192936
MFE-319,46191454,1.9662291290539835
KMS-26,159324,-4.353423626038214
PC-14,3062316,-3.26358834718932
NCI-H716,44566777,0.9919534286160064
L3.3,9935249,4.2075706542966955
NCI-N87,135440466,2.814988966864087
RCM-1 [Human rectal adenocarcinoma],vorinostat-carboplatin (1-1 mol-mol),3.4124582914647026
SK-UT-1,100016,6.311695779547894
KALS-1,25102847,3.196145388858035
WM793,53495165,1.4251272821754086
YH-13,11626560,1.8964713919919112
NCI-H647,446155,1.4908059059196843
NCI-H647,65628,4.301198610868103
MFE-319,crizotinib-PLX-4032 (2-1 mol-mol),3.099969265206969
TCCSUP,24748573,1.7257440496514025
HT-1197,15547703,3.890329607687824
KMH-2,208908,1.5627974363378532
KHM-1B,11507802,0.7645643199546858
NCI-H1092,227681,1.9884114901843049
EoL-1,9956119,1.6901844644534667
SK-N-SH,24753719,3.5601626189030746
BT 228,4705,2.9776742374727436
HuH-28,16038120,0.545707361532178
PK-59,3385,3.852360617326858
NCI-H716,11234052,1.058755738202647
RCH-ACV,89183176,2.435912391177826
BT 239,119182,-2.2180214290841485
EHEB,navitoclax-pluripotin (1-1 mol-mol),-1.9165707205627271
KHM-1B,126941,-4.224902593800319
SW1116,52912189,-0.2369939390539988
HuH-28,400769,-1.0051553866648788
HGC-27,73707398,0.4589955363470999
JeKo-1,9826308,-0.4257345031580311
HGC-27,71751553,3.896602890461538
IGR-37,53392493,3.725059349563032
SK-UT-1,16741245,3.1689132411737244
RCH-ACV,375860,-0.3160075920060057
SNU-719,5351362,0.9215396532454604
VMRC-LCD,135398516,3.576041875636431
RCM-1 [Human rectal adenocarcinoma],2871966,0.2370033726564668
MFE-319,4261,1.4614933838801396
Capan-1,10427712,4.454729999146339
RCH-ACV,9444,4.419025631000447
PC-14,16720766,2.9696351581057825
RCC10RGB,10074640,3.4095283906874956
RCM-1 [Human rectal adenocarcinoma],2729026,3.1482483825414698
WM793,49766530,-0.085641441031448
A3/Kawakami,25105715,3.105460592552827
NCI-H2081,6917907,-5.960779404992594
SUP-T1,3025986,-1.5163148815624932
HGC-27,135398744,6.47323705988127
P31/FUJ,9825149,2.400010374644864
NCI-H2081,9927531,2.933726437844289
P31/FUJ,89928392,-0.2575535361410093
EoL-1,613000,2.0653566264208933
RPMI-8402,246676,4.500897758755647
IGR-37,285033,-2.891289704521277
BT 245,135659046,4.182181998244751
NCI-H2081,10322450,4.110472568642291
P31/FUJ,11507802,-0.4015560413947272
RCM-1 [Human rectal adenocarcinoma],3025944,4.221207920184214
A3/Kawakami,4917,3.12550911427124
BT 428,426756,5.018935831662504
PC-14,ISOX-bortezomib (250-1 mol-mol),1.1155914488339396
SK-UT-1,3854666,2.1786369520498283
MFE-319,1750826,0.120173753583924
L3.3,4259181,-1.5745308976200183
KMH-2,3025944,3.4959476689889266
JeKo-1,104842,-6.680322236064047
SK-BR-3,168312962,2.7995342496298536
VMRC-LCD,9903786,1.8330708335593808
SK-N-SH,66577038,2.946745434463971
HOP-92,3062316,1.2616906375202632
MSTO-211H,vorinostat-navitoclax (4-1 mol-mol),-1.2418766725750991
HGC-27,135875424,2.7794180683242575
MG-63,2126,3.7063541013373302
BT 428,17755052,1.5816948743911896
KMS-26,11717001,3.966811849234462
EoL-1,44498493,4.3086517306828656
BT 245,5328940,1.7328762596340126
MFE-319,219104,4.752574158221445
RKO,135999136,6.045591123054076
HARA [Human squamous cell lung carcinoma],16038120,0.7093520184689783
KALS-1,navitoclax-gemcitabine (1-1 mol-mol),-1.8671271519077095
MG-63,docetaxel-tanespimycin (2-1 mol-mol),-6.225759489753539
A3/Kawakami,46907787,-2.1419759395724296
HuH-28,135411,1.2887103853728936
AML-193,6252,-1.3781310262717057
NCI-H2009,vorinostat-navitoclax (4-1 mol-mol),0.5355412888346941
BT 232,387447,-4.759475598097268
HARA [Human squamous cell lung carcinoma],56946209,-3.7436646215458182
SIG-M5,16659841,3.2880463785210887
NCI-N87,9825149,1.7110175659097178
HARA [Human squamous cell lung carcinoma],54618164,4.558968644978708
SK-N-SH,6918328,0.2175068396193798
RCC10RGB,3062316,3.7206614033239833
PC-14,9967941,4.035370880169342
BT 245,17755052,1.5011622664122757
PC-14,44137675,3.2204053533427284
MG-63,10410894,4.29189825299543
IGR-37,11626560,2.245348528756177
EHEB,navitoclax-piperlongumine (1-1 mol-mol),0.5125225467542266
SUP-T1,tretinoin-navitoclax (4-1 mol-mol),3.861907113448747
AU565,11152667,-0.8659767610796402
Capan-1,5746,1.4480838815581902
BT 428,49793307,-3.4439076798113857
KYSE-180,ISOX-bortezomib (250-1 mol-mol),0.5668882301656226
MSTO-211H,navitoclax-birinapant (1-1 mol-mol),-0.9866972359238844
HT-1197,24771867,4.03094674128079
SK-MEL-3,vorinostat-carboplatin (1-1 mol-mol),3.713857745038401
NCI-H716,168313016,4.474917633369443
AU565,613000,0.5241513608694668
RCH-ACV,72734382,2.4851718663192517
HDLM-2,9935249,2.6630480358330657
RPMI-8402,3815108,2.52829997476961
RCC10RGB,71751553,5.18764953581067
MG-63,54619267,4.056804785764192
VMRC-LCD,71466380,4.124444843081115
SIG-M5,72199292,1.5244906757806111
KMH-2,54619238,4.6045100189893935
PK-59,44819697,-0.7896271162004322
P31/FUJ,25195348,1.3039046822632598
MG-63,446155,0.3399420347566793
RCH-ACV,selumetinib-piperlongumine (8-1 mol-mol),2.3090201866938673
MSTO-211H,selumetinib-JQ-1 (4-1 mol-mol),1.9489551392518472
HT-1197,9825149,3.138952788067842
AML-193,11977753,0.1241462040367492
BT 245,12001922,1.1359321871248116
SNU-719,5329102,2.289249221612907
HGC-27,448949,1.8988935908257216
WM793,11455910,1.0189470974054349
NCI-H716,ISOX-bortezomib (250-1 mol-mol),0.1181690569502056
RCM-1 [Human rectal adenocarcinoma],selumetinib-decitabine (4-1 mol-mol),3.6407543671140417
RKO,969516,2.537841036798478
KMH-2,vorinostat-navitoclax (4-1 mol-mol),0.5827126499633882
RCM-1 [Human rectal adenocarcinoma],71304818,3.0028368617128485
WM793,JQ-1-vorinostat (2-1 mol-mol),2.1043160686090174
RCH-ACV,9911463,3.0164495694829903
NCI-H2009,54613361,-1.6701870677586086
BT 245,44632017,1.566469903011254
YH-13,tanespimycin-bortezomib (250-1 mol-mol),-0.5369599682458667
SCC-25,3136844,3.707454380555626
YH-13,52947716,-5.569011726742263
KALS-1,piperlongumine-MST-312 (1-1 mol-mol),1.9386378542678784
KU-19-19,702558,5.449368171937104
IGR-37,10184653,2.046250163747502
SCC-25,10296883,3.5302402637637145
HGC-27,46199207,1.7580950293119193
HCC2108,11612883,2.2731271711462573
BT 232,25227462,1.7060341914330142
RPMI-8402,JQ-1-UNC0638 (2-1 mol-mol),0.1706999740110269
WM793,72193861,2.0745792283120084
BT 232,25154868,4.860511225928993
NCI-H2081,9911463,2.5760332235225016
BT 232,2949965,2.8294278148117753
BT 245,969516,2.756256935872277
JeKo-1,4705,3.398339905986335
PK-59,10385095,1.2934299374128844
SCC-25,5328940,0.781399938220304
YH-13,6918837,-2.973076414332095
EoL-1,11238147,1.321419547046849
RCC10RGB,vorinostat-carboplatin (1-1 mol-mol),4.3210323450827275
SK-UT-1,6918837,-1.386854700757193
HGC-27,3543504,3.904531364678704
RCC10RGB,119607,6.074674808773517
EHEB,16736978,1.931050460573665
HT-1197,selumetinib-piperlongumine (8-1 mol-mol),3.567263764437125
SK-N-SH,9935249,0.7535155935236955
VMRC-LCD,675434,4.176552182661101
AU565,5978,-4.241011158819041
NCI-N87,SNX-2112-bortezomib (250-1 mol-mol),-4.305728707352715
EoL-1,5460769,1.0165285119643896
MFE-319,5746,2.2090660514232887
NCI-H2081,637858,0.9384843122739523
NCI-H2009,crizotinib-PLX-4032 (2-1 mol-mol),1.3104929839779844
KU-19-19,11612883,2.975593545287462
HGC-27,2733526,2.616352901939748
PK-59,49850262,4.589372067197883
RCH-ACV,53495165,-2.4907221082907993
SNU-719,24180125,2.565384193053944
HGC-27,15983966,-3.6796799728440623
HCC2108,135440466,2.000453402842669
RCM-1 [Human rectal adenocarcinoma],selumetinib-tretinoin (2-1 mol-mol),1.4034944184327462
IGR-37,2858523,3.1178039387742977
NCI-N87,vorinostat-carboplatin (1-1 mol-mol),2.026584102601564
HT-1197,tanespimycin-gemcitabine (1-1 mol-mol),-1.0623046173091863
SUP-T1,selumetinib-JQ-1 (4-1 mol-mol),-0.508172798980745
PC-14,6450551,1.723712317687973
EoL-1,5328940,0.0092559641518109
RCC10RGB,135423438,4.4299924289236055
PC-14,119182,-2.1067175342920925
BT 428,carboplatin-UNC0638 (2-1 mol-mol),3.4445307503856557
WM793,262093,3.640026682877067
SK-BR-3,6436223,-4.226706920960153
KMH-2,11497983,1.3232117971910344
KMH-2,44489675,3.7804388029972738
JeKo-1,23725625,4.932636632319576
MSTO-211H,ISOX-bortezomib (250-1 mol-mol),-0.1802030513255949
SIG-M5,327653,3.3709040199841445
HT-1197,7251185,2.048651236622351
KMH-2,49850262,2.963335221123529
YH-13,107970,3.012104980277858
KYSE-180,36314,2.411334755990669
AML-193,2126,4.23490732431981
YH-13,702558,5.825874792265712
BT 232,5280436,5.3370111984641575
VMRC-LCD,11497983,-3.821833866735507
IGR-37,322968,4.749468092228688
KALS-1,11364421,-3.8022042464983463
Capan-1,984333,2.1431605363901887
SIG-M5,448949,1.71717482163953
JeKo-1,53232,3.535979217447399
EoL-1,11396600,0.6541827154317742
Capan-1,24901704,4.239520175747103
HDLM-2,salermide-PLX-4032 (12-1 mol-mol),5.522313425202579
KYSE-180,702558,5.1302684030030905
KU-19-19,44819697,-2.543386759740491
HuH-28,219104,4.127630062721816
BT 232,53393127,4.90386519260413
BT 228,72376,-2.0044331913005733
NCI-H2009,24772860,-3.0306018162615342
NCI-H716,BRD-K55473186,5.790134641294757
MSTO-211H,135440466,1.110539790918092
NCI-H716,selumetinib-decitabine (4-1 mol-mol),1.8951434770360496
BT 245,11427553,3.2699623966803095
SIG-M5,71680916,4.62294543362651
HCC2108,6917907,-5.24436050839449
Capan-1,44589607,3.395398456883993
MG-63,1566236,1.8094317598532976
IGR-37,31703,-1.0360156019042484
NCI-H1092,107970,1.8386309101568237
RPMI-8402,selumetinib-JQ-1 (4-1 mol-mol),1.0607904490994169
RCM-1 [Human rectal adenocarcinoma],3062316,2.514926182355465
AML-193,54649381,3.6703519441302097
RKO,4259181,-0.4049041326260317
BT 239,702558,5.723875925849208
EoL-1,73707398,-3.0491075359956508
HGC-27,10322450,3.112046430554876
KYSE-180,67156097,-0.5044651468589622
SK-BR-3,6450551,3.8359924945243367
EoL-1,241158,0.7802478350206956
KYSE-180,16038120,1.625383238797563
NCI-H647,126941,-3.367711129760604
BT 428,24978538,-0.3373674737909561
HuH-28,decitabine-navitoclax (2-1 mol-mol),0.4549211679961444
BT 239,135928012,3.5752215268119003
MFE-319,11222830,1.6008050044679534
NCI-H2009,4261,0.1994590765469732
AML-193,10410894,2.616210876204415
MFE-319,53495165,2.823347614980056
HGC-27,44137675,1.271307594102974
SK-MEL-3,675434,4.482637675507391
VMRC-LCD,carboplatin-etoposide (40-17 mol-mol),4.608110206134295
SUP-T1,ISOX-bortezomib (250-1 mol-mol),-0.4930207290525963
KYSE-450,135421197,2.3081928088852774
EoL-1,3689413,-2.5778346492897266
HDLM-2,46174525,3.204946446355842
HOP-92,15953870,3.6997396384954766
WM793,6918837,-0.893478746769829
KYSE-450,53392493,3.727068470803864
TCCSUP,5738263,3.424558088510442
YH-13,carboplatin-etoposide (40-17 mol-mol),2.297149147603289
BT 239,2858523,1.8071568455914635
HARA [Human squamous cell lung carcinoma],5738263,3.6004475982525825
SK-BR-3,11960529,3.788556487813486
SK-UT-1,387447,-4.561746078529997
RPMI-8402,11485656,1.7497353972694758
SUP-T1,11396600,2.9540043474610287
HCC2108,15547703,2.896833120042048
MG-63,2828334,5.998189138669924
NCI-H2081,11507802,1.0351752373197651
NCI-H647,119182,0.3978117356512912
L3.3,25126798,4.136340325033448
HDLM-2,5281321,-2.3982757751883153
KHM-1B,72734382,4.262414843982703
NCI-H2009,135440466,0.1778924686528867
HARA [Human squamous cell lung carcinoma],208908,3.016531266929929
HGC-27,11317348,0.8118958587964176
SK-BR-3,49793307,-3.240789402843616
RCM-1 [Human rectal adenocarcinoma],crizotinib-PLX-4032 (2-1 mol-mol),1.6431753699859777
SK-BR-3,tanespimycin-gemcitabine (1-1 mol-mol),-1.3078403010064903
NCI-H2009,6918837,-3.78935135271195
NCI-H2009,15983966,-3.9047819028388178
SUP-T1,1641662,2.1559056181295264
HOP-92,3465537,1.2768665307356584
KYSE-180,107970,2.4041035075192196
NCI-H716,5282054,4.264002565076833
SK-MEL-3,selumetinib-JQ-1 (4-1 mol-mol),1.624169736782825
NCI-H647,12001922,1.9537768000320568
NCI-H1092,11455910,0.2647471022018075
KALS-1,54649381,4.765920507871789
NCI-H2009,135421197,1.5480281661357902
YH-13,67156097,-1.843734712267085
HuH-28,11404337,0.2716572522655043
A3/Kawakami,24797083,0.0413921044962863
IGR-37,salermide-PLX-4032 (12-1 mol-mol),3.3322652775263646
KYSE-180,piperlongumine-MST-312 (1-1 mol-mol),1.4705753188677493
P31/FUJ,6918736,-1.9353169891324984
MSTO-211H,285033,-3.2380358495287695
NCI-N87,6918837,-4.459129390963203
SIG-M5,135398738,1.4124599963506688
L3.3,1716436,3.5741303666735633
P31/FUJ,984333,-0.8646677641211812
HT-1197,4917,3.710334241841881
SK-UT-1,568763,0.546342581161539
NCI-H2009,136227924,2.9896301065010933
IGR-37,11964036,2.1061256097354755
BT 428,4705,1.6502431761366996
BT 232,984333,0.0092763121522632
TCCSUP,navitoclax-pluripotin (1-1 mol-mol),-0.7480541514950738
EoL-1,5281672,4.002399843985692
SCC-25,71466578,3.8530272156216103
EoL-1,1242560,2.192154452669064
KMS-26,24978538,3.650489283671334
HARA [Human squamous cell lung carcinoma],navitoclax-birinapant (1-1 mol-mol),1.3986072497708624
SUP-T1,107985,-3.4385434341277565
RKO,4917,3.097539294413192
AML-193,11222830,-0.3266068150882026
EHEB,11507802,1.0533498675891693
NCI-H2081,24964624,2.0878863741822395
NCI-H2081,10410894,3.3787731123867464
NCI-H716,6505803,-2.390779236038046
NCI-H716,5566,3.195902963008942
SK-UT-1,44632017,3.336083034229006
BT 428,10231331,-0.1978015197872311
P31/FUJ,5278396,3.2564464707559786
HOP-92,9866186,1.9398657349940212
HARA [Human squamous cell lung carcinoma],25102847,2.0322740825170555
NCI-H2009,serdemetan-SCH-529074 (1-1 mol-mol),2.304731385362492
NCI-H1092,76446078,4.704982368459853
NCI-N87,322968,2.9452063604799417
AML-193,selumetinib-decitabine (4-1 mol-mol),0.0768453827210187
KMH-2,5311281,1.6433918392337388
WM793,5328940,2.305774199257107
SIG-M5,42642645,0.5495592688599952
HGC-27,49846579,1.584134414535173
BEN,44486219,4.37644956091897
RCH-ACV,selumetinib-decitabine (4-1 mol-mol),2.8993822818124952
HARA [Human squamous cell lung carcinoma],24180125,3.640570848683534
RPMI-8402,568763,-0.2646261718321558
WM793,4521392,4.34292186054555
MFE-319,44185566,3.2063850001931766
MSTO-211H,9915743,-1.0722844498490078
HOP-92,44489675,4.7956623732697965
BT 239,4378219,1.0499899367803716
IGR-37,vorinostat-carboplatin (1-1 mol-mol),2.6072863182768233
WM793,71680916,6.03913470036381
P31/FUJ,11609586,2.709581392176905
SNU-719,vorinostat-navitoclax (4-1 mol-mol),-0.521574571988544
NCI-H2081,15547703,3.0939456177037945
NCI-H2009,135398516,3.792403018557381
BT 245,24753719,4.292609421440975
HOP-92,selumetinib-navitoclax (8-1 mol-mol),1.6104836463383296
MG-63,5951923,3.78322861623568
AML-193,10302451,3.844676833149803
P31/FUJ,3503,1.1912257572322915
SK-N-SH,72734382,4.595035335511755
AML-193,6918638,-1.1768920136459526
A3/Kawakami,sirolimus-bortezomib (250-1 mol-mol),-6.300755370161075
JeKo-1,1641662,2.821503177837697
TCCSUP,JQ-1-carboplatin (1-1 mol-mol),4.7242319921213225
HARA [Human squamous cell lung carcinoma],3825829,3.0637384073868787
KMH-2,doxorubicin-navitoclax (2-1 mol-mol),-2.698351404926901
TCCSUP,24771867,2.435510206237169
VMRC-LCD,11404337,0.4104249926978496
NCI-H1092,5351362,1.059712602120236
MFE-319,25105715,3.7220318511717823
NCI-N87,216239,2.2423368269273753
NCI-H2009,selumetinib-UNC0638 (4-1 mol-mol),-1.7113919065901229
Capan-1,tretinoin-navitoclax (4-1 mol-mol),4.050882710894933
BEN,5287620,-0.9336158164097534
WM793,66577038,3.1191342289924417
WM793,navitoclax-pluripotin (1-1 mol-mol),-0.4661023572804197
TCCSUP,9936388,1.8313124822353004
HuH-28,3025944,4.477014511235444
TCCSUP,44507138,1.5092098612229228
PK-59,5281321,-2.3266618874871035
YH-13,16065773,2.7841843870151086
BT 245,6918736,-3.031459019744447
MG-63,selumetinib-MK-2206 (8-1 mol-mol),3.5702272487791946
HOP-92,19582717,4.406087607764629
MG-63,11364421,-4.268619667660127
BEN,11964036,2.0281742726171457
SK-MEL-3,24180125,3.765958030378214
BT 228,148198,-4.966222395978798
NCI-H716,11625818,5.359613790613388
SNU-175,151289,0.0022937809462513
A3/Kawakami,selumetinib-MK-2206 (8-1 mol-mol),3.2887497827679035
NCI-H647,6918328,0.5150097937528129
HT-1197,navitoclax-birinapant (1-1 mol-mol),2.221570791537239
AML-193,5311,0.2155367094246835
RCH-ACV,36462,-2.5687954278265535
KU-19-19,46398810,3.059016393641159
MG-63,12001922,2.5146591169115484
NCI-H647,2945648,3.9908325658148778
NCI-H647,11152667,-0.8858853545948763
EHEB,11427553,3.092795318424686
SK-N-SH,36462,0.1553406914879444
HGC-27,25161177,3.424498462983212
BT 239,445643,3.172483396190406
MG-63,1716436,3.976078718087745
NCI-H716,6918878,3.809377355631782
HGC-27,5494449,-4.431433870877451
RCM-1 [Human rectal adenocarcinoma],11404337,-0.1256073852846617
AML-193,54765302,3.9213847179843264
HOP-92,3552672,1.8646186723263112
EoL-1,JQ-1-vorinostat (2-1 mol-mol),-2.5548685131700934
HOP-92,11647372,-0.2500580788547851
BT 239,vorinostat-navitoclax (4-1 mol-mol),-3.1195117698120516
NCI-H1092,2708,5.052405164442807
SK-BR-3,16038120,1.691393086943861
HuH-28,11228183,-0.0924796385887624
MG-63,10074640,3.493383234808238
NCI-H2081,5287969,-2.131479495140116
YH-13,322968,2.764039711973652
NCI-H1092,9927531,3.406213307022425
BT 428,navitoclax-MST-312 (1-1 mol-mol),0.4416625098436278
NCI-H647,119607,3.9420711393772447
SCC-25,4096211,0.5788516565174835
AML-193,3543504,3.1650511367754866
SCC-25,135421197,1.688972609410465
AU565,54596558,3.073830584555768
TCCSUP,11427553,2.2113489694115054
YH-13,5281321,-2.463748915985143
SUP-T1,10296883,3.2156381873423725
IGR-37,9936388,-3.744387709560832
BT 245,168312962,1.259279274299411
MSTO-211H,36314,2.7056254754018
SUP-T1,54454,3.685370103576001
HDLM-2,654092,0.8598005315948002
A3/Kawakami,11977753,-2.5410469265742353
BEN,71304818,3.6608216534497062
WM793,54618771,0.892561932009902
SK-N-SH,52912189,2.380888631634011
HuH-28,10184653,1.811032264316636
HT-1197,selumetinib-BRD-A02303741 (4-1 mol-mol),3.93591752601404
HGC-27,24771867,-2.6696273898106653
HDLM-2,24964624,2.0211191504464763
P31/FUJ,135999136,4.068676884464422
WM793,2828334,6.191612506266247
NCI-H2009,11152667,-0.3244172236423036
IGR-37,10322450,5.040348991848962
SW1116,285033,0.2696990604329895
BT 245,10296883,3.705541909006873
SK-MEL-3,4788,6.316682935795587
PC-14,selumetinib-JQ-1 (4-1 mol-mol),0.1857937435498048
KMH-2,alisertib-navitoclax (2-1 mol-mol),-1.958595821130802
L3.3,5311,1.4084906886854671
BT 245,46191454,1.8526201117274133
PC-14,4259181,0.4148318229863006
RCC10RGB,71576739,5.1028364410536735
BT 428,vorinostat-carboplatin (1-1 mol-mol),1.8525492351136472
PK-59,54618771,0.2590305123117813
HARA [Human squamous cell lung carcinoma],11364421,-4.71423157944935
SIG-M5,6852167,1.5544573482245505
RPMI-8402,54613361,-1.6659617397997422
MG-63,71751553,6.373877555127259
KYSE-180,4261,3.0762998469253366
KMH-2,25062766,1.196935006770044
BT 245,6918638,0.7917501577559235
NCI-H647,9907093,4.437935915682058
HDLM-2,6438330,2.181717088469399
MG-63,16736978,2.834614445433723
NCI-H2009,16722836,0.9347693241342916
L3.3,25154868,5.156852655599311
SK-MEL-3,sirolimus-bortezomib (250-1 mol-mol),0.3038157322659797
RCM-1 [Human rectal adenocarcinoma],15547703,3.173985625992098
AU565,5280436,3.6175977861549473
KHM-1B,55283,0.1410687049284859
AML-193,11427553,0.7784716885650269
PC-14,1242560,4.349160506408389
A3/Kawakami,56963564,0.0447746845468922
TCCSUP,16722836,1.624255919263104
MG-63,44137675,3.7530565249851273
RCH-ACV,2858523,2.554031827585176
NCI-N87,11647372,-1.5140697510658656
RPMI-8402,135398744,6.9217830210823434
SNU-719,25195348,2.6414439773099003
KU-19-19,1750826,-1.6748688873644846
VMRC-LCD,5281321,-3.4893845161335695
MSTO-211H,53392493,1.8202473930982712
RPMI-8402,71466445,1.5277227120720451
SK-UT-1,702558,5.233915547215681
SK-BR-3,11152667,-3.133407190107384
EoL-1,49836020,1.4161576765733714
NCI-H2009,docetaxel-tanespimycin (2-1 mol-mol),-5.612671071914989
RCM-1 [Human rectal adenocarcinoma],56946209,-4.301528027920143
SCC-25,56946209,-4.570077069054533
BT 228,71304818,2.6593883727879883
PK-59,6918328,0.1646217427066897
KYSE-180,SNX-2112-bortezomib (250-1 mol-mol),-2.01002465261766
L3.3,135421197,2.5730452840447415
Capan-1,11612883,2.876006011544112
BT 245,25195348,3.9905152863604663
AU565,54618305,4.305835133395234
RPMI-8402,9866186,-0.4243410663190033
MG-63,9911830,1.9513563305490416
HGC-27,piperlongumine-MST-312 (1-1 mol-mol),0.9904530028301648
HCC2108,5566,3.06575659173901
SK-UT-1,16725315,3.0339469216482127
KALS-1,11404337,0.5593043385497104
HGC-27,SNX-2112-bortezomib (250-1 mol-mol),-2.8498015383005932
AML-193,5738263,2.362921684201912
SIG-M5,72193861,1.2348957031290098
MFE-319,9823820,4.458761921743105
SW1116,44819697,-0.1581245709222752
SNU-175,alisertib-navitoclax (2-1 mol-mol),-2.539553725812368
RCM-1 [Human rectal adenocarcinoma],5291,3.9145533177301552
MFE-319,16722836,2.937095158138181
KYSE-450,11625818,5.066786117132594
HOP-92,135984461,4.9526709086531415
VMRC-LCD,8515,3.6418627663613767
SNU-719,36462,4.921998623089754
RCM-1 [Human rectal adenocarcinoma],5287620,-1.851018785369774
RCM-1 [Human rectal adenocarcinoma],25183872,-1.7223948932282942
IGR-37,carboplatin-etoposide (40-17 mol-mol),2.9586433015039835
KU-19-19,11364421,2.01242470272022
A3/Kawakami,613000,2.420767682886
MSTO-211H,5311281,0.6318902138586533
HOP-92,ISOX-bortezomib (250-1 mol-mol),0.4054518048518997
SK-BR-3,selumetinib-JQ-1 (4-1 mol-mol),2.4200828967398995
BT 245,676352,1.8753588664748664
PK-59,44589607,2.088701753410863
BEN,10074640,3.4996550075715693
JeKo-1,16722836,1.2702653136777635
BT 239,navitoclax-MST-312 (1-1 mol-mol),-3.9086197255757784
SUP-T1,11507802,-0.090213974521067
BT 228,selumetinib-tretinoin (2-1 mol-mol),5.4703204957019835
BT 428,10322450,4.171296655818114
NCI-N87,73707398,0.9429301881187698
L3.3,148198,-4.142602322676729
SUP-T1,36314,2.7069274982463245
SK-BR-3,navitoclax-gemcitabine (1-1 mol-mol),-3.2979724120517524
AU565,navitoclax-pluripotin (1-1 mol-mol),-0.1402455429535511
NCI-H647,piperlongumine-MST-312 (1-1 mol-mol),1.897589643392756
JeKo-1,5280436,1.3077120826880433
EoL-1,11719255,-1.2856614674062126
HGC-27,3676137,4.084548237759985
KYSE-180,216345,4.057216202518236
VMRC-LCD,76446078,4.226793178448001
SK-N-SH,4477,0.6230306905196077
BT 245,24951314,0.5765525749771954
KMH-2,42642645,0.908731492566517
Capan-1,4917,3.7825447452069856
SK-N-SH,carboplatin-UNC0638 (2-1 mol-mol),3.4796389437805333
BT 228,11955716,0.2467886175000924
Capan-1,2126,6.0405108524733135
SK-UT-1,36462,1.790037225485122
TCCSUP,2858523,3.01661264260951
HT-1197,selumetinib-GDC-0941 (4-1 mol-mol),0.2261426645121145
PK-59,9915743,1.423625885080464
HARA [Human squamous cell lung carcinoma],25105715,3.4880191589222966
IGR-37,2708,4.782271625288022
AML-193,400769,-1.1471582793124189
PK-59,24772860,-2.599285390225259
BT 428,285033,-2.2884561902812135
KHM-1B,tanespimycin-gemcitabine (1-1 mol-mol),-0.6092153686857478
P31/FUJ,carboplatin-UNC0638 (2-1 mol-mol),3.2617545834686155
SK-BR-3,1566236,2.316860466268058
MSTO-211H,216239,0.7405720543436254
SK-MEL-3,5281672,5.396977469460142
L3.3,16722836,1.76831050763334
RPMI-8402,135421197,0.8834932639167268
SUP-T1,9911830,2.159346176314347
HARA [Human squamous cell lung carcinoma],salermide-PLX-4032 (12-1 mol-mol),5.233652502193764
JeKo-1,selumetinib-piperlongumine (8-1 mol-mol),4.459843067237787
RCC10RGB,3081361,3.5981013353753464
MSTO-211H,6918837,-2.204195063499652
SNU-719,11364421,-1.0806542823825702
VMRC-LCD,4477,0.8107057027097921
JeKo-1,5281321,-1.5052407569254629
SNU-719,selumetinib-navitoclax (8-1 mol-mol),-2.079459033064121
HGC-27,16741245,3.664972672312539
SK-N-SH,374536,1.3416374449140271
KHM-1B,6450551,1.2159742345507
RCM-1 [Human rectal adenocarcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),4.856399530140112
PC-14,11404337,-0.86699452338107
BT 245,3465537,3.867182511877691
HCC2108,24180125,3.362517679132719
EoL-1,208908,1.4783963154656623
KHM-1B,5311,0.4270442632867264
NCI-H1092,23582824,0.4041583076972229
HuH-28,65628,4.297810748025056
NCI-H2081,6852167,2.954622232439069
KYSE-180,2945648,3.004828096065946
SCC-25,5335621,4.293891681452715
HGC-27,444795,2.4083732799097395
SUP-T1,4261,0.165278554681561
HOP-92,selumetinib-tretinoin (2-1 mol-mol),3.3423087953337323
EoL-1,3385,-0.3605554844875209
EHEB,1641662,3.4928026962929075
HGC-27,5470400,1.3477181787430994
SUP-T1,219104,1.7077080308389336
KMH-2,3136844,4.953174257927024
JeKo-1,25161177,4.186569793951063
SK-N-SH,6852167,2.0581991902600913
VMRC-LCD,5311,0.5785698660406623
SNU-175,16115403,-5.62777570793106
KMH-2,navitoclax-pluripotin (1-1 mol-mol),-0.3743173331291292
KYSE-450,1566236,2.943712788473633
HOP-92,4477,-0.0464747072150843
RKO,16741245,1.399079485469943
SK-MEL-3,10302451,3.716398360245668
SK-BR-3,10385095,0.7592595065406185
BT 228,24785538,1.1296433451562116
L3.3,65064,4.762523259447735
WM793,60750,-4.670115905093864
KMS-26,doxorubicin-navitoclax (2-1 mol-mol),-3.427851219991112
HGC-27,5460769,1.1785967516378393
SK-UT-1,54454,4.804941672260084
KALS-1,5311,2.357012743593578
JeKo-1,5311,0.6336949608382456
VMRC-LCD,53325874,5.164359905657892
AU565,selumetinib-GDC-0941 (4-1 mol-mol),0.6894235176740465
RKO,navitoclax-piperlongumine (1-1 mol-mol),3.004924162452904
JeKo-1,9840324,5.506608369234892
KMS-26,55283,0.019126771899953
MFE-319,676352,1.767117473005941
SCC-25,11964036,0.3001439499388176
TCCSUP,445091,4.296569463067844
PC-14,24797083,1.8906553904066348
SUP-T1,613753,2.6416859898042255
RPMI-8402,54618771,-0.5360819718373795
A3/Kawakami,984333,0.0009905880936502
SK-UT-1,51037431,1.6639996533413053
RCM-1 [Human rectal adenocarcinoma],72193861,4.277039631190645
NCI-H716,156414,5.804018273165498
NCI-N87,104842,-4.261750557946528
NCI-H2009,26596,-1.5885219134108934
AML-193,JQ-1-vorinostat (2-1 mol-mol),-0.57431887680694
P31/FUJ,selumetinib-piperlongumine (8-1 mol-mol),0.6855922532418997
NCI-H716,tretinoin-navitoclax (4-1 mol-mol),-2.2087088776652193
VMRC-LCD,44493528,5.517080304343614
RCH-ACV,selumetinib-vorinostat (8-1 mol-mol),1.2774108337481205
AU565,36462,0.154728470238132
KMH-2,54454,2.1726847492597097
SK-N-SH,11455910,2.5268556232530868
RCH-ACV,16725315,3.1183672712693435
P31/FUJ,25126798,3.55669651950966
NCI-H716,6917907,-5.347767608692224
KYSE-180,44259,1.7448132984126952
VMRC-LCD,24785538,0.1743845288428133
TCCSUP,5702613,2.0782660791611045
HuH-28,6184667,3.249102537413376
EoL-1,15983966,-4.467727865084833
SK-UT-1,5311281,3.3992849767981297
SUP-T1,387447,-4.745337935816621
KMH-2,2708,3.3421744997007856
KHM-1B,44489367,4.908857615770495
JeKo-1,3634881,3.044434124484679
NCI-H2081,4788,5.364194014939799
KHM-1B,JQ-1-carboplatin (1-1 mol-mol),-0.2133455800101861
SW1116,71304818,2.4767125599161077
A3/Kawakami,11152667,-1.367626298154913
TCCSUP,16720766,3.8833621535211074
RCH-ACV,216468,0.8259898718546647
SK-N-SH,11507802,0.2514513568221587
NCI-N87,5280436,4.116578666931142
HGC-27,11625818,1.970065381740924
BT 228,72193861,3.0301488074218033
SIG-M5,613753,2.860965991154503
PK-59,12001922,1.7937436025082794
SCC-25,60700,-0.2673835003031162
NCI-H1092,crizotinib-PLX-4032 (2-1 mol-mol),1.757742083775381
SUP-T1,49793307,-4.5171038779073855
KYSE-450,12001922,2.3081029542586027
Capan-1,15953870,4.132273739370711
SUP-T1,15953870,2.607748333286253
HOP-92,9927531,4.8467416959319625
SCC-25,72734382,3.88037726523563
SK-N-SH,6918736,-5.458973460419074
A3/Kawakami,25102847,1.8383224124417192
MSTO-211H,6918736,-4.031815262851263
KALS-1,54618164,4.429142679036427
A3/Kawakami,66577038,2.9204311956556044
SK-MEL-3,25195348,2.9899166301704994
MG-63,3503,1.614579234039666
KMS-26,54454,3.0228633388575887
SCC-25,selumetinib-MK-2206 (8-1 mol-mol),-0.2732249418938428
IGR-37,44507138,1.749239930852015
HGC-27,753704,4.827154806176179
BT 239,123631,2.056795824744589
SNU-175,123631,1.052635706512236
NCI-H2081,25102847,1.5133964528442754
HCC2108,2113511,6.206167164976693
NCI-H2081,4705,3.121794828383862
SK-UT-1,46843906,3.6979645993744032
PK-59,60700,1.4957389160263024
RCH-ACV,65064,5.0656496458111695
PC-14,selumetinib-GDC-0941 (4-1 mol-mol),1.0786711406515603
KHM-1B,BRD-A02303741-navitoclax (2-1 mol-mol),3.1307381995393153
P31/FUJ,vorinostat-carboplatin (1-1 mol-mol),1.4493920018144175
PK-59,56946209,-4.634234731947544
EHEB,104842,-5.697629761421609
YH-13,5282054,3.978961263004533
BT 232,4705,3.775264883664604
HDLM-2,208908,2.0331637469532624
NCI-H2009,6450551,1.0382100121131883
AML-193,135440466,-0.2011003510629582
WM793,11364421,-0.8939436431091912
WM793,3081361,2.8594902062102374
JeKo-1,24772860,-2.615674298718556
RCH-ACV,2746,0.9590882361015028
HGC-27,613000,2.786180415977608
BT 239,10410894,2.198005851193721
YH-13,11612883,3.2122521691176975
KMH-2,10302451,3.711688985022062
HT-1197,1716436,2.64185975168639
YH-13,24964624,2.65969154668954
SIG-M5,1716436,2.9519652680350137
NCI-H2081,9907093,4.181981134504412
NCI-H716,2871966,-1.4658018009002856
RCH-ACV,46907787,-0.324822109365263
SIG-M5,5351362,1.1313171620394398
AU565,9936388,-7.122590364363415
RCM-1 [Human rectal adenocarcinoma],11485656,1.8807064812530925
NCI-H2009,44486219,4.368704582532332
AML-193,16038120,-0.9758516761384544
BT 232,3503,1.1072992265451918
IGR-37,613753,3.96424908977574
KHM-1B,17755052,-0.5225933092645372
PK-59,16722836,1.3763942653664631
KMH-2,656346,0.0409670690742822
BEN,5328940,2.678834838730339
EHEB,5978,-2.167378408908765
SCC-25,25195348,2.8956047171592645
SCC-25,serdemetan-SCH-529074 (1-1 mol-mol),2.0905503706027178
HCC2108,65064,5.202771624484401
SNU-719,44589607,3.1531285880306825
BEN,6610355,6.16210463226387
WM793,6914657,-2.064615991168629
KHM-1B,156414,1.0383008800592366
SK-BR-3,2749,0.4245840979920193
EoL-1,25227462,-7.02078477264466
IGR-37,54618795,3.46834349469974
JeKo-1,57519531,1.3170113256582032
SK-N-SH,SNX-2112-bortezomib (250-1 mol-mol),-1.9946861103058215
BT 239,400769,-1.0721137853142315
SK-N-SH,3025986,1.6039379406672871
TCCSUP,71680916,5.285506040868583
EoL-1,1285940,0.9132051979704684
AU565,25227462,0.9575642046813388
JeKo-1,25105715,3.658635800282925
YH-13,6918736,-3.6084117176459913
SIG-M5,60700,-2.307580405046064
NCI-H647,44137675,3.3509534430230223
SW1116,68056272,3.569491362563028
NCI-H1092,24821094,3.179628760987399
EHEB,3854666,0.7564347377790305
SK-UT-1,71680916,6.2215373772831875
MSTO-211H,9444,4.1850544738080915
RCH-ACV,135440466,1.4490921925464593
NCI-H647,3081361,1.9949944268076525
SIG-M5,219104,2.10731930853068
SNU-175,5311281,1.4669976922848067
MFE-319,49793307,2.9789728536152205
BT 245,119607,5.434935491757685
MFE-319,5329102,3.1301731150248746
NCI-H647,10231331,3.723669651517376
P31/FUJ,6252,0.489412050489878
SNU-175,24964624,4.407981440735694
BT 239,3011155,4.408283986221625
AU565,46943432,5.0196372017891555
EoL-1,71751553,1.891736650896905
JeKo-1,sirolimus-bortezomib (250-1 mol-mol),0.3610522952079053
SIG-M5,2858523,3.1381204966440315
MFE-319,10322450,5.941485697503465
HARA [Human squamous cell lung carcinoma],3038522,4.1452744027346045
EHEB,vorinostat-navitoclax (4-1 mol-mol),0.5492722372244424
BT 239,4261,1.3309924256754924
NCI-H647,5282054,4.400867392439171
HT-1197,3543504,4.592987077918025
MSTO-211H,375860,0.0606650448750636
VMRC-LCD,135398744,6.4569642970049
YH-13,10074640,3.684344080158783
PK-59,24856436,1.6787268247901606
BEN,JQ-1-vorinostat (2-1 mol-mol),1.387044625300372
VMRC-LCD,9444,4.162300980668512
RCM-1 [Human rectal adenocarcinoma],135421197,1.2784797904555276
NCI-N87,24772860,-4.531203546207334
HGC-27,navitoclax-piperlongumine (1-1 mol-mol),1.5499341961082194
NCI-H2009,5460769,1.3316086312624285
RKO,selumetinib-navitoclax (8-1 mol-mol),2.1856811512057885
PC-14,568763,1.308843380200126
EoL-1,107985,-5.04062397019842
SK-BR-3,176870,1.7463534089533554
RPMI-8402,4521392,4.061148632538637
EoL-1,3136844,3.326483406194643
KMS-26,969516,2.003434773867993
NCI-H2081,5278396,2.9598770747140435
SK-UT-1,9884685,5.1525602917749875
NCI-H647,16725315,5.0108369527657795
RKO,11222830,1.6656419736189183
Capan-1,11960529,5.046533155700221
SK-UT-1,56963564,2.7705405230221967
KHM-1B,2733526,2.638104564736822
MFE-319,2733526,4.3054343577549155
BT 228,selumetinib-GDC-0941 (4-1 mol-mol),1.920248435578852
VMRC-LCD,25154868,2.5742593218803296
Capan-1,carboplatin-UNC0638 (2-1 mol-mol),3.5641927822654673
AML-193,3011155,4.3798629151837805
RKO,navitoclax-gemcitabine (1-1 mol-mol),-2.8709534482220196
SK-N-SH,10127622,4.675708392870869
SK-MEL-3,46215462,1.6315541515488632
NCI-H716,12003241,-5.132639925352329
HuH-28,12003241,-1.746609784805712
L3.3,5281321,2.3391738882410813
KYSE-450,navitoclax-MST-312 (1-1 mol-mol),1.0440074090451137
SK-BR-3,navitoclax-pluripotin (1-1 mol-mol),-0.7956969825899178
L3.3,6852167,2.807934515358382
SIG-M5,123631,3.630286849450441
SK-MEL-3,613753,3.2649367657096144
NCI-H716,9911463,3.7061520966996033
YH-13,selumetinib-MK-2206 (8-1 mol-mol),3.53074146528381
EoL-1,navitoclax-PLX-4032 (1-1 mol-mol),-3.423543633044369
HDLM-2,selumetinib-MK-2206 (8-1 mol-mol),4.390662541637413
NCI-H1092,6918837,-4.303898755117286
PK-59,241158,4.280180443060871
HDLM-2,alisertib-navitoclax (2-1 mol-mol),-1.8567863468556949
KALS-1,2842253,5.494882695230984
BT 428,25102847,3.205053945341453
RPMI-8402,3025986,-1.678267682848736
Capan-1,71751553,4.749042559112668
HGC-27,5284616,-9.112917405188378
HOP-92,44566777,-0.5407400150540453
KMH-2,44543605,2.718585220539699
HDLM-2,JQ-1-MK-0752 (1-1 mol-mol),-3.633021274538498
A3/Kawakami,7326481,2.113964509494145
EHEB,20959075,-3.303490374431417
RCH-ACV,54678924,1.005806571797481
HOP-92,11228183,0.8807712600061746
KU-19-19,1716436,3.531012736022478
RCC10RGB,400769,0.8506758933165035
JeKo-1,4261,0.0384034777593602
BT 428,11214940,3.9719128201938183
SCC-25,5566,2.921054240862228
MG-63,11213558,1.1387859672922136
NCI-H1092,44185566,2.7664666060668104
RPMI-8402,44489367,4.889305564658811
BT 428,56646779,6.2069674563861374
NCI-N87,387447,-5.408237770865747
KYSE-450,9915743,1.0249516523129705
IGR-37,9926054,1.73801540894826
NCI-H716,67156097,-0.9385431047267452
SUP-T1,452548,-4.156551841237093
KYSE-450,53325874,4.377584660975113
PC-14,4788,5.215846047111057
BT 239,5351362,1.047966392810198
NCI-H2081,16038120,0.2763554915628486
TCCSUP,44819697,-0.8958892266160017
HDLM-2,4477,0.1019673193672016
PC-14,107970,3.287444237855521
PC-14,44507138,1.924622634318641
BT 232,4259181,1.35980761769268
HDLM-2,3038522,3.262282776190153
IGR-37,9903786,4.593363058361211
RCH-ACV,100016,4.052738843081589
KYSE-450,44462760,5.018979644026392
NCI-H716,54143018,1.348557154942694
HT-1197,navitoclax-PLX-4032 (1-1 mol-mol),2.2059127041799056
HGC-27,6914657,-6.896291583225218
KMS-26,9926054,0.2958792952736858
L3.3,3038522,4.529448646795259
Capan-1,44185566,2.6165328244520976
HGC-27,676352,1.5323944892549626
HT-1197,72376,-0.0968755261718237
RCH-ACV,46215462,1.1784156564726251
MG-63,selumetinib-decitabine (4-1 mol-mol),5.580702187097441
SK-MEL-3,1641662,4.2233077543202935
SNU-719,451668,5.142214880354795
SK-BR-3,46191454,1.5183909283527055
MG-63,alisertib-navitoclax (2-1 mol-mol),-1.377450574316852
KYSE-450,9911830,2.46681001783931
SW1116,10410894,1.6328135710785707
SW1116,44607530,0.7411625024848351
NCI-H647,JQ-1-carboplatin (1-1 mol-mol),2.369977920664563
HARA [Human squamous cell lung carcinoma],637858,2.3831379320922728
MFE-319,89928392,1.7362976755005617
KMS-26,54686904,2.1105020260099168
BT 228,613753,3.796190196171235
VMRC-LCD,16736978,2.396418197585983
NCI-H2009,322968,4.70725114827159
HGC-27,46843906,2.0641647272516934
SUP-T1,54143018,-1.4826641398102518
EHEB,5328940,1.102391401728389
KALS-1,51039095,3.403770839267995
HCC2108,25183872,1.312487478805732
SCC-25,2858523,3.1541323992394332
MFE-319,navitoclax-sorafenib (1-1 mol-mol),1.585776786156771
HGC-27,decitabine-navitoclax (2-1 mol-mol),1.7857380127933111
NCI-H2081,2749,0.7188111553916358
BT 239,208908,1.477538645444953
NCI-N87,11404337,-0.8803091706648726
HT-1197,5978,2.729870278216933
BT 428,5287620,-2.636425649332777
HGC-27,9826308,0.5397481206249327
BT 228,11222830,1.618233067991606
SK-MEL-3,11152667,1.7453060671217775
BT 232,ISOX-bortezomib (250-1 mol-mol),0.7623808331715781
NCI-H2009,5282054,3.436101167626708
NCI-H647,8515,3.931635124559011
Capan-1,49793307,-5.160793196740979
L3.3,135440466,3.532632366582018
AML-193,9911463,2.567392494652272
SK-N-SH,23725625,4.378734323013145
AU565,3038522,2.241670788617941
SUP-T1,9884685,-0.9230730282342138
AML-193,4917,2.027519714673709
HT-1197,156422,-2.45619568424761
TCCSUP,65628,5.421928358435332
TCCSUP,446155,1.4238340154074924
KHM-1B,11178236,-5.183518181224002
MFE-319,6505803,1.682030282534213
HT-1197,56973724,4.331054372391055
PK-59,5329102,1.88282935997255
TCCSUP,168313016,5.913828803978875
HGC-27,285033,-4.563381839634632
MFE-319,docetaxel-tanespimycin (2-1 mol-mol),-5.036749984718091
SK-MEL-3,24821094,3.7511004888265296
TCCSUP,4477,1.3083766641686785
WM793,5281321,-1.0068304363485172
RKO,4705,3.750134101835121
AML-193,16219061,1.3798436640950875
HARA [Human squamous cell lung carcinoma],15953870,3.428154571209005
EoL-1,71576739,3.6856992550706615
KMS-26,ISOX-bortezomib (250-1 mol-mol),-1.7245105869731614
SUP-T1,135398738,1.306637404973195
SIG-M5,89928392,0.8313235813266826
SIG-M5,12001922,1.6775946264082653
RCC10RGB,54649381,5.891551456540707
L3.3,568763,0.380782352657369
RKO,navitoclax-pluripotin (1-1 mol-mol),0.0128409422156563
SUP-T1,67156097,-3.453923190201683
SK-MEL-3,11214940,4.048588185412394
BT 232,44819697,-2.7862173808477877
L3.3,168313016,5.4672449278411595
IGR-37,16725315,5.232725111463001
HGC-27,421610,3.3315516825646956
JeKo-1,969516,2.5616359343064943
KMH-2,5746,-1.6439308977847142
MG-63,56649450,3.468893462661745
NCI-H2081,25154868,4.423306661705061
A3/Kawakami,135411,-0.5963643141606774
KYSE-180,JQ-1-vorinostat (2-1 mol-mol),2.469302562652029
IGR-37,navitoclax-gemcitabine (1-1 mol-mol),-2.7449557636545108
KMH-2,53232,2.4238633478627976
AU565,11494412,-0.7938994603064
NCI-H2081,54626689,4.922665584817983
NCI-H1092,148198,-7.112179510843006
EoL-1,6610216,2.588029624216937
PK-59,24951314,1.3549218223785395
NCI-N87,327653,3.392428289503534
SNU-175,10302451,-1.3432217773837662
KMH-2,5329102,1.4498015385739376
SK-N-SH,25150857,1.2455001361939395
TCCSUP,1641662,4.954300722612746
NCI-N87,135411,0.0487965919912929
RPMI-8402,46174525,2.7077508109639243
HT-1197,11178236,-5.892225755933464
SK-UT-1,7326481,2.0066663774179108
TCCSUP,5278396,3.4986676958942304
NCI-H2081,3136844,3.846689018483167
MFE-319,4521392,5.298191395494016
HOP-92,9911830,1.5727433833284383
TCCSUP,JQ-1-navitoclax (2-1 mol-mol),2.4798341578974568
P31/FUJ,24856436,-2.072993507389728
BT 239,54626689,4.3043594859771
A3/Kawakami,73707438,4.237829251497225
TCCSUP,6918878,3.6529452991011766
NCI-H2081,tanespimycin-gemcitabine (1-1 mol-mol),-4.020630878954612
RKO,navitoclax-PLX-4032 (1-1 mol-mol),2.3429049321543083
BT 232,637858,2.601842990384653
AML-193,6610216,3.825540267355674
SK-BR-3,400769,-1.205622869941329
HGC-27,374536,0.7475716320500141
HGC-27,156422,3.482869463951032
HCC2108,11238147,2.303897319938246
RKO,docetaxel-tanespimycin (2-1 mol-mol),-5.095252166768177
RKO,4788,5.372325515812119
JeKo-1,11213558,1.6603048627626695
SK-UT-1,11238147,3.508126296570063
RPMI-8402,216239,2.4072469568954777
KMS-26,5278396,2.720584271676896
MG-63,23582824,0.3288291701361625
NCI-N87,2841722,4.410495760007658
SK-MEL-3,9903786,4.6944360721993545
EoL-1,11228183,-4.692121992506469
EoL-1,9907093,1.940481445511617
SNU-719,vorinostat-carboplatin (1-1 mol-mol),4.104614901764958
SK-MEL-3,44493528,4.418694031341945
TCCSUP,3689413,0.6301346851622357
SCC-25,11625818,3.0049602906929813
RCC10RGB,25150857,2.370598483016253
NCI-H716,676352,1.9418199461639616
SCC-25,4705,0.8659317696448142
SIG-M5,15953870,3.775492786372982
JeKo-1,3062316,1.4383551148241784
EoL-1,426756,2.2822485147447886
KMS-26,selumetinib-MK-2206 (8-1 mol-mol),0.704070499686837
YH-13,25102847,2.4303848050744747
SNU-719,49766530,-1.9010790195453584
SK-N-SH,selumetinib-GDC-0941 (4-1 mol-mol),1.1074164821021857
KMH-2,54613361,-1.5882427638951675
SK-N-SH,15953870,3.557399614154719
AU565,piperlongumine-MST-312 (1-1 mol-mol),1.980808732390433
SNU-719,crizotinib-PLX-4032 (2-1 mol-mol),2.9550180919393867
SUP-T1,9956119,1.623730746713992
KMS-26,44241473,4.230627074244854
PC-14,BRD-A02303741-navitoclax (2-1 mol-mol),2.254377627302129
SK-BR-3,9933475,1.8497788213808113
AU565,2945648,3.081352201841014
P31/FUJ,25062766,0.5108470478058419
JeKo-1,3136844,3.7415146181524017
RCH-ACV,60700,-3.348567687944923
BT 245,246676,4.341306530425761
KHM-1B,60700,-3.1057416609701463
EHEB,44589607,1.92892141933537
HOP-92,42611257,3.65568685883856
TCCSUP,9903786,3.558837088709428
MFE-319,sirolimus-bortezomib (250-1 mol-mol),0.3475063070174586
RCM-1 [Human rectal adenocarcinoma],6450551,4.167380741941181
VMRC-LCD,57330099,4.338541916129439
SK-MEL-3,56973724,4.850635380600185
TCCSUP,17759555,3.887278594694756
SCC-25,8515,2.6450161299147035
Capan-1,25154868,5.260055373654265
RCC10RGB,2746,4.042085650474663
NCI-H2081,2742550,2.443856607923171
IGR-37,10296883,3.844591108282479
NCI-H2009,71304818,2.93523377765095
SUP-T1,selumetinib-MK-2206 (8-1 mol-mol),2.9527005136132396
SK-BR-3,445455,4.838927933039495
SCC-25,9840324,5.899685589861863
HuH-28,11175137,1.959749669027105
KYSE-450,46843906,5.632374072388803
NCI-N87,doxorubicin-navitoclax (2-1 mol-mol),-2.375472287210564
MG-63,16720766,0.6324083113741473
PK-59,168312962,2.7802868491236743
NCI-H1092,2746,3.1114505923007583
KMS-26,selumetinib-PLX-4032 (8-1 mol-mol),4.577580276199963
YH-13,4521392,4.421044887945657
SIG-M5,5287620,-2.279783837875614
TCCSUP,10074640,2.6482462102155737
MG-63,25161177,4.876123251691686
WM793,ISOX-bortezomib (250-1 mol-mol),0.962793485948776
IGR-37,navitoclax-pluripotin (1-1 mol-mol),0.115552746933019
SK-N-SH,9933475,1.6422376782104129
NCI-H2009,71466380,3.950405172838994
SK-N-SH,4788,5.851071416229002
KMH-2,9868037,1.8367202409128176
BT 228,5281672,5.77775632414719
IGR-37,navitoclax-sorafenib (1-1 mol-mol),2.0982266701362215
RPMI-8402,11178236,-3.1061239917710273
AU565,24748573,1.9131971710517224
WM793,2746,3.494212158504219
SK-MEL-3,9825149,1.6924461649499078
KYSE-450,11955716,-2.223741431662978
BT 245,1716436,2.617302091979337
RPMI-8402,2733487,6.448043739089618
BT 228,24180125,1.4765108272863283
KHM-1B,24180125,1.7183751461282626
RCH-ACV,9887053,2.2719455234781796
BT 245,56946209,-4.793980648010386
TCCSUP,navitoclax-gemcitabine (1-1 mol-mol),0.0412224800820071
NCI-H647,135875424,4.395312958272854
HARA [Human squamous cell lung carcinoma],375860,-0.967052520231088
SIG-M5,2742550,3.8599440330266432
SK-UT-1,89928392,1.5133465040909966
HCC2108,11175137,3.2094968416883827
WM793,104842,-1.8319129864722523
RCM-1 [Human rectal adenocarcinoma],24821094,4.372062930620609
PC-14,navitoclax-birinapant (1-1 mol-mol),-0.0924928169959921
A3/Kawakami,36462,0.6765947493601843
KMS-26,11175137,-0.2317247115519337
MFE-319,16065773,3.318734780717062
KYSE-450,31703,1.0169298465386034
KU-19-19,4917,3.607977283390518
HGC-27,46398810,1.553931470840158
SK-UT-1,serdemetan-SCH-529074 (1-1 mol-mol),2.4516773204775215
SW1116,doxorubicin-navitoclax (2-1 mol-mol),1.021798348357056
NCI-H2081,selumetinib-tretinoin (2-1 mol-mol),6.041656888825654
NCI-H647,46843906,0.8241950682417447
SUP-T1,JQ-1-navitoclax (2-1 mol-mol),-0.7214514742765588
JeKo-1,444795,4.544640897314401
PC-14,11455910,0.0459407670906722
AML-193,3136844,2.3016102601438044
A3/Kawakami,crizotinib-PLX-4032 (2-1 mol-mol),1.1920478832569923
HT-1197,JQ-1-MK-0752 (1-1 mol-mol),3.1795958981962142
SK-MEL-3,5738263,4.416819512473588
L3.3,23725625,5.56548732943537
RPMI-8402,3385,2.1246782135813036
RCM-1 [Human rectal adenocarcinoma],46843906,3.578406808206158
JeKo-1,selumetinib-tretinoin (2-1 mol-mol),4.951774721268834
BT 228,5113032,4.390196718841583
KMH-2,3543504,3.885538325062561
AU565,46926350,-5.126810871510528
KHM-1B,erlotinib-PLX-4032 (2-1 mol-mol),2.9494241751240353
SK-N-SH,89928392,-0.0843723496989581
KYSE-450,doxorubicin-navitoclax (2-1 mol-mol),0.7817120569576905
HuH-28,46191454,2.3192886908569763
TCCSUP,6918289,2.234948683546108
BT 228,23725625,5.590143763340474
PK-59,11507802,3.057258453235266
TCCSUP,selumetinib-GDC-0941 (4-1 mol-mol),1.9950465927761605
RKO,11238147,3.3996395604326977
HGC-27,3025944,3.5548953737033284
SK-N-SH,56963564,-1.0719820645835316
SIG-M5,5291,3.984845520465957
SIG-M5,3689413,0.233032105010129
NCI-H2009,42642645,0.1491359953679814
AML-193,4096211,0.0065257270658561
BT 232,445091,4.368893044838443
HARA [Human squamous cell lung carcinoma],151289,0.6137813450564443
BT 245,11955716,-0.6906973419966477
TCCSUP,44185566,2.4741695937363506
BT 245,568763,1.30987431986763
EHEB,36462,-0.01305148556103
EoL-1,49867926,2.882691220769777
NCI-H647,327653,3.987842659559465
RCM-1 [Human rectal adenocarcinoma],6914657,-2.702554466691394
SUP-T1,5351362,1.256003763799444
BT 228,44819697,-2.9042592695301637
KHM-1B,vorinostat-carboplatin (1-1 mol-mol),1.1385799517319026
HDLM-2,216345,4.030197416257521
RPMI-8402,452548,-4.250179488233346
NCI-H2009,3503,2.6223022737526085
MG-63,71466380,4.412814673012785
PC-14,20959075,-3.579939594206626
MFE-319,24964624,3.0767848490872436
VMRC-LCD,sirolimus-bortezomib (250-1 mol-mol),2.1405006369000232
HOP-92,57330099,4.956971077935733
YH-13,4788,5.883867811277833
KYSE-180,4788,5.873750540393015
JeKo-1,25126798,3.317767038081006
BT 245,10427712,4.3445169798264995
YH-13,3062316,-1.0789668620002044
Capan-1,25195348,4.3726124840059
WM793,71304818,2.8457825987612293
VMRC-LCD,24753719,4.020316071517673
HDLM-2,445455,5.442720377225294
KMH-2,387447,-5.191236757244743
KHM-1B,selumetinib-piperlongumine (8-1 mol-mol),1.0909589836207738
HDLM-2,15953870,2.508458665439202
KMS-26,24748573,1.82027875140144
KMH-2,selumetinib-tretinoin (2-1 mol-mol),4.525741477760766
SUP-T1,5978,-3.750597939763207
AML-193,11364421,-1.372093879607525
MG-63,4477,0.6051682060015434
KALS-1,6918837,-1.0378033780250342
SK-MEL-3,9956119,4.495814439622994
NCI-H716,selumetinib-navitoclax (8-1 mol-mol),1.1381551263730607
MSTO-211H,5460769,-2.0887143253822615
HGC-27,navitoclax-gemcitabine (1-1 mol-mol),0.4875935358444195
KYSE-450,25102847,3.9805771767576057
P31/FUJ,6918328,-1.424420935100909
KMS-26,241158,1.8879300052760837
AU565,3465537,1.0667310492419344
RKO,1566236,3.4833841973625725
SK-MEL-3,52912189,2.222751321385997
L3.3,262093,4.054875705556861
KALS-1,122327,4.612577702155234
HOP-92,selumetinib-decitabine (4-1 mol-mol),3.144714910994581
KYSE-450,11175137,3.731022611434211
HGC-27,36462,-0.1990646362671453
KU-19-19,676352,2.681008284282423
KU-19-19,16722836,2.3762239171314894
L3.3,2708,4.48343396675343
MSTO-211H,5311,0.950405781568164
KYSE-180,216468,3.656318392003096
RCH-ACV,46843906,1.07479074893144
BT 239,2126,3.7431945026476687
VMRC-LCD,11626560,0.2308063037061775
SIG-M5,11152667,-1.411056546270547
NCI-H2081,4261,0.6223961435689531
SK-UT-1,9911830,2.8726761747893756
SK-UT-1,66577038,3.2613537535167874
SCC-25,3552672,3.590747551096479
HOP-92,2126,4.538325615770895
VMRC-LCD,24771867,-3.7563289324747737
HOP-92,10385095,1.1427882638896885
SUP-T1,JQ-1-MK-0752 (1-1 mol-mol),-0.3923416274792432
KYSE-180,4521392,4.793023543550177
NCI-H2009,decitabine-navitoclax (2-1 mol-mol),4.93341873674704
HGC-27,4578,3.915346231115219
KYSE-180,5311281,3.969841054896334
BT 428,100016,4.306836909333982
RCH-ACV,decitabine-navitoclax (2-1 mol-mol),-0.4171956851240461
BT 428,72376,-2.9842268279103523
MG-63,4705,3.9801982101515825
NCI-H647,vorinostat-navitoclax (4-1 mol-mol),1.1137744946554542
AU565,46907787,3.197599854412173
NCI-N87,6918328,-0.6140119948836108
NCI-H1092,400769,-0.5957387539071202
HCC2108,119182,4.202789641454693
RCM-1 [Human rectal adenocarcinoma],serdemetan-SCH-529074 (1-1 mol-mol),2.1552329187196393
NCI-H716,serdemetan-SCH-529074 (1-1 mol-mol),2.162936440702591
SIG-M5,JQ-1-vorinostat (2-1 mol-mol),-0.940871286086668
SCC-25,2746,2.621805832840377
L3.3,5566,3.1406901276995094
MFE-319,9927531,5.194887870380863
BT 232,44607530,1.01895024909591
SK-N-SH,16720766,0.860282800498404
YH-13,2113511,5.759844147331347
RCH-ACV,17755052,-0.7451470279060566
KMS-26,104842,-4.299195769948128
SCC-25,72376,-2.950799168385661
SK-UT-1,135411,0.7872586171820456
PC-14,613753,3.517699490649258
KMS-26,676352,1.4901274490538958
KYSE-450,4477,0.7200921978595938
KU-19-19,25183872,1.353604037781074
BT 245,68056272,3.625560234921114
HT-1197,11640390,2.8225834144345816
A3/Kawakami,3825829,3.643525487380167
A3/Kawakami,72734382,3.453761647865808
KYSE-450,16065773,3.8243324962121914
KALS-1,57519531,3.779111240499875
P31/FUJ,24771867,-2.604308550432203
KMS-26,2858523,2.363692510647204
RKO,9903786,4.184024439899693
VMRC-LCD,3025944,4.099884514790135
SIG-M5,19582717,3.2413737037332337
BT 245,navitoclax-pluripotin (1-1 mol-mol),-1.9779043115942032
SK-MEL-3,25262965,-0.7366845898562
NCI-H1092,salermide-PLX-4032 (12-1 mol-mol),5.357754410384337
JeKo-1,60700,-2.9236767406704893
KMH-2,219104,2.851565320163975
YH-13,16736978,1.9226883316273975
HCC2108,400769,-0.6211962512708786
EoL-1,24978538,-4.341439226876777
WM793,9887053,4.971798307876137
SK-UT-1,1566236,1.7242203991960865
KALS-1,219104,4.130430212948608
KMS-26,44589607,0.9561905550207028
MFE-319,6610355,5.495772913850426
KMS-26,16736978,-1.8564631807462737
KYSE-450,216239,1.9385995729786167
RPMI-8402,53232,1.7554059354401623
BT 428,135398744,8.121810698450407
AML-193,50905018,4.907887371316942
SK-BR-3,10427712,2.3021757953289113
A3/Kawakami,119607,3.9986838721376174
WM793,15983966,-0.2219786467978368
L3.3,5351362,1.6156165657787482
KYSE-450,24772860,-1.687862811669867
BT 239,11427553,2.6268195166618535
NCI-H647,5284616,3.459652284237091
MG-63,11228183,2.413523049203725
JeKo-1,71466445,3.0601358929071605
WM793,168313047,2.1825025569441405
MSTO-211H,54618164,3.0389284404004795
MFE-319,445091,4.465602134081131
SCC-25,4788,5.892195090967582
HuH-28,vorinostat-navitoclax (4-1 mol-mol),-0.0214540025717123
VMRC-LCD,2749,1.0244592256765468
RPMI-8402,11175137,0.3337055630236375
NCI-H647,3825829,3.822021409695252
VMRC-LCD,285033,-3.296004080828987
RKO,409805,3.580644131410829
NCI-H1092,3038522,3.1295884700931182
MSTO-211H,52912189,3.1066961080068123
KALS-1,9911463,4.316842396735623
RCC10RGB,24785538,4.443576486987547
P31/FUJ,9868037,1.2869642230829814
BT 428,2949965,2.4891980575016657
L3.3,135398744,6.452563021638662
VMRC-LCD,2874250,4.322649848457735
KHM-1B,2708,5.139604125220885
KHM-1B,31703,-2.376235984768286
YH-13,2871966,0.9039362697940406
RCH-ACV,3503,2.2596989127431484
NCI-H2081,11234052,3.237478562823228
NCI-H1092,9887053,3.38988914418067
BT 232,navitoclax-gemcitabine (1-1 mol-mol),0.5254778252332581
RCC10RGB,4917,3.4531775579708044
P31/FUJ,9967941,3.859476565836545
KMS-26,5328940,0.6559788078087634
AML-193,BRD-A02303741-navitoclax (2-1 mol-mol),1.8241952107814208
KMS-26,126941,-2.9708714686533195
AU565,selumetinib-MK-2206 (8-1 mol-mol),1.4284909775011103
VMRC-LCD,24797083,0.822257499123328
A3/Kawakami,40482356,5.618568759585912
RKO,serdemetan-SCH-529074 (1-1 mol-mol),2.0344925203933006
SK-UT-1,54619267,4.514007614998197
AML-193,5284616,2.787982187689001
BT 245,3689413,-2.318316316051159
MSTO-211H,3634881,2.531877742135044
MSTO-211H,selumetinib-vorinostat (8-1 mol-mol),2.5507506919352037
AU565,3676137,4.605193047317769
PC-14,5280436,5.041517753496301
KMS-26,4917,2.6400946927147677
MSTO-211H,4096211,1.4030307395810702
P31/FUJ,44202524,1.0280075167408849
HGC-27,17755052,-2.804791511723502
AML-193,676352,1.687792585897192
BT 228,6436223,-4.474148587806649
HT-1197,9884685,0.7490718797514191
SUP-T1,10074640,2.6216351874573123
SK-N-SH,selumetinib-UNC0638 (4-1 mol-mol),5.105964200899775
Capan-1,selumetinib-GDC-0941 (4-1 mol-mol),1.801614812477531
KMH-2,9915743,0.5597932998699471
NCI-H2009,54649381,3.659944396907473
BEN,44507138,3.723019659685084
SIG-M5,322968,2.555760455120465
SW1116,6918328,0.949973931483892
MSTO-211H,136227924,2.717505566177341
YH-13,4259181,0.5149162893859401
HGC-27,16725315,3.0920513308515245
TCCSUP,168313047,2.4299018394791507
NCI-H2081,salermide-PLX-4032 (12-1 mol-mol),5.178894750925086
L3.3,1242560,3.353722310779613
Capan-1,135875424,5.030307204242131
HDLM-2,57519531,2.1126691991292543
MSTO-211H,5328940,-0.7344582610548551
KYSE-450,5329102,3.4097073656415615
BT 239,3689413,-0.6991113979789645
YH-13,doxorubicin-navitoclax (2-1 mol-mol),-1.2809581142975497
BT 428,409805,5.8133328152421395
HOP-92,10184653,1.4840674956409712
AML-193,16720766,0.6043843814184503
NCI-H647,9866186,0.9582243165534676
KYSE-180,54454,2.017904173526763
BT 232,11626560,2.150628742976276
SK-BR-3,119182,-2.6426080519208957
SK-BR-3,2871966,-0.9050176836246168
SUP-T1,46191454,-0.6027339571642327
RCH-ACV,36314,4.138120320882057
RPMI-8402,23635314,-2.329872465230456
KMS-26,444795,3.741445044808976
YH-13,24180125,3.319627413046534
EoL-1,421610,0.8243522679340217
NCI-H2081,6610216,3.784534117796005
EoL-1,3384730,0.8332182955039186
VMRC-LCD,24901704,3.1923426497894156
L3.3,15953870,4.520919895902943
HOP-92,11955716,-1.135824751217448
TCCSUP,16725315,3.821087103273168
AU565,23725625,4.73732544358888
HuH-28,4261,0.793599901931944
SNU-175,400769,-0.6024782671248674
EoL-1,9933475,-6.288767358391641
SK-BR-3,11955716,-0.3257893898863742
SCC-25,9884685,0.9824143256806416
NCI-H716,7251185,2.4871270928836533
SCC-25,24901704,3.279290027968855
KALS-1,17759555,4.745034422852729
TCCSUP,5291,3.685939275525437
SIG-M5,54613361,-0.240216641556325
NCI-H647,16219061,3.7038734026880418
HT-1197,9866186,2.244476131338613
HDLM-2,navitoclax-birinapant (1-1 mol-mol),-0.4551783583355351
NCI-H2009,327653,3.1880644035572825
HCC2108,4788,5.8441996671956105
BT 428,selumetinib-UNC0638 (4-1 mol-mol),1.594617626064182
IGR-37,16065773,3.001563246121221
BT 428,tretinoin-navitoclax (4-1 mol-mol),2.288831928221758
MFE-319,selumetinib-piperlongumine (8-1 mol-mol),4.728985624833811
BEN,navitoclax-gemcitabine (1-1 mol-mol),2.6911937723791137
RCH-ACV,24964624,-0.4195208763721429
SK-MEL-3,135421197,1.515093492040075
YH-13,71304818,3.292650030763082
JeKo-1,11455910,-0.102644590273409
RKO,656346,1.2468664563159324
HGC-27,44566777,-0.0706420158423777
WM793,24856436,4.423556463104999
KMH-2,5284616,-5.421998333823896
AML-193,156422,3.308384906928092
AU565,salermide-PLX-4032 (12-1 mol-mol),3.909685759147712
AU565,tretinoin-carboplatin (2-1 mol-mol),5.430851550447548
SUP-T1,148198,-4.331447588752824
L3.3,124202324,3.558321901620073
IGR-37,54649381,3.787553488532969
BT 428,24951314,-0.4366021016990538
KALS-1,10074640,3.3483514569822437
NCI-H716,11609586,3.2006307150508406
YH-13,24753719,4.493928762122736
HARA [Human squamous cell lung carcinoma],136227924,3.047223136335837
KHM-1B,decitabine-navitoclax (2-1 mol-mol),0.777035437815577
HGC-27,148198,-6.389013328136406
NCI-H647,2949965,2.6487306684667566
KALS-1,6918289,3.0719546987180144
SCC-25,44819697,-0.0223975942468871
NCI-N87,salermide-PLX-4032 (12-1 mol-mol),5.428528810612746
BT 239,107970,0.200195118514019
YH-13,5113032,4.871050749600929
P31/FUJ,selumetinib-navitoclax (8-1 mol-mol),-1.1281624183387444
NCI-H2009,24771867,-1.6305331500245923
SIG-M5,selumetinib-GDC-0941 (4-1 mol-mol),-3.523170450051492
RCC10RGB,15983966,2.263334704673794
KMS-26,44491742,3.93722038391691
SK-BR-3,9803433,5.846555556897997
HT-1197,135875424,3.754015840236683
SIG-M5,5566,3.4536918894520134
P31/FUJ,6505803,0.2535639265329721
JeKo-1,72193861,0.7993918117217049
KMH-2,3385,4.061281204012652
HT-1197,409805,5.791869558181375
BT 232,73707438,3.071939367261752
A3/Kawakami,5278396,3.6164950387479866
SCC-25,10074640,2.6204901115491133
HOP-92,docetaxel-tanespimycin (2-1 mol-mol),1.6252556028095726
KMH-2,6918328,-1.001210153531207
HOP-92,44484893,4.090075187522945
BEN,439501,-2.2680431594189727
KU-19-19,5311,0.9327005340349652
VMRC-LCD,11152667,-1.4796067866772968
RCM-1 [Human rectal adenocarcinoma],676352,2.484571523504373
KU-19-19,6610216,4.876021689690227
L3.3,9911463,4.128757247123474
VMRC-LCD,11507802,1.055454017188068
NCI-H716,446155,1.5923328349465131
KMH-2,5351362,0.6914206308923384
RPMI-8402,25183872,-1.1519692987153758
KMH-2,tanespimycin-bortezomib (250-1 mol-mol),-0.7573218655291942
NCI-H2081,374536,1.9264579533537656
NCI-H1092,4705,2.99261822421246
MSTO-211H,4788,5.119342350142264
SK-UT-1,5282054,3.4735400684673077
RCH-ACV,4477,1.4416386145337845
BT 239,25105715,1.6919213390314507
SK-N-SH,10074640,2.7895648604887975
MFE-319,56649450,4.573900293609964
PK-59,4261,1.931463423718927
IGR-37,25183872,-1.399674541198316
KMS-26,25183872,-2.165521803840412
RCC10RGB,24797083,3.688734393817597
RPMI-8402,5113032,4.884602806225348
HT-1197,49867926,4.144246234535704
HT-1197,navitoclax-gemcitabine (1-1 mol-mol),1.4758578362364363
BT 228,107970,1.7919397546621243
KHM-1B,24772860,-4.094705330536473
VMRC-LCD,9911830,2.082442328496714
Capan-1,9936388,2.896402107939059
RKO,3854666,1.2691133577357363
RCM-1 [Human rectal adenocarcinoma],25262965,2.4523456450078323
JeKo-1,9926054,1.771855949205148
Capan-1,71304818,2.9902014080427857
AU565,9935249,2.085801217703038
IGR-37,227681,3.972075380779856
HOP-92,navitoclax-birinapant (1-1 mol-mol),0.2870144819527156
BEN,6623618,2.2217892754074486
AML-193,53245473,1.5415125866375567
NCI-H2081,piperlongumine-MST-312 (1-1 mol-mol),0.9288913570617896
HGC-27,9907093,2.610348602092314
KHM-1B,5281672,4.060074282228128
HuH-28,2749,2.976446418111687
MG-63,24753719,3.9781774427737617
NCI-H647,135398516,1.8527922930885312
SK-UT-1,24797083,-0.5976783400947587
NCI-H716,erlotinib-PLX-4032 (2-1 mol-mol),3.2620983842536164
NCI-N87,navitoclax-MST-312 (1-1 mol-mol),0.8705289738440536
NCI-H2009,44137675,2.9238442509206606
Capan-1,89928392,1.5877972138861185
BT 228,11609586,4.0582888324185475
KYSE-450,4578,4.488057266772786
JeKo-1,16659841,2.1949136943210283
Capan-1,4378219,3.5285591243290715
SNU-719,10302451,3.933124965880032
BT 228,136227924,3.2498510190278314
HDLM-2,375860,-0.88724972969489
KMH-2,2113511,6.2177043075937695
HT-1197,5311,2.1874079976743785
BEN,52912189,1.262599988136489
BT 239,71680916,4.080795982969438
RCC10RGB,676352,2.417271143726191
SNU-719,24753719,4.605269118671092
KMH-2,73707438,4.106138783340211
HOP-92,4917,3.0481639592321335
RKO,navitoclax-sorafenib (1-1 mol-mol),2.2009176263452983
HOP-92,285033,-0.8748005006842503
RCH-ACV,44607531,0.8816750147357818
RKO,44589607,3.597229089573096
NCI-H1092,151289,2.971736983161978
KMS-26,54613361,-1.7569083615236378
SNU-719,5311,1.0001677330442005
SK-MEL-3,25227462,1.984281977724994
PC-14,53232,0.6703608287087818
P31/FUJ,16725315,4.109597365862544
HDLM-2,24772860,-1.7444844847021763
SK-UT-1,44491742,5.121507877742128
EoL-1,67291369,-3.4155238894638664
KALS-1,176870,4.039138672464472
BT 228,11364421,1.7102833870690588
VMRC-LCD,11612883,1.0907518197509358
KYSE-180,52912189,6.205067529093029
KMH-2,135411,0.0392364050134285
HOP-92,44819697,0.2447586909592766
HGC-27,441298,1.1793610126124097
WM793,selumetinib-MK-2206 (8-1 mol-mol),3.306491798199423
NCI-H2081,3543504,2.734133783068638
HDLM-2,9549297,1.7199870656160052
MSTO-211H,53232,-0.5437095856797647
BT 228,9936388,0.9371184139441866
BT 245,216345,4.350748978953408
KHM-1B,5746,0.0152063150708083
TCCSUP,3385,5.839871573766512
KMS-26,156422,3.606545805680316
BT 239,168312962,2.1927376994891095
RCM-1 [Human rectal adenocarcinoma],10231331,1.8254668182041616
SK-BR-3,67156097,-2.2405834656470347
BT 428,11609586,2.660969893570498
KHM-1B,4917,2.355684811244976
AML-193,selumetinib-UNC0638 (4-1 mol-mol),1.6341760089352375
SUP-T1,9926054,1.5313307080964844
BT 228,11396600,1.874591390979962
HOP-92,6184667,2.3036334827507434
BT 245,9952709,2.755806227678446
NCI-H2009,selumetinib-GDC-0941 (4-1 mol-mol),-2.07577936678547
BT 245,11404337,-1.7449999203479594
KALS-1,448949,1.9621879689447232
L3.3,135875424,3.974579804692541
SK-UT-1,168313200,3.914325756565286
HGC-27,16720766,1.0027031092806908
HDLM-2,26596,-1.5696156753174118
HGC-27,1285940,1.7754260309252776
HARA [Human squamous cell lung carcinoma],9903786,2.5216559880194263
KMS-26,3503,1.3819914812233505
AU565,1242560,3.5510894145829286
P31/FUJ,54649381,3.661627004097492
NCI-H2081,54596558,4.74743870920133
NCI-H2081,selumetinib-navitoclax (8-1 mol-mol),3.86740666902644
KYSE-450,2828334,6.299741287777087
BT 245,400769,-0.589559634740479
Capan-1,46191454,3.9039499202918218
HOP-92,selumetinib-UNC0638 (4-1 mol-mol),2.8114505673929124
EHEB,5460769,-1.3281679410072365
BT 239,54454,3.794613852608304
RPMI-8402,44507138,0.8388126766229169
NCI-H647,52947716,2.7187457625112925
SW1116,9866186,2.478350921258821
AML-193,3552672,1.4370941805931052
P31/FUJ,navitoclax-sorafenib (1-1 mol-mol),0.3998417690889591
SCC-25,54618771,-1.4085770807185976
MG-63,6852167,1.3458734698302683
KYSE-180,73707398,1.6922150122396675
YH-13,637858,2.290172126875016
BT 245,JQ-1-carboplatin (1-1 mol-mol),4.46215850472978
SK-BR-3,selumetinib-MK-2206 (8-1 mol-mol),1.7586963035120902
KMS-26,25262965,-3.533285945987047
RPMI-8402,navitoclax-PLX-4032 (1-1 mol-mol),1.1002807157148775
HT-1197,11317348,6.381608113642139
HT-1197,71466445,4.752167556586409
KMH-2,6914657,-7.533849846968669
RPMI-8402,11612883,1.299439686583664
HARA [Human squamous cell lung carcinoma],3689413,3.203435099189031
NCI-N87,11609586,1.5678533381622328
NCI-H2081,1716436,2.350567267109174
RCH-ACV,5311,-0.1787526651728682
MSTO-211H,54454,-0.190602208325988
KMH-2,crizotinib-PLX-4032 (2-1 mol-mol),1.743016765908143
NCI-H716,135421197,1.426114705682071
SIG-M5,65064,5.320857613359673
AU565,444795,4.595530435398324
MFE-319,24785538,3.3885269597913603
HuH-28,5284329,5.189459047944751
KHM-1B,3503,2.6165416338561633
NCI-N87,6918736,-4.217256713101777
HT-1197,1323703,5.2579949675638336
HDLM-2,16038120,2.053577772324763
SUP-T1,serdemetan-SCH-529074 (1-1 mol-mol),1.668049433822106
EHEB,135999136,1.8833962574329148
HDLM-2,2113511,6.581283466756519
AU565,1750826,-0.6805778178680736
NCI-N87,6852167,1.8373876080574163
BT 232,45279963,4.075019012299989
NCI-H2009,73707398,1.4628489872410333
KU-19-19,2749,1.0704171129437314
HDLM-2,44202524,1.0191112180628716
NCI-N87,10113978,2.582247145825502
KMH-2,25262965,-1.7181390897064877
SIG-M5,36462,-1.757249636998404
SUP-T1,selumetinib-GDC-0941 (4-1 mol-mol),2.5812487961986226
BT 239,44202524,2.003485828714868
L3.3,26596,-0.871586326159775
L3.3,65628,4.284850303510067
WM793,1750826,-0.77104860711207
HT-1197,10127622,5.571388843191147
SK-MEL-3,123631,1.67544774320418
SIG-M5,135398516,1.0532798265646155
PK-59,25262965,-2.365413472311944
KU-19-19,6918878,0.8609723302141853
BT 245,3081361,2.7578947725363667
SK-BR-3,vorinostat-navitoclax (4-1 mol-mol),1.0600648312460794
HT-1197,46199207,2.877610603441686
HGC-27,3825829,2.9189466522382426
KMS-26,3689413,-5.054030253725733
RKO,16720766,-1.2722083569090707
NCI-H647,11485656,1.881364727029594
RKO,selumetinib-PLX-4032 (8-1 mol-mol),1.8013466074828854
RCM-1 [Human rectal adenocarcinoma],3552672,4.462538243049003
NCI-H1092,216239,1.663382184966008
HT-1197,8515,4.26553986516295
A3/Kawakami,2871966,-0.1358254548839889
KHM-1B,52912189,-0.4693344925919332
EoL-1,46199207,1.7453635666388008
RCM-1 [Human rectal adenocarcinoma],9936388,1.970083737001912
BT 245,135398516,2.3123017999822757
KALS-1,7326481,5.698079830395883
KU-19-19,44507138,1.5611189443326865
VMRC-LCD,4259181,-0.0718042548985789
NCI-H716,24951314,2.1948268090408263
AU565,54765302,2.5229399839825604
KHM-1B,159324,1.2436512528819574
AML-193,53393127,4.337886379788995
HGC-27,44632017,0.0970275136444261
SK-MEL-3,10074640,3.4529030166639396
AML-193,BRD9876-MK-1775 (4-1 mol-mol),0.1688039578044598
RPMI-8402,3689413,0.0751031286751058
HDLM-2,10074640,2.7374833951513113
RCM-1 [Human rectal adenocarcinoma],6918837,-4.6352405483445525
EoL-1,5351362,0.4364105589828927
PC-14,654092,0.4321002454947655
VMRC-LCD,4578,4.293870258561933
NCI-H2009,selumetinib-MK-2206 (8-1 mol-mol),-2.109665042041408
MSTO-211H,BRD-K55473186,4.0690738661382175
KALS-1,89928392,1.7785369686635086
NCI-H647,5351362,1.1800720518844507
SUP-T1,SNX-2112-bortezomib (250-1 mol-mol),-3.4504311051615457
SK-N-SH,151289,0.5034884939141393
BT 232,52947716,2.3030321029794014
AML-193,ISOX-bortezomib (250-1 mol-mol),-0.6645975741517673
P31/FUJ,tanespimycin-gemcitabine (1-1 mol-mol),-1.9905845316732809
BT 428,selumetinib-piperlongumine (8-1 mol-mol),1.208786974802762
NCI-H2081,11955716,-2.042301690942712
NCI-H647,107970,2.33869745071115
KHM-1B,241158,2.5921165995346565
EoL-1,445455,0.7791504696218842
SIG-M5,10074640,3.7949186372301154
AML-193,crizotinib-PLX-4032 (2-1 mol-mol),1.6231906260316449
MG-63,71466445,6.092565154113904
RKO,10296883,4.075814636405189
KYSE-180,3384730,1.3990214479335077
KYSE-180,5287620,-1.547969048447004
BT 428,9933475,1.589178678018796
RCH-ACV,451668,2.908354752315953
KHM-1B,9926054,1.3720275885206477
EHEB,9911463,3.619047359567488
RCH-ACV,10074640,2.763550481018419
HuH-28,3081361,2.090598934856842
RCM-1 [Human rectal adenocarcinoma],2828334,6.287208595728056
SCC-25,selumetinib-UNC0638 (4-1 mol-mol),0.7094798829067192
SCC-25,9444,4.340772364323642
HARA [Human squamous cell lung carcinoma],25262965,-0.7160848382234604
HOP-92,45100481,6.301350232744884
NCI-H647,selumetinib-BRD-A02303741 (4-1 mol-mol),4.730456309374106
NCI-H2009,5329102,2.1297157842750756
SIG-M5,5281321,-0.3026116768834708
YH-13,sirolimus-bortezomib (250-1 mol-mol),0.2727627020521754
EoL-1,285033,-6.4575976485599735
NCI-N87,carboplatin-UNC0638 (2-1 mol-mol),3.4159981227624394
RCH-ACV,serdemetan-SCH-529074 (1-1 mol-mol),0.2912426562316063
P31/FUJ,9911463,3.6551866379259743
JeKo-1,122327,5.705341398829239
KU-19-19,sirolimus-bortezomib (250-1 mol-mol),2.2113915758762133
L3.3,24951314,1.4054712073944002
SK-MEL-3,11625818,6.349528037167195
RKO,4096211,2.0568907070726397
Capan-1,24821094,3.618454875952158
KALS-1,65064,4.581222388732678
KU-19-19,57519531,2.7709295903751987
NCI-H2081,285033,-4.017735387470941
P31/FUJ,2749,0.384854271149864
MFE-319,44589607,3.378167093984026
BT 239,676352,1.6206381986340943
MSTO-211H,24772860,-3.3585393605141824
TCCSUP,126941,-3.009230192575239
KYSE-180,3062316,1.1998242220985431
Capan-1,16722836,1.345223833973372
SIG-M5,2749,1.6715894243593812
EHEB,3136844,4.591447211361851
SK-BR-3,navitoclax-piperlongumine (1-1 mol-mol),1.1847395936501264
SNU-719,119607,5.820437699558242
NCI-H1092,3081361,3.870512478612
L3.3,448949,2.9670184834605244
KYSE-450,3503,2.083749354383258
PK-59,docetaxel-tanespimycin (2-1 mol-mol),0.3713076938077683
RKO,selumetinib-vorinostat (8-1 mol-mol),2.2625933360113826
NCI-H2009,11626560,0.9059448501577204
HuH-28,6918837,-2.849073667392251
MG-63,5351362,1.3576066069326869
HARA [Human squamous cell lung carcinoma],25150857,2.860855820493058
KYSE-450,3689413,-0.3124621453247139
HGC-27,selumetinib-BRD-A02303741 (4-1 mol-mol),6.257283698021105
AML-193,16741245,5.803148626123018
KU-19-19,5328940,2.592216165266187
WM793,navitoclax-piperlongumine (1-1 mol-mol),2.3781458373034976
IGR-37,9887053,4.927098264959097
A3/Kawakami,44566777,-0.8220969352934574
L3.3,702558,3.3585745644546474
BT 239,5328940,1.7604806186592967
HDLM-2,241158,2.746701613084659
RPMI-8402,10410894,4.033201525991735
AML-193,208908,1.8306982882175429
HARA [Human squamous cell lung carcinoma],5311281,2.4258881489706217
AML-193,46398810,0.8418948928383599
KALS-1,9929138,7.477924351122795
KMH-2,71680916,4.235623447079222
HuH-28,49850262,5.041762151129408
HT-1197,24772860,0.6353489056825131
JeKo-1,navitoclax-birinapant (1-1 mol-mol),3.065109706859245
KHM-1B,navitoclax-piperlongumine (1-1 mol-mol),1.2579870657882444
L3.3,56963564,0.8777502284965835
MFE-319,12001922,2.352010536331228
L3.3,selumetinib-piperlongumine (8-1 mol-mol),4.6860683758170145
RPMI-8402,54686904,5.085007720519579
HARA [Human squamous cell lung carcinoma],26596,-2.1080424946580245
IGR-37,2733487,6.52178404380484
RPMI-8402,decitabine-carboplatin (1-1 mol-mol),-0.953523352319921
EoL-1,11657048,4.375944112972209
HARA [Human squamous cell lung carcinoma],navitoclax-gemcitabine (1-1 mol-mol),-0.596107332987684
NCI-H716,262093,3.1268134242095735
SCC-25,9956119,3.1394805365293563
SK-N-SH,4096211,1.4631243416967494
A3/Kawakami,25183872,-4.2162674481134035
IGR-37,24748573,2.930430092099725
NCI-H647,3689413,0.6953623673111984
PC-14,5978,-3.445347134539419
RCH-ACV,25262965,-2.151627320019585
RPMI-8402,24889392,5.4584302431333835
YH-13,46224516,2.974421814944524
BT 245,navitoclax-sorafenib (1-1 mol-mol),0.0648225747142713
RCC10RGB,11485656,3.364959979667133
EoL-1,44462760,0.1276636597158796
HuH-28,ISOX-bortezomib (250-1 mol-mol),-0.0098284133610321
IGR-37,9868037,4.196529232004268
Capan-1,16725315,5.248830481022713
SK-UT-1,11497983,5.637939301868167
SW1116,400769,0.0385944808492462
AU565,11214940,0.9865925706012508
SK-MEL-3,439501,-0.9323794711246036
NCI-H2081,72376,-1.7545095760528466
NCI-H2009,11396600,4.054693544346837
HGC-27,2871966,-0.6178921644840291
SK-MEL-3,5460769,5.404359476176559
KMS-26,24889392,1.013548510030451
SK-BR-3,16722836,2.2428711178906253
AU565,46843906,2.01919943296107
MSTO-211H,135421197,0.8053711662366769
SIG-M5,44589607,2.165500756478256
KALS-1,JQ-1-navitoclax (2-1 mol-mol),0.8993537314031772
SNU-719,5566,2.6004619248736565
SK-MEL-3,46199207,3.734779424011323
BT 232,25150857,2.4243709783157
KALS-1,135440466,3.2570474332689376
HGC-27,16219061,1.9329429469853785
AML-193,71304818,2.05888774438817
PC-14,navitoclax-piperlongumine (1-1 mol-mol),1.8502903613096509
EHEB,9936388,-5.642934540589324
SK-N-SH,4521392,4.3063206244494125
NCI-H716,3025986,1.202096556496776
VMRC-LCD,11719255,3.7002958505846832
KHM-1B,15983966,1.6900305517060583
YH-13,25262965,-2.705880227783202
HGC-27,1566236,2.3802027184021037
SUP-T1,72193861,-0.523204846617361
KU-19-19,5746,1.6270456089520258
A3/Kawakami,46224516,2.763214072426513
BT 239,11719255,0.8573700864659659
SCC-25,25105715,2.5063863847748364
HARA [Human squamous cell lung carcinoma],BRD-K27188169-navitoclax (2-1 mol-mol),2.401020533417727
HT-1197,5113032,4.707040659057624
KHM-1B,44259,0.3168726025779862
KMH-2,2858523,2.563233361065934
HuH-28,5281321,-3.1655098711785685
HGC-27,45279963,3.0305804355395862
HuH-28,3634881,2.4327623937940226
HGC-27,25262965,-4.323698792215334
SK-UT-1,10427712,4.800550596191128
KU-19-19,104842,-1.861779032385676
RCH-ACV,107970,1.9405981464406723
NCI-H1092,6917907,2.9110687137698443
SCC-25,3825829,3.937484757880054
EHEB,51039095,2.793639508249939
BT 245,44589607,2.158681314242706
SK-UT-1,5328940,1.756043494249043
BEN,ISOX-bortezomib (250-1 mol-mol),1.6967455049493485
AU565,11507802,1.2242731086346843
P31/FUJ,8515,2.4023085754769133
TCCSUP,71304818,2.998111065090722
HCC2108,16722836,1.4931143772418354
WM793,54613361,2.2041091886662736
SCC-25,44507138,1.121165052710151
IGR-37,241158,3.741796107382708
NCI-H716,11485656,1.4384613287076216
YH-13,216345,4.472180809621783
HDLM-2,5978,-3.408402735563554
P31/FUJ,135421197,1.0144502005310674
SUP-T1,17759555,2.3637344893509957
EHEB,11625818,2.7353109359046615
Capan-1,24779724,4.377169410070466
SK-BR-3,25183872,-1.52180224020969
IGR-37,122327,5.833239356939829
A3/Kawakami,2949965,2.6103031731442172
NCI-H2009,4096211,1.934112859371262
NCI-H647,10302451,1.873701044619417
Capan-1,374536,1.4426497482902372
MFE-319,5479543,3.827527487543578
NCI-H2081,24771867,-2.330318084024509
VMRC-LCD,400769,-1.0068717980407518
BT 245,2126,5.061422430889494
BT 428,3854666,1.1222123532361343
HARA [Human squamous cell lung carcinoma],24964624,2.781169175627229
NCI-H2009,8515,4.894015987740437
SUP-T1,10410894,1.1089188982057177
WM793,3025986,-0.3370576533498906
NCI-H647,24821094,3.78377405181909
BT 428,23582824,2.346133549471676
SK-MEL-3,11609586,3.0171859296022694
BEN,31703,1.9123294902819632
HGC-27,68056272,2.986145007411018
KALS-1,9825149,2.9897553374613968
BEN,11497983,4.423678286283092
KALS-1,24901704,4.19427839744332
PC-14,5335621,2.4579899492998223
KMS-26,375860,-1.2821443043959098
HDLM-2,49850262,3.091010248560921
JeKo-1,24797083,0.9754590302611944
BT 245,441298,1.783004401721438
NCI-H2081,17755052,2.5069462773108016
HGC-27,72193861,0.5028287021266483
KYSE-180,25183872,-0.5863433825832977
NCI-H2009,89928392,1.462956527326012
YH-13,136227924,2.93381240838723
L3.3,5113032,6.1935482945866545
KMS-26,19582717,1.645026241592369
IGR-37,2945648,3.0927439107737222
HOP-92,44589607,2.7555232680400996
EoL-1,11609586,-0.6980588823200733
L3.3,44489675,4.5650706631267175
AU565,15547703,3.2970552657128325
BT 232,selumetinib-tretinoin (2-1 mol-mol),5.292405847467004
RPMI-8402,72376,-3.6474789747643346
KYSE-180,15547703,3.316205173217497
RCM-1 [Human rectal adenocarcinoma],JQ-1-carboplatin (1-1 mol-mol),2.0139488398740637
SUP-T1,5282054,2.3105335543158234
RCH-ACV,10322450,3.427971439759819
SIG-M5,1641662,3.307162593266913
BT 428,navitoclax-piperlongumine (1-1 mol-mol),0.1404852536322988
HDLM-2,12001922,1.6187966717064417
MG-63,568763,1.4810199354220923
SIG-M5,4477,0.6309848732642754
KALS-1,2729026,3.0214039787916573
BEN,66577038,2.921622506847165
IGR-37,11214940,4.309272582753125
IGR-37,25102847,3.4884808655215744
MG-63,42642645,1.5055761317097798
WM793,11175137,2.573938317060376
KYSE-450,53232,2.6046887103681993
BT 232,decitabine-carboplatin (1-1 mol-mol),4.089563703687574
KYSE-180,156422,3.987230408696769
KHM-1B,6918328,-0.972639722757723
HCC2108,11214940,0.9644297504836672
VMRC-LCD,5351362,1.0387816370252212
VMRC-LCD,3634881,4.695581465171585
RPMI-8402,8515,2.725548300733334
BT 228,24797083,0.5763836817098033
SK-BR-3,25161177,4.109848310892794
RCM-1 [Human rectal adenocarcinoma],doxorubicin-navitoclax (2-1 mol-mol),0.7949647024919319
RCC10RGB,53245473,3.741106102916085
AU565,5351362,0.5336942302969934
L3.3,selumetinib-vorinostat (8-1 mol-mol),2.710739742780381
KMH-2,9444,2.9030886554096536
SUP-T1,10385095,1.0302013641160523
KMH-2,44259,0.757260384175628
JeKo-1,60750,-4.531251411373575
SK-N-SH,71751553,4.86546041028893
NCI-H647,45279963,3.8416340614693714
SK-N-SH,9915743,1.1616840064565594
RCH-ACV,46943432,0.6634078457695299
KYSE-450,6505803,0.925446652115482
TCCSUP,3081361,3.015590001754395
HGC-27,42642645,-0.9522403053623212
JeKo-1,46907787,2.135239462505942
SUP-T1,123631,1.8191464879325467
BT 228,5460769,3.1734234469755775
L3.3,387447,-2.8513357804813553
JeKo-1,156414,1.4830831458310074
SIG-M5,2126,3.752304085558634
PK-59,navitoclax-gemcitabine (1-1 mol-mol),0.5848903190241437
HCC2108,10074640,3.185327985640923
SCC-25,46843906,1.6238103246476487
HT-1197,3825829,4.6685347101076395
SK-N-SH,10113978,3.3507134650294756
NCI-N87,5460769,3.352422042402732
KYSE-450,46199207,3.793080332052943
NCI-H1092,9884685,5.208907292159036
MG-63,49793307,2.757454136383386
KYSE-450,6917907,-5.14733530155551
HT-1197,3384730,3.365997273139692
HGC-27,71729975,-0.2607747724253211
NCI-H716,9911830,-1.2258790072222217
SK-BR-3,9907093,3.7626445952652374
RCH-ACV,51039095,2.868448712001233
NCI-H647,2126,3.947322984849447
KMH-2,24785538,0.2368793011459556
HARA [Human squamous cell lung carcinoma],2858523,2.980861882613042
P31/FUJ,135398744,5.7727848933678
RCM-1 [Human rectal adenocarcinoma],168312962,3.7277757368773345
YH-13,JQ-1-UNC0638 (2-1 mol-mol),2.8302570708443757
BT 228,156414,1.710173414440736
KHM-1B,135875424,3.3101852288443276
RCM-1 [Human rectal adenocarcinoma],984333,1.0265914359647546
NCI-H1092,9936388,1.337118908669493
NCI-H1092,56649450,3.409643738416104
A3/Kawakami,135875424,3.019357204965879
RPMI-8402,3634881,2.5292280310173685
A3/Kawakami,4705,2.957663936707348
WM793,selumetinib-JQ-1 (4-1 mol-mol),1.649848066078306
HCC2108,docetaxel-tanespimycin (2-1 mol-mol),-0.9383807284852752
RKO,51037431,1.443783779144223
KYSE-180,54619267,4.811647968153079
KALS-1,24771867,3.000627523181766
IGR-37,71304818,2.7542049900150545
KYSE-450,24797083,1.908715906165
RCH-ACV,46191454,-0.013670649962106
KALS-1,selumetinib-JQ-1 (4-1 mol-mol),1.151640151549291
RCC10RGB,44507138,4.147954700367582
NCI-H647,2742550,3.61263816541944
RPMI-8402,5351362,1.0346473148100723
SCC-25,11626560,1.2686345781533712
MSTO-211H,5282054,2.057664237493602
A3/Kawakami,25062766,1.2082975230406068
SK-BR-3,44462760,4.336471440312601
EHEB,72734382,4.1680701190018965
SIG-M5,SNX-2112-bortezomib (250-1 mol-mol),-4.340010987853275
SK-BR-3,216239,2.0778122645816333
KMS-26,5460769,1.6781754946124072
Capan-1,44607531,2.050283892698384
YH-13,17755052,1.8478012162745872
NCI-H647,10127622,4.9135668272365605
IGR-37,2842253,6.235855759079484
VMRC-LCD,72376,-2.9120848348426183
PC-14,9840324,5.523880069172291
MFE-319,168312962,-2.545112888543327
HARA [Human squamous cell lung carcinoma],2729026,2.992927693558788
AML-193,135875424,2.8839431116482803
BT 239,9868037,2.51635002205042
AML-193,25183872,-1.359951468781168
P31/FUJ,navitoclax-pluripotin (1-1 mol-mol),-1.7547710657643
EoL-1,23635314,-5.069796040721717
SUP-T1,5280436,3.827333658534009
SIG-M5,3503,2.002213087127026
SUP-T1,676352,2.2749009007407626
NCI-H647,15983966,-0.2061089901436029
NCI-H647,salermide-PLX-4032 (12-1 mol-mol),4.795194614169008
KYSE-180,6505803,-2.0087833017185264
JeKo-1,25183872,-1.8986137914356085
KALS-1,5281321,-0.7256888528478989
SK-MEL-3,11494412,3.62103205508352
RPMI-8402,124202324,0.7809027378037724
SK-UT-1,25150857,3.291116369436408
HARA [Human squamous cell lung carcinoma],54618305,5.079823174852019
RPMI-8402,52947716,-5.070613976264482
BT 228,2949965,2.648017098972217
HT-1197,176870,5.64683923683635
MG-63,9866186,1.5355192655797545
KU-19-19,24753719,4.40371401160258
WM793,42642645,1.6343237729440876
HDLM-2,327653,3.054457178723177
SNU-175,26596,-1.9837379159345812
SNU-719,10113978,3.6627900474652098
PC-14,51039095,2.567022032708071
TCCSUP,BRD-A02303741-navitoclax (2-1 mol-mol),3.413405866150177
HARA [Human squamous cell lung carcinoma],45100309,5.833200435543825
HARA [Human squamous cell lung carcinoma],216345,4.215325728716343
SK-MEL-3,11404337,-1.6693959250085673
HDLM-2,374536,3.478917347860707
TCCSUP,3025944,4.64601572000857
MG-63,54454,1.1014729762734612
NCI-H1092,navitoclax-sorafenib (1-1 mol-mol),1.0021052217425306
HGC-27,637858,1.3770669368104775
MFE-319,vorinostat-carboplatin (1-1 mol-mol),3.765211637678425
PC-14,selumetinib-decitabine (4-1 mol-mol),1.378488741424842
NCI-H2081,119182,0.5857992910725418
NCI-H2081,387447,-5.408009728713125
P31/FUJ,9911830,2.020541196825024
PK-59,9929138,7.561658238332544
BT 428,5479543,4.050320279667783
BEN,44185566,1.3402981990243077
MFE-319,11625818,4.344843795986318
SIG-M5,5278396,3.751999447758836
IGR-37,54626689,4.807071545239909
JeKo-1,11719255,3.2150698533716837
RKO,12003241,-0.2410566552434749
EHEB,71466445,3.460498363916868
BT 428,4096211,1.6396351662368742
BT 245,387447,-4.390125196959702
MSTO-211H,65628,3.7458295220001
MFE-319,54618771,1.5027851162197383
VMRC-LCD,2708,5.678057458304435
RPMI-8402,23725625,2.9400439776803102
SK-UT-1,2708,5.491455066314142
SCC-25,613753,3.2356219851245527
HGC-27,9549297,1.3924456375350225
HCC2108,159324,4.9915636231764005
RPMI-8402,tanespimycin-bortezomib (250-1 mol-mol),0.8651644866846245
PC-14,24964624,3.1238694699720626
IGR-37,1239801,4.441329115956976
WM793,68056272,3.787649254718563
AML-193,24785538,-1.4483547112849793
SCC-25,72193861,0.0529596213432335
NCI-H716,2858523,3.2079099727454423
BT 239,135398516,2.7900959872152367
SUP-T1,9935249,2.0968505860065156
KU-19-19,148198,-3.572091199224797
HOP-92,JQ-1-vorinostat (2-1 mol-mol),0.1135682156922172
NCI-H647,25102847,2.15012681070303
PK-59,72734382,4.968787666344006
SCC-25,49793307,-3.1493129124226287
NCI-H2009,JQ-1-vorinostat (2-1 mol-mol),0.1591835457896471
MFE-319,2858523,3.211105614192511
TCCSUP,46199207,2.7417054506008967
BT 239,49793307,-4.699265195312621
MFE-319,9911830,2.7406441465342555
SK-UT-1,5329102,3.5213520964338207
VMRC-LCD,JQ-1-vorinostat (2-1 mol-mol),-0.3085641210667629
P31/FUJ,46191454,0.7861082656977861
SNU-719,10074640,2.9977756217409697
SIG-M5,426756,4.1987276924815635
YH-13,11178236,-3.430618404279131
PC-14,60700,-1.2251472186443342
BT 228,676352,1.8708877717456436
NCI-H2009,107985,-3.3237358160703843
BT 245,24797083,0.9697531210706976
SK-UT-1,67156097,0.3478511759074868
NCI-H2009,54143018,-0.2798924220132643
BT 228,46398810,1.7041666697525495
KHM-1B,4259181,-0.2095303903157825
BT 239,44507138,1.329456812771611
SCC-25,400769,-1.5634867526400646
EoL-1,2746,-0.0046206936254649
PC-14,10231331,0.5461377223152567
SK-MEL-3,selumetinib-GDC-0941 (4-1 mol-mol),0.6060957157966415
NCI-H647,2874250,-0.9265269952714488
HGC-27,3081361,2.100993626135221
Capan-1,2749,2.057414136850917
YH-13,23725625,5.130607279174726
EoL-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.0548301208208537
HOP-92,421610,3.735765209637502
NCI-H2009,16038120,-1.1539994385349277
KMS-26,49766530,-5.317731060061128
BT 428,46843906,3.437949363234708
HuH-28,168313047,2.196053639101238
SW1116,2949965,2.5720792413048437
PK-59,15953870,6.175335011158435
SK-MEL-3,107970,3.0007282894696967
SIG-M5,6610355,3.3951979648126263
HOP-92,10074640,3.4298368596464863
AU565,9868037,3.1053436778875843
HCC2108,613753,3.4104972330481615
KYSE-180,452548,0.8760289796861696
NCI-H1092,sirolimus-bortezomib (250-1 mol-mol),0.4958114346992872
TCCSUP,6918328,-0.4251652651497192
SK-BR-3,3552672,1.4899087214210769
PK-59,409805,4.129578188717334
A3/Kawakami,4259181,0.5157779937872828
NCI-H647,11717001,5.597380109715174
PK-59,4788,5.839932555913688
WM793,selumetinib-navitoclax (8-1 mol-mol),2.773218065087456
AML-193,168313200,1.5323685202636708
MFE-319,16725315,5.22401842743567
P31/FUJ,54454,2.7341923640247123
HARA [Human squamous cell lung carcinoma],9868037,3.8920643368101713
SW1116,5281321,-0.8565872780521203
NCI-H647,tanespimycin-bortezomib (250-1 mol-mol),-3.1460893933580727
HOP-92,5291,3.8346007310835377
SIG-M5,carboplatin-etoposide (40-17 mol-mol),-0.2009457729517104
YH-13,5287620,-2.012457236382429
KYSE-450,24771867,3.24164368139856
YH-13,26596,-1.6020780091570677
SK-BR-3,46843906,3.7029867518025927
YH-13,51039095,2.0739005868490983
NCI-H2081,6918736,-2.652468008724762
SK-MEL-3,7251185,3.2702826882005183
SK-N-SH,3825829,3.7303621997936887
AU565,3025944,3.700689922668097
NCI-N87,4261,0.8200487533079858
RPMI-8402,31703,-3.047934014646322
BT 228,984333,-0.4063827265298049
EoL-1,2130404,2.487882380870372
SK-BR-3,25150857,2.5637099306111435
PK-59,444795,4.575943921838248
SK-N-SH,2708,3.033337957101563
HT-1197,54618771,2.611053325854013
PC-14,6610355,4.737749939026015
SUP-T1,56946209,-4.75799224608544
NCI-H2009,439501,-2.087429471182781
EHEB,12003241,-2.0597430880681062
BT 228,5287969,-1.6068437398175914
WM793,3062316,1.9641420987669005
KALS-1,5311281,1.1712759764569023
RKO,56946209,-3.445993729976747
HDLM-2,2729026,2.382728805197318
SK-N-SH,72376,-2.6554913576180104
RCM-1 [Human rectal adenocarcinoma],3634881,3.579575013653745
KHM-1B,5291,3.0747502676954896
MFE-319,9907093,4.294355457930612
KMH-2,159324,1.5423120810193625
KU-19-19,2874250,6.302627434426347
Capan-1,6610355,5.1942349502658995
MG-63,vorinostat-navitoclax (4-1 mol-mol),0.91069613214945
KMS-26,51039095,2.1090176680930197
VMRC-LCD,44632017,0.8555845914890998
HARA [Human squamous cell lung carcinoma],alisertib-navitoclax (2-1 mol-mol),-2.092897901371494
EHEB,241158,3.817598938948392
MSTO-211H,navitoclax-PLX-4032 (1-1 mol-mol),-0.7263097826113902
RCC10RGB,969516,5.025939213907113
IGR-37,selumetinib-decitabine (4-1 mol-mol),0.5324699308016065
NCI-H716,docetaxel-tanespimycin (2-1 mol-mol),-2.896233903735701
NCI-H2081,11497983,-3.5541578106955516
KHM-1B,1750826,-3.7148108552334977
WM793,6505803,-1.695252066312567
MFE-319,445455,6.120415558999173
KHM-1B,doxorubicin-navitoclax (2-1 mol-mol),-2.1386947262651907
SK-BR-3,9826308,-0.3061693070114732
PK-59,65064,4.451099764682022
HuH-28,6610355,5.089557620893774
BT 245,25150857,2.481391794476999
PK-59,2746,3.5698867833367585
HDLM-2,9825149,2.3282746846058444
BT 239,387447,-4.078416605108376
RCC10RGB,navitoclax-birinapant (1-1 mol-mol),2.5525116990099015
NCI-H647,135398738,5.8851169922660995
P31/FUJ,67291369,0.7371006748241407
AML-193,5978,-5.444385643715103
HOP-92,17755052,0.3263188353297222
KALS-1,656346,1.2505212116971391
KYSE-450,5746,2.912407446662149
AML-193,52947716,1.965000322172021
RPMI-8402,5746,-2.312146347100348
HGC-27,19582717,3.3681880905458543
HGC-27,doxorubicin-navitoclax (2-1 mol-mol),-2.694923245542946
WM793,sirolimus-bortezomib (250-1 mol-mol),1.012836657947069
AML-193,44632017,0.0370822785636057
SIG-M5,24964624,2.441380888585346
NCI-H2081,5311,0.3244714847141396
JeKo-1,54596558,4.263597396547864
JeKo-1,441298,4.09856274748034
VMRC-LCD,25183872,0.7172771330994894
KMH-2,5738263,2.6573720905812275
HOP-92,11175137,1.9709650938951335
KMS-26,387447,-5.275247943312664
BT 428,11612883,3.704058274003065
HDLM-2,tretinoin-carboplatin (2-1 mol-mol),6.0807928959724995
KU-19-19,5351362,1.814646406429004
P31/FUJ,JQ-1-carboplatin (1-1 mol-mol),-0.13727273351174
RCC10RGB,24748573,3.544482176439233
YH-13,2749,2.5667946574986473
JeKo-1,6852167,1.633510922803868
NCI-H2009,72734382,3.739945681050146
HOP-92,decitabine-navitoclax (2-1 mol-mol),0.9228121492533315
JeKo-1,6918328,-1.3622043886785398
HGC-27,9903786,1.5115157472800849
IGR-37,55508,2.3836432328603774
MSTO-211H,135398516,-0.6247457561994184
SK-N-SH,10231331,6.160386015509348
HDLM-2,135875424,3.7112298908511017
EoL-1,16725315,2.743367583420033
TCCSUP,46398810,2.9354899983931433
BT 428,2842253,6.319982584211996
BT 245,4917,2.258069794178112
A3/Kawakami,11612883,1.7232512150061663
IGR-37,2742550,3.8549971974634465
A3/Kawakami,135984461,3.954538611976779
NCI-N87,444795,4.906796024963376
AU565,374536,-0.7311314672583101
KMH-2,44819697,-3.5125705811438217
EHEB,654092,-1.857578615070723
SCC-25,24753719,4.468812461486699
AU565,135875424,4.732736146663846
EoL-1,9825149,0.3060055313487981
HGC-27,11234052,3.352535346789583
KU-19-19,5470400,0.4514058362673593
SK-MEL-3,676352,1.7213279130042811
JeKo-1,24785538,0.0308568689807873
RCH-ACV,3689413,-1.349996625899334
SK-N-SH,119182,2.974133791038027
TCCSUP,10302451,3.6876382718765206
SUP-T1,104842,-9.09182169787133
KMH-2,11626560,1.1417294335260535
RKO,54618771,2.3159310195777985
L3.3,46191454,1.113033924578524
RKO,104842,-2.5196749638548
SK-BR-3,25154868,4.479374315401352
RPMI-8402,15547703,2.1033450326425007
BT 428,11485656,2.0550266467475407
Capan-1,3552672,3.187102552694537
MG-63,135411,0.9071792658080758
KHM-1B,10410894,4.907000133376468
BT 428,9915743,0.3842410251142636
VMRC-LCD,54618305,4.210523394539639
RPMI-8402,5311281,0.9063275151890504
PK-59,10302451,2.95389022276854
HT-1197,54618164,4.009562616962898
P31/FUJ,tanespimycin-bortezomib (250-1 mol-mol),0.0118872693017982
JeKo-1,613753,3.13207613140014
HT-1197,387447,-4.89553325968602
AML-193,10077130,4.387389621358432
RCC10RGB,107970,3.009214725762471
SIG-M5,3025986,-3.1792490424115294
SIG-M5,erlotinib-PLX-4032 (2-1 mol-mol),-1.277236590530043
JeKo-1,24821094,2.263640328687025
NCI-H1092,44237094,3.0131214117675835
RKO,selumetinib-JQ-1 (4-1 mol-mol),0.7539248953092096
SCC-25,2708,5.370848535068592
SK-UT-1,10113978,3.4066925150008864
Capan-1,168313200,2.9993325450618022
WM793,31703,-1.1808506154596277
KYSE-450,25126798,4.042128905943723
HGC-27,16722836,0.5184451232934393
RCC10RGB,53495165,3.554009618530711
SK-BR-3,71304818,2.239218303869405
KMS-26,72376,-3.2161536761771496
EHEB,vorinostat-carboplatin (1-1 mol-mol),1.7793348056073373
MSTO-211H,57519531,1.3086690033484818
NCI-H647,4578,5.096405674263879
SW1116,selumetinib-UNC0638 (4-1 mol-mol),1.3177227542227
SW1116,sirolimus-bortezomib (250-1 mol-mol),0.982406512308436
HT-1197,5335621,4.488387326981604
MFE-319,46199207,3.662460250144103
SIG-M5,25262965,-3.57555451179747
Capan-1,676352,2.416492609334049
SK-MEL-3,6918837,-3.0435035860127684
P31/FUJ,25102847,1.6695774391929423
HARA [Human squamous cell lung carcinoma],5470400,2.3733756266777037
RCM-1 [Human rectal adenocarcinoma],navitoclax-PLX-4032 (1-1 mol-mol),2.948451755079763
JeKo-1,702558,3.2625818729760905
EoL-1,54765302,0.4667889627185578
BT 239,4259181,0.729080593858997
RCH-ACV,44607530,1.5944451601126894
A3/Kawakami,4096211,1.1009885072241696
P31/FUJ,57519531,1.451496749892495
MSTO-211H,42642645,-0.4763575861779333
A3/Kawakami,462382,0.1367387620178582
KMH-2,6918736,-4.379337096779674
TCCSUP,675434,5.391055260540043
HGC-27,49867926,3.779187709485661
NCI-H647,24964624,2.268481331337833
HARA [Human squamous cell lung carcinoma],42611257,3.5357302300548716
PC-14,vorinostat-carboplatin (1-1 mol-mol),2.3386153603186517
NCI-H2009,60750,0.952457111724262
KMH-2,327653,2.6435192789338724
L3.3,241158,3.9670067644952702
KYSE-180,5746,1.1685724105246271
SK-UT-1,11364421,-4.077140333267383
VMRC-LCD,24180125,1.3284719175549995
RCM-1 [Human rectal adenocarcinoma],9911463,4.136675560401034
EoL-1,64971,0.3091623881710675
RCM-1 [Human rectal adenocarcinoma],54618305,4.342158128597338
HT-1197,11719255,3.051258052931378
KHM-1B,5280436,3.274905702190878
AML-193,24821094,3.6784562474419698
WM793,24951314,1.9814754728046269
KYSE-180,46191454,1.2517200441796488
KYSE-450,24785538,3.6513103906304942
SCC-25,50905018,4.410054052940247
VMRC-LCD,10296883,4.114131577263389
RCH-ACV,54649381,3.745504594626648
SK-BR-3,5278396,3.4405605635746417
BT 239,3634881,0.8968610733427502
MG-63,selumetinib-PLX-4032 (8-1 mol-mol),4.675212609852472
IGR-37,54613361,-0.2320017543796893
KHM-1B,54454,3.744465591598654
SCC-25,16013152,4.26893227216868
AML-193,5287620,-1.9831188556738035
BT 428,11626560,2.01118984130693
HOP-92,11656518,2.785895617716098
KMS-26,navitoclax-birinapant (1-1 mol-mol),3.037902591253747
P31/FUJ,SNX-2112-bortezomib (250-1 mol-mol),-3.0882098716957223
EHEB,73707438,3.85222556690395
NCI-H2081,selumetinib-piperlongumine (8-1 mol-mol),2.382828726466422
KMS-26,46191454,-2.189975890506598
VMRC-LCD,151289,0.8422251353629934
KALS-1,151289,1.722131739052175
EoL-1,2733526,2.5886434469315818
NCI-H647,navitoclax-sorafenib (1-1 mol-mol),2.009764204490943
KHM-1B,selumetinib-MK-2206 (8-1 mol-mol),-1.0193788552435303
PC-14,3825829,3.604955593937337
WM793,107985,-3.039809125194022
KMH-2,446155,2.2710682869847636
BEN,51039095,3.5044530445094284
HARA [Human squamous cell lung carcinoma],107970,2.425047737070786
SUP-T1,702558,4.481824390913202
BT 239,9952709,2.180590540495491
NCI-N87,6610216,4.734758596227503
MG-63,51039095,2.465038890143895
PK-59,16725315,3.300439701422596
KMS-26,73707398,0.2889997068369305
KYSE-180,11964036,1.5417763505782551
HGC-27,5351362,0.9147183427907444
WM793,15953870,5.050143340220593
KMS-26,24951314,-1.877270006940826
A3/Kawakami,5311,0.2531419791059345
KHM-1B,387447,-5.058175638788416
NCI-H2081,3854666,0.2078847774714705
MG-63,11178236,-3.7095193876132297
SCC-25,54143018,-0.7425585123898821
BT 239,5278396,3.608083942635692
EoL-1,24785538,0.1995704659327235
KMH-2,44137675,5.057620935637761
WM793,navitoclax-MST-312 (1-1 mol-mol),0.5700872528599389
MFE-319,1242560,3.533340826229735
EHEB,168313047,2.145249955872484
RPMI-8402,SNX-2112-bortezomib (250-1 mol-mol),-2.3853753849835466
P31/FUJ,676352,1.6175160353980318
NCI-H716,5311,2.0497122865752075
JeKo-1,5281672,4.362885273472302
SK-MEL-3,168313200,3.813993293038376
PK-59,3854666,3.1918550803858783
HCC2108,44185566,2.949072119702921
HuH-28,9840324,5.736282108239657
P31/FUJ,374536,-2.654779926412406
KYSE-180,vorinostat-navitoclax (4-1 mol-mol),2.04555281689964
MSTO-211H,16722836,0.7655247341289007
HARA [Human squamous cell lung carcinoma],piperlongumine-MST-312 (1-1 mol-mol),1.5629845870291592
KMS-26,9549297,1.273045822312039
RCC10RGB,carboplatin-UNC0638 (2-1 mol-mol),3.3801418218563337
NCI-H2009,12001922,2.0619007134450524
SIG-M5,71466445,2.546223661997516
Capan-1,1750826,0.2543836609056171
MG-63,5291,3.702437203849159
HGC-27,9952709,1.893128250480929
NCI-H647,24901704,3.39987304300846
IGR-37,60700,-1.969473753800008
PC-14,selumetinib-PLX-4032 (8-1 mol-mol),1.9609187733259617
SCC-25,675434,4.273172717942978
NCI-N87,168313047,2.984513904409232
NCI-H647,89928392,1.6648051311031258
KYSE-180,3854666,2.7659153089015898
SK-N-SH,45100481,5.709137833307256
MSTO-211H,5746,0.1838030897357816
SIG-M5,46398810,2.2928986796506323
EHEB,16725315,3.5389292854080505
KHM-1B,54639665,4.391144139421017
RKO,15547703,3.988071110220001
BEN,11222830,3.2464736122635425
HT-1197,vorinostat-navitoclax (4-1 mol-mol),1.8095257014780903
RCH-ACV,carboplatin-etoposide (40-17 mol-mol),-1.3260181933485886
Capan-1,7251185,2.671529094817842
BT 245,selumetinib-vorinostat (8-1 mol-mol),2.5548993263736235
HOP-92,10127622,2.853655081120482
BT 228,216345,2.339295891996544
SK-UT-1,11717001,5.457019686559972
SK-UT-1,24753719,3.8954683516034194
KMH-2,6918837,-4.411426707410838
Capan-1,crizotinib-PLX-4032 (2-1 mol-mol),2.501468557453161
HGC-27,176870,2.569950409971277
HuH-28,11364421,0.5040792605175038
SUP-T1,5281672,2.7662898605184747
SW1116,navitoclax-gemcitabine (1-1 mol-mol),2.0434267209572834
SK-UT-1,1317464,3.8102371333241023
BT 239,docetaxel-tanespimycin (2-1 mol-mol),-2.0793509597660123
RPMI-8402,44202524,1.1540481630819035
KU-19-19,54618771,0.4920305765445359
KU-19-19,11214940,3.3843502872937106
L3.3,20959075,-2.193253801628986
HT-1197,136227331,4.1686832896523685
RCM-1 [Human rectal adenocarcinoma],navitoclax-pluripotin (1-1 mol-mol),-0.3016699371514477
BEN,1716436,4.260780053924218
SK-MEL-3,24797083,1.649847606614986
SW1116,11213558,3.445113299124233
SK-UT-1,5335621,5.433304981154406
RCH-ACV,3384730,1.3407094467889185
NCI-N87,176870,1.1060804163410003
KYSE-180,selumetinib-JQ-1 (4-1 mol-mol),4.706272098527088
AML-193,decitabine-carboplatin (1-1 mol-mol),3.7070822072758065
KMS-26,5284373,-1.7552706443496189
YH-13,4096211,1.7553390235947497
RKO,JQ-1-navitoclax (2-1 mol-mol),1.6431758808285295
AML-193,66577038,3.044740880667596
PC-14,2858523,2.9944905399377584
RCH-ACV,9826308,-0.1773526487939199
KMH-2,1750826,-2.4192360478715877
SK-UT-1,119182,-0.2389735645577043
JeKo-1,9952709,2.3957676501436183
KHM-1B,246676,1.870399937828377
BT 428,1750826,-1.0084849946266714
HT-1197,6610355,3.6284848947596
KHM-1B,123631,2.5623362967553858
BT 428,16725315,3.4626765815418374
MG-63,5746,3.161303171770958
EoL-1,ISOX-bortezomib (250-1 mol-mol),-1.2225482677750494
VMRC-LCD,navitoclax-pluripotin (1-1 mol-mol),0.7114012115737944
MSTO-211H,49850262,3.597717946429448
NCI-H647,6450551,3.4599261787692313
AU565,53393127,4.519828407362072
RPMI-8402,71680916,4.522796750183947
EoL-1,11497983,-7.956862076421071
A3/Kawakami,3025944,3.903727047321102
TCCSUP,navitoclax-birinapant (1-1 mol-mol),2.81500851801963
RCC10RGB,2126,5.809199309072596
NCI-N87,24753719,4.36387060101307
HuH-28,613753,2.6535128582273595
MSTO-211H,selumetinib-UNC0638 (4-1 mol-mol),2.638630251212758
NCI-H2009,1750826,0.0733322198534379
BT 239,selumetinib-BRD-A02303741 (4-1 mol-mol),3.733604251898887
SK-BR-3,60700,-4.289206881530931
Capan-1,5470400,-0.2237292291053473
A3/Kawakami,644241,6.313721804681679
BT 232,46843906,4.432756339856534
RCH-ACV,2742550,3.694340545440027
BT 228,23582824,0.4117773539302274
BT 245,selumetinib-MK-2206 (8-1 mol-mol),2.8267994061207875
MG-63,387447,-4.9134398622205016
AU565,selumetinib-piperlongumine (8-1 mol-mol),3.265854364361565
RPMI-8402,56963564,-0.7911152016005226
SK-BR-3,374536,-1.7923241970053383
SIG-M5,15547703,3.1521738235614585
KYSE-450,11178236,-2.864393215026398
PC-14,3854666,0.2934048653754776
KHM-1B,10322450,2.734741066135324
KYSE-450,2729026,3.1949435983644414
SIG-M5,15983966,-4.364911308806047
AU565,285033,-2.964869253470222
SK-BR-3,46215462,1.7456629025510193
WM793,124202324,3.2510114503738894
BT 245,46398810,2.1794326255658216
SCC-25,637858,1.5386898989204256
KALS-1,3062316,2.9196570104203903
HOP-92,10231331,1.6069626352375108
BT 245,16219061,2.483085433457608
YH-13,984333,1.552799653388661
RKO,56649450,4.8662264096692684
NCI-H647,2828334,6.034498429625871
HuH-28,sirolimus-bortezomib (250-1 mol-mol),0.2799415361995808
NCI-H647,31703,0.6785044608595768
IGR-37,11485656,2.5244768295786697
BT 232,JQ-1-vorinostat (2-1 mol-mol),1.7229526901297294
SK-UT-1,54618164,4.334674071191232
BT 428,135999136,1.4549412998786355
TCCSUP,11175137,3.3484208163516587
SK-N-SH,7251185,1.3019343806823842
KMS-26,11396600,-5.248360616459154
MFE-319,71304818,1.6019661991526506
A3/Kawakami,2742550,3.663536756053575
HT-1197,doxorubicin-navitoclax (2-1 mol-mol),-1.5450455238577607
KMS-26,654092,-4.098201806835606
SK-UT-1,5470400,0.3907308309201836
KALS-1,9967941,4.749575003055428
A3/Kawakami,156422,3.814588070811697
HGC-27,11257553,-0.4055694380174927
SK-MEL-3,25154868,5.191403939065996
KMS-26,57519531,1.1198210334119951
MSTO-211H,216345,2.6222222224733702
PC-14,60750,0.123161460916901
HDLM-2,9926054,1.2404831446966105
EoL-1,tretinoin-navitoclax (4-1 mol-mol),-6.907493520330868
SUP-T1,selumetinib-decitabine (4-1 mol-mol),4.136963670717102
NCI-H716,25183872,-1.3518486815853676
SNU-175,89183176,1.592270463581723
NCI-H2081,54619267,3.7296456534329097
RCH-ACV,5566,3.0840124997395515
HOP-92,65628,6.008725293872382
A3/Kawakami,10127622,5.210442840456739
SIG-M5,67156097,-1.9562855803447317
HGC-27,136227924,2.541882907814414
TCCSUP,159324,3.967918889169363
YH-13,3025986,-1.231894259194408
HGC-27,6436223,-5.1983359179782545
L3.3,53392493,3.3534830778032045
RKO,44819697,-0.2126149769206573
SCC-25,24771867,0.3246558759824934
NCI-N87,4917,2.911504588829893
KU-19-19,tanespimycin-gemcitabine (1-1 mol-mol),1.208542786585586
SCC-25,selumetinib-GDC-0941 (4-1 mol-mol),-0.1587136183503204
SNU-719,piperlongumine-MST-312 (1-1 mol-mol),1.560509582605015
RPMI-8402,9936388,-6.946099895647247
BT 228,10427712,4.970898906680894
AU565,11647372,-0.7623159020318493
YH-13,9926054,1.834128888426512
HDLM-2,3025986,-1.8369429914705675
NCI-H1092,9933475,2.1569011395664934
KYSE-180,11507802,1.642318486353166
MG-63,44491742,4.049642181579157
A3/Kawakami,6917907,-5.797960244038731
BT 245,65064,5.684147690973874
KHM-1B,6438330,0.7214920302496746
L3.3,3062316,1.4450663843809155
KMS-26,638278,1.395039667533409
EHEB,3825829,3.7186558518100705
P31/FUJ,5284616,2.141886646431612
MFE-319,10172275,4.435803406611427
BT 428,984333,0.0078078070137453
KALS-1,doxorubicin-navitoclax (2-1 mol-mol),-0.8571013818032479
EoL-1,31703,-6.355136125534523
SNU-719,3854666,4.073079265106613
NCI-H2009,5278396,3.446569775137936
HGC-27,11404337,-1.4323340614808602
EoL-1,5311281,0.8929450198494882
KALS-1,9823820,5.073419198015459
IGR-37,11647372,1.7851686124282284
BT 239,16065773,2.126193312329101
EoL-1,6852167,-0.9141942843071824
SK-UT-1,25154868,1.7438224060222909
JeKo-1,54619267,3.7013993043911384
NCI-H1092,71304818,2.0604821765755497
SK-MEL-3,136227924,3.573502388362414
SK-MEL-3,selumetinib-MK-2206 (8-1 mol-mol),2.648820877835553
KU-19-19,19582717,2.992815973528006
NCI-H2081,3825829,4.196645416863087
HARA [Human squamous cell lung carcinoma],11647372,1.8404588933860024
SCC-25,46215462,1.2497858301757814
EoL-1,24772860,-4.421397988751503
BT 245,15983966,-4.244276078580228
RCM-1 [Human rectal adenocarcinoma],135411,0.5141731800260497
IGR-37,969516,2.9336315099024737
BT 428,19582717,3.674276995141217
RKO,168312962,-2.5117583451491012
MSTO-211H,54626689,2.3486455994654767
NCI-H647,52912189,1.7184934557070204
A3/Kawakami,676352,1.578332487088017
RKO,1750826,1.760307875609834
SK-BR-3,168313016,5.907534707953531
A3/Kawakami,25150857,1.056763733653955
AU565,ISOX-bortezomib (250-1 mol-mol),0.4986344136338663
HCC2108,216468,5.043012995009322
BT 228,675434,4.095988497539235
HARA [Human squamous cell lung carcinoma],navitoclax-piperlongumine (1-1 mol-mol),2.215632811452015
HDLM-2,44259,1.0140486186893352
MG-63,carboplatin-etoposide (40-17 mol-mol),3.615188659462788
KMS-26,56963564,-0.984302761467724
KALS-1,54143018,-0.5056360114126361
BT 239,navitoclax-birinapant (1-1 mol-mol),-3.454266592462389
L3.3,1641662,3.117391597616944
SK-BR-3,JQ-1-carboplatin (1-1 mol-mol),3.127240758828175
MFE-319,46907787,6.309736161106018
KYSE-180,navitoclax-sorafenib (1-1 mol-mol),1.4243310506512128
MFE-319,45279963,4.071493143646158
RKO,2858523,3.1569923390566332
BT 239,alisertib-navitoclax (2-1 mol-mol),-3.038847040617223
KALS-1,421610,3.363366209168492
AU565,decitabine-navitoclax (2-1 mol-mol),2.1782806047891095
RCC10RGB,alisertib-navitoclax (2-1 mol-mol),1.3902469753656497
NCI-H1092,selumetinib-MK-2206 (8-1 mol-mol),4.303588531613232
RCC10RGB,11214940,1.429625683961422
JeKo-1,15547703,2.948405163542325
SK-UT-1,10296883,3.957718672541511
RCM-1 [Human rectal adenocarcinoma],9967941,4.297033846683125
BT 428,selumetinib-MK-2206 (8-1 mol-mol),0.8351640279653656
Capan-1,alisertib-navitoclax (2-1 mol-mol),1.5775802310166271
HDLM-2,176870,2.5396559104178063
SW1116,46398810,1.9738343649367471
KHM-1B,16736978,0.8941116844537789
WM793,46191454,1.3645728185603727
HT-1197,24978538,1.8199297990017311
NCI-H647,252682,6.931770577008143
HT-1197,sirolimus-bortezomib (250-1 mol-mol),0.4279936775188873
WM793,135875424,3.1604105075223656
AML-193,46943432,2.338266793436764
AML-193,1317464,3.179425282236744
SUP-T1,16720766,-1.85190851355508
IGR-37,17755052,2.5070233938370428
IGR-37,5351362,1.511381732390236
BT 232,24951314,1.6823732013014463
MSTO-211H,135999136,4.2061059176098645
A3/Kawakami,9911463,3.9596615304001745
YH-13,375860,-0.5335760796053879
MSTO-211H,decitabine-navitoclax (2-1 mol-mol),0.593652289859318
SK-MEL-3,docetaxel-tanespimycin (2-1 mol-mol),3.087381810921054
KMS-26,9935249,-0.1717529790774238
WM793,73707438,4.408840784597168
PC-14,selumetinib-tretinoin (2-1 mol-mol),2.1541105166477017
PC-14,54618164,4.181975842638425
IGR-37,9935249,3.174032242283855
PK-59,135398516,1.9141148521256752
WM793,1641662,4.965953189176842
MG-63,71466578,4.43651141358513
WM793,4378219,1.9547593472491875
IGR-37,24951314,0.7145127859402508
NCI-N87,135421197,1.227136310912881
PC-14,1566236,4.058624946663528
NCI-H2081,carboplatin-etoposide (40-17 mol-mol),0.0768376373319903
PK-59,322968,2.6897513308784897
HGC-27,UNC0638-navitoclax (1-1 mol-mol),1.547939825071545
BT 232,89928392,1.5683300085165914
HOP-92,56646779,5.520075404764103
RCH-ACV,44589607,0.9135703886502088
YH-13,15983966,-4.17863717198839
NCI-H647,5287969,-1.9906765554720924
SIG-M5,71466380,4.544695432831537
TCCSUP,9967941,4.9073920600623415
SW1116,9935249,3.7478471232466464
NCI-N87,24951314,0.3588892807295563
KMS-26,23635314,-3.482236264568454
HDLM-2,52912189,1.315897071482906
MFE-319,3025944,4.644788284018735
AML-193,135398516,3.000673973572677
KU-19-19,49766530,0.1366302187334878
HuH-28,104842,-0.6881359844846967
RPMI-8402,JQ-1-carboplatin (1-1 mol-mol),0.3952055511625851
KHM-1B,24748573,1.6722296150954905
RCM-1 [Human rectal adenocarcinoma],25150857,2.2320644525888165
HARA [Human squamous cell lung carcinoma],11167602,3.2969276962649823
MSTO-211H,1750826,-4.930051018535606
SNU-719,6852167,2.8569668843128606
BT 232,24889392,3.7933398293430254
BT 239,46215462,1.5475932135035362
BT 228,9915743,2.3964891014052943
JeKo-1,navitoclax-sorafenib (1-1 mol-mol),1.5972083575781015
JeKo-1,11977753,-1.1197339549499636
KHM-1B,piperlongumine-MST-312 (1-1 mol-mol),1.4082068245453034
HT-1197,135421197,1.673772932436652
NCI-N87,3062316,-1.4174361948917271
HARA [Human squamous cell lung carcinoma],119182,-1.5549760643936197
BT 245,56963564,-0.2019842219541239
MG-63,135398738,4.6260909267672545
KMS-26,25062766,1.0863805707314511
NCI-H2009,9936388,-6.076047204085024
RKO,10184653,1.6814092199651305
P31/FUJ,11364421,-5.080526011220062
SK-BR-3,100016,6.79119351825136
L3.3,5329102,3.0035184311097245
MSTO-211H,9887053,4.1066593545259975
BT 428,3465537,1.041948856740563
HCC2108,9911463,3.889332679655138
RKO,135411,0.3039750611139232
BT 428,46191454,1.6030530915907617
PC-14,6918736,-5.3643030965094916
NCI-H647,6914657,-0.8573472602617072
AML-193,4477,0.1375354317213811
NCI-H647,decitabine-navitoclax (2-1 mol-mol),3.881260595389265
KALS-1,3384730,3.3264517718954627
HARA [Human squamous cell lung carcinoma],6450551,1.1333007709837388
NCI-H716,15547703,3.9357810979745422
A3/Kawakami,selumetinib-JQ-1 (4-1 mol-mol),2.7324114698986373
RCH-ACV,135421197,1.024054023197644
RCH-ACV,5329102,1.5365499259852136
SK-BR-3,5291,3.3765501502720157
WM793,9926054,1.9861694749243135
PK-59,24964624,2.722226232789244
VMRC-LCD,navitoclax-PLX-4032 (1-1 mol-mol),2.307017636614785
BT 239,448949,2.1129339424512175
RPMI-8402,1716436,3.3778333955163284
Capan-1,1641662,4.809133343169436
EoL-1,9915743,-0.0181598036434267
JeKo-1,19582717,3.441193169890261
AML-193,54613361,-0.4803630253243746
AU565,11497983,3.5183187315924185
EoL-1,23725625,1.8106923047526249
BT 239,1242560,3.379261156215957
BT 245,53495165,1.770570777726093
SW1116,44493952,3.6651965103953175
VMRC-LCD,5311281,1.0192565922238286
YH-13,126941,-0.9334172609353208
NCI-H647,54678924,2.5854930535524394
NCI-H647,5287620,-2.9365750083301063
NCI-H1092,3136844,4.087353218769457
KMS-26,11427553,-0.058821826829403
MFE-319,6852167,3.5625471714915395
SK-UT-1,2746,4.836098417840603
BT 228,446155,4.612099896055269
IGR-37,36314,-4.334390230912805
RCH-ACV,24771867,-2.4514427268817633
A3/Kawakami,46398810,2.3914642091963456
IGR-37,9956119,4.114764792241119
RCC10RGB,11152667,2.8531679730856268
P31/FUJ,123631,2.0303759233077017
SIG-M5,9956119,4.103039233363436
NCI-H2081,60700,-2.8603020139497115
YH-13,tanespimycin-gemcitabine (1-1 mol-mol),0.5639208789602934
HuH-28,25154868,4.662583347378461
MG-63,151289,0.9705584187460594
VMRC-LCD,JQ-1-carboplatin (1-1 mol-mol),0.5789512547654533
KMH-2,tanespimycin-gemcitabine (1-1 mol-mol),-3.4451248256703804
HDLM-2,89183176,-2.4026111296813477
SUP-T1,JQ-1-vorinostat (2-1 mol-mol),-1.0472201111711672
JeKo-1,216468,0.7479024152000964
SK-MEL-3,65064,5.4011922941418495
KU-19-19,25154868,3.204596310046931
KYSE-450,984333,1.1711925405074113
NCI-H716,9903786,1.532038090064473
BT 239,salermide-PLX-4032 (12-1 mol-mol),2.982081519404469
SK-BR-3,637858,1.5595701631801446
HARA [Human squamous cell lung carcinoma],374536,3.8012573814376567
HGC-27,11612883,1.2359774951095532
HOP-92,5282054,3.916188015322539
NCI-H647,selumetinib-MK-2206 (8-1 mol-mol),2.242570344080375
TCCSUP,2733526,3.083222005706137
HDLM-2,selumetinib-navitoclax (8-1 mol-mol),0.3039628896379399
JeKo-1,119607,4.967303874132693
HDLM-2,168313016,4.65822549892325
SIG-M5,23725625,4.870408177926442
RKO,219104,3.7756995047121658
SUP-T1,5329102,1.3322765109726755
SIG-M5,100016,4.056618507771364
KYSE-450,400769,-0.8881298454848809
KU-19-19,15547703,3.5460273004695364
AML-193,5278396,2.9245561571216196
MG-63,219104,4.134264294102115
MSTO-211H,3384730,2.0695323326007387
RCH-ACV,11213558,1.0109513836881232
NCI-H2081,11175137,1.6715050081020637
HDLM-2,2749,1.9573276574763951
HCC2108,124202324,2.908828368060783
KU-19-19,675434,4.307992798559183
AU565,54613361,-1.6068695222158444
RCM-1 [Human rectal adenocarcinoma],135440466,3.6704227989419738
SNU-719,11625818,5.737122780406627
KMS-26,11626560,0.0549124018646417
KMS-26,26596,-2.3246210028506873
MSTO-211H,24180719,1.9210037149309027
BT 239,60700,-0.5073036589056295
HOP-92,1242560,3.98657504082168
RCM-1 [Human rectal adenocarcinoma],135398744,7.791771320405332
SK-N-SH,navitoclax-sorafenib (1-1 mol-mol),1.0288057709992513
AU565,71466380,5.723316888337632
HuH-28,119607,5.603083900835767
EHEB,3503,1.3671280774661785
HOP-92,71680916,5.526188197986636
L3.3,2749,2.0470310524130717
KMS-26,53232,3.3930915714304577
PC-14,16065773,3.2165423601217347
RKO,54626689,4.750442055573677
AU565,613753,3.214352381260741
RCM-1 [Human rectal adenocarcinoma],11178236,-3.001745406812045
KALS-1,654092,0.1045779137887777
TCCSUP,439501,-2.3382973857263893
RCM-1 [Human rectal adenocarcinoma],327653,3.480028492466642
SCC-25,54626689,4.612651839692497
SK-N-SH,42642645,-0.6199182133596995
NCI-H2009,12003241,-1.6852069192913937
A3/Kawakami,decitabine-carboplatin (1-1 mol-mol),1.864964422326281
MG-63,15547703,2.879120204738136
RCM-1 [Human rectal adenocarcinoma],selumetinib-GDC-0941 (4-1 mol-mol),1.7782951057156742
L3.3,11964036,1.0452508880612652
YH-13,6918328,0.5686815123232866
HCC2108,SNX-2112-bortezomib (250-1 mol-mol),-2.1987674626028504
Capan-1,9884685,3.5003951132484485
NCI-H1092,613753,3.151391695683802
KALS-1,5329102,2.761943975213235
BT 428,73707398,0.9802493689904498
HT-1197,219104,4.311140788775573
KALS-1,BRD-K27188169-navitoclax (2-1 mol-mol),4.937746414126266
RKO,8515,4.32265921632429
SW1116,25183872,-0.1808563202107506
EoL-1,2708,0.6953704238210308
SUP-T1,11427553,2.31456667703879
KMS-26,3081361,2.5646516179753545
HDLM-2,89928392,0.7872080035594586
SK-BR-3,1641662,3.2963182884524778
SK-N-SH,3689413,0.7530548018951405
MFE-319,15547703,3.130793233833384
BT 228,3552672,1.2630801487298666
EoL-1,11625818,1.758116835053105
P31/FUJ,12003241,-0.93015536828776
BT 428,2828334,6.125929922668278
AU565,9952709,2.716124716701941
L3.3,5280436,4.8128342001361
EHEB,2858523,2.936982583884496
KHM-1B,6918837,-4.542516260541086
IGR-37,135440466,3.766189975364203
KHM-1B,tretinoin-carboplatin (2-1 mol-mol),2.496287811338483
BT 232,piperlongumine-MST-312 (1-1 mol-mol),1.4738938592781703
KMH-2,5281672,4.5141329255176705
RPMI-8402,selumetinib-navitoclax (8-1 mol-mol),2.238274557878357
SCC-25,107985,-3.48065127857335
EoL-1,9927531,2.893857253769426
MSTO-211H,17755052,-0.0733710656781619
YH-13,72376,-1.189178232069283
HGC-27,11152667,-1.849804730861495
VMRC-LCD,3503,1.5851884542661854
BT 228,selumetinib-BRD-A02303741 (4-1 mol-mol),4.292405714154379
JeKo-1,285033,-3.850688854029935
NCI-H716,25150857,1.708576042211123
EoL-1,676352,1.0525657969774709
BT 245,docetaxel-tanespimycin (2-1 mol-mol),-4.12456817717388
NCI-H2009,4917,2.9963488408029417
BT 228,24951314,0.3714746431740328
NCI-H1092,119607,5.038336546670844
SK-BR-3,1750826,-1.6067834424518297
JeKo-1,navitoclax-piperlongumine (1-1 mol-mol),0.7628404595849142
IGR-37,57519531,1.813310112991223
RCC10RGB,16725315,5.2458056955252275
AU565,17755052,-0.9729531204394496
HDLM-2,53232,3.2037523208701923
KALS-1,16219061,3.46560225430573
RCC10RGB,5328940,2.5920229504771264
Capan-1,JQ-1-UNC0638 (2-1 mol-mol),1.5938386873588442
EHEB,46174525,4.557834321859672
A3/Kawakami,9926054,1.6582602288279693
P31/FUJ,5460769,2.718083541162644
BT 232,4378219,2.0204698564843144
RKO,11485656,2.16906736756012
BT 245,46199207,1.6379088450164898
A3/Kawakami,10385095,0.4168450235753773
IGR-37,11167602,3.226073746517762
BT 232,327653,3.71280727706233
P31/FUJ,327653,2.543614095842417
SK-N-SH,54619267,3.9533755270306057
A3/Kawakami,24772860,-2.350052977986592
PC-14,selumetinib-piperlongumine (8-1 mol-mol),1.8405265821093273
NCI-H2081,sirolimus-bortezomib (250-1 mol-mol),-0.0413699313219798
KU-19-19,984333,-0.867877464903324
SIG-M5,selumetinib-vorinostat (8-1 mol-mol),-2.7749557072637083
KYSE-450,16725315,5.267357391878718
RCM-1 [Human rectal adenocarcinoma],4259181,1.1322876173551923
BT 239,446155,2.152747373555208
KMS-26,54649381,3.671421086556771
KMS-26,2113511,4.190409325052745
NCI-H2081,JQ-1-vorinostat (2-1 mol-mol),-0.2017741262953333
AU565,24775005,3.4802015368768657
KHM-1B,439501,-2.4289183886287535
SK-BR-3,5746,0.2327149935540588
NCI-H647,53481919,3.775228565550845
NCI-H716,1750826,0.25074394184893
RCH-ACV,11612883,1.4790951298575077
SK-BR-3,151289,1.0234996498381732
NCI-N87,navitoclax-pluripotin (1-1 mol-mol),-2.6023370603895337
NCI-N87,16736978,0.698711777805788
RKO,168313047,1.9322709085928884
JeKo-1,5287620,-0.0566730354938802
A3/Kawakami,445455,4.210728673353376
BT 239,216468,0.373469841577625
VMRC-LCD,107970,1.7842693363117308
BT 245,46215462,2.00474421855526
AML-193,navitoclax-birinapant (1-1 mol-mol),0.1150610270387614
A3/Kawakami,54454,2.196312302036638
EoL-1,4378219,2.030770464720386
JeKo-1,67291369,1.93331359788465
P31/FUJ,451668,0.4769801026955246
SNU-175,25126798,4.645876506465722
BT 239,44632017,2.559873862643969
NCI-H1092,3025986,-1.5280995504056256
NCI-H716,doxorubicin-navitoclax (2-1 mol-mol),0.9573757354027148
SUP-T1,17755052,0.5232369217733562
JeKo-1,89183176,6.440844900352252
KHM-1B,168313047,1.841337582388115
BT 428,2130404,2.4494899082687107
SIG-M5,8515,3.548062021757778
JeKo-1,25227462,-3.024359305905017
HDLM-2,10410894,4.921936886040524
RCM-1 [Human rectal adenocarcinoma],ISOX-bortezomib (250-1 mol-mol),0.2714695446270951
L3.3,10074640,3.5317966219825414
MG-63,1750826,-3.1937778393180523
KMH-2,73707440,5.915660341573708
BT 245,168313016,5.350977355116985
VMRC-LCD,23635314,-4.049801414912602
SUP-T1,57519531,1.1981891729424616
PC-14,25154868,4.52292180363284
TCCSUP,54626689,3.911629715273472
HGC-27,9929138,5.812966492872734
BT 228,374536,3.476556320735245
IGR-37,123631,2.0124697823900775
NCI-N87,439501,-2.2970478950560715
BT 228,44137675,3.298381522244784
HuH-28,navitoclax-MST-312 (1-1 mol-mol),-0.1080942167492178
A3/Kawakami,5335621,4.32532592547598
EoL-1,9967941,3.055789646436793
SIG-M5,9967941,3.831300861609763
KMS-26,JQ-1-vorinostat (2-1 mol-mol),-2.231162544488762
VMRC-LCD,JQ-1-navitoclax (2-1 mol-mol),-0.0146619487752862
NCI-H647,9911830,1.9312757537429064
BT 232,11497983,4.4035556509565215
IGR-37,navitoclax-birinapant (1-1 mol-mol),3.145155772518161
SW1116,6918289,3.06657670162102
NCI-H2009,25150857,2.992056775880064
BT 428,11167602,1.02406203093047
MFE-319,6914657,-4.417023871818982
VMRC-LCD,54613361,-0.2637227377344819
KALS-1,124202324,3.1877976113100437
PK-59,3543504,4.224524740043423
A3/Kawakami,216239,1.1539135628170505
HGC-27,selumetinib-tretinoin (2-1 mol-mol),3.301164466300265
HGC-27,72376,-2.7974657667666025
BT 239,24180125,1.280593014526314
Capan-1,tretinoin-carboplatin (2-1 mol-mol),5.059400001995013
MG-63,262093,3.0447141305088614
HuH-28,969516,2.255146002004764
SUP-T1,12003241,-2.125139255884817
EoL-1,24180719,0.9933546408071084
PC-14,4917,3.2092171400843457
SK-N-SH,44137675,2.5276726665822755
YH-13,11238147,2.49094347137922
L3.3,navitoclax-piperlongumine (1-1 mol-mol),3.3771859534422703
SK-UT-1,675434,4.504318177888332
HARA [Human squamous cell lung carcinoma],73707398,1.6371281450925783
SUP-T1,19582717,3.368697909890742
SNU-719,carboplatin-UNC0638 (2-1 mol-mol),3.3412545457886704
WM793,16741245,6.304850832164104
KYSE-180,17755052,1.875580831960164
KALS-1,25262965,-1.170595967843296
BT 239,erlotinib-PLX-4032 (2-1 mol-mol),2.8986711150464823
PC-14,31703,0.324790882634775
NCI-H647,10184653,2.3859694349558276
BT 239,11167602,1.6889728447058876
SK-MEL-3,19582717,4.28440303170222
IGR-37,11238147,5.569600501904409
MFE-319,11707110,5.473530510469355
HOP-92,JQ-1-carboplatin (1-1 mol-mol),4.25217637860204
BT 245,2746,2.160904338087323
BT 245,702558,4.805694350249343
KU-19-19,89183176,4.239044338938638
JeKo-1,54678924,1.671886291946033
HDLM-2,46943432,3.238903302333344
KYSE-180,375860,-0.0718407094344544
Capan-1,2746,3.367877422922766
HDLM-2,676352,2.0763679144777796
KU-19-19,JQ-1-vorinostat (2-1 mol-mol),1.2174768050309406
KYSE-180,16725315,4.4704171730121685
EoL-1,3825829,1.62057734053031
KALS-1,5351362,2.27558684008222
EHEB,2708,3.688555693681277
SCC-25,3385,5.426909393506688
RCH-ACV,67156097,-3.137118727178939
RCC10RGB,53481919,4.9196370953200805
SK-BR-3,46199207,3.3994095066962675
BT 232,11507802,3.062511258936667
BT 428,6450551,2.056715014092832
MG-63,439501,-2.9607530024491515
HDLM-2,54618164,3.4787631819448546
NCI-H2081,26596,-1.5856459484869678
VMRC-LCD,2746,2.492181384222375
HuH-28,9825149,2.3386221719548397
Capan-1,serdemetan-SCH-529074 (1-1 mol-mol),2.991803266147705
SK-UT-1,969516,2.241121714943991
Capan-1,11404337,1.6610188182670238
KHM-1B,25105715,2.694355871197866
HDLM-2,carboplatin-UNC0638 (2-1 mol-mol),2.981718433479172
BT 245,JQ-1-UNC0638 (2-1 mol-mol),5.423120004675633
AU565,375860,-0.7785666069738753
SIG-M5,11625818,4.306506371914501
VMRC-LCD,vorinostat-navitoclax (4-1 mol-mol),2.5565882526341057
TCCSUP,9935249,4.183000192911627
NCI-N87,3038522,3.5877635056945443
RPMI-8402,54143018,-0.8767012836092296
BT 428,46907787,0.0171893573997719
HCC2108,409805,5.256429084033282
BT 228,208908,1.6519103648692006
TCCSUP,637858,2.4470905671949996
WM793,654092,0.4910491362613845
HARA [Human squamous cell lung carcinoma],5746,1.191361240850758
KMH-2,135875424,3.335950960073661
KMH-2,selumetinib-UNC0638 (4-1 mol-mol),4.467214050459532
SK-UT-1,2749,1.8360529754995716
BT 232,24797083,1.041859358730135
RKO,6917907,-7.36544436443182
NCI-H2009,24856436,-1.037334288977755
KMS-26,24964624,-4.461878241855993
SNU-719,322968,3.725522650212231
BT 228,71729975,1.921164195711999
P31/FUJ,51039095,1.7212337572708742
RCC10RGB,241158,4.984223152954295
RCH-ACV,10113978,2.609375858514996
NCI-H2009,11404337,-0.0657811746758558
PC-14,4261,1.859443898930513
PK-59,44202524,4.081343809973839
NCI-H2081,46191454,1.7931363741805633
SK-BR-3,navitoclax-sorafenib (1-1 mol-mol),2.450380590059646
NCI-H2081,9887053,1.079075391336974
NCI-H716,4578,4.668363836641999
KYSE-180,387447,-4.108861459218713
IGR-37,10302451,3.8582187124778256
SK-BR-3,3101542,4.292427448411567
RPMI-8402,9868037,1.5465007663482742
NCI-H716,53232,2.1281021642014437
TCCSUP,2130404,3.221967733361771
HARA [Human squamous cell lung carcinoma],66577038,3.5726698245106445
SK-BR-3,10410894,3.0955237101745445
HARA [Human squamous cell lung carcinoma],11640390,3.0925981241806983
BEN,44202524,4.300737820819526
RPMI-8402,216345,3.176671948823498
AML-193,262093,1.541807961893536
SCC-25,68056272,3.7015200607504446
NCI-N87,54619267,3.778794485594146
MG-63,11964036,1.943248756586925
KHM-1B,16720766,-1.5556975858527622
KALS-1,54454,2.314132157350722
SK-N-SH,53232,1.5091330407343964
SUP-T1,100016,6.229647258472745
NCI-H1092,6505803,2.777743929422052
A3/Kawakami,5280436,1.7210805623535548
P31/FUJ,168312962,2.530788243280419
SK-UT-1,2871966,0.4353806456595583
EoL-1,675434,1.673301471816525
A3/Kawakami,6914657,-6.395707750824663
BT 228,25161177,3.433935539189681
KMS-26,156414,1.0739071723028757
AML-193,9868037,1.69446413413849
VMRC-LCD,104842,-0.0870360697155012
RPMI-8402,15953870,2.1946861333823677
PC-14,navitoclax-MST-312 (1-1 mol-mol),1.8324518221045003
SIG-M5,46926350,-5.121747869995948
HGC-27,10172275,4.590962596650706
BT 245,65628,4.476006410833118
EHEB,54613361,-0.7006236829490292
MG-63,5329102,1.6253932373472244
MSTO-211H,216468,0.7149646325927866
PC-14,8515,3.8030363012759327
HCC2108,2945648,3.0780429998691723
KYSE-450,erlotinib-PLX-4032 (2-1 mol-mol),3.596980184500655
JeKo-1,2871966,-0.5835789523393456
KYSE-450,10302451,4.575458638647607
RCM-1 [Human rectal adenocarcinoma],60750,2.8463966167693515
IGR-37,16038120,1.619824179764783
MSTO-211H,44486219,3.5621328730435216
L3.3,107985,-3.199791523822717
HGC-27,44486219,4.410757901247062
KALS-1,46398810,3.061608821586189
SNU-719,6505803,-1.6348433064714072
KMH-2,54618771,-0.6611868525273566
MFE-319,387447,-4.92293484170829
L3.3,439501,-0.248470622878828
AML-193,serdemetan-SCH-529074 (1-1 mol-mol),1.6468874208689035
NCI-H647,11640390,3.602834735590729
HCC2108,71466578,4.729290805364659
SNU-175,11364421,-4.730433046290476
AU565,11955716,1.5670888997114951
P31/FUJ,44137675,3.225768708166513
SK-BR-3,11222830,1.8253872494242256
RCH-ACV,6505803,0.7886152170301014
BT 228,2871966,-0.1029193597799751
RCM-1 [Human rectal adenocarcinoma],16065773,2.083422102332506
RCH-ACV,119182,-5.121368128054022
NCI-H716,12001922,1.6497991543254995
L3.3,135398516,2.485669059846241
P31/FUJ,navitoclax-PLX-4032 (1-1 mol-mol),0.0164871875305551
HARA [Human squamous cell lung carcinoma],44507138,3.9193587835112
KYSE-180,638278,3.4681101119910243
KU-19-19,54649381,3.8760376098429616
MFE-319,54596490,4.465210230923051
YH-13,vorinostat-carboplatin (1-1 mol-mol),4.1657170851740855
SNU-719,638278,3.7896838555765218
EHEB,2842253,6.477039888159031
NCI-N87,9926054,1.7069639615174013
SCC-25,72199292,-0.3852861561995409
KHM-1B,11152667,-2.085888250346346
RCM-1 [Human rectal adenocarcinoma],72734382,4.304323658475911
PC-14,613000,2.367652889107365
JeKo-1,5738263,2.4985083139869384
EoL-1,448949,-2.374197223448301
TCCSUP,9887053,4.648275902812988
NCI-H647,docetaxel-tanespimycin (2-1 mol-mol),-4.352437472861145
VMRC-LCD,126941,-4.0604386327467346
NCI-H1092,46174525,3.656769194454104
NCI-H1092,60750,0.6504249492062534
SW1116,3025944,3.934159905684231
Capan-1,9933475,2.537889727522014
JeKo-1,7251185,1.6934226023675576
SK-N-SH,9907093,3.950065012938692
KYSE-450,3062316,2.5043987549881725
RCH-ACV,44491742,3.725167954137364
SK-N-SH,46926350,-4.468052842347633
IGR-37,4521392,4.307772441745139
SK-UT-1,409805,5.339094874610304
A3/Kawakami,42611257,3.0767463019009305
L3.3,60700,-1.0594098724228993
BT 228,45279963,3.724105034034012
KMH-2,9887053,3.2360475812117757
BT 428,crizotinib-PLX-4032 (2-1 mol-mol),2.150996451830826
MG-63,decitabine-navitoclax (2-1 mol-mol),1.6794562854005726
NCI-H647,71680916,6.446782409002931
BT 428,BRD-A02303741-carboplatin (1-1 mol-mol),4.259029320114088
A3/Kawakami,72376,-2.5576148833189603
IGR-37,119182,-1.465318138350499
RCC10RGB,3503,3.522457107356278
RPMI-8402,176870,2.4688755128832383
PK-59,5278396,3.6603402814377946
NCI-H1092,25227462,1.0244248968881735
MFE-319,11178236,-5.82140521594727
P31/FUJ,46224516,2.421293495972869
NCI-H1092,3384730,3.333041277553113
HDLM-2,439501,-2.3355243460723747
SIG-M5,9826308,0.5278830677083878
HGC-27,53481919,3.349273092580209
A3/Kawakami,52912189,0.3462582049765401
KYSE-180,72193861,-0.0777927374537977
KHM-1B,2729026,0.9110795955585352
NCI-H2009,selumetinib-PLX-4032 (8-1 mol-mol),-1.4525193887521055
RCH-ACV,9866186,-0.0400126179592222
NCI-H1092,3503,1.0568837915666558
BT 228,11427553,3.065678899484807
HCC2108,60700,1.0851578183191786
AML-193,67291369,0.7694835614886573
SCC-25,4259181,-0.0888101612247617
KYSE-450,selumetinib-GDC-0941 (4-1 mol-mol),2.546868719199844
Capan-1,navitoclax-MST-312 (1-1 mol-mol),2.4568460898668913
AU565,9911463,3.1332064122278687
SK-MEL-3,241158,4.338095980194072
MSTO-211H,159324,-0.971759723426381
HGC-27,5311,0.7189989392650425
KMS-26,11455910,-0.0860099305648322
SK-N-SH,5311,0.9912749099663326
PC-14,erlotinib-PLX-4032 (2-1 mol-mol),-4.924011614622907
SUP-T1,4259181,-1.9215317609188305
SK-N-SH,tretinoin-carboplatin (2-1 mol-mol),4.592869766463431
SNU-719,docetaxel-tanespimycin (2-1 mol-mol),-1.1249390176501144
P31/FUJ,9926054,1.2698752833949425
SK-MEL-3,crizotinib-PLX-4032 (2-1 mol-mol),1.0585155661015655
A3/Kawakami,2746,0.9859280265710952
SK-UT-1,135999136,1.6451873526214251
RKO,4477,1.7070595719756474
BT 228,25150857,2.362509731941179
YH-13,72193861,0.945446843514748
SK-UT-1,44566777,0.4643066266972094
NCI-H647,3854666,2.4207197319409595
NCI-H2081,104842,-6.196868817242243
BT 239,46224516,2.359050145736268
HCC2108,107970,2.525568270617478
HOP-92,16038120,0.7164913968646823
HDLM-2,2828334,6.018648374275636
BT 228,49766530,0.5150432807946567
RPMI-8402,89183176,1.9377457505162872
KALS-1,10385095,1.3956260866944918
PK-59,262093,2.249881918634125
TCCSUP,421610,3.586976807709893
P31/FUJ,10385095,1.5135865779060806
HCC2108,54649381,3.8131747738004567
SIG-M5,54618305,4.363479672443714
EHEB,BRD-K27188169-navitoclax (2-1 mol-mol),5.0776573503309
A3/Kawakami,637858,1.0589616094349
SK-UT-1,selumetinib-piperlongumine (8-1 mol-mol),4.6362910530737595
NCI-H647,2729026,2.9713708744926803
MFE-319,285033,-1.8989232633755315
RCH-ACV,1716436,1.9567773925658896
SIG-M5,16741245,5.564628971648148
SK-MEL-3,10322450,3.9048135305000624
BT 232,5282054,4.714824882485455
KHM-1B,54618164,3.3281109403552795
RCM-1 [Human rectal adenocarcinoma],285033,0.1322577754861078
BT 239,44589607,1.739463764491551
KYSE-180,54618164,4.682866725736199
MSTO-211H,3552672,1.7334798735784387
KYSE-180,11626560,2.00053897353166
SIG-M5,1750826,-1.6924690728092435
AML-193,49766530,-0.6507980760292754
RCH-ACV,decitabine-carboplatin (1-1 mol-mol),3.1610378116020854
SIG-M5,9825149,1.953695727895555
RKO,salermide-PLX-4032 (12-1 mol-mol),6.251314610722333
NCI-H716,24180719,3.6005359501897525
AML-193,SNX-2112-bortezomib (250-1 mol-mol),-3.0726325338401503
HT-1197,445455,4.815511967534601
HGC-27,126941,-4.982174234626522
JeKo-1,selumetinib-JQ-1 (4-1 mol-mol),2.6629730147631587
EHEB,16038120,1.550937492892113
SK-BR-3,vorinostat-carboplatin (1-1 mol-mol),2.1927782746258577
RCH-ACV,11683005,2.7981531931788277
BT 228,docetaxel-tanespimycin (2-1 mol-mol),-0.0316557876309974
HOP-92,5284616,3.0760567725389727
VMRC-LCD,119607,5.04057570274335
P31/FUJ,104842,-4.465734156959207
AU565,6852167,0.824199435407992
IGR-37,5329102,1.9437134079660432
KYSE-450,46191454,2.021198534281789
BT 239,6438330,0.219136862477755
KU-19-19,ISOX-bortezomib (250-1 mol-mol),0.6477518582997711
YH-13,24951314,1.6254044283291555
NCI-H1092,44819697,-2.585083012775511
JeKo-1,11214940,1.5397836751075806
WM793,16038120,2.08609917753077
JeKo-1,168312962,1.028298648403931
BT 232,selumetinib-GDC-0941 (4-1 mol-mol),2.347635090849183
SK-BR-3,135411,0.1528289927830416
KMS-26,tretinoin-carboplatin (2-1 mol-mol),3.714299497044214
RPMI-8402,16741245,1.988119956224939
P31/FUJ,1641662,2.802136916275355
SK-N-SH,16725315,3.0870632348262497
Capan-1,56973724,4.3375979566881835
HuH-28,11427553,3.111566005238653
RKO,5460769,5.660789679983863
NCI-H1092,11497983,4.878334634479546
BT 239,24772860,-4.125311176298904
HOP-92,107985,-1.5945194541124064
L3.3,4788,5.85214112282752
SK-N-SH,24180719,3.49542412809488
AU565,4477,0.8975719043136093
HDLM-2,11507802,0.7219877164779799
NCI-H647,24775005,3.41824672825448
SNU-175,11626560,0.665048558830993
BT 245,25154868,4.682351390968789
EHEB,navitoclax-gemcitabine (1-1 mol-mol),-3.439930210813986
RCC10RGB,16038120,1.536821218292656
TCCSUP,navitoclax-MST-312 (1-1 mol-mol),1.0715632013876748
EoL-1,216239,-7.4826260252697825
NCI-H2081,3634881,3.1906450882675785
SK-BR-3,387447,-4.932591348822772
HCC2108,selumetinib-BRD-A02303741 (4-1 mol-mol),4.391486059277941
EoL-1,25150857,0.7231861789483869
SNU-719,JQ-1-UNC0638 (2-1 mol-mol),0.5787915675611492
HOP-92,selumetinib-PLX-4032 (8-1 mol-mol),2.410986006510257
AML-193,71751553,5.520545246875898
EoL-1,451668,-6.640908733285203
VMRC-LCD,451668,6.475724661835272
SK-UT-1,4096211,5.814618826658096
HGC-27,6918328,-0.8147451931060361
NCI-H647,12003241,-2.504495302724225
BT 228,16725315,3.24446920532856
HT-1197,400769,-0.945008312677684
KU-19-19,5281321,2.871465791170073
SK-N-SH,9911463,3.4426003417788618
HT-1197,73707371,6.232305901693353
SK-BR-3,135984461,4.752422329058812
A3/Kawakami,docetaxel-tanespimycin (2-1 mol-mol),-5.028846574806349
A3/Kawakami,1242560,3.3032546651988195
WM793,148198,-1.495249919530428
SNU-719,54454,2.086196095603944
EoL-1,11455910,-0.8638634709362212
RPMI-8402,24901704,1.3659381740088026
HGC-27,53301938,4.69104002952718
PK-59,216468,4.7266352471722
HARA [Human squamous cell lung carcinoma],439501,-2.358364257130844
NCI-H647,11626560,1.6587458756955542
HOP-92,navitoclax-PLX-4032 (1-1 mol-mol),0.2993987099690204
RCC10RGB,24180125,2.398663234613943
RCH-ACV,9840324,5.609030309515197
HOP-92,6918837,-3.32383211584293
SCC-25,decitabine-navitoclax (2-1 mol-mol),2.459269524095225
TCCSUP,984333,0.6886079351975192
SNU-175,2841722,5.618896469658908
NCI-N87,navitoclax-gemcitabine (1-1 mol-mol),-3.6490042770502815
HCC2108,25150857,2.994087068367986
BT 228,24753719,4.472096298736932
SK-BR-3,10184653,-4.909807603523273
NCI-H1092,72193861,1.411805795615286
KHM-1B,JQ-1-MK-0752 (1-1 mol-mol),-0.8214903492404299
KYSE-450,135411,0.9240917820052414
KALS-1,9840324,5.924862965423185
NCI-N87,17755052,-1.4521000328048816
MSTO-211H,71466445,2.2675767772231024
L3.3,10127622,6.808802938866309
NCI-H647,448949,1.2144556091467966
JeKo-1,119182,-4.449528276664472
P31/FUJ,445643,6.117258311867223
MG-63,25183872,-2.3178370691776187
HT-1197,16720766,3.5424615516938087
NCI-H647,135411,0.7702839137009989
P31/FUJ,54618771,-0.1557090961755644
RCC10RGB,613753,3.3201179844199498
SCC-25,25154868,4.350879067717356
PC-14,5281672,4.958845757843883
BT 228,24901704,3.2319759926678286
YH-13,3854666,0.9588236597385832
HuH-28,selumetinib-navitoclax (8-1 mol-mol),1.842179710870695
EoL-1,selumetinib-tretinoin (2-1 mol-mol),-3.6866934131601834
NCI-H647,9825149,2.3078820997590106
HARA [Human squamous cell lung carcinoma],387447,-4.146769649621688
MG-63,tretinoin-navitoclax (4-1 mol-mol),3.8106723853015176
KMH-2,71466578,4.074256853134251
SK-MEL-3,1242560,3.546477521803808
HGC-27,16013152,3.670809937068983
KALS-1,11964036,1.6157169400879243
AU565,navitoclax-piperlongumine (1-1 mol-mol),2.020927074963466
KU-19-19,57330099,3.159149106170822
EHEB,56946209,-4.4781864641183065
NCI-N87,19582717,3.5520999296373437
KMS-26,445643,4.2315222240477866
AU565,49793307,-1.974878634968376
RCM-1 [Human rectal adenocarcinoma],15983966,2.238460019878405
AML-193,89183176,3.75236773519048
IGR-37,6438330,3.1654073186680582
KMS-26,5566,2.4336069197587964
SNU-719,135411,-1.2607769967563354
A3/Kawakami,16736978,1.6189748533093355
PC-14,52947716,0.2660247014884829
NCI-H716,6914657,-6.42785745639151
JeKo-1,9933475,1.7403534804957494
NCI-H716,5328940,1.1614742246166732
BT 228,2828334,5.776186713606707
P31/FUJ,JQ-1-MK-0752 (1-1 mol-mol),-0.1535880671922636
KALS-1,135411,2.3952428324891355
SK-UT-1,9911463,4.1504947350424315
SUP-T1,11222830,1.5723837206607187
KMS-26,15547703,2.290089957160927
HGC-27,25150857,2.3848718038458117
HT-1197,53392493,1.9062696012041345
RCH-ACV,56963564,-0.3237825420674778
TCCSUP,3815108,3.0276070568390208
BT 239,6918638,2.260003296695808
YH-13,56963564,0.220500691161984
SNU-719,ISOX-bortezomib (250-1 mol-mol),0.7766171078990037
HT-1197,10302451,4.026289624888813
NCI-H2081,10302451,3.961972444166296
HDLM-2,3136844,3.1177830786590963
NCI-H2009,54454,1.843451372115344
JeKo-1,135984461,1.9350471702678365
HGC-27,6918638,0.210335220598235
RKO,71680916,5.910552922648844
BT 428,56946209,-4.380761985239821
KMH-2,72193861,-0.7870275994854161
NCI-H716,54454,3.3840628673390953
JeKo-1,4788,4.713232147281265
NCI-H1092,11964036,2.0347322907537624
KHM-1B,374536,2.314533071976094
NCI-H2009,11964036,0.3874991337590915
SCC-25,15547703,1.3599175574634892
YH-13,5284373,3.689481808678744
NCI-H647,25161177,5.327980006876861
TCCSUP,11238147,3.457873265179278
YH-13,25227462,0.7870312069105344
PC-14,decitabine-navitoclax (2-1 mol-mol),2.50877904816453
HGC-27,16659841,1.9997132479437252
Capan-1,3689413,0.3362458713829924
KU-19-19,52947716,-4.518413756843173
BEN,676352,3.2591263687627867
KYSE-450,3025944,4.332360551153181
YH-13,66577038,3.5409561648626293
RCH-ACV,44489675,3.705138592538492
IGR-37,10410894,4.1898618031778945
A3/Kawakami,54618164,3.8685963187989225
KMS-26,44489367,3.4322137837504254
EHEB,135875424,3.250653126047009
AML-193,119607,5.5727284273071485
RCM-1 [Human rectal adenocarcinoma],104842,-3.5875650629821942
VMRC-LCD,6852167,3.4717019465216037
SW1116,55508,3.840658535629498
SK-BR-3,selumetinib-UNC0638 (4-1 mol-mol),4.789540606657087
RKO,6918736,-1.762610939534952
SUP-T1,16741245,2.0071311375682437
A3/Kawakami,123631,1.64512172177268
PC-14,36314,-5.605050726088523
RCC10RGB,25102847,4.4790627708666255
HOP-92,25195348,4.202024281849463
KHM-1B,9866186,-0.1943937509034402
IGR-37,11364421,-5.80741504288342
L3.3,selumetinib-BRD-A02303741 (4-1 mol-mol),5.501199697080603
NCI-H716,51039095,-8.020181652688297
MFE-319,135440466,3.252340481014915
NCI-H716,53392493,2.953514620209901
NCI-H2081,46398810,2.7782565224728537
HDLM-2,46199207,2.8746059660644327
RCM-1 [Human rectal adenocarcinoma],44202524,4.374181896011121
KALS-1,68056272,4.357341927533155
BT 428,44185566,2.1375030535677433
BT 245,25183872,-1.3096475816145912
SK-N-SH,selumetinib-PLX-4032 (8-1 mol-mol),4.078111990009601
BT 428,tanespimycin-bortezomib (250-1 mol-mol),-1.9102610894463772
Capan-1,10184653,1.6573924093315286
SW1116,54626689,4.825596947242399
MSTO-211H,322968,3.0218271531726897
NCI-H2081,24785538,-0.1890476398389944
SK-UT-1,52912189,5.034004666881923
BT 239,crizotinib-PLX-4032 (2-1 mol-mol),1.7559693206037308
HGC-27,55508,1.8763433083568737
SK-UT-1,16722836,2.949695748270546
YH-13,5746,2.3705459380305256
BT 245,3503,1.1172167951544103
SIG-M5,9884685,0.6191669126899408
JeKo-1,1242560,2.9546256321129056
SIG-M5,5479543,3.2722039727130365
P31/FUJ,17759555,3.626728737883383
BT 245,4378219,2.684006607069923
KHM-1B,3634881,2.028654365237279
RKO,3062316,2.656751778030552
HGC-27,44489675,3.5966291104673656
MSTO-211H,11396600,3.2938939565791765
HuH-28,159324,2.8746957838350062
HCC2108,3825829,4.6343664994608496
KHM-1B,25154868,3.944420162324233
BT 228,151289,4.971547661447798
BT 245,11977753,-0.2716819809439988
KMH-2,12003241,-0.520398442259763
HARA [Human squamous cell lung carcinoma],24889392,3.022552356394008
BT 239,54618305,4.325444578852527
AU565,vorinostat-carboplatin (1-1 mol-mol),2.4881642304307463
KU-19-19,3689413,0.155027117273248
PK-59,44607531,1.8440573981852608
L3.3,6918837,-1.6341527445290025
RKO,24901704,3.90150667551114
NCI-H2081,151289,0.7108361073513202
HARA [Human squamous cell lung carcinoma],5351362,1.123570314509272
BT 232,16219061,3.121575338458022
A3/Kawakami,5746,-1.2156059444803518
SK-N-SH,55283,2.9878549564409846
MSTO-211H,9823820,1.3460489687603958
HOP-92,52947716,2.95231006584695
MG-63,10302451,3.049772862204908
HGC-27,5282054,2.492505770547714
VMRC-LCD,54596558,4.3517189810436285
SIG-M5,JQ-1-carboplatin (1-1 mol-mol),-0.4990095627989978
EoL-1,3062316,-6.540028864571942
HGC-27,56946209,-5.02718428457476
SNU-719,11404337,-0.3522965671167558
TCCSUP,44486219,5.057674735399276
KHM-1B,3854666,1.0178761505547558
NCI-H2009,119182,-1.1305543955582442
MSTO-211H,11609586,2.648073114002603
MSTO-211H,969516,2.440842922513423
RCH-ACV,135659046,3.4161353826802783
SK-UT-1,11626560,3.0514544041221043
RPMI-8402,135398516,1.6004798008823695
RCH-ACV,2126,4.138322509592932
KU-19-19,5738263,3.812580710038467
BT 245,10385095,1.400283775793094
JeKo-1,23635314,-3.6453677141441423
SNU-719,JQ-1-navitoclax (2-1 mol-mol),-0.4173946561383798
PK-59,71304818,2.6517258875319705
SK-MEL-3,2828334,5.977089758388309
IGR-37,23582824,1.4790624204547929
AU565,107985,-3.572249289009051
NCI-H647,11494412,2.106693333692888
TCCSUP,11364421,-0.436162091200716
BT 228,11707110,0.5540640116703306
BT 239,53495165,-1.4103250246044294
KHM-1B,44487061,4.467153172059052
BT 245,erlotinib-PLX-4032 (2-1 mol-mol),2.709107671122578
TCCSUP,52912189,5.693268432248509
MSTO-211H,107985,-3.699787970340743
SCC-25,JQ-1-carboplatin (1-1 mol-mol),0.0141568039533375
HT-1197,44462760,3.7280290831632183
HT-1197,31703,-1.0150512302831176
HuH-28,5311281,2.1564252311254655
KYSE-180,44484440,3.483431565437074
EoL-1,5291,-6.830453064734297
NCI-H716,6852167,2.05149641213453
RCM-1 [Human rectal adenocarcinoma],6184667,3.2761425368749477
SIG-M5,decitabine-navitoclax (2-1 mol-mol),0.903712773300871
NCI-H2009,613753,3.3208706433892483
RPMI-8402,6610355,4.581793287787705
HOP-92,6505803,0.7885009521193799
YH-13,25183872,-1.6197416035202905
TCCSUP,24951314,0.5782862351023664
HOP-92,5281672,4.826611065464558
SUP-T1,3025944,3.3719044805838947
EHEB,9866186,-0.355142067370403
SIG-M5,selumetinib-piperlongumine (8-1 mol-mol),-3.93486473679908
KHM-1B,4915,4.394677312814559
KALS-1,36462,2.7301613620046803
P31/FUJ,26596,-2.2448149587984836
BT 428,1714884,3.3561714156544618
HGC-27,24748573,1.5512010883504337
HGC-27,46943432,3.3342404916831825
NCI-H716,71751553,4.800404342202104
SIG-M5,984333,0.9967609067617222
BT 232,10385095,0.8696563866685341
MG-63,5328940,2.124746793466627
BT 239,56946209,-5.687509778695374
MFE-319,675434,4.1612440549043255
BEN,5351362,3.088330971972641
Capan-1,5311,1.703180961402411
IGR-37,6852167,3.6803333790062767
SK-N-SH,1641662,2.765509802135897
SK-UT-1,sirolimus-bortezomib (250-1 mol-mol),0.646773190163625
VMRC-LCD,JQ-1-UNC0638 (2-1 mol-mol),0.2895932454224424
EoL-1,selumetinib-BRD-A02303741 (4-1 mol-mol),0.1812661618005848
NCI-H2009,51039095,1.8360035457780568
NCI-H2081,6918878,1.3213602453376416
MG-63,3062316,1.4650156099117444
SK-N-SH,25154868,5.167514533841029
BT 232,123631,2.735992532077416
RKO,10127622,3.209405126939437
PK-59,654092,-1.052424839232504
KHM-1B,5281321,-2.452020874471456
JeKo-1,alisertib-navitoclax (2-1 mol-mol),-3.8748420442841858
NCI-N87,docetaxel-tanespimycin (2-1 mol-mol),-6.128008635109833
BT 232,49766530,1.9852556236627383
PK-59,327653,2.872249707318676
JeKo-1,6450551,1.453437977029318
BT 428,4917,2.014701262119917
HT-1197,5287969,-1.9899516824359431
SUP-T1,11485656,1.1772627696716973
HGC-27,3038522,2.2499297000457124
KALS-1,10231331,5.286218838371379
NCI-H1092,16013152,3.726585488555384
SNU-719,selumetinib-MK-2206 (8-1 mol-mol),-0.6039713024020268
A3/Kawakami,navitoclax-pluripotin (1-1 mol-mol),0.7648785571765147
JeKo-1,docetaxel-tanespimycin (2-1 mol-mol),-7.3918421398707395
SUP-T1,216468,1.0382398768610943
BT 245,89928392,0.8074253191697837
HT-1197,46926350,-4.036388663695743
EHEB,1750826,-3.083056512698404
AML-193,17755052,0.3363419174786969
SK-BR-3,3062316,2.590264707659421
P31/FUJ,5328940,0.1000739186855886
NCI-H647,navitoclax-birinapant (1-1 mol-mol),2.2713636056524447
BT 245,46907787,3.440577921160999
RPMI-8402,613753,3.056349499713088
HGC-27,vorinostat-navitoclax (4-1 mol-mol),0.3486308861708096
EoL-1,55283,-0.225909917765126
KALS-1,452548,0.7200864219905321
BT 239,55508,1.8404274553647852
NCI-H2081,24901704,2.205959847838861
AML-193,49793307,-4.122057660750982
KMH-2,10074640,2.2394056141087493
RKO,5281321,1.9988379902215376
MSTO-211H,6914657,-1.9341273237470331
PK-59,5978,4.943835389639869
PK-59,selumetinib-navitoclax (8-1 mol-mol),1.5188657013907954
NCI-N87,6252,-1.400414082532842
JeKo-1,9911463,3.294378834813148
RCM-1 [Human rectal adenocarcinoma],42642645,1.367998127032919
EoL-1,46398810,-1.3214962949312965
KHM-1B,25262965,-2.736326683370708
TCCSUP,carboplatin-etoposide (40-17 mol-mol),3.482858760059233
HDLM-2,25102847,5.128109325608665
HGC-27,25102847,1.676186300526047
PK-59,4378219,2.005391198678221
SK-BR-3,24772860,-2.10781871600694
RKO,9840324,5.302067215897717
MFE-319,selumetinib-PLX-4032 (8-1 mol-mol),4.912278466652954
EHEB,JQ-1-vorinostat (2-1 mol-mol),0.2631441629277845
KMH-2,49793307,-4.005365392804202
HGC-27,24180125,3.8514022431268113
A3/Kawakami,navitoclax-MST-312 (1-1 mol-mol),0.9853093730119762
SNU-175,66577038,2.9601920745246404
HCC2108,52947716,-4.821545884859311
SUP-T1,42642645,0.578403770532887
SIG-M5,25105715,3.6678067088186896
AU565,44607530,-0.2063452249558506
SK-UT-1,vorinostat-navitoclax (4-1 mol-mol),2.160306849194933
AU565,168313200,1.787588028354966
NCI-H647,selumetinib-JQ-1 (4-1 mol-mol),1.5451877783992325
KHM-1B,JQ-1-vorinostat (2-1 mol-mol),-0.1758433625327752
A3/Kawakami,3634881,3.182238914732956
BT 245,151289,1.3314671382833223
PC-14,56946209,-3.897840273037845
NCI-H647,5460769,0.6003032928308929
NCI-N87,46199207,2.9512504868324565
HARA [Human squamous cell lung carcinoma],68056272,4.667757023830857
VMRC-LCD,5738263,2.756297829670533
NCI-H716,navitoclax-pluripotin (1-1 mol-mol),-4.216352137739268
RCC10RGB,2729026,3.187414345119047
BT 228,10113978,3.922309495920737
AU565,3503,2.743681155949089
RCC10RGB,44489675,4.041451654117508
AML-193,216345,2.516539300001732
BT 239,11222830,1.096095911295922
SK-BR-3,65628,3.766479538164496
BT 239,6610216,3.2848009151202113
NCI-N87,6505803,-6.101345662019038
RCC10RGB,44491742,5.1484686760969645
KMH-2,11364421,-4.893528283668471
MFE-319,25126798,4.1849423235553225
JeKo-1,54626689,4.515438698631472
NCI-H647,46907787,2.2999063461602716
RCM-1 [Human rectal adenocarcinoma],JQ-1-UNC0638 (2-1 mol-mol),1.043202454490808
L3.3,11485656,2.040790548836277
KMS-26,5335621,3.7042566566817623
BT 428,176870,3.6826652854362862
SIG-M5,11719255,1.9809783967920664
Capan-1,49867926,4.2936556894654405
BT 428,11497983,4.077786737924683
BT 245,5287620,-3.6022603888175664
SK-N-SH,9884685,0.674262884402922
KMH-2,969516,1.6744989896078368
HT-1197,16725315,3.265654730556947
SK-N-SH,9936388,-5.065644908322296
NCI-H1092,25183872,-0.0477909858083303
RPMI-8402,44543605,3.8364906131310503
HT-1197,24779724,4.378865216004622
A3/Kawakami,3854666,0.4749804241070199
HOP-92,45279963,3.7884278644891514
HGC-27,11977753,-3.4727137197877043
NCI-H647,44462760,4.2597543617721305
HCC2108,374536,3.656255875705604
EHEB,135984461,4.428627188495882
SCC-25,24951314,0.7945999525904685
SUP-T1,23582824,0.1601620374225345
HDLM-2,72734382,3.4025970616499124
AML-193,441298,1.6468375169019394
IGR-37,11955716,5.6002893002768435
IGR-37,5113032,1.7543366798681286
L3.3,10410894,2.582309203973784
HCC2108,56946209,-3.5616140091997397
PK-59,54618305,4.329681142974429
SIG-M5,9927531,4.880658167161108
EHEB,26596,-2.0876334457911727
SIG-M5,107985,-4.712250940257049
RCH-ACV,ISOX-bortezomib (250-1 mol-mol),-0.2619678346480726
SUP-T1,11977753,-2.9038754599688192
SW1116,selumetinib-decitabine (4-1 mol-mol),-0.2663799203168696
AU565,6436223,-4.706952881213825
L3.3,107970,2.7957953106701305
BT 428,44819697,-2.8308902795698625
SIG-M5,9887053,1.921907892618564
BT 428,89928392,0.9038531733585348
NCI-H2009,ISOX-bortezomib (250-1 mol-mol),0.5557935848602048
WM793,135398516,2.614188359863261
BT 245,11222830,1.0250233618609572
HCC2108,262093,2.915848941362045
BT 245,53393127,4.870864218023685
BT 228,56649450,3.2027517114551407
IGR-37,11178236,-1.149533740388812
IGR-37,3081361,2.593563548943733
SNU-175,16720766,0.0297646986788907
SCC-25,44185566,1.1260282906282544
HDLM-2,9915743,-1.1010684043189596
HOP-92,erlotinib-PLX-4032 (2-1 mol-mol),3.3704106321811613
KU-19-19,16725315,4.810213458660102
SK-MEL-3,11175137,2.8418423929840837
SIG-M5,54619267,3.720918362873572
SIG-M5,285033,-4.3773078711527384
SNU-719,selumetinib-PLX-4032 (8-1 mol-mol),0.4572057715299554
KYSE-450,969516,2.907932259173941
SNU-175,452548,-1.6250949024611754
BT 232,11609586,3.770012542467479
JeKo-1,navitoclax-PLX-4032 (1-1 mol-mol),1.903970758563358
NCI-H716,6918736,-1.991487660809515
IGR-37,25227462,1.6614823406435526
SIG-M5,11485656,1.8173379361731008
MFE-319,60700,2.668812408067789
HOP-92,5460769,4.612763799526671
JeKo-1,5460769,3.2700758729193526
WM793,46398810,3.0163067396292944
TCCSUP,72193861,1.75237754953521
NCI-H1092,navitoclax-birinapant (1-1 mol-mol),1.7535361576658914
SK-N-SH,navitoclax-pluripotin (1-1 mol-mol),-0.96336609735669
Capan-1,107970,3.0385955558587434
RCH-ACV,tretinoin-navitoclax (4-1 mol-mol),-0.2377490977713408
NCI-H716,11404337,0.1274429986614186
HCC2108,navitoclax-sorafenib (1-1 mol-mol),3.578397373026766
BT 232,11656518,2.7517897262829916
YH-13,10113978,4.558059650015548
EHEB,piperlongumine-MST-312 (1-1 mol-mol),1.299458892155912
KYSE-180,15983966,-3.249627780516399
SK-N-SH,JQ-1-UNC0638 (2-1 mol-mol),1.3255309651974876
PC-14,2828334,6.799287199401149
NCI-H1092,54618771,1.961811722948082
MSTO-211H,11719255,2.56955632094912
MSTO-211H,6438330,1.6419113469823416
AU565,navitoclax-birinapant (1-1 mol-mol),2.4267027556232836
SCC-25,5978,-5.78654361456302
HGC-27,15547703,2.92775271566561
KMH-2,3825829,2.5333469127311004
HARA [Human squamous cell lung carcinoma],2945648,3.3865607820212316
PC-14,421610,3.0236503456668697
SUP-T1,51039095,1.7477818424022915
RCC10RGB,9911463,4.415558893727306
SUP-T1,10113978,1.904259768792726
HDLM-2,11609586,2.062240469915729
JeKo-1,135875424,3.073704073284497
EHEB,15547703,3.057077629561598
HGC-27,24964624,-2.5539015867637183
BT 245,23725625,4.903326466569384
NCI-H716,46843906,1.845350171826819
KYSE-450,613753,3.352975816171232
YH-13,selumetinib-tretinoin (2-1 mol-mol),4.993849877011519
PC-14,5311,0.5745844674676404
HT-1197,3025944,4.112651694426317
NCI-H2009,6505803,-0.1719772058921901
NCI-H647,navitoclax-gemcitabine (1-1 mol-mol),-1.3323858705075424
JeKo-1,25150857,2.6624074655114818
BT 228,selumetinib-decitabine (4-1 mol-mol),3.94184524725645
NCI-H2081,24797083,0.7037810965891612
SK-MEL-3,46926350,-3.109136293232628
SIG-M5,6610216,4.287770419963318
EHEB,5351362,0.8229401281543347
SW1116,selumetinib-JQ-1 (4-1 mol-mol),-1.5718709944273437
NCI-H2081,JQ-1-navitoclax (2-1 mol-mol),0.0671859130804495
HDLM-2,54619238,4.437192028795485
NCI-H716,11626560,1.2174050165610466
P31/FUJ,73707386,2.311695228129917
JeKo-1,46901937,3.7756491756369654
MSTO-211H,44589607,1.2735087838172758
BEN,2729026,3.2288794951502333
RCH-ACV,56949517,4.180492818285935
KU-19-19,selumetinib-MK-2206 (8-1 mol-mol),2.230752575212941
SCC-25,168312962,3.2060434191038043
Capan-1,31703,-0.638687799990559
IGR-37,45279963,4.164350555238922
NCI-H716,135411,1.2360299541171125
BT 228,65064,5.206743780759376
KMS-26,selumetinib-GDC-0941 (4-1 mol-mol),-0.996356335755467
BT 239,decitabine-navitoclax (2-1 mol-mol),-3.2491429839961032
BEN,46199207,3.6039924215654704
NCI-H1092,selumetinib-piperlongumine (8-1 mol-mol),4.34690656876425
HDLM-2,444795,4.905725806732837
HARA [Human squamous cell lung carcinoma],serdemetan-SCH-529074 (1-1 mol-mol),2.4213259806317335
RPMI-8402,44493528,4.185952710394156
BT 245,613753,3.2537695034625327
VMRC-LCD,71680916,4.404883787029812
WM793,selumetinib-tretinoin (2-1 mol-mol),2.5106551604776017
SK-BR-3,56649450,0.5325203761214842
HGC-27,tretinoin-carboplatin (2-1 mol-mol),5.523002948465698
RPMI-8402,107970,2.195898791012078
BT 428,107970,1.3396670576098808
RCC10RGB,11167602,3.5267453541831695
BT 228,6918837,1.334397558740299
HCC2108,25126798,3.42355668622167
MSTO-211H,57330099,2.804758704858228
RPMI-8402,71304818,0.9211398065973982
HGC-27,4261,1.8685532780809704
JeKo-1,44486219,3.832554665092235
KMS-26,11167602,0.2768125005658594
HDLM-2,selumetinib-JQ-1 (4-1 mol-mol),1.4826251454250057
HDLM-2,5460769,4.226839303780804
MFE-319,5311,0.3087543762832455
NCI-H716,alisertib-navitoclax (2-1 mol-mol),-0.3595801980367153
NCI-H716,107985,-2.4124318655022674
A3/Kawakami,15983966,-4.426242178568087
YH-13,10385095,0.585484965582367
KU-19-19,16115403,-3.194116920729502
HARA [Human squamous cell lung carcinoma],5329102,2.385019760073336
HGC-27,135423438,0.8474032670168677
PK-59,16736978,1.3887472521411
HT-1197,24180719,3.8565119139724544
SUP-T1,4705,3.362457199926275
HGC-27,216345,2.5463301223040147
SW1116,16219061,3.311893029789045
KHM-1B,72376,-2.838745131270772
RCM-1 [Human rectal adenocarcinoma],2746,2.384271625154073
HGC-27,89928392,-0.3342747122146413
KMS-26,11152667,-2.145052290186052
YH-13,24821094,3.938816405741356
KYSE-450,168313200,3.958386537902572
SCC-25,17759555,3.8375162265834537
EoL-1,JQ-1-MK-0752 (1-1 mol-mol),-1.8655787841074944
SK-N-SH,11214940,3.9175290151014552
BT 239,216345,0.6896392706036211
SW1116,46174525,4.7134586112168
PC-14,637858,2.799364880868444
RCC10RGB,doxorubicin-navitoclax (2-1 mol-mol),1.2475465934468772
EoL-1,tretinoin-carboplatin (2-1 mol-mol),-3.9442658369201182
RCH-ACV,26596,-2.407585357799557
BT 428,3025944,4.463058119543337
EoL-1,76446078,1.114225331427788
BT 239,46174525,3.8685847385836625
HCC2108,24951314,2.6304731468995457
SK-N-SH,8515,3.203327445964139
NCI-H2009,5311281,-0.1357038590739554
MFE-319,444795,3.938376988705715
SCC-25,6610355,3.859152655678156
RCH-ACV,10127622,4.906141517333951
BT 239,151289,3.5125938613927965
NCI-H1092,10184653,1.2833708133715205
RCH-ACV,387447,-4.01100204029626
JeKo-1,6918736,-2.3058865125232475
BEN,16722836,1.9859732409455253
P31/FUJ,445455,5.725867195241275
BT 228,5746,1.5331976056017464
MSTO-211H,445091,2.4700472101717312
BT 232,46199207,1.7355458268176462
WM793,10302451,3.996584762768067
WM793,6610355,4.692334548375442
SK-N-SH,31703,-1.5932706842204942
YH-13,11494412,0.8602319711686647
SK-MEL-3,JQ-1-navitoclax (2-1 mol-mol),1.0053286082450146
AML-193,60700,-3.8606788761043336
HOP-92,44185566,3.066048081370752
RKO,24779724,5.847036108864024
KYSE-180,2858523,2.9324338012206845
KMH-2,67291369,1.5421170432429974
IGR-37,11612883,3.345318983578966
HARA [Human squamous cell lung carcinoma],6918837,-1.4537868658939308
HOP-92,6450551,3.043201595005235
JeKo-1,409805,3.852708089186558
SIG-M5,3011155,4.40968484030326
EoL-1,BRD-A02303741-navitoclax (2-1 mol-mol),-1.725431006019431
KMH-2,135398738,1.012149914013246
SK-N-SH,168313016,5.308215001668749
HARA [Human squamous cell lung carcinoma],119607,5.240910567943734
BT 245,3062316,3.257896048072906
KHM-1B,135984461,4.335909278526869
MFE-319,vorinostat-navitoclax (4-1 mol-mol),1.2472823100276946
MG-63,241158,3.962785624190749
BT 239,2746,2.5478715326116252
P31/FUJ,36462,-0.6599401629031103
BT 232,25102847,3.433570365125839
JeKo-1,613000,2.262106543196391
HDLM-2,119607,5.1393067192722475
VMRC-LCD,10026128,6.362121773473112
KU-19-19,446155,2.785852834205258
RKO,15983966,1.976330033309676
RPMI-8402,24753719,3.36311083579876
AU565,7326481,2.6950900258123256
BT 239,44607531,-0.1543213708179517
TCCSUP,5311,0.9056986626797512
KYSE-450,241158,4.285328470501583
VMRC-LCD,5470400,0.5936049267491746
KHM-1B,2828334,5.467256536463017
KALS-1,2130404,2.39382848764739
BT 228,445091,4.0470033376837575
AU565,67156097,-2.287523284177128
NCI-N87,54649381,3.6397596564561487
RCH-ACV,6438330,0.5076312774435174
VMRC-LCD,10427712,4.125024919936873
SUP-T1,navitoclax-birinapant (1-1 mol-mol),-0.5405307045216123
MSTO-211H,327653,2.467891014920142
IGR-37,374536,0.9176034794816106
PC-14,vorinostat-navitoclax (4-1 mol-mol),0.6440039915346073
SCC-25,24856436,-1.9997251237580005
RCC10RGB,252682,6.528801566934436
SK-MEL-3,54626689,4.613351990823583
HARA [Human squamous cell lung carcinoma],568763,1.3363257274557196
SNU-719,5282054,3.8965197917178633
WM793,9825149,2.4189460978958266
NCI-H647,11647372,1.7560729069438374
MG-63,9926054,3.1754047574180815
BT 428,BRD-K55473186,4.152685201590297
PC-14,9868037,2.5861209247826644
PC-14,44607531,-3.5118481148163982
AML-193,72734382,3.998699759260014
RCH-ACV,44493528,4.3115996529369705
SIG-M5,11497983,3.8107089109633914
SCC-25,46907787,-0.5502677293335551
MFE-319,4259181,1.4040440632214766
P31/FUJ,2858523,2.921593087757198
KMS-26,11625818,1.3602559994989143
MG-63,selumetinib-JQ-1 (4-1 mol-mol),3.254737197001595
YH-13,54143018,0.7752211198324802
HARA [Human squamous cell lung carcinoma],159324,3.9851922367796937
SK-N-SH,sirolimus-bortezomib (250-1 mol-mol),0.20777860601932
IGR-37,navitoclax-PLX-4032 (1-1 mol-mol),1.4697094331710563
HuH-28,selumetinib-PLX-4032 (8-1 mol-mol),4.378320126621186
PC-14,107985,-3.662594404968572
RPMI-8402,219104,1.6157151228299
SNU-175,17759555,4.012568177666107
HDLM-2,31703,-1.334154318180108
BT 232,25195348,5.110368928934532
RKO,6918837,-1.4612228483082623
L3.3,100016,6.042484334243821
NCI-H716,46199207,3.4539649111127195
BT 228,123631,2.5046683222958603
NCI-H647,439501,-1.4518848962069395
RCH-ACV,57519531,1.5284392482594116
BT 239,56649450,1.4317881756114492
HuH-28,327653,3.326177611407744
AU565,421610,2.258686960610045
RCC10RGB,73707438,4.14323951901879
HDLM-2,11656518,-2.9864543152214194
EHEB,11964036,0.5022634413862269
SUP-T1,446155,3.6790108071531047
BT 239,24901704,2.5378652704426363
KU-19-19,24964624,3.8522438290321768
BT 232,6917907,3.415283890437736
NCI-H1092,11228183,0.9840040358909228
SK-N-SH,439501,-1.8318448964157588
A3/Kawakami,6918328,-1.518016376495572
MG-63,168312962,-1.888741351005103
HT-1197,216239,2.104288713398076
BT 245,9911463,3.0517796790400173
PC-14,25126798,3.0644071921081193
KHM-1B,49793307,-3.3171088772826707
HOP-92,5311,0.940186080115014
RCH-ACV,168313047,1.8390630921818312
NCI-H1092,216345,3.5494296383445105
HGC-27,carboplatin-UNC0638 (2-1 mol-mol),3.349897468439194
YH-13,4917,3.8244363131273458
KYSE-180,11152667,-0.8702132503194517
HOP-92,60700,2.031600185927495
NCI-H647,6438330,3.116055248691962
HuH-28,25062766,0.7688426464584222
HT-1197,selumetinib-tretinoin (2-1 mol-mol),3.204577085895437
WM793,44819697,-0.03600588144364
HT-1197,6918638,1.042258659945556
YH-13,JQ-1-MK-0752 (1-1 mol-mol),1.712752654360266
RKO,400769,-0.364727826621167
KMH-2,15983966,-5.543246989488695
BT 239,11455910,0.8577205226551546
RCC10RGB,6918328,1.0053978601828475
TCCSUP,54649381,3.810492846864681
KMS-26,5311,-1.4594384902276447
PK-59,66577038,3.1901947150333143
L3.3,5978,-0.2603821575839845
P31/FUJ,24180125,3.650250525491935
AML-193,6918736,-1.4792737426694578
NCI-H2009,81146,6.16166931928307
PK-59,serdemetan-SCH-529074 (1-1 mol-mol),2.1395317563235547
KALS-1,9956119,3.190016393363303
SIG-M5,444795,-5.244515717974557
Capan-1,54618305,4.4097719000547135
HGC-27,49793307,-4.278086504312048
KU-19-19,17759555,3.7275461226555566
HCC2108,5282054,3.0861306329764964
MSTO-211H,387447,-3.4382078488280063
KALS-1,44632017,1.7577038915561858
Capan-1,1716436,3.46729831255585
NCI-N87,11364421,-4.7214998150919065
SK-UT-1,4477,-0.1518162613562077
RCM-1 [Human rectal adenocarcinoma],241158,4.470658456064693
KHM-1B,753704,4.849440364052096
SIG-M5,10427712,3.892395685819202
SIG-M5,148198,-4.503742564102913
BT 239,375860,0.789468692413804
P31/FUJ,piperlongumine-MST-312 (1-1 mol-mol),1.5235846843184453
MG-63,SNX-2112-bortezomib (250-1 mol-mol),-0.1525386109654133
PK-59,6505803,-0.3559678115713951
MFE-319,135999136,3.968795924273322
HDLM-2,SNX-2112-bortezomib (250-1 mol-mol),-1.4815740507395652
A3/Kawakami,444795,4.277371495057248
BT 239,176870,1.8719104214559057
NCI-H647,25062766,1.0981038338090432
BT 428,72193861,1.1459450483713445
YH-13,123631,3.7042761573264023
HCC2108,11960529,3.759811240772432
PC-14,sirolimus-bortezomib (250-1 mol-mol),1.4531465186128956
EHEB,5566,2.7898733391986994
SNU-175,51039095,2.497453692642604
TCCSUP,5287620,-1.0602115166818715
HT-1197,4096211,3.0402809965624877
SK-BR-3,5328940,1.6053571266282252
SUP-T1,tretinoin-carboplatin (2-1 mol-mol),3.8601444758845105
HGC-27,25227462,-3.2490269739956252
AU565,36314,-7.774521242942876
NCI-H2009,selumetinib-tretinoin (2-1 mol-mol),-1.112372565869968
SK-N-SH,selumetinib-vorinostat (8-1 mol-mol),2.237833901076091
SNU-719,123631,2.4663082682215465
VMRC-LCD,selumetinib-PLX-4032 (8-1 mol-mol),4.898292447556943
EoL-1,16722836,-0.9862784882343278
SUP-T1,71304818,1.9477205829017512
MSTO-211H,3543504,4.118160915221066
BT 239,4096211,1.559136101612815
SNU-719,25150857,2.2650134392186163
SNU-175,3385,2.148857245507078
KMH-2,11625818,3.5304248739726565
BT 428,11364421,-5.7306732460234295
KYSE-180,tanespimycin-gemcitabine (1-1 mol-mol),-0.7772592135179538
NCI-N87,serdemetan-SCH-529074 (1-1 mol-mol),1.7996053995650736
SK-N-SH,25195348,4.976553365033552
SK-MEL-3,6917907,-5.363642878401659
KALS-1,19582717,5.496729093854677
SNU-175,126941,-2.9937922588297883
HCC2108,4259181,0.1536721114746798
PK-59,11626560,1.5487054283870785
EoL-1,135999136,4.026118373456707
EHEB,6610355,4.225572519993169
WM793,9907093,5.490749105587387
RCH-ACV,11234052,1.9997040211086037
SNU-719,31703,-0.4751938765915804
BT 232,6914657,-4.952284683498688
A3/Kawakami,60750,-4.47044850887436
RKO,9936388,0.8183869926163714
NCI-H647,9929138,4.265521593960728
HARA [Human squamous cell lung carcinoma],654092,0.0602204093244996
SK-N-SH,5746,-0.3613977511626192
KU-19-19,24772860,-1.0696999794461075
KYSE-180,5280436,4.019735307251945
HARA [Human squamous cell lung carcinoma],6918328,1.494996835192892
WM793,11497983,4.66927640579722
MG-63,6914657,-5.4013005539123995
YH-13,12001922,2.42245560318508
YH-13,89183176,4.032829383808348
NCI-H647,135398744,6.542739498462596
HT-1197,16065773,1.1915016783793806
PC-14,49850262,4.082010069589332
HARA [Human squamous cell lung carcinoma],4096211,1.410240196225579
KYSE-180,44589607,3.5167084117795513
AU565,46215462,1.837951563203271
BT 239,selumetinib-navitoclax (8-1 mol-mol),-0.9579916721773862
BT 428,54618164,4.165032933518285
MG-63,104842,-3.279169605303711
SUP-T1,11455910,0.2462561508535602
HDLM-2,44620216,4.057309796908866
KMH-2,44484440,3.223340167755633
HT-1197,10113978,4.215588271324688
HOP-92,148198,-3.4956728974738756
RPMI-8402,151289,0.1088689417752526
A3/Kawakami,9956119,2.246907375769423
BT 232,11396600,3.2918989092466813
NCI-H2009,10184653,1.0890186290305244
SNU-719,navitoclax-MST-312 (1-1 mol-mol),-1.266236883631716
JeKo-1,11427553,1.8776055163675505
BT 245,10074640,3.0792421506035774
TCCSUP,2828334,6.2469193029566235
MG-63,11626560,1.3968836743849502
SK-N-SH,24821094,2.8620955662642196
EoL-1,1641662,1.6978587472751492
KMH-2,54619267,4.781349834096086
SUP-T1,44491742,3.5302085503569782
RCH-ACV,9907093,2.485279045535831
HGC-27,24889392,1.9584014056566963
NCI-H647,168312962,-0.1751193177259856
Capan-1,19582717,5.319548469767872
RCC10RGB,25062766,2.0619451400109265
Capan-1,135984461,4.359340050025923
WM793,docetaxel-tanespimycin (2-1 mol-mol),-1.36432681223834
NCI-H716,10074640,3.234335385755219
NCI-H2081,54639701,4.415769472543696
KALS-1,4259181,0.4925771943360276
RCM-1 [Human rectal adenocarcinoma],1641662,3.738448071417011
BT 232,selumetinib-navitoclax (8-1 mol-mol),2.0905713325862165
JeKo-1,448949,1.2072871843824584
EHEB,carboplatin-etoposide (40-17 mol-mol),0.7214068333239794
HDLM-2,selumetinib-UNC0638 (4-1 mol-mol),4.205562707951402
HGC-27,44241473,4.2298295038521525
RPMI-8402,104842,-6.312132494216973
NCI-H2081,676352,1.7285025773311848
HuH-28,4259181,0.9633418141408334
KMH-2,675434,4.380536236973683
SK-BR-3,11455910,1.4950616471057503
Capan-1,2828334,5.9813232341333595
BT 239,24821094,1.4275753144624652
IGR-37,6450551,3.538187993545274
IGR-37,11640390,4.269188658959187
HuH-28,11609586,3.172009500886791
HGC-27,16065773,1.1010313032419272
Capan-1,JQ-1-vorinostat (2-1 mol-mol),0.9843393336030308
NCI-H2081,navitoclax-sorafenib (1-1 mol-mol),1.2084558654866828
NCI-H2009,56963564,-0.2763231945711286
HCC2108,46191454,1.2793271361980716
A3/Kawakami,24856436,0.10211023078217
RCM-1 [Human rectal adenocarcinoma],selumetinib-BRD-A02303741 (4-1 mol-mol),2.266377175881345
SK-N-SH,5282054,3.249469406255903
HGC-27,selumetinib-navitoclax (8-1 mol-mol),2.2185621096664523
KHM-1B,25150857,0.9778770077521932
A3/Kawakami,17755052,3.7416477204128697
MFE-319,piperlongumine-MST-312 (1-1 mol-mol),2.2283197114186644
Capan-1,44819697,0.7630725019701461
SNU-719,65064,4.2881239185817375
BT 245,49793307,-3.902983777687099
SK-N-SH,6438330,0.9710916931718644
NCI-H2081,25183872,-2.502554706433877
WM793,vorinostat-carboplatin (1-1 mol-mol),3.963017303085571
NCI-N87,52947716,-3.473486168283201
EHEB,11609586,1.2753249269460478
HT-1197,322968,4.394270402616033
HARA [Human squamous cell lung carcinoma],6252,0.9917938801151434
AU565,445643,3.872431437053606
A3/Kawakami,4477,-0.1384944170540566
A3/Kawakami,12001922,1.8297841659404463
NCI-H1092,55508,4.291309194674307
BT 232,carboplatin-UNC0638 (2-1 mol-mol),3.4278441060416265
HGC-27,8515,2.5882195628771565
KMS-26,JQ-1-carboplatin (1-1 mol-mol),-2.004743944030579
NCI-N87,219104,3.2437824126869415
RCH-ACV,3025986,-1.9023918957328672
NCI-H2009,89183176,3.352860584382055
HOP-92,JQ-1-UNC0638 (2-1 mol-mol),1.4677820054229196
KMS-26,piperlongumine-MST-312 (1-1 mol-mol),3.0073270481081353
EoL-1,151289,-0.2057900839976434
HARA [Human squamous cell lung carcinoma],9927531,4.552330692797245
PC-14,55508,2.800196673961477
HGC-27,107985,-4.025909310335491
AML-193,6505803,-1.7450029346129687
KMH-2,156422,4.647817894933367
BT 428,9926054,1.9432227600739695
IGR-37,126941,-2.3541435271311437
MSTO-211H,11625818,2.0984197145893853
SUP-T1,654092,-1.915570989960676
KYSE-180,44491742,6.4799420322622305
HDLM-2,24748573,4.220736388704362
RCH-ACV,11228183,0.3459941997608157
SK-UT-1,56649450,4.279287497438238
AU565,24856436,-0.2368560911374172
HuH-28,53232,0.6727445153066091
RCH-ACV,123631,2.319696146348769
BT 228,25262965,2.1304399064001207
SK-MEL-3,448949,3.2586722299337985
BT 228,54143018,2.9407568679312437
HT-1197,10385095,1.8216995461668084
NCI-H716,448949,1.511163886693119
NCI-N87,navitoclax-birinapant (1-1 mol-mol),2.0087616801931953
AU565,51039095,3.3315580468624795
RPMI-8402,2858523,2.2195441147340413
PC-14,119607,4.988479520693017
RPMI-8402,71466380,2.840501230248857
IGR-37,erlotinib-PLX-4032 (2-1 mol-mol),2.392388710978969
HGC-27,54596558,6.176742267926111
P31/FUJ,969516,2.490551298955204
NCI-H1092,16038120,0.7864664240058443
Capan-1,89183176,6.169626178658774
KHM-1B,3136844,3.849321357179878
NCI-H1092,56946209,-3.79263403316681
PC-14,11719255,2.8273442583778072
HGC-27,56646779,3.7264079299413577
JeKo-1,44493528,3.836571201329888
NCI-H2081,135984461,4.3718384438901285
A3/Kawakami,9840324,5.382301633471219
SK-N-SH,26596,-3.7665654883669664
NCI-H716,44185566,2.3305670218207095
BT 245,BRD-K55473186,1.9544137558001504
IGR-37,3384730,2.6012130083323957
HARA [Human squamous cell lung carcinoma],613753,4.606319217012033
BT 245,6505803,1.0921416598826974
BT 228,11640390,3.5732863774236043
BT 239,3384730,0.1080750970738735
A3/Kawakami,1641662,3.0362090352586497
TCCSUP,selumetinib-navitoclax (8-1 mol-mol),2.911223328987063
BT 228,4788,5.483170010822502
L3.3,57519531,2.574296584662942
RKO,5738263,3.4166283525852523
RPMI-8402,11404337,-1.8259507324161124
SK-UT-1,3503,1.0072553452312891
AML-193,15547703,2.564095530600783
HuH-28,2828334,5.806287951277398
KMS-26,2729026,0.5474788672880985
HGC-27,82146,3.2189508419253454
IGR-37,375860,-0.4375644933586405
NCI-H716,10410894,4.586332904266608
L3.3,11612883,3.0937227516492767
AML-193,11404337,0.8563534093329411
NCI-H2009,navitoclax-pluripotin (1-1 mol-mol),-1.5280134971991166
RPMI-8402,25102847,1.7538937689282126
SK-N-SH,10385095,0.0454755158879893
BT 228,crizotinib-PLX-4032 (2-1 mol-mol),2.2666654632617265
TCCSUP,selumetinib-PLX-4032 (8-1 mol-mol),3.752056719076424
RCH-ACV,11964036,-0.6422996479775142
P31/FUJ,11717001,4.27266863837082
NCI-H716,4261,1.315504793923613
AML-193,135999136,1.7506715164272186
KALS-1,2733526,3.540319442689929
KU-19-19,151289,4.45756440863607
HOP-92,135411,1.4111014193013556
KHM-1B,119182,-1.6156103715295518
A3/Kawakami,9907093,4.372218792783248
NCI-H647,SNX-2112-bortezomib (250-1 mol-mol),-1.7907973361623652
MG-63,navitoclax-gemcitabine (1-1 mol-mol),-2.5156054644677193
RCM-1 [Human rectal adenocarcinoma],46174525,4.230350619821445
KU-19-19,navitoclax-piperlongumine (1-1 mol-mol),2.9388781180521124
SK-MEL-3,25126798,4.330280420093532
IGR-37,3543504,6.398180323688354
YH-13,151289,0.8746416780528874
PC-14,3503,2.6027668022878134
P31/FUJ,46398810,1.6622931867453647
RKO,16038120,2.1201165412688385
TCCSUP,135440466,1.783942290366752
VMRC-LCD,46174525,4.19026700337316
RKO,11364421,1.233720517884939
AU565,45279963,3.869118795762884
NCI-H1092,44489675,3.6172638586076937
KALS-1,82146,5.832798530323358
BT 245,piperlongumine-MST-312 (1-1 mol-mol),1.2906691199722635
BT 245,selumetinib-JQ-1 (4-1 mol-mol),1.4299884719020757
TCCSUP,9926054,2.5470676869748763
AU565,navitoclax-MST-312 (1-1 mol-mol),1.5837862455188414
KMS-26,25195348,1.2411309796218792
PC-14,navitoclax-sorafenib (1-1 mol-mol),1.3495674721807007
RCH-ACV,107985,-4.015124921394137
HT-1197,25150857,3.0156695762816503
SK-MEL-3,salermide-PLX-4032 (12-1 mol-mol),5.795139814509308
PC-14,53392493,3.0751770373287894
P31/FUJ,135398516,1.7387657861081838
SK-BR-3,42642645,1.641863587303232
VMRC-LCD,10113978,2.0664584690809247
KMH-2,5566,2.7230843575338737
HDLM-2,25262965,2.4506157401200257
MFE-319,4378219,4.392527987141838
BT 239,11707110,-1.740234708390248
HARA [Human squamous cell lung carcinoma],10385095,1.0837341672046903
Capan-1,docetaxel-tanespimycin (2-1 mol-mol),0.9712710597327856
MFE-319,11955716,-2.113730481603779
PC-14,65064,5.646584439038967
PK-59,25183872,-1.376264663358824
KHM-1B,3025944,3.5975685819410503
NCI-H716,89928392,1.3613491385641576
RCH-ACV,5284616,1.5263733515199676
BT 428,11656518,-0.4028199439266288
WM793,1242560,3.830743442552037
SIG-M5,168313200,2.70239683850215
HCC2108,10302451,4.138705922344902
TCCSUP,10127622,5.496019179334474
NCI-H2081,6918328,-1.921531809564582
JeKo-1,25262965,-3.1971401084417805
PK-59,448949,1.7401007059453664
HDLM-2,135999136,4.831194178567747
YH-13,11955716,-0.8910132220684513
MSTO-211H,11213558,-0.8326933060339966
HGC-27,11719255,2.9445428690676256
AU565,16038120,1.417918520815656
KHM-1B,51037431,2.291600805718332
BT 228,104842,-0.7754357722749377
SIG-M5,10322450,3.963755242230549
NCI-H1092,5278396,3.4693209388519137
KMS-26,5281672,3.632444552778271
HT-1197,148124,5.0758471047510625
SK-N-SH,1716436,3.5809098311972996
AML-193,25102847,1.478285821387516
KALS-1,15953870,5.91178249332218
HOP-92,135659046,3.870872238104053
EoL-1,24753719,1.9160330711500224
MSTO-211H,16741245,3.31564558456852
WM793,969516,2.5069941114188485
SUP-T1,tanespimycin-gemcitabine (1-1 mol-mol),-5.859854424816937
NCI-N87,123631,-0.3933912143385343
SK-BR-3,3136844,4.597763640921218
RPMI-8402,11717001,5.584030283698482
IGR-37,387447,-4.39014205040547
SUP-T1,navitoclax-MST-312 (1-1 mol-mol),1.1259969556971916
SK-UT-1,3025944,4.81857732958154
SK-UT-1,10074640,3.5856267596228713
AML-193,3025944,4.290599077235341
NCI-H1092,11494412,2.17753949415027
NCI-H2009,17755052,1.0629457660851225
NCI-H1092,tretinoin-navitoclax (4-1 mol-mol),3.4593364841450085
SCC-25,322968,3.5908407485445033
PK-59,BRD-A02303741-carboplatin (1-1 mol-mol),4.4659430516991145
EoL-1,selumetinib-PLX-4032 (8-1 mol-mol),0.9999798492455172
HARA [Human squamous cell lung carcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1045864370631683
PC-14,2949965,3.1436858143877533
RCC10RGB,51039095,3.636696049778912
KYSE-450,navitoclax-PLX-4032 (1-1 mol-mol),4.746447722583796
AU565,11485656,2.0156354686346174
MSTO-211H,241158,2.290519528489604
BT 428,10427712,4.347844856094606
BT 245,9825149,1.25050062624055
VMRC-LCD,46215462,1.5630728330580814
Capan-1,11396600,3.9695297031649384
AML-193,10322450,2.9754304486857
SK-MEL-3,5281321,0.5043448942820424
BT 232,9911463,3.3781399253099256
RPMI-8402,5282054,2.986307194560814
MG-63,36462,2.529493271020798
EoL-1,136227331,3.409385468978638
SK-UT-1,11214940,1.922253876673372
BT 428,11955716,-1.491025984916854
SNU-175,208908,-1.6296862334111724
HuH-28,9907093,3.940485694888954
BEN,11175137,3.2680125641275146
HT-1197,JQ-1-vorinostat (2-1 mol-mol),1.1755644093506437
KMH-2,44632017,0.1133386123282452
HuH-28,9911830,1.7583822057953695
A3/Kawakami,10410894,3.05364110610356
RCM-1 [Human rectal adenocarcinoma],216468,3.6601371592015273
EoL-1,6918878,-3.363736043599486
SIG-M5,16736978,0.6805328381969573
AML-193,10127622,0.992086491636321
SIG-M5,4788,5.962535712462897
MFE-319,10184653,1.6772841193799803
RCH-ACV,9926054,1.6841422831368045
NCI-H2009,10385095,0.2451756361843044
VMRC-LCD,46843906,1.5565522354528554
HT-1197,2871966,-0.0294561586256031
AML-193,6450551,1.196223607769039
EoL-1,9826308,-0.9911017043544637
RCH-ACV,44202524,1.1011128019800978
MFE-319,123631,3.2349491279121234
Capan-1,6450551,3.486893590475519
SK-N-SH,67156097,-2.8531395065396965
KALS-1,156422,4.4484831822137005
P31/FUJ,11214940,0.6332731592867608
SK-BR-3,crizotinib-PLX-4032 (2-1 mol-mol),2.930604639625576
KU-19-19,navitoclax-gemcitabine (1-1 mol-mol),-0.4466146105667509
SUP-T1,6610355,3.794714495629332
HOP-92,42642645,4.076812094577793
JeKo-1,16065773,1.9099438770381456
AML-193,57519531,1.2884276615279509
EoL-1,11640390,1.0145053853623114
SNU-175,60750,0.5613304035524355
KMH-2,25126798,3.9705987433413976
SK-UT-1,11175137,3.4203767191490724
RPMI-8402,3011155,0.5445145736684268
HT-1197,2126,3.753341013949651
YH-13,11427553,1.71791693691315
KYSE-450,702558,5.8139297537708
KYSE-450,10296883,4.225795837642371
Capan-1,327653,3.1248384671803353
BT 228,5287620,-1.789940297422988
JeKo-1,11625818,4.197548151473419
Capan-1,12003241,-1.403867722449874
BT 239,72193861,1.5218562919026362
SIG-M5,25195348,1.1714720579011324
BT 428,54618771,1.9125909448822425
PC-14,9903786,1.3474672632704163
KHM-1B,107985,-4.92843539421015
KHM-1B,89928392,-0.1592315561663482
BT 245,56649450,2.8360361021464153
HARA [Human squamous cell lung carcinoma],5291,4.037970789679042
SK-UT-1,ISOX-bortezomib (250-1 mol-mol),0.217311614583509
WM793,6918328,0.9320540007065896
KMS-26,17755052,-1.064085461216224
SW1116,54678924,2.014242841274849
PK-59,135875424,3.737021018611698
BT 428,9825149,2.3400066362524297
TCCSUP,piperlongumine-MST-312 (1-1 mol-mol),1.4987709869908574
SK-MEL-3,11238147,2.619316669125483
MSTO-211H,23635314,-1.96294908215212
NCI-H647,53232,2.273735138101899
NCI-N87,11656518,1.4544081811160725
RKO,135875424,3.829354185480349
HARA [Human squamous cell lung carcinoma],11175137,1.814800704414418
SK-BR-3,9915743,-3.880272444164353
MFE-319,72193861,1.5398229894085662
RKO,11175137,2.9264569639519906
KYSE-180,navitoclax-gemcitabine (1-1 mol-mol),2.062581087909213
SK-MEL-3,42642645,1.5354776601943807
VMRC-LCD,16065773,2.4879467745571824
NCI-H2009,selumetinib-navitoclax (8-1 mol-mol),-2.134794996272836
KALS-1,72376,-1.287253887852265
HOP-92,89928392,2.8685504726519673
NCI-H647,36462,3.0130697946404874
HuH-28,54618164,3.756751318056744
HCC2108,11485656,2.4652137706419137
Capan-1,3465537,2.9960206717772104
KMS-26,71466578,1.2695574005883363
SK-N-SH,46224516,2.3152852596537072
JeKo-1,5113032,5.670151017731649
PK-59,11612883,2.5414084557448287
IGR-37,72199292,2.181062169628517
L3.3,23635314,-2.194996881934531
KU-19-19,654092,0.6096416345891582
SCC-25,BRD-A02303741-navitoclax (2-1 mol-mol),3.5372425846166857
AU565,57519531,1.889615726213954
EoL-1,10296883,0.2540444549811657
AML-193,10074640,2.546883898252909
KHM-1B,51039095,0.918931317329286
SCC-25,4378219,2.5143805183117864
SIG-M5,676352,1.7438083196580083
NCI-N87,10184653,-5.297353828317573
SUP-T1,2945648,2.337434398357025
HuH-28,168312962,3.909749481018215
RKO,5291,3.391339544898264
BT 239,56963564,0.4834943847585746
KALS-1,11396600,3.671510042060093
BT 228,4378219,1.3498100312418253
KMS-26,tretinoin-navitoclax (4-1 mol-mol),1.3544856466658282
BT 239,tanespimycin-bortezomib (250-1 mol-mol),-2.6769003708706594
SUP-T1,675434,3.980592250896976
RPMI-8402,3825829,2.8272382949394053
SK-N-SH,57519531,1.3480744947366816
SCC-25,2729026,1.6391649158792652
PK-59,10410894,4.837367755211167
RPMI-8402,25154868,3.3118136859237985
PK-59,89928392,1.3322949630136172
BT 239,2733487,6.03584886000042
TCCSUP,3062316,1.2176043198217033
AML-193,selumetinib-MK-2206 (8-1 mol-mol),-0.4999337492667394
Capan-1,60700,-0.8834938588864155
SIG-M5,60750,-4.565566939506873
RKO,24772860,-3.046302255649564
TCCSUP,11396600,4.109332889227832
KHM-1B,448949,2.2712398362063575
SK-MEL-3,6505803,3.3435678878510817
NCI-H2009,654092,0.0283248260105453
JeKo-1,11656518,2.0022357061795524
IGR-37,24964624,2.9809547889633063
HGC-27,123631,2.0637587555313757
MSTO-211H,126941,-2.2791548116201987
AML-193,44507138,1.5233372013609314
SNU-719,5281321,1.302118058511443
AU565,53495165,0.1395352595616783
NCI-H2009,navitoclax-piperlongumine (1-1 mol-mol),2.538490249667484
RKO,44202524,1.4476976505001866
L3.3,60750,-5.123801682120219
SK-N-SH,selumetinib-navitoclax (8-1 mol-mol),1.6427707604680395
NCI-H2009,3689413,0.5343246791806224
RCM-1 [Human rectal adenocarcinoma],51039095,3.29886736232205
HT-1197,53495165,-3.899512028569515
HCC2108,44259,2.0867454916119077
NCI-N87,3025944,4.18610508240951
KYSE-180,9903786,3.667884143051944
SUP-T1,54618164,4.107914943294929
PC-14,9866186,0.4772395714988762
A3/Kawakami,tretinoin-carboplatin (2-1 mol-mol),4.600903923951983
HuH-28,23939,4.409411822031412
BT 428,navitoclax-PLX-4032 (1-1 mol-mol),0.8709631832027047
SK-N-SH,136227924,2.487245372945198
KHM-1B,2749,0.8754642075989242
KYSE-180,6914657,-3.948494720102188
HOP-92,54619267,4.3091367541679695
NCI-N87,400769,-1.2757727144105298
Capan-1,11640390,4.548137329771506
RPMI-8402,3543504,3.180542650539495
NCI-H647,carboplatin-UNC0638 (2-1 mol-mol),3.6940239521306264
KHM-1B,656346,0.4212696332998811
L3.3,8515,4.3523389716154455
HARA [Human squamous cell lung carcinoma],51039095,3.2872110498619573
YH-13,24180719,3.7478543768890136
KALS-1,136227924,3.4972882997363257
AU565,44486219,4.217962962304986
HARA [Human squamous cell lung carcinoma],262093,3.694607099499911
NCI-H647,11625818,3.9715004492470314
VMRC-LCD,24951314,0.6542213038438345
NCI-H2009,JQ-1-carboplatin (1-1 mol-mol),0.1059252519818266
BT 245,4477,0.3069843021708344
PK-59,10127622,4.10543481734972
HuH-28,6914657,-3.560419012525228
BT 239,72376,-3.5653615199829405
BT 428,57330099,3.668978742066668
HuH-28,168313016,4.3836924047698
HT-1197,6852167,3.650905767737215
IGR-37,11222830,2.16220539429996
BT 245,11228183,1.197191358466469
EHEB,176870,3.9888726880158054
MSTO-211H,serdemetan-SCH-529074 (1-1 mol-mol),1.7679544322052605
HGC-27,135999136,4.659278272182858
AML-193,11955716,-2.5814500599213
KMH-2,6917907,-5.658415901866329
PC-14,9911830,1.0701556722840508
HDLM-2,1242560,3.9553070100697383
HDLM-2,71304818,2.362700133321309
AML-193,54619267,3.761258898953443
P31/FUJ,selumetinib-BRD-A02303741 (4-1 mol-mol),2.927335699972257
NCI-H2009,54618164,4.160237516111787
HGC-27,23725625,2.6381188166879963
NCI-H2081,135398738,4.309612048348404
NCI-N87,5311,0.9556802173694716
KMS-26,16038120,-1.358569117047382
PC-14,135440466,0.8720299056367994
VMRC-LCD,65064,5.359823147840231
YH-13,25150857,2.985150336849829
MSTO-211H,BRD-K27188169-navitoclax (2-1 mol-mol),1.2533198226261906
KYSE-180,10184653,1.7037524343136865
RPMI-8402,984333,-2.055140665843667
L3.3,44543605,3.679570515799513
SK-BR-3,9936388,-7.247395712922041
EoL-1,9929138,2.1880692859665984
SIG-M5,46907787,-1.5125615192651995
KU-19-19,piperlongumine-MST-312 (1-1 mol-mol),2.2377116602988187
KYSE-450,462382,0.9133555690572344
RKO,71304818,0.9175289508752972
SUP-T1,3011155,-1.0704619964631032
HCC2108,11507802,2.2568660355978607
YH-13,ISOX-bortezomib (250-1 mol-mol),0.2310542886202235
KHM-1B,17759555,2.7813398800723914
BEN,4788,6.151021872130316
SUP-T1,3062316,-0.1853308269442821
P31/FUJ,3384730,-0.5934712638177775
JeKo-1,5328940,0.7952867080464225
KALS-1,53232,2.5236605085659054
HARA [Human squamous cell lung carcinoma],5328940,0.878974684606101
NCI-H716,15983966,-4.26641169480727
TCCSUP,alisertib-navitoclax (2-1 mol-mol),-0.001751015596035
SK-UT-1,25102847,3.856160399391282
SK-BR-3,2874250,5.094922838741021
RCH-ACV,25126798,3.833375341748657
SUP-T1,151289,-0.1549685683143522
KMH-2,46943432,1.9293526492233928
NCI-H2081,navitoclax-gemcitabine (1-1 mol-mol),-4.71616424296242
KMH-2,9907093,3.572106113899987
P31/FUJ,5351362,0.932451869978648
JeKo-1,73707398,1.0235026447845044
RCH-ACV,322968,1.6612891066123274
AML-193,135928012,3.8560863444893982
MSTO-211H,71466578,5.31450298723974
BT 228,navitoclax-birinapant (1-1 mol-mol),1.0929833501287818
BT 228,6917907,0.4013788503384812
EHEB,24180125,1.8891722665908557
SK-MEL-3,3025944,4.533511339557258
KHM-1B,54686904,3.578603716754377
RCC10RGB,16722836,2.017391543442539
P31/FUJ,322968,1.4419696378870497
YH-13,1750826,-2.081763837802431
RCM-1 [Human rectal adenocarcinoma],11955716,-2.128476517967918
RPMI-8402,4788,4.096987356842214
HDLM-2,5746,0.3426127678877474
RPMI-8402,alisertib-navitoclax (2-1 mol-mol),-2.242025234409806
RCM-1 [Human rectal adenocarcinoma],44462760,4.900478491796212
WM793,285033,-1.0395353883933165
KMS-26,49793307,-4.5360304737769015
P31/FUJ,4096211,0.7441609883240002
HDLM-2,216468,2.2182717177829594
KHM-1B,1641662,3.357336532713352
RKO,10385095,1.2981289243482117
SK-BR-3,46398810,2.067983732255415
VMRC-LCD,11455910,1.1166938549694674
KMS-26,11404337,-1.1990569021181443
NCI-H647,56949517,4.422966747551043
HGC-27,24753719,4.105970639778359
HOP-92,446155,1.082985853866213
HGC-27,5328940,1.585270957470069
SK-BR-3,53392493,1.960206535045339
TCCSUP,44589607,3.4904966961167516
A3/Kawakami,15547703,2.560009873729758
RCH-ACV,2113511,3.904742009351072
BT 245,208908,2.1463018754155088
RCH-ACV,400769,-1.738351272206622
JeKo-1,46926350,-6.039670040356239
L3.3,2828334,6.9353242086196225
HT-1197,54143018,4.216052740192658
HuH-28,15953870,3.0591550960119127
YH-13,24797083,1.5819702777514613
HGC-27,49766530,-2.870861488456396
SW1116,42642645,0.6467991915782154
P31/FUJ,60700,-1.8341903870446763
RCM-1 [Human rectal adenocarcinoma],44493528,4.389573022277453
NCI-H716,navitoclax-sorafenib (1-1 mol-mol),0.6750206638156454
RCC10RGB,25227462,3.0929907596871646
BT 428,navitoclax-gemcitabine (1-1 mol-mol),-4.063147518351703
RCC10RGB,135875424,5.859031260595621
JeKo-1,BRD-A02303741-navitoclax (2-1 mol-mol),3.605121632996885
IGR-37,JQ-1-UNC0638 (2-1 mol-mol),2.2226577881456167
AML-193,2746,2.0410312997302698
KMS-26,176870,1.125290639459254
SK-UT-1,25126798,4.142879524330263
HT-1197,67156097,5.190862049820156
BT 239,15953870,4.70138897711737
SK-N-SH,252682,6.031889705025887
TCCSUP,71466578,6.231469242081688
HOP-92,3025944,4.493068201995373
RCM-1 [Human rectal adenocarcinoma],4788,6.143393528563881
KHM-1B,452548,-2.125621480774164
HOP-92,crizotinib-PLX-4032 (2-1 mol-mol),2.2283944072452653
BT 239,44489675,4.18995292855045
PC-14,1716436,3.681033549628276
HCC2108,89928392,0.7050545298033302
SK-N-SH,5281321,-4.225095327626317
HOP-92,carboplatin-etoposide (40-17 mol-mol),2.887309129836383
HOP-92,11977753,-0.5903962234566401
NCI-H716,637858,1.7981928369747582
HuH-28,46907787,0.1056590544791841
HOP-92,2749,3.8187837840798258
PC-14,11626927,1.825278064370036
KMH-2,44202524,1.0243970058234346
AU565,49836020,5.742264990221176
MSTO-211H,24856436,-1.8779899697418416
PC-14,126941,-2.146825063130458
JeKo-1,126941,-4.292917761778652
RCC10RGB,44566777,1.0790521939265936
Capan-1,400769,0.1130628883610215
HCC2108,44507138,1.6442706606036075
KHM-1B,53232,4.4462743832167035
BT 232,16722836,2.4744573454131205
Capan-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.4062427567503657
RKO,25154868,3.654559992823761
PK-59,54618164,4.180437133735424
KMH-2,5278396,2.550508189743561
KMH-2,71466380,4.597594303242699
HDLM-2,71466578,2.794885053670491
RCH-ACV,227681,1.6055363219546606
RPMI-8402,11964036,-0.0681542915121382
MFE-319,11455910,1.7600877604233616
SK-N-SH,11955716,-2.40400111178781
IGR-37,1750826,1.8910836159949376
AML-193,15953870,2.8318815624528706
KHM-1B,42642645,-0.1657476945294937
HGC-27,46907787,1.268146898786742
RCC10RGB,42642645,2.104174802814935
AU565,10184653,-2.737102807310711
HARA [Human squamous cell lung carcinoma],60700,-1.6734694813518207
RCC10RGB,11955716,4.4260489213830425
HuH-28,3689413,-1.8867540967033527
NCI-H647,55508,3.8809220727904097
Capan-1,71466578,4.438385256519558
YH-13,4578,5.582049884276352
MFE-319,984333,1.38399215990863
RKO,159324,3.5523933893017583
HDLM-2,49793307,-3.2603593767140846
SIG-M5,702558,5.6397289092700005
NCI-H716,11497983,5.9194156456451115
SUP-T1,4096211,0.01724934711339
BT 239,26596,-0.3538471097190154
MFE-319,11964036,2.3078120534713022
SK-N-SH,11364421,-3.2430906160419055
SK-MEL-3,135875424,4.254537076795971
HDLM-2,3025944,3.777206314731024
HuH-28,JQ-1-MK-0752 (1-1 mol-mol),-3.751890411114034
KMS-26,4259181,-1.695112614082753
HARA [Human squamous cell lung carcinoma],ISOX-bortezomib (250-1 mol-mol),0.5382016887520487
HOP-92,71751553,4.539782001552626
EoL-1,51037431,0.9479983595054025
MG-63,675434,4.5590347422962045
HDLM-2,6610216,4.231283339415114
L3.3,11455910,1.84757483649511
RCH-ACV,25195348,3.575236344855164
SK-N-SH,44486219,4.355316681168146
RCH-ACV,doxorubicin-navitoclax (2-1 mol-mol),-4.276469672156923
HuH-28,44489367,4.3287624589651035
EHEB,675434,4.751173059410473
EHEB,56963564,-0.4749386373308739
L3.3,54649381,4.658116253691046
PK-59,46398810,2.7267384193552138
HT-1197,11427553,3.679447791521151
PC-14,409805,5.400742947036561
RCC10RGB,BRD-A02303741-navitoclax (2-1 mol-mol),1.3031528560505037
VMRC-LCD,11427553,0.3807036947246872
SW1116,11364421,0.9990055379738184
VMRC-LCD,navitoclax-sorafenib (1-1 mol-mol),1.3015311216522478
BT 228,54678924,1.6160563755662858
HOP-92,31703,0.2945245175747765
JeKo-1,56946209,-4.833099647488267
NCI-N87,10385095,0.9731458206829144
TCCSUP,9927531,4.77726983491798
Capan-1,4705,2.4129084207631943
BT 428,60750,-4.5752474299452
NCI-N87,1641662,2.907963520285112
RCM-1 [Human rectal adenocarcinoma],71466380,4.350719813683452
JeKo-1,2113511,4.203687174612869
EHEB,24785538,2.1074242406827044
SNU-719,107970,1.9431075169363972
HuH-28,25150857,2.0598466888880855
SIG-M5,52912189,-1.1107508343796042
SNU-719,46907787,-0.0717572497015621
KU-19-19,4788,5.856744699338042
RCM-1 [Human rectal adenocarcinoma],12003241,-1.4246438063204208
KALS-1,9866186,2.4205776783426023
SK-UT-1,11955716,-2.40204232410625
MG-63,2871966,0.757655495380547
P31/FUJ,5470400,3.6840145170482383
BT 239,15983966,0.5280588343641246
EoL-1,54639665,4.29545945108559
EoL-1,168313016,2.0659145537185792
SK-UT-1,selumetinib-PLX-4032 (8-1 mol-mol),4.7803100019835005
AML-193,3634881,1.9030689789674349
IGR-37,10385095,1.6634682367301483
NCI-H2009,44607531,0.9822487023795796
SIG-M5,6918328,-0.986921545326446
RPMI-8402,168312962,-2.439046353391515
KMS-26,24772860,-3.367525017190178
TCCSUP,JQ-1-UNC0638 (2-1 mol-mol),6.070182975256097
AML-193,vorinostat-carboplatin (1-1 mol-mol),1.5919153481042276
EoL-1,53481919,1.7518290991474894
IGR-37,6436223,-4.3796769529138775
HGC-27,navitoclax-sorafenib (1-1 mol-mol),1.3784196393701529
RCH-ACV,136227331,3.661348982396994
HuH-28,serdemetan-SCH-529074 (1-1 mol-mol),2.297027849464172
BT 239,46907787,1.748010103728736
PK-59,44185566,1.9144325304784533
HGC-27,71304818,1.457484473344008
BT 232,54678924,1.700963067646327
PC-14,9952709,3.5197745889529983
HARA [Human squamous cell lung carcinoma],11507802,1.3937860028408913
BT 428,6852167,2.9431146688699275
HT-1197,135440466,3.2163865780969
SK-BR-3,54618164,4.481980343250785
BEN,23725625,5.259809129181273
VMRC-LCD,53232,2.9104808260764767
VMRC-LCD,46907787,0.5475756209741912
SK-BR-3,54143018,-0.2850908992862056
Capan-1,54618771,1.2966911040963736
SK-BR-3,56946209,-2.9488786143348986
NCI-N87,136227924,3.040461203265333
A3/Kawakami,208908,1.8645882694730205
BT 428,122327,5.820143762592548
KHM-1B,25183872,-1.3979896685185154
TCCSUP,15953870,3.2845347165405623
EHEB,selumetinib-tretinoin (2-1 mol-mol),4.625312744108104
HDLM-2,9866186,0.9667956625970776
BT 245,vorinostat-navitoclax (4-1 mol-mol),-1.0149929699055316
RPMI-8402,24964624,0.249743610671991
EoL-1,2113511,2.938348788571882
WM793,25062766,2.181773031529765
NCI-N87,44589607,2.3758044537421026
NCI-H2081,23582824,1.3516004716610026
WM793,serdemetan-SCH-529074 (1-1 mol-mol),2.1116726629279747
IGR-37,36462,1.327331458277256
BT 239,72734382,4.468226855931404
HCC2108,241158,3.0824386157377197
EHEB,44137675,1.9983784239702664
MG-63,11625818,4.698262498489251
NCI-H1092,11485656,1.8493866648869597
HOP-92,9933475,1.6031982514232128
SCC-25,24821094,-2.3133798043935045
SW1116,3136844,4.749108435900641
NCI-H647,400769,-0.9222524567413938
HT-1197,156414,1.5339590025962693
VMRC-LCD,67291369,2.386670164859032
VMRC-LCD,6917907,-5.723466368212933
MSTO-211H,6917907,-6.416473568686441
IGR-37,753704,6.735926792205307
MSTO-211H,3025986,-0.6925850648320051
VMRC-LCD,448949,1.9211227091767271
RKO,16725315,5.119694523443236
RCH-ACV,445643,3.32771554215392
NCI-H2081,72193861,0.0859869526456893
HT-1197,11228183,2.2776172755734865
NCI-H2081,10026128,5.597175491927259
BT 239,3062316,2.0966305389124744
NCI-H2081,119607,5.212257732916615
PK-59,5460769,5.2141758944681635
HuH-28,vorinostat-carboplatin (1-1 mol-mol),3.1323026868283677
HuH-28,selumetinib-vorinostat (8-1 mol-mol),2.5161900130942176
JeKo-1,44607531,0.9228570851865878
Capan-1,5329102,2.5314532033710067
SNU-175,23635314,-1.7175761216147465
BT 245,6914657,-5.090126903325334
NCI-H647,54618305,4.3213835050384315
BT 245,1714884,3.4976834364725784
RCC10RGB,6610216,4.531223922644925
MSTO-211H,10302451,2.2723798321327826
SK-MEL-3,445455,6.145439143215912
BT 245,5282054,3.505769359703823
HT-1197,selumetinib-JQ-1 (4-1 mol-mol),0.9011980112854324
L3.3,11404337,0.7171912876466348
HCC2108,969516,2.879700977011491
EoL-1,salermide-PLX-4032 (12-1 mol-mol),2.8811524498104943
HuH-28,tanespimycin-gemcitabine (1-1 mol-mol),5.502103027569167
SK-MEL-3,54618771,0.906293998556286
MFE-319,24771867,4.310253183233504
BT 245,navitoclax-PLX-4032 (1-1 mol-mol),0.016412534354773
L3.3,vorinostat-carboplatin (1-1 mol-mol),3.49555187429186
RCM-1 [Human rectal adenocarcinoma],2749,1.6658310830765266
NCI-H716,46215462,1.3325350435416894
RPMI-8402,60750,-3.921556834382599
NCI-N87,71466578,5.1108247117444865
NCI-H716,71466445,4.25396332421541
MFE-319,71466380,5.9327727025153205
KMS-26,6610355,3.356576447870165
RCM-1 [Human rectal adenocarcinoma],2945648,2.1413236480438544
HDLM-2,969516,2.5201785473848592
HOP-92,11609586,3.1459480983105497
HDLM-2,9929138,7.073059321939057
SIG-M5,6918837,-5.2531062558619395
NCI-N87,46191454,1.700307220457573
EoL-1,5281321,-4.9353742470461714
KMH-2,60700,-0.8567336285722738
KYSE-450,66577038,3.5261008260070232
BT 245,11257553,1.0028677037168507
MSTO-211H,9903786,1.212702371904443
KU-19-19,46191454,1.4474607873871597
EHEB,9825149,2.329615332433461
SCC-25,3854666,1.9347031057126212
EHEB,49793307,-3.85106101427491
BT 228,4917,2.0521135176210614
WM793,11485656,2.688663515558037
NCI-H716,46926350,-4.439844597077301
KU-19-19,107985,-2.420790531142743
L3.3,11626560,2.44177024695359
RCM-1 [Human rectal adenocarcinoma],322968,4.629178663880947
RCH-ACV,5291,3.4908324376405795
PC-14,selumetinib-BRD-A02303741 (4-1 mol-mol),1.6810269495399257
RPMI-8402,3854666,0.737448430208504
KMS-26,6918289,-7.849003358761914
HuH-28,5460769,2.112533024093989
KYSE-450,44607531,1.4871997171976696
AU565,JQ-1-MK-0752 (1-1 mol-mol),3.9179209493370175
SK-BR-3,15953870,2.675794235884171
EoL-1,135411,-1.9769058733801703
RPMI-8402,148198,-4.480624262249758
BT 245,446155,3.758613505986336
PK-59,5470400,2.668713102290907
KHM-1B,6917907,-6.365498814306295
HuH-28,49793307,-1.576287296372475
YH-13,9907093,4.406851873711971
Capan-1,25183872,-1.6529257202442298
HuH-28,24748573,1.4711585796197095
MFE-319,5351362,1.9312040521976863
WM793,6610216,4.179764818643997
TCCSUP,4788,5.506988938595266
A3/Kawakami,25126798,1.1688790944067855
SK-UT-1,56946209,-1.4025300669134206
RKO,6918328,0.803085247134139
BT 228,168312962,2.7272064785136902
SK-N-SH,9803433,4.463716908275682
KYSE-180,23635314,-1.91549509503103
BT 428,135421197,1.0281432833092603
EHEB,11640390,3.640025607015964
RCH-ACV,navitoclax-pluripotin (1-1 mol-mol),-2.7356668510910453
KYSE-450,5278396,4.032614684188798
PC-14,24901704,2.3587345537063538
SK-BR-3,navitoclax-birinapant (1-1 mol-mol),3.9073419106292473
NCI-H2009,SNX-2112-bortezomib (250-1 mol-mol),-2.754596306388576
AU565,erlotinib-PLX-4032 (2-1 mol-mol),2.347179893247943
HT-1197,6450551,3.5903477337360057
AML-193,vorinostat-navitoclax (4-1 mol-mol),-0.3217720116811762
KMH-2,5460769,1.5529919827376786
NCI-H1092,675434,3.921847980999154
P31/FUJ,219104,1.0946129740431632
P31/FUJ,15953870,2.7000087530897776
KYSE-450,12003241,-0.0119879221972118
JeKo-1,66577038,3.1265855104255293
MSTO-211H,16725315,3.290115596802182
SNU-719,159324,3.1054428054736793
RCM-1 [Human rectal adenocarcinoma],702558,5.773616649362023
PC-14,5282054,4.090465058158363
EoL-1,10427712,2.0815182333702653
A3/Kawakami,51037431,1.2982874412701566
VMRC-LCD,44607531,1.4694778415761305
PC-14,54678924,3.486960640257901
HT-1197,2113511,4.32009827001224
SK-UT-1,24772860,-2.1685737338015505
AML-193,3038522,2.029352719886159
HARA [Human squamous cell lung carcinoma],24748573,1.9169510591730587
EoL-1,selumetinib-piperlongumine (8-1 mol-mol),-0.3307673386487165
WM793,25126798,4.114576992305207
KYSE-450,23635314,4.2538404105785
NCI-N87,56946209,-4.157058230951839
BT 245,11719255,3.8696223772622753
KHM-1B,alisertib-navitoclax (2-1 mol-mol),-2.308284106027781
BT 245,9868037,3.6125967873896543
A3/Kawakami,11175137,3.661158377167222
RCH-ACV,1285940,6.198428951262983
HOP-92,11964036,1.3443523009180862
NCI-H1092,serdemetan-SCH-529074 (1-1 mol-mol),2.0594961272701453
NCI-H1092,64971,4.337644758899671
BT 239,9549297,1.887182274108706
BT 232,11234052,4.902206061102502
NCI-H716,6918638,0.7980253522475573
SCC-25,11977753,-5.800252848787052
BT 239,54619267,2.022530468415393
KHM-1B,322968,1.990474592363433
MFE-319,2871966,1.6614448488950515
KYSE-180,969516,2.4529447975335117
MFE-319,3825829,3.994579969985173
NCI-H2081,73707371,5.9412545737381075
BT 428,71729975,0.8355335318792699
KMH-2,serdemetan-SCH-529074 (1-1 mol-mol),1.597675127922174
MSTO-211H,16038120,0.2471942161915729
NCI-H2081,216345,3.6466668059147054
SK-N-SH,24785538,-1.0372342319186358
KYSE-450,10074640,3.7244937676634735
IGR-37,54618771,0.3967957480696406
Capan-1,122327,6.169926262791054
TCCSUP,11234052,4.361103658415106
JeKo-1,3025944,4.0625685961395925
P31/FUJ,navitoclax-piperlongumine (1-1 mol-mol),-0.4738069202441977
A3/Kawakami,selumetinib-BRD-A02303741 (4-1 mol-mol),4.954304172385198
HCC2108,446155,1.94698082724245
RKO,6252,0.5352436981906653
SIG-M5,11228183,1.6399432172623911
MFE-319,46843906,3.702658803393831
KYSE-180,53232,2.4967121988382983
HT-1197,11214940,2.236695176502006
KMH-2,409805,3.8048240258679256
KU-19-19,SNX-2112-bortezomib (250-1 mol-mol),-1.0111363937138018
SUP-T1,9929138,6.13855096958909
KMS-26,66890843,2.0590615299818302
SIG-M5,11455910,0.7552766623437589
YH-13,24856436,1.6547595238479382
RCH-ACV,31703,-4.692039274973977
KALS-1,6918736,-1.3064714954050471
BT 228,44491742,3.950846154014159
VMRC-LCD,44202524,1.4173180675974373
HT-1197,637858,1.1987341905705466
EHEB,53232,2.0797733628932
A3/Kawakami,71751553,4.362373152095837
KALS-1,375860,0.6178760797597267
BT 228,BRD-K55473186,1.7675168399279242
KMS-26,salermide-PLX-4032 (12-1 mol-mol),5.377619230397928
AU565,alisertib-navitoclax (2-1 mol-mol),2.3316727608646266
IGR-37,navitoclax-MST-312 (1-1 mol-mol),1.2165648457601097
RCM-1 [Human rectal adenocarcinoma],4521392,4.2393817604075705
BT 428,9549297,1.6281936648906872
SK-N-SH,6918638,-0.7450895378891518
RCM-1 [Human rectal adenocarcinoma],52912189,1.6859492587685891
AML-193,4261,1.0478618944886964
NCI-H716,3025944,4.548449736148048
EoL-1,44241473,3.8558981906070695
KYSE-180,4477,0.5315017524747986
HDLM-2,1750826,-1.1596708868444765
SK-UT-1,5978,-1.5541444209487143
RCC10RGB,216345,4.504390062805713
HuH-28,selumetinib-BRD-A02303741 (4-1 mol-mol),4.5989236312045
MFE-319,11657048,5.798827686603886
NCI-H2009,168312962,3.455210391348572
SK-MEL-3,9866186,3.272293778567184
YH-13,374536,3.765039330811098
YH-13,46398810,3.0158285746499645
KMS-26,44486219,2.9468918640338484
BT 245,12003241,-0.4272477548788383
MG-63,navitoclax-MST-312 (1-1 mol-mol),0.7294498846639642
NCI-H1092,5951923,4.507769777348797
SNU-719,16741245,6.4992392154897525
SK-MEL-3,2746,3.317338205228237
PC-14,selumetinib-MK-2206 (8-1 mol-mol),0.7353160190832573
HT-1197,44185566,2.9493436246034097
RCH-ACV,25102847,1.8687247230771409
KHM-1B,2945648,1.137982843837139
HT-1197,46398810,3.584304423029014
SK-UT-1,15983966,-3.143048923201685
SK-N-SH,46215462,1.6171172978185968
BT 239,25062766,1.72479000350824
KYSE-450,136227924,3.5350495950730645
SK-UT-1,46398810,3.3711222617391456
PC-14,46843906,3.8082460843083825
AU565,24772860,3.3222909323637455
HT-1197,5291,4.044800265096848
JeKo-1,676352,1.6816341278080182
KMH-2,5470400,-1.131447733049698
SK-BR-3,5978,-3.670964258754211
SCC-25,71466445,2.1328221809706336
AML-193,135659046,2.987496818828137
HARA [Human squamous cell lung carcinoma],5113032,5.077717215414557
Capan-1,navitoclax-pluripotin (1-1 mol-mol),-0.5129102388069634
PK-59,135411,1.4779223783785622
P31/FUJ,136227924,2.3905530687579497
HOP-92,2746,3.1946789045133217
L3.3,6252,0.2429415263286948
BT 428,2749,1.0613938203741178
TCCSUP,322968,4.50290577769941
SUP-T1,439501,-1.5599134432816564
NCI-H2081,42642645,-0.9606541390632763
HT-1197,135411,2.585993011625538
SNU-719,selumetinib-GDC-0941 (4-1 mol-mol),-0.9974612802611444
SK-MEL-3,67291369,4.102363107369417
AU565,23582824,-0.1593812680979049
SIG-M5,54626689,4.599183359939461
YH-13,16659841,3.3586443316598675
AU565,2746,2.9112036552039737
SK-N-SH,44197249,1.2076436443184098
SIG-M5,9911830,1.8905574063855235
JeKo-1,67156097,-2.4403093235962254
NCI-H2081,168313200,2.364564714683474
SK-N-SH,11609586,1.7647701112965206
P31/FUJ,24951314,0.294555023880993
KHM-1B,400769,-0.7563953043015217
MG-63,53232,0.8369388256831117
RPMI-8402,17759555,3.0217311877382023
AU565,56946209,-4.483098881483793
BT 239,3676137,4.93857199044607
SK-UT-1,10410894,3.1994132701076308
NCI-N87,702558,5.013224249903468
MSTO-211H,24753719,3.2448003358152286
NCI-H716,selumetinib-JQ-1 (4-1 mol-mol),-0.1504205000857164
KMS-26,446155,2.940722770552094
SCC-25,3025944,3.7816805896098367
PK-59,4477,2.9519162685553666
L3.3,piperlongumine-MST-312 (1-1 mol-mol),2.794540893097308
AU565,71304818,2.0398490425817144
YH-13,135411,1.4167541971469908
SK-BR-3,23582824,-0.4364392400643932
KMS-26,5746,-0.0041095130018496
NCI-H2081,148198,-5.584711698479823
HOP-92,46843906,3.507310480432144
RPMI-8402,5329102,1.009346950116501
KHM-1B,135411,-0.0530336141709349
P31/FUJ,4259181,-1.476581151251805
HOP-92,168313200,2.171997683243581
VMRC-LCD,46943432,3.939748255334783
NCI-H1092,65628,3.8308798172666183
MSTO-211H,tanespimycin-bortezomib (250-1 mol-mol),-0.4503897657817667
MSTO-211H,1242560,2.686361074048806
PC-14,11152667,-3.213893550122198
SK-UT-1,46199207,3.7020798689093466
RPMI-8402,19582717,2.8580171740334626
SNU-175,67156097,-2.1952878162066405
HT-1197,969516,2.5200444298294387
BT 428,11719255,3.4713354936656207
VMRC-LCD,176870,4.38101916210119
VMRC-LCD,44462760,4.73756529671491
SCC-25,441298,3.302481350491699
NCI-H647,9933475,1.8935307197114757
HCC2108,219104,3.718593761594277
SCC-25,16736978,0.5181010227665899
KHM-1B,107970,1.817903354032074
RKO,25183872,-1.1635703485572924
HARA [Human squamous cell lung carcinoma],24856436,-1.2762108597510684
BT 232,2708,5.603516637873742
BEN,159324,3.690228423182978
NCI-H716,11152667,-0.7087449737081221
SK-MEL-3,119607,5.884245914497075
SNU-719,11175137,2.8332391761617295
KU-19-19,11152667,0.8748891502312
NCI-H716,24797083,1.803306664358289
KHM-1B,5282054,1.6499895899015693
HGC-27,9967941,2.308439022822085
HuH-28,107970,2.16988663827051
HGC-27,11222830,0.5736896434231926
RKO,20959075,-2.9107192765247536
NCI-H716,5311281,1.9360045135417288
RKO,3815108,2.4813915623878264
PC-14,5746,1.1464831809049938
KYSE-450,11222830,1.7445073399277342
EHEB,969516,2.488094363127618
SCC-25,carboplatin-UNC0638 (2-1 mol-mol),3.1870205775520826
BT 232,5978,4.473153569045574
PC-14,carboplatin-etoposide (40-17 mol-mol),3.6148280985374193
A3/Kawakami,25154868,3.6431080855809697
BT 228,262093,2.371515805144491
KMS-26,44507138,1.099660595135721
KYSE-180,5328940,1.5841327354029733
RPMI-8402,73707398,0.6686223698322713
IGR-37,9907093,5.9089173756877855
HGC-27,5284329,2.444872353697559
HDLM-2,67156097,-2.169811124886079
YH-13,5278396,4.665825083326453
BEN,selumetinib-JQ-1 (4-1 mol-mol),2.435867815788394
HDLM-2,6917907,-6.215702300426253
WM793,613753,3.3762732235563733
Capan-1,36462,2.302180393835448
IGR-37,5284373,3.7500326723127384
RCH-ACV,25154868,3.6451033045541106
EoL-1,119607,2.8823643879157133
A3/Kawakami,71466578,1.5679419732297517
HuH-28,9936388,2.0438791197733632
EoL-1,11178236,-3.605466065519878
RPMI-8402,387447,-4.932828758424725
RCM-1 [Human rectal adenocarcinoma],carboplatin-etoposide (40-17 mol-mol),3.7784194640429822
BT 245,44607530,0.9122791762683272
RCC10RGB,6917907,3.54732574828972
NCI-H647,10427712,5.180324828187056
TCCSUP,216345,4.067577836181339
SUP-T1,25150857,1.0922391840459302
BT 245,10410894,2.9810995953961585
BT 228,2742550,2.4792885987707605
SIG-M5,44486219,4.154501399018368
KHM-1B,15547703,2.9789166957763045
NCI-H2081,1750826,-1.4408995085202256
BT 245,135999136,1.3733623937615662
KMH-2,60750,-4.113460548744094
YH-13,12003241,-0.7443010060517422
SK-UT-1,3825829,4.314395004241866
SK-MEL-3,4477,0.4229243601103183
Capan-1,2113511,5.814704716814982
HARA [Human squamous cell lung carcinoma],25195348,4.01900560130828
TCCSUP,3038522,3.5335989350872716
PK-59,387447,-2.937224287200573
HuH-28,25183872,-1.1977893916407416
PC-14,676352,2.34047579855133
RCH-ACV,72376,-3.8667771312116264
NCI-H2009,67291369,0.975633217461442
HT-1197,3503,1.5961096622928206
SK-UT-1,11455910,0.1513173468225572
RCH-ACV,2733487,6.4348559829034695
BT 239,4915,4.1784431411283425
KALS-1,9952709,3.4555689948164243
KMH-2,24951314,-0.1974890208476558
AU565,54618795,2.974070020268914
TCCSUP,3025986,0.0984647564914155
TCCSUP,24180125,2.590806345958597
WM793,54618164,4.258619603305177
NCI-H647,25150857,2.281720441877708
KMH-2,6505803,-1.1271558599433815
NCI-H1092,5978,-1.8741882782335129
NCI-H647,9936388,1.0931922000405532
PC-14,54454,0.5388288870311388
RCC10RGB,crizotinib-PLX-4032 (2-1 mol-mol),2.89623675646366
HCC2108,135423438,4.347791872690299
TCCSUP,11228183,2.2108434625291937
KU-19-19,6917907,-4.52253618895935
KU-19-19,51037431,1.6044173216619535
NCI-H1092,53392493,1.721482373156668
VMRC-LCD,73707398,0.967348855291882
SNU-175,119182,-2.0078920113499343
NCI-H1092,6914657,-5.953361692198434
WM793,168312962,3.5645743239810574
KYSE-180,44486219,4.201637826044419
EHEB,387447,-4.8695156526166175
SK-N-SH,2733487,6.422489522192857
YH-13,vorinostat-navitoclax (4-1 mol-mol),1.848157138564096
BT 428,57519531,1.7002973533738803
RCH-ACV,9936388,-7.0347905205950765
HuH-28,17759555,3.76716786174239
VMRC-LCD,148198,-4.056335514777046
RCC10RGB,1750826,-3.277944046627699
MG-63,24964624,2.290610083852092
SK-UT-1,5280436,0.2448868472823603
KMH-2,71304818,1.835622422813945
RCH-ACV,44185566,1.7189761987426309
HCC2108,72193861,0.1943107246781484
HT-1197,12001922,1.7997649435605243
BT 239,5282054,2.6612115813316133
SK-MEL-3,262093,2.386841982025131
IGR-37,9803433,4.045167348325523
SUP-T1,11404337,-1.5860390885647615
HuH-28,676352,2.032189927694234
AU565,24180125,2.1910645714042634
EHEB,159324,2.208250970812642
KYSE-450,16722836,3.1649590100923732
NCI-H1092,25126798,3.974673346500284
AML-193,navitoclax-PLX-4032 (1-1 mol-mol),2.54538838358564
RPMI-8402,46191454,-0.4669745203398311
NCI-H716,selumetinib-GDC-0941 (4-1 mol-mol),0.5800821260708712
L3.3,176870,2.4076894274707947
MFE-319,5328940,2.2317569199382317
NCI-H1092,25105715,3.7576457289964416
A3/Kawakami,3062316,1.713448070104182
BT 428,SNX-2112-bortezomib (250-1 mol-mol),-3.0058868319151406
KHM-1B,2742550,3.1994406451662045
RCM-1 [Human rectal adenocarcinoma],400769,-1.066885564414268
NCI-H1092,3854666,1.7831562708521254
IGR-37,46398810,1.961975603363092
Capan-1,navitoclax-sorafenib (1-1 mol-mol),2.800145717171437
HGC-27,46191454,-0.1810264887232431
HCC2108,2708,7.692601684388862
BT 239,11612883,1.3792558038056648
HGC-27,24978538,1.0374574807501538
BT 239,441298,3.2861074501938883
NCI-H647,5278396,3.423016666706127
SK-BR-3,3689413,-0.6055139082378386
HuH-28,89928392,0.8358525024495699
RCH-ACV,11497983,-2.6061749578134976
TCCSUP,5280436,3.7871287976810097
IGR-37,9915743,1.4211592255405934
HDLM-2,60750,-2.185977303575012
PC-14,3081361,-2.434323823830516
TCCSUP,11626560,1.9975269088878715
EHEB,17755052,0.9739934122056938
NCI-H716,11612883,-0.1108469122387739
HT-1197,6505803,0.6995636823670472
PC-14,57519531,1.535196812994606
KYSE-180,24180125,4.03262772641334
L3.3,3689413,1.7908878640591075
KMS-26,168313016,2.9457781921447146
YH-13,3634881,3.1869210851626075
KU-19-19,216345,3.688803948438149
RCH-ACV,selumetinib-JQ-1 (4-1 mol-mol),-0.4227837844361623
BT 239,31703,-4.200846073505667
KMS-26,124202324,-1.474652039404999
NCI-H647,71751553,4.622172981641497
KYSE-450,tanespimycin-gemcitabine (1-1 mol-mol),0.8586762777270994
SCC-25,selumetinib-BRD-A02303741 (4-1 mol-mol),0.6495300948611311
RCH-ACV,135875424,3.077448855642363
NCI-H647,71304818,2.1232430442903008
AML-193,25227462,1.084846242806632
SCC-25,208908,0.1902541724816732
NCI-H647,10172275,4.318443891650209
AU565,4259181,-0.781957409712965
HT-1197,25102847,2.798104629518369
KALS-1,46843906,4.101488431064947
AML-193,9903786,0.8964959082150169
BT 239,9911463,2.823437133731174
HGC-27,135440466,2.514560665723255
RCC10RGB,11612883,4.41570881394896
SW1116,2874250,4.203693908258186
MG-63,11427553,1.787943273029307
KALS-1,676352,2.435567101725909
EoL-1,375860,-1.005222990918516
HT-1197,5738263,3.7552670799393177
BT 428,11396600,2.03305192481219
HT-1197,24821094,3.4464620046656465
BT 239,10113978,3.3062535755307008
TCCSUP,400769,-0.9121100031738296
SK-N-SH,4705,2.8516151129930396
P31/FUJ,alisertib-navitoclax (2-1 mol-mol),-2.72541188794455
KMH-2,66577038,2.1103594166698483
MFE-319,16720766,2.6419600005427837
KYSE-180,9926054,1.7654325832877988
JeKo-1,11955716,-2.197849546405489
SW1116,1750826,-1.5935318567470695
KHM-1B,1242560,-1.3628719812202528
HARA [Human squamous cell lung carcinoma],6610216,4.810637550807952
BT 228,11238147,3.5785421883842683
A3/Kawakami,46215462,1.452403276594091
RPMI-8402,3384730,0.5466430591445036
HGC-27,2126,3.5780474357172265
EHEB,tanespimycin-bortezomib (250-1 mol-mol),-0.1449440337171298
EHEB,89183176,4.165917160627171
MG-63,54596558,4.367042408829977
RPMI-8402,25150857,1.5683323780883651
YH-13,25154868,5.479535858900875
NCI-H647,445643,4.105552086208616
KHM-1B,5460769,1.8331932839616616
NCI-H647,322968,4.968961246183668
P31/FUJ,16722836,0.3472605187822769
HGC-27,11964036,-0.3586511875644274
KALS-1,selumetinib-tretinoin (2-1 mol-mol),4.367733793928525
IGR-37,216239,3.16431254139908
JeKo-1,6914657,-7.14048032113608
SW1116,selumetinib-tretinoin (2-1 mol-mol),-1.1776393312637268
NCI-H1092,5460769,5.922318384562557
BT 428,2742550,3.051967949404776
SK-BR-3,navitoclax-MST-312 (1-1 mol-mol),1.086520611802461
HOP-92,25126798,4.53909325590885
SIG-M5,11213558,1.9892324871516665
BT 245,25062766,2.884724273285125
HDLM-2,445091,4.455947623866426
SK-MEL-3,11626560,1.60612058404091
YH-13,42642645,0.7428971462414599
PC-14,44819697,2.88284620615727
TCCSUP,72734382,5.972631043229241
KMS-26,10077130,2.09298306286886
AML-193,36462,0.2235615608129252
L3.3,52947716,-5.849313058865459
AML-193,54596558,4.548394826065483
EHEB,16741245,4.711370152707264
NCI-H1092,89928392,0.7576351526304943
TCCSUP,49793307,-2.5102688291438557
NCI-H716,16725315,5.367817781341624
P31/FUJ,637858,0.7903103947120294
NCI-H647,136227924,2.9483035397305164
NCI-N87,ISOX-bortezomib (250-1 mol-mol),-0.226060851576525
NCI-N87,JQ-1-navitoclax (2-1 mol-mol),0.0624511044953225
NCI-H716,72376,-2.515520372782626
RCH-ACV,49836020,-2.2684832321475774
RKO,54143018,-0.3751060369564643
KHM-1B,67156097,-2.0770884732643493
HT-1197,11494412,3.79217525742206
EoL-1,6505803,-1.4779318620644195
SK-UT-1,2828334,6.192773622415013
SK-BR-3,JQ-1-vorinostat (2-1 mol-mol),0.5500484419401577
NCI-H716,44589607,3.2627059074004094
TCCSUP,409805,5.441662511172961
SUP-T1,448949,0.908429400113907
A3/Kawakami,JQ-1-UNC0638 (2-1 mol-mol),-2.039254200709544
MSTO-211H,72193861,1.6065459514404858
NCI-H2081,9926054,1.7325996665522785
HDLM-2,11364421,-4.982673071010853
TCCSUP,6505803,-2.3370703799020323
IGR-37,71729975,0.7647548089190389
HOP-92,675434,5.048535015308364
JeKo-1,675434,4.192137602040157
MG-63,9884685,0.4591360322389684
NCI-H2081,613000,5.284324483502851
BT 232,24964624,2.7394801431949847
BT 245,11178236,-5.256571205029804
KHM-1B,3689413,-2.4012228391908783
KYSE-450,4261,3.512938253123631
P31/FUJ,5566,2.621678413077409
PC-14,1641662,3.170530164943573
NCI-H647,11364421,-0.293156976087633
NCI-H647,44819697,1.2042372907019998
SCC-25,25150857,1.8419439702000249
RCM-1 [Human rectal adenocarcinoma],12001922,1.85954377189608
BT 239,2871966,-1.0225454966743093
HCC2108,11427553,2.403363421771595
SCC-25,11612883,2.1655697401914407
SK-N-SH,216239,1.7160668921628042
KALS-1,67156097,-1.4831183343657517
PC-14,2874250,4.751781896690002
HuH-28,24771867,1.7711464010048796
AML-193,444795,4.361597558982522
KALS-1,25062766,2.4712832819753277
JeKo-1,11485656,1.8076114759672557
NCI-H716,3552672,2.2968101007084436
NCI-H2009,9903786,1.8298580590992315
JeKo-1,24856436,-2.277235589011733
RCH-ACV,25183872,-0.1890059741464272
PC-14,24889392,3.614733856805847
NCI-H2081,11964036,1.4263107800421957
KYSE-450,9840324,5.8174625933687265
RKO,107985,-4.24085601271806
SK-MEL-3,135398516,2.749197589012315
AML-193,135423438,1.545921076680538
SK-N-SH,10427712,4.748746580508719
YH-13,46907787,2.497821160225489
AU565,6918328,-1.0169109160359904
YH-13,3689413,-1.970237829798131
NCI-H1092,JQ-1-UNC0638 (2-1 mol-mol),3.1709081396689496
KHM-1B,navitoclax-birinapant (1-1 mol-mol),2.2294776266179057
NCI-H2081,9866186,-0.1809494281387173
YH-13,387447,-4.910282103327875
EHEB,36314,1.738223816404837
SW1116,446155,4.031620533219179
SNU-719,3062316,3.2966012793545953
BT 245,53392493,3.2440450832538343
AML-193,JQ-1-carboplatin (1-1 mol-mol),0.2220532745153866
A3/Kawakami,16725315,5.1266865620260615
HCC2108,675434,4.657843907712605
SCC-25,9825149,1.4739218924040065
SK-N-SH,11656518,0.7627367771064052
RPMI-8402,16038120,-0.4475349007572351
RPMI-8402,375860,-0.8555405736756128
SK-UT-1,11625818,5.186074210783149
IGR-37,5311,1.1430293991525324
SUP-T1,124202324,0.3623950223938539
VMRC-LCD,alisertib-navitoclax (2-1 mol-mol),-2.2918651490104356
SUP-T1,11175137,1.8026631846522507
A3/Kawakami,65628,3.260470610713876
EHEB,25150857,2.0197951403724224
KMH-2,24772860,-2.338344331022242
BT 232,3062316,3.1845921786754348
KYSE-450,crizotinib-PLX-4032 (2-1 mol-mol),2.9466068447817126
SK-BR-3,136227924,2.8779705448471975
KHM-1B,10302451,3.4740404834517156
MG-63,135421197,2.3239487693953627
NCI-H1092,51037431,6.3894384839452725
VMRC-LCD,selumetinib-MK-2206 (8-1 mol-mol),4.069205658952885
PC-14,19582717,3.344872206545546
JeKo-1,135411,-0.2186773636403685
SIG-M5,5328940,0.8501857610074691
HCC2108,216345,4.433678918617411
EoL-1,72376,-4.98531225523476
KMS-26,9884685,-2.486464178547567
KMS-26,9903786,0.9658613723306017
HOP-92,24779724,4.387185953628773
SIG-M5,135411,0.5082219987847001
SK-MEL-3,53392493,3.304672901887782
HuH-28,73707398,0.8791610389008363
HARA [Human squamous cell lung carcinoma],11222830,1.4006503885864872
NCI-H1092,44462760,4.232811059835202
NCI-N87,selumetinib-PLX-4032 (8-1 mol-mol),3.8712321401270406
RCH-ACV,5460769,1.517415725106548
SK-N-SH,19582717,4.486490794248497
VMRC-LCD,6450551,1.1609878192179426
HGC-27,54618305,4.217377303978183
SIG-M5,4261,1.1308382997094442
NCI-H2009,9907093,4.391694288558607
KALS-1,72199292,4.061632661938466
SK-MEL-3,44566777,3.7534937162001856
AML-193,UNC0638-navitoclax (1-1 mol-mol),1.223470800239613
KHM-1B,docetaxel-tanespimycin (2-1 mol-mol),-6.647221860436541
RPMI-8402,44491742,5.171904167752256
RCM-1 [Human rectal adenocarcinoma],10296883,4.143855024915708
KU-19-19,60700,0.8700483452505813
AML-193,selumetinib-PLX-4032 (8-1 mol-mol),2.0365252427245744
VMRC-LCD,89928392,1.359950737230542
HOP-92,53495165,1.3306772187912803
EoL-1,11707110,-5.721795492586231
NCI-H647,122327,3.9502860337297863
JeKo-1,10385095,0.5289255976933436
WM793,24785538,4.089053013969586
NCI-H2081,753704,4.35902455138568
KHM-1B,73707440,5.196065246508486
SK-N-SH,107985,-2.488646937508133
PC-14,46215462,0.6558574797092876
RCH-ACV,969516,2.3748072880119366
BT 239,4788,3.58487402672712
RCC10RGB,24775005,3.7293513155953737
HDLM-2,3854666,1.016562395835814
MG-63,60700,-0.1691173082170676
SK-MEL-3,426756,4.497453223086863
SCC-25,9935249,3.4774309357547413
P31/FUJ,25150857,2.053516150415863
KHM-1B,11640390,-1.4659593094548573
SCC-25,148198,-2.3874045507068895
HDLM-2,4521392,4.113253229073159
NCI-H2081,decitabine-carboplatin (1-1 mol-mol),5.393040193886032
BT 245,753704,4.7847711717833725
AU565,9549297,3.94244046983191
SUP-T1,26596,-4.2216278033342105
HDLM-2,107985,-3.6724604658720623
MFE-319,46215462,3.1953350174343056
KYSE-180,selumetinib-vorinostat (8-1 mol-mol),4.1823671735531835
NCI-H2009,638278,3.464543124143687
MFE-319,10302451,3.878997082885385
BT 245,3038522,2.4469235067564465
BT 232,6505803,-2.078004846595285
RCH-ACV,54619267,3.0894603256696485
KMH-2,441298,0.9682769144706788
MG-63,16722836,1.926597038083943
AML-193,selumetinib-GDC-0941 (4-1 mol-mol),-1.3342329805744104
NCI-H1092,135875424,3.039549904779009
SCC-25,9823820,3.857472257163365
SK-UT-1,54618771,2.629062811355061
RCC10RGB,3038522,2.595581097335362
EoL-1,4261,-3.0321530079280703
MFE-319,11609586,3.458116960067185
RCC10RGB,navitoclax-pluripotin (1-1 mol-mol),0.1501865832808995
EoL-1,67156097,-3.1975543967362072
BEN,107970,2.561102930550366
IGR-37,135411,0.8646527835114131
BT 239,5460769,-1.3091160600101754
MFE-319,5284616,3.212814122901402
HARA [Human squamous cell lung carcinoma],7326481,3.3732570103291657
KU-19-19,3025944,4.41555498235696
BT 245,6917907,3.833759317164153
NCI-N87,tretinoin-navitoclax (4-1 mol-mol),0.6005709555160592
HOP-92,9926054,1.661169949591577
SUP-T1,navitoclax-gemcitabine (1-1 mol-mol),-6.8991250270748585
SIG-M5,17755052,1.7293479016236128
KMS-26,56946209,-4.890431951784696
VMRC-LCD,12003241,3.8307047822357343
NCI-H647,selumetinib-tretinoin (2-1 mol-mol),4.056767877382818
HARA [Human squamous cell lung carcinoma],31703,-1.5277652674394486
EHEB,984333,0.8159443893987631
BT 245,11485656,1.931183051045247
EHEB,60750,-4.448701675460919
MFE-319,9967941,4.258218623206259
AU565,5113032,4.518377698044194
A3/Kawakami,25161177,4.29015162187569
YH-13,426756,4.439847465268924
AML-193,11167602,1.123439400433108
JeKo-1,6918638,-1.1344735337684004
BT 245,42642645,1.337897041981839
BT 239,8515,3.59714906944717
JeKo-1,23582824,0.0261929368826835
KMS-26,44137675,1.7443136706864044
HT-1197,285033,-1.7781593853968214
HOP-92,11507802,3.3995166058990085
HDLM-2,44507138,0.9758478302020508
BT 228,erlotinib-PLX-4032 (2-1 mol-mol),3.033781337769329
EoL-1,136227924,1.175653355009707
HOP-92,53393127,4.714217357012866
Capan-1,selumetinib-UNC0638 (4-1 mol-mol),3.343542419659516
HDLM-2,decitabine-carboplatin (1-1 mol-mol),5.956200850167664
HGC-27,10385095,0.038631327360896
KU-19-19,9911463,4.338553857034003
KHM-1B,selumetinib-navitoclax (8-1 mol-mol),1.5654531920852657
AML-193,44486219,4.364571438762503
KMS-26,216239,0.3645153119411693
NCI-N87,3503,2.784967297602414
HARA [Human squamous cell lung carcinoma],126941,-2.554285063423382
NCI-H716,8515,1.647950101342266
HGC-27,44589607,0.5980956495606705
NCI-H1092,42642645,1.4285528009484267
RPMI-8402,445643,3.7866902001623703
VMRC-LCD,ISOX-bortezomib (250-1 mol-mol),0.185442148843906
EoL-1,65628,1.668421818220866
RCH-ACV,168312962,1.8669071064791924
KYSE-450,25150857,3.125664809349332
HGC-27,327653,2.307850951814526
P31/FUJ,10322450,3.023071845081992
NCI-N87,16722836,0.5704530263405226
SK-N-SH,3385,2.386217437145816
KYSE-450,285033,-1.7116882105667988
P31/FUJ,409805,3.653161003579303
HDLM-2,54619267,3.2755482820714903
AML-193,7326481,2.6534883532004505
KHM-1B,46907787,-1.0017805456317357
SK-N-SH,54454,2.4167607558949165
IGR-37,613000,1.1104790752116782
PK-59,24785538,0.9732990059034498
BT 428,6505803,-2.216718160472342
A3/Kawakami,10296883,3.880092254870085
SK-BR-3,613753,2.9483119663553485
IGR-37,216345,4.319842844413779
MFE-319,9840324,5.553546719137376
HCC2108,49766530,-2.150620999142696
SK-UT-1,navitoclax-MST-312 (1-1 mol-mol),0.81365218885664
P31/FUJ,16720766,-1.2973124396101832
BT 232,46907787,4.9227176505536665
L3.3,9936388,-5.444309252993802
HT-1197,568763,-0.974907055521156
KMS-26,10127622,5.1953843505639865
KALS-1,11228183,3.991465748887889
NCI-H647,selumetinib-PLX-4032 (8-1 mol-mol),3.30792637605407
JeKo-1,5282054,2.4043015774467715
HGC-27,65064,5.1940992186834745
RCH-ACV,11485656,1.6994895445887253
SCC-25,JQ-1-navitoclax (2-1 mol-mol),0.7102241554714177
SK-BR-3,53232,2.263859936134593
HDLM-2,11612883,2.5701967584028025
SNU-719,44486219,4.318891037638522
RCH-ACV,piperlongumine-MST-312 (1-1 mol-mol),1.3510589298518911
PK-59,676352,2.541338758475476
VMRC-LCD,54626689,6.355642452262427
SK-UT-1,navitoclax-pluripotin (1-1 mol-mol),0.5029199208338406
HCC2108,387447,-3.2029305155754657
HCC2108,46398810,2.6632695646236773
SIG-M5,52947716,0.4535822922505594
BT 245,11707110,-1.4423058674160945
RKO,44507138,3.480554434186059
BT 428,73707438,3.9227425250284367
VMRC-LCD,5287969,-1.4183996992091554
BEN,216345,4.432590622198573
BT 228,46191454,1.7694800748570632
NCI-H647,72193861,2.413467221801852
RPMI-8402,44489127,5.2444031144596295
NCI-H2009,vorinostat-carboplatin (1-1 mol-mol),1.7172571438659243
SUP-T1,44185566,1.0687398564642472
VMRC-LCD,44491742,4.573213718781489
PK-59,11214940,1.5355548695731127
L3.3,3025944,4.713949011742796
AU565,9927531,4.912755977802547
SK-N-SH,25227462,0.6204153306813988
EoL-1,44487872,4.166402657118513
BT 228,5280436,3.4943501634148366
AML-193,5284373,2.195930945503649
HGC-27,JQ-1-navitoclax (2-1 mol-mol),0.1238155022989741
NCI-H2081,9935249,2.3780454134873263
SCC-25,1641662,3.163149987281394
EoL-1,tanespimycin-bortezomib (250-1 mol-mol),-1.822520413880902
A3/Kawakami,3689413,-2.523189913009787
WM793,54626689,6.182066538200824
SUP-T1,216239,2.3915962545707883
SIG-M5,5394,2.3715950686653953
NCI-H2009,4788,5.716428228211685
A3/Kawakami,49867926,3.673251166370078
RKO,5278396,3.510721289362286
MG-63,100016,6.791496028485962
P31/FUJ,216468,2.1049028903625673
SK-UT-1,tanespimycin-gemcitabine (1-1 mol-mol),-2.178654952286891
BT 428,11625818,4.823879668280646
MG-63,374536,3.483295272297847
RKO,1641662,3.3091455873155367
MFE-319,7251185,3.399744027237995
EHEB,446155,2.5622028140590083
MSTO-211H,73707398,0.6990065379334892
MFE-319,3081361,3.1640663121072192
RCM-1 [Human rectal adenocarcinoma],262093,3.1357995089449058
BT 228,25102847,2.7831943926663736
TCCSUP,66577038,3.1078780517410283
RCM-1 [Human rectal adenocarcinoma],selumetinib-MK-2206 (8-1 mol-mol),1.8238867716534872
NCI-H2081,9826308,-1.325713373036652
MG-63,5311,2.1432109539957005
EHEB,44607531,1.253327134816266
SUP-T1,5291,3.173580324900417
KHM-1B,71680916,4.347689376486287
RPMI-8402,676352,1.543105622153223
RCM-1 [Human rectal adenocarcinoma],11396600,4.9998303274937115
BT 428,vorinostat-navitoclax (4-1 mol-mol),-0.9989641301857834
SW1116,124202324,1.63903378008797
BT 245,3543504,4.959409053605103
WM793,9915743,2.18814480431127
A3/Kawakami,navitoclax-gemcitabine (1-1 mol-mol),0.7885522985217994
TCCSUP,5746,1.7637111796176403
P31/FUJ,9915743,-0.8907797257006451
RPMI-8402,5278396,2.608758914557694
AML-193,11152667,-3.2233662083382297
SCC-25,135398516,1.3196976716558764
NCI-N87,11228183,1.1576925814137384
P31/FUJ,448949,2.0159916590055067
KYSE-180,navitoclax-birinapant (1-1 mol-mol),5.391613379714011
KALS-1,navitoclax-birinapant (1-1 mol-mol),2.6671850870181033
P31/FUJ,decitabine-carboplatin (1-1 mol-mol),1.8939659397992608
KMH-2,984333,-2.1870876003258717
NCI-H2009,451668,5.323035746604961
BT 232,136227924,3.5495643934514223
AU565,7251185,1.9736319172199277
RCH-ACV,73707386,2.164720549147375
MSTO-211H,tanespimycin-gemcitabine (1-1 mol-mol),-0.5272277437526489
JeKo-1,11964036,2.400674695718121
YH-13,11609586,3.847087958422487
RPMI-8402,1242560,2.6400094164741468
L3.3,2874250,6.457091097770646
NCI-N87,44486219,4.180509732108111
KALS-1,168313200,3.0482766453888024
MSTO-211H,9866186,-1.5986440722967756
HGC-27,BRD-A02303741-carboplatin (1-1 mol-mol),4.854549441506773
MFE-319,24951314,1.9696388643167384
AML-193,3689413,-0.2908308590674514
EoL-1,44543605,3.298208248537999
BT 228,445643,3.678524318419115
RPMI-8402,46398810,1.69774991083194
RPMI-8402,5978,-4.090335390311146
KU-19-19,44607531,3.044914521934579
TCCSUP,9444,3.681679510708516
SIG-M5,445643,3.909548213167384
SK-UT-1,49766530,-1.8212556826920157
HDLM-2,56946209,-4.251471194675799
RCM-1 [Human rectal adenocarcinoma],3689413,0.4564681386605935
RCH-ACV,2749,0.6996148475953206
KALS-1,10127622,4.084285519522927
IGR-37,54596558,5.751687913852839
KHM-1B,11228183,3.292556863347854
HOP-92,10302451,3.9702293485609457
NCI-H647,148124,-3.9513276226558474
TCCSUP,42611257,3.7923980265844417
SK-BR-3,ISOX-bortezomib (250-1 mol-mol),0.4424851420752906
SK-N-SH,135411,0.5127151955242248
RCC10RGB,122327,5.581829763733156
AU565,119607,5.010456243294951
KMS-26,10074640,2.692294527974062
SUP-T1,5746,0.7718719974985713
BT 228,119182,-0.0452496350506841
BT 245,1750826,-2.1736985339579395
BT 232,54596558,4.334749950801219
SCC-25,36314,-7.467174689408419
RCC10RGB,9956119,4.44093701823858
VMRC-LCD,24856436,0.2397060617806844
NCI-N87,11238147,1.7339284670687316
KHM-1B,carboplatin-UNC0638 (2-1 mol-mol),1.8078700282440656
KALS-1,3038522,3.965518281724876
KMS-26,crizotinib-PLX-4032 (2-1 mol-mol),1.0951726556721022
SK-N-SH,vorinostat-navitoclax (4-1 mol-mol),0.3900719943839741
SK-N-SH,24772860,-2.329286483323852
NCI-H2009,375860,-0.9754800160336818
KALS-1,11427553,3.224870373636143
NCI-N87,44632017,1.346248550233927
KMS-26,123631,1.90235200729902
A3/Kawakami,11396600,1.9424572968751193
Capan-1,11625818,4.958529454342761
KMH-2,375860,-0.9905938635036066
BT 428,71576739,-3.554637052889279
HOP-92,44491742,4.695490745837731
A3/Kawakami,24901704,3.405672045546675
SK-MEL-3,23582824,1.1337442978820025
A3/Kawakami,12003241,0.0304416634107028
SK-MEL-3,44607531,1.7295390257855068
SK-BR-3,3384730,2.147100377022002
RPMI-8402,12003241,-0.4088888603650127
HOP-92,54596558,5.004654706449085
RPMI-8402,49766530,0.2151937728897686
BT 245,4259181,0.4559580659670063
HDLM-2,46907787,1.6560945810392764
RCM-1 [Human rectal adenocarcinoma],23582824,0.8636405428481416
HGC-27,969516,2.5033620173745565
PK-59,25154868,5.245486806165516
BT 228,selumetinib-UNC0638 (4-1 mol-mol),3.8796802004630577
HuH-28,3503,2.7202202030637586
SCC-25,159324,1.9288959923249809
NCI-H2081,135875424,3.067653141346589
PC-14,216239,2.3822524941299617
HOP-92,104842,-3.9683068931696153
Capan-1,637858,2.0066289365913588
NCI-H2081,9956119,4.1032174456876485
KALS-1,409805,4.7781064352481835
KMH-2,374536,2.08598760334219
EHEB,navitoclax-MST-312 (1-1 mol-mol),0.6175908191033533
PK-59,49793307,-4.31591299867936
RPMI-8402,selumetinib-vorinostat (8-1 mol-mol),2.302380796643318
NCI-H647,2858523,3.096810416885774
AML-193,421610,2.5775097100779254
KMH-2,5978,-1.6147166653692522
AU565,135411,0.1136824900578053
AML-193,241158,4.142634503453859
SIG-M5,11222830,1.5350562619908894
NCI-H2081,5978,-4.744970810463312
KHM-1B,11404337,0.2779693874185021
BT 245,11238147,3.258472399798465
BT 239,10184653,1.4755572031388666
MSTO-211H,25195348,2.7607409792089186
RPMI-8402,168313016,3.4100232859139465
EHEB,11234052,4.167418528594196
SK-UT-1,71304818,1.4453829824044986
SK-UT-1,9926054,1.807396230777958
SIG-M5,31703,-3.3025843294976314
EHEB,alisertib-navitoclax (2-1 mol-mol),-1.9971610366443435
L3.3,11152667,-1.6552573738209355
NCI-H2081,11609586,0.9464908978048564
NCI-H647,51037431,3.230357789465339
SK-UT-1,24951314,2.3185939064766954
SK-UT-1,44185566,3.0890330795466125
EHEB,219104,3.08550903293029
IGR-37,selumetinib-piperlongumine (8-1 mol-mol),1.1784635211315655
TCCSUP,11647372,0.3076356003247925
VMRC-LCD,4917,3.4464045222683253
KMH-2,2945648,2.630958732295752
BEN,5746,1.8090184846114743
EoL-1,753704,2.475731119120275
MFE-319,49766530,0.80428041774597
NCI-H716,25102847,0.2365109875903072
RCH-ACV,65628,2.7817124037332435
HGC-27,24901704,2.3922303785293466
P31/FUJ,2828334,6.241721397046506
AU565,5470400,-3.0594075513818995
RCC10RGB,637858,2.3286326267725084
YH-13,7251185,2.541379459758288
PK-59,452548,0.5932890815360226
KYSE-180,6918328,1.6181247370511698
RKO,6852167,3.601912647929868
SK-MEL-3,25105715,3.1741025035990353
SNU-719,4917,2.8659911309604107
RCM-1 [Human rectal adenocarcinoma],2708,5.228043564409416
HT-1197,5460769,3.9110228695560223
NCI-H1092,31703,-0.4568076370772141
JeKo-1,6505803,0.6415741653854196
SUP-T1,11719255,2.44526349665853
PC-14,12001922,2.282227019704268
KHM-1B,44489675,3.585809473125015
AML-193,45100481,4.119307670955739
HOP-92,selumetinib-MK-2206 (8-1 mol-mol),1.95487967592398
VMRC-LCD,11485656,1.8176321806721345
SK-MEL-3,24951314,1.951608416050075
SK-UT-1,4917,3.615993600878312
NCI-H716,selumetinib-tretinoin (2-1 mol-mol),0.2580816128863494
SK-MEL-3,2729026,3.1225614639515356
RCC10RGB,322968,3.1449149812629877
IGR-37,10074640,3.140855598379282
HDLM-2,3815108,2.835533163920076
KMS-26,9823820,2.0287443154540483
VMRC-LCD,5280436,2.9298654512576388
RKO,JQ-1-vorinostat (2-1 mol-mol),0.9623246898976432
AU565,5287969,-1.6574542255158256
RKO,42642645,1.3055497818976145
HGC-27,24785538,0.5690319658399052
MG-63,168313200,3.691285308934156
HCC2108,serdemetan-SCH-529074 (1-1 mol-mol),2.3033726270926
BT 239,5978,-2.992947245234745
RKO,5113032,5.90165838842917
HT-1197,3465537,3.2276782151604877
HT-1197,5746,2.0613080247131492
KU-19-19,24951314,1.2793314486163916
RCC10RGB,4259181,1.719089746142662
HOP-92,9868037,3.341339504436607
EoL-1,24180125,2.1114997357358485
BT 228,JQ-1-carboplatin (1-1 mol-mol),4.047543030971835
IGR-37,8515,3.3809165095861236
PK-59,selumetinib-UNC0638 (4-1 mol-mol),2.209283166348595
EoL-1,441298,1.0623981464489525
HDLM-2,15983966,-5.040007121561621
BT 228,327653,3.1357639702509865
AML-193,71680916,4.521521702030093
HDLM-2,navitoclax-PLX-4032 (1-1 mol-mol),-0.930651360534934
BT 428,46926350,-4.319561662968833
RKO,2729026,2.3662843020346753
TCCSUP,decitabine-carboplatin (1-1 mol-mol),4.4091116802817325
A3/Kawakami,2729026,3.162354903301809
BT 232,73707398,1.7633386245847071
EHEB,11960529,4.94849976240243
JeKo-1,71751553,4.358287051916344
TCCSUP,vorinostat-navitoclax (4-1 mol-mol),0.9791138752454284
SCC-25,2742550,3.0640378690909023
SCC-25,11455910,2.801880341049824
EHEB,6918736,-2.350232551992923
JeKo-1,navitoclax-MST-312 (1-1 mol-mol),0.4901598042393081
HuH-28,24951314,0.8090716437029668
KMS-26,docetaxel-tanespimycin (2-1 mol-mol),-8.04693315758793
NCI-H1092,10296883,3.8260798051213376
KALS-1,135984461,4.764345529991705
SW1116,46199207,1.946479167853303
RKO,3038522,3.342495330103654
PC-14,JQ-1-vorinostat (2-1 mol-mol),1.088268810915832
WM793,9956119,2.719502921417229
TCCSUP,107985,-3.010766846655704
HGC-27,46224516,2.4687297899447804
IGR-37,piperlongumine-MST-312 (1-1 mol-mol),2.0005055156036664
P31/FUJ,44489367,5.126164790260484
HARA [Human squamous cell lung carcinoma],9884685,2.402658407469787
VMRC-LCD,82146,4.4368191927949
HGC-27,5738263,2.3797187935888187
AU565,5311,0.7700744364318666
SIG-M5,53392493,1.853987055165764
EoL-1,5394,1.9614007296196296
SK-BR-3,10302451,2.9491683435141045
SIG-M5,46943432,-0.2982882437064111
IGR-37,44607530,2.793124404807661
BT 239,JQ-1-carboplatin (1-1 mol-mol),2.368101123229976
SK-N-SH,65064,5.031396635140295
KALS-1,3815108,3.128776444358639
PC-14,10302451,-1.9208505295158915
BT 428,selumetinib-BRD-A02303741 (4-1 mol-mol),0.7772774830085131
P31/FUJ,11152667,-2.5755274762926095
HGC-27,73707371,2.267476734354563
L3.3,54613361,-0.6336215633441857
NCI-H647,613753,3.236416210467872
EHEB,375860,-0.9049347764221136
A3/Kawakami,11404337,-1.3571350042405983
AML-193,9956119,3.219958415521101
RCH-ACV,54618164,3.616633396112511
RCH-ACV,262093,0.7174466036111895
RCH-ACV,49766530,-4.0327200092354305
SNU-719,11626560,1.4764163388395268
JeKo-1,49766530,-3.0518255026052454
YH-13,135440466,3.138970949638139
A3/Kawakami,6252,-1.0030919434246075
AU565,16736978,1.4090353018278403
HDLM-2,135421197,3.3057353966925613
SK-N-SH,12003241,-0.1782836435040178
HGC-27,11485656,1.9674233775632803
SK-N-SH,24964624,2.0855010260023255
KHM-1B,navitoclax-MST-312 (1-1 mol-mol),1.4754840901416553
PC-14,crizotinib-PLX-4032 (2-1 mol-mol),2.280079390306755
MSTO-211H,156414,0.8242215144670997
P31/FUJ,31703,-2.5575864334968976
NCI-H2081,3552672,1.4004455642024622
BT 428,24772860,-2.503252436850905
SW1116,568763,0.5509769931311748
KALS-1,3025986,-0.5699514307097172
NCI-H1092,doxorubicin-navitoclax (2-1 mol-mol),-2.111052945986695
RKO,6610216,3.958403220086871
KYSE-450,vorinostat-navitoclax (4-1 mol-mol),3.1121330202386974
SK-N-SH,9866186,0.0035576719193118
SUP-T1,6918328,-2.725230979811647
BT 428,51039095,3.0771615487260977
HOP-92,753704,5.097901193864493
BT 245,6918328,0.1943385135138843
NCI-H2081,148124,-3.831662126446776
HARA [Human squamous cell lung carcinoma],3025944,5.227932597847333
SK-N-SH,969516,2.0898342362263755
KMS-26,5311281,-0.5305664472772231
RPMI-8402,2749,0.5889286610449777
SCC-25,969516,1.4292224422506394
TCCSUP,24978538,1.7362039378241625
AML-193,644241,1.8416137938925805
VMRC-LCD,25150857,1.834589601182848
KMS-26,6918878,-0.5863995655952686
KMS-26,17759555,3.3409086746731775
SIG-M5,151289,0.8663605917838532
AML-193,3465537,0.6863913104025677
NCI-N87,107985,-3.2122311985508136
HT-1197,56963564,4.446007967977149
KALS-1,123631,3.3283188867819424
HOP-92,637858,1.5659474231121848
MG-63,4259181,1.2675663544534232
IGR-37,168313200,1.7746354442745738
SK-BR-3,327653,3.1347096083864816
SCC-25,10231331,0.4590527217191406
NCI-H2009,selumetinib-piperlongumine (8-1 mol-mol),-1.1472655544324035
KHM-1B,4378219,1.8511847617722708
KMS-26,2708,2.401901430039457
SNU-175,107985,-3.5287642870069136
A3/Kawakami,2874250,6.416644936661187
SK-MEL-3,49766530,1.022989661604762
EoL-1,5738263,1.2661103351724428
HCC2108,6918328,-0.0809019219950942
BT 428,135398516,2.6845925452826367
NCI-N87,44507138,1.5580904379761216
RCM-1 [Human rectal adenocarcinoma],10074640,3.542423635061651
SIG-M5,3854666,0.6952699424052499
NCI-N87,60700,-1.3451868063168757
KMH-2,4096211,0.0747534248684018
RCH-ACV,11960529,3.642318977500412
KMS-26,3385,2.6964451017383224
HT-1197,46191454,1.9851325865474223
KMH-2,31703,-2.071418108926546
HT-1197,carboplatin-UNC0638 (2-1 mol-mol),3.8934952931299702
MG-63,148124,3.329653323642378
MFE-319,9935249,3.387887066953814
NCI-N87,1750826,1.3506728687975464
RCH-ACV,BRD-A02303741-carboplatin (1-1 mol-mol),4.120412262857597
PK-59,400769,-1.222588595156963
SUP-T1,5278396,3.058092736818193
P31/FUJ,176870,1.9707243184949097
KU-19-19,24785538,4.6207321752497545
P31/FUJ,262093,1.035147161622815
RCM-1 [Human rectal adenocarcinoma],71680916,4.48717515696629
SK-BR-3,54618795,3.2977293960686147
SNU-719,9903786,2.245774395512323
HT-1197,168313016,4.3878653913585985
KYSE-450,135440466,3.4784789863702112
PK-59,11427553,2.899935057624285
KMH-2,5281321,-2.394829115643839
RKO,262093,2.7220373961576834
RCH-ACV,5746,-1.8140581004493088
SIG-M5,9911463,2.49992979660486
BEN,11485656,2.522824701097711
SNU-719,46398810,2.5238635135996126
HT-1197,9936388,2.7630776748899746
HOP-92,24748573,2.120346905937876
RCC10RGB,9803433,4.221770064596342
SK-BR-3,46926350,-4.173892984913858
BT 245,46224516,2.4010349649397535
AU565,selumetinib-BRD-A02303741 (4-1 mol-mol),5.383276880115408
IGR-37,1716436,2.867371514105322
VMRC-LCD,46199207,1.9604072265414572
SK-MEL-3,135398738,5.769942538426053
KYSE-180,11222830,1.7439687500469427
VMRC-LCD,4261,0.5146936485614676
RPMI-8402,6610216,3.283119634553979
NCI-H2081,2828334,5.70400376605512
HARA [Human squamous cell lung carcinoma],53481919,4.643044937502802
HOP-92,24978538,-0.2315564470725327
YH-13,168312962,3.022410497071698
BT 232,1566236,2.96800449677677
SNU-719,168312962,3.175057810619802
EHEB,1242560,2.6348256954742757
KYSE-450,navitoclax-sorafenib (1-1 mol-mol),2.514511411707921
EoL-1,16219061,1.1544898757444295
BT 245,5329102,2.0891856734220973
EoL-1,3503,0.9303369831867736
BT 245,54618771,0.8318467537608688
BT 228,navitoclax-sorafenib (1-1 mol-mol),1.517709367320687
SIG-M5,5280436,0.3610474364837536
MSTO-211H,11612883,1.8196539401694043
KYSE-450,73707398,1.7321370562114622
RCC10RGB,7251185,2.312506998895348
BT 245,44202524,1.394406643911058
NCI-H647,216239,1.845089463114662
JeKo-1,53392493,1.7941621543991624
NCI-N87,5287620,-2.9994225662437928
HDLM-2,6252,0.2484157638894688
AU565,216239,2.683840039589205
PC-14,439501,-2.395737625467809
NCI-H647,3543504,4.831221279142117
RCH-ACV,216239,2.162779386796007
MFE-319,54454,3.783639861692048
KYSE-180,selumetinib-BRD-A02303741 (4-1 mol-mol),6.582201455750035
NCI-H716,11178236,0.1232670835764805
BT 428,alisertib-navitoclax (2-1 mol-mol),-3.444908865078719
SUP-T1,126941,-2.152110952843233
IGR-37,24901704,3.733980257509003
SK-UT-1,676352,1.600998738511555
KMH-2,17755052,1.783758106889838
HCC2108,16725315,3.712302127233507
PK-59,navitoclax-pluripotin (1-1 mol-mol),-0.3555314837484112
SIG-M5,2113511,5.698902980210272
NCI-N87,11964036,0.5275056986755973
SNU-719,6918837,-2.492993106349853
SCC-25,erlotinib-PLX-4032 (2-1 mol-mol),-1.3512360641366732
BT 245,9803433,4.398096619195385
KHM-1B,6610355,4.543219092687797
A3/Kawakami,11640390,3.1568468046017326
VMRC-LCD,15983966,-8.304178403622274
YH-13,9933475,1.504253268653492
RKO,135440466,3.093117295091816
KYSE-180,9868037,4.629723429656334
AML-193,5287969,-1.8386157349507368
WM793,10184653,0.3319580671106031
BT 239,5566,1.9936143522159504
BT 428,11228183,2.124701614700109
P31/FUJ,49850262,2.7073676452568427
NCI-H716,49793307,-5.333790936981048
EoL-1,44819697,-4.179075159180259
BT 428,216239,2.223507048360596
NCI-H2081,107970,1.5324597930931985
SUP-T1,25262965,-0.5650245190460332
SIG-M5,67291369,1.6855090207229635
KYSE-180,44819697,-2.483025029894288
WM793,2858523,3.206623504237894
NCI-H2081,53495165,-2.055173508699106
SK-N-SH,135421197,1.303640254483224
AML-193,53301938,4.361232461856564
P31/FUJ,carboplatin-etoposide (40-17 mol-mol),0.2579285765316561
HDLM-2,54649381,3.58174421093447
SK-N-SH,24180125,3.172499964081901
SK-MEL-3,44589607,3.0195161948190896
HDLM-2,vorinostat-carboplatin (1-1 mol-mol),2.1113864728025797
JeKo-1,54618771,0.9651230591785864
EHEB,135421197,1.2947733633872678
HOP-92,11364421,0.2290946179026122
NCI-H1092,135999136,1.996402787689235
IGR-37,24889392,5.87126296969008
RKO,31703,-1.8438289452025527
HDLM-2,10184653,1.3410357855104271
NCI-H716,1716436,2.4874306466030607
HARA [Human squamous cell lung carcinoma],tanespimycin-gemcitabine (1-1 mol-mol),0.469334809183726
SCC-25,5460769,1.2990848940221191
HOP-92,54454,0.6525861640746738
BEN,119607,6.154786368004891
KMS-26,2841722,1.1607557192742055
Capan-1,2874250,5.365047375522904
KMH-2,445455,4.873752175923701
VMRC-LCD,9911463,3.586787073438602
KHM-1B,5329102,0.5280819798234874
HT-1197,ISOX-bortezomib (250-1 mol-mol),0.3628604267131879
KHM-1B,11497983,-3.4105993127539698
BT 245,11609586,3.46233196553391
KYSE-450,44185566,3.113770819226177
SK-MEL-3,24753719,4.863122553951076
RCM-1 [Human rectal adenocarcinoma],36462,2.9964453818745924
BT 239,148124,5.770262355155013
SK-BR-3,6252,-0.5571371196157848
SUP-T1,selumetinib-UNC0638 (4-1 mol-mol),2.542472797377753
EoL-1,15547703,2.339256749295448
MSTO-211H,5566,3.048712391825719
IGR-37,73707398,1.5804639662381832
A3/Kawakami,702558,4.806683024897613
NCI-H1092,44491742,3.604656167614849
AML-193,702558,5.797576033161934
BT 232,10410894,4.089658865631466
SUP-T1,55508,6.2393679185794495
IGR-37,135423438,1.6806022412705843
RCH-ACV,71680916,5.274958718511869
A3/Kawakami,426756,3.0804857067395397
Capan-1,56649450,3.219880492169686
SCC-25,285033,-2.273089675383067
SK-UT-1,2874250,6.155994559300563
L3.3,44607531,2.464561691878258
RCM-1 [Human rectal adenocarcinoma],11609586,3.4054743637312006
L3.3,44491742,6.349276489474054
EoL-1,navitoclax-gemcitabine (1-1 mol-mol),-5.48214423717849
SIG-M5,selumetinib-decitabine (4-1 mol-mol),-3.5962668938254025
SIG-M5,24753719,3.8499837054147656
PC-14,11507802,2.9522265346709227
SNU-719,5746,0.5721408007828379
NCI-H716,135875424,3.9271515423817047
KALS-1,46224516,2.61267911408714
PK-59,446155,4.009022985502684
MG-63,9444,5.197047556896822
NCI-H647,2113511,5.678805693215236
MFE-319,19582717,4.419222945663563
HARA [Human squamous cell lung carcinoma],644241,2.250939574369427
EHEB,702558,6.933646693723644
KHM-1B,54613361,-1.0335550774080653
AML-193,9444,4.0826216157969
P31/FUJ,89183176,3.539325961528454
SNU-719,5328940,1.766867190774188
HT-1197,3025986,-1.639040061053784
KHM-1B,136227924,1.9174951940989704
EoL-1,11214940,1.5224034526185524
KU-19-19,16741245,1.8623441782077492
KMH-2,24180125,2.3529996714086066
AU565,72376,-1.9935205494525805
HT-1197,16736978,2.82439978657222
SK-UT-1,216239,1.4894515561019788
SK-MEL-3,56649450,4.464161788344078
BT 428,1716436,2.552784613335119
SUP-T1,46174525,3.1982689706856218
HGC-27,72734382,3.886328770071126
L3.3,11609586,3.8992408569207018
NCI-H1092,11977753,0.4568762986768944
NCI-H2081,76446078,4.17311881830217
NCI-H1092,73707398,1.109051456829637
MFE-319,6918736,-2.4157413876655305
NCI-N87,6918878,2.817621762559668
HDLM-2,doxorubicin-navitoclax (2-1 mol-mol),-2.0179160989922296
SUP-T1,24180125,1.3532366602003478
BT 228,119607,5.946705112032896
NCI-H716,6610216,4.204233875034661
IGR-37,selumetinib-MK-2206 (8-1 mol-mol),0.3195516564365354
NCI-H716,5280436,2.1208894508044054
RCH-ACV,6184667,4.156727519812634
HDLM-2,serdemetan-SCH-529074 (1-1 mol-mol),1.7934457350578246
KALS-1,11647372,0.1149490813954117
HDLM-2,piperlongumine-MST-312 (1-1 mol-mol),3.3507532650979353
L3.3,erlotinib-PLX-4032 (2-1 mol-mol),3.685667045141098
HT-1197,107985,-4.558974920992082
NCI-H716,3384730,3.776610051442182
RCC10RGB,31703,2.24368059098483
EoL-1,54143018,-1.0900974432289037
HGC-27,6438330,1.3740169821590456
MFE-319,439501,-2.2775311995949035
HuH-28,44819697,-0.5814057541666047
NCI-H1092,11609586,2.567320203791852
NCI-H2081,135421197,1.057518505455496
RKO,erlotinib-PLX-4032 (2-1 mol-mol),3.5689359084165124
BT 232,9549297,2.160756107921838
RCM-1 [Human rectal adenocarcinoma],49793307,-2.331301981492291
HGC-27,445643,3.092523400350192
HT-1197,262093,2.0088485136907575
NCI-H1092,5281672,3.7306069141641856
RKO,60750,-2.2331483998906654
BT 232,12001922,1.1651494969808018
KYSE-450,71466380,4.437575150411749
MSTO-211H,9907093,3.5779290533064856
KMH-2,56963564,-1.1450506350043832
HOP-92,66577038,2.763079666918466
KYSE-180,322968,4.83956254664213
KYSE-180,docetaxel-tanespimycin (2-1 mol-mol),-5.030018128034541
RPMI-8402,6918837,-4.734294343000984
NCI-H1092,25262965,2.2331419117786617
MG-63,BRD-A02303741-navitoclax (2-1 mol-mol),3.6054444397334056
NCI-H647,4259181,0.924115846720778
PK-59,25126798,3.821997486892315
P31/FUJ,44486219,4.066329818545256
NCI-H1092,36314,4.877889816324306
RCH-ACV,327653,1.139116328551912
HOP-92,24797083,0.9932142558327732
SCC-25,387447,-4.090104079633871
KMH-2,10113978,1.9769897773276333
IGR-37,3854666,0.7173312278766348
RPMI-8402,44487061,4.352420976292524
BT 245,10231331,3.905394007999992
HCC2108,54618305,4.9170237432018435
SCC-25,119607,4.099914895316311
MG-63,24821094,3.8457624867949174
RCM-1 [Human rectal adenocarcinoma],135875424,4.234717543087367
HCC2108,12003241,-1.7779849182593923
L3.3,49850262,4.243504406455669
EHEB,9967941,3.291160377443194
MSTO-211H,46398810,1.7478948810000858
SK-UT-1,984333,0.8652999578170681
BT 228,11656518,0.9076384567950762
KMH-2,3634881,2.883123455365029
RPMI-8402,208908,1.719164491567183
RKO,11152667,-2.010180339323448
YH-13,navitoclax-pluripotin (1-1 mol-mol),0.1454276161313981
AU565,54596490,4.681317358630495
AU565,54618771,1.1954147839624212
MG-63,1242560,3.761459364362509
BT 245,46174525,2.383574955486469
KMH-2,selumetinib-GDC-0941 (4-1 mol-mol),1.8839311590073071
BT 239,44185566,1.2939485456320945
NCI-H647,135421197,2.605948730624533
A3/Kawakami,100016,3.999978023882096
MG-63,1641662,3.6681126763627296
BT 245,BRD9876-MK-1775 (4-1 mol-mol),2.4312783718303064
HuH-28,5280436,4.282205478412009
SUP-T1,4477,1.1405454101413746
SK-BR-3,148124,-5.1305926925012235
AU565,11719255,4.218610599596327
KYSE-450,439501,-3.185322034462323
PC-14,6917907,-7.815617224147094
SK-N-SH,613753,2.825238892816248
RCH-ACV,11609586,-0.0864397598845326
BT 232,9825149,2.259633224956524
RPMI-8402,44137675,2.3852684213151925
SK-N-SH,135999136,3.91639066262896
SCC-25,54613361,-0.658017958248108
NCI-H1092,3552672,1.5396506423580394
VMRC-LCD,262093,2.9924485884433496
AU565,9926054,0.9817648939808896
AU565,52947716,0.8422274137680903
HuH-28,10427712,4.211388290216202
NCI-N87,15953870,2.623738434863841
SK-BR-3,56963564,-0.3458339738577888
KHM-1B,44632017,0.9077135445845732
MSTO-211H,11626560,1.3885064506517848
EHEB,46398810,1.962348153679006
KYSE-180,9444,4.788423248663199
BT 245,44491742,4.161467905313556
BT 239,4917,1.9874028042936096
BT 232,9444,4.3863656395678445
HDLM-2,135411,0.5971288572289424
EHEB,49850262,3.0589099968114986
SUP-T1,156422,3.982888311569592
SW1116,73707398,1.201154114814001
KALS-1,56946209,-2.930940398987832
RCC10RGB,JQ-1-UNC0638 (2-1 mol-mol),2.5689754136574425
TCCSUP,11964036,1.9073082077869936
NCI-H647,JQ-1-MK-0752 (1-1 mol-mol),2.5437829331604656
KYSE-180,10427712,3.555551591768758
VMRC-LCD,44137675,4.237977234713832
MG-63,6918837,-0.7262065077660655
NCI-H1092,2871966,-0.9629545155853874
BT 232,136227331,4.34663354921091
HuH-28,9887053,6.189895466467789
L3.3,10184653,0.0220617179423389
BT 232,60700,-3.4631164596043704
Capan-1,54618164,5.43601274442026
BT 239,17755052,-0.7701549477866105
AML-193,448949,1.5925073398002192
HGC-27,44819697,-2.935022337855102
IGR-37,89183176,1.4247543323356175
NCI-H1092,54596490,4.303629834820445
MFE-319,9825149,3.3480780218082615
NCI-N87,24180125,2.059368273959215
BT 228,tanespimycin-gemcitabine (1-1 mol-mol),-0.299336394728821
KMH-2,25183872,-2.094788836829873
SUP-T1,135440466,1.719274962557054
EHEB,637858,1.5977612521222773
HOP-92,44607530,0.944009076711512
KALS-1,56973724,3.8228412860024465
KMH-2,26596,-2.508510760962814
HARA [Human squamous cell lung carcinoma],11427553,0.5044011516017802
AML-193,10231331,0.6322489911417504
SIG-M5,54618164,3.803874177030029
AU565,16725315,3.19394291041594
VMRC-LCD,vorinostat-carboplatin (1-1 mol-mol),1.8263141427546816
NCI-H2009,46398810,2.5614683956162554
AU565,5329102,2.0441914674842008
PK-59,73707386,3.024684722161558
NCI-N87,3543504,4.249309596150935
BT 228,2945648,3.017321406002997
KYSE-180,71304818,2.610394222514715
SK-MEL-3,vorinostat-navitoclax (4-1 mol-mol),1.9097694076844105
SCC-25,16720766,-0.206197307344064
BEN,6852167,3.945016619736351
NCI-H1092,24951314,0.6671727176626792
SW1116,23635314,4.505127279501018
SNU-719,16725315,4.5682930455006225
MSTO-211H,11234052,3.0252233847843515
NCI-H716,984333,-1.016664354401175
WM793,12003241,-0.659721194491695
KALS-1,44491742,4.207872917974877
KU-19-19,49850262,4.263742487880845
L3.3,navitoclax-pluripotin (1-1 mol-mol),0.1565483194262438
RPMI-8402,navitoclax-MST-312 (1-1 mol-mol),0.6288771767062216
RCH-ACV,3038522,3.516556481530355
PK-59,vorinostat-navitoclax (4-1 mol-mol),1.1814860729978631
AU565,81146,6.247262332137589
SK-MEL-3,135999136,4.927599963416982
KYSE-180,11178236,-2.9076352351606394
NCI-H647,17755052,1.569510953225637
BT 245,72193861,0.6235910054430077
HOP-92,613753,3.103376659983311
KMS-26,15983966,-4.3672457826301265
KALS-1,5282054,3.955567142166548
AU565,56649450,1.7738933823843377
A3/Kawakami,24821094,3.827442391102189
SCC-25,11485656,1.624439793066487
NCI-H2009,5566,2.98031688083636
SK-UT-1,4788,5.266389502617288
IGR-37,54618164,4.309961080908924
VMRC-LCD,969516,2.451474942148866
BT 239,3503,0.7862413691704749
NCI-H647,71466445,5.041902875168557
TCCSUP,654092,0.20661025220839
BT 428,11222830,0.8286486262937305
HT-1197,42642645,1.5402491011918673
NCI-H647,5291,3.948367703733179
MG-63,selumetinib-GDC-0941 (4-1 mol-mol),2.7889103104471227
HGC-27,54618795,3.1535778505427476
PK-59,selumetinib-vorinostat (8-1 mol-mol),2.306892423893395
AU565,6505803,-0.7592801042803803
SK-N-SH,46174525,4.289940449980378
VMRC-LCD,439501,-2.2001056287042715
IGR-37,serdemetan-SCH-529074 (1-1 mol-mol),1.9790950197474244
EHEB,3815108,2.965320927013124
PC-14,36462,2.3416403863743125
BT 239,JQ-1-navitoclax (2-1 mol-mol),-3.3753198298926756
NCI-H2009,46174525,3.5250507211438107
KYSE-180,107985,-3.532250408088534
NCI-H647,11507802,2.861339369856906
RCH-ACV,6623618,2.271657947852432
HDLM-2,984333,0.5112517547105558
RCH-ACV,navitoclax-birinapant (1-1 mol-mol),-3.4998460496957646
SK-UT-1,alisertib-navitoclax (2-1 mol-mol),3.539585462588412
Capan-1,24775005,4.477768987152729
RKO,crizotinib-PLX-4032 (2-1 mol-mol),0.8147825419497507
BT 239,44491742,3.7318422225870753
WM793,9911830,2.975609583515234
EoL-1,613753,2.4166693352250466
MFE-319,72376,0.0492481437718759
HOP-92,46199207,3.399071814749689
RCH-ACV,9935249,2.7024850725527165
MG-63,400769,0.3722293847347946
RCM-1 [Human rectal adenocarcinoma],vorinostat-navitoclax (4-1 mol-mol),2.52102368660606
KMH-2,24856436,-0.2017498878738879
SK-UT-1,262093,2.998836933826174
NCI-H2009,24964624,2.271229049936602
EHEB,selumetinib-vorinostat (8-1 mol-mol),1.837404923820544
HDLM-2,11427553,3.045592333401397
P31/FUJ,135984461,4.1454221372139894
SW1116,54618164,3.73631090457485
L3.3,613753,4.077511547969464
KU-19-19,3062316,3.300727237006398
SK-N-SH,3634881,2.5287208049107877
NCI-H1092,54619267,3.872554434622377
HARA [Human squamous cell lung carcinoma],1750826,2.2891380116234616
SNU-719,9907093,4.649261500124932
BT 232,4788,5.498058144823148
BT 428,11427553,3.3275114517957047
JeKo-1,5746,0.8673767278927498
HARA [Human squamous cell lung carcinoma],24901704,2.881552784728447
SNU-719,65628,4.730492639805566
HGC-27,9935249,1.1253542566009878
TCCSUP,3136844,3.997105269832927
BT 428,16038120,1.2716805707784735
PK-59,68056272,3.6251333748672656
A3/Kawakami,11222830,1.0231652049263062
SK-BR-3,11626560,2.515980478564591
AU565,71466445,4.046585104708946
MSTO-211H,44241473,3.911097970359605
L3.3,73707398,1.2944525096848456
MFE-319,2746,3.158531328998989
HuH-28,66577038,3.21542006189496
MSTO-211H,JQ-1-carboplatin (1-1 mol-mol),2.423353722828544
SNU-175,216345,1.2607862048756635
HT-1197,2858523,3.0180399678640657
SK-MEL-3,11640390,4.355496015660781
MSTO-211H,60700,-2.4521642225491065
SK-MEL-3,16725315,6.077942224112461
IGR-37,71466380,2.084419594146697
AU565,637858,2.0174799842455364
KMH-2,16725315,3.688730447598931
HuH-28,322968,2.8826025820034844
RKO,2113511,4.623772297498578
BT 245,5280436,3.2619777265426633
NCI-N87,135875424,4.206412745126992
A3/Kawakami,148124,-4.427555036012123
KALS-1,5738263,3.9095397018008993
KALS-1,6914657,-2.5382767071549517
BT 245,11317348,1.822035958732133
RPMI-8402,6505803,1.0273996849455458
HT-1197,25227462,2.598016981717048
NCI-H716,135398744,6.457168364956761
JeKo-1,3503,1.1916007602880756
EoL-1,119182,-4.336482854181367
SK-UT-1,6505803,-1.8087484782267416
KALS-1,54619267,4.352000929738332
KMH-2,9926054,1.558336314725876
SNU-175,11228183,-1.4641391988446448
KYSE-180,selumetinib-MK-2206 (8-1 mol-mol),4.332919329436686
YH-13,9915743,2.529803461221303
KYSE-180,11175137,2.9654350002556873
BT 428,5281321,2.045733777438055
AML-193,44202524,1.4047399507248244
KU-19-19,selumetinib-navitoclax (8-1 mol-mol),1.098074451823129
MSTO-211H,66577038,3.302731292752764
BT 239,10302451,3.768420544812393
MG-63,56946209,2.769749593173692
EHEB,168312962,3.113364364376791
HGC-27,docetaxel-tanespimycin (2-1 mol-mol),-5.638707385192065
HOP-92,3825829,4.4402375756937245
SUP-T1,11717001,4.33584991084183
NCI-H647,3384730,3.291719989362795
EoL-1,54639126,4.253732797979994
HGC-27,selumetinib-vorinostat (8-1 mol-mol),2.872290349693273
BT 228,322968,2.6981460407650872
KALS-1,3676137,4.810975808816414
HDLM-2,20959075,-3.3141052869399057
TCCSUP,53232,2.5556633861706453
BT 428,2729026,1.1838320666199753
AU565,25161177,3.67389505129512
MSTO-211H,6450551,1.5186693992042568
SK-N-SH,135398516,2.9387684834058527
KMS-26,151289,-0.1874033438159184
RKO,216345,4.0768365061219525
NCI-N87,12003241,-2.470820657410725
P31/FUJ,erlotinib-PLX-4032 (2-1 mol-mol),2.316286260335057
RCH-ACV,11507802,0.3136268324127928
JeKo-1,3038522,2.6091501798588084
RCC10RGB,selumetinib-piperlongumine (8-1 mol-mol),4.460336891472633
HGC-27,11640390,3.1225688727997523
RCH-ACV,2945648,2.646046482695263
BT 428,387447,-4.747611518769308
EoL-1,71466578,1.462556472813711
NCI-H647,9956119,3.610786696794671
BT 245,11657048,4.3799644982814705
IGR-37,11497983,4.405563182131382
SNU-719,10184653,1.624028587253992
HGC-27,44607531,1.336001435692593
SK-UT-1,11507802,0.5091133584540986
RKO,3384730,1.0492755436091918
NCI-H2081,11640390,3.2499982344751994
HGC-27,selumetinib-decitabine (4-1 mol-mol),5.477081361396889
NCI-H716,65064,5.418833053867247
BT 245,44486219,4.564101901235062
HT-1197,72193861,3.420973018414637
HARA [Human squamous cell lung carcinoma],15547703,3.5023955614710633
KHM-1B,11427553,0.8733560257670158
SCC-25,6438330,1.1828453180710656
SK-N-SH,11625818,4.137939887890498
HuH-28,3384730,3.847997013486512
RCM-1 [Human rectal adenocarcinoma],5566,3.137413738775102
MG-63,10127622,5.189209751161388
NCI-H2081,135999136,1.634974352928294
AU565,60750,-2.174078373186638
KALS-1,135423438,2.6558677077861783
RKO,216468,3.08027711257304
HT-1197,4259181,1.1662801512055228
RPMI-8402,57330099,4.035699000282407
RCM-1 [Human rectal adenocarcinoma],135398738,5.665186147666449
RCM-1 [Human rectal adenocarcinoma],5329102,2.5793782122473985
PK-59,vorinostat-carboplatin (1-1 mol-mol),3.4183134687002528
JeKo-1,JQ-1-UNC0638 (2-1 mol-mol),2.321221810993542
WM793,46199207,3.3538268783703895
IGR-37,9823820,4.272374134528184
VMRC-LCD,216345,3.865562528018024
KMH-2,navitoclax-sorafenib (1-1 mol-mol),-1.917288866212996
VMRC-LCD,4521392,4.9631297426940115
HDLM-2,5281672,4.292207712258258
KYSE-450,44486219,4.896382772199078
SW1116,selumetinib-piperlongumine (8-1 mol-mol),0.4966657503942199
MSTO-211H,73707386,2.8647689708389943
BT 228,9549297,1.7568571496805043
SK-UT-1,11404337,0.3155392200884543
NCI-H2009,71466445,2.5164920571758036
SIG-M5,262093,1.2071251684519244
P31/FUJ,5329102,0.6917422477571054
PK-59,67156097,3.162804008850741
A3/Kawakami,11455910,-1.104878748608077
KALS-1,3025944,4.872580488559528
PK-59,11977753,-3.3691065724699247
JeKo-1,11507802,0.2730377372696126
SIG-M5,445455,1.858013831411801
KALS-1,71304818,3.3723529361977778
SIG-M5,24785538,0.5174401003799642
HCC2108,67291369,1.6270621345157394
SCC-25,4261,1.1789520093036634
TCCSUP,2733487,6.902368396257458
KYSE-450,11612883,5.465517956514392
EoL-1,46215462,-3.6882387891231776
MFE-319,16741245,3.3254556564637525
RCC10RGB,5566,3.997570642857795
NCI-H2009,9826308,-0.026532071259288
EoL-1,JQ-1-navitoclax (2-1 mol-mol),-3.8014621525447665
NCI-N87,24901704,2.2078626603453664
P31/FUJ,148198,-3.664233852608881
RPMI-8402,445455,4.164431367381377
MSTO-211H,613753,2.697490548990984
RCM-1 [Human rectal adenocarcinoma],71576739,4.46778033750866
HDLM-2,446155,3.424797200061043
SUP-T1,11214940,-0.0801524907856721
AU565,4705,1.275846161151896
JeKo-1,9444,3.780010083988641
A3/Kawakami,navitoclax-piperlongumine (1-1 mol-mol),0.998132923065881
HuH-28,crizotinib-PLX-4032 (2-1 mol-mol),2.477898272621782
BT 245,3854666,0.2943168101858666
EHEB,57519531,1.438200929613056
SK-BR-3,26596,-2.188814054378237
NCI-H1092,135928012,3.192957596716536
BT 239,637858,1.534947650301569
IGR-37,5738263,4.19106799255601
SCC-25,navitoclax-MST-312 (1-1 mol-mol),1.1776580210292973
PC-14,3689413,2.901459905806189
P31/FUJ,100016,5.4217002529902185
SK-MEL-3,445643,3.9286369729943975
HGC-27,6184667,2.1171542775936563
HARA [Human squamous cell lung carcinoma],65064,5.174523602274789
KYSE-450,3025986,1.0073883663070609
YH-13,16725315,3.2502967771135096
SUP-T1,135984461,2.153486266323967
RCM-1 [Human rectal adenocarcinoma],2858523,3.3395777905719872
YH-13,135398516,1.589784182396859
SK-N-SH,11497983,1.5920221552050795
A3/Kawakami,11656518,1.1115488169057994
NCI-H2081,409805,3.646579192169883
NCI-H1092,45279963,3.5521369654749035
BT 232,JQ-1-UNC0638 (2-1 mol-mol),3.5266256141153756
YH-13,10296883,4.196539709790054
NCI-H647,23635314,2.890189776915987
NCI-H1092,44137675,4.14698117829052
MFE-319,448949,3.245263954899008
SUP-T1,409805,3.665439994658061
MFE-319,46926350,-4.138900404614356
RCC10RGB,9825149,2.634802111166888
NCI-H2081,SNX-2112-bortezomib (250-1 mol-mol),-1.4836997407724497
SNU-719,135984461,4.329152044939095
SK-MEL-3,9952709,2.451899545912975
MSTO-211H,3815108,2.5678993468563913
BT 232,107970,1.965995572624395
BT 239,16659841,3.5869856630154104
HT-1197,11507802,4.321974829643199
A3/Kawakami,16065773,1.547996771475256
MG-63,11656518,1.9461903625697667
HGC-27,9911463,2.724483471079002
P31/FUJ,3854666,0.6136756098719494
Capan-1,11485656,1.8375535341364733
HOP-92,136227924,3.2563886907656725
BT 228,2729026,1.8094400941179165
AML-193,44819697,1.4541892061823567
MFE-319,107985,-2.7027086117071386
AML-193,6610355,3.469986099209704
NCI-H647,25227462,-0.4491069439401917
SUP-T1,16038120,0.3321215455186371
BT 239,24785538,-3.4870873476786866
NCI-H1092,9935249,2.293612828813301
MFE-319,6438330,3.1907376477845113
VMRC-LCD,25102847,2.465012164526766
HCC2108,24964624,3.042744623925763
NCI-H716,9933475,-4.3730377752305145
KHM-1B,10113978,2.248565849983048
NCI-H647,49766530,1.518533488741799
HT-1197,16722836,3.088340512040065
EoL-1,5113032,4.027385434836825
YH-13,262093,3.0071094341497826
HCC2108,676352,1.822640586009688
JeKo-1,49793307,-5.236948425974963
BT 428,5494449,0.5844518768808629
SUP-T1,568763,-0.6335622062877265
HARA [Human squamous cell lung carcinoma],11455910,0.2072973533181662
BT 239,72967,3.6652679956846272
BT 428,644241,1.7841818020413711
RKO,675434,4.252493680505022
HuH-28,navitoclax-sorafenib (1-1 mol-mol),-1.4986499905557085
AML-193,25262965,3.197525323934428
BT 245,4096211,1.456957883337208
L3.3,navitoclax-gemcitabine (1-1 mol-mol),-4.48479777241671
NCI-H1092,6450551,2.2597381563726433
NCI-H716,2733487,3.41590514777934
YH-13,219104,3.421374487028668
KYSE-180,136227924,3.113518519432139
Capan-1,selumetinib-PLX-4032 (8-1 mol-mol),3.5681732220494844
KYSE-450,56649450,5.522708558477712
HDLM-2,25126798,1.6284644824258692
RCM-1 [Human rectal adenocarcinoma],11494412,4.241721696176272
BT 428,3136844,3.909056651603449
JeKo-1,selumetinib-PLX-4032 (8-1 mol-mol),4.810515126622351
BT 232,11955716,-1.1235451085037524
SK-BR-3,9926054,1.6318008391907537
BT 228,11175137,2.887615980443983
IGR-37,44137675,4.5147656758908745
P31/FUJ,selumetinib-UNC0638 (4-1 mol-mol),1.8703414483738705
SNU-175,135398738,4.087307088875958
HuH-28,11612883,3.063401264277344
HT-1197,2874250,-2.833185796406476
PK-59,107985,-3.7968575257166495
RCH-ACV,16722836,0.9117067083889738
IGR-37,49793307,-0.3138388910025303
KYSE-450,10184653,1.1641913359919105
MFE-319,1566236,3.6446257988507
HDLM-2,9903786,0.9941602221273084
HOP-92,387447,-4.191692232449402
IGR-37,9933475,1.7663472929728496
KYSE-180,44507138,3.1582868511502524
SW1116,60700,0.7157233850635775
NCI-H2081,7326481,2.574676844247029
HT-1197,25262965,-1.0250568168241334
RCM-1 [Human rectal adenocarcinoma],119607,5.94570045924447
HCC2108,piperlongumine-MST-312 (1-1 mol-mol),1.4523587020205275
EHEB,15953870,4.2659113550785595
P31/FUJ,46943432,0.8368365469264624
HT-1197,9911830,3.1425347559811967
HARA [Human squamous cell lung carcinoma],135398516,1.8495805389969304
NCI-H2081,vorinostat-navitoclax (4-1 mol-mol),0.2731238832512092
AU565,44620216,3.755834453350393
BT 245,alisertib-navitoclax (2-1 mol-mol),-2.3695244467769276
SK-MEL-3,navitoclax-piperlongumine (1-1 mol-mol),3.034050355407627
HDLM-2,17755052,2.770194020758197
BT 245,168313200,2.0916764208189895
RKO,selumetinib-tretinoin (2-1 mol-mol),2.520120690265609
NCI-H2081,9933475,1.7869131663343656
KMS-26,71466445,2.0250779935621868
NCI-H716,6450551,-2.029898333052656
SNU-719,327653,3.2757208144159913
JeKo-1,4259181,0.4142441656313368
A3/Kawakami,10184653,1.2127271760301537
HDLM-2,9868037,2.9118865294279943
IGR-37,decitabine-navitoclax (2-1 mol-mol),3.57563740113186
KMH-2,JQ-1-vorinostat (2-1 mol-mol),0.2759899908588843
SUP-T1,4521392,4.250108134980175
WM793,selumetinib-UNC0638 (4-1 mol-mol),2.385330899983246
PK-59,11396600,3.5699719356694573
SK-MEL-3,11964036,3.041798583160155
HGC-27,53232,3.4267810639454455
MFE-319,9911463,4.372172899539541
HARA [Human squamous cell lung carcinoma],11497983,-2.5330413808054333
IGR-37,72193861,0.0771925201724088
BT 239,73707398,0.5313402889199192
NCI-N87,46174525,4.699807035348161
BT 239,49846579,0.1798133266747162
KYSE-180,5278396,3.1226563629461705
VMRC-LCD,selumetinib-piperlongumine (8-1 mol-mol),3.7111082745712385
KU-19-19,124202324,2.2262797687523266
KALS-1,JQ-1-vorinostat (2-1 mol-mol),0.8454568408866707
PK-59,119607,5.342601752409214
KYSE-180,4259181,-2.278337111185809
MFE-319,23725625,4.814849253038922
HDLM-2,5566,2.9888023565895128
SCC-25,alisertib-navitoclax (2-1 mol-mol),-0.2463125152337996
NCI-H1092,JQ-1-MK-0752 (1-1 mol-mol),3.999675305705296
HOP-92,salermide-PLX-4032 (12-1 mol-mol),3.89922045537084
KMS-26,11222830,-0.6203753084078112
EHEB,613753,3.075305860436084
SIG-M5,16013152,4.164973931838877
SCC-25,3025986,-2.1482323576385554
TCCSUP,445643,3.731151770896645
SK-UT-1,637858,2.463996188946881
WM793,1716436,1.7539283172933289
KALS-1,374536,4.42928404322089
BT 228,sirolimus-bortezomib (250-1 mol-mol),-0.6325726268478239
SIG-M5,71751553,4.293006286134242
HOP-92,25102847,2.3286529210995197
Capan-1,135999136,4.351414780537385
MG-63,10427712,4.673704366159064
A3/Kawakami,9843750,4.466820425723187
BT 232,15547703,2.9804695396281726
NCI-H647,49793307,-5.1467165504146655
SK-N-SH,46199207,3.1435075152536975
KALS-1,753704,6.164228266085961
HARA [Human squamous cell lung carcinoma],54143018,-1.1176720961651934
HCC2108,9444,3.448443284867183
HGC-27,11717001,4.384145386449309
SK-BR-3,5287969,-1.6234720552231046
PC-14,56963564,-1.1093781360845574
KHM-1B,135440466,-1.206578017984145
KMS-26,5978,-4.2709234628756585
IGR-37,11257553,0.415038526007118
YH-13,46215462,1.6135517915003736
RCC10RGB,3825829,4.92777419243283
AML-193,piperlongumine-MST-312 (1-1 mol-mol),0.7947770333671972
SK-MEL-3,10427712,4.674327187404856
HOP-92,46907787,2.9516486383279488
A3/Kawakami,tretinoin-navitoclax (4-1 mol-mol),4.167440004519349
HGC-27,7326481,2.3355966830204697
SIG-M5,alisertib-navitoclax (2-1 mol-mol),-1.704018021118355
WM793,60700,0.4501720050415228
BT 245,9911830,3.123552720106954
SNU-175,9887053,3.375312386151919
HOP-92,54678924,2.9538712532530544
NCI-H2081,6918837,-5.022444332992493
BT 428,42642645,2.2161145652022465
AU565,16720766,2.906162391657848
EHEB,4521392,4.976004028778806
MG-63,322968,4.16834577852248
EoL-1,409805,2.9629225339184595
HT-1197,16659841,4.370665354973768
IGR-37,9825149,2.2615369805908796
EHEB,selumetinib-JQ-1 (4-1 mol-mol),-0.0163446257701156
KALS-1,16722836,1.772337522176617
SCC-25,5470400,0.801512844319177
SUP-T1,11640390,3.5665193725586417
KMH-2,selumetinib-vorinostat (8-1 mol-mol),2.389760502831543
KU-19-19,6438330,3.038685724131264
TCCSUP,navitoclax-PLX-4032 (1-1 mol-mol),2.317230132678856
RCC10RGB,JQ-1-navitoclax (2-1 mol-mol),1.088443536961304
SIG-M5,56649450,4.3535467231455645
KALS-1,alisertib-navitoclax (2-1 mol-mol),2.1380207268442244
HT-1197,445643,3.772861176313985
SK-MEL-3,16065773,1.9958849905997895
RPMI-8402,2729026,2.122177717633357
HGC-27,52912189,0.5788820844077441
SNU-719,navitoclax-piperlongumine (1-1 mol-mol),-0.8539956605428993
KMH-2,136227924,2.758064098306969
JeKo-1,9884685,1.0765625898866802
SK-UT-1,462382,0.5572290876246132
HARA [Human squamous cell lung carcinoma],9826308,0.352829852370258
RCH-ACV,16736978,0.960226141201578
NCI-H2081,54613361,-0.0228941732183183
HCC2108,navitoclax-pluripotin (1-1 mol-mol),-1.5801642437599936
AML-193,6918328,-2.09353039442145
MG-63,9936388,-4.191645899593892
SK-N-SH,JQ-1-navitoclax (2-1 mol-mol),0.094385105708453
RCH-ACV,5281321,-3.817786148333754
KHM-1B,sirolimus-bortezomib (250-1 mol-mol),0.0402110157809841
MG-63,969516,2.658739136717438
IGR-37,984333,0.6455814323917741
AML-193,16013152,3.8779296801639944
HuH-28,44137675,3.4111922570635933
NCI-H2081,11404337,-2.077246389622244
HARA [Human squamous cell lung carcinoma],52947716,4.13690029570622
MSTO-211H,selumetinib-piperlongumine (8-1 mol-mol),2.1949656994292455
BT 228,44607530,0.90142733520645
BT 245,136227331,4.251360717375094
NCI-N87,51039095,3.189774410902983
SK-UT-1,6917907,-5.759127548873742
JeKo-1,2945648,1.3400471616639216
IGR-37,6918837,-2.8623133680242874
EoL-1,44632017,0.15818528011435
A3/Kawakami,6610355,3.54206702996839
KMH-2,119607,3.775698687409495
NCI-H2081,46926350,-4.428589866932994
BT 239,selumetinib-UNC0638 (4-1 mol-mol),3.209893852329088
NCI-H2081,24753719,4.037731991107883
Capan-1,6914657,-2.092351074217911
SK-BR-3,107985,-3.8808400341324543
AML-193,46926350,-4.64469269810993
SUP-T1,375860,-0.5976007782888901
NCI-H2081,71304818,1.874241739609375
SUP-T1,56649450,4.005685625406002
SIG-M5,568763,-0.1671852203854653
PK-59,24797083,1.2491720369085026
HDLM-2,54454,2.6385752895112007
HCC2108,66577038,3.559393194333952
WM793,10296883,3.657255931485473
KMS-26,135398516,-0.7069645114625117
BT 232,5351362,2.0848480802233795
RPMI-8402,erlotinib-PLX-4032 (2-1 mol-mol),2.8206230015289036
RCC10RGB,navitoclax-piperlongumine (1-1 mol-mol),1.8990680206310235
NCI-N87,15983966,-4.100894125332804
BT 428,9956119,2.323897246428331
KU-19-19,25126798,3.8528221502524262
KHM-1B,2949965,3.6440598201563423
SUP-T1,erlotinib-PLX-4032 (2-1 mol-mol),3.4880373915681884
IGR-37,135999136,4.421370905538769
HCC2108,5280436,4.355594613728095
BT 239,6918837,0.4674096704137693
PK-59,11455910,1.1021180024981292
NCI-H2009,5311,0.3641463076187463
HuH-28,25262965,3.7379682421448712
RCM-1 [Human rectal adenocarcinoma],51037431,4.999864104870178
EoL-1,5746,-3.5264630085711173
BEN,123631,2.8540176100639503
MFE-319,9956119,4.280547494668359
JeKo-1,12003241,-2.1711036059300963
NCI-H647,24951314,1.8982467468883897
A3/Kawakami,7251185,1.2210599365736223
HOP-92,carboplatin-UNC0638 (2-1 mol-mol),3.2750932049203576
SK-MEL-3,9915743,2.9768628838576037
RPMI-8402,56946209,-4.577787843538742
EHEB,17759555,3.693788336759982
AU565,3552672,1.7684242008913282
SK-MEL-3,44819697,3.5928152602368386
HGC-27,387447,-3.492607517948141
VMRC-LCD,375860,-0.2754019641455896
BT 428,11717001,2.1851156946735544
PK-59,3062316,-0.1787843302655138
RKO,1716436,3.795795915163565
SK-MEL-3,navitoclax-pluripotin (1-1 mol-mol),-0.5836126407646707
MFE-319,168313200,2.8500220727002885
SIG-M5,2708,2.8636968215796
PK-59,25102847,1.7596066795217422
NCI-H647,9935249,3.357508970290888
EoL-1,53232,0.780233714790885
P31/FUJ,1317464,4.709019850634407
NCI-H2081,5738263,3.7116939105777687
HOP-92,5311281,1.2644704690895885
SNU-175,selumetinib-GDC-0941 (4-1 mol-mol),0.0356628717912123
RKO,11507802,1.7455765117352984
NCI-H2081,JQ-1-carboplatin (1-1 mol-mol),1.838328263048474
MSTO-211H,16736978,0.1439838744803616
SW1116,11404337,-1.048062477762995
KALS-1,sirolimus-bortezomib (250-1 mol-mol),0.8201349521844062
HARA [Human squamous cell lung carcinoma],2113511,5.545523050638764
SUP-T1,2746,1.6864160186054145
SNU-175,159324,0.7701191527474731
Capan-1,9935249,3.692856081858843
SNU-175,216468,0.2255293384078543
SIG-M5,JQ-1-UNC0638 (2-1 mol-mol),-1.803321584067572
TCCSUP,969516,3.191540501886845
BT 428,JQ-1-vorinostat (2-1 mol-mol),1.3063332491607542
NCI-H1092,11152667,0.3392565176972865
BT 228,46843906,3.697636032208851
AML-193,53481919,3.482467883284518
MG-63,216345,4.459941708485376
P31/FUJ,375860,-1.2092771030706315
RPMI-8402,9825149,1.437993383450544
AML-193,5282054,2.929983046590076
A3/Kawakami,selumetinib-PLX-4032 (8-1 mol-mol),3.5172798665634666
JeKo-1,135659046,3.5634335603711995
MFE-319,9866186,1.4143741611398308
KYSE-180,5470400,0.6957962839919276
SIG-M5,25227462,-6.076680915185229
AML-193,67156097,-2.673815299591117
JeKo-1,54613361,-1.7550685480423724
HuH-28,selumetinib-piperlongumine (8-1 mol-mol),3.4416958234226285
SK-N-SH,46843906,2.961091301785906
KYSE-180,5311,1.7867284684655886
HOP-92,vorinostat-carboplatin (1-1 mol-mol),2.3913874234777532
SK-BR-3,24748573,1.3803476323047792
NCI-H647,24180719,3.874894669402666
BT 428,salermide-PLX-4032 (12-1 mol-mol),3.1520457588313824
BT 239,136227924,1.4188260158561712
A3/Kawakami,10113978,2.4807426735322937
WM793,11152667,-0.0685864179324616
MG-63,119607,5.498659006767494
AML-193,136227331,3.928096776967208
AML-193,12001922,1.1501522551679335
SCC-25,151289,1.000658764001303
HARA [Human squamous cell lung carcinoma],1716436,3.773793106717324
NCI-H647,11404337,-0.2592601702494094
KYSE-180,6918878,4.793960218409927
KHM-1B,9936388,-7.3262126051433425
A3/Kawakami,168313200,2.7550323232462763
BT 245,71304818,2.4314094706229743
MSTO-211H,1566236,2.167071233614174
KYSE-180,5460769,3.044274290576871
BT 245,24748573,2.027135549432793
HGC-27,4521392,4.307243468009251
KU-19-19,119607,4.136898976237774
KMS-26,JQ-1-navitoclax (2-1 mol-mol),-2.445425113946911
KYSE-180,8515,4.449202894378201
PC-14,9823820,1.8036222521667309
TCCSUP,216468,4.422415170962146
NCI-H1092,1566236,1.754245151236072
SK-N-SH,241158,3.663182891539546
P31/FUJ,119182,-2.8125390579467244
BT 245,9840324,6.212048874713068
SK-MEL-3,4378219,4.648611006826355
MFE-319,alisertib-navitoclax (2-1 mol-mol),3.0379700778421412
SNU-175,11427553,-0.0173820219357246
NCI-N87,5746,-2.0970985848352837
TCCSUP,52947716,2.97003679265922
KYSE-180,10127622,5.464942572598225
AML-193,3025986,-2.106127573816962
KMH-2,decitabine-navitoclax (2-1 mol-mol),-0.6649345371848503
KMH-2,65064,3.079648002703383
SW1116,54618771,-0.9904180488449444
HT-1197,decitabine-navitoclax (2-1 mol-mol),2.8111830493711505
MSTO-211H,168313200,3.954855187852925
EHEB,3025944,4.323656262321947
JeKo-1,tanespimycin-gemcitabine (1-1 mol-mol),-2.260719585082542
JeKo-1,2708,2.9946854941632983
PC-14,219104,4.7491354511551345
NCI-H647,56649450,3.5231390369258277
EoL-1,66577038,0.9605105843922468
A3/Kawakami,421610,1.6913848317217657
NCI-H716,9823820,-2.2963877567176643
PC-14,4096211,1.790962002826893
SUP-T1,322968,2.060058656972421
BT 239,219104,2.383931915031164
NCI-H1092,25150857,2.120015833074409
SK-N-SH,49867930,6.374571424300081
NCI-H647,5951923,4.256110108432066
IGR-37,9866186,1.158755003326206
WM793,216345,3.0524169144377615
MG-63,2858523,2.996690912036439
EoL-1,126941,-7.4192556860094125
IGR-37,tanespimycin-bortezomib (250-1 mol-mol),1.387795726757113
A3/Kawakami,3384730,2.26342832620082
VMRC-LCD,24821094,3.800085647853821
MSTO-211H,selumetinib-decitabine (4-1 mol-mol),3.004409574636068
BT 428,421610,3.0025644151069595
KU-19-19,168313047,3.3084179069540696
SW1116,selumetinib-MK-2206 (8-1 mol-mol),-0.0547990281207436
AU565,156414,-1.7188953203880928
BT 239,selumetinib-GDC-0941 (4-1 mol-mol),-0.9250239368821744
SK-N-SH,11178236,1.9249574666931213
SIG-M5,46174525,3.9509957070819217
BT 232,selumetinib-vorinostat (8-1 mol-mol),2.9524508630620554
SK-N-SH,9825149,0.8307673233608358
NCI-H2081,52912189,1.203290286041043
HT-1197,11707110,2.50828975379121
BT 239,60750,-0.591272594792517
AU565,9908783,4.7252597511686965
IGR-37,6252,-0.2352579025438577
RKO,49793307,-1.4433237106321422
RCH-ACV,16720766,-0.4992848014498612
HDLM-2,6918328,-0.861134057920358
BT 228,53393127,4.498607894843436
BT 228,doxorubicin-navitoclax (2-1 mol-mol),-0.7034002400043885
EoL-1,11960529,3.55338030447138
PC-14,25062766,2.6228137259530326
MSTO-211H,451668,4.9569649646478515
NCI-H647,23725625,6.313962046168762
KMS-26,4788,4.0746589760104355
RCC10RGB,135440466,4.497503570362309
NCI-H1092,docetaxel-tanespimycin (2-1 mol-mol),-2.441864918067417
JeKo-1,56973724,3.591454743194686
MFE-319,216345,4.454507835717328
EHEB,638278,3.110605019807073
NCI-H716,24785538,-0.0489474377491455
NCI-H647,54619267,3.8310171272368185
SW1116,JQ-1-carboplatin (1-1 mol-mol),-0.0144510957041741
VMRC-LCD,25262965,0.3195216952622248
HCC2108,71304818,2.5553265093356186
KMS-26,23725625,4.2868566235217305
HT-1197,5281672,4.435603425764759
AU565,1716436,0.9342430141979629
NCI-H647,46398810,2.150078200828676
KYSE-180,126941,-3.004750085240848
AML-193,2945648,1.283814783098086
P31/FUJ,selumetinib-tretinoin (2-1 mol-mol),-0.8330243559244562
KHM-1B,445455,4.826586800965752
EoL-1,16741245,1.2519807563296603
SNU-175,54626689,3.625294864544097
MFE-319,JQ-1-vorinostat (2-1 mol-mol),1.4364194205897167
SK-UT-1,148198,-4.4190978779578565
TCCSUP,navitoclax-sorafenib (1-1 mol-mol),3.067250196506974
SK-BR-3,25227462,1.3725976658473762
KHM-1B,49766530,-2.233986045015649
HDLM-2,107970,1.9865274855394164
HARA [Human squamous cell lung carcinoma],15983966,-4.087930187377121
NCI-H647,11396600,2.927909062901915
NCI-H2009,alisertib-navitoclax (2-1 mol-mol),-2.130413891599744
RPMI-8402,6918736,-1.7950871645944833
BT 428,JQ-1-navitoclax (2-1 mol-mol),-0.6624158954827992
HOP-92,9825149,2.067752152122252
MSTO-211H,219104,2.9811404214526136
AML-193,46199207,1.7055072881340292
IGR-37,4096211,1.6289235832013125
SUP-T1,crizotinib-PLX-4032 (2-1 mol-mol),1.0771929306300223
BT 428,12003241,-1.1639537703903158
L3.3,6918328,0.6582944097969459
SIG-M5,9549297,1.7891511877903048
BT 245,51039095,2.78293299090603
EoL-1,1239801,2.5142736934290024
BT 228,387447,-6.110792335484957
HuH-28,alisertib-navitoclax (2-1 mol-mol),-0.979361674188214
AML-193,3854666,-0.1541161036359395
HT-1197,45279963,3.70389303728483
SNU-719,1750826,-0.096619098512795
YH-13,52912189,2.2271959636109693
HOP-92,3854666,3.1115994029267413
RKO,25150857,2.5785304193211247
AML-193,11609586,2.468494211807562
EoL-1,3081361,-1.1708533522235771
P31/FUJ,3689413,-2.495432751898851
NCI-H647,57519531,4.154168971568977
KMS-26,6852167,-0.4011200581134632
MSTO-211H,sirolimus-bortezomib (250-1 mol-mol),-4.356348785591885
NCI-H647,1750826,0.5896936945872244
HDLM-2,10113978,2.1407029633226915
AU565,135398516,2.596290086865212
HARA [Human squamous cell lung carcinoma],11485656,2.214748392282881
NCI-H2081,24821094,3.1641844707183417
SNU-719,5287620,-4.1338108644605445
AML-193,53392493,1.576920258646776
VMRC-LCD,selumetinib-navitoclax (8-1 mol-mol),2.7560957588080157
HDLM-2,9826308,-0.1129022949234974
WM793,10410894,3.504687642816823
TCCSUP,selumetinib-JQ-1 (4-1 mol-mol),2.2207378270123725
PK-59,9926054,1.7891376671835462
NCI-N87,5282054,3.4882884399441125
KHM-1B,11485656,1.807132568777105
KMS-26,46199207,2.6845642211973635
SK-MEL-3,216239,3.360619141122182
EoL-1,135398516,-1.231784473547514
SK-N-SH,4259181,0.0308340137854706
KMH-2,selumetinib-BRD-A02303741 (4-1 mol-mol),5.760290198732975
RPMI-8402,638278,2.641210332384632
NCI-H716,44202524,3.74622588446284
VMRC-LCD,462382,1.022695111269753
PK-59,5287620,-2.358394278164014
RKO,selumetinib-BRD-A02303741 (4-1 mol-mol),2.7729264296394276
BT 245,984333,-0.0164888250804615
HARA [Human squamous cell lung carcinoma],19582717,3.08314824082211
P31/FUJ,11175137,-0.7372235608093404
HOP-92,9935249,3.096811050653779
SW1116,decitabine-navitoclax (2-1 mol-mol),2.6515889458900244
VMRC-LCD,5329102,2.2136849992574255
BT 228,9935249,2.295715399425516
PC-14,44589607,3.5378384136887377
HCC2108,2749,3.7407563708836102
EoL-1,122327,3.2710772608368996
L3.3,984333,-1.3131333034824293
HARA [Human squamous cell lung carcinoma],216468,1.0737616041415703
HDLM-2,2733487,6.912198981618724
IGR-37,3025944,4.384157343429191
NCI-H2081,10427712,3.8865371884271265
HCC2108,3025944,4.0723705952966975
BT 239,71304818,1.728213799530195
SNU-719,25126798,3.7971637945057175
RPMI-8402,702558,3.031813519197699
SK-MEL-3,969516,3.412067810778305
KALS-1,5278396,4.574808173882762
KMS-26,5470400,1.1115263238389947
RCC10RGB,11656518,3.9855029209510215
AU565,carboplatin-etoposide (40-17 mol-mol),1.7469100851636217
KYSE-180,11234052,4.637440527326196
RCM-1 [Human rectal adenocarcinoma],sirolimus-bortezomib (250-1 mol-mol),0.4278853760712148
HuH-28,119182,3.4434982608507996
NCI-H716,tanespimycin-gemcitabine (1-1 mol-mol),-1.93519733163936
NCI-H647,148198,-1.832862483065856
HDLM-2,3503,1.7743841754917076
BT 239,2949965,2.157139880740184
NCI-H2009,56946209,-2.630012103472263
SNU-719,serdemetan-SCH-529074 (1-1 mol-mol),1.8458163537560512
NCI-H2081,10296883,3.746053952557345
TCCSUP,54618164,4.281824636120867
KHM-1B,119607,4.337560231303076
KMH-2,6852167,2.5301856007997348
NCI-N87,navitoclax-PLX-4032 (1-1 mol-mol),1.558715689605079
JeKo-1,26596,-2.667287216238713
SK-BR-3,107970,1.6836850193480015
KYSE-450,5291,4.139799755765828
HuH-28,25195348,4.253855063540982
SNU-175,navitoclax-sorafenib (1-1 mol-mol),-1.8980530594984175
KMS-26,6438330,0.8411442837213101
AU565,6918837,-4.408945103298963
BT 245,11234052,5.204468802593213
SK-N-SH,9911830,1.546281106531784
SCC-25,5746,1.8938322036119173
L3.3,25195348,5.818157346447802
HT-1197,tretinoin-navitoclax (4-1 mol-mol),2.833083980318988
HGC-27,644241,1.74526015473942
A3/Kawakami,JQ-1-carboplatin (1-1 mol-mol),-1.0104542056691184
HT-1197,piperlongumine-MST-312 (1-1 mol-mol),1.877972301894697
KU-19-19,73707440,5.592820593626321
AML-193,68056272,4.147913455836672
HDLM-2,448949,1.157020671621242
JeKo-1,6438330,0.51141476983467
PC-14,11222830,1.8160665948878003
BT 228,15547703,3.0570658580213954
KYSE-450,vorinostat-carboplatin (1-1 mol-mol),4.263576896954741
KYSE-450,6450551,3.3363850258393124
AML-193,969516,2.2758888201197984
SIG-M5,24951314,0.8995226481771079
Capan-1,44137675,4.743022816778694
BT 245,31703,-1.3451878084234994
RCH-ACV,56946209,-4.793861620323526
RCH-ACV,carboplatin-UNC0638 (2-1 mol-mol),2.526089841618545
KYSE-450,15983966,1.931035725285284
KALS-1,66577038,3.370636249602743
RPMI-8402,753704,3.186078195555112
KMS-26,9967941,2.784574124516626
KYSE-180,2874250,4.41639153643559
KMS-26,135440466,-0.7895646326688576
MFE-319,11717001,4.4570178115271935
BT 428,46199207,1.813101312958388
BT 228,4261,3.4304237003326414
MFE-319,462382,0.1636342780994136
IGR-37,4261,2.0838372874675097
SK-UT-1,16720766,0.6075309431652871
NCI-H647,23582824,0.6177148600200179
Capan-1,5278396,4.229684097141332
HOP-92,11234052,3.931636040823538
HOP-92,73707438,3.9615044305268503
AML-193,selumetinib-JQ-1 (4-1 mol-mol),-1.0603244627842072
HOP-92,73707398,1.019832404417608
EoL-1,135984461,1.5166332685892363
BT 239,5291,3.905032529923058
BT 228,selumetinib-PLX-4032 (8-1 mol-mol),3.740320114386346
AML-193,5311037,3.692474184165431
RCH-ACV,2828334,5.749794628039571
NCI-H2009,216468,1.7077485468094884
NCI-H716,136227924,3.096712149885638
BT 428,piperlongumine-MST-312 (1-1 mol-mol),1.2822392110514311
NCI-H716,52912189,0.6719803564588744
P31/FUJ,3634881,2.159990781463395
Capan-1,5282054,4.071564431224408
HOP-92,54618795,3.8710825799564423
NCI-H647,1641662,3.5129837315795793
NCI-H716,151289,1.5659482246281846
SUP-T1,89928392,-0.4762017353418148
BT 239,2742550,2.277540170314908
BT 228,11612883,2.830197112574911
HGC-27,46926350,-4.418488659081001
SIG-M5,2945648,2.4718695595737614
HARA [Human squamous cell lung carcinoma],168313047,3.4416690801744574
HDLM-2,25062766,0.9855424619862558
SNU-175,24978538,-2.1462374754555493
MSTO-211H,2729026,1.9618514095460544
NCI-H2081,11238147,1.888813561617346
P31/FUJ,54619267,3.5260071244925575
L3.3,4261,2.1698969963780055
BT 232,15983966,1.763167607537262
TCCSUP,25105715,3.142954215629872
BT 428,15953870,3.768281629986435
SK-MEL-3,4705,2.152547921158096
PK-59,46199207,3.049912543808079
KMS-26,216345,3.593225871203296
NCI-H2081,6918638,-1.1409095287475362
A3/Kawakami,selumetinib-UNC0638 (4-1 mol-mol),3.837378872558958
SNU-175,vorinostat-carboplatin (1-1 mol-mol),2.250774699998062
SCC-25,navitoclax-birinapant (1-1 mol-mol),-0.7640594627341792
P31/FUJ,selumetinib-GDC-0941 (4-1 mol-mol),0.2780140376369148
IGR-37,carboplatin-UNC0638 (2-1 mol-mol),3.196071296233089
SNU-175,72193861,0.7046096402077298
KALS-1,613000,3.2308531921872103
NCI-H2081,alisertib-navitoclax (2-1 mol-mol),-2.14822930035513
RCH-ACV,24901704,2.09031770451412
SNU-175,24785538,-1.0559816796925503
AML-193,25062766,0.6069883575626596
KMH-2,11455910,1.2516447842889498
TCCSUP,24964624,2.9604589319316985
TCCSUP,119607,5.1552378410509
L3.3,374536,1.2868097755844614
BT 428,UNC0638-navitoclax (1-1 mol-mol),0.5798906424997637
BT 428,23725625,4.442933224116811
KMH-2,54143018,-1.242880212456163
P31/FUJ,25183872,-2.108478877482417
A3/Kawakami,4261,-0.6968646121649373
NCI-N87,9911830,2.159086109533926
IGR-37,5280436,4.083955683661294
RPMI-8402,60700,-3.779289135893414
BT 245,salermide-PLX-4032 (12-1 mol-mol),3.942849865511171
BT 228,11404337,0.5365763312483942
P31/FUJ,56973724,0.796880831995934
NCI-H2081,selumetinib-vorinostat (8-1 mol-mol),1.9423097889386416
SW1116,2742550,3.2977805707201675
KALS-1,3081361,3.2223438996674165
RCH-ACV,216345,1.5116326055580118
SK-MEL-3,637858,2.888806865252382
BT 232,2842253,6.523182664779133
P31/FUJ,JQ-1-UNC0638 (2-1 mol-mol),-0.0749230690326744
SK-BR-3,11964036,0.376314512718304
HDLM-2,1641662,2.4763290818246104
YH-13,selumetinib-decitabine (4-1 mol-mol),4.949176752890973
RKO,6438330,2.4839059464581785
SK-UT-1,44202524,2.9453109499095853
SUP-T1,56963564,-0.9627926595598836
BT 232,tretinoin-carboplatin (2-1 mol-mol),6.1895443348333785
KU-19-19,3384730,2.4463371108200995
YH-13,10127622,5.098767589051213
BT 245,123631,3.2251145335322975
BT 245,36462,1.2671899599855267
MSTO-211H,56649450,2.845391743702004
MFE-319,5566,3.1293178236080332
MSTO-211H,navitoclax-piperlongumine (1-1 mol-mol),-1.4716070020924246
SUP-T1,11238147,2.6259491346251593
SUP-T1,3825829,2.6482464739936984
TCCSUP,9549297,3.547573054741186
BT 228,3038522,1.7330880319640674
BT 245,2945648,1.9337259429429097
AU565,12003241,-0.6235660341918571
WM793,11178236,-2.656687439817939
KALS-1,5284616,3.30964836017244
NCI-H647,71466380,4.0138241540038795
YH-13,462382,1.032048022649818
BT 245,2729026,1.7990947371771515
SK-MEL-3,24901704,4.330410092080822
HDLM-2,11485656,1.650668651442868
BT 245,24964624,2.33257975283963
NCI-N87,3854666,1.2679317332294615
Capan-1,erlotinib-PLX-4032 (2-1 mol-mol),4.212474106363966
AML-193,6918837,-5.399267268934231
BT 245,selumetinib-tretinoin (2-1 mol-mol),5.327283057457125
SUP-T1,24797083,1.4605909391264538
KMS-26,9911830,2.0574042745338725
KMS-26,9866186,0.307998262873816
YH-13,135875424,4.585935280505426
RCM-1 [Human rectal adenocarcinoma],25195348,3.936962209730735
VMRC-LCD,carboplatin-UNC0638 (2-1 mol-mol),3.4062365253455273
AML-193,322968,2.7491365531990453
BT 232,135875424,3.043961791838538
NCI-H647,4788,5.492190738387396
RCH-ACV,2946601,3.6480583158082753
SNU-719,doxorubicin-navitoclax (2-1 mol-mol),-1.6150612574102712
SCC-25,71466380,4.007265641042773
EHEB,decitabine-navitoclax (2-1 mol-mol),0.1121135025155182
RCC10RGB,46398810,2.467266718263722
IGR-37,16219061,3.4804271697589138
IGR-37,135398516,3.492355472727717
SK-N-SH,25183872,-1.5495841262614716
SNU-719,60750,1.3746126588516216
NCI-H1092,4788,4.950756900369662
SCC-25,89928392,0.7736465346662662
WM793,241158,3.83369214528036
BT 239,135440466,0.5260159610044564
A3/Kawakami,135421197,1.197973904783629
KHM-1B,12001922,1.027456865676835
IGR-37,11317348,4.381271864863252
SK-MEL-3,5282054,3.574735996579224
L3.3,16720766,-1.973453330210062
KHM-1B,3384730,0.7492899060268451
KYSE-450,67156097,3.411841611974051
RCH-ACV,selumetinib-MK-2206 (8-1 mol-mol),0.8366606818021679
MG-63,119182,1.893948499581824
SNU-719,3385,4.61552747132504
EoL-1,19582717,2.2043129792876615
HOP-92,selumetinib-BRD-A02303741 (4-1 mol-mol),2.579655780459309
SCC-25,6852167,1.4389858944642788
AML-193,81146,4.385726225817699
KYSE-180,16722836,1.8171321654098664
SCC-25,19582717,3.200726445603184
KHM-1B,23725625,4.172132187038291
NCI-H716,11494412,1.1252717992801926
SK-N-SH,44819697,-1.48361991676768
IGR-37,107970,2.921312490724966
SK-UT-1,9907093,4.521774895830979
BT 228,12003241,-1.6653206714884845
BT 232,1641662,4.310075595500358
MSTO-211H,409805,4.793476239157615
RCH-ACV,119607,4.431833008575324
PC-14,5566,3.0914991862540333
HARA [Human squamous cell lung carcinoma],11152667,-1.8717886502550631
IGR-37,2874250,-4.64803851129264
IGR-37,445091,4.406137119648946
BT 228,46215462,1.6957858530412222
SK-BR-3,24856436,-0.111389516696223
EHEB,54143018,-0.2425574036169623
BT 245,107970,1.8345714144721337
RCH-ACV,11640390,3.487983604746716
PK-59,tretinoin-navitoclax (4-1 mol-mol),4.640786679832576
RCM-1 [Human rectal adenocarcinoma],10184653,2.2395944761831372
NCI-H716,vorinostat-navitoclax (4-1 mol-mol),1.2370632892111568
HOP-92,445091,4.195488674121774
BEN,11626560,2.5410396157586472
KHM-1B,2874250,4.780971307568023
MFE-319,46174525,4.370073148555183
EHEB,5311,0.7316765744080972
HOP-92,2828334,6.243803183861556
SCC-25,crizotinib-PLX-4032 (2-1 mol-mol),1.3137634734233163
HGC-27,6852167,0.8540634851742253
KHM-1B,16741245,2.621472982126402
AU565,11234052,4.466615830851295
JeKo-1,42642645,-0.0384862855340998
WM793,5460769,5.840780592325561
BT 239,selumetinib-PLX-4032 (8-1 mol-mol),3.327208352209213
HARA [Human squamous cell lung carcinoma],46907787,3.600628557962214
KALS-1,322968,3.715208136944881
SNU-175,45100309,5.751283998477895
HDLM-2,decitabine-navitoclax (2-1 mol-mol),-0.79856366856792
NCI-H647,4096211,2.2813719743612046
RKO,11404337,-0.3534280477619294
IGR-37,tretinoin-carboplatin (2-1 mol-mol),6.371408639028006
BT 228,selumetinib-vorinostat (8-1 mol-mol),3.923422561678695
RCM-1 [Human rectal adenocarcinoma],56649450,3.837346847556256
HDLM-2,selumetinib-GDC-0941 (4-1 mol-mol),3.928521461465485
MSTO-211H,UNC0638-navitoclax (1-1 mol-mol),-1.567850255531391
KYSE-450,6852167,3.693304163934065
AML-193,11625818,4.041819687919522
NCI-N87,16038120,-0.0105690503285029
HOP-92,2858523,2.609710863753562
SK-MEL-3,72193861,3.4463146941691347
RCH-ACV,selumetinib-navitoclax (8-1 mol-mol),0.196281036597407
RCM-1 [Human rectal adenocarcinoma],9915743,2.171200504833566
BT 232,71466380,4.390281270696379
SCC-25,5351362,0.8613404265176136
NCI-H2009,5328940,1.7426808664178373
KU-19-19,tanespimycin-bortezomib (250-1 mol-mol),0.8089732350000719
MG-63,JQ-1-MK-0752 (1-1 mol-mol),2.0739102655937693
MSTO-211H,6918328,-0.4462053694736546
SUP-T1,selumetinib-tretinoin (2-1 mol-mol),4.774845020488407
IGR-37,25262965,1.810724137965973
RPMI-8402,56973724,0.8239372171062392
BT 245,crizotinib-PLX-4032 (2-1 mol-mol),2.460223390906092
TCCSUP,5351362,1.0787076559340512
SCC-25,409805,3.725109800952581
SCC-25,6505803,-1.2912802856416608
RCH-ACV,tanespimycin-gemcitabine (1-1 mol-mol),0.0450746231383598
RKO,6610355,5.147293026177706
HDLM-2,16741245,3.299537455911132
VMRC-LCD,51039095,3.00056620476357
NCI-H2081,25062766,3.110506006448837
NCI-H716,25062766,0.9462926223576716
A3/Kawakami,5281321,-2.344550188380158
NCI-H647,navitoclax-piperlongumine (1-1 mol-mol),3.117070013679449
RCM-1 [Human rectal adenocarcinoma],15953870,5.063824663341904
KMS-26,73707386,2.0283413542396365
MFE-319,54143018,1.0160606351731116
VMRC-LCD,168313200,3.7179740407892905
MFE-319,24821094,3.7726684873471017
SK-N-SH,6914657,-4.767788393540488
RPMI-8402,selumetinib-MK-2206 (8-1 mol-mol),2.8049056576386957
BT 228,637858,2.2538508050873016
MFE-319,tretinoin-navitoclax (4-1 mol-mol),5.4800572555093865
NCI-N87,44819697,-2.3159908553894932
YH-13,568763,0.2718115041974417
P31/FUJ,46199207,2.4446101047156215
HGC-27,11656518,0.2601895688309278
MSTO-211H,26596,-0.5653018529577997
SK-UT-1,tanespimycin-bortezomib (250-1 mol-mol),-0.7154967018113316
PK-59,148198,-2.6043559024802763
SK-BR-3,156414,3.9903950038310354
SUP-T1,73707398,0.2441086723916535
HuH-28,11152667,0.3540574012859301
PC-14,17759555,1.6519344508674516
RCM-1 [Human rectal adenocarcinoma],5328940,2.0329581384082944
BEN,54618771,1.4690006980639003
RPMI-8402,6450551,0.6913906875140242
BT 239,23635314,-0.8474101618321705
P31/FUJ,1716436,3.053886593694114
RKO,54678924,1.753529637740366
VMRC-LCD,navitoclax-piperlongumine (1-1 mol-mol),1.0480975312730074
NCI-H647,24772860,-2.1159584229199897
RPMI-8402,3025944,3.759270895901594
KALS-1,16065773,3.628013394668355
KYSE-180,44185566,2.1212784922440258
Capan-1,10410894,3.820475797503827
NCI-H1092,753704,4.364704525984801
KYSE-450,72376,0.4386506850457716
HuH-28,446155,-0.0941590227475815
SK-MEL-3,9926054,1.7891311822278144
NCI-H2081,49793307,-4.448015018456752
KMH-2,73707386,2.2684707650817453
HT-1197,11964036,1.6588818507428542
JeKo-1,JQ-1-vorinostat (2-1 mol-mol),0.0737735098525624
NCI-H2009,1242560,3.090706196906407
NCI-N87,89928392,0.9456157368763274
A3/Kawakami,375860,-0.4676935312596571
SK-MEL-3,11955716,4.4580470532723915
NCI-H647,9884685,1.1799984991000132
RCC10RGB,46199207,3.760684270246491
SK-N-SH,984333,0.0354693804871023
MSTO-211H,6623618,1.8328237574963773
SK-MEL-3,6918638,0.5772610172488114
MG-63,24901704,4.247380739493746
NCI-H2081,46843906,1.767144018608114
SUP-T1,9911463,3.1631435618556827
HT-1197,4261,1.314263914454418
HOP-92,71466380,4.554395944523312
NCI-H1092,445091,4.147919416996549
NCI-H647,sirolimus-bortezomib (250-1 mol-mol),1.438565345282899
MG-63,15983966,3.9628352889416063
NCI-N87,3385,5.19418058853999
SNU-719,107985,-3.2235683767483607
SCC-25,123631,0.0153805417560681
KU-19-19,46199207,3.5920417522591723
SK-BR-3,46907787,0.432844981405334
PC-14,11964036,1.9982884581849667
KALS-1,6184667,3.200200302281933
A3/Kawakami,11625818,-6.047732558546958
PK-59,4259181,0.3924216394548331
RKO,11717001,3.92417498432234
PC-14,25102847,1.7676592344294957
L3.3,44185566,3.1226996854840836
JeKo-1,6610216,5.101386243640172
PK-59,17759555,4.419467770520212
HGC-27,156414,1.4531209246757668
MSTO-211H,24978538,-1.489482683206989
SNU-175,439501,-1.724461019506839
HOP-92,445643,3.9494833884547433
JeKo-1,10184653,1.5055144345574198
EHEB,44185566,1.5991961670911994
HOP-92,11455910,1.423553791437778
KYSE-450,JQ-1-vorinostat (2-1 mol-mol),2.5632737661829488
EHEB,docetaxel-tanespimycin (2-1 mol-mol),-5.11927619590754
KMS-26,25105715,2.8869422140002503
AU565,11175137,1.8234152921093247
RPMI-8402,3062316,1.8027707112002145
NCI-H647,10322450,4.351576478086524
SK-N-SH,JQ-1-carboplatin (1-1 mol-mol),2.4267481661369734
SK-MEL-3,11427553,3.7231047490111897
PC-14,11626560,1.2085096706261982
PC-14,11364421,-4.686558002972056
MFE-319,53232,2.5736807317591612
SNU-175,decitabine-navitoclax (2-1 mol-mol),0.2422712829161107
KHM-1B,219104,1.6531557302016933
RCC10RGB,46215462,3.684591481140594
AML-193,24964624,2.4456156751961493
EoL-1,46843906,-0.4058604253210269
A3/Kawakami,23725625,4.513307903532424
RKO,tanespimycin-gemcitabine (1-1 mol-mol),-1.448163850865836
SIG-M5,156414,1.6593645678315314
NCI-H1092,11175137,2.874404641509256
Capan-1,56946209,-5.5852457709234695
BT 239,11494412,1.0989545703534742
NCI-H2009,100016,6.24887408197215
KHM-1B,56946209,-4.323127458316883
NCI-H1092,6610216,4.21553350442545
RCH-ACV,5280436,2.480105190272529
VMRC-LCD,71466578,3.283958940633181
EHEB,carboplatin-UNC0638 (2-1 mol-mol),3.0000584339231655
SUP-T1,23635314,-5.146855447877085
WM793,25150857,2.2772862447818047
SK-UT-1,4259181,0.5247904304596981
KU-19-19,52912189,3.155674258646967
AML-193,46215462,1.3715885421328713
L3.3,23582824,1.1997888978910711
MFE-319,25227462,1.562934822313389
KU-19-19,selumetinib-JQ-1 (4-1 mol-mol),-0.4288095691894706
L3.3,135411,0.9568641453583406
BT 239,46398810,1.637412265490798
VMRC-LCD,5278396,3.731652355358491
SNU-719,72193861,2.484724108008733
BT 428,71304818,2.642150513795867
KYSE-450,tanespimycin-bortezomib (250-1 mol-mol),0.2570143843515884
Capan-1,1242560,3.787794658735552
NCI-H2009,6610355,3.511475006316147
KMS-26,11214940,-0.122911157462179
Capan-1,72376,-0.1973828383534625
AU565,selumetinib-JQ-1 (4-1 mol-mol),3.812986745391109
AML-193,375860,-0.9246349933126312
SK-UT-1,72376,-0.4045590861192394
SIG-M5,45279963,3.731699395292511
SK-MEL-3,11222830,1.881638669674709
BT 428,6252,3.8655394364718942
SCC-25,2828334,5.97913090726267
SUP-T1,11497983,2.5272646371469887
BT 428,10410894,2.746869438201359
VMRC-LCD,54618771,1.8324078419915515
KMS-26,2733526,3.189401421423936
RCH-ACV,11396600,2.874378489903408
SNU-719,387447,-3.508056175019648
KHM-1B,9967941,3.052222735088891
L3.3,9911830,2.6705572013337195
RCH-ACV,12003241,-2.009657794147886
HGC-27,56973724,0.8603172215811888
SW1116,BRD-A02303741-carboplatin (1-1 mol-mol),4.7347948156838955
KHM-1B,44202524,1.0053468169161075
KMH-2,3689413,-1.7619354335242607
L3.3,54143018,0.1799627669965377
Capan-1,11222830,1.666928731729647
SK-N-SH,409805,5.798286026067844
BT 228,6610216,4.129545438534938
KYSE-180,64971,4.515399284830646
PK-59,3025986,-0.9792937784046736
KYSE-180,20959075,-3.178555830663627
NCI-H647,10113978,1.81441269264524
AML-193,JQ-1-navitoclax (2-1 mol-mol),-0.9836229262105972
IGR-37,selumetinib-GDC-0941 (4-1 mol-mol),-0.4447244170730294
HGC-27,44462760,4.045984199600086
KYSE-180,637858,2.310022745659766
BT 239,54618771,0.6858691475419959
Capan-1,409805,5.822948169887318
RKO,54613361,0.2998145946125954
KYSE-180,44202524,1.4429628152133265
MG-63,11238147,3.295680112654637
Capan-1,4259181,0.8226555222701868
RCH-ACV,3025944,4.063315496692066
SIG-M5,23582824,1.3114984198816753
HDLM-2,10322450,3.293303215923486
EHEB,10427712,4.001167017482681
KYSE-180,11640390,4.050800421029737
PC-14,9907093,4.14725283853085
KU-19-19,11178236,-2.578122805273377
KYSE-450,11485656,2.990129749938368
HGC-27,24180719,2.7787963276057046
L3.3,9926054,1.9335911906728165
HGC-27,3465537,1.8864187021975392
AML-193,82146,3.3371673157023665
NCI-N87,119182,-3.621619524843969
JeKo-1,11640390,3.083552253752392
HARA [Human squamous cell lung carcinoma],135421197,2.918907943246249
MSTO-211H,44507138,3.561974329612715
NCI-H1092,7326481,2.520886584471623
SK-N-SH,135984461,4.272548278190685
BT 232,49867926,5.824004291890405
SK-MEL-3,54618305,4.885800889564964
KMS-26,54143018,-1.4480473631745243
KU-19-19,4521392,6.281175440463305
PK-59,1566236,1.7362298213190046
NCI-N87,375860,-0.928197184659684
P31/FUJ,24964624,0.604485461730223
HOP-92,5566,3.079159463666978
RKO,9926054,1.883626680074333
PC-14,2841722,4.26384457063064
VMRC-LCD,46398810,2.691254151320335
KU-19-19,selumetinib-decitabine (4-1 mol-mol),2.1660518976484853
MFE-319,65064,5.623586165524231
HARA [Human squamous cell lung carcinoma],selumetinib-navitoclax (8-1 mol-mol),2.8572824243778725
P31/FUJ,568763,-0.9310646254211032
BEN,11427553,3.9521605157999455
HGC-27,31703,-2.697964706102057
KMS-26,11364421,-4.842667557553508
SK-MEL-3,73707398,1.6754793187128854
JeKo-1,446155,2.818122249024446
SCC-25,53392493,2.116393490518521
BT 428,327653,2.894003003794866
HOP-92,6610216,3.934588345083168
TCCSUP,11152667,-1.0569561728619483
NCI-H2081,44607531,1.066204155267354
NCI-H716,4788,5.87416821695179
HGC-27,24821094,1.6061877910288416
MFE-319,selumetinib-BRD-A02303741 (4-1 mol-mol),6.819757336701224
SCC-25,ISOX-bortezomib (250-1 mol-mol),0.4468617613122687
RCM-1 [Human rectal adenocarcinoma],5311,1.6255593512960202
MSTO-211H,448949,1.6774063902575909
RCC10RGB,9908783,5.908182650801537
KHM-1B,46398810,2.0305727625963756
RCM-1 [Human rectal adenocarcinoma],60700,-0.2980706312028528
KU-19-19,44589607,3.6813877406069246
RCM-1 [Human rectal adenocarcinoma],selumetinib-piperlongumine (8-1 mol-mol),2.9740491797534947
KALS-1,4788,6.082914827376421
KALS-1,387447,-4.425335240007256
L3.3,44819697,-3.2466678771673427
AU565,135421197,1.4743648854968991
BT 428,11152667,-0.1216773247617757
RCM-1 [Human rectal adenocarcinoma],selumetinib-navitoclax (8-1 mol-mol),2.9022286191617597
RKO,3503,2.683687073265507
YH-13,676352,1.7621508381493205
KALS-1,6438330,2.9227881430044995
HOP-92,JQ-1-navitoclax (2-1 mol-mol),-0.2081278919946404
AML-193,9911830,1.9616986118151176
SK-MEL-3,9549297,1.797422351842423
RKO,24797083,0.8657042008278414
NCI-H716,11964036,0.7879550042092468
KMS-26,44259,-0.1509847825097521
RPMI-8402,11640390,2.6365124058066916
HT-1197,984333,2.034218022958651
KALS-1,2828334,5.983319088498282
HGC-27,tretinoin-navitoclax (4-1 mol-mol),1.1074921177491124
RPMI-8402,327653,2.524650226639341
AML-193,24978538,-0.2522483332755755
EoL-1,2749,-1.6943956065790842
P31/FUJ,3552672,1.950832295752278
SUP-T1,327653,1.5396768902081992
KU-19-19,11717001,1.9129980214779312
SK-MEL-3,2945648,2.708463742233876
SK-MEL-3,54618164,4.268913642051635
NCI-H1092,selumetinib-PLX-4032 (8-1 mol-mol),4.373059758392111
SIG-M5,crizotinib-PLX-4032 (2-1 mol-mol),-1.149238557319554
KYSE-450,107970,3.4899067291718717
VMRC-LCD,9967941,3.463558551663106
BT 245,selumetinib-BRD-A02303741 (4-1 mol-mol),6.290408046736785
KYSE-450,5280436,3.3266706371790264
BT 245,11625818,4.365584281287599
BT 428,24771867,1.0803852417882902
KMH-2,262093,2.330746095077634
IGR-37,56946209,-1.783735381332987
BT 428,1566236,1.6245492383600229
NCI-H647,54618164,4.0719010175074475
RPMI-8402,17755052,0.4149243537536123
SNU-719,2841722,5.304180561621274
HGC-27,11455910,-0.7196123988614116
BT 245,9935249,1.99402432106235
VMRC-LCD,10127622,5.602031137464036
HARA [Human squamous cell lung carcinoma],89928392,1.691456490518517
KMS-26,3815108,-0.3373961907949976
WM793,65628,5.352978394453619
BT 245,2871966,0.3854225071557604
WM793,11609586,2.945181998270863
SK-UT-1,navitoclax-sorafenib (1-1 mol-mol),1.7980583949597466
HDLM-2,136227924,3.1256787357030937
MFE-319,9903786,4.166499809230756
HGC-27,11238147,1.4210278338546436
IGR-37,5278396,3.579819571947373
BT 428,BRD9876-MK-1775 (4-1 mol-mol),0.4985737987972167
VMRC-LCD,26596,-2.205960208364449
BT 239,5287620,-2.1675046365789075
NCI-H1092,4917,2.811199240132262
PC-14,3038522,3.8372175290130466
SIG-M5,tanespimycin-gemcitabine (1-1 mol-mol),-4.677276892858447
SUP-T1,6438330,1.042490830218176
BT 245,JQ-1-navitoclax (2-1 mol-mol),0.0796697322727722
RCH-ACV,135398516,1.4334392631702966
SK-UT-1,11609586,3.614390292326568
SNU-719,6918328,1.3725993483996588
NCI-H647,1716436,3.3784040261144805
SUP-T1,54613361,-0.5781541694248786
BT 228,216239,2.340223505135267
KYSE-180,11612883,2.294010181376236
HARA [Human squamous cell lung carcinoma],675434,4.319126364052166
KHM-1B,11238147,1.9683528585931505
KYSE-180,56946209,-3.779813924696878
HT-1197,11612883,3.1815250665224437
SK-N-SH,46191454,3.9996394166647327
MG-63,53392493,3.384207583987523
HT-1197,2742550,3.6280622418897743
TCCSUP,753704,5.368261344163991
KYSE-180,262093,4.394400122480356
HuH-28,JQ-1-carboplatin (1-1 mol-mol),1.577793116101398
SK-MEL-3,9936388,1.3818026560314072
KYSE-450,676352,2.3888034274358536
MFE-319,637858,3.461230658478568
KYSE-180,44632017,0.527293974927918
HDLM-2,72193861,-0.1337287038056833
Capan-1,1239801,5.505797550079682
SK-MEL-3,10296883,3.7969706070865423
IGR-37,16720766,1.4319094168734192
JeKo-1,65628,2.9302336616000417
KYSE-450,navitoclax-piperlongumine (1-1 mol-mol),3.113777220831491
RCM-1 [Human rectal adenocarcinoma],148124,4.246203808599277
SK-N-SH,navitoclax-birinapant (1-1 mol-mol),4.195320403442676
KMH-2,67156097,-2.3710292392349124
RCH-ACV,10296883,2.7404232752674273
HGC-27,9915743,-0.5179385932122726
RCH-ACV,66577038,3.0712723741604058
BEN,12001922,1.810873556180342
TCCSUP,216239,2.7641054306818265
BT 228,702558,3.1725786573401535
BT 428,71466445,5.17114192317244
HDLM-2,135398738,5.211615144630326
KYSE-180,159324,3.323934124765763
KHM-1B,9826308,0.2290503887290589
HOP-92,24180719,4.50522386688255
BT 245,selumetinib-PLX-4032 (8-1 mol-mol),4.2567558134590895
NCI-H1092,57519531,1.6858418046030903
NCI-H2081,2708,2.8987838262857264
SK-BR-3,9825149,2.5434608773552116
KU-19-19,9903786,4.470072542277405
KMS-26,46943432,-1.993034671230462
JeKo-1,6252,-3.1817220732160414
SCC-25,navitoclax-pluripotin (1-1 mol-mol),-1.3499333841572776
SIG-M5,44491742,3.8291239619503905
WM793,9911463,3.794379463406426
BT 245,5566,2.6954185394923886
BT 228,5284616,2.2329973044975686
NCI-N87,3825829,3.9513849877108207
NCI-H2081,2729026,2.0154063962132676
NCI-H716,135440466,0.1849105107884307
SIG-M5,44185566,1.1555278019868016
KHM-1B,46943432,-0.0724756226448156
HGC-27,11507802,0.11797362324824
RCC10RGB,11222830,2.1708629162803654
RCM-1 [Human rectal adenocarcinoma],24964624,3.1300744088166312
NCI-H647,5280436,2.1483689019186083
EoL-1,9549297,-0.4188520114254506
AML-193,216239,1.333985006104649
HGC-27,135659046,3.397555397732454
NCI-H1092,60700,-0.3122141816941802
AU565,11222830,1.6780695218323665
A3/Kawakami,148198,-4.4977809283586865
SW1116,374536,0.6726467432117932
TCCSUP,3676137,3.9595379052816857
PK-59,3081361,2.522625725891429
HARA [Human squamous cell lung carcinoma],241158,4.240217877475157
KHM-1B,208908,2.253244414744992
KMH-2,selumetinib-JQ-1 (4-1 mol-mol),-2.0810705685207265
BT 232,6438330,2.1292661629437593
P31/FUJ,serdemetan-SCH-529074 (1-1 mol-mol),2.3029277371957884
HOP-92,2742550,6.370201560373045
KALS-1,31703,-1.098292004374608
SIG-M5,11656518,-0.7305958202311026
SCC-25,216345,3.952866629992704
SUP-T1,BRD-A02303741-navitoclax (2-1 mol-mol),2.3520541821675516
KYSE-180,60700,1.3499298515602995
HuH-28,5282054,3.4341016633811017
KALS-1,72967,3.838723057282731
SK-MEL-3,5287620,-2.6095377725527036
KYSE-180,11364421,-2.9692931824369864
HARA [Human squamous cell lung carcinoma],doxorubicin-navitoclax (2-1 mol-mol),-1.5170547368842298
AML-193,2729026,1.1401001297307822
RKO,2841722,4.522769482159767
RCH-ACV,5282054,1.9142676176094324
PK-59,135984461,4.560793597848683
SK-MEL-3,285033,-1.647035522759713
Capan-1,9967941,2.3417401592243774
HT-1197,135999136,4.533058673840764
EHEB,124202324,1.636771857102227
P31/FUJ,246676,3.344572915959865
BT 245,135411,1.173620525211862
BT 232,66577038,2.5542345564499005
NCI-H2081,selumetinib-UNC0638 (4-1 mol-mol),2.5188590507358177
BT 232,BRD-A02303741-carboplatin (1-1 mol-mol),5.5575452657101785
SK-N-SH,doxorubicin-navitoclax (2-1 mol-mol),-2.545244009953481
KALS-1,9549297,4.413480010904805
NCI-H647,15547703,3.872036001426108
A3/Kawakami,26596,-1.4802505010126563
HDLM-2,46398810,1.4032799537758431
NCI-H647,4705,2.403903221755703
KMS-26,9868037,2.2608372373619035
RKO,9935249,5.020114551473781
AML-193,5284329,1.8048513189833293
RCC10RGB,5329102,2.357265375302505
SK-UT-1,12001922,1.8761579048113184
RCC10RGB,6438330,2.9900078425794385
KMH-2,10184653,1.455820590430646
SCC-25,5311281,1.5773118997241562
SK-N-SH,5287969,-2.5279933036606383
HARA [Human squamous cell lung carcinoma],3025986,-0.8541128463962537
NCI-H2081,5746,-1.1331646162653188
MSTO-211H,54678924,1.5146991125566602
HT-1197,148198,-3.334872937201218
MFE-319,54619267,4.163704482995424
PC-14,10410894,3.112460950624989
NCI-H2081,613753,3.0014003602908392
NCI-H716,10427712,3.193542466819944
SW1116,navitoclax-pluripotin (1-1 mol-mol),0.3202561225019927
L3.3,doxorubicin-navitoclax (2-1 mol-mol),-0.9996417914636118
TCCSUP,445455,5.141683708981469
NCI-H716,11396600,4.406293438661701
BT 232,71751553,4.301675554416272
RPMI-8402,46907787,-0.930500865109614
AML-193,613753,2.9863436043254556
MFE-319,11175137,2.692505454863682
BT 232,navitoclax-pluripotin (1-1 mol-mol),0.8710829325554165
RPMI-8402,55283,0.1167987475933399
NCI-H2081,216239,1.3066578972225331
HGC-27,11647372,-2.361289785179734
RCH-ACV,159324,1.0284560082881151
MFE-319,25262965,-2.10344560839328
KMS-26,5351362,0.2849777429911563
SW1116,445455,4.160579908204914
SUP-T1,15547703,2.165805038964572
SK-N-SH,5351362,0.8949187290137414
TCCSUP,54618305,5.536232511374765
MFE-319,24797083,0.9096298654378174
HT-1197,24856436,2.982960714997842
RKO,9866186,0.3829002704071885
SUP-T1,decitabine-carboplatin (1-1 mol-mol),3.3772292424267754
MG-63,2729026,3.009754587477254
SK-MEL-3,2871966,0.2926579845394049
HGC-27,136227331,3.820430594188932
BT 228,1566236,1.8075699945716677
BT 232,24772860,-2.3015888793150645
NCI-H2081,16736978,1.7422337137610255
NCI-H2081,5287620,-2.511505650083613
KALS-1,54613361,0.6861034796180931
P31/FUJ,11228183,-0.9086595542209992
SIG-M5,65628,3.9627714833655383
BT 228,5738263,3.403077471322035
MG-63,11152667,0.9825777114082088
BT 239,5335621,4.004001384954399
PC-14,doxorubicin-navitoclax (2-1 mol-mol),-1.022256177422171
HT-1197,24748573,2.759639634426718
EHEB,SNX-2112-bortezomib (250-1 mol-mol),-2.4396809580796908
KALS-1,ISOX-bortezomib (250-1 mol-mol),0.9826613361531238
KMH-2,44493528,4.009016955634305
SK-UT-1,11494412,1.7393092296584682
PC-14,46398810,3.04872906643706
SK-N-SH,docetaxel-tanespimycin (2-1 mol-mol),-4.282916081785324
NCI-H2081,9911830,1.4932773015429426
WM793,tanespimycin-bortezomib (250-1 mol-mol),-1.2734227949577797
A3/Kawakami,2733526,4.363237862154627
NCI-H2081,16741245,4.790981336180039
SK-N-SH,selumetinib-piperlongumine (8-1 mol-mol),2.018574443677547
NCI-H2081,31703,-2.720849472293294
KYSE-180,6610355,3.592606427588536
RCM-1 [Human rectal adenocarcinoma],9911830,2.5852143987743883
KALS-1,55508,5.551021699417172
KALS-1,46199207,3.744859330837507
KALS-1,216345,4.616791983168742
SIG-M5,10410894,2.3189330608752803
HT-1197,107970,2.1985623382097574
KALS-1,UNC0638-navitoclax (1-1 mol-mol),2.8792786842803673
RPMI-8402,9956119,3.015107715608006
P31/FUJ,36314,-5.221113398603202
SK-MEL-3,11497983,4.118667783716453
KYSE-180,selumetinib-GDC-0941 (4-1 mol-mol),2.772952616484782
KU-19-19,6505803,0.0199416611110358
KMS-26,54618164,3.749169095828711
RCC10RGB,52947716,3.397847809230189
RCH-ACV,25062766,1.6039665514763022
NCI-N87,656346,-0.0410900008101642
SNU-719,6917907,-5.14446951535842
RCM-1 [Human rectal adenocarcinoma],462382,0.7838643978728388
HGC-27,11657048,4.2685984266164585
RCH-ACV,50905018,4.282912194073229
NCI-N87,5335621,4.88881532131479
BT 428,676352,2.1642007424607557
PC-14,5287620,-3.1191762505389113
TCCSUP,11640390,3.766989584853525
RCM-1 [Human rectal adenocarcinoma],71751553,4.339346911330044
JeKo-1,tretinoin-navitoclax (4-1 mol-mol),2.469595697138711
SK-N-SH,60700,-2.9995116348641884
SK-BR-3,JQ-1-UNC0638 (2-1 mol-mol),1.372522523247758
MSTO-211H,5978,-2.861470631068365
TCCSUP,124202324,2.3353692726600173
BT 245,5281321,-1.5902093938584612
SK-MEL-3,erlotinib-PLX-4032 (2-1 mol-mol),3.350699197854307
SIG-M5,6918638,-0.9320116161211188
HT-1197,57519531,3.514972290201895
NCI-H647,285033,-1.696189666147036
JeKo-1,5278396,2.75969192652362
RCC10RGB,10302451,3.839480938635774
HARA [Human squamous cell lung carcinoma],219104,4.732621852676119
KYSE-450,57519531,6.208309628107499
VMRC-LCD,216239,1.7594727190569088
HDLM-2,60700,-0.522799568732717
NCI-H1092,11612883,3.1486493902012858
RCH-ACV,navitoclax-sorafenib (1-1 mol-mol),-0.2080085486468055
JeKo-1,322968,2.536969593167911
NCI-H647,navitoclax-pluripotin (1-1 mol-mol),-1.541712369284279
HCC2108,JQ-1-vorinostat (2-1 mol-mol),1.5555198543953237
L3.3,11497983,4.314112910656769
NCI-H1092,2749,2.105029797010796
RKO,135421197,1.472175761257966
MSTO-211H,11214940,0.3292815706978371
KALS-1,15547703,2.934415698774296
HARA [Human squamous cell lung carcinoma],10427712,4.036967432982734
AML-193,439501,-3.193215284595587
EHEB,119607,5.753474154470325
PK-59,11364421,1.7201977931210124
HGC-27,119607,3.8689037793010943
BT 228,4096211,2.809184628887691
BT 245,24771867,5.283841994129179
RCH-ACV,selumetinib-PLX-4032 (8-1 mol-mol),3.866342226130552
AU565,11455910,2.266336610800082
NCI-H647,3038522,2.6603012767739744
SK-N-SH,11494412,-1.1686339817034832
SK-MEL-3,104842,-1.519764848669419
KMS-26,441298,1.521108394150846
PK-59,sirolimus-bortezomib (250-1 mol-mol),-0.7779015062858902
PC-14,6918289,3.065230294140497
SK-MEL-3,23725625,5.281397453172565
KMS-26,25126798,2.734596190803549
SNU-719,9936388,-4.601692458666014
HOP-92,24775005,3.7512251089214463
SK-MEL-3,9911830,2.957131772222056
SUP-T1,11626560,0.7741772814302338
KMH-2,16722836,1.2656098893857526
BT 232,11455910,0.0350412788633053
HCC2108,445091,6.46099491199368
RKO,15953870,3.3462063589818034
SNU-719,124202324,2.4880635508648776
BT 228,5494449,2.555923944034129
SCC-25,23582824,-0.2825408851325616
KU-19-19,11427553,3.4053411651543035
HCC2108,36462,2.7422106684318077
KALS-1,16736978,3.2184809333869984
AML-193,25154868,4.440378337501174
KU-19-19,241158,4.34083218708613
AML-193,53495165,-1.7113160371245837
BT 245,24772860,-2.1859286876708035
BT 228,285033,-1.6798911572822182
AU565,9866186,0.5690553044247834
SUP-T1,60700,-4.498787872839537
RKO,10231331,2.816804700080647
KHM-1B,selumetinib-tretinoin (2-1 mol-mol),1.4198257519630046
HuH-28,3854666,3.680446535502344
HGC-27,11494412,-1.4088898855213312
EHEB,2729026,2.652912157322486
NCI-H1092,9866186,1.8744947815698976
KHM-1B,176870,4.52912328100578
HGC-27,23582824,-0.9661278600869976
MFE-319,3025986,-0.9952952607895296
SK-BR-3,135440466,3.387693990212075
NCI-H647,16013152,3.849127993281392
L3.3,3384730,1.5710194033023062
RPMI-8402,5280436,3.408830795003236
HT-1197,327653,2.757208589680578
RCM-1 [Human rectal adenocarcinoma],216345,4.578948480850923
A3/Kawakami,2749,1.5890892452437462
BT 239,11640390,-0.0630724292065552
BT 245,11214940,4.373430714456017
BT 232,54143018,5.900896056875585
NCI-H2009,3634881,3.6058977960867233
RPMI-8402,carboplatin-UNC0638 (2-1 mol-mol),2.1132194671362985
KMH-2,65628,3.890017095144683
KMS-26,selumetinib-UNC0638 (4-1 mol-mol),4.101162884171243
SK-MEL-3,6852167,3.696781944889267
PK-59,6623618,3.4905373489762916
HARA [Human squamous cell lung carcinoma],4917,3.022180747101803
TCCSUP,2841722,4.4181775283322
BT 228,3543504,5.060537396962815
Capan-1,2729026,3.1785431768913353
SUP-T1,24856436,-0.9293444180999574
NCI-H647,11427553,2.780407343554448
MSTO-211H,54613361,-0.4311183648022992
SIG-M5,1566236,1.4914390289257415
BT 428,5287969,-2.0247564794792643
RPMI-8402,5328940,0.7437116160846705
BT 232,9936388,1.379095675434134
P31/FUJ,52912189,-0.0654684439378525
BT 228,17755052,1.0436722548962285
KMH-2,123631,2.0681789518379197
EHEB,46907787,0.323033594148826
NCI-N87,9967941,2.944195178928737
KMH-2,702558,3.0708940474990736
YH-13,3552672,4.052352129280503
EHEB,44507138,1.7056650657187078
SK-N-SH,15983966,-4.173484912910887
JeKo-1,241158,1.9415728140254451
MSTO-211H,68056272,2.8034566103574825
EHEB,71304818,2.7376303187441966
P31/FUJ,3815108,3.712799909664185
KYSE-180,54618305,5.290256883782679
SCC-25,46174525,3.7379785352140806
NCI-H2081,3503,1.8029989394083912
Capan-1,49766530,2.9089609583789535
HuH-28,5746,0.7968943597844496
A3/Kawakami,9967941,3.7842746407030767
EHEB,10410894,2.894743254709859
KHM-1B,5978,-4.717973613430777
SW1116,24856436,0.1778795233563665
RCM-1 [Human rectal adenocarcinoma],53232,3.9030972816172262
HGC-27,10184653,1.4060985270418442
SK-MEL-3,4261,1.4063085960828023
RPMI-8402,11427553,1.0355078858593405
BT 245,2749,1.407270592041472
BT 245,26596,-1.3254238494846824
NCI-H2081,6438330,1.5625660396683954
HCC2108,568763,-0.0032676468194757
EoL-1,54596558,3.254047827542645
NCI-H2009,44632017,1.0717713653211387
KALS-1,JQ-1-MK-0752 (1-1 mol-mol),1.6412768731655074
SUP-T1,4788,5.81474052167417
KHM-1B,11964036,-0.558883521071404
RKO,135398516,4.318914396092429
RCH-ACV,docetaxel-tanespimycin (2-1 mol-mol),-7.693243273000736
A3/Kawakami,6918638,-1.1948916865846906
KYSE-180,208908,4.633003996676137
P31/FUJ,11640390,3.1324724534083277
MG-63,445643,3.883013690360592
RKO,9823820,5.913042612438718
HGC-27,135411,-0.7526174751077652
SIG-M5,71466578,3.616326103483652
L3.3,11364421,-3.724172704719069
SIG-M5,4705,3.652896158282669
WM793,119182,-3.1543080825396173
KHM-1B,168312962,-1.6342091010648556
HGC-27,2858523,2.4473612477493356
BT 428,24964624,2.3642345929381525
NCI-H2009,24753719,4.192950544032197
IGR-37,11427553,3.451301881133408
SIG-M5,4096211,1.460328581175123
AML-193,53232,2.624387531188414
NCI-N87,36314,2.766113993056904
SK-BR-3,sirolimus-bortezomib (250-1 mol-mol),-3.644794085557173
RCM-1 [Human rectal adenocarcinoma],docetaxel-tanespimycin (2-1 mol-mol),0.3001853485414289
RPMI-8402,10074640,2.235626523260303
HOP-92,25154868,4.840757234856236
NCI-N87,6914657,-3.795056001746233
TCCSUP,441298,2.479401374858522
KALS-1,selumetinib-vorinostat (8-1 mol-mol),3.138531968281592
L3.3,serdemetan-SCH-529074 (1-1 mol-mol),2.4729213733544366
HuH-28,5287620,-0.1339643648099603
AU565,400769,-0.800888344050601
NCI-N87,9903786,2.403456427338335
BT 228,5291,3.6978014123342384
MFE-319,44241473,5.487537752987347
NCI-H647,637858,3.278669479288834
JeKo-1,445091,3.878710456955377
KYSE-450,25183872,-0.8618407646936664
SNU-719,3543504,4.40413906644655
KU-19-19,16038120,2.2784541929956563
SIG-M5,374536,0.939365748644882
HGC-27,122327,5.001319016350778
NCI-H716,3136844,5.367852821729496
MSTO-211H,6918878,2.3677965777112653
RKO,24180719,5.308193040989237
BT 428,24901704,3.8281847797817994
MSTO-211H,9884685,-1.5007126123703023
YH-13,54618771,3.881155680896358
KALS-1,4917,3.720909678301258
KYSE-450,5311,3.212765544074189
KALS-1,24753719,4.821139206280144
BT 232,16065773,3.0122238061727415
HT-1197,216345,3.478709582709383
SK-MEL-3,11455910,1.2991192016646154
SIG-M5,446155,1.705295446757395
P31/FUJ,BRD-A02303741-navitoclax (2-1 mol-mol),0.458289206697817
BT 232,7251185,2.9491380945915946
MSTO-211H,10113978,1.403014421240365
RPMI-8402,5738263,2.776945893371598
RCC10RGB,1716436,3.489109378341682
KMS-26,56973724,1.09240911621848
EoL-1,4521392,2.949143863389218
JeKo-1,5311037,5.399222392792725
AML-193,9933475,1.6636717356610649
SIG-M5,11175137,1.5975497189399142
KU-19-19,387447,-3.0100561484626738
HGC-27,4917,2.2667176304266032
PK-59,656346,3.7782879142380223
KALS-1,56649450,4.301901107310455
MG-63,123631,1.8117726629778437
BT 428,11455910,0.0710771584645227
HT-1197,3038522,2.987544025956322
HGC-27,262093,2.210004437321543
EoL-1,9866186,-2.1602944929156247
HuH-28,4788,5.836319202824256
SK-BR-3,219104,2.271239726945387
NCI-H716,selumetinib-piperlongumine (8-1 mol-mol),2.2009373077770933
SK-BR-3,71680916,4.790059266260068
RCM-1 [Human rectal adenocarcinoma],24901704,4.114962911798603
EHEB,135398516,1.2491473291998236
SCC-25,10113978,5.632404145986929
BT 245,UNC0638-navitoclax (1-1 mol-mol),-0.0358626825022054
RPMI-8402,6917907,-6.09637099945027
HGC-27,11364421,-5.634268255926913
RCC10RGB,11257553,3.6405008146732434
NCI-H647,24889392,4.115638885598369
EoL-1,25126798,1.5957211662440265
RPMI-8402,JQ-1-MK-0752 (1-1 mol-mol),-0.2024944022331301
NCI-H647,9967941,6.2095026793857935
TCCSUP,10184653,2.1408620170071084
NCI-H2081,4259181,0.351932807704407
AML-193,3081361,2.707912005323853
HGC-27,12001922,1.011658387648396
KMS-26,5329102,1.3316565189778
BT 232,5479543,4.021440737042399
SK-UT-1,241158,3.8222099850046054
KMH-2,9866186,-0.3606868682849701
SUP-T1,135398516,1.6673378241012815
RCH-ACV,9884685,-0.7829826614387396
A3/Kawakami,122327,4.088752244537169
KYSE-180,6610216,4.857625528938267
SNU-719,12003241,0.0299382028109862
EoL-1,49867930,2.7828591884302067
AML-193,10184653,1.1806677352160988
SK-MEL-3,53232,4.126520927852223
RCM-1 [Human rectal adenocarcinoma],168313200,3.953722308471172
PC-14,11656518,1.9587684942770311
EHEB,753704,4.57215255992242
HCC2108,31703,-0.3826417360031045
SK-MEL-3,5951923,4.9496295649710715
KMS-26,702558,2.28829062995708
BT 228,decitabine-navitoclax (2-1 mol-mol),1.898692431001124
KYSE-180,16720766,1.7167051312732595
VMRC-LCD,6918837,-5.195703822418952
SK-UT-1,10385095,1.6809894125740852
KHM-1B,54618771,-0.6219515555388266
BT 228,carboplatin-etoposide (40-17 mol-mol),5.196974159307378
RCH-ACV,44486219,4.136674495070367
SK-MEL-3,16722836,2.564956602716348
AML-193,51039095,1.939832138411792
BT 232,135411,3.0273187561105757
RCM-1 [Human rectal adenocarcinoma],6918328,0.3348856135951876
SUP-T1,5460769,2.284635628978783
SK-UT-1,BRD-A02303741-navitoclax (2-1 mol-mol),5.142165719819776
NCI-H2009,15547703,2.9018345982556935
AML-193,10385095,0.4941953706733294
HARA [Human squamous cell lung carcinoma],676352,2.7556636695973515
PK-59,44137675,3.067468574429604
SUP-T1,1750826,-6.221260891982361
KALS-1,25105715,3.66760081873384
SK-BR-3,6918638,-0.1564610837276475
SK-MEL-3,71576739,-5.146260471350036
NCI-H2081,44607530,1.5089413575069657
KMS-26,44185566,1.3265590109759726
BT 232,10296883,4.252681745204764
KALS-1,49850262,4.2041421980249165
HT-1197,9952709,2.305017512373335
HDLM-2,65628,5.287608845235475
KMS-26,9952709,2.9032128704640328
Capan-1,11178236,-3.0567197166795363
NCI-H2081,4477,0.6401046576729016
BT 228,5328940,1.8504648009507263
SIG-M5,68056272,-6.800702724792539
HOP-92,alisertib-navitoclax (2-1 mol-mol),-0.048132148034596
L3.3,25062766,2.9099713416003463
KMS-26,135984461,1.0857498172669495
NCI-H647,UNC0638-navitoclax (1-1 mol-mol),3.07128640317944
SIG-M5,10184653,1.7364784355014904
RPMI-8402,serdemetan-SCH-529074 (1-1 mol-mol),2.043577692131592
MG-63,10385095,2.7143231062656197
HCC2108,73707398,1.1119632364432313
SNU-175,49867926,-5.236985736572836
BT 245,54618164,4.011070558028337
KHM-1B,4477,-0.1092447779535195
NCI-H1092,9911830,2.3624309911243313
BT 239,44137675,1.9017616531684407
NCI-H2081,6914657,-5.6218862052201155
AU565,322968,2.504214157528526
EHEB,6438330,0.8032584071441157
RKO,SNX-2112-bortezomib (250-1 mol-mol),-2.626179791835481
SNU-719,42642645,0.6837630111624428
MSTO-211H,11964036,1.836732040985672
SCC-25,51039095,1.91887614755867
AML-193,25126798,2.1316185655582163
A3/Kawakami,6184667,1.735780793361572
RKO,53232,4.485666667988006
HCC2108,doxorubicin-navitoclax (2-1 mol-mol),-0.6309858314473922
A3/Kawakami,107985,-4.442532010928943
NCI-H2009,135999136,4.285465393980956
SK-MEL-3,1750826,0.526523765684662
A3/Kawakami,vorinostat-carboplatin (1-1 mol-mol),3.815392870497898
RCM-1 [Human rectal adenocarcinoma],16725315,5.393896472431684
NCI-H716,46398810,1.4002303531939375
SK-N-SH,56649450,2.9180914669879576
SK-UT-1,400769,-1.5923135433790303
NCI-H647,11964036,1.6121760477464588
HDLM-2,44589607,1.4510918801424793
KMS-26,16741245,2.5576675028614257
KHM-1B,25062766,1.5737082616521652
A3/Kawakami,46843906,1.118623136119623
BT 428,4378219,1.777728517709583
RCM-1 [Human rectal adenocarcinoma],6610216,4.434175859871968
HuH-28,navitoclax-birinapant (1-1 mol-mol),-1.2898548969247512
NCI-H2009,sirolimus-bortezomib (250-1 mol-mol),2.102899194038225
BT 245,216239,2.117247096540108
P31/FUJ,11455910,0.7543092217738059
PC-14,46199207,3.3573036569250005
NCI-N87,54686904,4.2918164398278815
A3/Kawakami,72193861,0.976015443651618
SK-MEL-3,216345,4.55798995423662
SNU-719,2858523,2.524347512182869
SNU-719,66577038,3.4329085579886947
P31/FUJ,71680916,4.420716560192731
HCC2108,vorinostat-carboplatin (1-1 mol-mol),3.476281574567543
RPMI-8402,tanespimycin-gemcitabine (1-1 mol-mol),-2.5291460013279123
RPMI-8402,2708,2.863796641655521
YH-13,6917907,-5.576575659474619
SIG-M5,46224516,2.708027090861977
KALS-1,10427712,5.18453261290784
L3.3,25150857,3.2841029560324246
SIG-M5,selumetinib-UNC0638 (4-1 mol-mol),-3.1682743378304843
PC-14,24753719,5.07098831205633
EoL-1,44489675,2.842203367865713
WM793,6852167,3.317398724097228
RPMI-8402,9911830,1.9895553724691295
BT 239,25161177,1.4898121170256562
RCH-ACV,3854666,1.1311620148963422
IGR-37,46215462,1.7045347555935302
SIG-M5,navitoclax-piperlongumine (1-1 mol-mol),0.6896831957494847
IGR-37,12001922,1.586614371978584
KYSE-180,1750826,2.4925152788264726
NCI-H2081,6184667,2.212797142714644
IGR-37,crizotinib-PLX-4032 (2-1 mol-mol),1.6151420658710365
HARA [Human squamous cell lung carcinoma],44607531,1.5873617953354324
SK-MEL-3,doxorubicin-navitoclax (2-1 mol-mol),-0.048462891552725
HT-1197,50905018,4.308819635219612
SNU-175,docetaxel-tanespimycin (2-1 mol-mol),-6.022003499181449
BT 228,serdemetan-SCH-529074 (1-1 mol-mol),1.6798363462002612
RCC10RGB,44607531,1.912198544747903
RKO,24856436,0.2423564692967549
RCM-1 [Human rectal adenocarcinoma],1566236,2.0083001744148596
SNU-719,selumetinib-JQ-1 (4-1 mol-mol),-1.673282940163647
AML-193,11640390,1.4257972039733555
P31/FUJ,10074640,2.9862675466657764
HDLM-2,9840324,6.36927686787801
KALS-1,71680916,6.153524123238927
MG-63,5566,3.04710191021757
KMS-26,10302451,3.168611946824231
BT 239,445455,4.356713903377922
EHEB,selumetinib-UNC0638 (4-1 mol-mol),3.5739302718016597
RKO,100016,5.817852214634293
HOP-92,9952709,2.799251837030474
KHM-1B,9903786,1.5275790345873377
RCM-1 [Human rectal adenocarcinoma],409805,6.9502249218901975
NCI-H2009,71466578,3.1093531088855797
HCC2108,5281321,-0.1705555691898866
SCC-25,11152667,-0.6154723920828342
AML-193,72193861,0.2166937497228163
A3/Kawakami,42642645,0.9558867808126186
BT 245,6918837,-2.1752341240473463
HGC-27,9927531,3.8749849093672744
P31/FUJ,71466380,4.574945433624961
RCH-ACV,3062316,-1.4671550530393678
SK-MEL-3,53495165,-0.3329107060467318
VMRC-LCD,piperlongumine-MST-312 (1-1 mol-mol),2.107138785416144
MSTO-211H,100016,4.243846732059744
KYSE-450,23725625,7.184930321255073
MSTO-211H,151289,1.1545674452198869
BEN,vorinostat-carboplatin (1-1 mol-mol),3.6756024220256354
RPMI-8402,49836020,4.366358527241826
KU-19-19,vorinostat-navitoclax (4-1 mol-mol),1.414230786423441
SK-MEL-3,66577038,2.24442053641863
NCI-H1092,10127622,5.156307996468707
BT 428,53325874,4.630334381106429
RCC10RGB,25126798,4.759098567819552
KU-19-19,71304818,1.8280747292346609
SW1116,9936388,1.5004696743438164
BT 228,5281321,-0.4304721512396702
KALS-1,49793307,0.2022730228094879
Capan-1,6438330,3.295907493126958
SUP-T1,11964036,0.6244915391891143
EoL-1,637858,0.3936490265761631
KMS-26,3854666,0.369015191618214
RPMI-8402,262093,1.1284769386432876
SK-BR-3,11427553,3.793829846338994
L3.3,53232,3.8050949011624806
KYSE-450,24753719,4.912608563377894
NCI-H716,5329102,0.2446001158349389
BT 228,73707398,1.4280479826464054
VMRC-LCD,9887053,6.217580915821706
AML-193,9952709,2.7375599637172883
SCC-25,3081361,0.920207196995044
HOP-92,doxorubicin-navitoclax (2-1 mol-mol),-1.7597976970458191
EoL-1,16065773,1.3667705461588662
KMH-2,5335621,4.707137208906537
MSTO-211H,20959075,-3.222615813929693
A3/Kawakami,9935249,1.5690106286668166
A3/Kawakami,54618305,4.415479239877224
EoL-1,42611257,0.7290223968994339
RCM-1 [Human rectal adenocarcinoma],SNX-2112-bortezomib (250-1 mol-mol),-0.995249621859288
AML-193,5281321,-0.0683276752518065
P31/FUJ,12001922,1.6134382673725098
SK-UT-1,10184653,1.553177213936907
WM793,24753719,4.8266947199238786
KU-19-19,9926054,2.3371072555508445
AML-193,11178236,-0.4867347304594882
NCI-H2009,JQ-1-navitoclax (2-1 mol-mol),-0.3100400196592782
SCC-25,4917,2.5811829217965396
KMS-26,24901704,2.0743142501965997
RCH-ACV,71466380,2.8962713809076304
SIG-M5,vorinostat-carboplatin (1-1 mol-mol),3.6465437784892094
NCI-H1092,9907093,4.298683896140943
BT 245,53232,4.832235937520063
SIG-M5,3634881,3.210178594349469
EHEB,71466380,4.118712365127363
IGR-37,24856436,0.4452249024251921
RCM-1 [Human rectal adenocarcinoma],46191454,2.186617263372051
WM793,65064,3.5713682680127574
HCC2108,selumetinib-tretinoin (2-1 mol-mol),5.736477688995886
KHM-1B,54143018,-0.2893377484312812
VMRC-LCD,4788,5.035447309103891
SK-MEL-3,3503,2.1055873183785017
BT 239,11964036,-0.3334870568527492
P31/FUJ,24901704,1.8625310117446785
IGR-37,24978538,3.158314284014703
SK-BR-3,5284616,-0.039553799461116
Capan-1,135411,1.1920717014747266
BT 239,16722836,1.4526147742424915
SNU-175,44202524,1.1215885294748964
BT 428,selumetinib-navitoclax (8-1 mol-mol),-0.6596829505842847
NCI-H2081,selumetinib-GDC-0941 (4-1 mol-mol),2.2419889571626146
EHEB,2749,0.1808975316830207
NCI-H2081,327653,2.703400517065932
IGR-37,168312962,3.0167892290675367
HARA [Human squamous cell lung carcinoma],11626560,1.1307601374566012
BT 228,2708,5.054368462520845
AML-193,11612883,0.9347686243348016
RCC10RGB,24856436,4.070420512574028
HT-1197,1285940,5.658307620695291
KMS-26,445091,2.5099568123430753
IGR-37,sirolimus-bortezomib (250-1 mol-mol),0.8968777908953848
IGR-37,JQ-1-navitoclax (2-1 mol-mol),2.5201389538190586
SUP-T1,46199207,1.7678992372420643
SIG-M5,16038120,0.0620052664037508
SUP-T1,45100481,4.356360101983197
SK-UT-1,445643,4.614923035667888
NCI-H1092,alisertib-navitoclax (2-1 mol-mol),0.2122885178318103
SK-MEL-3,5746,1.5459764957523512
RCM-1 [Human rectal adenocarcinoma],3854666,3.226193389725711
MFE-319,9936388,3.279926844383342
RCC10RGB,9935249,3.9754060705766943
SIG-M5,24772860,-3.9797980314379098
SNU-719,262093,3.356379511241945
YH-13,135421197,2.4430977346174165
WM793,71466578,5.303096396012995
HT-1197,5278396,3.8164554208982726
SCC-25,46224516,1.4080713371025844
KU-19-19,4261,0.7367611445661113
RCM-1 [Human rectal adenocarcinoma],11175137,3.6620571654650846
TCCSUP,2945648,3.149020866253819
KU-19-19,123631,3.236221278135049
SUP-T1,3854666,-0.1009501914586207
HDLM-2,24180125,2.355202505563582
SK-N-SH,tretinoin-navitoclax (4-1 mol-mol),3.361746552288218
BT 239,2945648,1.184824768136571
RCM-1 [Human rectal adenocarcinoma],navitoclax-MST-312 (1-1 mol-mol),1.2670160922961198
L3.3,216239,2.590745343804584
NCI-H647,16736978,1.9806830901408192
EHEB,9887053,2.923841050224105
SK-MEL-3,11178236,-2.7704412009391217
TCCSUP,17755052,2.4596977315219504
BEN,piperlongumine-MST-312 (1-1 mol-mol),3.1021072899259465
TCCSUP,11404337,-0.4859326706611666
IGR-37,16659841,6.30783620072396
HCC2108,135999136,4.648622110630223
SK-BR-3,11494412,0.3073008464211634
NCI-H647,7326481,2.510713168822661
HOP-92,24771867,2.2961333191414703
P31/FUJ,44819697,-1.8374306821299025
Capan-1,11427553,3.6208766835823223
HOP-92,25227462,1.338315054071212
KYSE-450,16720766,2.1902157415608836
PC-14,selumetinib-vorinostat (8-1 mol-mol),1.2532439157087734
MSTO-211H,65064,5.509158922836103
RCM-1 [Human rectal adenocarcinoma],9903786,4.3108216230747685
SNU-175,9936388,-6.345283130310661
RPMI-8402,4261,-0.1985065223321786
MSTO-211H,46215462,0.9168806818627014
SCC-25,984333,1.4739536875461228
BT 228,1750826,-0.0840522380794247
MG-63,25105715,3.5959501730647694
SCC-25,135875424,4.102070818018105
NCI-H2081,46174525,2.628990819300419
HGC-27,49867930,4.215462471713748
AU565,31703,-1.2264921928318224
KALS-1,568763,-0.1466204331633934
SUP-T1,5566,2.9975667384650793
MSTO-211H,5281321,-2.386258436411726
SIG-M5,9840324,5.8731783368708115
RCH-ACV,3634881,2.4116387383680196
MG-63,9907093,4.36557254058986
SNU-719,tanespimycin-bortezomib (250-1 mol-mol),-1.2568282299836298
HGC-27,11396600,2.081101267240524
KMH-2,613753,3.3587916695976845
SK-N-SH,3025944,4.258662434299478
RPMI-8402,126941,-4.527471589791952
NCI-H1092,23725625,4.586662466959233
KHM-1B,5394,4.374287495449882
HARA [Human squamous cell lung carcinoma],54626689,4.600126869473187
NCI-H647,135984461,5.580010344943138
BT 428,25161177,1.960995133539942
IGR-37,156414,1.774854831406992
L3.3,656346,0.8770519202421161
SK-BR-3,71466578,3.2651400994537134
AML-193,984333,1.6253699403739277
RCH-ACV,9927531,3.1896486071629724
HT-1197,136227924,5.329383648142769
YH-13,2708,5.143963890139275
NCI-H647,9903786,3.1378024767973827
SNU-719,selumetinib-UNC0638 (4-1 mol-mol),-0.0559107953644729
IGR-37,15953870,3.832718760347283
AML-193,168312962,2.549775346624471
YH-13,navitoclax-MST-312 (1-1 mol-mol),0.5038954748118908
AU565,2729026,2.5804084357046033
NCI-H2009,44185566,3.0429431135599607
SK-N-SH,23635314,-4.918851364673094
P31/FUJ,71466578,3.434376258750051
EHEB,23635314,-1.6580881181075813
YH-13,53232,2.004863331527642
KMS-26,100016,3.884140356330727
SK-MEL-3,5329102,1.63691507395264
KALS-1,17755052,1.6345792259398693
KMS-26,52947716,-5.021036923946177
L3.3,11234052,5.199825372855332
WM793,159324,3.425736366761861
Capan-1,5460769,0.8848211247496085
Capan-1,10302451,2.5563331533364373
SCC-25,9967941,4.20162846398581
HCC2108,49850262,3.743305220709595
AU565,753704,4.59624742359194
RPMI-8402,57519531,1.0491955743758632
SK-N-SH,24771867,-4.618722010839445
IGR-37,6918736,-1.4127810250151536
HOP-92,11719255,3.185123363982542
BT 239,45279963,3.781063613979918
NCI-H1092,444795,4.269979452389004
NCI-H647,selumetinib-GDC-0941 (4-1 mol-mol),1.4549802874182485
KMH-2,selumetinib-navitoclax (8-1 mol-mol),5.9412533496878
HDLM-2,5282054,2.889592362106946
BT 232,168312962,1.6259551412599254
SK-N-SH,426756,4.4239936667871875
BT 428,ISOX-bortezomib (250-1 mol-mol),-0.7964078251606408
BT 232,11175137,2.494682725512178
AML-193,tretinoin-carboplatin (2-1 mol-mol),4.779434345573409
EHEB,25262965,-0.476476540262067
HOP-92,216345,4.236337539032466
RKO,selumetinib-piperlongumine (8-1 mol-mol),2.2390647410806306
KHM-1B,6252,-0.4471831766807136
KMS-26,selumetinib-vorinostat (8-1 mol-mol),-0.8161988345197432
SUP-T1,2729026,1.937719337588338
KU-19-19,107970,3.004209688555129
PK-59,31703,-1.0177732893436835
SK-UT-1,5746,2.0150479755751425
SW1116,11647372,1.2865378563296934
PK-59,24901704,3.4146535420150053
MFE-319,11612883,3.7966332979498576
MFE-319,148124,-4.371578171845129
MSTO-211H,4259181,-0.7585521679245923
NCI-H647,10074640,3.5645358244050196
HuH-28,5284373,-1.8063606252764952
IGR-37,11404337,-0.93778882861888
KMS-26,24856436,-1.861913871882874
EoL-1,11213558,-3.648762897171201
SUP-T1,docetaxel-tanespimycin (2-1 mol-mol),-7.1452785737380315
YH-13,2746,3.803826628530811
KU-19-19,656346,4.826208082880011
YH-13,46843906,3.1529849009094604
HARA [Human squamous cell lung carcinoma],44185566,2.9912273208606552
BT 428,4578,5.08813255057657
MFE-319,selumetinib-UNC0638 (4-1 mol-mol),4.664467917028076
KYSE-180,5351362,1.0664205921449423
IGR-37,104842,-3.856961779971808
KHM-1B,11213558,1.7651393697887354
MSTO-211H,5738263,2.0448017247583996
BT 228,8515,3.7604007756554583
NCI-H647,3025986,-1.3393829663445187
SUP-T1,24821094,1.04889566557073
MFE-319,11507802,1.350103624626366
SK-BR-3,4917,2.832691539713605
SK-N-SH,44607531,1.3181792543934407
NCI-H1092,5335621,4.115542911112419
NCI-H2081,24772860,-1.2700497080166275
SCC-25,49766530,-2.1571219685765195
YH-13,10427712,4.6201171639095815
BT 232,selumetinib-PLX-4032 (8-1 mol-mol),4.233382860822702
SNU-719,selumetinib-BRD-A02303741 (4-1 mol-mol),0.1990831379726958
NCI-N87,1242560,3.6090545678814983
EHEB,54618771,1.2042140049426533
SIG-M5,11640390,3.0458714404085736
BT 428,65628,3.929247019179895
VMRC-LCD,45279963,3.727597229136878
BT 239,serdemetan-SCH-529074 (1-1 mol-mol),0.1161443491051615
BT 232,navitoclax-MST-312 (1-1 mol-mol),0.979696913461984
AML-193,5494449,1.7301120380873802
KALS-1,1242560,3.1581399986458436
A3/Kawakami,selumetinib-tretinoin (2-1 mol-mol),4.6027319564938365
SUP-T1,159324,-0.7674662281240341
AML-193,54618771,0.4173774880605814
RCH-ACV,44137675,1.3480250220639034
AU565,5281321,-1.6701173206544262
SUP-T1,2858523,3.114565589511675
AML-193,46907787,-0.6702200808347925
KMS-26,71304818,1.9230092115564157
RPMI-8402,9967941,3.834341652756267
SNU-175,168312962,-0.6641951273571093
NCI-H647,JQ-1-vorinostat (2-1 mol-mol),0.9124895034446466
MG-63,65064,5.235378070660617
P31/FUJ,11178236,-2.454576103037029
SCC-25,568763,0.3541587148979058
NCI-H1092,1716436,2.458293295551776
JeKo-1,9911830,1.55296695781185
SCC-25,salermide-PLX-4032 (12-1 mol-mol),5.681586059319919
RCH-ACV,JQ-1-vorinostat (2-1 mol-mol),-1.0744303960114758
NCI-H2081,36314,-5.947411488726424
AML-193,11214940,3.8677045030443953
BT 239,168313200,1.5980864637494772
RCM-1 [Human rectal adenocarcinoma],374536,0.8021830219773941
NCI-H647,11222830,1.8839971792659485
SNU-719,44607531,1.362282400323897
MFE-319,SNX-2112-bortezomib (250-1 mol-mol),-0.7368760870436791
SK-UT-1,53392493,1.8561003470526265
EHEB,135440466,1.7844203552470492
IGR-37,44566777,3.007363923291811
HGC-27,107970,1.5990120472762
Capan-1,46926350,-4.595989334301445
NCI-H647,2733526,4.1365244995734045
RCH-ACV,4917,2.9917514563741845
BT 428,54678924,1.6942851351706048
KMS-26,16115403,-4.74710463250037
SUP-T1,9903786,2.605502996973438
HCC2108,5351362,2.023612240814503
BT 239,11626560,0.9060265236160768
NCI-N87,613753,3.043533794547513
YH-13,11455910,2.765771134789071
AU565,5566,3.0303294385930584
A3/Kawakami,54765302,3.9378050370857194
RKO,148198,-2.1467795088860875
SK-N-SH,3081361,2.123061422417188
SUP-T1,44202524,0.8327630491122889
HDLM-2,crizotinib-PLX-4032 (2-1 mol-mol),2.1368270598895243
KMS-26,44819697,-3.5984115564964023
A3/Kawakami,5113032,4.69432823276537
IGR-37,5281321,0.0602525450231945
VMRC-LCD,676352,1.5969835443771891
VMRC-LCD,322968,3.3790902239995906
MFE-319,46398810,3.805575637844485
NCI-H647,5328940,1.3410631629670722
RPMI-8402,9908783,5.831842979518446
HGC-27,60750,-0.2910958677969573
EoL-1,serdemetan-SCH-529074 (1-1 mol-mol),0.2425327773366689
BT 228,441298,1.6992885732245018
BT 245,3025986,-0.5996935775765925
HuH-28,984333,0.809873793253345
TCCSUP,56946209,-3.1340499895794487
NCI-N87,568763,-0.5346616138078667
TCCSUP,tanespimycin-gemcitabine (1-1 mol-mol),-2.519262130533681
HOP-92,5470400,1.6515798526459493
MSTO-211H,JQ-1-vorinostat (2-1 mol-mol),0.928346567061831
SIG-M5,400769,-1.362996702325647
HT-1197,46907787,2.8838222010198975
SNU-719,6252,4.042517923239096
TCCSUP,6184667,2.5617640060179823
A3/Kawakami,9825149,3.1163877330674055
JeKo-1,9866186,-1.0204184057053436
Capan-1,doxorubicin-navitoclax (2-1 mol-mol),-1.0320263724996168
KMS-26,JQ-1-MK-0752 (1-1 mol-mol),-3.6226631896411954
SK-BR-3,3854666,0.6288211894501958
NCI-H647,16038120,1.315583254156664
KMS-26,3062316,-0.2151783808732146
PK-59,969516,2.8385611744423724
SUP-T1,44819697,-3.339488574233733
KYSE-450,100016,6.589468110151047
NCI-H1092,24785538,0.314823204123774
MFE-319,6450551,3.344887453110109
SK-UT-1,136227924,4.460190875137593
BT 239,5738263,2.4471257766605734
NCI-H716,2746,2.8210994981095556
NCI-H647,24180125,3.804113444039596
JeKo-1,168313200,3.3744952164536537
SK-BR-3,375860,-0.5619604471367267
RCM-1 [Human rectal adenocarcinoma],45279963,4.209581344916876
AML-193,24748573,1.3479353704534731
BT 428,136227331,3.9646009077151456
NCI-H2081,227681,2.433511689406021
SK-UT-1,4261,3.439977939207012
KMH-2,36462,-0.642209166172259
L3.3,16065773,3.089788322580725
SK-BR-3,11485656,1.9391537366026357
BT 239,6610355,3.4323080879310433
BT 239,104842,-3.281017705408914
NCI-H647,54765302,4.411648314052091
RCM-1 [Human rectal adenocarcinoma],navitoclax-piperlongumine (1-1 mol-mol),2.7027440652786807
MFE-319,322968,4.855150863893599
KHM-1B,71304818,1.1498757447247578
SNU-719,126941,-1.4365283606985382
BT 245,tanespimycin-gemcitabine (1-1 mol-mol),-1.410081063260151
KMS-26,72193861,-0.63074927683014
RPMI-8402,374536,1.7667437897249685
HDLM-2,selumetinib-PLX-4032 (8-1 mol-mol),4.389448831513184
HGC-27,10427712,3.416891070689866
A3/Kawakami,9549297,1.3046584077816277
NCI-H716,969516,2.678986375865827
KHM-1B,675434,3.385795736646719
MG-63,44566777,0.3175802322880545
SNU-175,42642645,-0.9671913024447542
NCI-N87,36462,0.3600781388020123
NCI-H2081,216468,0.1625451412214818
HDLM-2,159324,1.0950285882033006
AML-193,1716436,2.357068271611697
HDLM-2,409805,3.613104828003659
KHM-1B,11647372,-0.566073234789779
HARA [Human squamous cell lung carcinoma],2733526,3.2699742840947414
AML-193,387447,-4.453165066909558
NCI-H2081,24951314,0.5279638616093859
YH-13,327653,3.132127686900927
NCI-H647,51039095,3.2173197749433777
NCI-H2009,6852167,1.9075911063810396
BT 232,2871966,1.1342035932462715
VMRC-LCD,16722836,0.7729239426768862
SNU-175,10184653,-1.7356445345566704
VMRC-LCD,11238147,2.1573746434422327
SCC-25,25262965,-3.347252547222993
IGR-37,568763,1.6811438647277726
PC-14,24856436,-0.4978882217078796
AU565,135999136,4.178255303593246
KMH-2,10385095,1.3020469045256973
MFE-319,10074640,3.7526129117404023
KMS-26,9915743,-1.9616830637475051
HOP-92,4578,4.3311904829124055
NCI-H716,56963564,0.807080131154313
NCI-H2081,56946209,-6.444502083933019
KU-19-19,135421197,1.2163789616721166
YH-13,24901704,3.58648266528955
NCI-N87,446155,3.321702095578996
PK-59,9907093,3.832557382502477
MFE-319,73707398,1.6772690272757178
SK-UT-1,11178236,-3.1476087704036453
SNU-719,49850262,4.508086148217829
NCI-H2081,23635314,-3.63845546552979
HGC-27,51037431,1.993537267135852
HARA [Human squamous cell lung carcinoma],25126798,3.0348047735223935
SCC-25,15953870,3.436709615565111
NCI-H716,46174525,4.236548373782582
HGC-27,3385,2.6398949639733975
RCC10RGB,24951314,2.138755705452886
HGC-27,6610216,3.4161175560596244
RCH-ACV,89928392,-2.313588975561899
HuH-28,11213558,0.1776771561221462
BT 232,568763,0.2204507219220751
BT 428,67156097,-0.2408897526562682
NCI-N87,452548,-1.772451424496647
EHEB,3543504,5.334270443674065
EHEB,54454,1.897710954280459
BT 428,12001922,1.1406957911423092
SIG-M5,56973724,2.1064347313854355
SK-UT-1,42642645,1.4382792591793798
BT 245,doxorubicin-navitoclax (2-1 mol-mol),-1.4892094322491367
SK-MEL-3,8515,4.372397104094242
HDLM-2,5328940,0.7915620931981028
HOP-92,11152667,0.0194334457460503
YH-13,1566236,1.6600939078751014
HCC2108,6918837,-2.190970663092924
BT 245,5113032,4.358683416759354
SNU-175,3025986,-1.7067265346568157
NCI-H716,675434,4.3947611806432
RCH-ACV,navitoclax-PLX-4032 (1-1 mol-mol),-0.8750005010828589
HGC-27,5329102,0.9444004661188669
KALS-1,9926054,2.3431755062482487
SK-MEL-3,44137675,4.543805058147876
RCC10RGB,327653,3.228661308812885
EoL-1,6252,-5.233621981463173
HGC-27,6610355,3.5763635306174897
KYSE-450,11427553,3.7801306516191384
PK-59,637858,1.5777202295297317
KYSE-450,46926350,-4.1870362089493804
SNU-719,11152667,2.1367048146797294
TCCSUP,11656518,3.701677280495769
TCCSUP,6918837,-3.2032955112997623
HDLM-2,11964036,1.905362417014545
SK-UT-1,3689413,-2.3572164451465105
AML-193,tanespimycin-bortezomib (250-1 mol-mol),-1.641441169090329
VMRC-LCD,10074640,3.5241225805354013
NCI-H716,11175137,3.010024100916108
RKO,89183176,-5.254565057669901
EHEB,11175137,2.3201035229404186
HCC2108,ISOX-bortezomib (250-1 mol-mol),1.2590401469034869
NCI-N87,31703,-2.5850470675010175
L3.3,322968,4.952946424555438
KMS-26,439501,-2.394060102049288
KMH-2,4261,0.8972500118962282
HDLM-2,12003241,-2.9289857152710344
EoL-1,26596,-3.796383365572035
BT 232,5738263,4.271272917629151
BEN,452548,3.554622544247462
SNU-719,6610355,3.629757335735517
RCC10RGB,5494449,5.764110819730859
RCM-1 [Human rectal adenocarcinoma],1750826,-0.1499809417024857
A3/Kawakami,3385,-0.3752985457338789
BT 232,25105715,2.740751037558136
SK-BR-3,doxorubicin-navitoclax (2-1 mol-mol),-0.869181259383936
HT-1197,6918328,0.5381396375643374
HuH-28,44589607,2.6419565246755186
RKO,54454,4.6965621210229225
SUP-T1,44493528,4.4942343110915655
KU-19-19,44185566,3.361767971446376
SCC-25,5281321,-2.411651567678298
KYSE-180,124202324,3.3270800786084154
PK-59,73707398,1.1955784126278513
RCC10RGB,salermide-PLX-4032 (12-1 mol-mol),5.5053951487435775
RCM-1 [Human rectal adenocarcinoma],25102847,3.88391486543544
EHEB,136227924,2.586993854279513
PK-59,5311281,1.9258741170169784
AU565,148198,-3.941648532890003
KHM-1B,969516,2.482442021285449
P31/FUJ,49836020,4.674155414221834
RCH-ACV,46199207,2.339868417133843
IGR-37,selumetinib-JQ-1 (4-1 mol-mol),0.4307789680425182
NCI-H2009,3815108,3.061482559784255
A3/Kawakami,241158,1.613723809197875
SUP-T1,11612883,2.005750573206772
HARA [Human squamous cell lung carcinoma],9926054,1.843677597683555
BT 228,135411,2.59709347329382
BT 428,36462,0.8626568513499365
AML-193,11238147,3.1798206586367663
HT-1197,23582824,1.0158241115755549
SNU-175,navitoclax-birinapant (1-1 mol-mol),-1.8932879428514044
KMH-2,9903786,1.3660293069385576
HDLM-2,4259181,-0.5875112476137577
KHM-1B,89183176,4.960393231670367
SCC-25,219104,3.413354350971759
SK-BR-3,5287620,-4.253169459520154
HARA [Human squamous cell lung carcinoma],16722836,2.4020375260133595
BT 245,selumetinib-piperlongumine (8-1 mol-mol),4.075741848963224
KMH-2,3503,1.3006105599305138
TCCSUP,3503,2.528239452217975
SNU-719,tanespimycin-gemcitabine (1-1 mol-mol),-1.0194269764883654
WM793,44493528,4.356787444460569
VMRC-LCD,3062316,3.5671929911904305
RCC10RGB,135421197,4.393109316582631
RCC10RGB,156422,4.423389512885201
BT 232,selumetinib-decitabine (4-1 mol-mol),5.145542900456173
RCM-1 [Human rectal adenocarcinoma],5287969,-2.1782985548113336
SCC-25,15983966,1.481913293306472
WM793,400769,-0.3284339771877358
RCH-ACV,72199292,0.5270492680979041
TCCSUP,135421197,2.510598154952076
AML-193,3676137,4.291984502421881
TCCSUP,6852167,2.775293027732918
RKO,984333,1.1849980625737155
HARA [Human squamous cell lung carcinoma],selumetinib-vorinostat (8-1 mol-mol),4.369788913914824
JeKo-1,1566236,1.2971928286160908
BT 232,72193861,2.815932251551518
SK-BR-3,119607,5.632381290593283
EHEB,BRD-K03911514,2.273371159476054
MG-63,65628,4.3545217389034425
L3.3,ISOX-bortezomib (250-1 mol-mol),1.440349868344241
RCC10RGB,24978538,2.2083570886635258
MFE-319,702558,5.58743848401893
HDLM-2,24856436,-1.0914500394926507
NCI-N87,24180719,3.957157119616887
MSTO-211H,44202524,1.4972222665959742
IGR-37,135421197,1.178661342091473
VMRC-LCD,selumetinib-GDC-0941 (4-1 mol-mol),3.316694263206271
SK-MEL-3,11228183,5.686289185065266
L3.3,10427712,3.981964931961501
TCCSUP,5329102,2.310933732009281
KALS-1,11178236,-3.24934672669711
SUP-T1,16725315,3.2469628840099425
PC-14,1239801,1.7160946167393711
AML-193,123631,1.9503084276599996
KMH-2,9911830,2.2989781797044313
HCC2108,selumetinib-MK-2206 (8-1 mol-mol),3.375677921262827
NCI-N87,53232,3.890681715203442
AU565,9933475,1.5968241540352486
KHM-1B,16115403,-6.426338372507057
BT 428,135440466,3.5920664282237937
KU-19-19,6918837,-3.3861016705907203
EoL-1,135928012,1.9970775215699643
KU-19-19,9907093,4.38040739031281
MSTO-211H,erlotinib-PLX-4032 (2-1 mol-mol),1.1572104860425592
PC-14,54143018,-1.3029373778236335
BT 245,7251185,1.9708124814214532
BT 239,10127622,2.083326885414152
SK-UT-1,44819697,-1.700169587058806
MSTO-211H,9935249,0.534197831206919
YH-13,6438330,2.6622356468059736
Capan-1,3081361,3.3108350368372887
SIG-M5,44202524,1.2134398092515557
JeKo-1,1750826,-4.154422614247159
HARA [Human squamous cell lung carcinoma],44137675,4.310894105428011
PK-59,25150857,2.6294485310245777
RPMI-8402,9884685,1.0462032171352182
SK-MEL-3,135659046,3.5354638551340756
RCH-ACV,11317348,1.650156514105399
JeKo-1,vorinostat-navitoclax (4-1 mol-mol),0.6862537065535679
KYSE-180,676352,2.6978947803601057
YH-13,serdemetan-SCH-529074 (1-1 mol-mol),3.0020411747572098
BT 239,54649381,3.7055214741556752
SW1116,9915743,-1.8123899004443464
NCI-H647,107985,-3.43875812490285
WM793,4259181,0.9321312927301734
RKO,16013152,4.038378204585466
BT 232,9935249,2.6697754129604183
PC-14,44632017,1.2382575385480483
Capan-1,4788,6.04239861928531
NCI-H647,5746,1.3621550256056163
KMH-2,51039095,2.0991700648895013
JeKo-1,107970,1.751754163116744
BT 228,66577038,2.3942154642246445
SK-MEL-3,46907787,3.879205812014703
A3/Kawakami,5329102,1.0265561174144966
VMRC-LCD,11609586,1.5709482293108756
PK-59,1750826,-0.8335670584844378
RPMI-8402,5460769,1.919918299685469
TCCSUP,15547703,4.005095774110686
KMS-26,135411,0.6977602532774166
IGR-37,9911830,3.620959954917233
AML-193,1641662,1.9597588397724988
A3/Kawakami,11494412,-0.0217688682403614
RCH-ACV,156414,0.8173746965984037
RKO,9915743,2.8851858618766957
KALS-1,148198,-1.8271090842643645
BT 428,serdemetan-SCH-529074 (1-1 mol-mol),1.657658062234635
SK-UT-1,73707398,0.9883439046575164
KU-19-19,9935249,4.318045076797651
A3/Kawakami,44137675,4.3383661148547485
HCC2108,sirolimus-bortezomib (250-1 mol-mol),3.017488658473148
TCCSUP,19582717,3.018222004156177
PK-59,124202324,2.744479074012848
RCM-1 [Human rectal adenocarcinoma],67156097,4.4289502620646415
NCI-N87,decitabine-navitoclax (2-1 mol-mol),0.6446345774598216
YH-13,46191454,1.7299937465263655
A3/Kawakami,9929138,3.117210627279925
SK-MEL-3,56946209,-4.287361416501386
IGR-37,decitabine-carboplatin (1-1 mol-mol),5.24274123095895
IGR-37,doxorubicin-navitoclax (2-1 mol-mol),-1.265536355584056
NCI-H2009,44507138,1.543580962147717
EoL-1,11485656,-6.598388814450544
SCC-25,selumetinib-navitoclax (8-1 mol-mol),1.382420199382957
KYSE-450,5281321,2.0309467216777657
BT 428,9887053,4.346878495583028
MSTO-211H,12001922,2.4775669078904397
KALS-1,5566,3.4963858873042972
KMH-2,9967941,3.413814046598107
NCI-H2009,2729026,1.97459320968498
PC-14,16038120,0.0190258428468705
PK-59,216345,4.453291295697538
NCI-H647,24779724,4.284354116768243
KHM-1B,36314,1.0802720035135625
SNU-175,10385095,-0.1957909072596834
EHEB,5335621,4.71040970914542
SNU-719,73707398,1.6522942539342995
RCC10RGB,72967,3.7162805539485775
Capan-1,5311281,4.246270844486242
SCC-25,46199207,3.11337130368269
SK-N-SH,5278396,3.383689729318605
P31/FUJ,3038522,3.230912995410489
SIG-M5,56963564,0.3502390729356471
HARA [Human squamous cell lung carcinoma],42642645,0.3266919515257925
EoL-1,11317348,-6.65468649767328
NCI-H2009,4477,0.2115452666376647
EHEB,400769,-1.1131056733057492
HDLM-2,6918878,0.8195302952779613
SW1116,44589607,1.390187051865578
RCM-1 [Human rectal adenocarcinoma],tretinoin-navitoclax (4-1 mol-mol),-2.5028847208859637
RCM-1 [Human rectal adenocarcinoma],10427712,4.591789634520137
SK-MEL-3,3825829,4.277239969217916
NCI-H2009,25183872,2.394233803753281
A3/Kawakami,44819697,-1.6938625233668798
SK-BR-3,2858523,2.9984768643354105
RPMI-8402,5281321,-2.110764548620017
HCC2108,tanespimycin-gemcitabine (1-1 mol-mol),0.2372099864187673
JeKo-1,11178236,-6.0595873606692905
RPMI-8402,25195348,1.329987395065802
AML-193,carboplatin-etoposide (40-17 mol-mol),1.2477537905696687
SK-BR-3,3503,1.395775394508457
SK-UT-1,navitoclax-piperlongumine (1-1 mol-mol),3.105185528724131
MSTO-211H,JQ-1-MK-0752 (1-1 mol-mol),2.3232645118005015
RPMI-8402,159324,-4.775028439509436
BT 239,tretinoin-carboplatin (2-1 mol-mol),4.092541066978285
JeKo-1,10410894,2.866666421101318
SK-MEL-3,25102847,3.118726155131008
RCM-1 [Human rectal adenocarcinoma],3136844,4.175493618298147
EoL-1,6918736,-1.0473205036303437
MSTO-211H,44632017,1.2059374560785627
AML-193,4578,4.062273131569963
RCH-ACV,374536,-4.30360935865895
EHEB,54619267,5.440652083155126
P31/FUJ,11238147,2.0504580426090286
WM793,11626560,2.3104279907190124
NCI-H2009,49766530,0.9767616789625324
KYSE-180,15953870,2.8572759517399677
KYSE-180,9866186,0.5701832390810861
SK-BR-3,24180125,2.453332615132994
Capan-1,135440466,2.086323480426832
L3.3,carboplatin-etoposide (40-17 mol-mol),2.812808375332559
NCI-H647,ISOX-bortezomib (250-1 mol-mol),0.2254795150713305
Capan-1,439501,-1.7438578400457687
MSTO-211H,24964624,0.1425074184859401
RPMI-8402,25126798,3.7839461923520146
KMH-2,104842,-3.8663712291757975
P31/FUJ,135875424,3.622681212031297
SK-UT-1,1716436,3.7795606206738337
VMRC-LCD,9933475,2.0696353412497945
PK-59,11222830,1.7075966552291613
KU-19-19,selumetinib-BRD-A02303741 (4-1 mol-mol),2.399823528664379
KYSE-180,6917907,-5.842795191649857
SCC-25,53232,1.44049487186662
RCH-ACV,46224516,2.8167534869732473
SIG-M5,6438330,1.2946673248283371
SK-N-SH,9926054,1.7311235151913027
AU565,42642645,1.544546710659079
NCI-N87,11427553,2.9770783714757005
RPMI-8402,100016,6.7779334067701145
AML-193,135421197,0.7876033807150744
NCI-H1092,49793307,-5.3090977764299145
SCC-25,24797083,-0.4584099740239653
SK-N-SH,5738263,2.34664500520751
P31/FUJ,25262965,-1.897985536240049
NCI-H2009,navitoclax-PLX-4032 (1-1 mol-mol),4.434532653738059
A3/Kawakami,serdemetan-SCH-529074 (1-1 mol-mol),2.4719519958032783
JeKo-1,1716436,3.304461536508339
HGC-27,241158,3.1465337742819135
SNU-175,5470400,-5.114135667562133
BT 428,3384730,-1.1186762550581884
SIG-M5,16725315,5.1730816477451675
RCC10RGB,decitabine-navitoclax (2-1 mol-mol),2.143538063867694
RPMI-8402,6918878,-0.944708715782594
WM793,135984461,3.5730556754970175
Capan-1,selumetinib-MK-2206 (8-1 mol-mol),2.4755969092778947
HuH-28,3543504,4.332449693244785
KALS-1,54618771,1.5195853448840246
KALS-1,650361,4.294663890793572
KYSE-180,72376,-2.661600784164128
KHM-1B,104842,-4.441757010359471
MG-63,49766530,-2.6108444064120686
MFE-319,navitoclax-MST-312 (1-1 mol-mol),1.0978712937217856
KMH-2,16741245,3.840749402657228
EHEB,452548,-2.012657575306965
HOP-92,SNX-2112-bortezomib (250-1 mol-mol),-2.684217234979205
L3.3,409805,5.10307456372432
SK-UT-1,753704,5.7414548623534305
RCC10RGB,6918638,2.235907203261483
BT 428,16219061,1.0304344533203371
P31/FUJ,selumetinib-PLX-4032 (8-1 mol-mol),0.7192847011043231
HT-1197,89928392,1.3005689204947632
MG-63,10184653,1.7606852511408682
BT 428,navitoclax-pluripotin (1-1 mol-mol),-1.5284405566658936
HDLM-2,5351362,0.8084341523090489
NCI-H647,676352,1.7870539846924864
HDLM-2,613753,2.775551673623425
NCI-H647,navitoclax-PLX-4032 (1-1 mol-mol),2.804410557058145
JeKo-1,400769,-1.1356901493984448
NCI-H647,16722836,1.7891170295508898
RCM-1 [Human rectal adenocarcinoma],1716436,2.8487797947795226
KMS-26,119182,-3.650360356715155
KMH-2,1242560,1.2847001062875232
SK-UT-1,7251185,2.9981286588919303
RCC10RGB,BRD9876-MK-1775 (4-1 mol-mol),3.486807022828034
NCI-H716,25195348,4.627299317341385
HT-1197,51037431,1.5154051682877436
HOP-92,10322450,5.279706344713567
SCC-25,3634881,2.926098056136672
BT 228,135999136,1.184789757824171
NCI-H647,49867926,4.117100796808367
KALS-1,3854666,1.8076760580597435
NCI-H647,54626689,4.686941591996974
SIG-M5,216345,1.8535513786170312
BT 428,2858523,3.085177452566525
KMH-2,44487061,4.455067778773301
JeKo-1,4917,3.4768978149250196
HARA [Human squamous cell lung carcinoma],navitoclax-sorafenib (1-1 mol-mol),1.2625473684238606
NCI-N87,4788,6.175336883845895
HOP-92,5281321,-2.4250466380365285
KALS-1,docetaxel-tanespimycin (2-1 mol-mol),-3.2218390886822457
HOP-92,navitoclax-sorafenib (1-1 mol-mol),1.2140039240726823
AU565,44507138,1.5217719455679517
HARA [Human squamous cell lung carcinoma],docetaxel-tanespimycin (2-1 mol-mol),-6.628155731353656
NCI-H716,9907093,4.313226468645286
NCI-H2081,44486219,4.417324221540856
Capan-1,2742550,4.040805186459864
YH-13,navitoclax-piperlongumine (1-1 mol-mol),2.7253521934801217
NCI-H1092,66577038,3.0171960065263077
SIG-M5,25183872,-1.6302864694053505
RCH-ACV,11404337,-3.4886710255299516
BT 428,4788,4.272474838968475
AML-193,122327,4.760390978201369
KU-19-19,5566,3.5813761109507154
SCC-25,374536,3.416517907222855
EoL-1,11507802,0.3790760800214007
HDLM-2,322968,2.711016347814527
MG-63,72193861,2.004185103526447
NCI-N87,72376,-2.7230406051655676
RPMI-8402,44632017,0.5440950196061413
TCCSUP,BRD-K27188169-navitoclax (2-1 mol-mol),3.571342544762983
L3.3,16038120,1.9292348544241311
NCI-H2009,448949,2.535639173937985
HARA [Human squamous cell lung carcinoma],20959075,-3.3968163713216657
EoL-1,46943432,-1.6312084333642909
NCI-N87,11222830,1.733835072175261
NCI-H647,10385095,0.97952933951215
BT 239,selumetinib-decitabine (4-1 mol-mol),2.2239033457744135
HGC-27,11960529,3.884254936720695
BT 232,12003241,0.7689860927775146
KHM-1B,613753,3.0054296749373095
KMS-26,9840324,5.4510067196493095
SK-BR-3,216345,4.20416072234797
WM793,selumetinib-BRD-A02303741 (4-1 mol-mol),2.9195666143098356
NCI-H647,135423438,3.3344215247990507
NCI-H2009,5280436,3.59103147994178
NCI-H2009,119607,5.663513162505294
BT 228,9956119,4.079659859385672
KALS-1,BRD-A02303741-navitoclax (2-1 mol-mol),4.549703778314409
NCI-N87,25126798,3.678424158745535
KMS-26,selumetinib-JQ-1 (4-1 mol-mol),-2.213502870233135
MSTO-211H,crizotinib-PLX-4032 (2-1 mol-mol),1.678384538966045
SUP-T1,44507138,0.1688563513383507
A3/Kawakami,400769,-1.77145388993019
AU565,46191454,1.308540851634407
IGR-37,UNC0638-navitoclax (1-1 mol-mol),2.547238827516404
SK-MEL-3,135440466,3.5253653900687016
KMS-26,31703,-3.4337819351101984
MSTO-211H,24748573,5.719931334372704
L3.3,3503,3.0907711446371
A3/Kawakami,9903786,0.9564213610990896
JeKo-1,135440466,2.5383717679923694
RPMI-8402,3503,1.6586365136848369
HGC-27,9956119,3.847397391966058
NCI-H1092,5282054,2.5552812504046742
SUP-T1,984333,-1.53865397816133
KHM-1B,637858,1.18497480261582
KALS-1,selumetinib-navitoclax (8-1 mol-mol),3.466386380814354
MFE-319,4477,0.1940335773756215
NCI-H2081,19582717,3.032200893690187
EoL-1,44185566,0.1635657401895224
EoL-1,piperlongumine-MST-312 (1-1 mol-mol),0.8585653760489445
RKO,23725625,3.9986828157613616
AU565,11257553,-0.514738811981399
BT 228,568763,1.1475439883163068
KALS-1,241158,1.844994871137429
IGR-37,54765302,4.527235214613552
HARA [Human squamous cell lung carcinoma],4259181,-0.0825087225465529
JeKo-1,6610355,3.693791418903024
BT 228,15953870,3.98907826196433
EoL-1,148198,-7.742780807176134
RPMI-8402,5311,-0.2500349186426445
RCM-1 [Human rectal adenocarcinoma],44185566,2.9642149554045
EoL-1,3038522,-8.304141802256863
BT 239,11175137,1.8428661644614428
KMS-26,1641662,2.427408733876266
AML-193,49867926,4.261276304538993
RPMI-8402,selumetinib-GDC-0941 (4-1 mol-mol),2.2206105962068645
A3/Kawakami,BRD-A02303741-navitoclax (2-1 mol-mol),3.642175570007592
PK-59,2729026,2.543125862606278
P31/FUJ,6918289,5.395091759648689
HuH-28,72734382,4.701075564806335
SIG-M5,135875424,3.9161233057534584
NCI-H716,44486219,4.213676696838089
NCI-H716,2749,1.7432569945733043
MG-63,135440466,1.977451098629129
BT 428,4261,1.0264453227673789
HOP-92,16659841,4.103046774266946
SK-UT-1,10302451,4.065117068717504
A3/Kawakami,6438330,1.0549158507152725
HuH-28,54649381,3.7524268374632905
RCH-ACV,navitoclax-piperlongumine (1-1 mol-mol),-1.104480159352546
HOP-92,tanespimycin-gemcitabine (1-1 mol-mol),0.7431425090974371
HuH-28,54454,-0.0746386993024276
SNU-719,52912189,0.7214310839910616
P31/FUJ,452548,-2.598049093653093
IGR-37,68056272,3.716055966289072
SW1116,17755052,6.3985859318096585
MG-63,4578,5.230018987153115
EHEB,11612883,2.202439191099921
SCC-25,10184653,-6.163884724529639
NCI-H716,selumetinib-MK-2206 (8-1 mol-mol),1.0263677216845877
HT-1197,tretinoin-carboplatin (2-1 mol-mol),4.776583137767212
NCI-H2081,navitoclax-pluripotin (1-1 mol-mol),1.3803711022863172
SCC-25,24889392,4.639325710892408
HOP-92,11404337,-0.857854163470874
SNU-719,10385095,1.1651309868833004
MG-63,11485656,3.0709685561149076
KMS-26,409805,3.707967657643135
AML-193,4521392,4.270055068512442
RKO,selumetinib-UNC0638 (4-1 mol-mol),2.378322605916553
NCI-N87,72193861,-0.2047514956394879
BT 239,11485656,1.6389778224376736
BT 232,1242560,3.6502727265422488
RKO,73707398,0.9128481241529548
NCI-H716,JQ-1-MK-0752 (1-1 mol-mol),0.5340805960072722
KALS-1,107985,-2.955854025233171
AML-193,55283,0.0071540318924945
RCC10RGB,6918837,-1.099435459858538
HGC-27,5951923,5.413503924566131
RCM-1 [Human rectal adenocarcinoma],107985,-2.8907916820196156
SIG-M5,9926054,1.755465184389032
MG-63,16038120,-0.0776194719291767
SK-N-SH,446155,0.7593926303008401
HOP-92,25183872,-0.1254045296391763
BT 245,selumetinib-GDC-0941 (4-1 mol-mol),1.6158024411915433
BEN,JQ-1-carboplatin (1-1 mol-mol),1.5811982122787027
P31/FUJ,ISOX-bortezomib (250-1 mol-mol),-0.0400156428773503
HOP-92,4705,3.0147714927694387
NCI-H2081,10113978,3.1143213489087755
RCM-1 [Human rectal adenocarcinoma],11625818,4.3229587777026035
KU-19-19,11175137,2.6409229524549858
SCC-25,448949,1.985657670863448
MG-63,126941,-1.917990998547778
BT 245,11507802,1.2817333093626646
RCM-1 [Human rectal adenocarcinoma],46907787,1.929794927586623
JeKo-1,9927531,3.3417502019075473
KMH-2,107985,-4.440693549832868
RCH-ACV,24978538,-1.4490608088208552
NCI-H647,2746,3.2477313608093143
MSTO-211H,53495165,-2.281905985837366
BT 228,5278396,3.711757185669569
MG-63,navitoclax-pluripotin (1-1 mol-mol),-0.133870113888594
BT 228,2749,1.0716795271065458
HDLM-2,54618771,0.2228052898730796
SK-MEL-3,46398810,2.990629314874608
BT 245,5311,1.2295057752213503
BT 232,53232,6.926362701251441
SCC-25,107970,2.0623920721619564
BT 228,89928392,0.853173355712995
RKO,54618164,4.0326978900214705
A3/Kawakami,54619267,3.75747361768558
EHEB,44491742,5.293750317448726
HGC-27,168313200,1.6271310885098942
BT 245,36314,-4.128140431647543
Capan-1,9915743,1.7686030457629929
RCH-ACV,11364421,-3.7179905087698577
HARA [Human squamous cell lung carcinoma],9936388,-6.286258703982233
KMH-2,72376,-2.9516442192946313
MFE-319,selumetinib-decitabine (4-1 mol-mol),7.419949967568279
NCI-H647,44607530,2.1118379342715934
RCH-ACV,439501,-2.6930538101979575
RKO,10427712,4.823698606341804
SK-N-SH,9908783,4.839451621753886
WM793,409805,4.444302991596743
EoL-1,11494412,-1.5028659812721048
P31/FUJ,9866186,-0.5408158091236333
SK-UT-1,15547703,4.119517534228275
NCI-H2009,6918878,-0.4863456687538305
EoL-1,5951923,1.481448743453953
SK-MEL-3,11364421,2.311375029113868
TCCSUP,4261,0.2387476158798516
MFE-319,selumetinib-JQ-1 (4-1 mol-mol),1.6766813591617562
BT 232,44566777,0.0141290034357306
HDLM-2,25150857,1.873420038021688
PC-14,5328940,-3.455221746073052
MSTO-211H,148198,-2.180219295506665
HARA [Human squamous cell lung carcinoma],9549297,1.8946305959472185
SK-BR-3,6918328,-1.6027331571145336
HARA [Human squamous cell lung carcinoma],3854666,0.7328632401261175
BT 245,6436223,-5.553533241536654
Capan-1,53495165,-0.3981930532787378
TCCSUP,73707398,0.9718071298936178
A3/Kawakami,71466380,3.591682460242944
P31/FUJ,5287620,-2.889875327880449
L3.3,selumetinib-GDC-0941 (4-1 mol-mol),2.633566714315937
NCI-H2081,3038522,1.7557154711324474
HOP-92,123631,1.989157626802639
NCI-H716,24821094,1.153625459774695
SIG-M5,44493528,4.118953354797346
KYSE-450,2749,3.233270096277708
MFE-319,JQ-1-navitoclax (2-1 mol-mol),2.1030178477311585
HuH-28,448949,2.113805138367954
SK-UT-1,107985,-4.193387591911345
KMS-26,44632017,-0.0747973466667393
HOP-92,2949965,2.571878952392172
EHEB,11485656,2.717011543878295
KMS-26,73707438,4.268238066609722
NCI-H2009,5470400,0.3791383114910072
RCH-ACV,3385,3.56200252642106
SK-MEL-3,BRD-A02303741-navitoclax (2-1 mol-mol),5.339110532887004
SK-UT-1,168312962,-2.178754145996638
RCM-1 [Human rectal adenocarcinoma],5460769,3.958915694045798
KMH-2,638278,2.326730208589123
HGC-27,53392493,1.6570659179083984
PC-14,3815108,3.796609713170094
SNU-175,6917907,-5.4838778186048565
IGR-37,56973724,2.647100743957026
SUP-T1,241158,1.808139416871087
HGC-27,25154868,3.2852129585447374
HOP-92,2871966,0.8576862502777673
BT 228,42642645,1.049898841414108
SCC-25,24772860,-2.6570530223857496
KHM-1B,6184667,4.636571439855277
AU565,4788,5.691461260554478
KHM-1B,71466380,4.706065807266485
SK-BR-3,10127622,6.124845566688295
SCC-25,selumetinib-decitabine (4-1 mol-mol),0.413834191700858
KALS-1,16038120,1.3294229254806909
SIG-M5,UNC0638-navitoclax (1-1 mol-mol),1.9019832326670536
RKO,452548,0.942587279069954
EHEB,119182,-1.3653952638717988
EoL-1,11175137,-1.2370098127144016
L3.3,sirolimus-bortezomib (250-1 mol-mol),2.0691121038567144
EHEB,15983966,-3.458477351874515
AML-193,11507802,-1.343238882058303
HGC-27,675434,3.3190892089425703
HCC2108,54618164,5.127082823492277
SCC-25,46398810,1.8046606965109464
KU-19-19,65628,4.405271017285275
SK-BR-3,SNX-2112-bortezomib (250-1 mol-mol),-1.2771579360418317
NCI-H716,JQ-1-carboplatin (1-1 mol-mol),0.4768639572382123
NCI-H2081,71466578,5.057643127393127
SNU-719,60700,0.5626547401667288
BT 245,6852167,3.061843713920685
MG-63,135398744,6.808455799902383
AML-193,11234052,3.1221561834967204
MSTO-211H,selumetinib-MK-2206 (8-1 mol-mol),1.2523786732506748
BT 245,11612883,3.133910870711437
AU565,2871966,0.5985779022023225
AML-193,753704,6.989426434419144
Capan-1,9825149,3.905274962823832
L3.3,446155,3.865906870912223
RCH-ACV,16741245,3.5089315303457647
NCI-H2009,23635314,-2.363129056883172
MSTO-211H,53325874,5.432400358349695
RKO,54619267,4.028311361432676
VMRC-LCD,51037431,2.5205420598110413
KU-19-19,66577038,3.864819378735941
AML-193,3384730,1.670436347531055
HT-1197,11175137,3.7064365517620144
HARA [Human squamous cell lung carcinoma],9935249,3.837366541191349
SK-BR-3,carboplatin-etoposide (40-17 mol-mol),0.8601471642940264
MFE-319,446155,2.174031391832163
MG-63,9840324,5.516000829234419
HDLM-2,navitoclax-sorafenib (1-1 mol-mol),-1.2935696230139155
MSTO-211H,3503,2.7854032891391163
AML-193,6184667,2.259405710229799
JeKo-1,46843906,1.6069014247110966
KYSE-180,sirolimus-bortezomib (250-1 mol-mol),1.6916229080787213
NCI-H647,5311281,1.240515032206998
KMH-2,49766530,-1.67617119568669
NCI-H2009,54618771,-0.2233577251443086
JeKo-1,387447,-5.188650578129272
AML-193,148124,-4.5095548877680045
PC-14,54626689,4.5901854787123515
SK-N-SH,10302451,3.675886207337339
A3/Kawakami,3676137,4.5175846106556685
NCI-H716,16722836,0.7002135066981959
NCI-H1092,15983966,1.932051104008448
JeKo-1,5291,3.6809713108034727
RKO,123631,2.6120370559458155
SK-BR-3,17755052,-1.6806611098850694
KMH-2,89928392,0.3434587206066553
KYSE-450,57330099,4.469167864214201
RPMI-8402,24856436,-1.7252241981885692
KMS-26,136227924,1.9705002365993127
RCM-1 [Human rectal adenocarcinoma],piperlongumine-MST-312 (1-1 mol-mol),1.7783627662163426
MFE-319,10296883,4.228563171543355
RKO,17755052,3.988455753476612
EoL-1,52912189,-2.3334635510591735
P31/FUJ,5311281,0.8046363155731003
HuH-28,navitoclax-gemcitabine (1-1 mol-mol),-0.9766074129135492
EHEB,6918328,-0.9331880587360782
AML-193,11647372,0.6704142848080875
BT 239,5746,-1.6534207845395668
WM793,11427553,3.4959048575417304
SNU-719,10231331,-1.4600362678469236
RCM-1 [Human rectal adenocarcinoma],11222830,1.840895437487006
HT-1197,4788,5.437133093495148
NCI-H2009,36462,0.0033291412741449
A3/Kawakami,23582824,1.241506590343337
KMH-2,6438330,1.5352425056894736
KMS-26,49850262,0.7093816750361389
A3/Kawakami,54678924,0.863865481945523
WM793,23939,4.513894312283566
YH-13,10410894,5.153853208310613
KMS-26,421610,3.4323979273943115
SCC-25,53495165,-0.0152860232749343
KMS-26,tanespimycin-gemcitabine (1-1 mol-mol),-4.584955300249398
SNU-719,46191454,1.392002923842842
SK-BR-3,49836020,6.022467534114696
VMRC-LCD,selumetinib-vorinostat (8-1 mol-mol),2.297585943130406
SK-BR-3,23635314,-4.004895122839062
SNU-719,12001922,1.3802679998627916
RCC10RGB,123631,3.672101761387351
NCI-H716,2729026,3.0409126954919414
KHM-1B,16038120,-2.393017359341735
KALS-1,navitoclax-PLX-4032 (1-1 mol-mol),3.898903581132082
HT-1197,24797083,1.5733372701373114
BT 228,11507802,2.259457775581249
RCH-ACV,23725625,2.846661543237042
A3/Kawakami,71304818,1.5759191717752106
NCI-H2009,656346,1.3969032628362248
RCH-ACV,246676,4.239213024568716
MFE-319,JQ-1-UNC0638 (2-1 mol-mol),2.717075494810569
KYSE-180,4917,2.992329233033062
BEN,selumetinib-navitoclax (8-1 mol-mol),5.996784008976618
RPMI-8402,5281672,5.027553366622458
EoL-1,9884685,-2.267367014131727
NCI-H2081,selumetinib-PLX-4032 (8-1 mol-mol),4.306569856872656
HOP-92,135875424,3.091462315962494
MFE-319,selumetinib-tretinoin (2-1 mol-mol),6.337464117159501
BT 245,5287969,-1.6523463786351291
RCH-ACV,salermide-PLX-4032 (12-1 mol-mol),4.858331017518017
BT 428,9823820,4.120074007569746
P31/FUJ,49793307,-4.015617000908982
NCI-H716,4096211,1.8958562993103305
SK-N-SH,375860,-1.202026834926373
IGR-37,9884685,1.000968603362932
VMRC-LCD,53495165,-1.4997534460304898
BT 239,16038120,-0.0461322747222334
MG-63,5738263,3.330484328422529
KYSE-450,17755052,4.184551596541284
HGC-27,57330099,3.275250157225731
EoL-1,tanespimycin-gemcitabine (1-1 mol-mol),-5.059880546991209
TCCSUP,ISOX-bortezomib (250-1 mol-mol),0.0880640354872425
HGC-27,6918878,5.6595455570667585
HT-1197,53232,3.574396927387496
HDLM-2,19582717,3.906738347125687
PC-14,16741245,4.805807368524508
RCC10RGB,285033,2.114091727684993
MG-63,285033,-1.425009067121221
HT-1197,44607531,1.6930137213154288
AML-193,637858,1.3897000366082406
HT-1197,5328940,2.4291736650333555
NCI-H2009,66577038,3.427367822074961
EHEB,60700,-2.619794830780626
SUP-T1,71466445,1.8491194915279467
KHM-1B,6623618,1.2635861125154564
KHM-1B,11612883,4.120699306463628
BT 428,44607530,0.8800412627899294
NCI-H2081,4917,1.6033986047844857
KMH-2,11238147,1.9401814426833337
RCH-ACV,53392493,1.3417320100499484
RPMI-8402,vorinostat-navitoclax (4-1 mol-mol),0.0709461583976251
HARA [Human squamous cell lung carcinoma],16741245,4.4624437574750955
MSTO-211H,124202324,2.766151060695559
SCC-25,11647372,-0.6437907951088745
HT-1197,10296883,4.022509724629416
BT 245,11175137,2.6042649387575416
AML-193,675434,3.3619879927387726
NCI-N87,5329102,2.120238068250485
EoL-1,219104,1.9308995373558473
SW1116,2842253,4.59280790478934
HT-1197,16219061,3.0622069579513496
EHEB,3385,0.9451951233490862
RCC10RGB,5311,2.218274000934613
VMRC-LCD,3825829,3.794583756543404
PK-59,374536,3.3895651049795483
SIG-M5,24180719,-1.1806497001291554
SW1116,9911830,1.7664188791377746
PC-14,445091,5.963684061014051
BT 228,carboplatin-UNC0638 (2-1 mol-mol),3.8259672436277623
RKO,25105715,3.388469834531371
HCC2108,637858,1.810315688111992
RCM-1 [Human rectal adenocarcinoma],24856436,1.4266113819026696
PC-14,441298,3.020679167194442
L3.3,452548,-0.800912327932342
PC-14,25262965,-1.0782016960514162
YH-13,613753,3.198655088804402
HCC2108,2729026,3.184070590056279
SNU-719,3503,2.2782754399458245
HT-1197,56946209,-5.052653538760733
SCC-25,5278396,3.1570214127780685
NCI-H2081,168312962,2.2709613246712395
SIG-M5,675434,4.22708973096091
L3.3,73707438,4.465616964273929
RCH-ACV,navitoclax-MST-312 (1-1 mol-mol),-0.5317286513425824
TCCSUP,12003241,-0.9458347981681208
KHM-1B,44185566,1.2108718099020337
RPMI-8402,1641662,2.733233307286145
VMRC-LCD,19582717,3.303648470643174
MSTO-211H,23582824,0.616921606097025
KALS-1,613753,3.1266868846320013
EHEB,151289,0.953950234753323
PC-14,46191454,2.117335177137966
HT-1197,11238147,3.729667786315669
EoL-1,2945648,1.1090870980913885
P31/FUJ,135440466,3.423250795887436
RCC10RGB,73707398,3.9170227295506304
KALS-1,1239801,5.055637044136656
A3/Kawakami,56946209,-5.114246331529574
KMH-2,11427553,1.2431761665882468
KMS-26,12003241,-3.93647753580664
HDLM-2,56963564,-0.8731918521974633
SNU-719,409805,4.713440373446098
BEN,135421197,5.032233949916212
AML-193,44589607,1.8330108172196944
IGR-37,119607,5.865118433323597
HDLM-2,selumetinib-vorinostat (8-1 mol-mol),2.3904496984026884
AU565,12001922,1.255153902569356
BT 428,25105715,3.661945595355312
MFE-319,44486219,4.502220022869246
SIG-M5,9907093,4.491121230488794
RPMI-8402,selumetinib-decitabine (4-1 mol-mol),-0.5620771838397934
MFE-319,126941,-1.5656396867924716
MFE-319,5978,-3.2494990298877298
RCC10RGB,5738263,4.593697299478501
HCC2108,navitoclax-MST-312 (1-1 mol-mol),1.0917424387869863
NCI-H647,44566777,-0.3147675941213947
BT 239,tretinoin-navitoclax (4-1 mol-mol),-2.646725985310346
KYSE-450,71304818,3.197699947963966
NCI-H2081,1566236,1.4725524820150873
RCM-1 [Human rectal adenocarcinoma],11707110,-2.81784904286785
HOP-92,168312962,3.8506225783858734
MG-63,72376,1.469717794213186
SK-MEL-3,5470400,2.4296314302431505
NCI-H716,11317348,-0.9372410471692496
TCCSUP,serdemetan-SCH-529074 (1-1 mol-mol),2.1769637397515997
BT 228,JQ-1-navitoclax (2-1 mol-mol),1.36782145529272
BT 428,54618305,4.316661671711245
KMS-26,11485656,1.8786999049789332
NCI-H1092,JQ-1-navitoclax (2-1 mol-mol),1.6253507016019415
HDLM-2,tretinoin-navitoclax (4-1 mol-mol),0.0897926455277653
NCI-H716,10302451,3.670682861692165
MSTO-211H,navitoclax-sorafenib (1-1 mol-mol),-1.757065878159517
HuH-28,erlotinib-PLX-4032 (2-1 mol-mol),3.3347715490533907
SK-UT-1,9826308,0.8326524601340544
EHEB,9935249,3.177814055372344
Capan-1,11609586,3.997247283785782
MFE-319,navitoclax-gemcitabine (1-1 mol-mol),2.6919094335174596
BT 232,11317348,1.8043966320131444
SCC-25,16741245,5.462665186984978
TCCSUP,2126,3.8917278062770566
BT 228,969516,2.769783139251389
SK-UT-1,selumetinib-UNC0638 (4-1 mol-mol),4.7391323910259935
JeKo-1,135928012,3.8687150177410783
IGR-37,alisertib-navitoclax (2-1 mol-mol),-6.267185662585046
SCC-25,44589607,2.138596672615889
EoL-1,9908783,4.142828117156902
VMRC-LCD,24964624,3.026578150802491
RCC10RGB,46907787,5.224507823938942
TCCSUP,53481919,3.87542192202802
RCC10RGB,vorinostat-navitoclax (4-1 mol-mol),1.2015093799520282
VMRC-LCD,11494412,0.3498055732572009
KMH-2,11214940,0.9300275380390216
WM793,navitoclax-gemcitabine (1-1 mol-mol),-2.7261707189545783
SK-N-SH,11152667,0.0675911998351618
SK-UT-1,16038120,1.834689793828048
SNU-719,9825149,1.0355210378174482
KMS-26,alisertib-navitoclax (2-1 mol-mol),-3.1111800059026966
SK-MEL-3,2749,2.017646387426729
AU565,56963564,-0.3705062094323867
NCI-H647,24797083,1.6332381116709602
SCC-25,11238147,1.583103772558918
KMH-2,3025986,-0.257740003575554
MSTO-211H,2858523,3.0747353868294627
HOP-92,5328940,1.5508181548546054
KMH-2,4521392,3.848949710187479
KMH-2,44241473,4.307492980589522
TCCSUP,54686904,5.934830892995649
PK-59,5281672,4.383076932761096
NCI-N87,6917907,-5.514556019160177
BT 245,serdemetan-SCH-529074 (1-1 mol-mol),1.604944963016723
SIG-M5,5978,-3.200912339593883
BT 228,176870,4.246899223129983
SW1116,6623618,1.8559748528141653
AML-193,107985,-4.640089928252453
KMS-26,10184653,0.4362321976953422
RPMI-8402,969516,2.635095624836386
NCI-H1092,2733526,5.304612787284194
NCI-H2009,11507802,1.1556617167312242
HGC-27,227681,3.354975270797925
PK-59,702558,6.286075132274527
SUP-T1,73707438,4.27678177298214
NCI-H647,3136844,4.211694107828882
BT 428,72734382,4.0549357466643805
NCI-H716,3854666,1.816337211721982
SIG-M5,tretinoin-navitoclax (4-1 mol-mol),-3.210265157958891
AML-193,JQ-1-UNC0638 (2-1 mol-mol),-0.0998627120499949
EoL-1,168313200,1.1681418802699055
YH-13,16720766,0.962389750080769
TCCSUP,5311281,1.9794455257416368
RCH-ACV,67291369,-0.8454020963895923
KMH-2,54618305,4.158753389755641
TCCSUP,25154868,4.544338525999724
KYSE-450,9866186,1.0868221005132463
BT 428,15983966,-4.76517467861946
KYSE-180,984333,0.4630057299456917
SK-N-SH,71466380,4.094259048601923
NCI-H716,148198,-5.232540582479685
TCCSUP,36462,2.278863397956304
SK-BR-3,66577038,3.0111277358889157
VMRC-LCD,navitoclax-MST-312 (1-1 mol-mol),0.9505505464778304
KYSE-180,23725625,5.7318866037383165
P31/FUJ,446155,2.867326521256313
JeKo-1,4096211,1.686622876599177
JeKo-1,262093,0.8663217724360005
JeKo-1,5284616,2.8835996452222714
BT 228,3854666,1.688749434997188
MFE-319,25183872,-1.137908986325753
BT 232,9933475,1.5925999125605983
BT 239,53393127,4.2032238153585695
HARA [Human squamous cell lung carcinoma],176870,3.342277724847585
NCI-H647,9927531,5.004225610104877
KYSE-180,2729026,3.0243505230230565
SIG-M5,5282054,3.597170537934254
BT 239,227681,1.8199980026615736
SCC-25,navitoclax-piperlongumine (1-1 mol-mol),1.637250667554565
TCCSUP,crizotinib-PLX-4032 (2-1 mol-mol),1.6984016449467694
PK-59,2828334,5.980207208191742
PK-59,159324,2.910821247421296
NCI-N87,52912189,1.61892272115858
NCI-H2081,156414,1.7676788858922157
JeKo-1,168313016,4.381746397495715
SUP-T1,9803433,6.371348299974705
KMS-26,SNX-2112-bortezomib (250-1 mol-mol),-3.665041548670727
NCI-H2081,11485656,1.3595446454141742
SNU-719,3384730,5.132436448213883
P31/FUJ,tretinoin-navitoclax (4-1 mol-mol),0.2737114955755992
SCC-25,10127622,1.9790894161284076
AU565,46199207,2.977397460043432
BEN,54649381,3.777732124891488
HT-1197,3136844,4.18722926919612
HGC-27,navitoclax-MST-312 (1-1 mol-mol),0.5911451472131103
A3/Kawakami,1239801,3.1644411969458077
MFE-319,24856436,0.3374212981069636
NCI-H647,46224516,3.168075610652588
HCC2108,9967941,3.249509678327182
RCM-1 [Human rectal adenocarcinoma],54619267,4.6297481177667725
HGC-27,65628,4.265310037500784
BT 428,637858,2.1785026029472454
NCI-N87,10074640,2.8038201142488504
BT 239,46191454,0.7736169786374765
KALS-1,53481919,4.119530694761383
HARA [Human squamous cell lung carcinoma],24771867,-1.145662696893675
SK-MEL-3,409805,5.886045786440892
NCI-H2081,51039095,1.7581275368381517
SUP-T1,9826308,-1.2452063654499914
HuH-28,JQ-1-vorinostat (2-1 mol-mol),-1.0681378768930003
IGR-37,5494449,3.4972892261356674
RPMI-8402,16736978,1.4520191712878625
EHEB,11396600,3.4241723821303314
EoL-1,36462,-3.6767399444136464
RCC10RGB,BRD-K55473186,4.42890698658841
SK-MEL-3,16736978,3.303983495005755
NCI-H2081,8515,3.558797146048482
BT 232,25183872,-1.193869012578023
SUP-T1,285033,-2.26020172201967
AML-193,100016,3.9854178308912074
AU565,15983966,1.7541662071439053
HARA [Human squamous cell lung carcinoma],selumetinib-PLX-4032 (8-1 mol-mol),5.192132134204876
HARA [Human squamous cell lung carcinoma],54686904,4.432396143260886
HDLM-2,5287620,-2.918887536012017
TCCSUP,6914657,-4.082102009024434
NCI-N87,1716436,1.6921610156965474
NCI-H1092,selumetinib-GDC-0941 (4-1 mol-mol),3.727074735978538
AML-193,23582824,0.4525583697735205
SK-N-SH,2746,2.865356656524813
BT 428,675434,4.849249419991457
BT 232,3854666,3.559831057180391
KU-19-19,56946209,-3.434845070293707
SK-MEL-3,6438330,2.9336479537531397
BT 245,11656518,1.5210228533202237
KHM-1B,216468,0.1436700661739532
BT 232,72376,-2.539263776428301
SUP-T1,72734382,3.2374995667270823
IGR-37,448949,2.8876774746497937
PK-59,navitoclax-piperlongumine (1-1 mol-mol),1.4703383378883492
MG-63,122327,5.692030618056149
MSTO-211H,6852167,2.890925130180435
L3.3,44632017,1.809753180552785
BT 428,24748573,2.5154789435675333
HGC-27,9911830,1.4787770441539565
SK-UT-1,selumetinib-navitoclax (8-1 mol-mol),6.349573563603245
HARA [Human squamous cell lung carcinoma],3503,1.5305596721968624
AU565,73707398,1.1644887368044523
BT 428,2874250,-3.4115860652418504
BT 228,9444,4.379543200764215
BT 228,2733526,2.6281498613375223
MSTO-211H,11427553,1.7459714847796464
YH-13,54613361,-0.2526246447247056
RCM-1 [Human rectal adenocarcinoma],10302451,3.9774689486836383
NCI-H647,selumetinib-decitabine (4-1 mol-mol),5.7674797524374695
AML-193,46191454,1.0807613426408085
HT-1197,15953870,3.885327712470257
BT 232,16725315,4.287768508453549
NCI-H1092,54613361,1.771000250382894
SUP-T1,65064,3.006583549253244
SK-UT-1,3136844,6.414538606040479
BT 245,9967941,5.489848387677759
BT 428,31703,-1.9162450248977527
NCI-H1092,107985,-3.3152950865622564
SIG-M5,73707398,0.4222046163414817
KYSE-450,46398810,3.648883715738529
SCC-25,5329102,1.4685985827024457
NCI-H2009,11612883,2.3268324416241777
EHEB,4259181,-0.3918316132670805
KHM-1B,54626689,4.681502909310955
Capan-1,46398810,3.0433408644153523
HuH-28,3815108,2.835726431789329
BT 245,53481919,4.235316494892971
A3/Kawakami,44632017,0.6679396873570188
HDLM-2,9911830,3.146801382603546
HCC2108,51039095,3.0641076776382055
RPMI-8402,16115403,-5.387429514685855
NCI-H647,11609586,3.1575582813708083
KYSE-180,navitoclax-piperlongumine (1-1 mol-mol),3.2533869345330446
BT 428,6918638,-0.3537388396166394
SK-MEL-3,15547703,3.0069371865015007
RCM-1 [Human rectal adenocarcinoma],53392493,3.4798204288234165
NCI-H1092,navitoclax-piperlongumine (1-1 mol-mol),0.63980848570381
NCI-H1092,53232,4.715701338222689
RPMI-8402,11396600,3.4463493734861186
NCI-H716,46901937,3.750898934979689
BT 428,JQ-1-carboplatin (1-1 mol-mol),-0.3144310627215171
RKO,5351362,1.5688417029382893
KU-19-19,11404337,0.0275069311149896
AML-193,11656518,0.4669898022684433
KHM-1B,3081361,2.464663283347417
SK-UT-1,9933475,2.6906239244816352
AML-193,24797083,0.506330101857892
HDLM-2,156414,0.7266431352631084
IGR-37,11977753,-0.0859241169431114
KMH-2,5311,0.2262898573021068
HDLM-2,168312962,3.041991545246007
BT 232,tanespimycin-bortezomib (250-1 mol-mol),-2.012927947463912
SK-BR-3,11612883,2.33238952555282
BT 228,44507138,3.772225399645668
SK-BR-3,49766530,-0.361082625264213
SUP-T1,25126798,3.654816895962435
MG-63,9911463,4.367195765244299
HCC2108,3025986,-0.2941479125016869
HCC2108,23725625,5.803627153290559
JeKo-1,17755052,3.3491290360740753
KALS-1,3689413,-0.2176182562401838
RCH-ACV,BRD-K27188169-navitoclax (2-1 mol-mol),-0.4738742154532085
SK-BR-3,carboplatin-UNC0638 (2-1 mol-mol),3.8748276296824686
TCCSUP,246676,4.500819346374967
KALS-1,42642645,1.6177449386823612
KHM-1B,65064,3.270159834561764
HCC2108,2858523,2.774928001952886
BT 428,3634881,2.0818785010291654
HGC-27,168312962,-1.1253681849552108
NCI-H647,serdemetan-SCH-529074 (1-1 mol-mol),2.6690095864678014
HDLM-2,73707398,0.2540391654131073
KYSE-180,11404337,-0.9460930401604244
NCI-H716,tanespimycin-bortezomib (250-1 mol-mol),-2.992165698836288
EoL-1,322968,2.010745746975707
BT 245,11497983,3.4938717564559525
HOP-92,24821094,2.840377283658166
SW1116,53232,4.123252621024031
BT 428,46398810,1.87301725051414
SK-N-SH,4917,2.9795044500185046
KMS-26,11507802,0.1381133408633793
HDLM-2,135440466,1.731816567810835
SK-BR-3,3025986,-1.3193206747757422
MG-63,11175137,2.224395078431532
NCI-H2081,docetaxel-tanespimycin (2-1 mol-mol),-5.990158626012855
MG-63,135875424,4.139194892831929
NCI-N87,25183872,-2.1426120555107824
SNU-175,8515,2.468175220100517
BT 239,10385095,0.554561661848966
HT-1197,tanespimycin-bortezomib (250-1 mol-mol),-0.7318651528628731
KALS-1,2746,4.252891034132703
BT 428,11317348,1.729852202559467
BT 228,selumetinib-JQ-1 (4-1 mol-mol),2.3416360255070523
Capan-1,3634881,3.6132154941296815
SUP-T1,5335621,3.7413871665946328
BT 428,decitabine-navitoclax (2-1 mol-mol),0.1303056330200717
KMS-26,148198,-4.824995568216466
HCC2108,navitoclax-gemcitabine (1-1 mol-mol),1.646339925390015
HOP-92,2729026,2.8598779698618255
SCC-25,24748573,-1.0193002912782725
P31/FUJ,56946209,-4.67609529352027
NCI-H647,104842,-1.221988284429078
TCCSUP,9952709,2.608000071984436
HOP-92,9903786,4.828960304549442
NCI-H2009,25062766,1.439977805675878
BT 228,54618795,3.2711933416525056
RPMI-8402,44259,0.5338211517553204
PK-59,24821094,3.619889091404484
HOP-92,15547703,3.507989280248378
AU565,24753719,4.632017214490639
BT 239,613753,3.2023080354919906
KMH-2,5287620,-1.6671599112607127
AU565,9840324,5.90463961449661
NCI-H2081,57519531,0.9438571598062376
BT 228,3384730,2.046923304134837
MFE-319,969516,3.6779916844294744
AML-193,5702613,2.5312946478060137
HARA [Human squamous cell lung carcinoma],9444,4.21141613858085
SK-UT-1,15953870,4.0206121025368216
VMRC-LCD,44819697,-0.2788733381009413
AML-193,73707438,4.279770718051208
SUP-T1,135421197,0.9840092633419462
SUP-T1,72376,-4.00974893922415
YH-13,46926350,-4.088990629945516
RCH-ACV,135999136,3.734219341327072
VMRC-LCD,71466445,3.0345394698478647
BT 428,374536,-2.5752106252331113
RKO,3825829,4.017808531984142
PC-14,24772860,-3.422596924284342
HOP-92,25150857,2.493715264562783
MFE-319,ISOX-bortezomib (250-1 mol-mol),0.3471371446144857
AU565,serdemetan-SCH-529074 (1-1 mol-mol),1.652601677572969
BT 239,6505803,-2.8170451599207733
SIG-M5,11364421,-5.470316093559291
L3.3,12003241,-0.3315333583144895
SW1116,2130404,3.3720651468665253
AML-193,45279963,2.7066153954764554
AML-193,71466445,1.808334525963911
IGR-37,6918638,0.9669989882697694
BT 245,6610216,4.100969243175901
EoL-1,24964624,-2.225697111405004
NCI-H2009,5746,1.7505534195957702
MG-63,44607531,1.630116079019452
SK-BR-3,44489675,3.8697948855287576
KYSE-180,25195348,3.031032559566134
PC-14,46907787,2.390406251773133
NCI-H716,54596558,4.409405401281788
PC-14,656346,0.6979496632306237
KMS-26,3038522,2.8017103173487485
RCC10RGB,54596490,4.957303932772775
NCI-N87,11152667,-0.2953714197447944
HGC-27,24779724,5.013063083172612
BT 245,44607531,1.525096692433067
HGC-27,44185566,1.2932865535846312
IGR-37,24797083,2.9019580428856924
IGR-37,24771867,4.593816018133968
SIG-M5,11494412,0.6608906203269307
SK-N-SH,25126798,4.050510139794063
SK-N-SH,11719255,2.9041919167957007
KMS-26,637858,-0.2587644829981909
P31/FUJ,6610355,3.438139996915945
JeKo-1,6917907,-5.800773106709135
NCI-H2009,135928012,4.098076343567735
HOP-92,11626560,1.343733500020981
WM793,24901704,3.981835922445403
MFE-319,5287969,-1.0232824452566789
MFE-319,44566777,1.182662385496246
NCI-H2081,53232,2.211955699015755
NCI-H2081,65628,3.78371199726488
AML-193,219104,1.8862646982032427
SUP-T1,carboplatin-UNC0638 (2-1 mol-mol),4.5196871738317235
KYSE-450,374536,3.719128608597957
JeKo-1,2729026,2.7554494361122335
SNU-719,sirolimus-bortezomib (250-1 mol-mol),2.0194347248370432
NCI-H647,156414,2.1873385810737043
TCCSUP,5460769,3.7572024912117103
HuH-28,SNX-2112-bortezomib (250-1 mol-mol),0.5167516114082511
VMRC-LCD,613753,3.1174747468404127
HARA [Human squamous cell lung carcinoma],9956119,4.138225192842101
IGR-37,72376,-1.188437436039424
HARA [Human squamous cell lung carcinoma],12001922,1.8002757111950325
HCC2108,10184653,1.422898929180728
NCI-H2081,5329102,1.7214489652710063
SIG-M5,49793307,-2.179552377279903
L3.3,19582717,4.421931624871946
SUP-T1,656346,0.3360986651377137
P31/FUJ,10410894,5.368264014178215
SK-UT-1,11222830,1.0435371315792576
BT 228,10074640,3.0423917596853185
RCM-1 [Human rectal adenocarcinoma],107970,2.147130016699997
VMRC-LCD,25195348,3.6388354014082633
YH-13,448949,1.5692102118953517
KMS-26,2749,1.5488874213348676
TCCSUP,vorinostat-carboplatin (1-1 mol-mol),2.1894231074754185
RCH-ACV,3011155,2.7186231841010686
SK-MEL-3,9907093,4.3652338856541295
BT 428,400769,-1.0780976491085523
NCI-H1092,702558,4.580378170457022
RKO,119607,4.75876667689532
Capan-1,24951314,2.1680837931819146
AML-193,24856436,-1.7097872107919616
HT-1197,10410894,3.785412808638247
SNU-175,doxorubicin-navitoclax (2-1 mol-mol),-2.4487334445522633
SIG-M5,24771867,-2.220706789767579
KYSE-450,72967,3.7351940397417023
PC-14,serdemetan-SCH-529074 (1-1 mol-mol),2.471132541468487
KMS-26,208908,2.1974807480072145
BT 232,5311,2.984076796234112
HARA [Human squamous cell lung carcinoma],82146,4.619283658647928
A3/Kawakami,246676,3.7408216321489256
YH-13,9911830,3.324457602349572
SIG-M5,135659046,3.608194247499591
KHM-1B,54619267,2.762925132943408
BT 245,9884685,1.0158676742482895
HDLM-2,navitoclax-pluripotin (1-1 mol-mol),-4.333695458223547
BT 228,11960529,3.7150962932318854
SIG-M5,5329102,1.1236854879863696
SK-MEL-3,25150857,2.405547367105504
MSTO-211H,vorinostat-carboplatin (1-1 mol-mol),3.1229894172951043
HOP-92,65064,5.2608441730147595
NCI-H647,10410894,3.2773609612368357
BT 239,selumetinib-vorinostat (8-1 mol-mol),0.2511204621924663
NCI-N87,3081361,1.4568926260691408
EoL-1,54626689,2.476018203222032
HGC-27,navitoclax-pluripotin (1-1 mol-mol),-2.080842759055604
MFE-319,1716436,3.800957721302237
SW1116,4259181,0.852960615063059
NCI-H647,11167602,1.715536193581494
HGC-27,10302451,1.8923411487775068
HARA [Human squamous cell lung carcinoma],10113978,3.460603354098383
HARA [Human squamous cell lung carcinoma],104842,-3.702627319243614
BT 428,613753,2.9143775070940268
BT 428,9903786,3.72207082245763
HARA [Human squamous cell lung carcinoma],60750,0.0702005032300629
NCI-H2009,6918736,-2.2815319513344896
L3.3,637858,2.497804094781357
PK-59,doxorubicin-navitoclax (2-1 mol-mol),-0.5069735777128803
JeKo-1,selumetinib-decitabine (4-1 mol-mol),2.727836027546119
SIG-M5,375860,-0.3879584489386603
RPMI-8402,ISOX-bortezomib (250-1 mol-mol),-0.0815647624346699
RCH-ACV,vorinostat-carboplatin (1-1 mol-mol),1.1614397742606404
NCI-H2081,73707438,4.181676139303675
SIG-M5,135440466,1.1787966632350595
SCC-25,11222830,0.992273304961022
SNU-719,11234052,5.4138830702465155
SIG-M5,81146,4.486074956612608
BT 428,24797083,1.0535104552635692
HDLM-2,erlotinib-PLX-4032 (2-1 mol-mol),3.1813556633535325
HT-1197,2828334,5.9196940292611755
BT 245,73707398,1.0043109985849346
NCI-N87,navitoclax-piperlongumine (1-1 mol-mol),-1.185093256857405
SUP-T1,24748573,-0.9919094793960872
SK-UT-1,navitoclax-gemcitabine (1-1 mol-mol),-2.364824391850715
PC-14,25195348,1.7826194825719548
EHEB,JQ-1-MK-0752 (1-1 mol-mol),0.5958653616888636
A3/Kawakami,navitoclax-sorafenib (1-1 mol-mol),1.358591632708254
KMH-2,vorinostat-carboplatin (1-1 mol-mol),1.58568108614195
TCCSUP,241158,3.99107653461265
A3/Kawakami,16038120,1.6835117980507206
KYSE-450,25195348,3.344057018387479
NCI-H1092,piperlongumine-MST-312 (1-1 mol-mol),1.5005628811138385
BT 239,53392493,1.5353222317702424
HARA [Human squamous cell lung carcinoma],638278,3.613202989039307
RCH-ACV,8515,3.0347140209850973
Capan-1,navitoclax-PLX-4032 (1-1 mol-mol),3.6135611560758014
HuH-28,387447,-4.5886015489859435
KMS-26,erlotinib-PLX-4032 (2-1 mol-mol),3.0035307359335133
PK-59,46191454,2.034431145284872
BT 239,navitoclax-piperlongumine (1-1 mol-mol),-3.521652205061859
SNU-719,2729026,1.8232816497721136
SIG-M5,135421197,1.947558909075972
Capan-1,11228183,2.614398442819315
BT 232,216239,3.464570312581102
RKO,24821094,3.7157598247146977
KMH-2,carboplatin-etoposide (40-17 mol-mol),0.7571954359380428
HOP-92,46398810,2.1199754019093913
HGC-27,208908,2.0701569342921777
BT 239,6436223,-4.670538331051868
SK-BR-3,9935249,2.056401078503904
BT 428,5470400,1.3904243607719449
RCM-1 [Human rectal adenocarcinoma],73707398,2.4695798871265473
BT 245,16720766,1.4230320257311897
MG-63,53495165,3.2155543547990706
MSTO-211H,11977753,-3.756718801235006
SCC-25,42642645,0.655225205153659
AML-193,44137675,3.691829225340739
SCC-25,23635314,-1.9631338973427583
HGC-27,57519531,1.7021965554199845
NCI-H2009,135411,0.2253946709705592
NCI-H2009,24180125,3.399696031265864
VMRC-LCD,25126798,4.10429304410039
JeKo-1,56963564,-0.0298851945905445
TCCSUP,72376,-1.3114530344547206
HOP-92,71304818,2.0983100680916382
BT 232,15953870,4.315203211904352
SIG-M5,4578,4.069945051369785
MSTO-211H,3101542,4.302130070317232
KU-19-19,9967941,2.4242338826427794
NCI-H2081,44202524,1.210790184755557
WM793,46224516,3.4822726042013055
HARA [Human squamous cell lung carcinoma],4788,5.847017929418924
SK-BR-3,71751553,4.291196523141903
RCM-1 [Human rectal adenocarcinoma],25227462,1.022239632483553
RKO,441298,2.3183923582018107
AU565,135440466,3.093480574806016
RPMI-8402,11625818,3.525604496213884
WM793,219104,4.075990982755825
AML-193,6852167,1.3321437801414788
AU565,11178236,-4.26632575473861
A3/Kawakami,9866186,-0.4375125966453834
KMS-26,vorinostat-navitoclax (4-1 mol-mol),-0.8191635373615571
EoL-1,51039095,-0.8942787694390282
PC-14,122327,4.862590373540679
NCI-H2081,135411,-0.7766989256852646
HT-1197,9903786,4.0222787047996915
L3.3,16725315,5.215482090576187
BT 239,135875424,2.359781873979594
A3/Kawakami,68056272,3.394980999523467
SK-UT-1,65064,5.311545954072784
NCI-N87,100016,7.118039999797619
P31/FUJ,159324,1.227532336429348
KMH-2,46907787,0.3409672144404854
SIG-M5,54678924,1.645370707088477
NCI-H1092,24856436,2.3450141967184233
MG-63,3025944,5.351332763932989
MFE-319,36314,-4.311015155102992
EoL-1,56646779,2.331905888826058
VMRC-LCD,44185566,2.95813371535898
SIG-M5,3384730,2.264933057045543
SK-N-SH,11977753,0.1926695382371385
L3.3,675434,4.909949648038981
TCCSUP,387447,-4.825347113965475
KALS-1,54678924,2.266383859735997
JeKo-1,25062766,1.3564600764292958
RCC10RGB,46224516,2.231293839634299
KALS-1,262093,3.291549071505813
HuH-28,JQ-1-navitoclax (2-1 mol-mol),-1.5115703129861195
PC-14,4521392,4.078954262243556
PC-14,6918837,-4.156310961446877
RKO,3689413,3.093382349703003
EHEB,10385095,1.253390881214325
SCC-25,9926054,1.6689856093207305
KHM-1B,carboplatin-etoposide (40-17 mol-mol),0.9308702262934592
BT 428,24753719,4.392925021958881
NCI-H647,11612883,2.7727257333373077
SK-BR-3,11497983,4.266820579845918
HDLM-2,10302451,3.39330830228014
HGC-27,5281321,-2.299741804666081
RCH-ACV,124202324,0.425140274633714
KALS-1,24821094,3.5201370742800107
MG-63,3136844,4.156249547370532
IGR-37,409805,5.961933065604735
IGR-37,148198,-3.2890285430700064
JeKo-1,10113978,1.882824753145764
HDLM-2,637858,1.3890823822291447
AU565,104842,-3.8153307910583014
HGC-27,445455,3.852978038845402
SK-BR-3,11178236,-4.544041610178567
HuH-28,doxorubicin-navitoclax (2-1 mol-mol),-1.423099886403624
RCH-ACV,54454,2.013594143671449
BT 245,tanespimycin-bortezomib (250-1 mol-mol),-0.2118058496398642
WM793,10427712,4.81488735871317
BT 228,ISOX-bortezomib (250-1 mol-mol),-0.3492196339369864
IGR-37,4917,2.693915277327
NCI-H647,168313200,2.222361802043905
SK-MEL-3,71466380,2.757819143737033
RPMI-8402,656346,-0.4053079427391535
SNU-719,56946209,-4.079529939556518
KALS-1,tanespimycin-gemcitabine (1-1 mol-mol),-0.8776205546646038
AU565,BRD9876-MK-1775 (4-1 mol-mol),-0.166226177958293
HOP-92,navitoclax-piperlongumine (1-1 mol-mol),0.4265263983748638
HT-1197,4477,-0.1883805163537248
EoL-1,10184653,-0.0810011520604666
TCCSUP,docetaxel-tanespimycin (2-1 mol-mol),-3.3662554716877167
AML-193,navitoclax-gemcitabine (1-1 mol-mol),-3.2153592342510513
NCI-H716,71466578,4.437548482216156
SUP-T1,135411,-0.5274545577034621
L3.3,119182,-1.782056546640076
IGR-37,676352,2.4162033865409587
SK-UT-1,6918736,0.0102936907283031
TCCSUP,24856436,0.0318600345010346
SIG-M5,11167602,1.4551156840002482
HCC2108,104842,-1.1232837273374026
KMH-2,4477,-1.02526806933475
VMRC-LCD,387447,-3.363086673945957
NCI-H2009,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.4079843447100908
IGR-37,6610355,4.673107362690812
RPMI-8402,navitoclax-piperlongumine (1-1 mol-mol),0.631240610078549
HOP-92,56649450,2.985999486427908
RPMI-8402,3136844,6.316630545290792
HGC-27,44507138,1.721131844798839
KMS-26,12001922,1.5310966537372677
RCM-1 [Human rectal adenocarcinoma],46398810,3.3659833177824563
AU565,176870,1.580958212812136
WM793,16720766,1.530656675591024
NCI-N87,46398810,2.1002609832839187
WM793,vorinostat-navitoclax (4-1 mol-mol),2.767153736935034
MSTO-211H,5351362,0.1292531164344693
RKO,65064,4.5178366082525
MSTO-211H,24901704,1.657456360567008
BEN,crizotinib-PLX-4032 (2-1 mol-mol),3.206633584594631
RCH-ACV,73707438,3.9047748245181673
P31/FUJ,54618164,3.783909273991047
MG-63,6918638,1.818394000557256
A3/Kawakami,5291,3.7260491929501
KYSE-180,135440466,2.158709883591087
HuH-28,5311,1.2824721628733302
JeKo-1,2858523,3.053351892739787
L3.3,2729026,3.1026966432102863
NCI-H2081,52947716,1.970928272197099
PC-14,docetaxel-tanespimycin (2-1 mol-mol),-4.510003946272339
SK-N-SH,6917907,-6.2982121532906135
SK-BR-3,serdemetan-SCH-529074 (1-1 mol-mol),1.5641247347710447
SK-UT-1,6450551,2.944918696564172
PK-59,3689413,-0.088836641292159
BT 428,3503,0.957907344028984
HGC-27,16736978,-2.020760517758062
NCI-H2081,12003241,2.480414390654569
SK-MEL-3,3854666,3.3514333338797697
RCM-1 [Human rectal adenocarcinoma],387447,-5.081876711684109
HGC-27,2945648,3.001291472755688
KHM-1B,3062316,-0.287496267646507
AML-193,3503,1.0537152545586077
AML-193,57330099,2.9943878371755783
PK-59,73707438,4.318396616638754
BT 428,10302451,3.296855722335022
AML-193,60750,-4.075711541869279
NCI-H647,9926054,1.878907234482811
WM793,44607530,2.440109588672552
NCI-H1092,BRD-A02303741-navitoclax (2-1 mol-mol),2.482084229088134
KYSE-450,piperlongumine-MST-312 (1-1 mol-mol),1.338613375106185
NCI-N87,5566,2.8110881508350567
PC-14,16013152,4.486002154562109
RCM-1 [Human rectal adenocarcinoma],10385095,1.0940876839597544
TCCSUP,2708,4.555473359535819
KYSE-450,25262965,0.1139193640059102
SK-N-SH,carboplatin-etoposide (40-17 mol-mol),1.0362528741150383
MSTO-211H,9967941,1.8027522151796112
BT 239,carboplatin-etoposide (40-17 mol-mol),1.0425977388639005
SK-BR-3,135928012,3.7159994767081352
NCI-H2009,60700,0.1880080174398503
KMH-2,6610355,4.256977158989411
HARA [Human squamous cell lung carcinoma],9825149,2.481612932411
NCI-H647,441298,3.008330578604314
KMS-26,5287620,-3.048327990707737
NCI-H2009,53232,2.115043522086945
SK-UT-1,3384730,2.824211371066942
SCC-25,44491742,4.077227537084196
SK-MEL-3,decitabine-navitoclax (2-1 mol-mol),5.249595104070457
BT 239,65064,3.2174391975890866
BT 428,1242560,3.758823907284281
Capan-1,navitoclax-birinapant (1-1 mol-mol),1.0191522912614333
SCC-25,16038120,0.3002536599682385
NCI-H647,72376,-2.1842259531636135
SK-BR-3,9887053,3.751749968465411
EoL-1,135423438,-6.8618615828632565
P31/FUJ,11396600,3.188193103342261
SK-N-SH,24951314,0.8938602009359505
RCM-1 [Human rectal adenocarcinoma],6918878,1.3044693080210874
NCI-N87,2733487,6.3981873446173285
BT 428,46174525,1.8458447975466572
SK-N-SH,6505803,1.028408820078618
NCI-H647,54618771,1.14773606602027
SCC-25,3038522,2.8542248857530113
NCI-H716,71304818,2.355826084916689
KHM-1B,135398516,0.0363584972585632
AML-193,23635314,-2.882868286504265
PC-14,3136844,4.323237919355452
RCC10RGB,2708,5.228545547030361
HGC-27,1750826,-2.8458434314396115
WM793,10231331,2.277080944837622
NCI-N87,1239801,5.115918121174403
SIG-M5,54765302,4.74907446613913
IGR-37,644241,2.2341406718555814
AU565,71729975,2.800801196457704
AU565,446155,4.298434988536317
SNU-719,9911463,3.4585682156791555
MG-63,25227462,2.9570302562230184
SK-BR-3,5335621,5.286301388559446
HuH-28,44259,-1.1249030720385569
NCI-H2009,5978,-2.257242885332271
AML-193,19582717,4.265779856964878
Capan-1,3062316,-0.8221277233615402
HARA [Human squamous cell lung carcinoma],44202524,1.300312464104863
L3.3,44137675,3.3686484205760783
SIG-M5,selumetinib-navitoclax (8-1 mol-mol),-3.232524252942175
JeKo-1,753704,3.540716531939119
HOP-92,3689413,-2.4488363425715076
JeKo-1,11497983,-3.3673964302473087
SK-UT-1,selumetinib-JQ-1 (4-1 mol-mol),5.500503252581381
KHM-1B,24775005,4.409922848852168
P31/FUJ,5113032,4.875284905433655
HuH-28,6917907,-6.93418379001103
NCI-H2009,selumetinib-decitabine (4-1 mol-mol),-0.75536294855302
RKO,11612883,3.106052261550285
RCC10RGB,46191454,4.887818963424851
Capan-1,9866186,2.144909924490332
PC-14,SNX-2112-bortezomib (250-1 mol-mol),-3.312261812996962
SUP-T1,46907787,-1.0799760028641845
RCC10RGB,ISOX-bortezomib (250-1 mol-mol),1.8255695347909304
SNU-719,alisertib-navitoclax (2-1 mol-mol),-1.750044537449145
RCH-ACV,15983966,-5.342152754294977
KHM-1B,36462,-0.5615447034427615
NCI-H2009,104741,-5.941055510927969
RCC10RGB,2858523,3.1824977664847833
SNU-719,54619267,6.416305867244571
MSTO-211H,439501,-1.1644309958543906
BT 239,5284616,2.257948561490005
SIG-M5,54143018,0.9300695098607992
P31/FUJ,selumetinib-decitabine (4-1 mol-mol),-0.417260560947631
KALS-1,24785538,3.1175979480531435
VMRC-LCD,60700,1.6109767519306728
EoL-1,462382,-0.105332149579201
BEN,BRD-K16130065,4.206876741952794
YH-13,10231331,5.93947704147761
HCC2108,11178236,-3.6455661628602742
PK-59,675434,4.323322110216469
Capan-1,11717001,4.598409217972395
JeKo-1,31703,0.0222460563222861
TCCSUP,444795,5.142441230913875
NCI-H647,16720766,1.0898244954694405
RCH-ACV,BRD-K55473186,2.8342902689002782
TCCSUP,44607531,1.6121278568791757
NCI-H2009,10074640,3.329342225437922
MSTO-211H,445643,1.8400808237063873
BT 239,2842253,6.361656121785149
SK-BR-3,4096211,1.4563869141695764
HuH-28,262093,3.3718876693981175
BT 245,decitabine-navitoclax (2-1 mol-mol),-0.3555263751398617
HARA [Human squamous cell lung carcinoma],4261,3.400371454492322
PK-59,136227924,3.43326158684526
SIG-M5,4378219,1.9811797818384451
WM793,984333,0.8846427573574175
VMRC-LCD,2858523,2.6889992436432397
AML-193,25105715,3.5297696158847
NCI-H2081,71466445,4.38598643785932
AU565,6184667,2.5363760520525247
NCI-H2009,10302451,1.2105403110698565
P31/FUJ,65064,5.109694638799521
EHEB,216345,1.2200668921328206
NCI-H1092,navitoclax-pluripotin (1-1 mol-mol),0.8124337915703985
MSTO-211H,docetaxel-tanespimycin (2-1 mol-mol),-6.863228932141716
KYSE-180,9887053,4.517108897198139
Capan-1,10385095,2.965633532815102
SUP-T1,selumetinib-piperlongumine (8-1 mol-mol),2.473058453380001
SK-N-SH,navitoclax-gemcitabine (1-1 mol-mol),-3.273924669365007
HARA [Human squamous cell lung carcinoma],441298,0.3301976976056055
SUP-T1,54619267,3.057965406377237
WM793,16065773,2.8314108092374
JeKo-1,navitoclax-gemcitabine (1-1 mol-mol),-3.674227326202149
NCI-H716,375860,0.0273336501108971
AML-193,5351362,0.9173486676897408
AML-193,sirolimus-bortezomib (250-1 mol-mol),0.7759141374550513
AML-193,54143018,-0.9159459021050996
PC-14,11213558,0.2378242160835004
HT-1197,49846579,1.6716618831204737
BT 245,11396600,2.7099317658056927
MG-63,9803433,5.695257668262412
HARA [Human squamous cell lung carcinoma],72376,-2.3262904878865083
AU565,5278396,3.257778157431963
KMH-2,2729026,1.9828733907594425
NCI-H1092,72376,-1.2021536382065705
AML-193,56946209,-4.813620627566033
SNU-175,selumetinib-decitabine (4-1 mol-mol),-2.8711938873217897
L3.3,36314,2.044128713808568
EoL-1,56963564,-0.6381222350148184
SIG-M5,4917,3.801710905093952
BT 228,25126798,4.153548041547734
TCCSUP,5566,3.1120135973832386
EHEB,374536,2.309110674045564
L3.3,25262965,-0.71498955679679
NCI-H2081,7251185,1.1327722028105756
SIG-M5,10302451,3.7315924612449134
RCM-1 [Human rectal adenocarcinoma],54618771,0.5185720985561021
HGC-27,11175137,0.6426067405917641
RKO,52947716,-6.611161073849914
NCI-H647,16065773,2.614848101385591
NCI-H2081,BRD-A02303741-navitoclax (2-1 mol-mol),1.572790594213783
MSTO-211H,23725625,2.234746785874409
SUP-T1,66577038,2.983560495780086
RPMI-8402,11222830,1.5559026788898014
SUP-T1,3634881,2.626070811694409
L3.3,11175137,3.713617877823204
PK-59,5351362,2.762271541017513
KMS-26,5280436,3.68915237550207
YH-13,9884685,0.7618617096747208
BT 232,702558,5.028818733375539
RCM-1 [Human rectal adenocarcinoma],navitoclax-gemcitabine (1-1 mol-mol),1.5505113720092498
NCI-H647,54596558,4.357381651282546
SUP-T1,6918878,-0.6268463953057096
AML-193,5746,-0.3479804309348192
RPMI-8402,52912189,0.4974334242941066
KHM-1B,5351362,0.671182618644872
AU565,navitoclax-gemcitabine (1-1 mol-mol),-2.716980570642507
IGR-37,25154868,5.082482124939083
P31/FUJ,66577038,3.0536576112540916
IGR-37,46191454,2.5055335496688658
PK-59,46174525,4.871380850283114
HOP-92,72376,0.5730367953440298
VMRC-LCD,JQ-1-MK-0752 (1-1 mol-mol),1.4282858464211865
BT 232,SNX-2112-bortezomib (250-1 mol-mol),-2.880920314589382
P31/FUJ,53232,3.343897726239282
NCI-H2081,crizotinib-PLX-4032 (2-1 mol-mol),0.7820959087513495
NCI-H647,4261,0.9478676963318644
WM793,25195348,2.400822719494433
PC-14,100016,6.551425062945198
PC-14,24779724,4.4167236388652364
P31/FUJ,4261,-0.12536828191131
BT 228,5470400,-1.6037773096977788
BT 228,10302451,3.762994795422787
HDLM-2,selumetinib-piperlongumine (8-1 mol-mol),3.881331181955644
SUP-T1,carboplatin-etoposide (40-17 mol-mol),0.6401873984593939
AU565,6918638,0.3564513775218086
RCM-1 [Human rectal adenocarcinoma],637858,2.624063294513633
IGR-37,25195348,3.352878102344857
SW1116,56946209,-4.718429275744117
HOP-92,400769,-0.8524985582549023
HGC-27,119182,-1.7001979173689332
HCC2108,3815108,3.7436297083403938
BEN,25126798,4.405899950982828
MFE-319,11234052,4.559403195951768
KALS-1,11222830,1.6551310522089124
VMRC-LCD,42642645,-0.9727939003733428
BT 228,5978,1.610433335303923
HOP-92,BRD-A02303741-navitoclax (2-1 mol-mol),0.7360545036264873
JeKo-1,3385,1.9512937434961737
KMH-2,135440466,2.7627804900872266
RPMI-8402,24785538,0.0064852246301263
HGC-27,5287969,-1.7794366906005237
NCI-H716,72193861,1.3287137383304275
SK-MEL-3,2708,5.344714114373152
BT 239,BRD-K55473186,1.8009129748765509
BT 428,JQ-1-MK-0752 (1-1 mol-mol),-0.1467022602363411
JeKo-1,46398810,1.86225395569912
AML-193,46224516,1.8716574199888352
KHM-1B,148198,-5.169783546510426
SK-BR-3,1716436,1.7727999999856203
KHM-1B,638278,3.418404486503754
SK-MEL-3,462382,1.013612735098144
IGR-37,6917907,-5.0520895724436325
KALS-1,44137675,3.7039719175629258
BT 428,25062766,2.445496816920869
NCI-H2081,9444,4.107001529584513
EoL-1,1716436,1.6530628681775867
NCI-H2081,46224516,0.9232346266515704
BT 428,10127622,0.916398468380164
KMH-2,52912189,0.6759981038988053
EHEB,2828334,6.1224071915617735
MG-63,JQ-1-navitoclax (2-1 mol-mol),0.4108982513728119
BT 232,25161177,3.748670274677706
BT 232,54596490,5.37904940780473
SW1116,156414,1.6393126370911288
Capan-1,SNX-2112-bortezomib (250-1 mol-mol),0.376129092904322
IGR-37,24180125,4.183476947530839
SCC-25,44137675,1.9982871613841056
VMRC-LCD,637858,1.7836003197528063
NCI-H2009,5113032,6.328717344861362
BT 228,navitoclax-piperlongumine (1-1 mol-mol),0.8838283832907398
NCI-H1092,67156097,2.7476633426389863
KALS-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.613841457820584
HGC-27,6252,1.7137140422575865
EHEB,135411,-0.07398268976703
MG-63,46199207,3.4640975933718043
BT 232,doxorubicin-navitoclax (2-1 mol-mol),-2.096273957242618
AU565,2858523,2.8415967437488443
NCI-H647,1239801,4.543868879457951
NCI-H716,26596,0.0248584598201427
EoL-1,54678924,1.286717574478855
KALS-1,2858523,3.462089700083376
JeKo-1,44202524,1.3516148211310646
NCI-H647,46191454,1.7105873880989968
NCI-H2081,44137675,3.995852216137384
HuH-28,54618771,1.3880976899184387
NCI-H2081,702558,5.114835001496795
MG-63,6438330,1.9742130144931391
EHEB,24753719,3.508920403296929
NCI-H716,31703,1.35294993677711
KALS-1,10410894,3.659285633376007
AML-193,104842,-5.323514959067951
HT-1197,123631,3.470784595123611
NCI-H647,navitoclax-MST-312 (1-1 mol-mol),0.980680929478178
RPMI-8402,25062766,1.273126044843805
KYSE-450,5566,4.0898855069679785
HGC-27,151289,0.3987729432700477
A3/Kawakami,119182,-2.6914891584440777
HDLM-2,452548,-1.0469652263728562
HCC2108,5329102,2.0081576367450964
RCH-ACV,57330099,4.596668653056905
HCC2108,168313047,3.002355785890527
RCH-ACV,176870,3.178202051213816
RPMI-8402,54454,1.386864337432023
EHEB,3025986,-0.9608953944291202
MG-63,5281672,5.126504370605709
EoL-1,10231331,-2.1863910131139326
A3/Kawakami,11707110,2.5947795299140264
KALS-1,2113511,5.871557310203855
KU-19-19,452548,1.4010535434747853
HDLM-2,4788,5.611914483000877
KMS-26,46907787,-2.97816119814664
HARA [Human squamous cell lung carcinoma],tretinoin-navitoclax (4-1 mol-mol),0.6020182307201102
EHEB,107970,2.1350318268920776
HDLM-2,71466445,2.6757992406645505
NCI-H1092,36462,1.746172568826328
TCCSUP,702558,5.6887223150764035
KHM-1B,66577038,2.058186544179473
Capan-1,135421197,1.617926303344926
VMRC-LCD,6918736,-3.5539614576536778
KYSE-450,44566777,1.0165509502605254
HuH-28,selumetinib-UNC0638 (4-1 mol-mol),3.738196860532696
HGC-27,6918837,-4.407826937404899
BT 428,1239801,5.0858766726357985
AU565,JQ-1-vorinostat (2-1 mol-mol),0.9003268678800701
HCC2108,44484440,3.875901941244504
TCCSUP,122327,4.306454567710715
AML-193,11707110,-3.4607630849723403
JeKo-1,107985,-3.6689778441734777
KHM-1B,6918878,3.029851495909813
AML-193,446155,3.130682728451949
KHM-1B,67291369,-0.148329679394903
KMS-26,selumetinib-navitoclax (8-1 mol-mol),4.602108368638831
HARA [Human squamous cell lung carcinoma],135411,-0.5831763791629045
HuH-28,2708,4.96017019279685
BT 428,445091,4.296908052102406
JeKo-1,11238147,2.924885924890673
KHM-1B,25126798,3.5572512627861053
WM793,5470400,2.631713444324304
JeKo-1,carboplatin-etoposide (40-17 mol-mol),3.1675115392358766
HGC-27,navitoclax-birinapant (1-1 mol-mol),1.262905551205713
HT-1197,24964624,3.0917732806837055
BT 245,16722836,1.659253387533303
NCI-H2081,2871966,0.7006851296353342
KALS-1,25154868,5.435638768460365
NCI-N87,25150857,2.476373943211786
KYSE-180,168312962,3.1351492164159045
MFE-319,5278396,3.953472378026313
EHEB,selumetinib-GDC-0941 (4-1 mol-mol),0.6698070674262858
Capan-1,5328940,2.2672478320164497
AML-193,4788,3.908061400556029
A3/Kawakami,5328940,1.7120435941360743
BT 239,54618795,3.095943677116927
KYSE-180,24856436,3.3632320307562185
P31/FUJ,25154868,4.728907139536709
NCI-H716,126941,-4.642353846734587
SK-UT-1,5351362,2.3369266208176556
KYSE-450,219104,4.59986524517568
A3/Kawakami,56949517,3.8717037276163793
KALS-1,2841722,4.620534945057791
TCCSUP,24772860,-2.3994622500716503
SK-UT-1,24964624,3.065767628621786
HARA [Human squamous cell lung carcinoma],5566,3.127581032716584
RKO,5328940,1.7974237645790871
SK-BR-3,25262965,-2.9113228379304825
KYSE-180,2742550,4.361413861886047
AML-193,73707371,2.164482229688541
A3/Kawakami,16013152,3.65671304304695
NCI-N87,4259181,-0.3128226187706996
HCC2108,638278,3.3485085363474285
SK-N-SH,71680916,4.4115643313831265
BT 239,9935249,0.5202539451214898
HDLM-2,44185566,1.1751606253391182
BT 239,selumetinib-MK-2206 (8-1 mol-mol),1.505990010931873
NCI-H716,1566236,2.5544710796905044
RCM-1 [Human rectal adenocarcinoma],7326481,3.471788060157272
NCI-H647,11228183,2.982149489464041
RKO,24964624,3.0430796891613903
RPMI-8402,135411,-0.7281276056296015
KALS-1,24748573,2.4305597462441333
KYSE-180,135398516,2.6781533642805933
NCI-H2081,44185566,0.8061811733567802
SCC-25,11175137,1.848946756069019
HGC-27,3503,0.9998398072890542
SK-UT-1,135398738,5.687512813913111
SK-MEL-3,carboplatin-etoposide (40-17 mol-mol),4.279599548431094
IGR-37,156422,4.587034792202124
KMS-26,46224516,1.724637659245213
BEN,9915743,3.139870035792778
HARA [Human squamous cell lung carcinoma],1641662,3.0207416829742058
SIG-M5,6917907,-5.826713963760937
RCH-ACV,54143018,-1.1815834166936812
PK-59,72193861,3.077938122785057
A3/Kawakami,6505803,-0.1184666814431136
KU-19-19,6610355,5.477302473020379
SK-UT-1,25062766,3.896240815707035
NCI-H716,462382,0.1356158939777434
RCH-ACV,9915743,0.3296075403381741
NCI-H716,15953870,4.3589430553409185
HARA [Human squamous cell lung carcinoma],656346,-0.3153592740671193
RCC10RGB,11364421,1.2845393833467151
MSTO-211H,3689413,-2.1873545800685865
EoL-1,3854666,-0.2024908872180563
RCM-1 [Human rectal adenocarcinoma],11964036,2.7270949198537195
RKO,9444,4.448790979485227
TCCSUP,9840324,5.608027140401768
EHEB,3062316,0.0300315004197751
TCCSUP,262093,2.756857712955527
KU-19-19,23725625,4.865374475902274
NCI-H647,11175137,2.2007611483969587
RCH-ACV,71466445,1.275442483005524
L3.3,67156097,-1.9530361511710264
KALS-1,984333,1.1842181918309762
SCC-25,selumetinib-PLX-4032 (8-1 mol-mol),0.5690865113569565
NCI-H2081,5470400,-3.843190665542197
P31/FUJ,241158,2.9181679480161997
AML-193,55508,1.9868546918370436
MFE-319,53392493,3.3304498516843535
HuH-28,44507138,1.5518286260410368
SK-BR-3,445643,3.724729411499146
KALS-1,11640390,5.157811135598342
L3.3,9903786,3.5860218860878263
L3.3,11640390,3.7293417266479905
PK-59,107970,2.298393992220364
JeKo-1,72199292,1.0867198362805237
KYSE-450,65064,5.6341173249680345
P31/FUJ,11404337,-0.879305702132212
RKO,11964036,1.8153618806471208
SK-MEL-3,3025986,0.2271216307397203
SK-BR-3,tanespimycin-bortezomib (250-1 mol-mol),-1.1582465529639416
EHEB,100016,6.596024177667571
JeKo-1,11364421,-5.909388672331507
AU565,doxorubicin-navitoclax (2-1 mol-mol),-1.8766069789082105
WM793,49850262,4.533978488158691
HGC-27,439501,-3.477587502070629
RPMI-8402,135440466,1.4460433008351892
NCI-H647,5329102,1.7335425609344843
A3/Kawakami,44491742,3.8621679307370953
HOP-92,441298,1.6850645889585818
BT 239,9936388,1.03619999927196
RCM-1 [Human rectal adenocarcinoma],5746,1.2509488539194744
NCI-H2081,16065773,2.352319766762804
PC-14,11175137,2.2075577694334103
BT 428,4477,0.4418546409842698
NCI-H1092,11507802,0.7710347538539816
SK-MEL-3,44185566,2.884811804112233
SK-N-SH,11238147,3.403396694980768
AU565,6610216,3.647426232490327
SK-BR-3,4259181,-0.0321422954421751
NCI-H1092,6438330,0.9695610451657
BT 245,selumetinib-decitabine (4-1 mol-mol),6.897297339382343
JeKo-1,52947716,-3.821364035289773
HARA [Human squamous cell lung carcinoma],24785538,-0.0579889747329333
KALS-1,serdemetan-SCH-529074 (1-1 mol-mol),2.3710406080193853
NCI-H2081,1641662,3.083642159017046
WM793,tanespimycin-gemcitabine (1-1 mol-mol),-0.8794425804429231
HGC-27,135398516,-0.6790121267559199
SK-MEL-3,421610,1.7899954995973413
AU565,4096211,1.4857810053347718
BT 245,24901704,3.4690715705542416
NCI-N87,168312962,2.346349065468924
HARA [Human squamous cell lung carcinoma],9866186,-0.525705997781229
YH-13,25062766,1.542076592026761
BT 245,navitoclax-piperlongumine (1-1 mol-mol),0.2591253706551492
KALS-1,9884685,0.3630123980894349
P31/FUJ,656346,-0.3707458386499477
PK-59,6610216,4.292036954059538
KMS-26,serdemetan-SCH-529074 (1-1 mol-mol),1.3719320923020462
HT-1197,16038120,1.4860566918877516
HARA [Human squamous cell lung carcinoma],JQ-1-navitoclax (2-1 mol-mol),2.200588179814963
NCI-H1092,44202524,3.663544570122555
KYSE-180,168313047,3.1175173804941307
RKO,16065773,3.3120716405166615
HGC-27,10296883,3.371644583045061
EoL-1,374536,-1.7433445254821776
VMRC-LCD,erlotinib-PLX-4032 (2-1 mol-mol),3.653736661029392
SCC-25,25102847,1.8118946016134436
Capan-1,25150857,2.941877679789578
KALS-1,2126,5.264406447927796
NCI-H716,54618305,4.001171648016114
SK-UT-1,5566,3.086414513691759
L3.3,11178236,-1.5128667899079982
KMH-2,docetaxel-tanespimycin (2-1 mol-mol),-4.953459019568371
MSTO-211H,25102847,1.842661618149511
SK-BR-3,9911463,3.827340075959426
Capan-1,45279963,5.461431726659015
RCH-ACV,637858,0.8093595227428888
HT-1197,23725625,4.56956088946172
KALS-1,216239,3.408580336104845
HDLM-2,151289,-0.7419604478541427
HT-1197,9933475,2.7618174201584957
BT 428,2708,3.3990260220989983
HT-1197,44566777,1.1989195237383017
HT-1197,6917907,-6.949875580644214
HCC2108,9903786,2.237017286795856
JeKo-1,5329102,1.8782949381772711
MG-63,16065773,2.3735127012493296
BT 232,11612883,4.370339005352012
IGR-37,11396600,3.951317160447081
RCH-ACV,44819697,4.498833207638388
HDLM-2,54613361,-1.2881449899054014
HuH-28,135440466,0.9279061873692512
HARA [Human squamous cell lung carcinoma],71304818,2.9544117211144147
NCI-N87,44486093,4.414725106733636
PC-14,6184667,3.393270938692378
SNU-175,71304818,1.818515390405273
IGR-37,1714884,1.932026921052337
SK-BR-3,4261,0.9219345316014232
BT 245,66577038,2.2166864722744157
TCCSUP,568763,0.1575730969992337
RCC10RGB,selumetinib-navitoclax (8-1 mol-mol),2.731385168920209
A3/Kawakami,vorinostat-navitoclax (4-1 mol-mol),0.6366238647661099
SUP-T1,BRD-K55473186,4.200956026660112
EHEB,4378219,1.3108988632273402
KYSE-180,51039095,3.462973951569757
BT 232,25126798,4.357441453124137
SUP-T1,2828334,5.73361256935546
NCI-H2081,45279963,2.492987124324476
HARA [Human squamous cell lung carcinoma],5311,2.3146371221244184
SUP-T1,23725625,2.687077446275733
SNU-175,49850262,3.219717091813884
AML-193,11657048,3.860818612232192
SK-UT-1,docetaxel-tanespimycin (2-1 mol-mol),-3.9315857495546735
KALS-1,BRD-A02303741-carboplatin (1-1 mol-mol),3.186935558155361
MG-63,10296883,4.161966556004564
YH-13,9903786,3.849279075978848
KMS-26,451668,-3.3568106041329404
EHEB,409805,3.764078268707581
HOP-92,51039095,3.330389221655758
RKO,11427553,3.456895276763714
JeKo-1,216345,3.4869647689055747
IGR-37,46224516,2.0085796793178297
L3.3,969516,2.9670664389679677
BT 245,285033,-1.4017098727124946
BT 228,alisertib-navitoclax (2-1 mol-mol),1.7273605069067173
BT 239,16725315,3.2967766702627577
VMRC-LCD,136227924,2.9641387298533868
AML-193,11485656,-1.7272529013303597
BT 232,44241473,4.409909383747932
KYSE-450,2858523,3.2293705558979813
PC-14,156422,2.966030422722191
NCI-N87,3815108,3.1427265495234513
BEN,2858523,3.283020822993544
SNU-175,25183872,0.4564062418112697
BT 239,44486219,4.298482101948936
TCCSUP,9911830,2.7321009507297727
SW1116,serdemetan-SCH-529074 (1-1 mol-mol),2.082066333820028
HGC-27,JQ-1-UNC0638 (2-1 mol-mol),0.4820693582404344
HuH-28,16722836,0.5843594711011912
NCI-H1092,285033,-2.138341448649312
SK-MEL-3,168312962,3.08140039207503
L3.3,9956119,3.8207787288773063
SNU-719,4259181,-1.3711079243063935
RCH-ACV,11455910,1.239951006790748
KYSE-180,24951314,1.8172088790949268
WM793,123631,2.8618988617204253
NCI-H2081,9549297,1.131692292209531
SNU-719,446155,1.2634047338573389
YH-13,25126798,3.838421818647453
NCI-H716,44632017,1.5674967865426792
NCI-H2009,969516,2.7623608328977314
WM793,675434,6.301966569766523
EoL-1,11222830,0.2620624132665743
RCC10RGB,439501,-2.548266242367821
SW1116,6852167,3.995945836747335
NCI-H716,24856436,0.8481578014281793
EoL-1,216345,-0.1625493260233451
BT 239,10231331,1.4016139195268935
SIG-M5,16722836,0.995040246315532
EHEB,11364421,-3.039867247755455
SK-N-SH,selumetinib-decitabine (4-1 mol-mol),3.902984186782925
RCH-ACV,selumetinib-GDC-0941 (4-1 mol-mol),0.9468989618385945
IGR-37,44202524,1.705914828657736
SK-N-SH,16722836,1.2873041413773267
IGR-37,25150857,2.1803042996242454
HDLM-2,24978538,-1.5481692655983714
NCI-H2081,23725625,3.532612655790426
RPMI-8402,6438330,0.7880942350044629
PC-14,44202524,1.5372693250421796
PK-59,crizotinib-PLX-4032 (2-1 mol-mol),1.9792405847759436
SNU-175,JQ-1-navitoclax (2-1 mol-mol),-1.612257403150792
AU565,53392493,1.7262495119460306
NCI-H647,4521392,4.2841218310994424
RPMI-8402,11960529,3.6383383692562346
Capan-1,5566,3.1951411956308924
WM793,56649450,6.114929722972158
AML-193,2828334,8.010751837070458
HT-1197,9907093,4.546734047479066
RPMI-8402,25262965,-1.3755591839443129
BT 428,selumetinib-JQ-1 (4-1 mol-mol),-0.8814562357404941
YH-13,11640390,4.546437350580995
SNU-719,613753,4.049929920683692
BT 239,3552672,1.0002772544844791
MSTO-211H,4261,1.9115438043118669
TCCSUP,9911463,4.056352676279941
SIG-M5,sirolimus-bortezomib (250-1 mol-mol),0.1286056255448012
BT 239,5280436,3.6457436339308327
HOP-92,6918328,-1.1914337763050131
MG-63,5281321,-0.6543860766165706
AML-193,11494412,-0.7844966821773789
BT 245,9933475,1.6459708164616211
MSTO-211H,400769,-2.118881346037636
SIG-M5,tretinoin-carboplatin (2-1 mol-mol),-2.632061508071635
AU565,3634881,4.304518749556461
KYSE-450,docetaxel-tanespimycin (2-1 mol-mol),-3.366078664284114
SNU-719,136227924,2.577096412948206
HOP-92,10296883,4.19032829919567
P31/FUJ,135411,-0.6620772647112111
HGC-27,51039095,1.9600515797309075
NCI-H2081,241158,4.1289817617864575
EHEB,6918837,-4.415870025794879
KALS-1,6450551,3.5286143047169514
RCC10RGB,25105715,3.76392637454814
PC-14,15983966,-5.390386977647823
RPMI-8402,36314,-5.184903454293672
HuH-28,17755052,2.9286907011855168
SCC-25,10427712,3.3656818954950785
AU565,10385095,1.377392665812461
BT 428,3081361,1.5863318204290036
SK-UT-1,4521392,4.374260531561281
NCI-H2081,11178236,-4.898241631670769
BEN,JQ-1-navitoclax (2-1 mol-mol),0.3726717071466982
HOP-92,7251185,2.0997369163345487
P31/FUJ,57330099,4.216278217816623
MSTO-211H,11717001,4.186640197436745
HOP-92,11178236,-4.16716135318997
SW1116,selumetinib-PLX-4032 (8-1 mol-mol),0.4271602580748421
KALS-1,SNX-2112-bortezomib (250-1 mol-mol),-3.4281686274078087
RCM-1 [Human rectal adenocarcinoma],11152667,-0.80003376539758
TCCSUP,448949,2.8809822031870778
SIG-M5,56946209,-4.7925532661278485
HT-1197,135659046,3.3219776451446923
VMRC-LCD,3689413,-0.1897073669297062
HuH-28,654092,-0.1115393399354003
KMH-2,5113032,5.224680794267088
NCI-H2009,selumetinib-JQ-1 (4-1 mol-mol),-2.491953444120814
YH-13,5329102,1.6719454710321933
RPMI-8402,selumetinib-piperlongumine (8-1 mol-mol),3.6428960314111936
SIG-M5,6918736,-1.1503224023127576
AML-193,11175137,2.2181667433971755
SIG-M5,107970,2.1274244329826417
PK-59,3634881,4.345814467593551
MFE-319,56963564,0.8247632400549254
P31/FUJ,6610216,4.336076332167018
HGC-27,135421197,0.8927042884556606
BT 228,9911463,2.83539892477779
PC-14,BRD-K27188169-navitoclax (2-1 mol-mol),0.9936418350863891
JeKo-1,tretinoin-carboplatin (2-1 mol-mol),4.269505438778677
HDLM-2,5311,0.7736288561382163
BT 239,10322450,3.395640435178443
RCM-1 [Human rectal adenocarcinoma],selumetinib-JQ-1 (4-1 mol-mol),0.8519093027045113
BT 239,216239,1.729143199677776
NCI-N87,9952709,5.048469263792704
NCI-H2081,445455,4.231009644823477
RCH-ACV,409805,3.911784107181204
MG-63,19582717,4.622286264200632
Capan-1,11977753,0.8400592134793909
MFE-319,BRD-A02303741-navitoclax (2-1 mol-mol),3.5953067983493456
BT 245,24775005,3.45379033795863
HARA [Human squamous cell lung carcinoma],vorinostat-navitoclax (4-1 mol-mol),1.9090977342000552
KYSE-450,4788,5.909868922921636
RCH-ACV,11238147,1.7572163151431777
KHM-1B,68056272,3.2538841376284973
NCI-H2081,36462,-1.2215520528836945
NCI-H2081,9915743,0.926591953046768
EoL-1,4788,2.796073298666351
EHEB,44819697,-0.6865336192844265
BT 232,5328940,1.941175339723819
MFE-319,7326481,2.2769187482253725
TCCSUP,42642645,1.035198778312657
SUP-T1,53232,3.382612871246101
BT 228,11964036,2.5310936830878803
HOP-92,5746,2.852044269543689
NCI-N87,54618771,0.8863121899707505
TCCSUP,31703,-0.5078441003760595
BT 232,JQ-1-navitoclax (2-1 mol-mol),4.8176767786200765
MSTO-211H,11656518,-2.9147381038014095
SIG-M5,carboplatin-UNC0638 (2-1 mol-mol),3.106944398706879
IGR-37,BRD9876-MK-1775 (4-1 mol-mol),0.974552105676193
HuH-28,24856436,4.093000706970363
MG-63,erlotinib-PLX-4032 (2-1 mol-mol),4.017033660110712
NCI-H1092,tanespimycin-bortezomib (250-1 mol-mol),0.328880127360426
KHM-1B,984333,-0.473471772340059
RPMI-8402,448949,1.5294232598853288
TCCSUP,89928392,1.641879388054528
SIG-M5,72376,-4.374171411679185
HOP-92,676352,1.70729490983168
EoL-1,SNX-2112-bortezomib (250-1 mol-mol),-5.541290379404506
SNU-719,15983966,-0.4890430936246725
SK-MEL-3,16720766,1.6771930105471904
EoL-1,6918837,-7.92691188939158
BT 228,54596558,3.926545581110017
IGR-37,3038522,2.396643680288265
MSTO-211H,doxorubicin-navitoclax (2-1 mol-mol),-1.8407653022035375
BT 239,7251185,1.366551480685554
NCI-H2081,tanespimycin-bortezomib (250-1 mol-mol),0.018908734219335
SUP-T1,637858,0.5136167225072658
EoL-1,176870,1.1921773982843933
VMRC-LCD,72734382,4.33269964228104
Capan-1,156422,4.318134575433505
NCI-H716,6918837,-1.948991520241825
BEN,168313047,2.1774574728380744
SNU-719,676352,2.2251634095270236
NCI-H2081,56963564,0.1641201817536982
HOP-92,44607531,1.4701343976445995
HARA [Human squamous cell lung carcinoma],448949,2.536052822584039
SCC-25,46191454,0.9992042972815424
AML-193,25150857,1.9335964933761656
WM793,3543504,4.269438666760458
PK-59,10074640,3.125062946800061
EoL-1,5335621,3.205144058846969
AU565,148124,-5.63717967948206
EoL-1,2874250,3.0350183366586356
AU565,227681,3.7153411694983887
HOP-92,11222830,1.782851486631402
BT 245,5351362,1.446473574669942
NCI-H2009,JQ-1-MK-0752 (1-1 mol-mol),0.489585373897599
BT 232,4477,0.0104275778818603
NCI-H647,6505803,-1.8408777306089303
NCI-H716,9936388,-4.976580043871955
P31/FUJ,navitoclax-MST-312 (1-1 mol-mol),-0.1859808943498902
SUP-T1,3689413,-3.2638224504497195
RCC10RGB,44202524,4.922768729279552
SIG-M5,54618771,-0.4946927468469176
HuH-28,9866186,1.631947436587495
HDLM-2,168313047,1.88256113554016
HuH-28,135875424,3.694475868133385
VMRC-LCD,6918328,-1.6598404522872343
SK-MEL-3,44607530,1.1197128401399183
BT 232,135440466,3.178819635259247
BT 228,16038120,0.8948088249655233
SK-BR-3,71729975,2.4880113649696365
SK-UT-1,6918638,1.3984076220807655
HARA [Human squamous cell lung carcinoma],8515,3.1956320485149265
A3/Kawakami,19582717,2.2926924801738955
NCI-H716,285033,-0.9972671635832154
EoL-1,1750826,-3.4954975324534208
HOP-92,piperlongumine-MST-312 (1-1 mol-mol),1.5718891198302938
IGR-37,136227924,2.9944260233382667
HuH-28,selumetinib-MK-2206 (8-1 mol-mol),2.8302377311516023
HT-1197,3062316,2.4507585021340126
RCM-1 [Human rectal adenocarcinoma],17755052,4.178055403408082
NCI-H716,9840324,7.149462111428474
KMH-2,46191454,0.7646488495082653
PK-59,9956119,3.699648332900661
HDLM-2,tanespimycin-gemcitabine (1-1 mol-mol),0.1599493979743506
KYSE-450,11640390,4.647540881608271
HGC-27,3136844,3.764945838611833
SK-UT-1,11427553,3.3051570066468248
SNU-175,JQ-1-vorinostat (2-1 mol-mol),-6.124804594441146
NCI-H2081,10184653,0.9038087955146576
HGC-27,selumetinib-UNC0638 (4-1 mol-mol),4.563933233367128
NCI-N87,9866186,-0.0362526715344146
KYSE-450,54143018,5.589609383601229
BT 239,71729975,0.2676872338583978
KMS-26,36462,-0.4512101792241657
SK-BR-3,2842253,6.131337775193048
HT-1197,54619267,3.830970726665477
TCCSUP,5479543,3.29896380845353
BT 428,24821094,3.1016694947845687
RCH-ACV,6918837,-4.995807557149807
HCC2108,44137675,4.225822582282624
A3/Kawakami,216345,2.0716906221336435
RCH-ACV,4705,2.8616908433941495
MSTO-211H,24771867,-1.256499005348058
SK-UT-1,crizotinib-PLX-4032 (2-1 mol-mol),2.7419345363185608
NCI-H2081,219104,2.665049667127658
EHEB,73707398,0.3528380726382398
YH-13,11625818,3.6537350019321897
KU-19-19,637858,2.3404288739792314
VMRC-LCD,16659841,2.1825009004436646
HOP-92,9823820,4.68005113362342
MFE-319,44202524,1.738361566217426
RPMI-8402,451668,-2.2929495506635216
L3.3,SNX-2112-bortezomib (250-1 mol-mol),1.42333058116923
JeKo-1,135398516,1.8861708233132837
HOP-92,53392493,1.6672481972864253
KYSE-450,9907093,5.309173304412392
TCCSUP,2749,2.6496774688336004
SW1116,24797083,1.0967394866263165
IGR-37,44632017,0.98440941846671
TCCSUP,selumetinib-tretinoin (2-1 mol-mol),7.288595889127544
KYSE-180,66577038,3.3144658202336945
NCI-H716,16038120,-1.892031577844466
KYSE-450,246676,4.496442396396831
NCI-N87,65628,4.009039012864223
NCI-N87,11175137,1.8903805503335804
SIG-M5,387447,-4.808050086142086
JeKo-1,ISOX-bortezomib (250-1 mol-mol),0.1979816504064232
NCI-N87,241158,3.56045646229574
RPMI-8402,675434,3.9441301869838807
P31/FUJ,5738263,2.6277017246063252
HDLM-2,51039095,2.211995501587615
KHM-1B,44137675,2.3063788474236957
SK-N-SH,123631,1.7275562881339488
MSTO-211H,44607530,1.4093785076150551
BT 228,60750,4.218705164646758
SK-MEL-3,24771867,3.8427008859182625
SNU-719,17759555,3.6003487461748453
BEN,doxorubicin-navitoclax (2-1 mol-mol),1.5666901077201256
YH-13,11507802,0.9123185813590028
YH-13,piperlongumine-MST-312 (1-1 mol-mol),1.341145556901202
EoL-1,24771867,-3.753621458977194
SK-UT-1,1242560,4.227021541575825
MG-63,46215462,1.7208694980746142
HDLM-2,46224516,2.4322093806826297
SK-N-SH,12001922,1.092658851526272
SK-N-SH,6610355,3.4423877522825017
P31/FUJ,navitoclax-gemcitabine (1-1 mol-mol),-2.2174176001996626
IGR-37,56963564,0.1768593183624416
IGR-37,11494412,1.023778204341386
HuH-28,3038522,3.661959558068783
L3.3,159324,3.32597872906173
TCCSUP,44259,0.3711906611875216
SUP-T1,3543504,2.334973881908084
KALS-1,12003241,-0.678278256964916
SCC-25,sirolimus-bortezomib (250-1 mol-mol),0.9940787042699578
RPMI-8402,54649381,2.4015230280117144
HARA [Human squamous cell lung carcinoma],25062766,2.285935640348263
L3.3,375860,0.2158630030269858
NCI-H2009,24785538,-2.0037312151285462
WM793,3825829,4.563508127916012
EoL-1,100016,3.3783759894754795
SNU-175,49793307,-2.300936015292743
HT-1197,675434,3.740405140149355
HGC-27,4788,3.778703887089077
KALS-1,400769,-0.1383028130917652
KYSE-450,11152667,0.9209824146572594
IGR-37,107985,-4.09870344472461
KMH-2,57519531,1.3356837866594973
PK-59,1716436,2.606347183959893
BT 239,12003241,-1.4894008844853184
SK-N-SH,JQ-1-MK-0752 (1-1 mol-mol),3.698426396074268
SK-UT-1,25227462,1.0186750982564137
TCCSUP,60700,-0.1040459377874521
BT 428,11178236,-5.187797814465357
WM793,3038522,3.898471306442064
PC-14,5738263,2.3868626596390903
RCH-ACV,5351362,0.8317039970937735
SK-MEL-3,6610216,4.385153925999174
HCC2108,crizotinib-PLX-4032 (2-1 mol-mol),1.5096161008299982
HGC-27,25183872,0.6809076514132804
BT 245,57330099,3.6959757169322094
L3.3,3025986,-0.2391966335119921
PC-14,9915743,-2.4249555987147615
P31/FUJ,15547703,2.950164329068843
HARA [Human squamous cell lung carcinoma],vorinostat-carboplatin (1-1 mol-mol),4.151404263307493
BT 232,2126,5.461860659381571
KHM-1B,9840324,5.635096396232016
KALS-1,navitoclax-MST-312 (1-1 mol-mol),1.2925919276039777
NCI-H1092,11427553,2.7182169046328837
SK-N-SH,2858523,3.145154141698922
AU565,11626560,1.628517095800036
EHEB,46943432,1.4009693182531664
RPMI-8402,11152667,-1.9551493741804535
HT-1197,126941,-3.8488798527955432
HARA [Human squamous cell lung carcinoma],6917907,-4.425737266076785
HCC2108,135411,0.8115668550852202
HARA [Human squamous cell lung carcinoma],6918736,-1.65788247009277
RCH-ACV,3543504,4.224407826850642
NCI-H716,1242560,3.2854048037814554
KYSE-450,126941,-4.1478729331459006
SNU-719,11485656,-1.1383067501667237
IGR-37,2126,5.5477546973124285
SK-N-SH,1750826,0.5967089798070715
HARA [Human squamous cell lung carcinoma],navitoclax-MST-312 (1-1 mol-mol),0.8639589641874816
SCC-25,57519531,3.4969432512017167
NCI-H2009,46191454,2.1369399253900347
Capan-1,25102847,3.186263795832946
NCI-H716,11238147,3.7483033713648086
SK-N-SH,5311281,0.9012377360040712
KHM-1B,26596,-2.1296194509234576
PC-14,1750826,-0.15538351601615
JeKo-1,71466578,4.343774195814426
EoL-1,1714884,-0.5301368602735893
RCH-ACV,24951314,-0.0754853736042561
PK-59,46224516,4.853840905200155
IGR-37,52912189,3.0880813436060737
KYSE-450,11626560,3.018886838641868
BT 239,9903786,2.77679173166366
SK-N-SH,53495165,-2.9750522847167944
MG-63,107970,2.132030955920877
KU-19-19,selumetinib-tretinoin (2-1 mol-mol),2.7257099010203047
MG-63,36314,1.0637927864859802
SUP-T1,168313200,3.8217155223423
KALS-1,15983966,-1.3515784951184973
KYSE-450,10385095,1.1558983027763154
Capan-1,2733526,4.318876166578228
KYSE-450,1750826,-1.5410905710283038
SCC-25,5280436,2.9951948316205117
SNU-175,24180125,-0.5173296686160461
SK-UT-1,6610216,4.443950873518219
BT 228,46199207,1.6152979345806688
P31/FUJ,6184667,2.9500590386465393
NCI-H716,3503,1.2314763948336878
WM793,44589607,3.080108180448729
BT 245,ISOX-bortezomib (250-1 mol-mol),0.3438224089520051
BT 232,53495165,2.714741210772743
TCCSUP,46224516,2.7201046077438793
AML-193,5566,2.5550757556477084
HOP-92,selumetinib-JQ-1 (4-1 mol-mol),1.8971159146724967
MG-63,24951314,1.7361304329190028
MFE-319,3854666,1.5302957515422178
BT 428,5311,0.1050590840820652
AML-193,tanespimycin-gemcitabine (1-1 mol-mol),-3.267052631151675
RCH-ACV,24821094,2.132202877280572
SCC-25,57330099,4.354854391682489
SIG-M5,10296883,3.681364440246351
HT-1197,52912189,2.719577939378215
SIG-M5,2729026,3.0719954327746164
SIG-M5,969516,2.6932764188301346
TCCSUP,49850262,3.4610282531940615
NCI-N87,selumetinib-MK-2206 (8-1 mol-mol),0.3550893984048577
YH-13,36462,2.0221735206643743
SK-UT-1,16013152,4.42318413525966
HCC2108,1750826,-2.504101992023161
NCI-H1092,11640390,3.833743684940511
EoL-1,sirolimus-bortezomib (250-1 mol-mol),-9.043460932568856
AU565,16065773,1.4318565791423328
RPMI-8402,54619267,3.227200484781902
IGR-37,2746,2.835708308282215
SCC-25,6918328,-2.840799932661106
JeKo-1,crizotinib-PLX-4032 (2-1 mol-mol),1.5439752945550445
TCCSUP,89183176,6.470181866122735
RPMI-8402,24978538,-0.6659526723316158
EoL-1,BRD-A02303741-carboplatin (1-1 mol-mol),2.481434197569937
MG-63,11222830,0.9081725168316672
EoL-1,erlotinib-PLX-4032 (2-1 mol-mol),0.9826457888886988
BT 428,9927531,4.812195201637174
HGC-27,56949517,4.310678422084889
NCI-H2081,439501,-4.570953887500971
HuH-28,241158,2.528595827749566
BT 239,969516,1.9867133689196268
NCI-N87,2828334,6.0279909292271165
HT-1197,4705,3.093520040309316
A3/Kawakami,11234052,2.2599861732413973
KYSE-180,12001922,1.7478221517465942
SK-MEL-3,10077130,4.759238822302159
KYSE-450,5328940,1.9152649667159072
Capan-1,9911463,4.415677524412553
SCC-25,9903786,1.6185741180598072
NCI-H2081,11612883,1.5585709489952069
HuH-28,10074640,3.002836479053407
BT 245,135421197,1.3239460835535384
EoL-1,11404337,-2.4489617476913432
A3/Kawakami,53495165,-2.2058065854557207
BT 245,49766530,0.0902413739193597
KHM-1B,9911463,3.1729521589558125
RKO,46199207,3.448070090368443
HuH-28,702558,5.873458298379352
HuH-28,11964036,1.1719878068136105
BT 228,44566777,-1.3340502834367478
NCI-N87,11626560,1.9254713694635637
KHM-1B,44607531,1.2480469496992657
EoL-1,UNC0638-navitoclax (1-1 mol-mol),-2.9986936858021616
HOP-92,11396600,3.514379135780385
VMRC-LCD,10184653,1.505089585469464
NCI-H1092,16722836,3.014278758354336
NCI-H716,10296883,2.894605704782392
KMH-2,24964624,2.0132989934839536
WM793,168313016,5.214677912138177
SK-N-SH,5329102,1.5390693421682526
SUP-T1,444795,1.0883115007500728
PC-14,3385,4.025433343560732
SIG-M5,11214940,1.544963032048038
HOP-92,46215462,1.98686044455128
HOP-92,54649381,4.061578826366214
KU-19-19,969516,2.8919422545546043
HGC-27,JQ-1-MK-0752 (1-1 mol-mol),1.4770851546322177
SCC-25,24180719,3.13778330208101
SW1116,9952709,3.0555178772435796
NCI-H716,409805,5.889888908173006
RCH-ACV,654092,-0.6191884154872385
MSTO-211H,10427712,4.183883954719584
HuH-28,selumetinib-GDC-0941 (4-1 mol-mol),1.7329089617670326
BT 239,11364421,0.163999014512071
P31/FUJ,71466445,3.0287439983851225
IGR-37,4578,5.015383969672807
EHEB,10074640,2.9654868346265024
JeKo-1,11396600,2.6042135230770325
KMS-26,5291,3.1247922683318863
BT 228,46224516,2.5351508923869512
KYSE-180,148198,-3.2204698770091653
KYSE-180,445455,4.928349979351992
HT-1197,54765302,3.010370712815299
BT 428,6918878,3.9952196892532896
RCM-1 [Human rectal adenocarcinoma],82146,3.3691200384154456
BEN,10302451,4.117279782065388
KMS-26,9927531,3.4485802259646703
MFE-319,2126,4.901457884008495
SK-N-SH,54618771,1.3194145394853296
KYSE-180,46398810,2.9758827771155003
SW1116,31703,0.9899689024056206
BT 245,16038120,0.491051079838287
JeKo-1,151289,0.3743876727186704
L3.3,6610355,5.020819543145525
AML-193,1242560,3.178566676799782
P31/FUJ,11626560,0.2148563033664798
HGC-27,5479543,1.685871366357501
SK-BR-3,969516,2.0909398638883694
SNU-175,675434,3.677594840031136
BT 428,52947716,0.8492719052726573
SNU-175,24772860,-3.38201311177162
HCC2108,carboplatin-etoposide (40-17 mol-mol),4.105964444699461
HT-1197,2708,4.735159242056589
SNU-719,25183872,1.282094511571242
RKO,2749,1.3580925102381314
RCC10RGB,5282054,3.6705963985990993
KHM-1B,9825149,-1.748191139364394
Capan-1,16720766,1.0483138495065485
SW1116,10322450,3.761194873514236
HDLM-2,3543504,4.239556443592014
MG-63,7251185,1.924755496905263
VMRC-LCD,168313016,5.458908786396005
HOP-92,1716436,3.125653316338052
KALS-1,11152667,-0.748944464329897
AU565,387447,-4.131425766006191
BT 232,11404337,-0.4479930144977115
HARA [Human squamous cell lung carcinoma],10302451,4.803964333247322
SCC-25,12003241,-2.271238083973026
RPMI-8402,BRD-A02303741-navitoclax (2-1 mol-mol),1.203810739041688
SCC-25,9866186,1.68822534907718
SCC-25,54678924,2.160263767066307
HGC-27,45100481,5.487606729804892
SK-UT-1,24785538,2.9370151695629985
VMRC-LCD,2729026,2.93502463443281
A3/Kawakami,46191454,0.2872125904630605
KYSE-450,135875424,4.8684130020868235
SNU-719,navitoclax-pluripotin (1-1 mol-mol),-0.0702975361596815
JeKo-1,54618164,3.7993181207921127
TCCSUP,11609586,3.3577179942858737
A3/Kawakami,374536,1.8044111522001824
SCC-25,vorinostat-carboplatin (1-1 mol-mol),1.9172913805267409
TCCSUP,selumetinib-vorinostat (8-1 mol-mol),2.3847964981208305
KYSE-180,24772860,-1.944704874720706
KMH-2,9935249,3.3935783727628426
A3/Kawakami,2113511,5.095793233340432
MFE-319,26596,-1.024111788947852
HuH-28,65064,3.1056946554956557
A3/Kawakami,11719255,2.995151252000103
BT 232,44589607,3.1052580385067663
BT 228,10322450,4.52310265932876
BEN,46398810,3.1867355146755902
BT 232,24180125,3.864278163608165
BT 239,5470400,-1.515836575672715
HDLM-2,3062316,1.8493196967127783
BT 232,erlotinib-PLX-4032 (2-1 mol-mol),3.206042069685594
NCI-H647,44486219,4.610211551905298
KALS-1,126941,-2.189174222114028
HOP-92,3136844,4.430942650818718
HDLM-2,docetaxel-tanespimycin (2-1 mol-mol),-5.041384906796401
KALS-1,73707398,0.9491392932530416
L3.3,216345,4.451682719982746
A3/Kawakami,89183176,2.4554351004174495
NCI-H1092,3062316,3.749220976786342
RKO,16722836,2.0172870973895085
IGR-37,5287620,-2.7213577373800413
TCCSUP,16736978,1.6866417014298338
EoL-1,72193861,-1.0409405159377023
AU565,5494449,3.8187307918252262
KALS-1,9936388,2.309164316423604
PC-14,452548,-0.0582862590511638
HuH-28,24901704,3.0555402593510435
JeKo-1,10127622,5.712610474608164
SK-N-SH,5566,2.753836710558925
RCC10RGB,136227924,3.611686331312014
SK-N-SH,11175137,1.5085580630644129
NCI-H716,5287969,-2.4318074879673
KYSE-450,107985,-2.5991622295290413
JeKo-1,doxorubicin-navitoclax (2-1 mol-mol),-0.8722972859046373
HuH-28,12001922,1.6625633047238413
SCC-25,44493528,4.171746510853467
EoL-1,9952709,-1.848543464245512
HCC2108,11625818,5.912984069907385
L3.3,selumetinib-JQ-1 (4-1 mol-mol),7.047753882053292
BT 239,5329102,2.01799390668225
PK-59,piperlongumine-MST-312 (1-1 mol-mol),2.100017437550193
EoL-1,53301938,1.7958746853776055
KMS-26,24785538,-4.535894035969364
NCI-H647,5311,1.9176093851436644
BEN,24785538,3.847236473475121
SUP-T1,5113032,4.762737516184988
KU-19-19,262093,2.7281718696395303
NCI-H2009,107970,2.2954238398166344
JeKo-1,327653,2.5433327541113333
Capan-1,66577038,2.7067551375053194
NCI-H716,9967941,4.637929090594087
AML-193,5280436,2.872904926313804
KMH-2,56946209,-4.458352530363758
SK-UT-1,60700,0.6162687225827331
HT-1197,11234052,3.845634357532313
RPMI-8402,16720766,-2.1653296483840156
SK-MEL-3,11234052,5.100015299734299
MSTO-211H,374536,3.2477584475462904
BT 228,9933475,1.2972153022291073
EHEB,9915743,0.5785876427148751
SK-UT-1,9866186,0.9156760057280894
L3.3,11238147,4.461700161811432
SK-UT-1,24180125,3.450035886510637
Capan-1,4096211,2.90533463412958
MSTO-211H,BRD-A02303741-navitoclax (2-1 mol-mol),0.3230364092955163
RCC10RGB,409805,6.020159348453613
SW1116,19582717,5.17151511541441
MG-63,16725315,5.2363237499005235
RPMI-8402,16722836,0.5499130845996831
Capan-1,44566777,3.765334304819449
SUP-T1,9887053,3.808477169767825
AML-193,6438330,0.754077267776276
BEN,5329102,2.368488899099106
SIG-M5,3025944,3.95294971944253
BT 245,25105715,3.758279367316379
NCI-H2009,25126798,3.423512143516965
PC-14,44185566,3.23113420718539
RKO,227681,3.9032876810461814
HuH-28,123631,2.2644586082118905
NCI-H716,23635314,-2.526793322615456
JeKo-1,10427712,3.6152831909050662
BT 228,5311,3.7822552700574774
KHM-1B,327653,2.4267430839124455
HARA [Human squamous cell lung carcinoma],3081361,3.3764732224556533
SK-N-SH,selumetinib-JQ-1 (4-1 mol-mol),2.2586391294611974
SK-N-SH,16065773,1.7750875062951856
HGC-27,219104,2.229303596776572
HuH-28,3062316,-2.0199498376824874
SNU-175,12003241,-1.252002444372071
HCC2108,42642645,0.687631636914302
PK-59,104842,-1.311368852734091
AML-193,71729975,1.760380788116278
BT 428,doxorubicin-navitoclax (2-1 mol-mol),-2.0978990539886597
PC-14,123631,-5.454121984956304
EoL-1,57330099,3.481123307578786
KMH-2,216468,1.6482750667767774
NCI-H2081,208908,1.5488690353253576
HuH-28,11178236,-1.156819325427655
TCCSUP,5335621,5.467256858897498
JeKo-1,24951314,0.6257465728706688
SIG-M5,168313016,4.915391806280637
NCI-H716,176870,3.4552895584045458
SK-N-SH,60750,-4.125781194317487
P31/FUJ,decitabine-navitoclax (2-1 mol-mol),-1.2834649241305407
SK-BR-3,6917907,-6.271731924013965
IGR-37,2729026,2.763080318961624
MFE-319,11167602,3.3061519307992944
HuH-28,124202324,1.7729081186139335
HOP-92,navitoclax-pluripotin (1-1 mol-mol),-1.8710317317019285
KU-19-19,409805,5.730069773001202
RCH-ACV,tretinoin-carboplatin (2-1 mol-mol),3.1853466785408404
A3/Kawakami,4788,5.210125755828317
PC-14,54618305,4.281679623383799
BT 232,5566,2.572758125267395
SK-MEL-3,5278396,3.809258125484314
KMS-26,11178236,-5.256028874961328
KYSE-180,tanespimycin-bortezomib (250-1 mol-mol),-0.8459544412135208
JeKo-1,11609586,2.3742337816264505
AU565,2949965,1.8156290557963255
HGC-27,5978,-4.5123764417077465
MSTO-211H,selumetinib-GDC-0941 (4-1 mol-mol),1.2827616524915244
KHM-1B,10427712,2.4564060072092486
NCI-N87,156414,-4.435299577962505
P31/FUJ,24978538,-1.1674360999825653
AML-193,445643,3.4797651697477243
SNU-175,6505803,-3.2820452967658778
SUP-T1,36462,-0.1805467194258707
MFE-319,36462,2.8535196136146626
SIG-M5,3825829,3.9959318617447823
AU565,9911830,3.457946854316075
A3/Kawakami,selumetinib-GDC-0941 (4-1 mol-mol),2.6174879982933317
SK-UT-1,135440466,3.5602856179357327
BT 232,11707110,0.691036541254005
IGR-37,421610,2.4144418128081067
RCH-ACV,25022340,-3.2109098386216957
HuH-28,selumetinib-tretinoin (2-1 mol-mol),4.880227188759738
BT 239,15547703,3.007108037386688
YH-13,65064,5.536237996349119
SCC-25,241158,3.0649196018080653
NCI-H1092,decitabine-navitoclax (2-1 mol-mol),4.733361910852782
KU-19-19,44241473,5.030815161961597
NCI-H1092,11404337,-0.107357005094737
NCI-H2081,25262965,-3.276528067385419
PC-14,42642645,-0.2758248149200779
SK-MEL-3,46191454,3.3072022256848697
BEN,25183872,3.429963659011639
BT 245,23635314,-1.7980588401926882
HARA [Human squamous cell lung carcinoma],135875424,5.177992671051203
IGR-37,10113978,3.470850132593586
HGC-27,tanespimycin-bortezomib (250-1 mol-mol),-1.4262734798711498
KALS-1,3136844,4.737550704479588
Capan-1,5351362,1.480191228093905
YH-13,selumetinib-JQ-1 (4-1 mol-mol),2.881387318518872
NCI-H1092,10074640,3.1933502668870464
YH-13,72734382,5.819140658588148
VMRC-LCD,52912189,1.6124904127490771
SIG-M5,navitoclax-PLX-4032 (1-1 mol-mol),-1.8353221511026792
RKO,375860,-0.2095842697906711
A3/Kawakami,44607530,1.7612674700472004
SUP-T1,46224516,1.0842657900591472
HGC-27,9884685,-2.183204546291056
A3/Kawakami,1566236,1.0129797315712863
SW1116,4705,0.6661703449380979
KYSE-180,5113032,5.165592461043619
IGR-37,56649450,5.506939018133372
BT 239,JQ-1-vorinostat (2-1 mol-mol),1.1998102990003867
YH-13,SNX-2112-bortezomib (250-1 mol-mol),-1.3355072923544795
NCI-H647,100016,4.3873613110575045
MG-63,selumetinib-BRD-A02303741 (4-1 mol-mol),5.957190095047904
EHEB,4917,2.7157925783041073
NCI-N87,208908,-2.7799590207113014
KMH-2,168312962,1.8657992133114711
YH-13,23635314,-3.92693267445326
RCH-ACV,12001922,2.443580413607848
SK-UT-1,6914657,-5.220536780204265
NCI-H1092,carboplatin-etoposide (40-17 mol-mol),2.1846305146298852
TCCSUP,11455910,2.681471740921846
KALS-1,3825829,4.265035068794827
RKO,10302451,3.926970734642152
KYSE-180,carboplatin-UNC0638 (2-1 mol-mol),4.06711505487647
RCH-ACV,445091,3.843867205159077
BT 245,vorinostat-carboplatin (1-1 mol-mol),2.699793967141184
KMH-2,sirolimus-bortezomib (250-1 mol-mol),-3.0653636595991203
HOP-92,11657048,3.8871193816037017
SUP-T1,9444,3.716537659253536
AU565,11977753,-1.5018138963846497
SUP-T1,400769,-1.416770744697815
JeKo-1,10302451,3.7878208830718862
MFE-319,44462760,4.522471816798023
NCI-H2081,89928392,0.9325631325341028
IGR-37,151289,0.9445598463800874
KMS-26,60700,-2.2365134717151043
KYSE-180,24785538,2.7061039911851723
HGC-27,vorinostat-carboplatin (1-1 mol-mol),2.3081316424352747
YH-13,5311281,1.1254096591203009
RCM-1 [Human rectal adenocarcinoma],89928392,1.6489632684947326
SK-BR-3,31703,-1.415556901270963
HGC-27,54678924,1.4189103849418931
HGC-27,3025986,-2.164949294013532
A3/Kawakami,24785538,1.2586001677749867
RCH-ACV,49850262,1.8723986787742797
MSTO-211H,15547703,3.049193057044517
SCC-25,11640390,3.3568304460765757
KALS-1,tanespimycin-bortezomib (250-1 mol-mol),0.1032603454372563
HDLM-2,3081361,2.5545842689906544
SK-UT-1,5113032,5.060629024627444
AML-193,1285940,2.1314364516367665
RCH-ACV,9825149,2.1938606628141155
NCI-H1092,11626560,1.887558219337559
EoL-1,44566777,-0.6366066148638891
BT 428,156414,0.1234393926344954
PC-14,5329102,2.2211830308707925
RPMI-8402,136227924,2.2526718879349694
HOP-92,984333,1.7757369097301727
RCM-1 [Human rectal adenocarcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1580465121550203
WM793,17759555,4.44870242372694
SIG-M5,3081361,2.9682515480591443
KMS-26,119607,4.018406791191676
PC-14,53481919,3.604196886603432
HARA [Human squamous cell lung carcinoma],24772860,-1.3203429479269333
IGR-37,BRD-A02303741-carboplatin (1-1 mol-mol),6.220713812531444
WM793,5566,3.1211189784720923
JeKo-1,44491742,3.7422814982420056
AML-193,31703,-2.845714238323963
MFE-319,salermide-PLX-4032 (12-1 mol-mol),5.648402985210755
NCI-H2009,6610216,3.953101400309774
RKO,selumetinib-GDC-0941 (4-1 mol-mol),1.3988498652301435
RCM-1 [Human rectal adenocarcinoma],44607531,1.8642852142992712
HOP-92,54626689,3.9009772387198702
RPMI-8402,654092,0.4039840016168103
AML-193,doxorubicin-navitoclax (2-1 mol-mol),-2.4862630641854513
AU565,60700,-0.684074891390158
RCC10RGB,71466445,4.397911896340776
SNU-175,selumetinib-JQ-1 (4-1 mol-mol),-0.1305665077886403
KHM-1B,44486219,3.979705310962138
NCI-H647,135440466,1.5817650788104878
BT 239,11178236,-5.776957750941361
KMS-26,322968,1.851056399637936
RCC10RGB,72199289,4.762339751475906
BT 239,568763,0.2037804472767022
HDLM-2,9887053,5.158038800358598
MG-63,24771867,1.908460951729608
HuH-28,36462,5.296756264251177
EHEB,JQ-1-carboplatin (1-1 mol-mol),0.4941102336804299
EHEB,31703,-2.7035431722217744
AU565,10296883,3.47614106437246
EoL-1,969516,1.2342872342433735
HARA [Human squamous cell lung carcinoma],44819697,3.9048868362328264
MG-63,6917907,3.184862600094584
VMRC-LCD,doxorubicin-navitoclax (2-1 mol-mol),-0.2895821135055071
RCC10RGB,3634881,4.1231622503065495
P31/FUJ,107985,-4.114404549725097
HARA [Human squamous cell lung carcinoma],11609586,3.326388879496588
HARA [Human squamous cell lung carcinoma],16725315,4.551171651287005
KHM-1B,11214940,1.6917073338671202
SK-N-SH,637858,0.7787528931707683
SUP-T1,107970,1.556646477102781
SNU-719,46943432,1.63856313223
SIG-M5,11238147,1.5650307709099935
BT 239,54143018,0.3666039895679077
Capan-1,148198,-2.3520537722391075
BT 228,135421197,1.0231801193279042
PC-14,675434,4.614829643257481
HOP-92,navitoclax-gemcitabine (1-1 mol-mol),-1.6137148957894063
NCI-H716,navitoclax-piperlongumine (1-1 mol-mol),2.0253316762697917
AML-193,6918878,0.7016492064404843
NCI-N87,11213558,1.0018400483751706
NCI-H2009,erlotinib-PLX-4032 (2-1 mol-mol),3.949302222933775
IGR-37,53481919,3.911835982990022
SK-BR-3,73707398,0.4064106830128078
KALS-1,44185566,3.1354122236137125
SNU-719,3025986,-2.12619815771166
KMH-2,168313047,1.8405045282737191
KALS-1,6918328,1.221963570086389
BT 245,10302451,3.8870647023268448
NCI-H716,219104,4.657897835899996
RCH-ACV,4788,4.825773646039427
WM793,56946209,-4.12818494071316
VMRC-LCD,navitoclax-gemcitabine (1-1 mol-mol),2.103233024042817
SK-N-SH,676352,1.6221352444120412
KMS-26,135875424,3.4699512465530713
IGR-37,5291,3.752313122377395
NCI-H2081,6252,0.369666564038939
NCI-H647,6852167,1.3113478854499263
BT 228,3136844,3.8510652049111327
HOP-92,11707110,-2.300746115795429
HARA [Human squamous cell lung carcinoma],46398810,2.9743064800682912
BEN,16725315,5.811841741409827
BT 239,67156097,0.4610372502908328
HOP-92,9884685,-0.9123746680711942
Capan-1,42611257,4.727080573973262
NCI-H2081,16720766,0.6801529058840203
L3.3,11625818,4.38532777510286
KYSE-180,57519531,3.399978539206015
BT 239,241158,3.9563335392907097
A3/Kawakami,16722836,0.7873276381291899
BT 428,9967941,4.804492876249159
KYSE-180,3689413,3.064535959483158
AML-193,71466380,4.423326867795695
HARA [Human squamous cell lung carcinoma],16115403,-4.2638303939611335
TCCSUP,tretinoin-navitoclax (4-1 mol-mol),3.293954548754522
NCI-H2081,54143018,0.6248059952712489
KYSE-450,selumetinib-MK-2206 (8-1 mol-mol),3.9509923248068928
TCCSUP,65064,5.167716602731698
SUP-T1,60750,-6.719591275354955
KMH-2,3062316,2.1798230916808055
AML-193,carboplatin-UNC0638 (2-1 mol-mol),3.1424243662515075
VMRC-LCD,serdemetan-SCH-529074 (1-1 mol-mol),1.7540063251093
BT 245,11364421,-5.459811904764016
SK-MEL-3,10184653,2.851228829645962
RCH-ACV,11152667,-4.538548761334481
RCH-ACV,16065773,1.5307169545207922
SK-UT-1,23725625,5.077881708764169
PK-59,55508,6.204825346541673
NCI-H647,15953870,3.2923326421266235
L3.3,JQ-1-vorinostat (2-1 mol-mol),2.1502729900256807
SUP-T1,9936388,-4.413014724970872
TCCSUP,156422,3.9310929272005466
KALS-1,54626689,4.8560707555478455
EoL-1,9803433,4.163662763604796
HDLM-2,2858523,2.6152534340306643
RPMI-8402,446155,2.0699111104046524
MSTO-211H,54143018,-0.309857947329572
HDLM-2,6852167,1.8499669564369137
JeKo-1,375860,-0.4106112996091592
MFE-319,262093,3.9047520178061856
RKO,selumetinib-MK-2206 (8-1 mol-mol),2.0156387563640337
AU565,1239801,6.39587237663574
MSTO-211H,navitoclax-MST-312 (1-1 mol-mol),-0.7166631771213113
EoL-1,702558,2.7343791150027723
AML-193,25161177,2.6468606137819046
SUP-T1,168312962,-0.8819526147331627
RCM-1 [Human rectal adenocarcinoma],11427553,3.480492721904053
SK-MEL-3,216468,4.011248364900872
KALS-1,11167602,3.631671875961461
SNU-175,73707398,0.569469638672086
KYSE-180,252682,7.9563998050087745
PC-14,11427553,1.8046600537431947
RCC10RGB,68056272,3.770230744947895
SW1116,2733526,2.8851174395534813
VMRC-LCD,409805,5.2545104964155485
VMRC-LCD,11178236,-3.5101325591346817
BT 428,208908,2.06929748575706
NCI-H647,5281321,-2.662284147366212
MG-63,462382,0.4333208627902833
A3/Kawakami,15953870,3.5307965463933315
AML-193,72199292,1.621467407062966
EoL-1,24951314,-1.2442515001565393
BT 239,66577038,3.050612156123004
HDLM-2,ISOX-bortezomib (250-1 mol-mol),-0.0463179309298685
PC-14,54618771,1.2873092129984136
PC-14,72734382,4.364446921513513
NCI-H647,24771867,2.439298815176434
MFE-319,6918328,0.5467330710628938
NCI-H716,57330099,4.394194836184818
Capan-1,11455910,2.2189515930780312
SNU-175,25102847,0.936265869081484
KHM-1B,3815108,2.9895861179131704
JeKo-1,44566777,-1.2393427545983822
IGR-37,24779724,4.966607724183206
KMH-2,11507802,-0.0005253325323591
A3/Kawakami,25227462,-4.74329961388126
BT 245,2733526,2.6638967927808
MG-63,11396600,3.547749871707555
SNU-719,3038522,4.447144973531184
SK-MEL-3,tanespimycin-gemcitabine (1-1 mol-mol),5.358896223035843
TCCSUP,doxorubicin-navitoclax (2-1 mol-mol),-1.0692959342225303
HGC-27,salermide-PLX-4032 (12-1 mol-mol),2.940408718975506
A3/Kawakami,45279963,3.0022347666125007
Capan-1,448949,2.6757472347156273
BT 228,439501,-2.264868941994625
BT 245,73707438,1.8182629031547448
WM793,119607,5.577999044145194
SIG-M5,9903786,1.9849552317824917
PC-14,11640390,3.3680946545298096
KU-19-19,11485656,2.7576201496249264
AML-193,44484893,-1.63744173074126
KMS-26,51037431,2.261828571273169
PC-14,151289,1.4486982071000016
RPMI-8402,11609586,1.8452124246874744
SUP-T1,46398810,1.6240640687564845
YH-13,1242560,3.390662173618847
VMRC-LCD,11964036,2.1682893504203573
KMH-2,23635314,-3.793708760952174
HT-1197,49793307,-5.1737839593887776
BT 239,11625818,3.6013680268723074
PK-59,23582824,0.9321651251989737
AML-193,156414,0.8692506520261336
SCC-25,6918837,-3.881192102267314
WM793,24180719,3.9443550279133186
SK-BR-3,44137675,1.2217485868546172
EHEB,JQ-1-navitoclax (2-1 mol-mol),-0.4814265909259828
SIG-M5,439501,-3.273907668571148
PK-59,613753,3.2991610676424683
NCI-H2009,11364421,-4.013811791110126
MFE-319,4578,5.550579365161006
AU565,9967941,3.769081839228565
SNU-719,46224516,2.210102191334428
MG-63,3689413,-2.4336894587390323
SK-UT-1,3062316,3.08976408403466
NCI-H716,322968,4.685697059636517
BT 239,46199207,1.5986285586386515
RCH-ACV,selumetinib-BRD-A02303741 (4-1 mol-mol),3.748980634786139
NCI-H1092,15547703,3.51736308964877
SK-MEL-3,2858523,3.121479964404761
EoL-1,262093,0.636688142118246
KYSE-180,2113511,7.401895265754639
EHEB,tanespimycin-gemcitabine (1-1 mol-mol),-4.432752806947547
EoL-1,5470400,1.523898374457353
NCI-H2081,67291369,3.286816150820097
IGR-37,JQ-1-vorinostat (2-1 mol-mol),1.6720987257597657
TCCSUP,44241473,5.1111150240253975
SK-BR-3,44486219,5.186954424022404
HuH-28,10302451,3.3389802568514257
SCC-25,5284616,1.206325134480087
SK-MEL-3,piperlongumine-MST-312 (1-1 mol-mol),2.164122261311365
HuH-28,piperlongumine-MST-312 (1-1 mol-mol),3.272099467386602
AML-193,2749,0.4019302718485013
WM793,9840324,5.828227085394811
WM793,25183872,-1.026450709028654
BT 239,36462,-0.612323435298888
HDLM-2,9907093,3.972292747970419
BT 228,6852167,4.103615495734906
NCI-H647,24856436,0.4224455124084718
Capan-1,9887053,5.359399529574409
HGC-27,15953870,2.2715241692137007
RPMI-8402,119607,3.8158836667089937
JeKo-1,44632017,0.6641983776580194
SK-BR-3,246676,6.129452787407131
VMRC-LCD,66577038,3.2744936176108776
SW1116,12003241,0.0582707461824652
SCC-25,31703,-1.8495096246661873
IGR-37,439501,-2.841973609481132
MFE-319,11656518,2.920899563605482
PK-59,3503,2.783654869313988
A3/Kawakami,8515,2.8179142633064416
SK-UT-1,322968,4.5187212828437815
SUP-T1,54639665,5.160624619206478
KMS-26,6918837,-7.7614774329727965
EHEB,6184667,4.2340057403581115
Capan-1,decitabine-navitoclax (2-1 mol-mol),1.9858177618631832
HOP-92,568763,0.919066803961904
SK-MEL-3,54619267,3.923726102455585
RCH-ACV,navitoclax-gemcitabine (1-1 mol-mol),-0.9875781524949212
MFE-319,44607531,2.4511124265587054
RPMI-8402,46224516,0.9238390642245782
HuH-28,54613361,3.5079977832934266
AU565,262093,2.3992948308197093
SIG-M5,2746,2.071797250841479
HGC-27,25062766,1.0250494123064562
RPMI-8402,11234052,2.2353833302356714
P31/FUJ,654092,-2.277731190350674
NCI-H716,135398738,4.926720371578042
MFE-319,107970,2.9739758734328774
EHEB,72376,-2.605248149465708
BT 245,3825829,4.258245820597346
NCI-H647,9840324,5.222960105037154
KALS-1,644241,2.759278664699006
NCI-H1092,erlotinib-PLX-4032 (2-1 mol-mol),3.728956989705323
MG-63,24797083,1.5172585079109746
MSTO-211H,56946209,-4.75779739938848
PK-59,16038120,0.424356092272954
BT 428,25183872,-1.6758373608436137
EHEB,3634881,2.279328443256432
AML-193,49846579,1.2325552010488818
KMH-2,JQ-1-MK-0752 (1-1 mol-mol),0.9361910549949944
SIG-M5,82146,-1.1820211449035531
YH-13,119607,5.844423836114236
NCI-N87,crizotinib-PLX-4032 (2-1 mol-mol),2.5035050425609673
SK-N-SH,49793307,-3.646041380028573
VMRC-LCD,31703,0.1606176794864109
KHM-1B,72193861,0.3865062028609871
SNU-719,navitoclax-gemcitabine (1-1 mol-mol),-1.012867628981298
JeKo-1,9907093,4.029319400065939
KALS-1,vorinostat-carboplatin (1-1 mol-mol),3.9307564444041745
HARA [Human squamous cell lung carcinoma],2130404,2.6459509712703246
RCH-ACV,73707398,0.2793180424503238
KMH-2,25195348,3.2079117056805755
NCI-H647,tanespimycin-gemcitabine (1-1 mol-mol),-2.7126248261535664
SK-N-SH,51037431,4.984605778470548
Capan-1,42642645,1.1819071124577496
SK-N-SH,5287620,-3.46968538095915
BT 232,11222830,1.4391281933366096
NCI-H2081,11626560,1.2362543076571495
SCC-25,17755052,-0.8425909280116741
KU-19-19,17755052,6.06318579738538
A3/Kawakami,151289,0.7664829074224649
SK-UT-1,285033,-2.26051652032599
HuH-28,56946209,-3.335154553360183
HuH-28,navitoclax-PLX-4032 (1-1 mol-mol),-0.0756423555171375
NCI-H2009,2828334,6.796615650463657
NCI-H647,46215462,1.7372007912084342
MFE-319,25195348,4.442818376223946
JeKo-1,52912189,1.421884439815816
EHEB,46224516,2.156286002861633
YH-13,crizotinib-PLX-4032 (2-1 mol-mol),1.6930776874276643
AML-193,4378219,1.2402464882131368
WM793,3025944,4.634648353889454
HARA [Human squamous cell lung carcinoma],123631,2.9564926917309635
BT 228,9825149,2.0643081838863804
KMS-26,66577038,2.713726912042384
SIG-M5,2874250,4.549085602827419
EoL-1,4917,1.3349137668550943
HGC-27,3384730,2.4272145270986187
BT 232,42642645,1.569258938157716
IGR-37,24821094,3.8129441292651567
KU-19-19,53232,3.650570649303299
HGC-27,BRD9876-MK-1775 (4-1 mol-mol),0.3479804460187037
NCI-H716,11507802,0.973792967378281
SIG-M5,216468,3.29794994806152
HARA [Human squamous cell lung carcinoma],11404337,-1.2743672881567891
HCC2108,5278396,3.8392308280377425
EHEB,25183872,-1.17879257651429
NCI-N87,3634881,3.127468365851455
HuH-28,6610216,3.8460491643808727
BT 428,navitoclax-birinapant (1-1 mol-mol),-0.1607704019821585
AML-193,135984461,4.549999355322756
RPMI-8402,42642645,-1.09919815686106
NCI-N87,262093,3.0008468279122607
RCC10RGB,5113032,2.807854627845623
MSTO-211H,10385095,1.0224754227931234
HT-1197,57330099,5.27062503846507
NCI-N87,selumetinib-UNC0638 (4-1 mol-mol),3.172064031081815
NCI-H716,JQ-1-vorinostat (2-1 mol-mol),0.3749386424144045
NCI-H2009,3543504,4.270240870629309
TCCSUP,11485656,2.4858219651419966
KALS-1,navitoclax-piperlongumine (1-1 mol-mol),2.5126995384896436
KALS-1,erlotinib-PLX-4032 (2-1 mol-mol),4.739305030469412
IGR-37,6918328,-0.1145030138880141
L3.3,9444,4.344069420298931
NCI-H647,6610355,4.538409801965896
MSTO-211H,15983966,-3.5322347663594016
BT 228,10385095,1.1315778331384152
VMRC-LCD,374536,-2.6397150595741925
P31/FUJ,doxorubicin-navitoclax (2-1 mol-mol),-2.963925883799113
KHM-1B,1716436,3.4645640712789545
KMS-26,24771867,-3.579078717742708
BT 245,9936388,0.9041726045525886
MFE-319,selumetinib-vorinostat (8-1 mol-mol),2.3643464051369483
YH-13,135984461,4.0881390777757245
SK-MEL-3,31703,0.3591978090840684
A3/Kawakami,31703,-3.984375757716084
SK-UT-1,11719255,5.479588049288889
RKO,72193861,0.7735395045157347
PC-14,44607530,-2.8516012431883366
L3.3,3825829,3.356100526361819
AU565,44566777,1.2994228207825576
RCH-ACV,3825829,3.3036400241390287
RCC10RGB,9444,4.509247284467684
MG-63,serdemetan-SCH-529074 (1-1 mol-mol),2.404157325037557
WM793,11404337,-0.7690985454206903
P31/FUJ,navitoclax-birinapant (1-1 mol-mol),-0.4716815446348188
SK-N-SH,444795,4.912607426917253
BT 228,11625818,5.898691316213348
MSTO-211H,11152667,-3.5300772231011703
RKO,3025944,4.391654014934833
L3.3,crizotinib-PLX-4032 (2-1 mol-mol),2.765628359334359
MFE-319,6184667,3.068987423352979
MG-63,46943432,5.483589733735585
NCI-N87,9936388,-5.070095106907016
NCI-H2081,262093,2.026605801788383
SIG-M5,JQ-1-navitoclax (2-1 mol-mol),-1.4667618241552018
YH-13,alisertib-navitoclax (2-1 mol-mol),-1.4191269033717964
HT-1197,11955716,1.5189569216078018
L3.3,44589607,3.517286764473911
NCI-H716,5351362,2.095032753689366
KMS-26,60750,-4.688759707611789
HGC-27,5566,2.5082466714500296
MSTO-211H,168312962,-1.9489367550084584
BEN,6918837,-2.1077550209062963
P31/FUJ,6438330,0.60015264799364
RCH-ACV,5743,-3.5832536323624486
YH-13,73707398,1.2587835012572517
IGR-37,6184667,3.169525996725723
BT 428,navitoclax-sorafenib (1-1 mol-mol),-0.0980408532530621
JeKo-1,24753719,3.5760839503149873
HOP-92,219104,3.689467417474404
SK-MEL-3,11656518,1.7597165355268345
RCC10RGB,54626689,5.11978438920743
